data_2mzr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mzr _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.0 t . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 121.208 0.528 . . . . 0.0 112.047 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 9.9 pt -146.41 150.64 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 126.676 1.99 . . . . 0.0 109.806 -171.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -126.19 149.61 48.9 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.443 1.897 . . . . 0.0 109.709 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.03 118.76 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.907 0.883 . . . . 0.0 110.101 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.44 -3.21 37.96 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 116.967 1.547 . . . . 0.0 116.967 -160.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -142.77 22.61 1.95 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.102 1.451 . . . . 0.0 113.795 -170.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.6 pp -77.53 178.78 6.97 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.757 1.223 . . . . 0.0 111.832 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.3 t -73.56 133.87 43.64 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.77 0.828 . . . . 0.0 111.536 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -66.88 -8.9 32.45 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -87.63 -4.44 58.94 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.473 1.509 . . . . 0.0 113.622 170.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 7.7 t -69.12 139.76 54.73 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 121.064 -1.023 . . . . 0.0 112.509 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 27.4 p -102.6 162.19 20.95 Favored Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 125.589 1.556 . . . . 0.0 109.985 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -58.69 -32.27 96.55 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.139 1.892 . . . . 0.0 112.025 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.76 -38.65 91.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.092 0.957 . . . . 0.0 112.231 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.24 -44.01 97.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.782 0.719 . . . . 0.0 111.443 176.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 36.4 mt -70.45 -29.58 66.19 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.232 -0.89 . . . . 0.0 112.955 173.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 96.4 m -70.0 -51.24 33.95 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.24 0.927 . . . . 0.0 110.678 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -65.9 -24.32 66.82 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.868 0.758 . . . . 0.0 112.676 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -73.55 -66.21 0.72 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.046 1.738 . . . . 0.0 111.594 173.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -69.86 -33.97 72.97 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.8 t -73.45 -3.97 30.75 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -172.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -64.54 -18.49 64.89 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.117 -0.989 . . . . 0.0 112.831 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 30.1 mm -77.98 -23.5 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.856 1.263 . . . . 0.0 112.455 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 169.67 -90.16 0.09 OUTLIER Glycine 0 N--CA 1.468 0.802 0 C-N-CA 124.357 0.979 . . . . 0.0 112.437 -171.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -155.76 110.35 2.89 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.105 0.962 . . . . 0.0 112.845 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 37.4 t -73.66 132.0 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 157.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.37 -29.52 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 171.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -153.35 135.8 15.07 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.192 1.397 . . . . 0.0 110.056 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -115.92 159.58 21.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.595 1.158 . . . . 0.0 110.404 157.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -153.2 129.95 10.86 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.633 1.173 . . . . 0.0 112.081 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 6.0 mt . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 124.664 1.186 . . . . 0.0 111.855 177.812 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 28.3 ptm . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -158.19 -172.0 24.79 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.747 1.165 . . . . 0.0 114.814 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 20.6 m -137.19 150.81 48.16 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.523 1.929 . . . . 0.0 110.254 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.7 t -141.44 142.99 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.881 1.272 . . . . 0.0 110.514 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -126.11 130.67 51.54 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 126.974 2.11 . . . . 0.0 110.782 -176.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -108.87 168.04 9.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.502 1.921 . . . . 0.0 110.952 -177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 49.1 p -81.4 0.06 39.16 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 167.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -127.99 154.56 45.47 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.865 1.666 . . . . 0.0 111.797 -167.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.5 p -114.39 -1.34 13.53 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.729 1.612 . . . . 0.0 113.685 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -130.05 -46.2 1.13 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.983 1.313 . . . . 0.0 112.714 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -65.88 -20.75 66.34 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.082 -1.011 . . . . 0.0 112.925 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.6 p -63.74 -33.29 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.24 1.816 . . . . 0.0 112.547 170.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -77.58 -36.76 51.67 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.66 0.784 . . . . 0.0 112.643 168.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -63.95 -24.14 67.61 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.145 0.978 . . . . 0.0 112.633 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.47 -56.81 15.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.948 1.299 . . . . 0.0 111.569 165.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.35 -35.22 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.735 1.214 . . . . 0.0 111.871 -172.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -57.07 -12.72 2.28 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.252 1.421 . . . . 0.0 114.039 172.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -117.43 -4.87 11.27 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.309 1.844 . . . . 0.0 112.685 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -129.46 -21.05 3.21 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.97 120.95 14.01 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 120.041 1.291 . . . . 0.0 110.381 176.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 97.24 0.73 59.64 Favored Glycine 0 N--CA 1.471 0.967 0 CA-C-O 118.189 -1.339 . . . . 0.0 114.772 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.97 106.52 0.72 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.759 1.779 . . . . 0.0 111.137 173.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -54.19 117.69 3.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.684 0.794 . . . . 0.0 109.461 155.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -137.89 108.68 6.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.5 1.52 . . . . 0.0 107.141 -165.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 18.1 ttt 50.42 47.1 24.51 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.679 0.791 . . . . 0.0 111.413 -162.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 21.5 t70 72.55 0.29 3.57 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 127.189 2.196 . . . . 0.0 114.652 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -123.68 125.05 44.09 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.215 1.406 . . . . 0.0 110.974 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -81.34 102.73 10.63 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.767 1.227 . . . . 0.0 114.264 -165.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -55.1 142.33 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.765 0.826 . . . . 0.0 111.434 167.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -136.4 134.59 37.94 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.084 1.353 . . . . 0.0 108.515 168.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 5.4 t -103.59 143.49 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.461 1.104 . . . . 0.0 110.559 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.47 0 C-N-CA 127.032 2.133 . . . . 0.0 108.639 169.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 64.9 m . . . . . 0 N--CA 1.472 0.63 0 CA-C-O 121.696 0.76 . . . . 0.0 112.648 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 7.6 pt -139.29 154.3 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.803 1.241 . . . . 0.0 111.144 -172.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -134.03 105.31 6.64 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.289 1.435 . . . . 0.0 110.317 -169.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.8 t -89.66 120.22 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.416 1.886 . . . . 0.0 109.08 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.95 -5.94 24.93 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 116.951 1.541 . . . . 0.0 116.951 -168.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -147.7 21.85 1.14 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 119.698 1.749 . . . . 0.0 114.983 -170.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -178.02 2.21 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.672 -1.268 . . . . 0.0 112.806 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 91.4 m -86.95 118.84 26.6 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.597 1.159 . . . . 0.0 108.875 172.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -68.59 -7.99 37.72 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -169.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -74.45 -12.93 60.63 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.005 1.322 . . . . 0.0 112.997 168.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 20.6 t -60.6 138.89 57.99 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.181 -0.95 . . . . 0.0 112.358 173.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 32.7 p -80.87 168.82 22.42 Favored Pre-proline 0 N--CA 1.472 0.666 0 C-N-CA 124.078 0.951 . . . . 0.0 109.216 162.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.67 -20.3 26.81 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.209 1.939 . . . . 0.0 112.887 163.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -69.02 -35.7 76.93 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.498 1.045 . . . . 0.0 111.697 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -59.94 -38.92 83.81 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.122 0.969 . . . . 0.0 111.477 170.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 56.1 mt -70.33 -41.0 73.82 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-O 118.067 -0.968 . . . . 0.0 111.492 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 17.3 m -56.5 -51.04 69.99 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.796 1.18 . . . . 0.0 110.667 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -58.61 -46.18 87.58 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.274 0.488 . . . . 0.0 111.553 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -62.43 -52.84 61.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.487 1.515 . . . . 0.0 112.799 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -71.4 -18.1 62.36 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.973 1.309 . . . . 0.0 114.215 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 64.4 p -64.06 -16.66 62.2 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -65.31 -21.64 66.73 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.737 1.215 . . . . 0.0 113.384 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 37.5 mm -90.47 -16.16 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.675 1.19 . . . . 0.0 112.6 -168.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.56 -90.93 0.11 Allowed Glycine 0 N--CA 1.467 0.767 0 C-N-CA 125.073 1.32 . . . . 0.0 111.974 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -155.44 138.0 15.07 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.078 1.351 . . . . 0.0 111.368 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.1 144.5 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 125.04 1.336 . . . . 0.0 109.566 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.02 -34.54 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.076 0.55 . . . . 0.0 112.146 -160.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -155.91 153.77 30.16 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.352 2.261 . . . . 0.0 109.285 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -151.29 145.71 25.53 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.72 1.608 . . . . 0.0 111.461 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -156.05 156.07 33.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.768 1.627 . . . . 0.0 111.486 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 10.2 mt . . . . . 0 N--CA 1.474 0.75 0 C-N-CA 124.983 1.313 . . . . 0.0 108.034 172.176 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 92.3 mtp . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 120.568 0.223 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.6 146.5 16.08 Favored Glycine 0 N--CA 1.469 0.86 0 C-N-CA 124.522 1.058 . . . . 0.0 111.864 171.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 4.0 p -143.05 147.69 35.48 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.936 1.294 . . . . 0.0 110.921 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.9 t -150.76 142.1 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.517 1.127 . . . . 0.0 109.305 -171.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.94 134.83 54.26 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.922 1.689 . . . . 0.0 110.792 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -113.16 159.87 18.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.272 1.829 . . . . 0.0 111.382 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 38.1 p -74.85 -21.42 59.27 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -137.68 -146.42 0.22 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.965 1.306 . . . . 0.0 111.843 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 62.6 p -136.39 -57.88 0.74 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.647 1.112 . . . . 0.0 113.254 -172.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.58 -29.34 70.51 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.905 -1.122 . . . . 0.0 113.697 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -72.11 -28.69 63.44 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.75 1.62 . . . . 0.0 112.992 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.5 t -69.42 -33.31 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.359 1.463 . . . . 0.0 111.802 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -74.14 -41.94 60.76 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.601 -0.687 . . . . 0.0 112.163 170.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -62.49 -28.48 69.86 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.058 0.943 . . . . 0.0 112.77 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.56 -60.11 4.15 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.761 1.224 . . . . 0.0 111.583 169.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.11 -23.04 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.16 -0.963 . . . . 0.0 112.892 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -14.59 13.3 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.243 1.017 . . . . 0.0 113.549 167.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -101.14 -20.25 15.4 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.046 1.338 . . . . 0.0 112.901 173.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -122.17 -17.56 7.14 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 -159.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -68.15 120.53 14.49 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 120.628 1.558 . . . . 0.0 110.079 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 94.27 0.39 65.45 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 117.791 -1.56 . . . . 0.0 115.015 -169.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.13 107.17 0.51 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 120.0 1.9 . . . . 0.0 110.906 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -53.69 119.85 5.46 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.92 0.888 . . . . 0.0 109.812 160.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -146.88 110.37 4.87 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.411 1.485 . . . . 0.0 108.038 -163.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 51.4 mtt 53.42 35.32 20.21 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.563 0.745 . . . . 0.0 111.757 -169.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 86.01 0.48 0.66 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 128.95 2.9 . . . . 0.0 116.035 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -124.3 140.29 53.1 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.431 1.092 . . . . 0.0 111.974 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 103.14 6.82 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.244 -0.91 . . . . 0.0 112.766 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -52.31 143.31 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 121.36 -0.837 . . . . 0.0 111.015 164.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -129.72 147.42 51.5 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 164.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.2 p -151.09 127.76 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.584 0.707 . . . . 0.0 111.969 -166.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 . . . . . 0 CA--C 1.534 0.327 0 C-N-CA 125.222 1.409 . . . . 0.0 109.971 170.71 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.1 p . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 120.451 0.167 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.6 pt -141.04 154.85 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.21 1.004 . . . . 0.0 112.189 -161.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -122.23 147.43 46.21 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.686 1.995 . . . . 0.0 110.526 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.6 t -134.14 122.65 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.317 1.447 . . . . 0.0 109.766 -172.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.3 -46.12 2.65 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 116.254 1.262 . . . . 0.0 116.254 -163.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -121.57 23.62 10.18 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -163.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.57 -175.97 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.942 1.697 . . . . 0.0 112.882 165.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.6 p -73.7 127.08 31.83 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 120.958 -1.089 . . . . 0.0 110.023 165.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -70.0 -9.46 55.3 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -97.68 0.27 46.8 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.836 2.054 . . . . 0.0 113.283 171.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 7.9 t -58.11 149.16 24.33 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.132 -0.98 . . . . 0.0 113.299 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.1 p -95.12 151.84 39.07 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 123.594 0.758 . . . . 0.0 110.229 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.23 -25.91 30.57 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.376 2.051 . . . . 0.0 111.927 171.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -69.43 -42.79 74.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.209 1.004 . . . . 0.0 112.539 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -65.7 -41.61 92.13 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.718 -0.614 . . . . 0.0 111.547 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 25.5 mt -69.32 -29.26 67.05 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.6 -0.714 . . . . 0.0 112.226 173.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 49.7 m -66.11 -50.94 62.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.515 1.052 . . . . 0.0 109.658 171.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.32 -34.69 74.18 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 118.624 0.647 . . . . 0.0 112.253 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -70.13 -58.18 4.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.663 1.585 . . . . 0.0 112.406 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -71.24 -35.78 71.56 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.6 t -73.43 -6.0 43.51 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -51.98 -25.93 9.46 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.188 1.795 . . . . 0.0 112.544 164.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 28.4 mm -77.1 -22.35 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.198 1.799 . . . . 0.0 113.215 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.69 -90.47 0.11 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.304 0.954 . . . . 0.0 112.892 -172.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -152.47 95.47 2.03 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -171.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 39.9 t -70.09 134.11 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 161.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 5.1 p -104.38 -25.17 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.085 0.954 . . . . 0.0 112.645 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -164.6 119.7 1.43 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.683 1.193 . . . . 0.0 111.567 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -107.48 154.25 21.63 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.216 1.006 . . . . 0.0 111.067 161.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -156.14 131.89 9.7 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.538 1.535 . . . . 0.0 110.89 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 4.8 mm . . . . . 0 N--CA 1.482 1.142 0 C-N-CA 125.117 1.367 . . . . 0.0 109.79 178.532 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.45 156.72 20.33 Favored Glycine 0 N--CA 1.467 0.73 0 C-N-CA 124.593 1.092 . . . . 0.0 112.89 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.0 p -144.42 149.22 35.7 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.903 1.681 . . . . 0.0 111.099 174.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 10.9 t -145.42 139.06 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.983 0.913 . . . . 0.0 110.667 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -127.8 132.1 49.5 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.172 2.189 . . . . 0.0 109.012 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -110.7 164.26 12.93 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.442 1.497 . . . . 0.0 110.055 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 33.1 p -81.05 -25.36 37.17 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 122.01 -0.431 . . . . 0.0 111.893 164.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -81.26 168.44 18.47 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.97 1.708 . . . . 0.0 112.248 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.3 m -122.62 -76.75 0.59 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.575 0.75 . . . . 0.0 110.972 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.94 -25.15 67.42 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.8 -1.187 . . . . 0.0 113.835 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.13 -21.71 61.43 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.09 -25.05 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.565 0.746 . . . . 0.0 111.661 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -73.09 -43.79 61.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.998 0.919 . . . . 0.0 111.231 167.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -60.1 -32.27 70.82 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.888 0.875 . . . . 0.0 112.111 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.07 -65.13 0.67 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.768 1.227 . . . . 0.0 111.748 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 45.2 mt -59.91 -34.76 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.401 -0.812 . . . . 0.0 112.12 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -63.34 -2.76 1.59 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.076 1.35 . . . . 0.0 114.356 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -122.0 -2.99 9.13 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.893 1.677 . . . . 0.0 112.8 171.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -129.09 -21.09 3.33 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -170.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -62.53 120.94 12.09 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.393 1.451 . . . . 0.0 110.079 173.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 97.31 0.52 59.64 Favored Glycine 0 N--CA 1.471 1.011 0 CA-C-O 118.136 -1.369 . . . . 0.0 115.266 -169.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.61 106.66 0.99 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.815 1.808 . . . . 0.0 110.789 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -53.63 115.37 1.93 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 154.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -137.23 110.91 8.09 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.078 1.351 . . . . 0.0 108.758 -166.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 18.9 mmt 60.26 19.1 8.57 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.052 1.341 . . . . 0.0 113.949 -178.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 18.6 t70 106.91 0.14 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 130.929 3.692 . . . . 0.0 115.148 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -129.69 138.21 51.03 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.571 1.078 . . . . 0.0 112.844 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -71.22 104.59 3.15 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.251 1.42 . . . . 0.0 113.191 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 pt -55.15 144.27 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.267 0.627 . . . . 0.0 111.326 168.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -139.76 140.03 36.61 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.848 1.259 . . . . 0.0 109.359 174.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.05 135.06 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.144 1.378 . . . . 0.0 110.35 -171.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 . . . . . 0 N--CA 1.471 0.592 0 C-N-CA 125.333 1.453 . . . . 0.0 108.418 170.275 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.6 m . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 121.414 0.626 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 35.5 pt -141.36 142.19 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 126.531 1.932 . . . . 0.0 109.018 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -109.96 128.67 55.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.365 1.066 . . . . 0.0 110.842 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.09 106.04 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.864 1.666 . . . . 0.0 107.905 -169.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -99.68 -11.58 43.55 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 117.09 1.596 . . . . 0.0 117.09 -158.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -157.25 38.43 0.29 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.335 1.568 . . . . 0.0 113.507 -171.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.35 177.78 6.34 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.011 -1.056 . . . . 0.0 112.441 175.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 t -76.67 142.06 40.71 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.978 1.311 . . . . 0.0 111.806 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -64.04 -12.78 41.7 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 170.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -75.45 -15.24 60.45 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.502 1.121 . . . . 0.0 113.547 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 57.9 m -71.49 137.68 48.36 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.992 -1.068 . . . . 0.0 113.286 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 43.0 p -100.75 159.2 30.24 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 125.377 1.471 . . . . 0.0 109.262 163.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.48 -24.53 78.25 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 121.963 1.775 . . . . 0.0 112.774 170.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.18 -41.33 90.43 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.871 1.214 . . . . 0.0 111.7 173.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -60.56 -47.44 86.17 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.414 0.686 . . . . 0.0 110.858 176.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -62.89 -37.52 87.26 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.552 1.141 . . . . 0.0 111.999 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.6 m -63.76 -50.42 69.14 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.203 1.001 . . . . 0.0 110.568 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.62 -41.92 83.18 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.509 0.595 . . . . 0.0 111.694 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -57.17 -55.46 34.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.744 1.618 . . . . 0.0 112.29 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -71.15 -28.34 64.2 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.2 m -73.26 0.24 12.47 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -66.84 -20.91 66.02 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 120.892 -1.13 . . . . 0.0 112.594 166.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 24.1 mm -84.07 -39.91 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.866 1.266 . . . . 0.0 111.762 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -173.62 -98.04 0.11 Allowed Glycine 0 N--CA 1.468 0.796 0 C-N-CA 125.662 1.601 . . . . 0.0 111.633 -174.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -144.41 123.11 12.57 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.539 1.135 . . . . 0.0 112.469 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 29.4 t -74.4 133.54 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 156.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.2 -23.62 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.068 0.547 . . . . 0.0 112.043 175.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -176.18 146.49 0.67 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 127.714 2.405 . . . . 0.0 110.494 176.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -130.45 158.79 38.93 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.548 1.539 . . . . 0.0 112.092 168.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -155.45 142.19 18.9 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.003 1.721 . . . . 0.0 110.772 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 4.1 mt . . . . . 0 N--CA 1.48 1.051 0 C-N-CA 124.802 1.241 . . . . 0.0 110.114 -175.61 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 120.417 0.151 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -149.51 -178.37 24.43 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.204 0.907 . . . . 0.0 114.383 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.2 m -150.99 144.75 25.1 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.829 1.651 . . . . 0.0 108.457 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.84 143.38 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.851 0.86 . . . . 0.0 110.014 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -110.28 135.13 51.51 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.198 1.799 . . . . 0.0 110.223 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -117.19 159.79 22.08 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.539 1.936 . . . . 0.0 112.118 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.5 p -83.66 -25.46 30.71 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -148.51 142.79 26.16 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 -168.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.8 p -76.36 -14.73 60.07 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.84 2.456 . . . . 0.0 116.013 -161.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -102.05 -33.88 9.53 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.113 0.87 . . . . 0.0 112.776 169.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -62.07 -43.32 99.08 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.703 0.801 . . . . 0.0 110.962 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 13.3 p -62.67 -35.85 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.172 1.389 . . . . 0.0 113.971 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.48 -47.0 35.94 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.739 -0.601 . . . . 0.0 112.609 172.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -58.08 -34.98 70.74 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.799 1.24 . . . . 0.0 112.43 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.67 -58.1 9.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.632 1.173 . . . . 0.0 111.636 171.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 45.1 mt -69.96 -29.88 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.485 -1.385 . . . . 0.0 112.466 -173.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.48 -14.37 12.34 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 168.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -105.92 -40.67 5.62 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.341 1.856 . . . . 0.0 111.963 171.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -95.04 -13.88 24.8 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 -165.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.01 120.62 13.96 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 120.614 1.552 . . . . 0.0 109.936 174.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 93.78 0.78 66.22 Favored Glycine 0 N--CA 1.473 1.104 0 CA-C-O 117.861 -1.522 . . . . 0.0 115.19 -167.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.33 107.0 0.59 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.221 2.01 . . . . 0.0 110.912 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -53.13 120.89 6.47 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.035 0.934 . . . . 0.0 109.85 160.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -141.24 110.74 6.39 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.462 1.505 . . . . 0.0 107.804 -170.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 19.3 mmt 51.22 41.52 27.91 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.587 1.155 . . . . 0.0 111.722 -162.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 76.28 0.53 3.26 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 127.681 2.392 . . . . 0.0 115.169 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -116.14 130.3 56.73 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.597 1.159 . . . . 0.0 111.622 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -71.01 104.15 2.9 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.042 -1.036 . . . . 0.0 112.837 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.1 pt -52.81 146.6 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.246 0.618 . . . . 0.0 111.016 156.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -135.53 147.55 48.84 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.864 1.266 . . . . 0.0 108.576 169.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 1.6 p -153.02 140.56 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.11 0.964 . . . . 0.0 111.254 -166.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 . . . . . 0 CA--C 1.533 0.326 0 C-N-CA 124.817 1.247 . . . . 0.0 110.169 173.57 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.4 t . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 121.783 0.802 . . . . 0.0 112.952 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 6.8 pt -147.62 151.47 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 127.364 2.266 . . . . 0.0 109.989 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -121.85 134.53 54.88 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.298 1.839 . . . . 0.0 110.367 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.47 121.29 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.757 1.223 . . . . 0.0 108.808 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.32 -44.79 1.13 Allowed Glycine 0 N--CA 1.475 1.257 0 N-CA-C 115.333 0.893 . . . . 0.0 115.333 -168.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -100.45 7.41 44.21 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -166.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -62.88 169.01 3.48 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.148 1.379 . . . . 0.0 111.926 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.7 m -64.15 138.87 58.66 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.129 0.972 . . . . 0.0 112.324 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -70.15 0.12 6.79 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.478 1.911 . . . . 0.0 115.244 -169.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -111.9 0.55 16.14 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.244 2.217 . . . . 0.0 112.692 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 9.8 t -61.95 154.87 25.15 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.1 p -130.49 152.28 80.06 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 125.545 1.538 . . . . 0.0 111.062 -168.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.57 -42.87 19.22 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.761 2.307 . . . . 0.0 113.236 -171.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.73 -27.96 67.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.542 1.065 . . . . 0.0 112.816 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.05 -30.2 63.55 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.971 0.909 . . . . 0.0 112.094 174.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 13.8 mt -74.51 -34.04 62.94 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.058 -0.972 . . . . 0.0 113.283 164.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 81.6 m -62.21 -50.61 71.1 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.145 1.339 . . . . 0.0 110.73 177.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -62.03 -26.74 68.42 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -78.43 -60.12 2.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.522 1.529 . . . . 0.0 111.521 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -71.24 -34.07 70.43 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -175.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.0 t -73.37 -1.21 17.21 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -64.45 -17.65 64.02 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.054 0.942 . . . . 0.0 112.855 169.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.3 mm -82.09 -25.31 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.6 1.56 . . . . 0.0 113.089 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 175.23 -103.45 0.18 Allowed Glycine 0 N--CA 1.47 0.954 0 C-N-CA 124.506 1.051 . . . . 0.0 112.367 -169.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -147.77 109.67 4.48 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.508 0.723 . . . . 0.0 112.489 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 25.6 t -71.25 129.77 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 164.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.81 -33.48 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 118.362 0.528 . . . . 0.0 112.005 173.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -154.71 134.82 13.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.285 1.434 . . . . 0.0 110.715 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -109.71 153.94 23.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.245 1.018 . . . . 0.0 110.595 153.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -153.13 123.03 6.91 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.822 1.249 . . . . 0.0 111.262 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 6.0 mt . . . . . 0 N--CA 1.482 1.147 0 C-N-CA 123.657 0.783 . . . . 0.0 113.023 -175.774 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 93.4 mtp . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -173.75 -165.84 31.08 Favored Glycine 0 N--CA 1.474 1.192 0 N-CA-C 116.144 1.218 . . . . 0.0 116.144 -169.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.7 p -132.66 160.9 35.35 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.832 1.653 . . . . 0.0 113.582 -164.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 12.2 t -141.84 142.15 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.942 1.297 . . . . 0.0 110.202 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -125.45 134.98 51.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.862 2.065 . . . . 0.0 111.341 -171.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -118.46 151.66 37.39 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.071 1.748 . . . . 0.0 111.895 -169.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 61.3 p -75.93 -38.21 57.87 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.467 0.307 . . . . 0.0 110.817 163.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -61.18 160.49 10.26 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.377 1.871 . . . . 0.0 113.09 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.7 p -127.08 -66.01 0.92 Allowed 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.707 -0.621 . . . . 0.0 111.895 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -61.95 -30.24 70.78 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.425 1.011 . . . . 0.0 112.154 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -72.21 -17.43 61.92 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 12.4 t -70.26 -22.81 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.872 0.76 . . . . 0.0 112.042 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -74.07 -45.76 47.32 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.752 -1.217 . . . . 0.0 110.967 164.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 10.1 ttt85 -57.01 -29.35 63.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.597 1.559 . . . . 0.0 113.753 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.62 -68.7 0.29 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.681 1.592 . . . . 0.0 110.586 166.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.23 -27.87 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 121.204 -0.935 . . . . 0.0 113.266 -166.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -58.54 -18.79 32.31 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.861 0.864 . . . . 0.0 113.319 170.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -107.46 -6.7 16.91 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.369 1.467 . . . . 0.0 113.295 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -124.68 -22.87 4.48 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -170.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.64 120.5 14.75 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 120.399 1.454 . . . . 0.0 109.833 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 94.62 0.43 64.61 Favored Glycine 0 N--CA 1.469 0.888 0 CA-C-O 118.016 -1.435 . . . . 0.0 115.028 -168.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.8 108.84 1.08 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.909 1.855 . . . . 0.0 110.536 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -48.44 116.72 1.68 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.151 0.98 . . . . 0.0 109.351 156.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -152.0 110.77 3.82 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.851 1.26 . . . . 0.0 108.808 -172.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.13 50.52 13.41 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.472 1.109 . . . . 0.0 112.019 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 16.8 t70 77.48 0.14 2.88 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 127.257 2.223 . . . . 0.0 115.807 171.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 -135.55 154.8 51.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.925 1.29 . . . . 0.0 111.898 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 103.97 16.38 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.311 -0.868 . . . . 0.0 110.611 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.4 pt -54.76 139.54 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 121.215 -0.928 . . . . 0.0 111.287 171.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -132.69 142.66 49.17 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.626 1.17 . . . . 0.0 108.139 167.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 1.1 p -136.93 134.82 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.321 1.048 . . . . 0.0 111.682 -165.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 . . . . . 0 CA--C 1.534 0.364 0 C-N-CA 126.275 1.83 . . . . 0.0 109.919 173.438 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.5 p . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 121.502 0.668 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 28.7 pt -144.1 145.48 21.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 125.589 1.556 . . . . 0.0 110.341 -171.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 94.4 t80 -109.29 150.2 28.32 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.825 1.65 . . . . 0.0 109.56 170.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.95 102.86 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.105 1.362 . . . . 0.0 108.786 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -82.49 -16.28 71.55 Favored Glycine 0 N--CA 1.471 0.974 0 C-N-CA 124.223 0.916 . . . . 0.0 114.315 -171.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -152.2 133.43 14.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.858 1.663 . . . . 0.0 109.926 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 mp -144.01 -77.96 0.22 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.63 1.572 . . . . 0.0 109.95 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 11.3 t -172.25 140.21 1.12 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.975 2.51 . . . . 0.0 108.588 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -63.43 -13.65 42.28 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -88.7 0.09 56.78 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.201 1.4 . . . . 0.0 113.418 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 7.6 t -78.46 152.82 31.89 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.682 -1.261 . . . . 0.0 113.509 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.49 159.7 32.26 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 126.556 1.943 . . . . 0.0 109.066 -176.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.0 -27.07 17.77 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 121.988 1.792 . . . . 0.0 113.29 -167.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.04 -34.77 78.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.196 0.907 . . . . 0.0 111.573 173.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -70.38 -41.27 73.28 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.059 0.944 . . . . 0.0 110.964 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.1 mt -66.59 -29.69 69.8 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.815 169.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 86.0 m -69.4 -48.36 61.35 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.402 1.001 . . . . 0.0 109.89 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -61.33 -33.77 74.15 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.431 0.693 . . . . 0.0 112.571 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -73.14 -61.48 1.8 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.998 1.719 . . . . 0.0 111.962 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.37 -39.75 71.05 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.3 t -73.28 -7.07 49.96 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -174.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -60.05 -18.62 47.91 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.782 1.233 . . . . 0.0 112.65 167.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 20.6 mm -78.96 -26.0 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.831 1.652 . . . . 0.0 112.607 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 166.22 -95.67 0.12 Allowed Glycine 0 N--CA 1.469 0.87 0 C-N-CA 124.734 1.159 . . . . 0.0 112.457 -171.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -141.67 110.13 6.01 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.361 1.064 . . . . 0.0 112.85 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.66 135.18 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 154.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.29 -18.31 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 172.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -160.47 138.2 9.63 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.419 1.488 . . . . 0.0 111.13 170.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -124.27 152.47 42.98 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.277 1.431 . . . . 0.0 110.554 160.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -152.32 137.0 16.97 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.201 1.001 . . . . 0.0 112.513 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.1 mt . . . . . 0 N--CA 1.483 1.206 0 C-N-CA 126.153 1.781 . . . . 0.0 111.255 179.265 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 4.0 ppp? . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 157.76 -144.79 10.92 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 115.314 0.886 . . . . 0.0 115.314 -174.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.6 m -144.84 150.39 37.04 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.269 1.428 . . . . 0.0 111.13 -160.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.8 t -139.14 147.65 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.733 1.213 . . . . 0.0 110.82 173.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -131.45 133.76 45.51 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.75 2.02 . . . . 0.0 111.001 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -120.61 164.82 15.91 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.985 2.114 . . . . 0.0 111.502 -174.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 29.3 p -74.55 -38.41 62.74 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -150.49 152.8 34.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -171.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 30.8 p -54.05 -40.0 66.73 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.328 1.851 . . . . 0.0 113.326 171.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -76.37 -23.6 54.15 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -79.59 -51.25 9.53 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.886 0.874 . . . . 0.0 112.438 169.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 15.0 p -69.3 -42.46 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -167.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.77 -13.3 62.0 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.158 0.89 . . . . 0.0 113.367 -173.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -73.37 -19.4 61.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.468 1.107 . . . . 0.0 112.657 173.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.65 -61.18 2.0 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.302 1.041 . . . . 0.0 112.612 -173.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . 0.451 ' H ' HD12 ' A' ' 217' ' ' ILE . 4.2 mp -68.91 -29.21 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 121.447 -0.783 . . . . 0.0 112.271 -160.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -58.5 -21.43 51.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.66 1.184 . . . . 0.0 113.566 170.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -101.4 -10.73 19.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.192 1.397 . . . . 0.0 112.889 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -126.0 -23.69 3.89 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -166.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.97 120.75 13.67 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.379 1.445 . . . . 0.0 109.8 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 93.08 0.83 67.74 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-O 117.982 -1.454 . . . . 0.0 115.079 -169.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.01 109.31 0.93 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.686 1.743 . . . . 0.0 110.501 171.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -57.05 124.17 17.79 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.265 0.555 . . . . 0.0 109.627 155.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -145.88 110.43 5.09 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.315 1.846 . . . . 0.0 107.103 -161.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 88.6 mmm 49.88 41.48 22.73 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.864 0.866 . . . . 0.0 111.728 -163.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 11.6 t70 77.71 -0.41 2.76 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 128.284 2.634 . . . . 0.0 115.085 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -120.38 137.73 54.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.564 1.146 . . . . 0.0 111.626 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -79.62 112.72 17.16 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.697 -1.252 . . . . 0.0 113.435 -170.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -68.18 143.88 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 121.219 -0.926 . . . . 0.0 112.98 169.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -132.31 130.28 40.62 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.282 1.433 . . . . 0.0 109.643 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 12.4 t -119.24 151.09 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.772 2.029 . . . . 0.0 109.541 -170.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 42.0 ptt85 . . . . . 0 N--CA 1.467 0.392 0 C-N-CA 123.546 0.738 . . . . 0.0 110.12 155.621 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 63.5 p . . . . . 0 N--CA 1.472 0.653 0 CA-C-O 121.444 0.64 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 10.4 pt -143.83 142.14 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.522 1.529 . . . . 0.0 109.571 -177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -128.73 123.9 34.22 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.648 1.179 . . . . 0.0 109.401 -168.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.8 t -113.93 129.68 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.814 1.645 . . . . 0.0 109.151 -164.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -74.59 -109.05 0.09 OUTLIER Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.272 1.415 . . . . 0.0 114.652 -169.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -84.26 -26.94 28.24 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.438 ' HG ' ' H ' ' A' ' 169' ' ' THR 0.32 2.3 pt? 32.7 -120.22 0.07 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.579 2.352 . . . . 0.0 115.0 -178.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.438 ' H ' ' HG ' ' A' ' 168' ' ' LEU . 57.2 m -142.28 130.32 21.94 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.684 1.594 . . . . 0.0 110.123 -162.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -61.45 -23.37 65.8 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.19 -0.89 57.78 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.885 1.674 . . . . 0.0 113.269 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 92.3 p -72.09 151.97 42.69 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 34.5 p -143.15 162.52 42.6 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 127.654 2.382 . . . . 0.0 108.372 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -63.16 -30.33 74.78 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 121.58 1.52 . . . . 0.0 112.951 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -69.28 -40.16 77.93 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.1 0.864 . . . . 0.0 112.207 173.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -66.18 -40.72 90.68 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.562 1.145 . . . . 0.0 111.838 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.34 -36.06 82.44 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.134 0.973 . . . . 0.0 112.025 170.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 91.7 m -69.48 -50.11 48.44 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.153 0.581 . . . . 0.0 110.314 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -58.75 -28.61 66.05 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.626 0.77 . . . . 0.0 112.399 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -75.56 -66.09 0.82 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.064 1.346 . . . . 0.0 111.7 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.28 -30.84 66.77 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -172.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.35 -5.33 39.02 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.011 -1.056 . . . . 0.0 113.701 -173.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -64.91 -19.45 65.94 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.685 1.194 . . . . 0.0 113.219 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 24.9 mm -82.83 -24.13 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.643 1.177 . . . . 0.0 112.655 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 176.14 -86.04 0.07 OUTLIER Glycine 0 N--CA 1.468 0.771 0 C-N-CA 124.923 1.249 . . . . 0.0 111.707 -175.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -157.51 116.47 3.26 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.494 1.118 . . . . 0.0 112.198 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 19.2 t -71.9 129.99 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 160.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.5 p -100.69 -17.04 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.657 0.783 . . . . 0.0 112.981 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -162.58 138.57 7.35 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.109 1.363 . . . . 0.0 112.112 169.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -127.35 156.02 42.65 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.986 1.314 . . . . 0.0 112.406 165.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -156.52 143.28 18.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.548 1.539 . . . . 0.0 112.27 -174.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.5 mm . . . . . 0 N--CA 1.476 0.871 0 C-N-CA 125.694 1.597 . . . . 0.0 108.012 170.281 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 4.7 ppp? . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -127.27 157.12 20.67 Favored Glycine 0 N--CA 1.471 1.031 0 C-N-CA 124.427 1.013 . . . . 0.0 114.865 -172.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 85.4 m -142.86 144.11 32.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.944 1.698 . . . . 0.0 109.107 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 43.7 t -141.63 152.52 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.848 0.859 . . . . 0.0 109.495 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -130.06 137.46 50.23 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.916 1.687 . . . . 0.0 111.21 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -121.06 160.5 23.49 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 127.306 2.243 . . . . 0.0 110.224 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 43.7 p -88.19 -14.38 38.73 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -175.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -156.25 130.93 8.96 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.2 m -46.79 -50.74 17.8 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 129.372 3.069 . . . . 0.0 115.113 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.75 -26.46 44.6 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.003 -1.061 . . . . 0.0 113.108 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.37 -39.7 64.94 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.303 -0.873 . . . . 0.0 113.332 170.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 14.0 p -69.05 -29.26 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.541 -0.724 . . . . 0.0 112.384 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.91 -39.78 83.52 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.514 0.726 . . . . 0.0 112.56 169.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 53.3 mtt85 -61.97 -33.19 73.84 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.329 0.652 . . . . 0.0 112.494 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.81 -63.71 1.13 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.409 1.004 . . . . 0.0 113.176 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 56.3 mt -65.46 -27.6 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 121.35 -0.844 . . . . 0.0 111.771 -170.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -51.39 -27.73 10.8 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.043 1.337 . . . . 0.0 113.558 168.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -98.88 -13.38 20.07 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.416 1.086 . . . . 0.0 113.443 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -125.18 -19.62 5.09 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -163.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -67.64 120.89 14.76 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 120.408 1.458 . . . . 0.0 110.769 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 91.34 0.82 72.85 Favored Glycine 0 N--CA 1.469 0.885 0 CA-C-O 117.44 -1.755 . . . . 0.0 114.75 -170.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.37 106.22 0.36 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.894 1.847 . . . . 0.0 110.32 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.502 ' CZ ' ' HE2' ' A' ' 229' ' ' LYS . 56.4 m-85 -60.3 116.92 4.61 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 156.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -133.95 110.33 9.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.24 1.416 . . . . 0.0 107.288 -164.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 12.9 ttt 50.07 38.88 17.85 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.13 0.972 . . . . 0.0 111.897 -159.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.7 t70 76.45 6.78 3.47 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 126.858 2.063 . . . . 0.0 114.965 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -121.12 138.67 54.09 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.45 1.1 . . . . 0.0 112.105 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.502 ' HE2' ' CZ ' ' A' ' 224' ' ' PHE . 42.4 mmtt -68.01 115.88 8.02 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.149 1.379 . . . . 0.0 113.584 -175.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.03 145.87 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 120.998 -1.064 . . . . 0.0 110.743 151.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -146.58 142.42 27.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.64 1.976 . . . . 0.0 108.43 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.2 t -137.27 135.38 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -165.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 . . . . . 0 N--CA 1.47 0.526 0 C-N-CA 126.259 1.824 . . . . 0.0 110.965 168.176 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.0 pt -136.43 147.06 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.09 1.356 . . . . 0.0 110.824 176.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -129.48 114.21 15.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.555 1.942 . . . . 0.0 109.356 -167.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.46 106.29 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.308 1.843 . . . . 0.0 108.197 -172.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.54 -10.78 78.97 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.237 0.922 . . . . 0.0 115.268 -169.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -159.44 157.92 31.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.009 1.724 . . . . 0.0 110.408 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 178.26 -144.55 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 128.838 2.855 . . . . 0.0 107.984 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 21.8 p -108.56 141.83 39.89 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 120.865 1.666 . . . . 0.0 111.221 170.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -59.68 -25.18 64.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -88.52 -1.85 58.27 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.045 1.738 . . . . 0.0 113.423 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 22.7 t -69.63 154.64 41.7 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.984 -1.072 . . . . 0.0 112.163 174.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 32.5 p -128.4 155.57 78.35 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 125.33 1.452 . . . . 0.0 109.746 -172.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.02 -23.48 53.79 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.45 1.434 . . . . 0.0 112.394 174.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -69.07 -36.38 77.57 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.516 1.053 . . . . 0.0 111.987 171.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -71.33 -37.98 71.69 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.307 -0.871 . . . . 0.0 111.859 174.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.8 mt -66.14 -30.36 70.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.418 -0.801 . . . . 0.0 112.787 166.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 63.6 m -67.71 -46.82 71.1 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.571 1.078 . . . . 0.0 109.35 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.31 -36.13 79.26 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.796 0.726 . . . . 0.0 112.118 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -66.41 -64.14 0.92 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.55 1.14 . . . . 0.0 111.511 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -71.23 -39.21 71.84 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -173.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.73 -3.88 31.1 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -72.77 -15.95 61.65 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.161 -0.962 . . . . 0.0 112.892 165.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.07 -45.65 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.007 0.822 . . . . 0.0 111.295 175.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.39 -90.75 0.08 OUTLIER Glycine 0 N--CA 1.468 0.779 0 C-N-CA 125.062 1.315 . . . . 0.0 112.405 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -158.4 109.56 2.17 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.74 0.816 . . . . 0.0 112.09 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 36.0 t -74.06 130.44 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 167.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.6 p -102.94 -16.99 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.22 1.008 . . . . 0.0 113.107 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -164.95 134.22 3.55 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.147 1.779 . . . . 0.0 111.066 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -130.15 152.94 49.04 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.716 1.606 . . . . 0.0 112.299 165.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -156.76 156.78 33.89 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.844 2.058 . . . . 0.0 111.216 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.3 mt . . . . . 0 N--CA 1.482 1.147 0 C-N-CA 124.7 1.2 . . . . 0.0 111.316 178.063 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 27.1 ptm . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -108.06 164.73 12.81 Favored Glycine 0 N--CA 1.469 0.865 0 C-N-CA 124.874 1.226 . . . . 0.0 113.789 -177.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.77 142.54 27.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.992 1.717 . . . . 0.0 109.836 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 19.4 t -146.27 146.89 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.609 0.764 . . . . 0.0 109.999 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -129.2 131.95 47.19 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.164 1.786 . . . . 0.0 109.369 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -95.99 171.77 8.42 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.626 1.17 . . . . 0.0 109.915 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 59.0 p -81.48 0.15 39.15 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 168.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -136.22 178.49 7.02 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.264 1.826 . . . . 0.0 112.433 -166.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 20.9 p -124.82 -68.3 0.86 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.179 1.792 . . . . 0.0 110.897 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -54.37 -38.53 66.21 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.016 -1.053 . . . . 0.0 112.956 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.6 -18.38 64.97 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.446 1.098 . . . . 0.0 113.077 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 13.0 t -75.79 -37.23 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.137 1.375 . . . . 0.0 112.062 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -62.17 -43.67 98.31 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.768 -0.582 . . . . 0.0 110.434 168.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -65.74 -17.14 64.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.981 1.312 . . . . 0.0 113.523 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -74.49 -64.27 1.06 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.24 0.927 . . . . 0.0 111.425 166.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 53.5 mt -69.23 -30.8 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.444 -0.785 . . . . 0.0 112.04 -167.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.69 -4.2 2.87 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.545 1.138 . . . . 0.0 113.835 170.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -118.24 -4.91 10.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.388 1.475 . . . . 0.0 112.569 172.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -127.54 -24.03 3.38 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -171.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.54 120.92 12.07 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 121.001 1.728 . . . . 0.0 110.501 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 91.64 0.68 72.14 Favored Glycine 0 N--CA 1.469 0.844 0 CA-C-O 118.06 -1.411 . . . . 0.0 115.336 -171.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.47 107.6 0.81 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.76 1.78 . . . . 0.0 110.363 169.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -52.98 120.4 5.81 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 156.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -142.15 111.06 6.27 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.26 1.424 . . . . 0.0 108.314 -166.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 20.5 ttt 56.72 40.5 29.14 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 121.776 0.798 . . . . 0.0 110.751 -165.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 18.3 t70 74.97 0.18 3.48 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 127.912 2.485 . . . . 0.0 115.285 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -125.64 141.27 52.11 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.05 1.34 . . . . 0.0 111.982 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -87.32 102.62 14.68 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.002 0.921 . . . . 0.0 112.621 -165.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.88 149.73 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 121.226 -0.921 . . . . 0.0 112.484 169.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -141.49 140.49 33.53 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.823 1.649 . . . . 0.0 108.696 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 16.0 t -133.03 133.55 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 118.556 0.616 . . . . 0.0 112.299 -168.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? . . . . . 0 CA--C 1.537 0.454 0 C-N-CA 126.128 1.771 . . . . 0.0 109.456 169.42 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.1 pt -139.06 148.21 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.831 1.652 . . . . 0.0 110.786 -171.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -99.34 148.87 23.73 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.106 1.363 . . . . 0.0 110.601 166.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 14.8 t -131.01 101.41 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.01 -12.86 82.89 Favored Glycine 0 N--CA 1.475 1.247 0 C-N-CA 124.128 0.871 . . . . 0.0 114.963 -161.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -164.26 148.48 9.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.531 1.932 . . . . 0.0 108.785 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.3 mp -144.51 -79.42 0.19 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.541 1.937 . . . . 0.0 109.63 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.5 t 177.03 162.64 0.46 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 128.232 2.613 . . . . 0.0 108.652 -162.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -91.75 0.37 57.49 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.407 1.083 . . . . 0.0 113.511 -174.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -120.24 0.42 10.64 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.424 1.89 . . . . 0.0 114.543 -173.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.8 t -90.15 168.51 11.9 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.932 -1.105 . . . . 0.0 113.152 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 40.0 p -143.41 163.72 35.21 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 127.488 2.315 . . . . 0.0 109.798 -174.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -60.58 -29.08 87.78 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.249 1.966 . . . . 0.0 113.193 169.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -69.08 -39.89 78.76 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.339 0.972 . . . . 0.0 111.837 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -60.98 -40.47 93.55 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.561 0.744 . . . . 0.0 111.585 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.4 mt -70.04 -31.67 69.42 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 172.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 51.8 m -65.9 -47.4 74.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.964 0.802 . . . . 0.0 110.868 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.03 -19.74 60.53 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -79.13 -55.93 4.74 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.307 1.443 . . . . 0.0 111.081 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -70.98 -28.16 64.24 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.162 0.985 . . . . 0.0 113.489 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 45.3 m -72.92 -2.31 20.37 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -64.91 -18.85 65.56 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.244 -0.91 . . . . 0.0 112.58 165.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 23.3 mm -90.08 -21.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.88 1.272 . . . . 0.0 112.222 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 168.64 -87.27 0.09 OUTLIER Glycine 0 N--CA 1.468 0.804 0 C-N-CA 125.379 1.466 . . . . 0.0 111.872 -173.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -162.07 120.18 2.22 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.663 1.185 . . . . 0.0 112.448 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 43.7 t -73.71 131.9 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 157.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.55 -18.34 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 171.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -162.37 141.21 9.11 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.144 1.778 . . . . 0.0 110.803 172.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -132.58 158.05 43.17 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.223 1.409 . . . . 0.0 111.522 164.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -153.31 143.91 22.61 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.471 1.508 . . . . 0.0 111.937 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 N--CA 1.481 1.115 0 C-N-CA 125.697 1.599 . . . . 0.0 110.632 -179.757 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 11.7 ptt? . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 119.45 -0.31 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 164.99 -144.65 9.5 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-N 118.638 0.654 . . . . 0.0 114.388 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.5 p -144.46 159.77 42.2 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.34 1.456 . . . . 0.0 112.954 -165.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 37.8 t -144.97 141.53 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.003 1.321 . . . . 0.0 110.322 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -121.16 134.32 55.22 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 127.018 2.127 . . . . 0.0 110.922 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -118.96 172.79 7.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.676 2.39 . . . . 0.0 111.234 -173.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 80.9 p -92.2 -22.03 20.04 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -148.49 137.4 21.64 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -169.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 19.3 m -69.84 -22.89 63.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.98 2.112 . . . . 0.0 115.814 -168.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -90.24 -36.92 14.46 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.639 0.654 . . . . 0.0 111.951 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -72.23 -37.11 69.25 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.102 -0.998 . . . . 0.0 112.573 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 14.2 p -63.46 -28.7 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.607 0.763 . . . . 0.0 113.01 170.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.62 -46.57 37.45 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.86 0.864 . . . . 0.0 112.974 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -59.31 -27.84 66.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.317 1.447 . . . . 0.0 112.896 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.64 -60.93 2.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.216 1.006 . . . . 0.0 112.879 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 43.9 mt -65.09 -29.06 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 121.128 -0.982 . . . . 0.0 112.428 -169.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -51.44 -29.1 14.97 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.622 1.569 . . . . 0.0 113.19 168.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -93.87 -15.86 24.62 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.988 1.315 . . . . 0.0 113.698 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -127.6 -18.6 4.33 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -159.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.81 120.9 13.36 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 121.227 1.831 . . . . 0.0 110.506 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 92.98 0.78 68.02 Favored Glycine 0 N--CA 1.472 1.039 0 CA-C-O 117.941 -1.477 . . . . 0.0 115.059 -170.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.97 108.16 0.99 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.839 1.82 . . . . 0.0 110.348 171.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -55.68 129.25 38.44 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.313 0.645 . . . . 0.0 110.333 160.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -152.25 110.84 3.77 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.996 1.719 . . . . 0.0 106.685 -162.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 2.6 mpt? 41.15 59.28 2.35 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.152 0.981 . . . . 0.0 111.435 -160.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 73.21 0.05 3.54 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.922 2.089 . . . . 0.0 116.174 170.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -137.58 147.0 44.71 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.622 1.169 . . . . 0.0 111.775 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -70.83 124.22 23.79 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.903 -1.123 . . . . 0.0 113.698 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.4 pt -65.78 137.13 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.336 -0.853 . . . . 0.0 111.332 153.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -129.76 129.84 44.63 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.068 1.347 . . . . 0.0 109.596 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -156.32 129.09 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.992 0.917 . . . . 0.0 111.614 -169.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? . . . . . 0 N--CA 1.469 0.495 0 C-N-CA 125.919 1.687 . . . . 0.0 109.443 168.354 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 80.2 p . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 121.179 0.514 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 5.1 pt -144.58 154.37 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.219 1.407 . . . . 0.0 111.806 -165.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -119.02 125.85 50.32 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.553 1.941 . . . . 0.0 109.627 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 12.2 t -107.94 129.96 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.743 1.217 . . . . 0.0 109.111 -175.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.37 -97.66 0.12 Allowed Glycine 0 N--CA 1.472 1.094 0 C-N-CA 125.667 1.604 . . . . 0.0 115.036 -161.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -92.68 -56.86 2.85 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 117.625 0.713 . . . . 0.0 111.924 -173.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.45 6.67 1.52 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 118.752 2.871 . . . . 0.0 118.752 155.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.7 m 79.18 124.23 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 127.783 2.433 . . . . 0.0 110.422 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -68.25 -13.35 62.19 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -81.45 -9.14 59.78 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.503 1.521 . . . . 0.0 113.319 172.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.0 m -74.77 141.78 44.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.998 0.919 . . . . 0.0 112.551 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.8 p -122.87 152.78 63.21 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.971 1.308 . . . . 0.0 111.554 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.6 -25.9 14.46 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.607 2.205 . . . . 0.0 113.057 -173.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -69.43 -39.44 77.84 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.437 1.017 . . . . 0.0 111.891 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -73.16 -36.23 66.59 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.451 -0.781 . . . . 0.0 111.349 177.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 49.3 mt -62.24 -31.93 72.55 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.773 0.829 . . . . 0.0 112.289 166.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 54.8 m -67.0 -51.06 59.74 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.48 1.036 . . . . 0.0 109.634 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.92 -36.15 78.55 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.424 0.556 . . . . 0.0 112.359 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -67.38 -57.41 6.64 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.014 1.726 . . . . 0.0 112.29 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -71.57 -34.01 69.57 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.9 t -72.53 -8.79 56.95 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 121.004 -1.06 . . . . 0.0 113.441 -174.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -52.54 -27.99 18.93 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.362 2.265 . . . . 0.0 113.053 164.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 28.4 mm -80.52 -17.26 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.547 1.539 . . . . 0.0 112.451 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 117.25 90.98 1.54 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.909 1.719 . . . . 0.0 112.324 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? 69.69 91.29 0.09 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 126.751 2.02 . . . . 0.0 114.472 162.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 13.9 t -73.14 128.09 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 162.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 66.5 t -91.12 -22.51 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.892 1.677 . . . . 0.0 111.25 -175.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -178.43 140.03 0.2 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.243 2.217 . . . . 0.0 109.576 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -120.03 141.33 49.84 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.487 1.115 . . . . 0.0 110.52 162.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -143.7 92.95 2.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.677 1.191 . . . . 0.0 111.595 -169.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.482 1.148 0 C-N-CA 124.689 1.196 . . . . 0.0 110.815 173.776 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 28.2 ptm . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -166.22 -166.74 25.76 Favored Glycine 0 N--CA 1.471 1.025 0 C-N-CA 124.031 0.824 . . . . 0.0 114.088 174.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.8 p -141.84 161.14 38.69 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.83 1.252 . . . . 0.0 112.599 -167.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 6.4 t -143.54 142.28 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.651 1.18 . . . . 0.0 110.435 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -114.49 145.26 42.12 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.225 2.21 . . . . 0.0 111.218 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -129.83 161.69 30.2 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.936 2.494 . . . . 0.0 109.535 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.2 p -84.21 -28.56 27.22 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.99 -0.444 . . . . 0.0 111.396 171.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -84.66 174.7 9.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.36 1.864 . . . . 0.0 112.902 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 39.3 t -126.03 -65.92 0.96 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.85 0.86 . . . . 0.0 111.49 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -64.5 -25.48 68.01 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.51 -1.369 . . . . 0.0 113.821 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -72.06 -20.92 61.59 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.561 1.144 . . . . 0.0 113.315 171.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 22.0 t -70.05 -28.3 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.049 0.94 . . . . 0.0 111.591 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -74.44 -37.07 63.37 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.283 -0.886 . . . . 0.0 112.208 167.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -64.8 -23.66 67.31 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.239 1.016 . . . . 0.0 112.405 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.97 -63.87 1.12 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.19 0.996 . . . . 0.0 110.565 164.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 83.8 mt -62.09 -35.63 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.215 1.006 . . . . 0.0 112.396 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -64.03 -6.56 6.52 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -114.29 -5.15 12.96 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.525 1.53 . . . . 0.0 112.535 172.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -128.06 -19.43 3.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -169.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -58.64 121.43 10.97 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.072 1.306 . . . . 0.0 109.227 162.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 93.83 0.51 66.35 Favored Glycine 0 N--CA 1.468 0.786 0 CA-C-O 118.379 -1.234 . . . . 0.0 114.849 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.57 108.53 2.46 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.512 1.656 . . . . 0.0 110.463 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -54.8 123.24 12.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.434 0.694 . . . . 0.0 109.963 155.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -148.62 116.51 6.35 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.422 1.489 . . . . 0.0 108.335 -167.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 56.21 31.58 18.67 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.101 0.96 . . . . 0.0 111.968 -163.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 10.7 t70 86.61 0.66 0.57 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 128.37 2.668 . . . . 0.0 115.582 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.4 152.77 48.69 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.638 1.175 . . . . 0.0 111.782 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -82.38 123.68 29.33 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -158.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.75 153.4 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 126.037 1.735 . . . . 0.0 113.318 167.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -145.86 146.65 31.2 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.552 1.941 . . . . 0.0 108.787 164.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 23.4 t -117.41 128.57 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.727 1.211 . . . . 0.0 110.586 -173.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 . . . . . 0 CA--C 1.538 0.493 0 C-N-CA 123.863 0.865 . . . . 0.0 109.364 168.828 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.0 pt -143.61 147.32 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 125.301 1.44 . . . . 0.0 112.275 -165.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -113.78 118.98 35.78 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 128.041 2.536 . . . . 0.0 109.257 173.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 25.5 t -94.57 97.15 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.363 1.465 . . . . 0.0 107.397 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.39 -9.22 67.26 Favored Glycine 0 N--CA 1.475 1.25 0 N-CA-C 116.052 1.181 . . . . 0.0 116.052 -160.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -139.61 18.13 2.53 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -164.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.02 -174.92 2.86 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.28 1.432 . . . . 0.0 112.689 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 38.1 m -97.26 122.96 40.88 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.023 1.329 . . . . 0.0 109.503 171.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -66.94 -10.42 48.92 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -171.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -74.82 -13.11 60.53 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.486 1.514 . . . . 0.0 113.867 174.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 5.8 m -67.24 137.89 56.5 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.022 -1.049 . . . . 0.0 111.447 168.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 78.8 p -76.21 163.27 67.51 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 123.836 0.855 . . . . 0.0 109.908 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -59.91 -35.64 92.98 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 121.758 1.639 . . . . 0.0 111.917 168.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.42 -29.01 69.06 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.787 0.722 . . . . 0.0 112.88 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -65.21 -33.72 76.67 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.078 0.951 . . . . 0.0 111.992 173.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.3 mt -74.59 -34.16 62.81 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 118.003 -0.998 . . . . 0.0 113.451 165.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 84.8 m -61.08 -51.12 70.48 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.94 1.246 . . . . 0.0 110.62 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.24 -30.5 70.95 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.889 0.768 . . . . 0.0 112.973 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -68.27 -56.37 8.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.034 1.334 . . . . 0.0 111.514 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -71.65 -23.38 61.67 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.7 t -61.98 -19.65 63.03 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.651 -1.28 . . . . 0.0 113.457 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -60.97 -17.95 54.55 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.281 1.833 . . . . 0.0 113.306 169.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 25.8 mm -104.45 -51.87 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.144 1.378 . . . . 0.0 111.851 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -172.33 -177.42 41.79 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.165 1.364 . . . . 0.0 112.403 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -74.24 105.6 5.5 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 121.624 -0.927 . . . . 0.0 112.168 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 48.3 t -59.68 130.13 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 160.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.02 -40.16 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.312 0.645 . . . . 0.0 110.422 171.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -155.54 139.4 16.24 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.871 2.068 . . . . 0.0 109.983 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -125.31 152.96 43.99 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.313 1.445 . . . . 0.0 110.665 164.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -150.97 131.67 14.01 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.541 1.136 . . . . 0.0 112.203 -171.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.7 mt . . . . . 0 N--CA 1.48 1.057 0 C-N-CA 125.225 1.41 . . . . 0.0 110.974 171.863 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 3.6 ppp? . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -147.09 172.85 27.45 Favored Glycine 0 N--CA 1.468 0.774 0 C-N-CA 126.025 1.774 . . . . 0.0 112.808 177.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.3 p -142.81 148.77 37.67 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.12 1.368 . . . . 0.0 111.013 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.29 137.28 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.09 0.956 . . . . 0.0 109.983 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -116.09 137.08 52.44 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.706 1.603 . . . . 0.0 109.635 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -110.98 159.12 18.03 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.17 1.788 . . . . 0.0 110.411 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 64.1 p -77.07 0.48 21.28 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 169.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -130.01 157.18 43.05 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.106 1.762 . . . . 0.0 112.886 -165.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 72.1 p -109.14 -7.85 15.24 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.601 1.56 . . . . 0.0 114.916 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.71 -45.42 1.46 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.39 1.476 . . . . 0.0 111.914 -166.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.23 -30.08 68.16 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.596 -0.69 . . . . 0.0 111.505 172.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.5 p -61.13 -32.11 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.276 1.43 . . . . 0.0 113.025 174.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -74.16 -48.11 31.48 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.965 0.906 . . . . 0.0 111.436 171.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -72.34 -11.76 60.84 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.62 -56.75 17.46 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.6 1.16 . . . . 0.0 111.381 163.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 71.2 mt -66.87 -30.33 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.055 0.942 . . . . 0.0 112.109 -168.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -52.41 -28.37 19.58 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.507 1.123 . . . . 0.0 113.471 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -97.1 -15.23 21.07 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.399 1.48 . . . . 0.0 112.579 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -123.29 -15.64 7.14 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -165.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -61.31 120.65 10.83 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.53 1.514 . . . . 0.0 108.88 162.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 97.57 -0.24 59.58 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 118.153 -1.36 . . . . 0.0 114.844 -172.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.17 103.88 2.46 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.727 1.764 . . . . 0.0 110.469 173.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -60.81 119.69 8.67 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 158.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -150.38 110.85 4.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.152 1.381 . . . . 0.0 108.633 -165.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 57.13 55.38 6.04 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.298 1.039 . . . . 0.0 110.865 -170.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 19.5 t70 76.13 0.18 3.23 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.749 2.02 . . . . 0.0 116.088 169.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -146.86 157.36 43.63 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.311 0.959 . . . . 0.0 112.787 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 4.2 tmmm? -86.36 105.42 16.69 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.673 1.189 . . . . 0.0 112.647 -172.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.22 154.1 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.188 0.995 . . . . 0.0 112.052 165.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -156.45 144.77 19.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.466 1.906 . . . . 0.0 107.486 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 13.2 t -127.36 140.31 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.632 0.773 . . . . 0.0 111.926 -162.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 81.6 mtt85 . . . . . 0 CA--C 1.536 0.411 0 C-N-CA 126.95 2.1 . . . . 0.0 108.318 175.399 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 CA--C 1.541 0.617 0 CA-C-O 122.05 0.928 . . . . 0.0 112.806 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 31.7 pt -138.95 138.89 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.898 2.079 . . . . 0.0 107.948 175.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -105.73 131.3 53.25 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.59 1.156 . . . . 0.0 109.52 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.7 t -111.2 122.96 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.677 1.591 . . . . 0.0 108.354 -170.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.12 -141.67 1.78 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.195 1.855 . . . . 0.0 113.312 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -74.97 47.26 0.34 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -162.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -53.99 -50.1 67.34 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.819 -1.175 . . . . 0.0 112.606 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.1 t 145.23 142.96 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.388 1 C-N-CA 131.705 4.002 . . . . 0.0 110.18 173.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -68.95 -9.5 52.39 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -80.59 -6.07 57.75 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.748 1.219 . . . . 0.0 113.198 170.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 6.2 t -88.72 167.06 13.63 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.957 0.903 . . . . 0.0 113.163 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.45 151.74 64.71 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 125.741 1.617 . . . . 0.0 111.385 -170.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.41 -21.76 11.42 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.797 2.332 . . . . 0.0 114.331 -167.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.02 -34.79 75.81 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.156 1.344 . . . . 0.0 111.567 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.42 -41.66 84.48 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.777 1.231 . . . . 0.0 110.874 175.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.4 tp -67.38 -33.59 75.51 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.478 1.911 . . . . 0.0 111.455 174.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 68.3 m -64.26 -50.45 67.91 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.428 1.491 . . . . 0.0 110.41 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -67.59 -40.5 84.79 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.918 0.487 . . . . 0.0 111.622 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -56.07 -56.58 19.1 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.484 1.513 . . . . 0.0 112.235 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -71.13 -27.46 63.59 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.6 m -73.3 0.51 11.8 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -68.75 -19.59 64.34 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.169 -0.957 . . . . 0.0 112.597 164.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 14.0 mm -95.05 -55.29 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.104 0.961 . . . . 0.0 111.137 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -135.68 -109.68 1.02 Allowed Glycine 0 N--CA 1.468 0.779 0 C-N-CA 125.906 1.717 . . . . 0.0 110.372 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -152.84 121.99 6.63 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.213 1.005 . . . . 0.0 111.097 173.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 49.1 t -73.4 129.95 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 170.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.61 -24.05 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 170.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -152.78 135.7 15.51 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.463 1.505 . . . . 0.0 110.257 172.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -128.09 148.79 50.58 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.014 1.326 . . . . 0.0 110.598 160.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -145.53 134.98 23.15 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.6 1.16 . . . . 0.0 112.13 -172.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 59.2 mt . . . . . 0 N--CA 1.483 1.201 0 C-N-CA 125.64 1.576 . . . . 0.0 110.165 170.923 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 120.334 0.111 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -145.61 -179.08 21.61 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 124.383 0.992 . . . . 0.0 114.905 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 12.7 m -141.55 148.56 39.53 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.361 1.465 . . . . 0.0 109.087 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 19.6 t -141.25 147.15 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.263 1.025 . . . . 0.0 110.472 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.04 131.1 47.31 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.589 1.556 . . . . 0.0 110.976 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -102.53 161.69 13.52 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.51 1.524 . . . . 0.0 111.196 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 54.1 p -70.52 0.21 7.21 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.559 1.543 . . . . 0.0 113.893 166.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -141.75 162.21 36.03 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.432 1.893 . . . . 0.0 112.108 -165.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 12.5 m -132.67 13.42 4.45 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -132.06 -36.5 1.17 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.068 1.347 . . . . 0.0 112.661 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -66.51 -21.53 66.17 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.748 0.819 . . . . 0.0 112.397 167.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.1 m -63.87 -28.17 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.507 1.523 . . . . 0.0 112.907 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -74.3 -49.64 22.21 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.55 1.14 . . . . 0.0 111.449 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 23.4 ptt-85 -74.37 -11.86 60.36 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.7 -64.5 0.88 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.939 0.895 . . . . 0.0 110.835 160.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 66.3 mt -62.19 -32.83 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.938 0.895 . . . . 0.0 112.449 -171.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 35.0 ttm105 -57.21 -22.69 42.67 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 173.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -98.06 -11.14 23.25 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.41 1.084 . . . . 0.0 112.943 175.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -123.56 -21.29 5.3 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -165.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -66.2 120.44 13.23 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 120.415 1.461 . . . . 0.0 109.559 172.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 90.06 0.59 77.35 Favored Glycine 0 N--CA 1.473 1.127 0 CA-C-O 117.884 -1.509 . . . . 0.0 115.146 -168.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.8 109.46 1.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.986 1.893 . . . . 0.0 109.482 167.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -55.97 119.89 6.57 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 157.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -148.87 118.35 6.94 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.215 1.406 . . . . 0.0 108.259 -172.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.38 44.07 18.87 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-O 122.398 1.094 . . . . 0.0 110.212 -163.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 71.55 0.52 3.51 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 128.066 2.546 . . . . 0.0 116.253 173.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 30.1 mmt85 -135.04 148.69 49.97 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.07 1.348 . . . . 0.0 112.105 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -64.54 117.07 6.83 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.194 -0.941 . . . . 0.0 113.234 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.26 153.56 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.635 0.774 . . . . 0.0 110.684 156.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -137.53 157.37 46.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.533 1.533 . . . . 0.0 107.857 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.12 139.24 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.528 1.058 . . . . 0.0 111.681 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 . . . . . 0 CA--C 1.538 0.481 0 C-N-CA 125.828 1.651 . . . . 0.0 108.84 169.347 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.7 m . . . . . 0 CA--C 1.54 0.58 0 CA-C-O 120.993 0.425 . . . . 0.0 111.917 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.9 pt -130.92 150.2 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.976 1.71 . . . . 0.0 110.976 -170.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -110.0 138.88 45.76 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.503 1.521 . . . . 0.0 111.197 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 44.8 t -126.79 131.04 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.923 1.689 . . . . 0.0 108.786 -169.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.32 -164.2 7.2 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.976 1.751 . . . . 0.0 113.283 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -67.52 -14.96 63.39 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 118.062 2.615 . . . . 0.0 118.062 -157.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.3 mp 51.03 -112.71 0.65 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.537 1.535 . . . . 0.0 109.857 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 71.2 p -122.87 153.39 39.69 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.056 2.143 . . . . 0.0 109.312 154.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -57.12 -28.84 63.05 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -175.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -91.73 -0.98 57.59 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.821 2.048 . . . . 0.0 114.114 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 85.8 p -67.47 160.91 26.56 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.45 152.67 60.97 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 125.799 1.64 . . . . 0.0 111.593 -169.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.79 -18.53 11.7 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.151 2.567 . . . . 0.0 114.647 -165.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.43 -35.48 81.07 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.519 1.054 . . . . 0.0 111.112 172.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -69.64 -36.86 76.48 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.773 1.229 . . . . 0.0 111.399 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.8 mt -67.98 -31.89 71.91 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-O 118.685 -0.674 . . . . 0.0 112.326 169.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 59.7 m -67.16 -50.89 59.51 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.969 0.804 . . . . 0.0 109.516 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -58.13 -38.8 77.23 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.669 0.788 . . . . 0.0 112.293 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -65.56 -63.25 1.14 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.343 1.457 . . . . 0.0 112.236 176.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.16 -33.95 70.5 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -173.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.25 -3.39 26.55 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -172.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -65.47 -18.17 65.12 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 120.967 -1.083 . . . . 0.0 112.739 169.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 29.8 mm -78.53 -27.4 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.616 1.567 . . . . 0.0 112.31 174.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 139.25 169.45 11.58 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.994 1.759 . . . . 0.0 110.755 -158.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -57.72 106.54 0.36 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -164.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 53.9 t -71.05 131.36 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 151.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.29 -26.5 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 171.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 50.7 ttt-85 -162.74 110.47 1.28 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.856 0.463 . . . . 0.0 110.825 -170.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.72 151.74 19.84 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.192 0.997 . . . . 0.0 110.259 161.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -153.23 125.28 7.93 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.911 0.884 . . . . 0.0 111.615 -170.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mt . . . . . 0 N--CA 1.482 1.161 0 C-N-CA 125.565 1.546 . . . . 0.0 111.354 -179.125 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -175.92 -152.46 9.56 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.8 p -143.01 159.83 41.5 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.124 1.77 . . . . 0.0 112.172 -172.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 18.8 t -140.42 140.89 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.294 1.038 . . . . 0.0 110.306 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -128.86 127.68 42.35 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.383 1.473 . . . . 0.0 109.981 -172.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -110.8 170.71 7.92 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.53 1.932 . . . . 0.0 109.746 -174.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 80.9 p -81.47 0.07 39.45 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -139.07 155.08 48.19 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.831 1.253 . . . . 0.0 114.088 -167.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 66.4 p -108.38 4.73 24.73 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.775 1.63 . . . . 0.0 113.68 -177.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -120.37 -46.04 2.41 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.634 1.174 . . . . 0.0 112.783 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -63.53 -22.04 66.67 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.313 -0.867 . . . . 0.0 113.039 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.3 m -61.34 -29.74 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.896 2.079 . . . . 0.0 113.363 173.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -74.48 -49.46 22.13 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.026 0.83 . . . . 0.0 110.541 166.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -58.4 -28.28 65.05 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.797 1.239 . . . . 0.0 113.399 -174.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.2 -59.57 5.21 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.23 1.412 . . . . 0.0 112.291 168.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 51.6 mt -66.39 -31.25 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.22 1.008 . . . . 0.0 112.282 -170.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -58.91 -5.77 0.67 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 171.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -133.07 5.68 3.86 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.52 1.128 . . . . 0.0 114.038 172.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -123.11 -22.14 5.25 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.01 120.64 13.98 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 121.327 1.876 . . . . 0.0 110.653 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 92.16 0.83 70.38 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-O 118.025 -1.43 . . . . 0.0 115.119 -169.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.42 107.47 0.79 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.953 1.877 . . . . 0.0 109.926 168.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -52.02 123.95 11.68 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.957 161.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -147.97 120.83 8.72 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.022 1.329 . . . . 0.0 108.709 -172.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 50.5 mtt 60.37 28.07 17.68 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.154 0.982 . . . . 0.0 112.159 -169.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.6 t70 92.27 -0.06 0.13 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 129.449 3.1 . . . . 0.0 115.419 173.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 42.9 mmt180 -136.69 150.48 48.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.751 1.221 . . . . 0.0 112.184 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -65.12 111.71 3.05 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.862 -1.149 . . . . 0.0 112.555 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.47 152.0 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 O-C-N 121.169 -0.957 . . . . 0.0 109.761 151.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -132.12 156.66 45.96 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.145 1.378 . . . . 0.0 108.429 170.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.7 p -150.44 127.0 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.517 0.675 . . . . 0.0 112.113 -169.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 125.481 1.512 . . . . 0.0 108.403 175.917 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 6.7 pt -139.22 150.94 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.69 1.596 . . . . 0.0 109.784 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -122.95 143.77 49.69 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.216 1.406 . . . . 0.0 111.986 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.0 t -124.34 116.82 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.226 1.81 . . . . 0.0 108.193 -174.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.06 -25.43 59.77 Favored Glycine 0 N--CA 1.475 1.24 0 C-N-CA 123.542 0.591 . . . . 0.0 114.403 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -162.17 151.22 15.48 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.742 2.017 . . . . 0.0 108.571 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -173.16 11.19 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 126.054 1.742 . . . . 0.0 114.917 -171.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 34.9 m 86.42 111.45 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 128.739 2.816 . . . . 0.0 109.403 -165.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -62.64 -17.43 60.36 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -83.42 -0.35 49.59 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.703 1.601 . . . . 0.0 113.529 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 10.0 t -67.66 167.56 12.9 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.834 -1.166 . . . . 0.0 113.797 175.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 44.8 p -135.7 153.32 77.32 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 125.972 1.709 . . . . 0.0 110.416 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.56 -23.96 26.54 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.566 2.177 . . . . 0.0 113.13 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.28 -37.19 77.75 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.885 0.766 . . . . 0.0 111.712 172.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.47 -35.37 68.21 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.507 -0.746 . . . . 0.0 111.424 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 20.9 mt -62.91 -35.85 81.44 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-O 118.807 -0.616 . . . . 0.0 112.334 166.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 74.7 m -67.93 -45.83 73.22 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.222 0.919 . . . . 0.0 110.337 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.7 -15.79 54.32 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.811 1.245 . . . . 0.0 113.502 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -96.5 -57.94 2.18 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.285 1.834 . . . . 0.0 111.896 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -71.6 -34.2 69.65 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 3.7 t -73.16 -15.92 61.45 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -159.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -64.35 -17.9 64.15 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 35.8 mm -59.8 -24.18 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.114 1.365 . . . . 0.0 112.641 173.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 167.52 -72.05 0.16 Allowed Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.926 1.25 . . . . 0.0 111.467 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -160.28 118.39 2.6 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.965 1.306 . . . . 0.0 111.158 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.29 137.93 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 165.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.5 m -110.27 -16.67 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -159.91 158.46 30.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.739 1.215 . . . . 0.0 111.881 176.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -160.06 149.13 17.5 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.939 1.696 . . . . 0.0 111.696 174.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -149.58 152.54 35.66 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.619 1.967 . . . . 0.0 111.641 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 26.6 mm . . . . . 0 N--CA 1.479 1.019 0 C-N-CA 126.145 1.778 . . . . 0.0 107.844 170.292 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 3.0 mpp? . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 121.256 0.55 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -110.43 158.97 14.11 Favored Glycine 0 N--CA 1.468 0.806 0 C-N-CA 124.656 1.122 . . . . 0.0 113.458 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.2 m -141.97 142.4 32.97 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.887 1.675 . . . . 0.0 108.032 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.7 t -142.4 149.97 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.972 0.909 . . . . 0.0 109.433 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -132.65 129.72 39.23 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.891 0.876 . . . . 0.0 111.523 -176.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -114.9 172.7 6.89 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.243 1.817 . . . . 0.0 111.102 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.8 p -86.85 -11.57 50.44 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -149.35 127.96 12.38 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 116.749 2.129 . . . . 0.0 116.749 -169.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 33.0 p -73.8 2.29 8.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 128.116 2.566 . . . . 0.0 116.064 -174.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -114.07 -36.76 4.64 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.269 1.428 . . . . 0.0 111.693 169.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.68 -27.68 69.09 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.5 -0.75 . . . . 0.0 112.775 173.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.9 m -59.55 -33.43 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 171.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -74.17 -46.61 41.15 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.958 0.799 . . . . 0.0 110.214 172.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -57.88 -29.7 65.25 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.673 0.789 . . . . 0.0 112.829 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.95 -68.57 0.35 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.778 1.231 . . . . 0.0 111.492 167.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 64.7 mt -61.99 -34.83 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.43 -0.793 . . . . 0.0 112.193 -167.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -58.69 -12.78 4.59 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.754 1.222 . . . . 0.0 114.187 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -116.62 -1.99 12.04 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.719 1.608 . . . . 0.0 112.888 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -128.91 -23.21 3.11 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.67 120.57 11.45 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 120.498 1.499 . . . . 0.0 109.832 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 95.68 0.48 62.46 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-O 118.11 -1.383 . . . . 0.0 115.725 -170.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.96 108.46 1.04 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.721 1.76 . . . . 0.0 109.973 169.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -58.12 124.17 18.46 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.788 -0.57 . . . . 0.0 109.921 158.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -150.38 110.97 4.24 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.852 1.261 . . . . 0.0 108.912 -159.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 49.8 mtt 57.91 23.36 9.72 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.585 1.154 . . . . 0.0 113.487 -169.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 19.8 t70 101.16 -11.61 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 130.811 3.644 . . . . 0.0 115.24 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -116.29 147.0 41.97 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 119.978 1.263 . . . . 0.0 111.801 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -68.09 112.06 4.83 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.308 1.443 . . . . 0.0 112.229 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.5 pt -61.21 141.69 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.473 1.033 . . . . 0.0 111.609 166.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -138.37 129.76 27.51 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.644 1.178 . . . . 0.0 109.158 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.2 126.81 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 123.626 0.771 . . . . 0.0 110.713 -164.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 52.7 ttt85 . . . . . 0 CA--C 1.534 0.352 0 C-N-CA 126.539 1.936 . . . . 0.0 108.768 170.937 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 CA--C 1.541 0.608 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -131.15 142.83 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.233 0.613 . . . . 0.0 110.024 158.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -111.93 142.48 44.28 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.71 1.604 . . . . 0.0 111.166 -174.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.3 t -144.61 121.32 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.161 0.984 . . . . 0.0 109.989 174.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -137.75 19.56 3.32 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.88 1.229 . . . . 0.0 115.602 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -128.57 20.02 6.16 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.305 1.442 . . . . 0.0 112.707 -171.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.3 pp -96.54 -175.88 3.45 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 126.984 2.114 . . . . 0.0 111.245 -174.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 48.4 m -79.81 121.5 25.47 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.782 0.833 . . . . 0.0 109.407 168.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -66.54 -11.56 53.47 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -170.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -81.38 -10.97 59.42 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.956 1.303 . . . . 0.0 113.588 171.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 91.5 p -77.66 142.6 38.75 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.6 -0.688 . . . . 0.0 111.664 172.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 68.2 p -102.52 163.63 17.25 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 125.067 1.347 . . . . 0.0 111.205 -171.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -64.54 -26.8 61.91 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.499 2.133 . . . . 0.0 112.931 171.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -69.34 -40.03 77.81 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.472 1.033 . . . . 0.0 111.729 171.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -66.93 -36.58 82.56 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.817 0.847 . . . . 0.0 111.64 175.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 45.7 mt -66.21 -32.66 74.22 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.547 -0.74 . . . . 0.0 112.725 166.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 81.8 m -67.1 -48.22 68.83 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.686 1.13 . . . . 0.0 109.965 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.05 -27.84 69.18 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -78.69 -58.96 2.98 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.53 1.532 . . . . 0.0 112.106 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -71.1 -37.83 72.39 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.65 -1.67 19.89 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -176.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -55.87 -26.87 49.09 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.797 1.639 . . . . 0.0 112.165 164.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.4 mm -75.87 -30.7 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.815 1.646 . . . . 0.0 112.88 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 166.86 -103.84 0.21 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.783 1.182 . . . . 0.0 112.181 -165.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -135.01 106.35 6.77 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.991 0.916 . . . . 0.0 113.396 -175.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 56.2 t -80.96 135.68 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 153.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.33 -24.72 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -157.88 88.66 0.98 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.547 0.739 . . . . 0.0 112.235 -170.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -91.18 140.97 29.3 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.812 -1.18 . . . . 0.0 111.709 168.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -153.28 121.44 6.17 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.919 1.287 . . . . 0.0 112.201 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 20.3 mt . . . . . 0 N--CA 1.484 1.252 0 C-N-CA 125.459 1.504 . . . . 0.0 111.08 174.357 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 26.8 ptm . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 120.933 0.397 . . . . 0.0 111.74 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 169.6 -143.45 7.94 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.932 0.777 . . . . 0.0 113.002 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 25.0 p -137.87 160.87 38.12 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.986 0.914 . . . . 0.0 113.272 -162.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.3 t -136.03 102.42 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.126 1.371 . . . . 0.0 108.056 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -88.53 122.85 32.45 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.205 1.002 . . . . 0.0 110.457 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -90.02 176.03 6.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.86 1.664 . . . . 0.0 109.814 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 72.4 p -68.09 0.16 3.91 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 168.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 27.3 m120 85.77 2.91 0.6 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.743 2.817 . . . . 0.0 114.977 165.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.7 t -110.8 -168.53 1.32 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.462 1.505 . . . . 0.0 112.136 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -34.08 -38.37 0.06 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 130.531 3.533 . . . . 0.0 117.28 -164.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -52.15 -33.69 41.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.101 1.76 . . . . 0.0 112.733 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.0 p -68.83 -37.41 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.107 1.363 . . . . 0.0 112.952 -169.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -75.16 -52.07 11.86 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.734 1.214 . . . . 0.0 112.382 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -74.0 -18.47 60.85 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.654 1.182 . . . . 0.0 114.057 -171.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.47 -60.03 4.11 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.065 0.946 . . . . 0.0 111.911 170.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 27.9 mt -65.46 -28.73 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.706 0.803 . . . . 0.0 112.41 -171.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -28.63 37.53 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.324 1.05 . . . . 0.0 112.511 169.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -98.24 -11.31 22.8 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.443 1.097 . . . . 0.0 113.432 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -126.32 -20.12 4.51 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -164.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -62.42 120.79 11.73 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 120.038 1.29 . . . . 0.0 109.627 169.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 95.1 0.52 63.5 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-O 118.163 -1.354 . . . . 0.0 115.334 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.15 107.06 0.81 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.757 1.778 . . . . 0.0 110.673 170.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -57.22 107.32 0.41 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 154.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -129.74 110.66 11.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.323 1.049 . . . . 0.0 108.921 -167.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 48.2 ttm 53.88 43.92 30.22 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.923 0.889 . . . . 0.0 110.816 -168.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.8 t70 86.76 0.21 0.56 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 128.091 2.557 . . . . 0.0 116.146 170.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -136.19 135.89 39.5 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.622 1.101 . . . . 0.0 112.542 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -68.17 102.55 1.37 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.546 1.538 . . . . 0.0 113.541 -176.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.51 151.25 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.117 0.967 . . . . 0.0 111.456 164.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -148.01 135.41 20.61 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.083 1.353 . . . . 0.0 108.921 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -156.94 137.08 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.217 1.407 . . . . 0.0 109.867 -165.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 . . . . . 0 CA--C 1.536 0.438 0 C-N-CA 124.855 1.262 . . . . 0.0 109.579 171.148 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.5 p . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 43.5 pt -137.26 138.04 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.647 1.179 . . . . 0.0 110.06 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -98.99 148.7 23.73 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.907 1.283 . . . . 0.0 109.489 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.6 t -126.4 131.67 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.537 1.535 . . . . 0.0 108.759 -172.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -74.17 -154.57 3.59 Favored Glycine 0 N--CA 1.474 1.192 0 C-N-CA 125.543 1.544 . . . . 0.0 112.93 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -55.48 -42.73 74.77 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -166.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 57.34 -169.44 0.11 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 128.061 2.545 . . . . 0.0 115.81 165.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.2 t -76.39 73.14 3.16 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.258 1.823 . . . . 0.0 110.416 166.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -68.05 -9.29 44.86 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -74.37 -12.42 60.52 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.113 1.365 . . . . 0.0 113.132 167.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 3.8 t -101.3 151.06 22.34 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.274 1.03 . . . . 0.0 113.523 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 17.6 p -81.94 152.67 69.06 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 126.444 1.898 . . . . 0.0 111.457 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.36 -25.79 80.66 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.213 2.609 . . . . 0.0 115.482 -173.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -67.21 -17.03 64.65 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.865 1.211 . . . . 0.0 113.439 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -70.74 -33.99 71.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.29 1.036 . . . . 0.0 111.25 170.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.1 mt -74.33 -32.48 62.83 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.336 -0.84 . . . . 0.0 111.782 167.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 31.1 m -62.75 -51.34 67.52 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.731 1.151 . . . . 0.0 110.264 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.53 -34.12 75.0 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.336 0.516 . . . . 0.0 112.119 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -67.0 -65.04 0.73 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.608 1.563 . . . . 0.0 111.329 176.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -71.24 -29.0 64.58 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -173.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.4 t -73.25 -23.63 60.36 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -173.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -67.34 -10.89 55.46 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 29.5 mm -69.89 -31.31 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.439 1.496 . . . . 0.0 112.59 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.66 42.01 0.03 OUTLIER Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.242 0.925 . . . . 0.0 114.221 -172.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 83.4 tttt 79.34 124.45 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 128.708 2.803 . . . . 0.0 113.606 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.7 149.32 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 126.159 1.784 . . . . 0.0 108.097 164.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 4.3 m -110.27 -18.27 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -157.32 147.29 20.65 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.846 0.858 . . . . 0.0 111.245 -175.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -154.48 144.39 21.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.729 1.611 . . . . 0.0 110.559 170.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -155.11 153.07 30.29 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 122.096 0.95 . . . . 0.0 113.262 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 51.0 mm . . . . . 0 CA--C 1.544 0.745 0 C-N-CA 127.3 2.24 . . . . 0.0 110.543 171.868 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 22.8 ptp . . . . . 0 N--CA 1.475 0.801 0 CA-C-O 120.58 0.228 . . . . 0.0 111.527 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -156.47 175.22 34.16 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.195 1.379 . . . . 0.0 113.197 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 27.5 m -148.17 147.05 29.02 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.148 1.379 . . . . 0.0 109.889 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.1 t -139.0 141.55 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.448 1.099 . . . . 0.0 109.541 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -123.93 131.64 53.6 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.603 1.161 . . . . 0.0 111.509 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -102.2 173.81 6.2 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.306 1.842 . . . . 0.0 110.426 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 81.3 p -68.88 0.65 4.15 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 176.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 93.04 52.48 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 128.169 2.587 . . . . 0.0 113.606 161.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.7 t -161.4 -165.35 1.29 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.947 0.899 . . . . 0.0 112.872 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -57.86 -10.37 1.69 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.097 2.159 . . . . 0.0 115.234 -168.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -52.07 -34.11 42.25 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.177 1.391 . . . . 0.0 111.729 162.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.54 -39.48 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.742 1.617 . . . . 0.0 111.427 176.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.65 -55.03 6.32 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.323 1.049 . . . . 0.0 111.919 171.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -59.11 -29.71 67.58 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.183 1.393 . . . . 0.0 113.706 -172.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.26 -60.59 3.57 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.931 0.892 . . . . 0.0 112.681 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 3.5 mp -68.79 -22.36 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.088 -1.008 . . . . 0.0 112.803 -168.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 16.5 mmt-85 -54.23 -27.91 37.73 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.401 0.68 . . . . 0.0 112.773 168.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -95.5 -17.71 21.24 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.795 1.238 . . . . 0.0 112.817 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -122.46 -18.87 6.57 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -161.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -58.24 120.21 8.27 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 120.585 1.539 . . . . 0.0 110.276 175.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 79.94 0.3 84.93 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.277 -1.291 . . . . 0.0 116.094 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.58 97.67 2.18 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 120.082 1.941 . . . . 0.0 111.377 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -48.92 135.63 15.32 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.028 0.931 . . . . 0.0 112.532 176.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -143.87 116.9 8.88 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.356 1.062 . . . . 0.0 109.852 -162.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 16.8 ttt 59.89 34.36 21.69 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.391 1.077 . . . . 0.0 111.156 -168.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 67.67 0.68 2.33 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.888 2.075 . . . . 0.0 114.095 -174.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -112.26 165.37 12.23 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.297 2.239 . . . . 0.0 111.423 -171.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -66.35 168.91 8.07 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.342 1.057 . . . . 0.0 113.144 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 41.8 pt -158.3 146.76 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 1 C-N-CA 132.204 4.201 . . . . 0.0 107.058 171.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -149.49 141.94 24.3 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.712 1.605 . . . . 0.0 107.219 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.8 p -150.44 137.38 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 120.068 1.303 . . . . 0.0 113.632 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 . . . . . 0 CA--C 1.541 0.626 0 C-N-CA 126.572 1.949 . . . . 0.0 110.931 176.993 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 121.06 0.457 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 8.0 pt -142.36 138.24 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.243 -0.911 . . . . 0.0 110.9 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -128.39 134.41 48.82 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.166 1.786 . . . . 0.0 109.951 -175.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.65 134.24 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.875 1.27 . . . . 0.0 109.979 -156.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.85 -116.23 0.12 Allowed Glycine 0 N--CA 1.478 1.455 0 C-N-CA 127.055 2.264 . . . . 0.0 115.002 -170.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -68.25 -62.59 1.33 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.71 1.255 . . . . 0.0 111.999 -176.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 62.92 5.03 1.66 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.533 2.333 . . . . 0.0 117.166 167.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 58.7 m 74.51 98.25 0.07 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 127.416 2.286 . . . . 0.0 108.643 -162.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -65.03 -16.18 63.16 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -170.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.15 0.38 51.18 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.883 1.673 . . . . 0.0 114.0 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 95.6 p -70.67 167.14 19.29 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 172.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 18.7 p -123.9 151.5 64.86 Favored Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 124.936 1.294 . . . . 0.0 112.392 -170.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.35 -17.44 16.68 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.347 2.698 . . . . 0.0 115.385 -169.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.8 -36.9 81.25 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.966 1.257 . . . . 0.0 111.953 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -72.98 -35.78 66.95 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.284 -0.885 . . . . 0.0 111.536 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.3 mt -64.07 -33.39 75.65 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.119 0.968 . . . . 0.0 111.903 168.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.4 m -65.57 -49.72 67.77 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.009 0.822 . . . . 0.0 109.666 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.35 -41.08 98.3 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.484 0.584 . . . . 0.0 112.008 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.68 -56.33 20.83 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.145 1.378 . . . . 0.0 112.29 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.23 -43.44 67.28 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.4 t -73.62 -12.6 60.8 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -171.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -62.59 -16.48 56.58 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.656 1.116 . . . . 0.0 113.101 170.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 16.3 mm -72.98 -33.0 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.751 1.22 . . . . 0.0 111.976 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.44 -84.49 0.08 OUTLIER Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.221 1.391 . . . . 0.0 112.517 -170.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -157.3 103.48 1.99 Allowed 'General case' 0 CA--C 1.55 0.942 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -170.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 40.4 t -77.35 136.81 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 156.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.0 p -104.86 -20.23 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.282 1.033 . . . . 0.0 112.813 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 30.8 ttm-85 -164.38 139.3 5.68 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.369 1.468 . . . . 0.0 111.706 173.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -129.67 147.12 51.43 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.864 1.266 . . . . 0.0 111.259 164.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -159.11 152.29 22.37 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 174.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 126.564 1.946 . . . . 0.0 111.224 171.888 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -114.84 168.89 12.67 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.887 1.708 . . . . 0.0 113.82 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 21.8 m -141.09 144.59 35.0 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.916 1.286 . . . . 0.0 109.838 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.8 t -137.15 136.87 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.8 0.84 . . . . 0.0 109.185 171.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -104.58 119.8 39.82 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.079 1.751 . . . . 0.0 109.205 173.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -93.09 176.77 6.29 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.301 1.44 . . . . 0.0 109.034 163.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 45.6 p -97.4 -15.73 20.54 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -150.29 126.41 10.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.182 0.993 . . . . 0.0 113.226 -172.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.4 p -46.89 -53.58 11.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.68 1.992 . . . . 0.0 114.261 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -60.05 -28.58 67.89 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.89 -35.45 67.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.498 1.119 . . . . 0.0 112.644 173.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -69.79 -40.52 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.013 0.925 . . . . 0.0 112.272 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.52 -47.53 66.73 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.577 -176.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -66.34 -18.29 65.27 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -70.84 -62.87 1.23 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.696 0.798 . . . . 0.0 110.475 167.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 60.8 mt -60.96 -33.86 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.446 1.099 . . . . 0.0 112.667 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -52.0 -19.9 2.1 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.971 1.709 . . . . 0.0 114.02 170.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -114.26 -6.79 12.99 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.849 1.66 . . . . 0.0 112.815 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -126.84 -22.72 3.8 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -166.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.88 120.71 13.04 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 120.916 1.689 . . . . 0.0 109.637 173.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 98.15 0.28 58.56 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-O 118.219 -1.323 . . . . 0.0 115.2 -168.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.33 108.23 1.26 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.718 1.759 . . . . 0.0 110.218 170.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -56.57 125.14 20.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.273 0.558 . . . . 0.0 109.772 154.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -149.59 110.84 4.41 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.319 1.447 . . . . 0.0 108.076 -159.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 24.1 mmt 55.87 32.95 20.66 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.626 0.77 . . . . 0.0 112.192 -169.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 87.49 0.37 0.47 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.888 2.875 . . . . 0.0 115.985 174.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.49 152.69 50.82 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.806 1.184 . . . . 0.0 112.043 173.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -77.48 129.12 35.3 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.8 -1.187 . . . . 0.0 114.104 -167.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.3 pt -75.58 133.52 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 120.997 -1.064 . . . . 0.0 110.487 164.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -118.24 144.47 45.75 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 166.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.3 p -150.85 140.19 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 120.162 1.347 . . . . 0.0 112.677 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 . . . . . 0 C--O 1.234 0.276 0 C-N-CA 126.113 1.765 . . . . 0.0 110.255 171.716 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 52.9 m . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 6.8 pt -130.57 151.74 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.815 1.646 . . . . 0.0 110.011 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -132.86 143.51 49.58 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.448 1.899 . . . . 0.0 109.717 -173.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.16 134.59 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 119.495 1.043 . . . . 0.0 111.177 -175.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.42 -71.83 1.03 Allowed Glycine 0 N--CA 1.473 1.161 0 C-N-CA 124.124 0.869 . . . . 0.0 113.657 -173.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -83.91 39.03 0.67 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.032 1.333 . . . . 0.0 114.245 -165.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.75 170.86 15.38 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.339 -1.476 . . . . 0.0 110.677 165.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 45.9 m -75.55 124.39 27.11 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.707 0.803 . . . . 0.0 109.06 167.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -70.18 -13.71 62.31 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -167.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -89.14 0.08 57.02 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 170.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 32.0 t -63.57 138.18 58.4 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 121.254 -0.904 . . . . 0.0 111.022 161.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 41.4 p -98.47 159.89 29.42 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 124.704 1.201 . . . . 0.0 110.728 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.16 -19.52 68.9 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.921 1.747 . . . . 0.0 112.486 167.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -69.16 -44.49 72.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 120.225 1.375 . . . . 0.0 111.2 170.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -59.14 -45.99 89.51 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.396 0.679 . . . . 0.0 110.755 172.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -27.37 68.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.999 0.92 . . . . 0.0 113.341 173.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 52.2 m -76.48 -47.77 21.81 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.52 1.055 . . . . 0.0 110.0 176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -59.02 -31.1 68.52 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.718 1.145 . . . . 0.0 112.168 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -70.87 -67.88 0.47 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.389 1.476 . . . . 0.0 112.005 174.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -71.14 -35.04 71.56 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.5 t -73.33 -10.46 59.78 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -170.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -62.04 -17.25 56.77 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.223 -0.923 . . . . 0.0 113.343 171.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.66 -21.84 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 125.714 1.606 . . . . 0.0 112.667 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 169.94 -90.24 0.09 OUTLIER Glycine 0 N--CA 1.467 0.709 0 C-N-CA 125.055 1.312 . . . . 0.0 110.789 -172.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -159.63 120.31 3.11 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.118 0.967 . . . . 0.0 112.693 174.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.4 t -72.38 127.72 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 162.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.37 -34.03 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 118.691 0.678 . . . . 0.0 110.554 175.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -172.33 145.68 1.72 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.385 1.474 . . . . 0.0 112.045 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -129.23 171.26 12.63 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.821 2.049 . . . . 0.0 110.706 161.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -145.95 -60.18 0.32 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.81 1.782 . . . . 0.0 115.81 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 3.9 mt . . . . . 0 N--CA 1.49 1.531 0 C-N-CA 127.712 2.405 . . . . 0.0 113.219 -178.88 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.28 158.82 19.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.237 1.399 . . . . 0.0 112.81 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.7 m -147.45 142.55 27.11 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.011 1.725 . . . . 0.0 108.745 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 10.8 t -142.95 142.09 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.119 0.967 . . . . 0.0 110.788 -177.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -119.95 139.08 53.0 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.213 1.805 . . . . 0.0 110.01 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -116.78 154.05 31.36 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.676 1.591 . . . . 0.0 112.383 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.3 p -81.07 -17.93 48.37 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.92 0.888 . . . . 0.0 113.102 171.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -102.11 173.03 6.56 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.265 1.426 . . . . 0.0 113.061 -169.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 65.3 p -107.08 -101.1 0.35 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.915 1.686 . . . . 0.0 111.954 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -60.65 -22.16 63.53 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.739 1.216 . . . . 0.0 113.592 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -67.74 -18.04 64.76 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.072 0.949 . . . . 0.0 113.384 173.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.47 -28.99 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.326 0.966 . . . . 0.0 112.033 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.25 -45.96 44.61 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.44 -0.788 . . . . 0.0 110.843 167.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -52.88 -27.35 18.15 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.633 1.973 . . . . 0.0 114.112 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.59 -71.76 0.17 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.023 1.329 . . . . 0.0 110.929 165.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 36.4 mt -54.62 -44.33 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.323 1.449 . . . . 0.0 112.451 -172.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -64.84 0.35 1.21 Allowed 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 176.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -118.31 -1.41 11.31 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.846 1.659 . . . . 0.0 112.566 167.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -122.96 -14.0 7.71 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.132 1.773 . . . . 0.0 114.136 -176.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -48.68 120.96 4.12 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.338 1.455 . . . . 0.0 110.294 166.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 88.89 0.81 80.81 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-O 118.129 -1.373 . . . . 0.0 115.41 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.68 105.19 0.42 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.653 1.727 . . . . 0.0 111.507 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -55.98 110.43 0.74 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 152.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -127.54 110.8 13.09 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.466 1.106 . . . . 0.0 109.317 -170.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 89.9 mtp 55.55 36.14 26.58 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.708 1.203 . . . . 0.0 111.974 -173.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 14.4 t70 98.46 0.14 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 129.216 3.007 . . . . 0.0 115.79 170.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -138.85 137.52 36.65 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.547 1.067 . . . . 0.0 112.592 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -77.0 102.07 6.29 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.211 1.404 . . . . 0.0 113.707 -170.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.3 pt -54.24 143.63 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.535 0.734 . . . . 0.0 112.766 172.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -132.76 135.38 45.69 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.508 1.523 . . . . 0.0 107.4 166.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.6 p -119.8 132.53 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.294 1.038 . . . . 0.0 111.81 -168.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 . . . . . 0 CA--C 1.536 0.416 0 C-N-CA 127.41 2.284 . . . . 0.0 109.576 167.565 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.6 pt -139.39 155.92 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 126.007 1.723 . . . . 0.0 111.321 -170.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -118.16 153.13 34.33 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.749 2.02 . . . . 0.0 111.391 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.1 t -138.89 128.4 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.528 1.531 . . . . 0.0 110.131 -174.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.84 -91.03 1.85 Allowed Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.034 1.302 . . . . 0.0 114.179 -173.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -84.26 35.68 0.55 Allowed 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -160.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -80.3 -5.68 56.7 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -169.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.4 p 91.05 127.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 131.018 3.727 . . . . 0.0 110.609 -167.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -70.64 -13.11 61.95 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -169.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -81.84 -5.49 58.26 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.375 1.47 . . . . 0.0 113.084 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.5 m -64.77 143.02 58.23 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.212 1.005 . . . . 0.0 113.089 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 51.7 p -105.67 157.37 34.75 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 125.108 1.363 . . . . 0.0 110.919 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.08 -31.42 65.38 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.385 2.057 . . . . 0.0 112.606 174.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.31 -39.35 92.37 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.115 0.871 . . . . 0.0 111.621 174.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.17 -29.55 66.47 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.705 -0.622 . . . . 0.0 112.626 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.8 mt -74.06 -27.43 60.91 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 164.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 98.4 m -71.46 -51.14 25.39 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.402 1.001 . . . . 0.0 110.035 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -63.06 -24.61 67.99 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.628 0.649 . . . . 0.0 112.72 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.29 -69.14 0.5 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.54 1.536 . . . . 0.0 111.585 174.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -65.31 -32.41 74.05 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.4 t -73.35 0.08 13.15 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -175.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -71.67 -18.78 62.16 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.318 -0.864 . . . . 0.0 113.179 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 19.4 mm -81.56 -55.0 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.118 0.967 . . . . 0.0 111.628 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -138.74 -96.31 0.36 Allowed Glycine 0 N--CA 1.467 0.75 0 C-N-CA 126.379 1.942 . . . . 0.0 109.878 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -156.03 128.61 7.78 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.898 0.879 . . . . 0.0 112.145 169.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.73 134.93 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 167.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.52 -42.62 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 118.275 0.489 . . . . 0.0 110.426 172.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -157.35 141.24 16.02 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 127.105 2.162 . . . . 0.0 109.529 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -117.69 158.99 23.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.889 1.276 . . . . 0.0 111.055 161.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -152.9 132.07 12.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.071 1.349 . . . . 0.0 111.37 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 3.2 mt . . . . . 0 N--CA 1.486 1.345 0 C-N-CA 125.051 1.34 . . . . 0.0 112.401 179.89 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -94.82 164.93 25.4 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 115.24 0.856 . . . . 0.0 115.24 -159.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.7 p -146.69 148.35 31.92 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.886 2.074 . . . . 0.0 110.201 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 13.7 t -147.57 136.68 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.674 0.79 . . . . 0.0 110.865 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -109.34 131.61 54.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.551 1.94 . . . . 0.0 109.547 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -103.25 158.34 16.39 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.059 1.343 . . . . 0.0 110.545 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 78.8 p -71.24 0.21 8.43 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.859 0.864 . . . . 0.0 112.899 170.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -138.92 -175.99 4.34 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.203 2.201 . . . . 0.0 112.011 -167.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.6 p -142.8 -66.34 0.38 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.584 1.554 . . . . 0.0 110.16 -174.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -53.15 -33.31 51.89 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 120.677 -1.265 . . . . 0.0 113.288 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.97 -24.85 61.66 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.318 1.447 . . . . 0.0 114.054 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.4 m -70.75 -31.91 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -169.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -56.95 -46.21 82.28 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.691 1.196 . . . . 0.0 111.146 166.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -71.68 -23.69 61.7 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.881 0.872 . . . . 0.0 112.25 -171.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.39 -61.99 1.98 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.992 0.917 . . . . 0.0 110.949 165.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 80.9 mt -59.78 -37.32 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.329 1.051 . . . . 0.0 112.123 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 47.1 ttm-85 -62.46 -4.86 2.1 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.493 1.517 . . . . 0.0 113.838 176.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -121.86 -3.62 9.17 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.498 1.919 . . . . 0.0 112.922 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -124.49 -21.92 4.78 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -173.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.92 120.69 12.43 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 120.22 1.373 . . . . 0.0 109.882 174.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 94.04 0.5 65.88 Favored Glycine 0 N--CA 1.471 1.032 0 CA-C-O 118.107 -1.385 . . . . 0.0 115.522 -170.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.8 108.54 0.87 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.756 1.778 . . . . 0.0 110.725 174.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -55.56 121.28 8.7 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.231 1.013 . . . . 0.0 110.715 161.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -152.53 110.86 3.71 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.511 1.924 . . . . 0.0 107.575 -158.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 16.8 ttt 54.08 35.86 23.28 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.581 0.705 . . . . 0.0 111.397 -164.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 76.05 0.22 3.26 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.394 2.677 . . . . 0.0 115.286 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -120.55 144.02 48.28 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.118 1.367 . . . . 0.0 110.749 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.99 111.49 15.25 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.584 -1.322 . . . . 0.0 112.764 -176.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.4 pt -54.18 148.07 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.472 -0.767 . . . . 0.0 110.928 164.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -137.62 137.52 38.55 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.226 1.01 . . . . 0.0 109.327 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.85 126.6 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 124.163 0.985 . . . . 0.0 109.659 -171.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 . . . . . 0 CA--C 1.532 0.285 0 C-N-CA 124.251 1.02 . . . . 0.0 110.05 164.521 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.8 p . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.59 161.48 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 121.915 -0.491 . . . . 0.0 112.012 -154.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -121.36 124.22 44.03 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.545 1.138 . . . . 0.0 110.688 170.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.27 134.94 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 127.175 2.19 . . . . 0.0 107.772 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.61 -133.47 0.4 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.886 1.232 . . . . 0.0 112.665 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -60.54 -28.19 68.24 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 -168.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . 0.292 2.5 pt? 28.52 -129.96 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.651 1.98 . . . . 0.0 113.192 -164.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.9 m -142.4 130.38 21.86 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.444 1.498 . . . . 0.0 109.133 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -64.5 -18.21 64.58 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -171.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -75.01 -3.38 32.06 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.563 1.545 . . . . 0.0 113.779 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 77.0 p -104.18 168.88 8.82 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.769 1.228 . . . . 0.0 114.124 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 52.1 p -137.06 165.68 32.92 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 126.922 2.089 . . . . 0.0 110.741 -171.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -59.86 -25.04 78.21 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.333 2.022 . . . . 0.0 113.199 169.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.13 -40.83 78.05 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.478 1.035 . . . . 0.0 111.8 172.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -62.72 -42.47 99.67 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.347 0.659 . . . . 0.0 111.097 173.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.6 mt -64.31 -31.3 72.45 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 118.49 -0.766 . . . . 0.0 112.515 170.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.8 m -68.69 -51.26 43.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.633 1.106 . . . . 0.0 110.272 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.95 -30.97 72.0 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.916 0.78 . . . . 0.0 112.26 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -70.85 -61.22 1.85 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.404 1.482 . . . . 0.0 111.718 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -71.34 -36.96 71.7 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.4 t -73.41 -1.52 18.62 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -173.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -73.44 -16.5 61.31 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.431 -0.793 . . . . 0.0 113.01 167.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.5 mm -80.97 -55.24 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 119.176 0.898 . . . . 0.0 111.144 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -134.57 -100.11 0.65 Allowed Glycine 0 N--CA 1.468 0.824 0 C-N-CA 126.0 1.762 . . . . 0.0 110.443 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -156.88 126.73 6.28 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.437 1.095 . . . . 0.0 111.88 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 20.5 t -76.56 134.5 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.01 0.924 . . . . 0.0 108.651 169.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.72 -15.52 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.57 1.148 . . . . 0.0 113.882 168.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.1 mtp85 -161.72 132.28 5.03 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.501 1.521 . . . . 0.0 110.874 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -129.23 145.7 51.29 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.582 1.953 . . . . 0.0 111.494 170.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -161.49 145.31 12.83 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.912 1.285 . . . . 0.0 111.651 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.6 mt . . . . . 0 N--CA 1.478 0.953 0 C-N-CA 124.499 1.119 . . . . 0.0 109.653 178.95 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 76.9 mtm . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.52 163.32 13.55 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 124.913 1.244 . . . . 0.0 115.164 -165.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.2 p -153.63 153.1 31.68 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.38 1.872 . . . . 0.0 111.352 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.97 147.15 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.046 1.338 . . . . 0.0 111.17 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -125.52 130.89 52.64 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.364 2.266 . . . . 0.0 110.068 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -108.42 165.09 11.78 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.136 1.374 . . . . 0.0 111.698 -174.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 40.5 p -76.51 0.27 20.5 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.546 1.538 . . . . 0.0 114.559 169.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -133.03 168.77 17.89 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.024 1.73 . . . . 0.0 111.796 -169.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.7 p -107.75 -62.62 1.41 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.728 1.211 . . . . 0.0 112.373 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -79.88 -35.34 38.19 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.896 1.678 . . . . 0.0 112.942 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -60.12 -24.44 64.68 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.7 1.2 . . . . 0.0 112.447 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.69 -29.51 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.462 1.905 . . . . 0.0 112.546 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.34 -38.67 63.19 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.335 -0.853 . . . . 0.0 111.058 172.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -67.63 -21.87 65.36 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.712 1.605 . . . . 0.0 112.969 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.86 -55.84 25.59 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.937 0.895 . . . . 0.0 111.39 164.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 73.5 mt -66.24 -28.54 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 O-C-N 121.292 -0.88 . . . . 0.0 111.851 -171.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -18.82 9.56 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.955 1.302 . . . . 0.0 113.987 171.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -106.62 -14.5 15.02 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.407 1.883 . . . . 0.0 112.109 176.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -122.4 -17.89 6.91 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.806 2.15 . . . . 0.0 116.806 -164.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -66.75 120.68 13.92 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 120.32 1.418 . . . . 0.0 109.991 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 92.52 0.69 69.5 Favored Glycine 0 N--CA 1.472 1.09 0 CA-C-O 117.714 -1.603 . . . . 0.0 115.081 -169.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.83 108.02 0.69 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 120.158 1.979 . . . . 0.0 111.081 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -52.03 122.95 9.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.647 0.779 . . . . 0.0 109.535 155.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -147.57 114.3 6.06 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.496 1.518 . . . . 0.0 107.734 -166.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 54.17 38.44 29.18 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.68 0.792 . . . . 0.0 111.335 -166.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 17.0 t70 84.24 0.61 0.93 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 128.526 2.731 . . . . 0.0 115.417 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.36 141.94 35.6 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.17 0.988 . . . . 0.0 112.663 -173.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -71.48 120.4 17.0 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -169.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.76 156.18 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.669 1.588 . . . . 0.0 112.019 154.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -140.18 156.17 46.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.918 1.687 . . . . 0.0 108.795 167.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 40.3 t -140.47 133.97 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.496 0.718 . . . . 0.0 111.733 -168.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 . . . . . 0 CA--C 1.539 0.521 0 C-N-CA 124.906 1.282 . . . . 0.0 109.854 170.918 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 112.019 -0.432 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.1 t 72.72 168.1 0.31 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.801 2.04 . . . . 0.0 113.614 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -163.06 153.33 16.13 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.948 1.699 . . . . 0.0 112.058 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 59.38 35.11 23.02 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.861 1.664 . . . . 0.0 113.43 171.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -78.28 156.89 29.42 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.757 1.223 . . . . 0.0 111.921 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -157.28 164.24 37.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.954 1.702 . . . . 0.0 112.152 -175.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -159.97 149.62 18.07 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.782 1.633 . . . . 0.0 111.405 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 35.2 m -166.37 156.29 11.91 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.504 1.922 . . . . 0.0 111.242 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 41.6 p -140.44 155.3 46.76 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.847 1.659 . . . . 0.0 110.912 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -145.33 160.03 42.14 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.348 1.459 . . . . 0.0 112.141 -170.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -161.69 157.13 23.97 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.405 1.482 . . . . 0.0 111.768 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -113.22 130.29 56.27 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.304 1.442 . . . . 0.0 109.614 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -160.41 150.44 17.98 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.876 1.27 . . . . 0.0 111.855 -168.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 18.3 m -134.94 155.96 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.549 1.54 . . . . 0.0 111.337 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -142.6 164.56 29.77 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.554 1.542 . . . . 0.0 112.029 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.2 mtm105 67.09 30.47 7.37 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.645 1.978 . . . . 0.0 113.153 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -80.46 93.97 6.12 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.37 1.068 . . . . 0.0 111.511 -171.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -168.07 166.3 13.1 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.814 2.046 . . . . 0.0 111.669 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 66.8 m 68.77 177.15 0.26 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.285 1.834 . . . . 0.0 114.152 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -144.22 27.9 1.39 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.437 1.895 . . . . 0.0 111.646 -176.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.0 t -138.5 153.34 48.77 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.988 1.315 . . . . 0.0 112.047 -169.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 9.9 pt -146.41 150.64 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 126.676 1.99 . . . . 0.0 109.806 -171.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -126.19 149.61 48.9 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.443 1.897 . . . . 0.0 109.709 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.03 118.76 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.907 0.883 . . . . 0.0 110.101 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.44 -3.21 37.96 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 116.967 1.547 . . . . 0.0 116.967 -160.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -142.77 22.61 1.95 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.102 1.451 . . . . 0.0 113.795 -170.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.6 pp -77.53 178.78 6.97 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.757 1.223 . . . . 0.0 111.832 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.3 t -73.56 133.87 43.64 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.77 0.828 . . . . 0.0 111.536 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -66.88 -8.9 32.45 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -87.63 -4.44 58.94 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.473 1.509 . . . . 0.0 113.622 170.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 7.7 t -69.12 139.76 54.73 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 121.064 -1.023 . . . . 0.0 112.509 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 27.4 p -102.6 162.19 20.95 Favored Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 125.589 1.556 . . . . 0.0 109.985 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -58.69 -32.27 96.55 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.139 1.892 . . . . 0.0 112.025 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.76 -38.65 91.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.092 0.957 . . . . 0.0 112.231 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.24 -44.01 97.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.782 0.719 . . . . 0.0 111.443 176.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 36.4 mt -70.45 -29.58 66.19 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.232 -0.89 . . . . 0.0 112.955 173.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 96.4 m -70.0 -51.24 33.95 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.24 0.927 . . . . 0.0 110.678 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -65.9 -24.32 66.82 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.868 0.758 . . . . 0.0 112.676 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -73.55 -66.21 0.72 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.046 1.738 . . . . 0.0 111.594 173.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -69.86 -33.97 72.97 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.8 t -73.45 -3.97 30.75 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -172.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -64.54 -18.49 64.89 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.117 -0.989 . . . . 0.0 112.831 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 30.1 mm -77.98 -23.5 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.856 1.263 . . . . 0.0 112.455 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 169.67 -90.16 0.09 OUTLIER Glycine 0 N--CA 1.468 0.802 0 C-N-CA 124.357 0.979 . . . . 0.0 112.437 -171.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -155.76 110.35 2.89 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.105 0.962 . . . . 0.0 112.845 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 37.4 t -73.66 132.0 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 157.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.37 -29.52 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 171.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -153.35 135.8 15.07 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.192 1.397 . . . . 0.0 110.056 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -115.92 159.58 21.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.595 1.158 . . . . 0.0 110.404 157.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -153.2 129.95 10.86 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.633 1.173 . . . . 0.0 112.081 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 6.0 mt -145.98 -48.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 124.664 1.186 . . . . 0.0 111.855 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 40.9 mm -71.18 139.11 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.783 0.833 . . . . 0.0 110.447 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 40.8 p -130.37 155.9 45.61 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.251 1.42 . . . . 0.0 110.757 -176.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.3 t -71.56 -11.95 61.12 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -100.74 -32.25 10.8 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.79 1.236 . . . . 0.0 112.647 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 73.22 24.09 76.19 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 116.138 1.215 . . . . 0.0 116.138 161.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -81.19 60.46 4.33 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.98 1.39 . . . . 0.0 114.309 -170.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 54.26 34.59 20.78 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 126.256 1.822 . . . . 0.0 114.169 164.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -62.89 -40.96 99.14 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -157.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 70.99 22.23 78.4 Favored Glycine 0 N--CA 1.479 1.512 0 C-N-CA 123.753 0.692 . . . . 0.0 114.533 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 28.3 ptm -156.28 150.17 25.07 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.85 1.26 . . . . 0.0 112.849 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -158.19 -172.0 24.79 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.747 1.165 . . . . 0.0 114.814 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 20.6 m -137.19 150.81 48.16 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.523 1.929 . . . . 0.0 110.254 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.7 t -141.44 142.99 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.881 1.272 . . . . 0.0 110.514 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -126.11 130.67 51.54 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 126.974 2.11 . . . . 0.0 110.782 -176.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -108.87 168.04 9.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.502 1.921 . . . . 0.0 110.952 -177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 49.1 p -81.4 0.06 39.16 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 167.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -127.99 154.56 45.47 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.865 1.666 . . . . 0.0 111.797 -167.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.5 p -114.39 -1.34 13.53 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.729 1.612 . . . . 0.0 113.685 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -130.05 -46.2 1.13 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.983 1.313 . . . . 0.0 112.714 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -65.88 -20.75 66.34 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.082 -1.011 . . . . 0.0 112.925 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.6 p -63.74 -33.29 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.24 1.816 . . . . 0.0 112.547 170.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -77.58 -36.76 51.67 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.66 0.784 . . . . 0.0 112.643 168.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -63.95 -24.14 67.61 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.145 0.978 . . . . 0.0 112.633 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.47 -56.81 15.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.948 1.299 . . . . 0.0 111.569 165.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.35 -35.22 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.735 1.214 . . . . 0.0 111.871 -172.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -57.07 -12.72 2.28 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.252 1.421 . . . . 0.0 114.039 172.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -117.43 -4.87 11.27 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.309 1.844 . . . . 0.0 112.685 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -129.46 -21.05 3.21 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.97 120.95 14.01 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 120.041 1.291 . . . . 0.0 110.381 176.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 97.24 0.73 59.64 Favored Glycine 0 N--CA 1.471 0.967 0 CA-C-O 118.189 -1.339 . . . . 0.0 114.772 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.97 106.52 0.72 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.759 1.779 . . . . 0.0 111.137 173.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -54.19 117.69 3.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.684 0.794 . . . . 0.0 109.461 155.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -137.89 108.68 6.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.5 1.52 . . . . 0.0 107.141 -165.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 18.1 ttt 50.42 47.1 24.51 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.679 0.791 . . . . 0.0 111.413 -162.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 21.5 t70 72.55 0.29 3.57 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 127.189 2.196 . . . . 0.0 114.652 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -123.68 125.05 44.09 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.215 1.406 . . . . 0.0 110.974 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -81.34 102.73 10.63 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.767 1.227 . . . . 0.0 114.264 -165.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -55.1 142.33 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.765 0.826 . . . . 0.0 111.434 167.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -136.4 134.59 37.94 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.084 1.353 . . . . 0.0 108.515 168.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 5.4 t -103.59 143.49 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.461 1.104 . . . . 0.0 110.559 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.24 137.83 54.7 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.032 2.133 . . . . 0.0 108.639 169.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -72.69 160.52 32.1 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 121.333 -0.854 . . . . 0.0 110.303 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.47 117.69 9.78 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.324 -0.86 . . . . 0.0 111.341 166.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 . . . . . 0 C--O 1.253 1.268 0 C-N-CA 126.52 1.928 . . . . 0.0 113.208 178.235 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 112.306 -0.317 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.1 p -162.03 163.26 28.91 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.198 1.399 . . . . 0.0 112.14 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -158.68 162.29 37.19 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.449 1.5 . . . . 0.0 112.025 -177.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -156.25 132.48 9.99 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.498 1.519 . . . . 0.0 110.842 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -166.06 165.07 18.08 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.568 1.947 . . . . 0.0 110.831 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 pp -155.84 170.97 20.85 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.493 1.517 . . . . 0.0 112.395 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -166.41 168.85 14.53 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.934 2.094 . . . . 0.0 111.276 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 48.2 m -159.58 129.6 5.56 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.977 1.311 . . . . 0.0 111.104 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.3 p -149.44 146.95 27.71 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.604 1.962 . . . . 0.0 110.221 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -158.52 158.85 34.81 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.364 1.066 . . . . 0.0 113.237 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -165.74 163.23 18.98 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.592 1.957 . . . . 0.0 110.879 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -155.51 136.07 13.35 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.86 1.264 . . . . 0.0 110.815 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -160.01 128.56 4.91 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.822 1.649 . . . . 0.0 110.674 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.9 p -161.08 140.3 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.731 1.213 . . . . 0.0 111.233 -176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -145.55 156.47 43.72 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.809 1.644 . . . . 0.0 111.112 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -140.52 126.16 19.13 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.873 1.669 . . . . 0.0 109.373 173.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -78.04 -15.79 58.62 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -165.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -122.07 145.84 47.77 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.856 1.262 . . . . 0.0 112.561 -174.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.4 m -63.12 140.32 58.86 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.998 0.919 . . . . 0.0 112.383 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 47.9 p-10 -150.66 -169.65 3.44 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -164.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 64.9 m -142.17 176.08 9.25 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.33 1.052 . . . . 0.0 112.648 -154.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 7.6 pt -139.29 154.3 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.803 1.241 . . . . 0.0 111.144 -172.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -134.03 105.31 6.64 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.289 1.435 . . . . 0.0 110.317 -169.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.8 t -89.66 120.22 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.416 1.886 . . . . 0.0 109.08 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.95 -5.94 24.93 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 116.951 1.541 . . . . 0.0 116.951 -168.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -147.7 21.85 1.14 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 119.698 1.749 . . . . 0.0 114.983 -170.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -178.02 2.21 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.672 -1.268 . . . . 0.0 112.806 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 91.4 m -86.95 118.84 26.6 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.597 1.159 . . . . 0.0 108.875 172.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -68.59 -7.99 37.72 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -169.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -74.45 -12.93 60.63 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.005 1.322 . . . . 0.0 112.997 168.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 20.6 t -60.6 138.89 57.99 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.181 -0.95 . . . . 0.0 112.358 173.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 32.7 p -80.87 168.82 22.42 Favored Pre-proline 0 N--CA 1.472 0.666 0 C-N-CA 124.078 0.951 . . . . 0.0 109.216 162.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.67 -20.3 26.81 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.209 1.939 . . . . 0.0 112.887 163.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -69.02 -35.7 76.93 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.498 1.045 . . . . 0.0 111.697 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -59.94 -38.92 83.81 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.122 0.969 . . . . 0.0 111.477 170.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 56.1 mt -70.33 -41.0 73.82 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-O 118.067 -0.968 . . . . 0.0 111.492 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 17.3 m -56.5 -51.04 69.99 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.796 1.18 . . . . 0.0 110.667 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -58.61 -46.18 87.58 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.274 0.488 . . . . 0.0 111.553 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -62.43 -52.84 61.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.487 1.515 . . . . 0.0 112.799 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -71.4 -18.1 62.36 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.973 1.309 . . . . 0.0 114.215 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 64.4 p -64.06 -16.66 62.2 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -65.31 -21.64 66.73 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.737 1.215 . . . . 0.0 113.384 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 37.5 mm -90.47 -16.16 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.675 1.19 . . . . 0.0 112.6 -168.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.56 -90.93 0.11 Allowed Glycine 0 N--CA 1.467 0.767 0 C-N-CA 125.073 1.32 . . . . 0.0 111.974 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -155.44 138.0 15.07 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.078 1.351 . . . . 0.0 111.368 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.1 144.5 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 125.04 1.336 . . . . 0.0 109.566 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.02 -34.54 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.076 0.55 . . . . 0.0 112.146 -160.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -155.91 153.77 30.16 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.352 2.261 . . . . 0.0 109.285 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -151.29 145.71 25.53 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.72 1.608 . . . . 0.0 111.461 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -156.05 156.07 33.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.768 1.627 . . . . 0.0 111.486 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 10.2 mt -137.82 124.08 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.983 1.313 . . . . 0.0 108.034 172.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.78 107.71 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -172.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 41.5 p -96.73 171.76 8.32 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.866 1.667 . . . . 0.0 111.872 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 37.4 m -167.83 177.01 5.94 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 127.455 2.302 . . . . 0.0 110.64 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -62.53 -29.65 70.72 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.761 0.824 . . . . 0.0 112.915 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -137.58 -148.62 5.43 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 126.242 1.877 . . . . 0.0 112.478 173.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -72.02 0.86 8.35 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.097 1.759 . . . . 0.0 115.454 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -49.3 -30.62 7.66 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.874 2.07 . . . . 0.0 116.301 -167.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -128.68 -96.23 0.4 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.289 1.436 . . . . 0.0 110.351 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 84.34 1.61 89.35 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.046 1.307 . . . . 0.0 115.155 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 92.3 mtp -74.07 140.82 45.61 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.035 1.417 . . . . 0.0 111.492 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.6 146.5 16.08 Favored Glycine 0 N--CA 1.469 0.86 0 C-N-CA 124.522 1.058 . . . . 0.0 111.864 171.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 4.0 p -143.05 147.69 35.48 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.936 1.294 . . . . 0.0 110.921 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.9 t -150.76 142.1 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.517 1.127 . . . . 0.0 109.305 -171.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.94 134.83 54.26 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.922 1.689 . . . . 0.0 110.792 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -113.16 159.87 18.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.272 1.829 . . . . 0.0 111.382 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 38.1 p -74.85 -21.42 59.27 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -137.68 -146.42 0.22 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.965 1.306 . . . . 0.0 111.843 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 62.6 p -136.39 -57.88 0.74 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.647 1.112 . . . . 0.0 113.254 -172.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.58 -29.34 70.51 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.905 -1.122 . . . . 0.0 113.697 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -72.11 -28.69 63.44 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.75 1.62 . . . . 0.0 112.992 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.5 t -69.42 -33.31 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.359 1.463 . . . . 0.0 111.802 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -74.14 -41.94 60.76 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.601 -0.687 . . . . 0.0 112.163 170.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -62.49 -28.48 69.86 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.058 0.943 . . . . 0.0 112.77 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.56 -60.11 4.15 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.761 1.224 . . . . 0.0 111.583 169.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.11 -23.04 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.16 -0.963 . . . . 0.0 112.892 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -14.59 13.3 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.243 1.017 . . . . 0.0 113.549 167.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -101.14 -20.25 15.4 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.046 1.338 . . . . 0.0 112.901 173.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -122.17 -17.56 7.14 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 -159.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -68.15 120.53 14.49 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 120.628 1.558 . . . . 0.0 110.079 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 94.27 0.39 65.45 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 117.791 -1.56 . . . . 0.0 115.015 -169.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.13 107.17 0.51 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 120.0 1.9 . . . . 0.0 110.906 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -53.69 119.85 5.46 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.92 0.888 . . . . 0.0 109.812 160.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -146.88 110.37 4.87 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.411 1.485 . . . . 0.0 108.038 -163.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 51.4 mtt 53.42 35.32 20.21 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.563 0.745 . . . . 0.0 111.757 -169.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 86.01 0.48 0.66 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 128.95 2.9 . . . . 0.0 116.035 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -124.3 140.29 53.1 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.431 1.092 . . . . 0.0 111.974 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 103.14 6.82 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.244 -0.91 . . . . 0.0 112.766 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -52.31 143.31 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 121.36 -0.837 . . . . 0.0 111.015 164.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -129.72 147.42 51.5 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 164.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.2 p -151.09 127.76 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.584 0.707 . . . . 0.0 111.969 -166.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -85.31 136.65 33.39 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.222 1.409 . . . . 0.0 109.971 170.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.62 142.69 27.49 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.795 1.238 . . . . 0.0 108.648 167.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.3 131.24 50.41 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.183 0.901 . . . . 0.0 111.382 167.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.9 p30 . . . . . 0 C--O 1.253 1.24 0 C-N-CA 125.605 1.562 . . . . 0.0 112.661 -177.535 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.1 m -169.63 156.6 6.61 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.865 2.066 . . . . 0.0 111.104 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -156.73 156.67 33.76 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.219 1.407 . . . . 0.0 111.786 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.7 tpp85 -163.69 -33.21 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -159.03 149.14 19.28 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.664 1.586 . . . . 0.0 110.155 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 pp -80.04 0.05 33.44 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -173.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -74.78 141.53 44.36 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.188 1.395 . . . . 0.0 111.921 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 58.1 p -160.88 173.61 15.06 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.2 t -62.69 159.92 15.24 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.952 0.901 . . . . 0.0 110.974 158.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -121.19 11.28 10.83 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.332 1.853 . . . . 0.0 112.639 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -67.99 165.78 17.16 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.138 1.375 . . . . 0.0 113.791 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 80.22 -1.73 1.99 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 127.756 2.422 . . . . 0.0 113.528 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 17.7 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 117.074 2.25 . . . . 0.0 117.074 -172.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.3 p -170.5 141.47 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 128.637 2.775 . . . . 0.0 109.516 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -161.72 -37.37 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.025 1.33 . . . . 0.0 112.575 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -155.36 132.69 10.99 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.325 1.85 . . . . 0.0 109.168 173.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -90.28 101.8 14.52 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.584 0.754 . . . . 0.0 111.416 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -162.5 148.15 12.59 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.383 1.473 . . . . 0.0 112.317 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.3 t -174.79 160.52 2.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.703 2.001 . . . . 0.0 110.666 165.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 177.47 -35.16 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 127.739 2.415 . . . . 0.0 112.213 176.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.1 p -141.45 139.63 33.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.285 1.434 . . . . 0.0 110.873 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.6 pt -141.04 154.85 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.21 1.004 . . . . 0.0 112.189 -161.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -122.23 147.43 46.21 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.686 1.995 . . . . 0.0 110.526 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.6 t -134.14 122.65 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.317 1.447 . . . . 0.0 109.766 -172.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.3 -46.12 2.65 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 116.254 1.262 . . . . 0.0 116.254 -163.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -121.57 23.62 10.18 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -163.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.57 -175.97 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.942 1.697 . . . . 0.0 112.882 165.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.6 p -73.7 127.08 31.83 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 120.958 -1.089 . . . . 0.0 110.023 165.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -70.0 -9.46 55.3 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -97.68 0.27 46.8 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.836 2.054 . . . . 0.0 113.283 171.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 7.9 t -58.11 149.16 24.33 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.132 -0.98 . . . . 0.0 113.299 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.1 p -95.12 151.84 39.07 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 123.594 0.758 . . . . 0.0 110.229 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.23 -25.91 30.57 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.376 2.051 . . . . 0.0 111.927 171.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -69.43 -42.79 74.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.209 1.004 . . . . 0.0 112.539 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -65.7 -41.61 92.13 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.718 -0.614 . . . . 0.0 111.547 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 25.5 mt -69.32 -29.26 67.05 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.6 -0.714 . . . . 0.0 112.226 173.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 49.7 m -66.11 -50.94 62.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.515 1.052 . . . . 0.0 109.658 171.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.32 -34.69 74.18 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 118.624 0.647 . . . . 0.0 112.253 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -70.13 -58.18 4.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.663 1.585 . . . . 0.0 112.406 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -71.24 -35.78 71.56 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.6 t -73.43 -6.0 43.51 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -51.98 -25.93 9.46 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.188 1.795 . . . . 0.0 112.544 164.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 28.4 mm -77.1 -22.35 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.198 1.799 . . . . 0.0 113.215 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.69 -90.47 0.11 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.304 0.954 . . . . 0.0 112.892 -172.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -152.47 95.47 2.03 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -171.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 39.9 t -70.09 134.11 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 161.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 5.1 p -104.38 -25.17 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.085 0.954 . . . . 0.0 112.645 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -164.6 119.7 1.43 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.683 1.193 . . . . 0.0 111.567 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -107.48 154.25 21.63 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.216 1.006 . . . . 0.0 111.067 161.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -156.14 131.89 9.7 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.538 1.535 . . . . 0.0 110.89 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 4.8 mm -118.02 39.28 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 125.117 1.367 . . . . 0.0 109.79 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.7 pp -108.22 162.53 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.698 1.599 . . . . 0.0 111.663 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 17.2 p -134.39 126.67 30.04 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.874 1.27 . . . . 0.0 109.806 -173.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.4 m -73.28 -14.66 61.36 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -161.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 53.6 ttm-85 -91.02 0.01 57.64 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.403 1.481 . . . . 0.0 112.762 176.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.12 -152.55 21.35 Favored Glycine 0 N--CA 1.471 0.994 0 C-N-CA 125.087 1.327 . . . . 0.0 110.501 -166.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -59.29 138.23 57.69 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -160.47 -77.59 0.06 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.651 1.18 . . . . 0.0 112.388 -175.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -153.54 11.4 0.44 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -171.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 62.26 26.43 67.8 Favored Glycine 0 N--CA 1.478 1.483 0 N-CA-C 116.067 1.187 . . . . 0.0 116.067 167.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -66.1 146.55 54.53 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.744 1.272 . . . . 0.0 112.64 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.45 156.72 20.33 Favored Glycine 0 N--CA 1.467 0.73 0 C-N-CA 124.593 1.092 . . . . 0.0 112.89 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.0 p -144.42 149.22 35.7 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.903 1.681 . . . . 0.0 111.099 174.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 10.9 t -145.42 139.06 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.983 0.913 . . . . 0.0 110.667 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -127.8 132.1 49.5 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.172 2.189 . . . . 0.0 109.012 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -110.7 164.26 12.93 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.442 1.497 . . . . 0.0 110.055 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 33.1 p -81.05 -25.36 37.17 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 122.01 -0.431 . . . . 0.0 111.893 164.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -81.26 168.44 18.47 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.97 1.708 . . . . 0.0 112.248 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.3 m -122.62 -76.75 0.59 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.575 0.75 . . . . 0.0 110.972 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.94 -25.15 67.42 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.8 -1.187 . . . . 0.0 113.835 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.13 -21.71 61.43 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.09 -25.05 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.565 0.746 . . . . 0.0 111.661 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -73.09 -43.79 61.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.998 0.919 . . . . 0.0 111.231 167.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -60.1 -32.27 70.82 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.888 0.875 . . . . 0.0 112.111 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.07 -65.13 0.67 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.768 1.227 . . . . 0.0 111.748 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 45.2 mt -59.91 -34.76 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.401 -0.812 . . . . 0.0 112.12 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -63.34 -2.76 1.59 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.076 1.35 . . . . 0.0 114.356 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -122.0 -2.99 9.13 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.893 1.677 . . . . 0.0 112.8 171.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -129.09 -21.09 3.33 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -170.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -62.53 120.94 12.09 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.393 1.451 . . . . 0.0 110.079 173.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 97.31 0.52 59.64 Favored Glycine 0 N--CA 1.471 1.011 0 CA-C-O 118.136 -1.369 . . . . 0.0 115.266 -169.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.61 106.66 0.99 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.815 1.808 . . . . 0.0 110.789 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -53.63 115.37 1.93 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 154.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -137.23 110.91 8.09 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.078 1.351 . . . . 0.0 108.758 -166.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 18.9 mmt 60.26 19.1 8.57 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.052 1.341 . . . . 0.0 113.949 -178.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 18.6 t70 106.91 0.14 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 130.929 3.692 . . . . 0.0 115.148 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -129.69 138.21 51.03 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.571 1.078 . . . . 0.0 112.844 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -71.22 104.59 3.15 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.251 1.42 . . . . 0.0 113.191 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 pt -55.15 144.27 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.267 0.627 . . . . 0.0 111.326 168.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -139.76 140.03 36.61 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.848 1.259 . . . . 0.0 109.359 174.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.05 135.06 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.144 1.378 . . . . 0.0 110.35 -171.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -138.16 136.89 37.11 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.333 1.453 . . . . 0.0 108.418 170.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -79.81 155.14 28.0 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.031 0.932 . . . . 0.0 110.898 -167.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -154.76 151.66 28.95 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -173.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 34.7 m120 . . . . . 0 C--O 1.256 1.407 0 C-N-CA 125.451 1.5 . . . . 0.0 112.44 176.41 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.769 0 N-CA-C 112.288 -0.325 . . . . 0.0 112.288 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 79.4 p -163.0 165.25 25.12 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.352 1.461 . . . . 0.0 111.945 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -156.41 153.7 29.3 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.197 1.399 . . . . 0.0 112.004 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -69.13 -45.75 69.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.466 1.106 . . . . 0.0 112.224 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 78.28 133.98 0.06 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 128.585 2.754 . . . . 0.0 112.049 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.2 mt -137.23 151.66 48.98 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.763 1.625 . . . . 0.0 111.019 -175.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -162.46 155.04 19.39 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.112 1.765 . . . . 0.0 111.108 -176.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.4 p -160.4 142.52 12.82 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.566 1.146 . . . . 0.0 112.815 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.2 m -73.03 142.23 47.67 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.443 1.497 . . . . 0.0 111.053 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -62.34 145.33 54.14 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.596 1.159 . . . . 0.0 113.139 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -87.88 -10.08 51.78 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -174.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 61.85 -123.13 0.77 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.947 1.699 . . . . 0.0 112.343 174.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.4 157.95 36.48 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.945 1.698 . . . . 0.0 113.306 -174.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.2 t -141.88 134.84 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.218 1.407 . . . . 0.0 110.107 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -165.18 178.54 6.9 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.605 2.362 . . . . 0.0 110.295 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -128.13 -174.79 3.31 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.972 1.309 . . . . 0.0 110.617 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -69.12 -23.13 63.95 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -168.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -103.3 -49.76 3.64 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -169.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.0 m 59.75 24.18 13.1 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.99 1.716 . . . . 0.0 113.826 -175.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -63.58 -32.52 74.01 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.542 1.137 . . . . 0.0 112.369 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.6 m -138.55 168.48 19.69 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.341 1.056 . . . . 0.0 112.566 -173.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 35.5 pt -141.36 142.19 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 126.531 1.932 . . . . 0.0 109.018 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -109.96 128.67 55.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.365 1.066 . . . . 0.0 110.842 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.09 106.04 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.864 1.666 . . . . 0.0 107.905 -169.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -99.68 -11.58 43.55 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 117.09 1.596 . . . . 0.0 117.09 -158.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -157.25 38.43 0.29 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.335 1.568 . . . . 0.0 113.507 -171.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.35 177.78 6.34 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.011 -1.056 . . . . 0.0 112.441 175.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 t -76.67 142.06 40.71 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.978 1.311 . . . . 0.0 111.806 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -64.04 -12.78 41.7 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 170.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -75.45 -15.24 60.45 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.502 1.121 . . . . 0.0 113.547 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 57.9 m -71.49 137.68 48.36 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.992 -1.068 . . . . 0.0 113.286 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 43.0 p -100.75 159.2 30.24 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 125.377 1.471 . . . . 0.0 109.262 163.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.48 -24.53 78.25 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 121.963 1.775 . . . . 0.0 112.774 170.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.18 -41.33 90.43 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.871 1.214 . . . . 0.0 111.7 173.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -60.56 -47.44 86.17 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.414 0.686 . . . . 0.0 110.858 176.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -62.89 -37.52 87.26 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.552 1.141 . . . . 0.0 111.999 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.6 m -63.76 -50.42 69.14 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.203 1.001 . . . . 0.0 110.568 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.62 -41.92 83.18 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.509 0.595 . . . . 0.0 111.694 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -57.17 -55.46 34.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.744 1.618 . . . . 0.0 112.29 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -71.15 -28.34 64.2 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.2 m -73.26 0.24 12.47 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -66.84 -20.91 66.02 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 120.892 -1.13 . . . . 0.0 112.594 166.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 24.1 mm -84.07 -39.91 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.866 1.266 . . . . 0.0 111.762 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -173.62 -98.04 0.11 Allowed Glycine 0 N--CA 1.468 0.796 0 C-N-CA 125.662 1.601 . . . . 0.0 111.633 -174.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -144.41 123.11 12.57 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.539 1.135 . . . . 0.0 112.469 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 29.4 t -74.4 133.54 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 156.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.2 -23.62 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.068 0.547 . . . . 0.0 112.043 175.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -176.18 146.49 0.67 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 127.714 2.405 . . . . 0.0 110.494 176.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -130.45 158.79 38.93 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.548 1.539 . . . . 0.0 112.092 168.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -155.45 142.19 18.9 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.003 1.721 . . . . 0.0 110.772 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 4.1 mt -146.13 137.46 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.802 1.241 . . . . 0.0 110.114 -175.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.3 mp -104.7 107.71 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.669 1.187 . . . . 0.0 109.104 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 60.7 p -144.22 166.29 25.45 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 127.061 2.144 . . . . 0.0 110.246 -175.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.8 m -170.03 177.52 4.27 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.922 2.089 . . . . 0.0 110.808 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 80.3 ttt-85 -63.14 -39.06 93.58 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.769 0.828 . . . . 0.0 111.883 173.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -88.58 161.06 30.76 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.038 1.304 . . . . 0.0 111.792 168.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -78.72 61.34 2.98 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.839 1.255 . . . . 0.0 112.813 -175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -80.46 -18.74 47.77 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -165.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -163.38 -61.73 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 174.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 73.63 40.25 46.92 Favored Glycine 0 N--CA 1.477 1.431 0 CA-C-N 119.073 0.851 . . . . 0.0 113.838 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 60.2 mtt -140.82 156.62 46.11 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.139 1.375 . . . . 0.0 111.068 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -149.51 -178.37 24.43 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.204 0.907 . . . . 0.0 114.383 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.2 m -150.99 144.75 25.1 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.829 1.651 . . . . 0.0 108.457 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.84 143.38 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.851 0.86 . . . . 0.0 110.014 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -110.28 135.13 51.51 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.198 1.799 . . . . 0.0 110.223 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -117.19 159.79 22.08 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.539 1.936 . . . . 0.0 112.118 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.5 p -83.66 -25.46 30.71 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -148.51 142.79 26.16 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 -168.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.8 p -76.36 -14.73 60.07 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.84 2.456 . . . . 0.0 116.013 -161.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -102.05 -33.88 9.53 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.113 0.87 . . . . 0.0 112.776 169.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -62.07 -43.32 99.08 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.703 0.801 . . . . 0.0 110.962 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 13.3 p -62.67 -35.85 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.172 1.389 . . . . 0.0 113.971 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.48 -47.0 35.94 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.739 -0.601 . . . . 0.0 112.609 172.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -58.08 -34.98 70.74 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.799 1.24 . . . . 0.0 112.43 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.67 -58.1 9.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.632 1.173 . . . . 0.0 111.636 171.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 45.1 mt -69.96 -29.88 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.485 -1.385 . . . . 0.0 112.466 -173.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.48 -14.37 12.34 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 168.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -105.92 -40.67 5.62 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.341 1.856 . . . . 0.0 111.963 171.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -95.04 -13.88 24.8 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 -165.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.01 120.62 13.96 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 120.614 1.552 . . . . 0.0 109.936 174.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 93.78 0.78 66.22 Favored Glycine 0 N--CA 1.473 1.104 0 CA-C-O 117.861 -1.522 . . . . 0.0 115.19 -167.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.33 107.0 0.59 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.221 2.01 . . . . 0.0 110.912 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -53.13 120.89 6.47 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.035 0.934 . . . . 0.0 109.85 160.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -141.24 110.74 6.39 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.462 1.505 . . . . 0.0 107.804 -170.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 19.3 mmt 51.22 41.52 27.91 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.587 1.155 . . . . 0.0 111.722 -162.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 76.28 0.53 3.26 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 127.681 2.392 . . . . 0.0 115.169 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -116.14 130.3 56.73 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.597 1.159 . . . . 0.0 111.622 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -71.01 104.15 2.9 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.042 -1.036 . . . . 0.0 112.837 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.1 pt -52.81 146.6 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.246 0.618 . . . . 0.0 111.016 156.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -135.53 147.55 48.84 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.864 1.266 . . . . 0.0 108.576 169.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 1.6 p -153.02 140.56 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.11 0.964 . . . . 0.0 111.254 -166.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 -117.0 137.98 51.87 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.817 1.247 . . . . 0.0 110.169 173.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -65.88 138.18 57.7 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 62.86 -84.47 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.064 1.745 . . . . 0.0 113.388 -175.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 . . . . . 0 C--O 1.254 1.34 0 C-N-CA 127.043 2.137 . . . . 0.0 112.039 -163.017 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.808 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 47.6 t -164.49 -53.81 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.531 1.132 . . . . 0.0 111.978 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . 58.07 14.28 2.62 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.459 1.904 . . . . 0.0 115.212 171.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 56.29 35.33 25.63 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.959 1.704 . . . . 0.0 112.445 -169.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -68.46 140.45 55.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.135 1.374 . . . . 0.0 111.473 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.8 pp -157.51 179.11 9.55 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.288 1.835 . . . . 0.0 111.423 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -155.52 153.87 30.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.252 1.421 . . . . 0.0 111.847 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 75.3 m -141.29 151.21 43.45 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.573 1.549 . . . . 0.0 111.376 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 54.8 p -132.04 157.81 43.18 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.777 1.231 . . . . 0.0 112.08 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -144.04 139.4 28.96 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.879 1.672 . . . . 0.0 111.092 -172.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -163.62 149.07 11.1 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.597 1.559 . . . . 0.0 109.974 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -130.63 119.71 22.87 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.957 1.303 . . . . 0.0 109.88 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -158.06 117.5 3.23 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.414 1.486 . . . . 0.0 109.583 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.5 m -68.38 153.0 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.157 0.583 . . . . 0.0 112.573 -176.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -142.59 112.52 6.96 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.368 1.467 . . . . 0.0 110.3 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -145.93 121.12 10.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.344 1.057 . . . . 0.0 111.324 -172.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -167.48 157.07 10.38 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.032 2.133 . . . . 0.0 110.309 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -70.29 -17.41 63.1 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 73.0 m -137.83 140.11 40.31 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.175 1.79 . . . . 0.0 109.672 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -139.72 132.14 28.51 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.367 1.067 . . . . 0.0 110.513 -169.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.4 t -155.81 162.14 40.52 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.783 0.802 . . . . 0.0 112.952 -168.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 6.8 pt -147.62 151.47 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 127.364 2.266 . . . . 0.0 109.989 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -121.85 134.53 54.88 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.298 1.839 . . . . 0.0 110.367 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.47 121.29 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.757 1.223 . . . . 0.0 108.808 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.32 -44.79 1.13 Allowed Glycine 0 N--CA 1.475 1.257 0 N-CA-C 115.333 0.893 . . . . 0.0 115.333 -168.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -100.45 7.41 44.21 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -166.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -62.88 169.01 3.48 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.148 1.379 . . . . 0.0 111.926 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.7 m -64.15 138.87 58.66 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.129 0.972 . . . . 0.0 112.324 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -70.15 0.12 6.79 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.478 1.911 . . . . 0.0 115.244 -169.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -111.9 0.55 16.14 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.244 2.217 . . . . 0.0 112.692 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 9.8 t -61.95 154.87 25.15 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.1 p -130.49 152.28 80.06 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 125.545 1.538 . . . . 0.0 111.062 -168.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.57 -42.87 19.22 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.761 2.307 . . . . 0.0 113.236 -171.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.73 -27.96 67.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.542 1.065 . . . . 0.0 112.816 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.05 -30.2 63.55 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.971 0.909 . . . . 0.0 112.094 174.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 13.8 mt -74.51 -34.04 62.94 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.058 -0.972 . . . . 0.0 113.283 164.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 81.6 m -62.21 -50.61 71.1 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.145 1.339 . . . . 0.0 110.73 177.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -62.03 -26.74 68.42 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -78.43 -60.12 2.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.522 1.529 . . . . 0.0 111.521 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -71.24 -34.07 70.43 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -175.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.0 t -73.37 -1.21 17.21 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -64.45 -17.65 64.02 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.054 0.942 . . . . 0.0 112.855 169.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.3 mm -82.09 -25.31 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.6 1.56 . . . . 0.0 113.089 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 175.23 -103.45 0.18 Allowed Glycine 0 N--CA 1.47 0.954 0 C-N-CA 124.506 1.051 . . . . 0.0 112.367 -169.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -147.77 109.67 4.48 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.508 0.723 . . . . 0.0 112.489 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 25.6 t -71.25 129.77 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 164.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.81 -33.48 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 118.362 0.528 . . . . 0.0 112.005 173.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -154.71 134.82 13.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.285 1.434 . . . . 0.0 110.715 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -109.71 153.94 23.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.245 1.018 . . . . 0.0 110.595 153.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -153.13 123.03 6.91 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.822 1.249 . . . . 0.0 111.262 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 6.0 mt -143.87 -52.01 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.657 0.783 . . . . 0.0 113.023 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 18.7 tt -76.92 141.44 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 118.722 0.692 . . . . 0.0 111.769 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 67.3 p -128.77 161.58 29.42 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.725 1.61 . . . . 0.0 111.777 -166.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 63.2 m -100.25 6.81 44.73 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -176.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.1 0.18 22.5 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -176.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 125.83 -131.1 7.42 Favored Glycine 0 N--CA 1.468 0.791 0 C-N-CA 125.97 1.748 . . . . 0.0 110.816 -171.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -60.61 136.9 58.2 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.899 0.88 . . . . 0.0 113.027 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -70.9 143.72 50.87 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.86 1.264 . . . . 0.0 112.14 174.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 42.0 mtm105 -123.59 -6.48 8.08 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 72.81 10.56 77.07 Favored Glycine 0 N--CA 1.476 1.323 0 CA-C-O 118.285 -1.286 . . . . 0.0 116.038 170.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 93.4 mtp -107.73 128.97 55.05 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.238 1.519 . . . . 0.0 109.797 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -173.75 -165.84 31.08 Favored Glycine 0 N--CA 1.474 1.192 0 N-CA-C 116.144 1.218 . . . . 0.0 116.144 -169.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.7 p -132.66 160.9 35.35 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.832 1.653 . . . . 0.0 113.582 -164.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 12.2 t -141.84 142.15 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.942 1.297 . . . . 0.0 110.202 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -125.45 134.98 51.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.862 2.065 . . . . 0.0 111.341 -171.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -118.46 151.66 37.39 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.071 1.748 . . . . 0.0 111.895 -169.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 61.3 p -75.93 -38.21 57.87 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.467 0.307 . . . . 0.0 110.817 163.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -61.18 160.49 10.26 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.377 1.871 . . . . 0.0 113.09 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.7 p -127.08 -66.01 0.92 Allowed 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.707 -0.621 . . . . 0.0 111.895 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -61.95 -30.24 70.78 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.425 1.011 . . . . 0.0 112.154 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -72.21 -17.43 61.92 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 12.4 t -70.26 -22.81 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.872 0.76 . . . . 0.0 112.042 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -74.07 -45.76 47.32 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.752 -1.217 . . . . 0.0 110.967 164.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 10.1 ttt85 -57.01 -29.35 63.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.597 1.559 . . . . 0.0 113.753 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.62 -68.7 0.29 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.681 1.592 . . . . 0.0 110.586 166.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.23 -27.87 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 121.204 -0.935 . . . . 0.0 113.266 -166.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -58.54 -18.79 32.31 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.861 0.864 . . . . 0.0 113.319 170.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -107.46 -6.7 16.91 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.369 1.467 . . . . 0.0 113.295 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -124.68 -22.87 4.48 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -170.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.64 120.5 14.75 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 120.399 1.454 . . . . 0.0 109.833 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 94.62 0.43 64.61 Favored Glycine 0 N--CA 1.469 0.888 0 CA-C-O 118.016 -1.435 . . . . 0.0 115.028 -168.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.8 108.84 1.08 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.909 1.855 . . . . 0.0 110.536 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -48.44 116.72 1.68 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.151 0.98 . . . . 0.0 109.351 156.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -152.0 110.77 3.82 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.851 1.26 . . . . 0.0 108.808 -172.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.13 50.52 13.41 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.472 1.109 . . . . 0.0 112.019 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 16.8 t70 77.48 0.14 2.88 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 127.257 2.223 . . . . 0.0 115.807 171.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 -135.55 154.8 51.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.925 1.29 . . . . 0.0 111.898 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 103.97 16.38 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.311 -0.868 . . . . 0.0 110.611 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.4 pt -54.76 139.54 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 121.215 -0.928 . . . . 0.0 111.287 171.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -132.69 142.66 49.17 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.626 1.17 . . . . 0.0 108.139 167.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 1.1 p -136.93 134.82 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.321 1.048 . . . . 0.0 111.682 -165.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -101.12 141.2 34.34 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.275 1.83 . . . . 0.0 109.919 173.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -75.08 132.56 41.36 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.8 125.62 28.55 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.441 1.019 . . . . 0.0 112.294 -173.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 . . . . . 0 C--O 1.254 1.318 0 C-N-CA 126.258 1.823 . . . . 0.0 111.514 -172.126 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 CA-C-O 121.137 0.298 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.3 t -162.06 160.05 26.99 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.353 1.461 . . . . 0.0 111.388 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -160.94 159.25 29.36 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.123 1.769 . . . . 0.0 111.663 -176.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -158.41 131.02 7.08 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.171 1.388 . . . . 0.0 111.03 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -163.49 157.16 19.38 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.254 1.821 . . . . 0.0 110.628 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.9 pp -162.29 173.62 13.94 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.78 1.632 . . . . 0.0 112.292 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -161.79 161.49 29.17 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.495 1.918 . . . . 0.0 111.565 -177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.3 t -161.73 150.47 15.62 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.558 1.143 . . . . 0.0 111.88 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.9 t -165.46 155.19 12.75 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.607 1.963 . . . . 0.0 110.328 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -162.73 160.77 25.85 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.638 1.575 . . . . 0.0 112.57 -174.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -163.08 160.83 24.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.806 1.642 . . . . 0.0 111.258 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -135.85 128.73 31.21 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.39 1.476 . . . . 0.0 109.559 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -143.29 147.7 35.18 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.05 1.34 . . . . 0.0 112.22 -170.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.4 p -164.83 135.47 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 126.171 1.788 . . . . 0.0 110.051 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -89.12 -20.48 24.23 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -167.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 57.66 37.3 27.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.865 1.666 . . . . 0.0 113.969 167.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -62.64 -40.89 98.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.761 0.824 . . . . 0.0 112.56 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -153.37 -55.7 0.12 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.456 1.903 . . . . 0.0 111.832 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.0 m 60.91 8.94 2.05 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.562 1.945 . . . . 0.0 114.961 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -62.69 -7.69 5.32 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -172.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.5 p -151.96 164.4 37.24 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.401 -1.437 . . . . 0.0 111.225 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 28.7 pt -144.1 145.48 21.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 125.589 1.556 . . . . 0.0 110.341 -171.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 94.4 t80 -109.29 150.2 28.32 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.825 1.65 . . . . 0.0 109.56 170.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.95 102.86 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.105 1.362 . . . . 0.0 108.786 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -82.49 -16.28 71.55 Favored Glycine 0 N--CA 1.471 0.974 0 C-N-CA 124.223 0.916 . . . . 0.0 114.315 -171.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -152.2 133.43 14.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.858 1.663 . . . . 0.0 109.926 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 mp -144.01 -77.96 0.22 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.63 1.572 . . . . 0.0 109.95 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 11.3 t -172.25 140.21 1.12 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.975 2.51 . . . . 0.0 108.588 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -63.43 -13.65 42.28 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -88.7 0.09 56.78 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.201 1.4 . . . . 0.0 113.418 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 7.6 t -78.46 152.82 31.89 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.682 -1.261 . . . . 0.0 113.509 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.49 159.7 32.26 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 126.556 1.943 . . . . 0.0 109.066 -176.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.0 -27.07 17.77 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 121.988 1.792 . . . . 0.0 113.29 -167.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.04 -34.77 78.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.196 0.907 . . . . 0.0 111.573 173.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -70.38 -41.27 73.28 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.059 0.944 . . . . 0.0 110.964 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.1 mt -66.59 -29.69 69.8 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.815 169.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 86.0 m -69.4 -48.36 61.35 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.402 1.001 . . . . 0.0 109.89 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -61.33 -33.77 74.15 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.431 0.693 . . . . 0.0 112.571 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -73.14 -61.48 1.8 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.998 1.719 . . . . 0.0 111.962 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.37 -39.75 71.05 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.3 t -73.28 -7.07 49.96 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -174.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -60.05 -18.62 47.91 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.782 1.233 . . . . 0.0 112.65 167.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 20.6 mm -78.96 -26.0 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.831 1.652 . . . . 0.0 112.607 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 166.22 -95.67 0.12 Allowed Glycine 0 N--CA 1.469 0.87 0 C-N-CA 124.734 1.159 . . . . 0.0 112.457 -171.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -141.67 110.13 6.01 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.361 1.064 . . . . 0.0 112.85 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.66 135.18 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 154.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.29 -18.31 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 172.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -160.47 138.2 9.63 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.419 1.488 . . . . 0.0 111.13 170.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -124.27 152.47 42.98 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.277 1.431 . . . . 0.0 110.554 160.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -152.32 137.0 16.97 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.201 1.001 . . . . 0.0 112.513 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.1 mt -145.57 -53.5 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 126.153 1.781 . . . . 0.0 111.255 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.8 pp -72.79 164.87 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 72.3 p -124.45 160.78 27.47 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.152 1.381 . . . . 0.0 112.141 -162.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 41.7 t -64.36 -33.35 75.65 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.045 0.938 . . . . 0.0 113.396 -174.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -99.21 -6.07 28.81 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.721 1.208 . . . . 0.0 113.266 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 83.24 2.16 90.4 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.282 1.42 . . . . 0.0 114.653 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -77.64 131.0 37.56 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 118.568 1.184 . . . . 0.0 112.393 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 13.6 t60 69.02 158.99 0.17 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 127.352 2.261 . . . . 0.0 114.99 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -164.68 152.41 11.8 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.622 1.969 . . . . 0.0 109.921 -173.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 99.41 21.96 13.8 Favored Glycine 0 N--CA 1.476 1.327 0 N-CA-C 116.214 1.246 . . . . 0.0 116.214 173.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -157.21 157.32 34.13 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.358 1.863 . . . . 0.0 111.569 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 157.76 -144.79 10.92 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 115.314 0.886 . . . . 0.0 115.314 -174.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.6 m -144.84 150.39 37.04 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.269 1.428 . . . . 0.0 111.13 -160.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.8 t -139.14 147.65 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.733 1.213 . . . . 0.0 110.82 173.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -131.45 133.76 45.51 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.75 2.02 . . . . 0.0 111.001 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -120.61 164.82 15.91 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.985 2.114 . . . . 0.0 111.502 -174.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 29.3 p -74.55 -38.41 62.74 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -150.49 152.8 34.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -171.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 30.8 p -54.05 -40.0 66.73 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.328 1.851 . . . . 0.0 113.326 171.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -76.37 -23.6 54.15 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -79.59 -51.25 9.53 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.886 0.874 . . . . 0.0 112.438 169.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 15.0 p -69.3 -42.46 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -167.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.77 -13.3 62.0 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.158 0.89 . . . . 0.0 113.367 -173.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -73.37 -19.4 61.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.468 1.107 . . . . 0.0 112.657 173.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.65 -61.18 2.0 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.302 1.041 . . . . 0.0 112.612 -173.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.451 ' H ' HD12 ' A' ' 217' ' ' ILE . 4.2 mp -68.91 -29.21 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 121.447 -0.783 . . . . 0.0 112.271 -160.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -58.5 -21.43 51.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.66 1.184 . . . . 0.0 113.566 170.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -101.4 -10.73 19.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.192 1.397 . . . . 0.0 112.889 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -126.0 -23.69 3.89 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -166.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.97 120.75 13.67 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.379 1.445 . . . . 0.0 109.8 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 93.08 0.83 67.74 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-O 117.982 -1.454 . . . . 0.0 115.079 -169.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.01 109.31 0.93 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.686 1.743 . . . . 0.0 110.501 171.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -57.05 124.17 17.79 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.265 0.555 . . . . 0.0 109.627 155.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -145.88 110.43 5.09 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.315 1.846 . . . . 0.0 107.103 -161.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 88.6 mmm 49.88 41.48 22.73 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.864 0.866 . . . . 0.0 111.728 -163.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 11.6 t70 77.71 -0.41 2.76 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 128.284 2.634 . . . . 0.0 115.085 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -120.38 137.73 54.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.564 1.146 . . . . 0.0 111.626 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -79.62 112.72 17.16 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.697 -1.252 . . . . 0.0 113.435 -170.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -68.18 143.88 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 121.219 -0.926 . . . . 0.0 112.98 169.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -132.31 130.28 40.62 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.282 1.433 . . . . 0.0 109.643 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 12.4 t -119.24 151.09 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.772 2.029 . . . . 0.0 109.541 -170.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 42.0 ptt85 -133.4 148.63 51.81 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.546 0.738 . . . . 0.0 110.12 155.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -77.08 164.64 25.52 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.7 -0.625 . . . . 0.0 110.31 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -107.13 132.39 53.06 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.27 1.428 . . . . 0.0 111.079 168.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 . . . . . 0 C--O 1.254 1.331 0 C-N-CA 126.97 2.108 . . . . 0.0 111.771 -173.434 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 112.076 -0.409 . . . . 0.0 112.076 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 12.4 t -162.61 158.83 23.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.291 1.436 . . . . 0.0 111.312 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -160.35 155.72 25.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.878 1.671 . . . . 0.0 111.844 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 35.4 ptt-85 -162.48 157.11 21.89 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.975 1.71 . . . . 0.0 112.038 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -162.41 153.32 17.44 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.629 1.571 . . . . 0.0 111.595 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 60.7 tp -159.97 130.02 5.43 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.03 1.732 . . . . 0.0 109.657 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -162.55 139.75 8.02 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.388 1.475 . . . . 0.0 111.398 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 31.9 m -169.1 138.39 2.11 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.967 2.107 . . . . 0.0 110.823 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.5 t -166.12 148.19 6.98 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.235 1.814 . . . . 0.0 110.232 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -147.86 129.71 15.24 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.019 1.328 . . . . 0.0 111.625 -171.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -148.7 134.6 19.01 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.584 1.554 . . . . 0.0 110.254 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -165.18 147.87 8.07 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.286 1.434 . . . . 0.0 111.874 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -164.63 152.19 11.71 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.254 1.821 . . . . 0.0 112.018 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.8 m -148.94 139.77 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 125.58 1.552 . . . . 0.0 111.018 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -167.9 147.38 4.83 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.824 1.65 . . . . 0.0 111.738 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -146.77 16.86 1.26 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.547 1.539 . . . . 0.0 113.745 174.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -72.0 163.6 27.58 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -152.45 114.36 4.39 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.309 1.444 . . . . 0.0 110.184 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.8 p -167.45 151.55 6.63 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -171.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -146.72 -3.47 0.61 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 63.5 p -134.13 154.7 51.04 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.497 -1.377 . . . . 0.0 112.053 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 10.4 pt -143.83 142.14 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.522 1.529 . . . . 0.0 109.571 -177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -128.73 123.9 34.22 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.648 1.179 . . . . 0.0 109.401 -168.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.8 t -113.93 129.68 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.814 1.645 . . . . 0.0 109.151 -164.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -74.59 -109.05 0.09 OUTLIER Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.272 1.415 . . . . 0.0 114.652 -169.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -84.26 -26.94 28.24 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.438 ' HG ' ' H ' ' A' ' 169' ' ' THR 0.32 2.3 pt? 32.7 -120.22 0.07 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.579 2.352 . . . . 0.0 115.0 -178.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.438 ' H ' ' HG ' ' A' ' 168' ' ' LEU . 57.2 m -142.28 130.32 21.94 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.684 1.594 . . . . 0.0 110.123 -162.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -61.45 -23.37 65.8 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.19 -0.89 57.78 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.885 1.674 . . . . 0.0 113.269 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 92.3 p -72.09 151.97 42.69 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 34.5 p -143.15 162.52 42.6 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 127.654 2.382 . . . . 0.0 108.372 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -63.16 -30.33 74.78 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 121.58 1.52 . . . . 0.0 112.951 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -69.28 -40.16 77.93 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.1 0.864 . . . . 0.0 112.207 173.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -66.18 -40.72 90.68 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.562 1.145 . . . . 0.0 111.838 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.34 -36.06 82.44 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.134 0.973 . . . . 0.0 112.025 170.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 91.7 m -69.48 -50.11 48.44 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.153 0.581 . . . . 0.0 110.314 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -58.75 -28.61 66.05 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.626 0.77 . . . . 0.0 112.399 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -75.56 -66.09 0.82 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.064 1.346 . . . . 0.0 111.7 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.28 -30.84 66.77 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -172.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.35 -5.33 39.02 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.011 -1.056 . . . . 0.0 113.701 -173.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -64.91 -19.45 65.94 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.685 1.194 . . . . 0.0 113.219 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 24.9 mm -82.83 -24.13 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.643 1.177 . . . . 0.0 112.655 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 176.14 -86.04 0.07 OUTLIER Glycine 0 N--CA 1.468 0.771 0 C-N-CA 124.923 1.249 . . . . 0.0 111.707 -175.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -157.51 116.47 3.26 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.494 1.118 . . . . 0.0 112.198 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 19.2 t -71.9 129.99 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 160.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.5 p -100.69 -17.04 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.657 0.783 . . . . 0.0 112.981 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -162.58 138.57 7.35 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.109 1.363 . . . . 0.0 112.112 169.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -127.35 156.02 42.65 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.986 1.314 . . . . 0.0 112.406 165.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -156.52 143.28 18.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.548 1.539 . . . . 0.0 112.27 -174.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.5 mm -128.64 120.32 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.694 1.597 . . . . 0.0 108.012 170.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 20.7 tt -108.73 107.81 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.581 1.153 . . . . 0.0 110.998 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 6.3 t -152.64 172.46 16.6 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.878 1.671 . . . . 0.0 111.612 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 58.7 m -149.5 156.42 41.96 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.428 1.891 . . . . 0.0 111.389 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -62.27 -33.31 74.38 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.062 0.945 . . . . 0.0 113.275 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -87.3 -90.63 1.02 Allowed Glycine 0 N--CA 1.471 1.0 0 C-N-CA 125.31 1.433 . . . . 0.0 110.556 170.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -159.6 148.28 17.72 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.619 1.568 . . . . 0.0 112.161 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -166.37 -62.26 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.786 1.234 . . . . 0.0 113.172 -177.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -144.52 -69.32 0.3 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.817 1.647 . . . . 0.0 110.595 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 81.1 42.18 9.7 Favored Glycine 0 N--CA 1.47 0.962 0 C-N-CA 124.508 1.052 . . . . 0.0 113.105 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -150.87 171.53 17.09 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.175 0.99 . . . . 0.0 113.326 -171.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -127.27 157.12 20.67 Favored Glycine 0 N--CA 1.471 1.031 0 C-N-CA 124.427 1.013 . . . . 0.0 114.865 -172.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 85.4 m -142.86 144.11 32.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.944 1.698 . . . . 0.0 109.107 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 43.7 t -141.63 152.52 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.848 0.859 . . . . 0.0 109.495 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -130.06 137.46 50.23 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.916 1.687 . . . . 0.0 111.21 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -121.06 160.5 23.49 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 127.306 2.243 . . . . 0.0 110.224 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 43.7 p -88.19 -14.38 38.73 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -175.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -156.25 130.93 8.96 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.2 m -46.79 -50.74 17.8 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 129.372 3.069 . . . . 0.0 115.113 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.75 -26.46 44.6 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.003 -1.061 . . . . 0.0 113.108 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.37 -39.7 64.94 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.303 -0.873 . . . . 0.0 113.332 170.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 14.0 p -69.05 -29.26 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.541 -0.724 . . . . 0.0 112.384 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.91 -39.78 83.52 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.514 0.726 . . . . 0.0 112.56 169.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 53.3 mtt85 -61.97 -33.19 73.84 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.329 0.652 . . . . 0.0 112.494 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.81 -63.71 1.13 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.409 1.004 . . . . 0.0 113.176 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 56.3 mt -65.46 -27.6 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 121.35 -0.844 . . . . 0.0 111.771 -170.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -51.39 -27.73 10.8 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.043 1.337 . . . . 0.0 113.558 168.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -98.88 -13.38 20.07 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.416 1.086 . . . . 0.0 113.443 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -125.18 -19.62 5.09 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -163.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -67.64 120.89 14.76 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 120.408 1.458 . . . . 0.0 110.769 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 91.34 0.82 72.85 Favored Glycine 0 N--CA 1.469 0.885 0 CA-C-O 117.44 -1.755 . . . . 0.0 114.75 -170.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.37 106.22 0.36 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.894 1.847 . . . . 0.0 110.32 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.502 ' CZ ' ' HE2' ' A' ' 229' ' ' LYS . 56.4 m-85 -60.3 116.92 4.61 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 156.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -133.95 110.33 9.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.24 1.416 . . . . 0.0 107.288 -164.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 12.9 ttt 50.07 38.88 17.85 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.13 0.972 . . . . 0.0 111.897 -159.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.7 t70 76.45 6.78 3.47 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 126.858 2.063 . . . . 0.0 114.965 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -121.12 138.67 54.09 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.45 1.1 . . . . 0.0 112.105 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.502 ' HE2' ' CZ ' ' A' ' 224' ' ' PHE . 42.4 mmtt -68.01 115.88 8.02 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.149 1.379 . . . . 0.0 113.584 -175.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.03 145.87 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 120.998 -1.064 . . . . 0.0 110.743 151.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -146.58 142.42 27.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.64 1.976 . . . . 0.0 108.43 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.2 t -137.27 135.38 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -165.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -101.43 141.47 34.25 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.259 1.824 . . . . 0.0 110.965 168.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -92.98 122.07 34.97 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.819 0.848 . . . . 0.0 110.005 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.37 -26.66 0.14 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 128.883 2.873 . . . . 0.0 117.49 164.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.079 0 C-N-CA 128.039 2.536 . . . . 0.0 110.918 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.835 0 CA-C-O 121.179 0.322 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.0 t -162.57 150.32 13.94 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.212 1.405 . . . . 0.0 111.552 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -85.06 -5.24 59.35 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.583 1.153 . . . . 0.0 113.758 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 62.71 -151.4 0.35 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.088 1.755 . . . . 0.0 111.52 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -162.48 161.25 26.98 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.971 1.708 . . . . 0.0 111.297 -174.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 93.7 mt -141.26 159.24 42.64 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.269 1.828 . . . . 0.0 111.09 -177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -160.08 161.53 33.89 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.949 1.7 . . . . 0.0 112.183 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.3 m -165.37 152.98 10.92 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.408 1.883 . . . . 0.0 111.484 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.6 p -144.0 148.3 35.08 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.109 1.764 . . . . 0.0 111.13 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -158.7 169.33 24.62 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.349 1.459 . . . . 0.0 112.735 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -142.11 156.83 45.39 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.754 1.622 . . . . 0.0 111.1 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -141.48 150.66 42.52 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.728 1.611 . . . . 0.0 110.758 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -154.09 142.01 20.17 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.998 1.319 . . . . 0.0 111.748 -173.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.6 m -143.3 152.39 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.531 1.533 . . . . 0.0 111.633 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -161.91 148.91 14.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.045 1.738 . . . . 0.0 111.22 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -156.9 136.96 12.66 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.922 1.289 . . . . 0.0 112.137 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -161.03 142.72 12.02 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.84 2.056 . . . . 0.0 109.801 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -137.44 -21.24 1.17 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.415 1.486 . . . . 0.0 113.468 -172.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 54.4 p -149.06 178.55 8.61 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.197 0.999 . . . . 0.0 113.01 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -92.11 8.91 35.74 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.189 0.996 . . . . 0.0 112.066 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.4 m -90.19 143.28 26.91 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.858 1.263 . . . . 0.0 113.835 -165.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.0 pt -136.43 147.06 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.09 1.356 . . . . 0.0 110.824 176.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -129.48 114.21 15.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.555 1.942 . . . . 0.0 109.356 -167.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.46 106.29 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.308 1.843 . . . . 0.0 108.197 -172.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.54 -10.78 78.97 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.237 0.922 . . . . 0.0 115.268 -169.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -159.44 157.92 31.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.009 1.724 . . . . 0.0 110.408 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 178.26 -144.55 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 128.838 2.855 . . . . 0.0 107.984 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 21.8 p -108.56 141.83 39.89 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 120.865 1.666 . . . . 0.0 111.221 170.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -59.68 -25.18 64.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -88.52 -1.85 58.27 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.045 1.738 . . . . 0.0 113.423 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 22.7 t -69.63 154.64 41.7 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.984 -1.072 . . . . 0.0 112.163 174.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 32.5 p -128.4 155.57 78.35 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 125.33 1.452 . . . . 0.0 109.746 -172.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.02 -23.48 53.79 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.45 1.434 . . . . 0.0 112.394 174.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -69.07 -36.38 77.57 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.516 1.053 . . . . 0.0 111.987 171.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -71.33 -37.98 71.69 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.307 -0.871 . . . . 0.0 111.859 174.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.8 mt -66.14 -30.36 70.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.418 -0.801 . . . . 0.0 112.787 166.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 63.6 m -67.71 -46.82 71.1 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.571 1.078 . . . . 0.0 109.35 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.31 -36.13 79.26 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.796 0.726 . . . . 0.0 112.118 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -66.41 -64.14 0.92 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.55 1.14 . . . . 0.0 111.511 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -71.23 -39.21 71.84 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -173.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.73 -3.88 31.1 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -72.77 -15.95 61.65 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.161 -0.962 . . . . 0.0 112.892 165.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.07 -45.65 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.007 0.822 . . . . 0.0 111.295 175.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.39 -90.75 0.08 OUTLIER Glycine 0 N--CA 1.468 0.779 0 C-N-CA 125.062 1.315 . . . . 0.0 112.405 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -158.4 109.56 2.17 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.74 0.816 . . . . 0.0 112.09 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 36.0 t -74.06 130.44 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 167.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.6 p -102.94 -16.99 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.22 1.008 . . . . 0.0 113.107 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -164.95 134.22 3.55 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.147 1.779 . . . . 0.0 111.066 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -130.15 152.94 49.04 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.716 1.606 . . . . 0.0 112.299 165.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -156.76 156.78 33.89 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.844 2.058 . . . . 0.0 111.216 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.3 mt -141.75 133.57 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.7 1.2 . . . . 0.0 111.316 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 63.5 mt -93.81 107.52 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.205 1.402 . . . . 0.0 107.753 168.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 8.9 t -151.93 141.17 21.4 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.544 1.538 . . . . 0.0 110.036 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 68.9 m -157.58 163.34 38.43 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.706 2.003 . . . . 0.0 109.82 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 27.4 mmt85 -70.99 -15.93 62.6 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -91.05 -137.86 7.47 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.901 1.715 . . . . 0.0 113.863 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 35.1 p80 -82.22 0.1 42.74 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 -170.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -63.61 150.41 44.21 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.535 1.134 . . . . 0.0 113.351 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -33.64 74.3 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -168.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 75.78 78.86 0.65 Allowed Glycine 0 N--CA 1.473 1.141 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -168.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 27.1 ptm -148.13 134.69 19.77 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.157 0.983 . . . . 0.0 112.372 -168.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -108.06 164.73 12.81 Favored Glycine 0 N--CA 1.469 0.865 0 C-N-CA 124.874 1.226 . . . . 0.0 113.789 -177.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.77 142.54 27.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.992 1.717 . . . . 0.0 109.836 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 19.4 t -146.27 146.89 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.609 0.764 . . . . 0.0 109.999 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -129.2 131.95 47.19 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.164 1.786 . . . . 0.0 109.369 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -95.99 171.77 8.42 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.626 1.17 . . . . 0.0 109.915 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 59.0 p -81.48 0.15 39.15 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 168.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -136.22 178.49 7.02 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.264 1.826 . . . . 0.0 112.433 -166.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 20.9 p -124.82 -68.3 0.86 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.179 1.792 . . . . 0.0 110.897 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -54.37 -38.53 66.21 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.016 -1.053 . . . . 0.0 112.956 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.6 -18.38 64.97 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.446 1.098 . . . . 0.0 113.077 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 13.0 t -75.79 -37.23 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.137 1.375 . . . . 0.0 112.062 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -62.17 -43.67 98.31 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.768 -0.582 . . . . 0.0 110.434 168.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -65.74 -17.14 64.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.981 1.312 . . . . 0.0 113.523 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -74.49 -64.27 1.06 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.24 0.927 . . . . 0.0 111.425 166.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 53.5 mt -69.23 -30.8 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.444 -0.785 . . . . 0.0 112.04 -167.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.69 -4.2 2.87 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.545 1.138 . . . . 0.0 113.835 170.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -118.24 -4.91 10.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.388 1.475 . . . . 0.0 112.569 172.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -127.54 -24.03 3.38 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -171.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.54 120.92 12.07 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 121.001 1.728 . . . . 0.0 110.501 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 91.64 0.68 72.14 Favored Glycine 0 N--CA 1.469 0.844 0 CA-C-O 118.06 -1.411 . . . . 0.0 115.336 -171.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.47 107.6 0.81 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.76 1.78 . . . . 0.0 110.363 169.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -52.98 120.4 5.81 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 156.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -142.15 111.06 6.27 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.26 1.424 . . . . 0.0 108.314 -166.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 20.5 ttt 56.72 40.5 29.14 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 121.776 0.798 . . . . 0.0 110.751 -165.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 18.3 t70 74.97 0.18 3.48 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 127.912 2.485 . . . . 0.0 115.285 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -125.64 141.27 52.11 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.05 1.34 . . . . 0.0 111.982 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -87.32 102.62 14.68 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.002 0.921 . . . . 0.0 112.621 -165.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.88 149.73 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 121.226 -0.921 . . . . 0.0 112.484 169.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -141.49 140.49 33.53 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.823 1.649 . . . . 0.0 108.696 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 16.0 t -133.03 133.55 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 118.556 0.616 . . . . 0.0 112.299 -168.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -107.31 145.03 33.31 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.128 1.771 . . . . 0.0 109.456 169.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -104.59 148.17 26.81 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.123 0.969 . . . . 0.0 110.475 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 71.21 -34.3 0.3 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 128.048 2.539 . . . . 0.0 115.457 172.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 29.6 m120 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 126.929 2.091 . . . . 0.0 112.978 -174.546 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.3 p -164.8 144.96 7.37 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.934 1.294 . . . . 0.0 111.688 -176.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -161.49 163.29 30.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.319 1.448 . . . . 0.0 111.964 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 32.1 mmm180 -70.45 150.56 46.08 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.275 1.03 . . . . 0.0 112.056 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -160.0 145.26 15.18 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.143 1.777 . . . . 0.0 109.543 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 31.0 mt 69.38 5.86 5.37 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 126.972 2.109 . . . . 0.0 113.416 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -75.48 145.1 41.67 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.647 1.979 . . . . 0.0 113.306 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.7 t -163.57 136.87 5.53 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.05 1.34 . . . . 0.0 111.121 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.6 m -167.3 144.91 4.67 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.309 2.244 . . . . 0.0 109.154 -176.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -152.2 139.26 19.16 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.253 1.421 . . . . 0.0 111.611 176.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -164.56 152.14 11.8 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.419 1.488 . . . . 0.0 110.586 -174.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 67.34 -161.6 0.23 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.566 1.946 . . . . 0.0 111.893 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 69.9 tttt 68.7 15.57 9.02 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.577 1.551 . . . . 0.0 114.707 167.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 99.1 t -140.26 134.21 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 125.858 1.663 . . . . 0.0 110.055 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -158.46 123.66 4.34 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.872 1.669 . . . . 0.0 110.32 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -156.85 52.91 0.51 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.221 1.408 . . . . 0.0 110.837 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -134.33 126.4 29.6 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.723 1.209 . . . . 0.0 111.031 -173.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -130.33 22.22 5.19 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.926 1.69 . . . . 0.0 112.14 -171.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 80.6 p -95.7 -172.94 2.73 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.866 2.466 . . . . 0.0 111.923 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -147.87 25.6 1.03 Allowed 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.11 -0.994 . . . . 0.0 113.257 172.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.9 t -149.76 149.92 31.27 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.676 -1.265 . . . . 0.0 111.595 -174.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.1 pt -139.06 148.21 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.831 1.652 . . . . 0.0 110.786 -171.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -99.34 148.87 23.73 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.106 1.363 . . . . 0.0 110.601 166.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 14.8 t -131.01 101.41 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.01 -12.86 82.89 Favored Glycine 0 N--CA 1.475 1.247 0 C-N-CA 124.128 0.871 . . . . 0.0 114.963 -161.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -164.26 148.48 9.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.531 1.932 . . . . 0.0 108.785 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.3 mp -144.51 -79.42 0.19 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.541 1.937 . . . . 0.0 109.63 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.5 t 177.03 162.64 0.46 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 128.232 2.613 . . . . 0.0 108.652 -162.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -91.75 0.37 57.49 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.407 1.083 . . . . 0.0 113.511 -174.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -120.24 0.42 10.64 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.424 1.89 . . . . 0.0 114.543 -173.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.8 t -90.15 168.51 11.9 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.932 -1.105 . . . . 0.0 113.152 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 40.0 p -143.41 163.72 35.21 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 127.488 2.315 . . . . 0.0 109.798 -174.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -60.58 -29.08 87.78 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.249 1.966 . . . . 0.0 113.193 169.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -69.08 -39.89 78.76 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.339 0.972 . . . . 0.0 111.837 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -60.98 -40.47 93.55 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.561 0.744 . . . . 0.0 111.585 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.4 mt -70.04 -31.67 69.42 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 172.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 51.8 m -65.9 -47.4 74.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.964 0.802 . . . . 0.0 110.868 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.03 -19.74 60.53 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -79.13 -55.93 4.74 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.307 1.443 . . . . 0.0 111.081 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -70.98 -28.16 64.24 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.162 0.985 . . . . 0.0 113.489 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 45.3 m -72.92 -2.31 20.37 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -64.91 -18.85 65.56 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.244 -0.91 . . . . 0.0 112.58 165.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 23.3 mm -90.08 -21.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.88 1.272 . . . . 0.0 112.222 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 168.64 -87.27 0.09 OUTLIER Glycine 0 N--CA 1.468 0.804 0 C-N-CA 125.379 1.466 . . . . 0.0 111.872 -173.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -162.07 120.18 2.22 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.663 1.185 . . . . 0.0 112.448 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 43.7 t -73.71 131.9 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 157.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.55 -18.34 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 171.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -162.37 141.21 9.11 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.144 1.778 . . . . 0.0 110.803 172.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -132.58 158.05 43.17 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.223 1.409 . . . . 0.0 111.522 164.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -153.31 143.91 22.61 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.471 1.508 . . . . 0.0 111.937 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 29.2 mm -141.13 137.43 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.697 1.599 . . . . 0.0 110.632 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 75.6 mt -89.77 113.74 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.625 1.57 . . . . 0.0 107.855 166.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 41.5 p -98.46 -178.85 4.15 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.35 1.86 . . . . 0.0 112.324 -170.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 26.6 t -156.62 167.25 31.01 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.091 1.356 . . . . 0.0 111.484 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -68.11 -18.23 64.59 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.11 1.364 . . . . 0.0 114.004 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 161.19 -1.3 0.07 OUTLIER Glycine 0 N--CA 1.475 1.292 0 N-CA-C 116.573 1.389 . . . . 0.0 116.573 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -151.74 143.76 23.85 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.791 1.296 . . . . 0.0 112.437 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 65.48 175.11 0.22 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 126.569 1.947 . . . . 0.0 113.452 -177.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 14.0 mmp_? 59.16 -145.41 0.53 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.328 1.451 . . . . 0.0 109.755 -171.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 79.25 62.11 2.24 Favored Glycine 0 N--CA 1.47 0.924 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -175.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 11.7 ptt? -155.83 155.65 33.35 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.862 1.665 . . . . 0.0 111.036 -170.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 164.99 -144.65 9.5 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-N 118.638 0.654 . . . . 0.0 114.388 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.5 p -144.46 159.77 42.2 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.34 1.456 . . . . 0.0 112.954 -165.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 37.8 t -144.97 141.53 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.003 1.321 . . . . 0.0 110.322 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -121.16 134.32 55.22 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 127.018 2.127 . . . . 0.0 110.922 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -118.96 172.79 7.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.676 2.39 . . . . 0.0 111.234 -173.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 80.9 p -92.2 -22.03 20.04 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -148.49 137.4 21.64 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -169.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 19.3 m -69.84 -22.89 63.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.98 2.112 . . . . 0.0 115.814 -168.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -90.24 -36.92 14.46 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.639 0.654 . . . . 0.0 111.951 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -72.23 -37.11 69.25 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.102 -0.998 . . . . 0.0 112.573 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 14.2 p -63.46 -28.7 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.607 0.763 . . . . 0.0 113.01 170.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.62 -46.57 37.45 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.86 0.864 . . . . 0.0 112.974 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -59.31 -27.84 66.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.317 1.447 . . . . 0.0 112.896 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.64 -60.93 2.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.216 1.006 . . . . 0.0 112.879 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 43.9 mt -65.09 -29.06 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 121.128 -0.982 . . . . 0.0 112.428 -169.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -51.44 -29.1 14.97 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.622 1.569 . . . . 0.0 113.19 168.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -93.87 -15.86 24.62 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.988 1.315 . . . . 0.0 113.698 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -127.6 -18.6 4.33 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -159.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.81 120.9 13.36 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 121.227 1.831 . . . . 0.0 110.506 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 92.98 0.78 68.02 Favored Glycine 0 N--CA 1.472 1.039 0 CA-C-O 117.941 -1.477 . . . . 0.0 115.059 -170.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.97 108.16 0.99 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.839 1.82 . . . . 0.0 110.348 171.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -55.68 129.25 38.44 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.313 0.645 . . . . 0.0 110.333 160.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -152.25 110.84 3.77 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.996 1.719 . . . . 0.0 106.685 -162.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 2.6 mpt? 41.15 59.28 2.35 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.152 0.981 . . . . 0.0 111.435 -160.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 73.21 0.05 3.54 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.922 2.089 . . . . 0.0 116.174 170.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -137.58 147.0 44.71 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.622 1.169 . . . . 0.0 111.775 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -70.83 124.22 23.79 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.903 -1.123 . . . . 0.0 113.698 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.4 pt -65.78 137.13 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.336 -0.853 . . . . 0.0 111.332 153.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -129.76 129.84 44.63 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.068 1.347 . . . . 0.0 109.596 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -156.32 129.09 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.992 0.917 . . . . 0.0 111.614 -169.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -106.95 148.59 28.45 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.919 1.687 . . . . 0.0 109.443 168.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.21 162.0 27.72 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.884 0.874 . . . . 0.0 111.806 178.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -131.63 153.58 49.79 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.433 1.493 . . . . 0.0 112.209 -171.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 37.5 t30 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.032 1.733 . . . . 0.0 111.978 -179.994 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 112.186 -0.366 . . . . 0.0 112.186 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.1 m -169.24 152.22 4.9 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.959 2.104 . . . . 0.0 110.781 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -160.66 162.8 32.77 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.513 1.525 . . . . 0.0 111.833 -176.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -66.71 145.68 55.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.557 1.143 . . . . 0.0 111.924 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -147.31 138.36 23.72 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.559 1.544 . . . . 0.0 110.528 173.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 pp -168.39 175.61 6.26 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.343 1.857 . . . . 0.0 111.906 -169.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -146.66 152.52 39.0 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.455 1.902 . . . . 0.0 110.839 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 10.4 t -160.33 160.94 33.05 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.636 1.174 . . . . 0.0 112.033 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.8 m -165.22 138.72 4.65 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 127.349 2.26 . . . . 0.0 108.734 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -160.11 145.32 15.05 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.429 1.091 . . . . 0.0 113.197 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.71 153.06 7.1 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.997 2.119 . . . . 0.0 109.243 173.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -161.72 129.76 4.18 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.282 1.033 . . . . 0.0 111.916 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -139.14 154.48 48.11 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.061 1.745 . . . . 0.0 111.258 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.38 146.82 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 125.547 1.539 . . . . 0.0 111.2 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -162.26 149.93 14.2 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.26 1.424 . . . . 0.0 111.55 -174.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.2 mmt-85 -140.07 118.32 12.03 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.531 1.532 . . . . 0.0 109.909 172.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -166.11 144.3 5.64 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.231 1.813 . . . . 0.0 110.743 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -129.53 123.5 31.59 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.18 0.992 . . . . 0.0 110.135 165.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 67.7 m -149.26 93.78 2.13 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.929 1.292 . . . . 0.0 110.417 -174.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -96.78 11.71 34.63 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 80.2 p -151.11 155.67 39.42 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.652 -1.28 . . . . 0.0 111.861 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 5.1 pt -144.58 154.37 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.219 1.407 . . . . 0.0 111.806 -165.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -119.02 125.85 50.32 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.553 1.941 . . . . 0.0 109.627 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 12.2 t -107.94 129.96 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.743 1.217 . . . . 0.0 109.111 -175.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.37 -97.66 0.12 Allowed Glycine 0 N--CA 1.472 1.094 0 C-N-CA 125.667 1.604 . . . . 0.0 115.036 -161.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -92.68 -56.86 2.85 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 117.625 0.713 . . . . 0.0 111.924 -173.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.45 6.67 1.52 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 118.752 2.871 . . . . 0.0 118.752 155.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.7 m 79.18 124.23 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 127.783 2.433 . . . . 0.0 110.422 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -68.25 -13.35 62.19 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -81.45 -9.14 59.78 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.503 1.521 . . . . 0.0 113.319 172.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.0 m -74.77 141.78 44.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.998 0.919 . . . . 0.0 112.551 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.8 p -122.87 152.78 63.21 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.971 1.308 . . . . 0.0 111.554 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.6 -25.9 14.46 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.607 2.205 . . . . 0.0 113.057 -173.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -69.43 -39.44 77.84 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.437 1.017 . . . . 0.0 111.891 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -73.16 -36.23 66.59 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.451 -0.781 . . . . 0.0 111.349 177.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 49.3 mt -62.24 -31.93 72.55 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.773 0.829 . . . . 0.0 112.289 166.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 54.8 m -67.0 -51.06 59.74 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.48 1.036 . . . . 0.0 109.634 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.92 -36.15 78.55 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.424 0.556 . . . . 0.0 112.359 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -67.38 -57.41 6.64 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.014 1.726 . . . . 0.0 112.29 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -71.57 -34.01 69.57 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.9 t -72.53 -8.79 56.95 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 121.004 -1.06 . . . . 0.0 113.441 -174.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -52.54 -27.99 18.93 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.362 2.265 . . . . 0.0 113.053 164.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 28.4 mm -80.52 -17.26 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.547 1.539 . . . . 0.0 112.451 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 117.25 90.98 1.54 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.909 1.719 . . . . 0.0 112.324 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? 69.69 91.29 0.09 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 126.751 2.02 . . . . 0.0 114.472 162.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 13.9 t -73.14 128.09 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 162.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 66.5 t -91.12 -22.51 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.892 1.677 . . . . 0.0 111.25 -175.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -178.43 140.03 0.2 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.243 2.217 . . . . 0.0 109.576 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -120.03 141.33 49.84 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.487 1.115 . . . . 0.0 110.52 162.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -143.7 92.95 2.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.677 1.191 . . . . 0.0 111.595 -169.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.6 -49.53 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.689 1.196 . . . . 0.0 110.815 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 18.8 tt -70.26 132.32 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.341 0.656 . . . . 0.0 111.923 -172.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 7.1 t -151.9 150.27 29.87 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.174 1.79 . . . . 0.0 110.559 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 3.9 t -95.99 -0.07 51.08 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.371 1.068 . . . . 0.0 112.769 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -82.72 0.13 44.92 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.191 1.397 . . . . 0.0 114.487 -171.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.98 162.43 28.72 Favored Glycine 0 N--CA 1.472 1.098 0 C-N-CA 125.606 1.574 . . . . 0.0 112.841 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -140.89 131.55 25.62 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.747 1.219 . . . . 0.0 112.868 -169.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -133.67 12.02 4.06 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.22 1.408 . . . . 0.0 113.487 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -167.19 -40.11 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.394 1.878 . . . . 0.0 112.909 -176.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 90.26 16.94 54.74 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.604 1.097 . . . . 0.0 114.317 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 28.2 ptm -66.95 162.52 21.74 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.954 1.302 . . . . 0.0 113.76 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -166.22 -166.74 25.76 Favored Glycine 0 N--CA 1.471 1.025 0 C-N-CA 124.031 0.824 . . . . 0.0 114.088 174.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.8 p -141.84 161.14 38.69 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.83 1.252 . . . . 0.0 112.599 -167.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 6.4 t -143.54 142.28 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.651 1.18 . . . . 0.0 110.435 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -114.49 145.26 42.12 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.225 2.21 . . . . 0.0 111.218 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -129.83 161.69 30.2 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.936 2.494 . . . . 0.0 109.535 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.2 p -84.21 -28.56 27.22 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.99 -0.444 . . . . 0.0 111.396 171.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -84.66 174.7 9.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.36 1.864 . . . . 0.0 112.902 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 39.3 t -126.03 -65.92 0.96 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.85 0.86 . . . . 0.0 111.49 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -64.5 -25.48 68.01 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.51 -1.369 . . . . 0.0 113.821 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -72.06 -20.92 61.59 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.561 1.144 . . . . 0.0 113.315 171.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 22.0 t -70.05 -28.3 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.049 0.94 . . . . 0.0 111.591 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -74.44 -37.07 63.37 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.283 -0.886 . . . . 0.0 112.208 167.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -64.8 -23.66 67.31 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.239 1.016 . . . . 0.0 112.405 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.97 -63.87 1.12 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.19 0.996 . . . . 0.0 110.565 164.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 83.8 mt -62.09 -35.63 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.215 1.006 . . . . 0.0 112.396 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -64.03 -6.56 6.52 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -114.29 -5.15 12.96 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.525 1.53 . . . . 0.0 112.535 172.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -128.06 -19.43 3.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -169.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -58.64 121.43 10.97 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.072 1.306 . . . . 0.0 109.227 162.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 93.83 0.51 66.35 Favored Glycine 0 N--CA 1.468 0.786 0 CA-C-O 118.379 -1.234 . . . . 0.0 114.849 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.57 108.53 2.46 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.512 1.656 . . . . 0.0 110.463 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -54.8 123.24 12.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.434 0.694 . . . . 0.0 109.963 155.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -148.62 116.51 6.35 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.422 1.489 . . . . 0.0 108.335 -167.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 56.21 31.58 18.67 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.101 0.96 . . . . 0.0 111.968 -163.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 10.7 t70 86.61 0.66 0.57 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 128.37 2.668 . . . . 0.0 115.582 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.4 152.77 48.69 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.638 1.175 . . . . 0.0 111.782 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -82.38 123.68 29.33 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -158.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.75 153.4 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 126.037 1.735 . . . . 0.0 113.318 167.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -145.86 146.65 31.2 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.552 1.941 . . . . 0.0 108.787 164.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 23.4 t -117.41 128.57 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.727 1.211 . . . . 0.0 110.586 -173.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -75.56 129.59 37.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.863 0.865 . . . . 0.0 109.364 168.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -100.28 136.94 39.39 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.005 1.322 . . . . 0.0 108.605 173.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 69.19 150.31 0.08 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 127.088 2.155 . . . . 0.0 113.96 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 12.0 t30 . . . . . 0 C--O 1.255 1.345 0 C-N-CA 125.7 1.6 . . . . 0.0 112.076 -179.859 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.824 0 N-CA-C 112.335 -0.306 . . . . 0.0 112.335 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.1 m -170.06 155.36 5.48 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.908 2.083 . . . . 0.0 110.98 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.34 143.08 50.37 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.835 0.854 . . . . 0.0 112.15 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -153.38 22.0 0.55 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.901 1.28 . . . . 0.0 114.171 -174.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -141.05 154.47 45.98 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.06 1.744 . . . . 0.0 110.631 -175.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -159.06 168.92 25.45 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.074 1.75 . . . . 0.0 112.177 -176.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -143.7 145.84 32.73 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.785 1.634 . . . . 0.0 111.307 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.7 p -164.23 167.44 20.0 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.648 1.579 . . . . 0.0 111.642 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.7 p -139.91 152.47 46.43 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.415 1.486 . . . . 0.0 111.449 -173.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -71.21 -10.77 60.31 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -172.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -78.39 -7.27 57.15 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -78.95 60.14 2.82 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 123.045 1.403 . . . . 0.0 111.271 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -81.98 -9.39 59.58 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.35 1.86 . . . . 0.0 114.542 -173.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.6 t 72.82 -69.68 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 128.38 2.672 . . . . 0.0 112.282 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 68.02 144.44 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 127.33 2.252 . . . . 0.0 113.339 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? 62.1 55.56 2.45 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.276 1.83 . . . . 0.0 111.348 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -81.82 57.12 3.3 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.903 1.681 . . . . 0.0 112.498 -168.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -129.78 18.94 5.63 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.667 1.587 . . . . 0.0 113.058 -166.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 29.8 t -154.24 163.7 39.72 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.498 1.519 . . . . 0.0 111.267 -171.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -153.16 22.29 0.56 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.891 1.276 . . . . 0.0 113.843 -169.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.2 t -144.88 156.86 44.23 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.508 -1.37 . . . . 0.0 113.165 -174.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.0 pt -143.61 147.32 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 125.301 1.44 . . . . 0.0 112.275 -165.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -113.78 118.98 35.78 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 128.041 2.536 . . . . 0.0 109.257 173.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 25.5 t -94.57 97.15 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.363 1.465 . . . . 0.0 107.397 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.39 -9.22 67.26 Favored Glycine 0 N--CA 1.475 1.25 0 N-CA-C 116.052 1.181 . . . . 0.0 116.052 -160.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -139.61 18.13 2.53 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -164.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.02 -174.92 2.86 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.28 1.432 . . . . 0.0 112.689 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 38.1 m -97.26 122.96 40.88 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.023 1.329 . . . . 0.0 109.503 171.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -66.94 -10.42 48.92 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -171.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -74.82 -13.11 60.53 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.486 1.514 . . . . 0.0 113.867 174.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 5.8 m -67.24 137.89 56.5 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.022 -1.049 . . . . 0.0 111.447 168.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 78.8 p -76.21 163.27 67.51 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 123.836 0.855 . . . . 0.0 109.908 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -59.91 -35.64 92.98 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 121.758 1.639 . . . . 0.0 111.917 168.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.42 -29.01 69.06 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.787 0.722 . . . . 0.0 112.88 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -65.21 -33.72 76.67 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.078 0.951 . . . . 0.0 111.992 173.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.3 mt -74.59 -34.16 62.81 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 118.003 -0.998 . . . . 0.0 113.451 165.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 84.8 m -61.08 -51.12 70.48 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.94 1.246 . . . . 0.0 110.62 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.24 -30.5 70.95 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.889 0.768 . . . . 0.0 112.973 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -68.27 -56.37 8.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.034 1.334 . . . . 0.0 111.514 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -71.65 -23.38 61.67 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.7 t -61.98 -19.65 63.03 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.651 -1.28 . . . . 0.0 113.457 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -60.97 -17.95 54.55 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.281 1.833 . . . . 0.0 113.306 169.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 25.8 mm -104.45 -51.87 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.144 1.378 . . . . 0.0 111.851 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -172.33 -177.42 41.79 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.165 1.364 . . . . 0.0 112.403 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -74.24 105.6 5.5 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 121.624 -0.927 . . . . 0.0 112.168 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 48.3 t -59.68 130.13 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 160.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.02 -40.16 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.312 0.645 . . . . 0.0 110.422 171.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -155.54 139.4 16.24 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.871 2.068 . . . . 0.0 109.983 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -125.31 152.96 43.99 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.313 1.445 . . . . 0.0 110.665 164.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -150.97 131.67 14.01 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.541 1.136 . . . . 0.0 112.203 -171.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.7 mt -142.48 -63.28 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.225 1.41 . . . . 0.0 110.974 171.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 15.7 tt -80.47 137.34 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.554 0.742 . . . . 0.0 111.081 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 43.5 p -137.08 144.34 43.07 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.354 1.062 . . . . 0.0 110.879 -168.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 14.4 m -61.07 -12.86 13.41 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -170.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 26.3 mmt85 -74.47 -17.69 60.74 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.048 0.939 . . . . 0.0 113.029 173.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 77.06 8.08 86.82 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.429 1.49 . . . . 0.0 115.562 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -83.58 137.01 34.03 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 118.9 1.35 . . . . 0.0 113.419 -174.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -72.7 101.69 3.14 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.897 0.879 . . . . 0.0 111.415 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -85.76 -30.21 23.24 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -173.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 73.5 14.61 79.44 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 123.888 0.756 . . . . 0.0 114.759 -175.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -153.97 167.82 28.47 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.04 1.336 . . . . 0.0 112.809 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -147.09 172.85 27.45 Favored Glycine 0 N--CA 1.468 0.774 0 C-N-CA 126.025 1.774 . . . . 0.0 112.808 177.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.3 p -142.81 148.77 37.67 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.12 1.368 . . . . 0.0 111.013 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.29 137.28 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.09 0.956 . . . . 0.0 109.983 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -116.09 137.08 52.44 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.706 1.603 . . . . 0.0 109.635 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -110.98 159.12 18.03 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.17 1.788 . . . . 0.0 110.411 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 64.1 p -77.07 0.48 21.28 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 169.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -130.01 157.18 43.05 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.106 1.762 . . . . 0.0 112.886 -165.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 72.1 p -109.14 -7.85 15.24 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.601 1.56 . . . . 0.0 114.916 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.71 -45.42 1.46 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.39 1.476 . . . . 0.0 111.914 -166.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.23 -30.08 68.16 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.596 -0.69 . . . . 0.0 111.505 172.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.5 p -61.13 -32.11 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.276 1.43 . . . . 0.0 113.025 174.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -74.16 -48.11 31.48 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.965 0.906 . . . . 0.0 111.436 171.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -72.34 -11.76 60.84 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.62 -56.75 17.46 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.6 1.16 . . . . 0.0 111.381 163.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 71.2 mt -66.87 -30.33 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.055 0.942 . . . . 0.0 112.109 -168.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -52.41 -28.37 19.58 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.507 1.123 . . . . 0.0 113.471 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -97.1 -15.23 21.07 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.399 1.48 . . . . 0.0 112.579 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -123.29 -15.64 7.14 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -165.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -61.31 120.65 10.83 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.53 1.514 . . . . 0.0 108.88 162.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 97.57 -0.24 59.58 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 118.153 -1.36 . . . . 0.0 114.844 -172.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.17 103.88 2.46 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.727 1.764 . . . . 0.0 110.469 173.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -60.81 119.69 8.67 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 158.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -150.38 110.85 4.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.152 1.381 . . . . 0.0 108.633 -165.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 57.13 55.38 6.04 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.298 1.039 . . . . 0.0 110.865 -170.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 19.5 t70 76.13 0.18 3.23 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.749 2.02 . . . . 0.0 116.088 169.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -146.86 157.36 43.63 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.311 0.959 . . . . 0.0 112.787 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 4.2 tmmm? -86.36 105.42 16.69 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.673 1.189 . . . . 0.0 112.647 -172.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.22 154.1 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.188 0.995 . . . . 0.0 112.052 165.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -156.45 144.77 19.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.466 1.906 . . . . 0.0 107.486 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 13.2 t -127.36 140.31 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.632 0.773 . . . . 0.0 111.926 -162.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 81.6 mtt85 -119.25 136.73 54.08 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.95 2.1 . . . . 0.0 108.318 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -94.76 151.78 18.98 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.227 -0.92 . . . . 0.0 110.49 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -73.29 140.47 46.82 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.672 -0.642 . . . . 0.0 111.561 167.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.253 0 C-N-CA 125.869 1.668 . . . . 0.0 111.097 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.5 t -163.45 -47.33 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.08 0.952 . . . . 0.0 113.379 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.93 -10.97 59.99 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -173.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 57.3 55.91 5.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.131 1.773 . . . . 0.0 112.265 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -73.07 134.1 44.43 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.58 0.752 . . . . 0.0 109.725 170.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.4 mt -140.69 158.66 43.65 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.295 1.438 . . . . 0.0 111.925 -171.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -72.51 166.22 23.08 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.221 1.408 . . . . 0.0 112.832 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.9 m -160.92 152.92 19.9 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.275 1.83 . . . . 0.0 111.679 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 37.8 p -126.66 147.05 49.97 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.569 1.548 . . . . 0.0 111.537 -172.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -144.05 162.71 35.53 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.196 1.398 . . . . 0.0 112.279 -170.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -160.21 163.03 33.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.992 1.317 . . . . 0.0 112.436 -175.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.86 126.49 17.92 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.768 1.627 . . . . 0.0 109.541 173.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -87.12 152.07 22.66 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.251 1.02 . . . . 0.0 112.37 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.5 m -146.1 152.23 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 126.068 1.747 . . . . 0.0 111.152 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -145.86 139.98 26.71 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.228 1.411 . . . . 0.0 111.474 -175.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -95.47 135.53 37.0 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.969 1.308 . . . . 0.0 110.949 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -92.8 -8.03 44.78 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 48.3 t80 76.37 117.44 0.06 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 128.461 2.704 . . . . 0.0 113.109 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 30.6 m 50.49 39.28 20.54 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.186 1.395 . . . . 0.0 113.189 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -60.19 131.54 51.14 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -154.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.7 t -78.04 158.38 29.23 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.529 1.532 . . . . 0.0 112.806 170.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 31.7 pt -138.95 138.89 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.898 2.079 . . . . 0.0 107.948 175.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -105.73 131.3 53.25 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.59 1.156 . . . . 0.0 109.52 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.7 t -111.2 122.96 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.677 1.591 . . . . 0.0 108.354 -170.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.12 -141.67 1.78 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.195 1.855 . . . . 0.0 113.312 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -74.97 47.26 0.34 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -162.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -53.99 -50.1 67.34 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.819 -1.175 . . . . 0.0 112.606 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.1 t 145.23 142.96 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.388 1 C-N-CA 131.705 4.002 . . . . 0.0 110.18 173.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -68.95 -9.5 52.39 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -80.59 -6.07 57.75 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.748 1.219 . . . . 0.0 113.198 170.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 6.2 t -88.72 167.06 13.63 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.957 0.903 . . . . 0.0 113.163 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.45 151.74 64.71 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 125.741 1.617 . . . . 0.0 111.385 -170.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.41 -21.76 11.42 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.797 2.332 . . . . 0.0 114.331 -167.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.02 -34.79 75.81 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.156 1.344 . . . . 0.0 111.567 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.42 -41.66 84.48 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.777 1.231 . . . . 0.0 110.874 175.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.4 tp -67.38 -33.59 75.51 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.478 1.911 . . . . 0.0 111.455 174.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 68.3 m -64.26 -50.45 67.91 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.428 1.491 . . . . 0.0 110.41 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -67.59 -40.5 84.79 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.918 0.487 . . . . 0.0 111.622 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -56.07 -56.58 19.1 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.484 1.513 . . . . 0.0 112.235 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -71.13 -27.46 63.59 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.6 m -73.3 0.51 11.8 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -68.75 -19.59 64.34 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.169 -0.957 . . . . 0.0 112.597 164.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 14.0 mm -95.05 -55.29 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.104 0.961 . . . . 0.0 111.137 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -135.68 -109.68 1.02 Allowed Glycine 0 N--CA 1.468 0.779 0 C-N-CA 125.906 1.717 . . . . 0.0 110.372 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -152.84 121.99 6.63 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.213 1.005 . . . . 0.0 111.097 173.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 49.1 t -73.4 129.95 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 170.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.61 -24.05 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 170.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -152.78 135.7 15.51 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.463 1.505 . . . . 0.0 110.257 172.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -128.09 148.79 50.58 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.014 1.326 . . . . 0.0 110.598 160.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -145.53 134.98 23.15 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.6 1.16 . . . . 0.0 112.13 -172.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 59.2 mt -142.7 -60.48 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 125.64 1.576 . . . . 0.0 110.165 170.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 9.8 tp -65.68 137.21 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.729 0.811 . . . . 0.0 111.911 -175.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 3.7 t -151.44 136.74 17.6 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.061 1.744 . . . . 0.0 110.083 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 62.8 p -97.38 -2.99 41.14 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.916 1.286 . . . . 0.0 112.937 174.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -109.07 -33.35 6.92 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.669 1.588 . . . . 0.0 112.964 -176.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -97.08 168.36 24.49 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.129 1.347 . . . . 0.0 112.318 173.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -76.33 162.59 27.77 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-O 121.392 0.615 . . . . 0.0 112.254 169.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -79.58 83.56 5.55 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.316 -0.865 . . . . 0.0 111.572 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -71.0 -24.0 62.3 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.473 1.509 . . . . 0.0 113.458 -173.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 77.91 35.13 36.13 Favored Glycine 0 N--CA 1.475 1.243 0 C-N-CA 124.035 0.826 . . . . 0.0 112.483 -174.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 61.0 mtt -145.04 159.57 42.74 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.027 2.131 . . . . 0.0 110.772 -173.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -145.61 -179.08 21.61 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 124.383 0.992 . . . . 0.0 114.905 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 12.7 m -141.55 148.56 39.53 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.361 1.465 . . . . 0.0 109.087 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 19.6 t -141.25 147.15 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.263 1.025 . . . . 0.0 110.472 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.04 131.1 47.31 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.589 1.556 . . . . 0.0 110.976 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -102.53 161.69 13.52 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.51 1.524 . . . . 0.0 111.196 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 54.1 p -70.52 0.21 7.21 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.559 1.543 . . . . 0.0 113.893 166.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -141.75 162.21 36.03 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.432 1.893 . . . . 0.0 112.108 -165.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 12.5 m -132.67 13.42 4.45 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -132.06 -36.5 1.17 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.068 1.347 . . . . 0.0 112.661 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -66.51 -21.53 66.17 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.748 0.819 . . . . 0.0 112.397 167.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.1 m -63.87 -28.17 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.507 1.523 . . . . 0.0 112.907 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -74.3 -49.64 22.21 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.55 1.14 . . . . 0.0 111.449 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 23.4 ptt-85 -74.37 -11.86 60.36 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.7 -64.5 0.88 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.939 0.895 . . . . 0.0 110.835 160.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 66.3 mt -62.19 -32.83 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.938 0.895 . . . . 0.0 112.449 -171.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 35.0 ttm105 -57.21 -22.69 42.67 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 173.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -98.06 -11.14 23.25 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.41 1.084 . . . . 0.0 112.943 175.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -123.56 -21.29 5.3 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -165.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -66.2 120.44 13.23 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 120.415 1.461 . . . . 0.0 109.559 172.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 90.06 0.59 77.35 Favored Glycine 0 N--CA 1.473 1.127 0 CA-C-O 117.884 -1.509 . . . . 0.0 115.146 -168.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.8 109.46 1.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.986 1.893 . . . . 0.0 109.482 167.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -55.97 119.89 6.57 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 157.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -148.87 118.35 6.94 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.215 1.406 . . . . 0.0 108.259 -172.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.38 44.07 18.87 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-O 122.398 1.094 . . . . 0.0 110.212 -163.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 71.55 0.52 3.51 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 128.066 2.546 . . . . 0.0 116.253 173.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 30.1 mmt85 -135.04 148.69 49.97 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.07 1.348 . . . . 0.0 112.105 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -64.54 117.07 6.83 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.194 -0.941 . . . . 0.0 113.234 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.26 153.56 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.635 0.774 . . . . 0.0 110.684 156.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -137.53 157.37 46.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.533 1.533 . . . . 0.0 107.857 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.12 139.24 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.528 1.058 . . . . 0.0 111.681 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -115.62 136.57 52.94 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.828 1.651 . . . . 0.0 108.84 169.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -72.51 139.9 47.87 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.512 -0.742 . . . . 0.0 109.278 172.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -126.42 -141.15 0.28 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.158 0.983 . . . . 0.0 111.333 -169.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 125.471 1.508 . . . . 0.0 111.654 -178.697 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 112.101 -0.4 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.0 t -161.86 159.1 26.44 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.18 1.392 . . . . 0.0 111.356 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -161.49 157.23 24.65 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.163 1.785 . . . . 0.0 111.579 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -74.09 132.02 41.89 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.042 0.937 . . . . 0.0 111.538 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -165.66 154.81 12.0 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.395 1.878 . . . . 0.0 110.894 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.7 pp -161.52 175.03 12.56 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.849 1.66 . . . . 0.0 112.247 -176.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -158.81 157.76 32.2 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.986 1.714 . . . . 0.0 111.731 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.3 t -164.58 176.23 9.11 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.286 1.435 . . . . 0.0 111.515 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.6 t -160.57 160.19 31.51 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.354 1.861 . . . . 0.0 110.849 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -65.51 127.64 32.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.842 0.857 . . . . 0.0 112.798 -177.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -159.08 129.6 5.92 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.451 1.9 . . . . 0.0 108.232 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -162.72 135.09 5.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.571 0.748 . . . . 0.0 111.505 -163.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -85.76 176.44 8.13 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.43 1.092 . . . . 0.0 113.431 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 31.2 m -128.55 170.64 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 125.497 1.519 . . . . 0.0 111.056 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -152.55 133.93 14.42 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.868 1.267 . . . . 0.0 110.564 -173.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -121.82 117.94 27.76 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.137 1.375 . . . . 0.0 109.966 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -163.98 139.46 6.19 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.225 1.81 . . . . 0.0 109.337 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -106.54 8.86 31.55 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.315 1.446 . . . . 0.0 114.311 -176.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.5 m -78.86 178.77 7.69 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.485 1.114 . . . . 0.0 113.387 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -64.46 34.62 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 128.271 2.628 . . . . 0.0 114.447 171.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.7 m -148.72 144.99 27.45 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.968 1.707 . . . . 0.0 111.917 -165.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.9 pt -130.92 150.2 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.976 1.71 . . . . 0.0 110.976 -170.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -110.0 138.88 45.76 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.503 1.521 . . . . 0.0 111.197 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 44.8 t -126.79 131.04 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.923 1.689 . . . . 0.0 108.786 -169.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.32 -164.2 7.2 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.976 1.751 . . . . 0.0 113.283 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -67.52 -14.96 63.39 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 118.062 2.615 . . . . 0.0 118.062 -157.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.3 mp 51.03 -112.71 0.65 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.537 1.535 . . . . 0.0 109.857 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 71.2 p -122.87 153.39 39.69 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.056 2.143 . . . . 0.0 109.312 154.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -57.12 -28.84 63.05 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -175.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -91.73 -0.98 57.59 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.821 2.048 . . . . 0.0 114.114 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 85.8 p -67.47 160.91 26.56 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.45 152.67 60.97 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 125.799 1.64 . . . . 0.0 111.593 -169.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.79 -18.53 11.7 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.151 2.567 . . . . 0.0 114.647 -165.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.43 -35.48 81.07 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.519 1.054 . . . . 0.0 111.112 172.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -69.64 -36.86 76.48 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.773 1.229 . . . . 0.0 111.399 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.8 mt -67.98 -31.89 71.91 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-O 118.685 -0.674 . . . . 0.0 112.326 169.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 59.7 m -67.16 -50.89 59.51 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.969 0.804 . . . . 0.0 109.516 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -58.13 -38.8 77.23 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.669 0.788 . . . . 0.0 112.293 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -65.56 -63.25 1.14 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.343 1.457 . . . . 0.0 112.236 176.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.16 -33.95 70.5 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -173.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.25 -3.39 26.55 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -172.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -65.47 -18.17 65.12 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 120.967 -1.083 . . . . 0.0 112.739 169.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 29.8 mm -78.53 -27.4 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.616 1.567 . . . . 0.0 112.31 174.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 139.25 169.45 11.58 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.994 1.759 . . . . 0.0 110.755 -158.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -57.72 106.54 0.36 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -164.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 53.9 t -71.05 131.36 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 151.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.29 -26.5 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 171.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 50.7 ttt-85 -162.74 110.47 1.28 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.856 0.463 . . . . 0.0 110.825 -170.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.72 151.74 19.84 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.192 0.997 . . . . 0.0 110.259 161.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -153.23 125.28 7.93 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.911 0.884 . . . . 0.0 111.615 -170.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mt -138.29 -53.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 125.565 1.546 . . . . 0.0 111.354 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 40.0 pt -65.9 124.72 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-O 121.409 0.623 . . . . 0.0 112.534 -168.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 14.6 t -151.7 153.33 34.16 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.494 1.918 . . . . 0.0 110.116 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 5.0 t 70.12 -173.61 0.18 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.077 1.751 . . . . 0.0 112.396 -168.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -81.34 -32.77 32.86 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.315 1.046 . . . . 0.0 112.884 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -104.59 127.56 9.13 Favored Glycine 0 N--CA 1.471 1.025 0 C-N-CA 125.488 1.518 . . . . 0.0 111.363 175.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -105.09 85.4 2.27 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.27 1.028 . . . . 0.0 111.995 -172.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -145.7 22.91 1.43 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.021 1.328 . . . . 0.0 112.869 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -97.56 -13.82 21.4 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -165.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 74.6 -76.74 1.13 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.881 1.229 . . . . 0.0 113.661 174.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.33 153.73 14.92 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.138 1.375 . . . . 0.0 114.545 -169.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -175.92 -152.46 9.56 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.8 p -143.01 159.83 41.5 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.124 1.77 . . . . 0.0 112.172 -172.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 18.8 t -140.42 140.89 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.294 1.038 . . . . 0.0 110.306 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -128.86 127.68 42.35 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.383 1.473 . . . . 0.0 109.981 -172.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -110.8 170.71 7.92 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.53 1.932 . . . . 0.0 109.746 -174.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 80.9 p -81.47 0.07 39.45 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -139.07 155.08 48.19 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.831 1.253 . . . . 0.0 114.088 -167.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 66.4 p -108.38 4.73 24.73 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.775 1.63 . . . . 0.0 113.68 -177.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -120.37 -46.04 2.41 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.634 1.174 . . . . 0.0 112.783 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -63.53 -22.04 66.67 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.313 -0.867 . . . . 0.0 113.039 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.3 m -61.34 -29.74 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.896 2.079 . . . . 0.0 113.363 173.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -74.48 -49.46 22.13 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.026 0.83 . . . . 0.0 110.541 166.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -58.4 -28.28 65.05 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.797 1.239 . . . . 0.0 113.399 -174.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.2 -59.57 5.21 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.23 1.412 . . . . 0.0 112.291 168.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 51.6 mt -66.39 -31.25 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.22 1.008 . . . . 0.0 112.282 -170.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -58.91 -5.77 0.67 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 171.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -133.07 5.68 3.86 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.52 1.128 . . . . 0.0 114.038 172.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -123.11 -22.14 5.25 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.01 120.64 13.98 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 121.327 1.876 . . . . 0.0 110.653 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 92.16 0.83 70.38 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-O 118.025 -1.43 . . . . 0.0 115.119 -169.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.42 107.47 0.79 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.953 1.877 . . . . 0.0 109.926 168.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -52.02 123.95 11.68 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.957 161.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -147.97 120.83 8.72 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.022 1.329 . . . . 0.0 108.709 -172.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 50.5 mtt 60.37 28.07 17.68 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.154 0.982 . . . . 0.0 112.159 -169.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.6 t70 92.27 -0.06 0.13 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 129.449 3.1 . . . . 0.0 115.419 173.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 42.9 mmt180 -136.69 150.48 48.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.751 1.221 . . . . 0.0 112.184 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -65.12 111.71 3.05 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.862 -1.149 . . . . 0.0 112.555 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.47 152.0 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 O-C-N 121.169 -0.957 . . . . 0.0 109.761 151.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -132.12 156.66 45.96 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.145 1.378 . . . . 0.0 108.429 170.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.7 p -150.44 127.0 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.517 0.675 . . . . 0.0 112.113 -169.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -85.0 131.7 34.44 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.481 1.512 . . . . 0.0 108.403 175.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.44 ' NE2' ' H ' ' A' ' 235' ' ' ASP . 0.1 OUTLIER -86.51 154.78 20.84 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.315 1.046 . . . . 0.0 109.774 178.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.44 ' H ' ' NE2' ' A' ' 234' ' ' GLN . 3.3 p30 -68.78 150.57 47.7 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.919 -1.113 . . . . 0.0 113.38 178.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 . . . . . 0 C--O 1.255 1.364 0 C-N-CA 128.125 2.57 . . . . 0.0 113.04 -178.565 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.718 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 25.3 m -130.94 14.25 5.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.067 0.947 . . . . 0.0 113.452 -169.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.18 137.67 48.93 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.378 1.071 . . . . 0.0 112.626 -177.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.1 mtt-85 -77.73 153.45 32.96 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.525 1.13 . . . . 0.0 112.033 177.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.06 -11.15 1.27 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.812 1.645 . . . . 0.0 113.788 177.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -84.9 -3.78 58.84 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.725 1.61 . . . . 0.0 114.312 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -80.75 40.7 0.53 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.609 2.364 . . . . 0.0 113.626 -171.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 49.0 m -162.51 140.37 8.44 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.634 1.974 . . . . 0.0 111.456 177.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.7 t -165.66 165.95 18.35 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.61 1.964 . . . . 0.0 110.639 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -161.12 162.43 31.49 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.727 1.611 . . . . 0.0 113.015 -174.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -160.64 127.44 4.19 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.524 1.53 . . . . 0.0 110.078 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -164.53 146.12 8.31 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.846 1.658 . . . . 0.0 110.45 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -150.57 -55.85 0.16 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.344 1.058 . . . . 0.0 112.59 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.9 m -145.66 141.5 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 125.958 1.703 . . . . 0.0 110.429 174.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -122.0 -3.45 9.1 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -173.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 73.2 ttp85 -165.82 140.53 4.71 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.428 1.491 . . . . 0.0 111.583 -172.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -159.97 -42.91 0.05 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.394 1.078 . . . . 0.0 112.737 166.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 67.48 160.06 0.16 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 127.527 2.331 . . . . 0.0 114.516 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 80.8 p -167.97 172.44 8.91 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.903 1.281 . . . . 0.0 112.867 -174.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -168.12 -46.09 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.834 2.054 . . . . 0.0 110.186 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 1.9 m -73.1 155.48 39.67 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 143.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 6.7 pt -139.22 150.94 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.69 1.596 . . . . 0.0 109.784 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -122.95 143.77 49.69 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.216 1.406 . . . . 0.0 111.986 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.0 t -124.34 116.82 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.226 1.81 . . . . 0.0 108.193 -174.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.06 -25.43 59.77 Favored Glycine 0 N--CA 1.475 1.24 0 C-N-CA 123.542 0.591 . . . . 0.0 114.403 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -162.17 151.22 15.48 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.742 2.017 . . . . 0.0 108.571 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -173.16 11.19 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 126.054 1.742 . . . . 0.0 114.917 -171.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 34.9 m 86.42 111.45 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 128.739 2.816 . . . . 0.0 109.403 -165.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -62.64 -17.43 60.36 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -83.42 -0.35 49.59 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.703 1.601 . . . . 0.0 113.529 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 10.0 t -67.66 167.56 12.9 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.834 -1.166 . . . . 0.0 113.797 175.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 44.8 p -135.7 153.32 77.32 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 125.972 1.709 . . . . 0.0 110.416 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.56 -23.96 26.54 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.566 2.177 . . . . 0.0 113.13 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.28 -37.19 77.75 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.885 0.766 . . . . 0.0 111.712 172.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.47 -35.37 68.21 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.507 -0.746 . . . . 0.0 111.424 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 20.9 mt -62.91 -35.85 81.44 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-O 118.807 -0.616 . . . . 0.0 112.334 166.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 74.7 m -67.93 -45.83 73.22 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.222 0.919 . . . . 0.0 110.337 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.7 -15.79 54.32 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.811 1.245 . . . . 0.0 113.502 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -96.5 -57.94 2.18 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.285 1.834 . . . . 0.0 111.896 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -71.6 -34.2 69.65 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 3.7 t -73.16 -15.92 61.45 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -159.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -64.35 -17.9 64.15 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 35.8 mm -59.8 -24.18 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.114 1.365 . . . . 0.0 112.641 173.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 167.52 -72.05 0.16 Allowed Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.926 1.25 . . . . 0.0 111.467 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -160.28 118.39 2.6 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.965 1.306 . . . . 0.0 111.158 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.29 137.93 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 165.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.5 m -110.27 -16.67 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -159.91 158.46 30.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.739 1.215 . . . . 0.0 111.881 176.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -160.06 149.13 17.5 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.939 1.696 . . . . 0.0 111.696 174.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -149.58 152.54 35.66 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.619 1.967 . . . . 0.0 111.641 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 26.6 mm -133.29 128.0 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 126.145 1.778 . . . . 0.0 107.844 170.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 17.4 tt -80.59 140.29 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 O-C-N 121.494 -0.753 . . . . 0.0 111.775 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 49.4 p -146.14 174.9 10.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.342 1.857 . . . . 0.0 111.049 -174.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 45.7 p -149.55 -173.27 4.36 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.836 1.254 . . . . 0.0 112.086 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.91 -10.55 58.93 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.253 1.021 . . . . 0.0 113.172 175.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -134.33 -151.38 6.39 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.025 1.774 . . . . 0.0 112.464 176.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -73.3 149.68 42.5 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.153 0.581 . . . . 0.0 112.273 170.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -154.74 163.7 39.87 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.18 1.392 . . . . 0.0 112.145 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -63.38 -24.93 68.06 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.975 1.31 . . . . 0.0 113.721 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 74.55 37.26 46.86 Favored Glycine 0 N--CA 1.471 1.008 0 CA-C-O 119.175 -0.792 . . . . 0.0 114.79 164.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -59.34 148.18 33.29 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.507 1.154 . . . . 0.0 112.415 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -110.43 158.97 14.11 Favored Glycine 0 N--CA 1.468 0.806 0 C-N-CA 124.656 1.122 . . . . 0.0 113.458 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.2 m -141.97 142.4 32.97 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.887 1.675 . . . . 0.0 108.032 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.7 t -142.4 149.97 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.972 0.909 . . . . 0.0 109.433 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -132.65 129.72 39.23 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.891 0.876 . . . . 0.0 111.523 -176.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -114.9 172.7 6.89 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.243 1.817 . . . . 0.0 111.102 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.8 p -86.85 -11.57 50.44 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -149.35 127.96 12.38 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 116.749 2.129 . . . . 0.0 116.749 -169.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 33.0 p -73.8 2.29 8.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 128.116 2.566 . . . . 0.0 116.064 -174.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -114.07 -36.76 4.64 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.269 1.428 . . . . 0.0 111.693 169.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.68 -27.68 69.09 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.5 -0.75 . . . . 0.0 112.775 173.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.9 m -59.55 -33.43 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 171.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -74.17 -46.61 41.15 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.958 0.799 . . . . 0.0 110.214 172.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -57.88 -29.7 65.25 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.673 0.789 . . . . 0.0 112.829 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.95 -68.57 0.35 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.778 1.231 . . . . 0.0 111.492 167.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 64.7 mt -61.99 -34.83 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.43 -0.793 . . . . 0.0 112.193 -167.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -58.69 -12.78 4.59 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.754 1.222 . . . . 0.0 114.187 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -116.62 -1.99 12.04 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.719 1.608 . . . . 0.0 112.888 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -128.91 -23.21 3.11 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.67 120.57 11.45 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 120.498 1.499 . . . . 0.0 109.832 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 95.68 0.48 62.46 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-O 118.11 -1.383 . . . . 0.0 115.725 -170.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.96 108.46 1.04 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.721 1.76 . . . . 0.0 109.973 169.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -58.12 124.17 18.46 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.788 -0.57 . . . . 0.0 109.921 158.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -150.38 110.97 4.24 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.852 1.261 . . . . 0.0 108.912 -159.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 49.8 mtt 57.91 23.36 9.72 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.585 1.154 . . . . 0.0 113.487 -169.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 19.8 t70 101.16 -11.61 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 130.811 3.644 . . . . 0.0 115.24 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -116.29 147.0 41.97 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 119.978 1.263 . . . . 0.0 111.801 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -68.09 112.06 4.83 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.308 1.443 . . . . 0.0 112.229 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.5 pt -61.21 141.69 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.473 1.033 . . . . 0.0 111.609 166.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -138.37 129.76 27.51 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.644 1.178 . . . . 0.0 109.158 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.2 126.81 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 123.626 0.771 . . . . 0.0 110.713 -164.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 52.7 ttt85 -97.04 140.57 31.37 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.539 1.936 . . . . 0.0 108.768 170.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 13.0 mp0 -70.68 101.27 2.03 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 169.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -163.78 147.17 9.98 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.862 1.265 . . . . 0.0 111.54 -166.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.795 1.638 . . . . 0.0 111.787 -167.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.3 t -163.57 173.37 13.11 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.64 1.576 . . . . 0.0 111.162 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . 63.97 15.84 9.47 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.882 2.073 . . . . 0.0 115.209 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -63.9 132.01 49.47 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.735 1.214 . . . . 0.0 111.618 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -73.77 162.87 28.67 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.47 1.108 . . . . 0.0 113.266 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.8 pp -155.66 178.4 10.29 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.037 1.735 . . . . 0.0 111.863 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -142.84 152.65 42.4 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.394 1.477 . . . . 0.0 112.248 -173.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.4 m -147.07 167.45 24.06 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.412 1.885 . . . . 0.0 111.136 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.2 t -148.94 150.68 33.31 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.278 1.431 . . . . 0.0 111.193 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -150.2 163.99 36.83 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.595 1.558 . . . . 0.0 112.614 -167.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -92.24 157.79 16.49 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.443 1.097 . . . . 0.0 111.201 170.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -146.42 40.87 1.13 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.02 1.328 . . . . 0.0 110.667 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -132.92 153.09 51.72 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.502 1.921 . . . . 0.0 111.33 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.2 p -160.96 143.04 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.879 1.272 . . . . 0.0 111.547 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -159.69 145.77 15.99 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.541 1.536 . . . . 0.0 111.497 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -153.44 143.13 21.89 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.963 1.305 . . . . 0.0 112.033 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -166.55 136.91 3.26 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.383 1.473 . . . . 0.0 111.315 -171.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -53.4 123.16 11.23 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.62 0.768 . . . . 0.0 111.67 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 69.0 m -133.32 126.3 31.1 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.783 0.833 . . . . 0.0 110.855 -165.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -76.12 -11.6 59.96 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.852 1.426 . . . . 0.0 114.852 -169.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.6 t -170.96 161.35 6.95 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.02 1.328 . . . . 0.0 111.486 -169.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -131.15 142.83 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.233 0.613 . . . . 0.0 110.024 158.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -111.93 142.48 44.28 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.71 1.604 . . . . 0.0 111.166 -174.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.3 t -144.61 121.32 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.161 0.984 . . . . 0.0 109.989 174.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -137.75 19.56 3.32 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.88 1.229 . . . . 0.0 115.602 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -128.57 20.02 6.16 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.305 1.442 . . . . 0.0 112.707 -171.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.3 pp -96.54 -175.88 3.45 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 126.984 2.114 . . . . 0.0 111.245 -174.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 48.4 m -79.81 121.5 25.47 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.782 0.833 . . . . 0.0 109.407 168.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -66.54 -11.56 53.47 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -170.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -81.38 -10.97 59.42 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.956 1.303 . . . . 0.0 113.588 171.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 91.5 p -77.66 142.6 38.75 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.6 -0.688 . . . . 0.0 111.664 172.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 68.2 p -102.52 163.63 17.25 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 125.067 1.347 . . . . 0.0 111.205 -171.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -64.54 -26.8 61.91 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.499 2.133 . . . . 0.0 112.931 171.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -69.34 -40.03 77.81 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.472 1.033 . . . . 0.0 111.729 171.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -66.93 -36.58 82.56 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.817 0.847 . . . . 0.0 111.64 175.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 45.7 mt -66.21 -32.66 74.22 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.547 -0.74 . . . . 0.0 112.725 166.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 81.8 m -67.1 -48.22 68.83 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.686 1.13 . . . . 0.0 109.965 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.05 -27.84 69.18 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -78.69 -58.96 2.98 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.53 1.532 . . . . 0.0 112.106 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -71.1 -37.83 72.39 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.65 -1.67 19.89 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -176.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -55.87 -26.87 49.09 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.797 1.639 . . . . 0.0 112.165 164.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.4 mm -75.87 -30.7 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.815 1.646 . . . . 0.0 112.88 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 166.86 -103.84 0.21 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.783 1.182 . . . . 0.0 112.181 -165.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -135.01 106.35 6.77 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.991 0.916 . . . . 0.0 113.396 -175.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 56.2 t -80.96 135.68 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 153.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.33 -24.72 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -157.88 88.66 0.98 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.547 0.739 . . . . 0.0 112.235 -170.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -91.18 140.97 29.3 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.812 -1.18 . . . . 0.0 111.709 168.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -153.28 121.44 6.17 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.919 1.287 . . . . 0.0 112.201 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 20.3 mt -141.78 -56.75 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 125.459 1.504 . . . . 0.0 111.08 174.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.4 mm -88.04 111.1 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 40.0 p -140.01 151.5 45.51 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.775 1.23 . . . . 0.0 111.052 -166.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 18.9 t -75.91 -28.54 58.09 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -172.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.34 -0.12 44.42 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.949 1.3 . . . . 0.0 113.286 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -78.33 162.1 49.24 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.69 1.138 . . . . 0.0 114.522 -174.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -130.28 0.95 4.62 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 126.827 2.051 . . . . 0.0 112.577 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -138.66 27.42 2.48 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.508 1.923 . . . . 0.0 113.119 -155.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -51.06 142.27 12.55 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.619 1.167 . . . . 0.0 113.076 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 100.06 -4.71 57.48 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.197 1.38 . . . . 0.0 114.161 -169.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 26.8 ptm -149.42 153.0 36.66 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.21 1.404 . . . . 0.0 111.74 173.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 169.6 -143.45 7.94 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.932 0.777 . . . . 0.0 113.002 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 25.0 p -137.87 160.87 38.12 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.986 0.914 . . . . 0.0 113.272 -162.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.3 t -136.03 102.42 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.126 1.371 . . . . 0.0 108.056 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -88.53 122.85 32.45 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.205 1.002 . . . . 0.0 110.457 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -90.02 176.03 6.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.86 1.664 . . . . 0.0 109.814 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 72.4 p -68.09 0.16 3.91 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 168.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 27.3 m120 85.77 2.91 0.6 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.743 2.817 . . . . 0.0 114.977 165.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.7 t -110.8 -168.53 1.32 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.462 1.505 . . . . 0.0 112.136 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -34.08 -38.37 0.06 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 130.531 3.533 . . . . 0.0 117.28 -164.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -52.15 -33.69 41.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.101 1.76 . . . . 0.0 112.733 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.0 p -68.83 -37.41 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.107 1.363 . . . . 0.0 112.952 -169.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -75.16 -52.07 11.86 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.734 1.214 . . . . 0.0 112.382 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -74.0 -18.47 60.85 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.654 1.182 . . . . 0.0 114.057 -171.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.47 -60.03 4.11 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.065 0.946 . . . . 0.0 111.911 170.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 27.9 mt -65.46 -28.73 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.706 0.803 . . . . 0.0 112.41 -171.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -28.63 37.53 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.324 1.05 . . . . 0.0 112.511 169.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -98.24 -11.31 22.8 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.443 1.097 . . . . 0.0 113.432 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -126.32 -20.12 4.51 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -164.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -62.42 120.79 11.73 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 120.038 1.29 . . . . 0.0 109.627 169.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 95.1 0.52 63.5 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-O 118.163 -1.354 . . . . 0.0 115.334 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.15 107.06 0.81 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.757 1.778 . . . . 0.0 110.673 170.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -57.22 107.32 0.41 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 154.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -129.74 110.66 11.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.323 1.049 . . . . 0.0 108.921 -167.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 48.2 ttm 53.88 43.92 30.22 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.923 0.889 . . . . 0.0 110.816 -168.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.8 t70 86.76 0.21 0.56 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 128.091 2.557 . . . . 0.0 116.146 170.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -136.19 135.89 39.5 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.622 1.101 . . . . 0.0 112.542 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -68.17 102.55 1.37 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.546 1.538 . . . . 0.0 113.541 -176.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.51 151.25 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.117 0.967 . . . . 0.0 111.456 164.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -148.01 135.41 20.61 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.083 1.353 . . . . 0.0 108.921 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -156.94 137.08 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.217 1.407 . . . . 0.0 109.867 -165.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -119.55 140.6 50.27 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.855 1.262 . . . . 0.0 109.579 171.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -65.8 165.07 13.48 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.07 0.948 . . . . 0.0 111.819 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -72.25 5.26 2.95 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.315 1.446 . . . . 0.0 114.192 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 . . . . . 0 C--O 1.254 1.319 0 C-N-CA 126.622 1.969 . . . . 0.0 112.317 -179.247 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.693 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.6 m 69.92 172.78 0.3 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.682 1.993 . . . . 0.0 113.76 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -154.06 153.71 32.39 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.964 1.305 . . . . 0.0 112.46 -175.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.95 136.02 4.06 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.671 1.988 . . . . 0.0 111.242 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -90.28 -28.02 19.07 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -172.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 76.9 mt 66.42 -34.18 0.21 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 128.859 2.864 . . . . 0.0 115.452 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -69.49 129.14 38.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.375 1.47 . . . . 0.0 112.727 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 13.8 t -170.15 154.96 5.21 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.245 1.818 . . . . 0.0 110.811 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.4 t -164.85 158.12 17.01 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.997 1.719 . . . . 0.0 111.7 -174.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -159.47 143.24 14.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.404 1.882 . . . . 0.0 111.885 175.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -146.63 144.7 29.69 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.194 1.797 . . . . 0.0 110.173 178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -159.73 139.25 11.3 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.965 1.306 . . . . 0.0 109.851 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -76.54 42.92 0.3 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.996 1.318 . . . . 0.0 113.135 -172.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.2 136.78 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.566 1.147 . . . . 0.0 110.575 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -163.89 -50.92 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.631 1.573 . . . . 0.0 111.096 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 68.54 156.82 0.13 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 127.499 2.32 . . . . 0.0 114.162 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -77.1 -27.94 54.29 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.264 -0.898 . . . . 0.0 112.987 174.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -169.04 149.27 4.25 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.843 2.057 . . . . 0.0 111.219 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.1 m -167.92 123.45 1.02 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.123 0.969 . . . . 0.0 112.366 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -147.31 -40.8 0.18 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.629 1.971 . . . . 0.0 111.817 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.5 p -166.97 168.06 14.2 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.73 -1.231 . . . . 0.0 114.08 -166.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 43.5 pt -137.26 138.04 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.647 1.179 . . . . 0.0 110.06 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -98.99 148.7 23.73 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.907 1.283 . . . . 0.0 109.489 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.6 t -126.4 131.67 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.537 1.535 . . . . 0.0 108.759 -172.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -74.17 -154.57 3.59 Favored Glycine 0 N--CA 1.474 1.192 0 C-N-CA 125.543 1.544 . . . . 0.0 112.93 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.449 HD22 ' CD2' ' A' ' 199' ' ' HIS . 19.0 m120 -55.48 -42.73 74.77 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -166.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 57.34 -169.44 0.11 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 128.061 2.545 . . . . 0.0 115.81 165.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.2 t -76.39 73.14 3.16 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.258 1.823 . . . . 0.0 110.416 166.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -68.05 -9.29 44.86 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -74.37 -12.42 60.52 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.113 1.365 . . . . 0.0 113.132 167.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 3.8 t -101.3 151.06 22.34 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.274 1.03 . . . . 0.0 113.523 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 17.6 p -81.94 152.67 69.06 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 126.444 1.898 . . . . 0.0 111.457 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.36 -25.79 80.66 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.213 2.609 . . . . 0.0 115.482 -173.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -67.21 -17.03 64.65 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.865 1.211 . . . . 0.0 113.439 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -70.74 -33.99 71.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.29 1.036 . . . . 0.0 111.25 170.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.1 mt -74.33 -32.48 62.83 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.336 -0.84 . . . . 0.0 111.782 167.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 31.1 m -62.75 -51.34 67.52 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.731 1.151 . . . . 0.0 110.264 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.53 -34.12 75.0 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.336 0.516 . . . . 0.0 112.119 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -67.0 -65.04 0.73 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.608 1.563 . . . . 0.0 111.329 176.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -71.24 -29.0 64.58 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -173.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.4 t -73.25 -23.63 60.36 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -173.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -67.34 -10.89 55.46 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 29.5 mm -69.89 -31.31 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.439 1.496 . . . . 0.0 112.59 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.66 42.01 0.03 OUTLIER Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.242 0.925 . . . . 0.0 114.221 -172.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 83.4 tttt 79.34 124.45 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 128.708 2.803 . . . . 0.0 113.606 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.7 149.32 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 126.159 1.784 . . . . 0.0 108.097 164.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 4.3 m -110.27 -18.27 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -157.32 147.29 20.65 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.846 0.858 . . . . 0.0 111.245 -175.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -154.48 144.39 21.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.729 1.611 . . . . 0.0 110.559 170.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -155.11 153.07 30.29 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 122.096 0.95 . . . . 0.0 113.262 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 51.0 mm -110.32 -23.65 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 127.3 2.24 . . . . 0.0 110.543 171.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 46.3 mm -68.76 120.66 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 O-C-N 120.792 -1.193 . . . . 0.0 108.206 170.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 2.5 p -151.2 160.79 43.64 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.356 1.462 . . . . 0.0 111.35 -159.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.4 m -63.78 158.59 21.39 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.474 1.109 . . . . 0.0 113.019 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -57.48 -43.36 84.02 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -175.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 56.28 -140.88 41.88 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.081 1.324 . . . . 0.0 114.016 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -139.96 132.41 28.54 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.014 1.726 . . . . 0.0 110.665 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.449 ' CD2' HD22 ' A' ' 167' ' ' ASN . 1.4 t60 70.44 138.09 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 127.588 2.355 . . . . 0.0 113.082 -173.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -74.71 135.19 41.84 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.163 0.985 . . . . 0.0 112.4 -171.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 88.16 131.23 3.64 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.698 1.618 . . . . 0.0 112.773 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 22.8 ptp -174.3 168.66 3.94 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 127.219 2.207 . . . . 0.0 111.527 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -156.47 175.22 34.16 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.195 1.379 . . . . 0.0 113.197 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 27.5 m -148.17 147.05 29.02 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.148 1.379 . . . . 0.0 109.889 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.1 t -139.0 141.55 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.448 1.099 . . . . 0.0 109.541 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -123.93 131.64 53.6 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.603 1.161 . . . . 0.0 111.509 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -102.2 173.81 6.2 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.306 1.842 . . . . 0.0 110.426 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 81.3 p -68.88 0.65 4.15 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 176.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 93.04 52.48 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 128.169 2.587 . . . . 0.0 113.606 161.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.7 t -161.4 -165.35 1.29 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.947 0.899 . . . . 0.0 112.872 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -57.86 -10.37 1.69 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.097 2.159 . . . . 0.0 115.234 -168.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -52.07 -34.11 42.25 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.177 1.391 . . . . 0.0 111.729 162.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.54 -39.48 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.742 1.617 . . . . 0.0 111.427 176.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.65 -55.03 6.32 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.323 1.049 . . . . 0.0 111.919 171.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -59.11 -29.71 67.58 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.183 1.393 . . . . 0.0 113.706 -172.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.26 -60.59 3.57 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.931 0.892 . . . . 0.0 112.681 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 3.5 mp -68.79 -22.36 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.088 -1.008 . . . . 0.0 112.803 -168.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 16.5 mmt-85 -54.23 -27.91 37.73 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.401 0.68 . . . . 0.0 112.773 168.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -95.5 -17.71 21.24 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.795 1.238 . . . . 0.0 112.817 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -122.46 -18.87 6.57 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -161.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -58.24 120.21 8.27 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 120.585 1.539 . . . . 0.0 110.276 175.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 79.94 0.3 84.93 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.277 -1.291 . . . . 0.0 116.094 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.58 97.67 2.18 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 120.082 1.941 . . . . 0.0 111.377 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -48.92 135.63 15.32 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.028 0.931 . . . . 0.0 112.532 176.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -143.87 116.9 8.88 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.356 1.062 . . . . 0.0 109.852 -162.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 16.8 ttt 59.89 34.36 21.69 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.391 1.077 . . . . 0.0 111.156 -168.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 67.67 0.68 2.33 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.888 2.075 . . . . 0.0 114.095 -174.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -112.26 165.37 12.23 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.297 2.239 . . . . 0.0 111.423 -171.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -66.35 168.91 8.07 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.342 1.057 . . . . 0.0 113.144 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 41.8 pt -158.3 146.76 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 1 C-N-CA 132.204 4.201 . . . . 0.0 107.058 171.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -149.49 141.94 24.3 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.712 1.605 . . . . 0.0 107.219 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.8 p -150.44 137.38 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 120.068 1.303 . . . . 0.0 113.632 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -99.06 139.08 35.23 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.572 1.949 . . . . 0.0 110.931 176.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -106.26 1.79 26.26 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.43 1.492 . . . . 0.0 113.671 -167.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -118.09 69.24 0.78 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.654 1.182 . . . . 0.0 114.188 -156.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 24.5 t30 . . . . . 0 C--O 1.252 1.192 0 C-N-CA 126.493 1.917 . . . . 0.0 112.453 167.58 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.8 m 70.14 15.97 7.51 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.952 1.701 . . . . 0.0 114.698 171.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.92 137.21 51.37 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.332 1.053 . . . . 0.0 111.933 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -80.94 101.33 9.41 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.137 0.975 . . . . 0.0 110.845 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -164.67 127.86 2.39 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.98 1.312 . . . . 0.0 110.492 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 87.0 mt -145.29 117.3 8.29 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.623 1.569 . . . . 0.0 109.271 174.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -166.23 158.64 14.33 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.781 1.632 . . . . 0.0 111.449 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.6 t -161.86 162.18 29.21 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.041 1.337 . . . . 0.0 110.82 175.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.8 t -163.95 157.1 18.17 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.434 1.894 . . . . 0.0 111.133 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -162.46 122.81 2.44 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.575 1.55 . . . . 0.0 111.816 -171.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -86.25 103.66 15.06 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.739 1.216 . . . . 0.0 108.609 172.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.56 142.99 38.69 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -164.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -68.69 131.09 44.6 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.536 1.534 . . . . 0.0 112.234 -174.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 33.4 m -84.97 -10.96 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -89.72 7.37 37.13 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.884 1.274 . . . . 0.0 113.968 -173.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -60.62 140.05 57.57 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.046 0.938 . . . . 0.0 111.027 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -162.55 -41.48 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.457 1.103 . . . . 0.0 113.552 -170.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -81.14 -33.38 33.21 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.776 -0.578 . . . . 0.0 111.808 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.4 m 60.9 25.18 15.16 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 156.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -87.1 -5.3 59.07 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -173.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.8 m -125.09 164.37 20.37 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.739 1.616 . . . . 0.0 111.719 -171.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 8.0 pt -142.36 138.24 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.243 -0.911 . . . . 0.0 110.9 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -128.39 134.41 48.82 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.166 1.786 . . . . 0.0 109.951 -175.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.65 134.24 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.875 1.27 . . . . 0.0 109.979 -156.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.85 -116.23 0.12 Allowed Glycine 0 N--CA 1.478 1.455 0 C-N-CA 127.055 2.264 . . . . 0.0 115.002 -170.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -68.25 -62.59 1.33 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.71 1.255 . . . . 0.0 111.999 -176.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 62.92 5.03 1.66 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.533 2.333 . . . . 0.0 117.166 167.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 58.7 m 74.51 98.25 0.07 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 127.416 2.286 . . . . 0.0 108.643 -162.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -65.03 -16.18 63.16 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -170.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.15 0.38 51.18 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.883 1.673 . . . . 0.0 114.0 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 95.6 p -70.67 167.14 19.29 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 172.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 18.7 p -123.9 151.5 64.86 Favored Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 124.936 1.294 . . . . 0.0 112.392 -170.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.35 -17.44 16.68 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.347 2.698 . . . . 0.0 115.385 -169.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.8 -36.9 81.25 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.966 1.257 . . . . 0.0 111.953 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -72.98 -35.78 66.95 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.284 -0.885 . . . . 0.0 111.536 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.3 mt -64.07 -33.39 75.65 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.119 0.968 . . . . 0.0 111.903 168.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.4 m -65.57 -49.72 67.77 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.009 0.822 . . . . 0.0 109.666 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.35 -41.08 98.3 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.484 0.584 . . . . 0.0 112.008 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.68 -56.33 20.83 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.145 1.378 . . . . 0.0 112.29 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.23 -43.44 67.28 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.4 t -73.62 -12.6 60.8 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -171.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -62.59 -16.48 56.58 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.656 1.116 . . . . 0.0 113.101 170.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 16.3 mm -72.98 -33.0 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.751 1.22 . . . . 0.0 111.976 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.44 -84.49 0.08 OUTLIER Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.221 1.391 . . . . 0.0 112.517 -170.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -157.3 103.48 1.99 Allowed 'General case' 0 CA--C 1.55 0.942 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -170.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 40.4 t -77.35 136.81 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 156.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.0 p -104.86 -20.23 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.282 1.033 . . . . 0.0 112.813 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 30.8 ttm-85 -164.38 139.3 5.68 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.369 1.468 . . . . 0.0 111.706 173.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -129.67 147.12 51.43 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.864 1.266 . . . . 0.0 111.259 164.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -159.11 152.29 22.37 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 174.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.6 mm -113.78 -19.92 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 126.564 1.946 . . . . 0.0 111.224 171.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.03 136.12 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.857 1.263 . . . . 0.0 108.935 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 76.6 p -128.96 126.7 40.16 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.951 1.3 . . . . 0.0 110.245 -177.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 59.6 p -107.2 -16.99 14.27 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -171.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -87.07 -5.7 58.95 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.528 1.131 . . . . 0.0 113.508 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 163.82 173.37 32.42 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.336 1.922 . . . . 0.0 112.508 -178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -77.73 138.96 39.32 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.615 0.766 . . . . 0.0 112.989 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -131.06 128.46 40.29 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.507 1.523 . . . . 0.0 110.001 171.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -82.73 59.14 4.61 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.232 1.413 . . . . 0.0 112.172 -171.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 96.87 -13.66 64.85 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.251 1.881 . . . . 0.0 115.213 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -64.15 135.87 56.73 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.047 1.423 . . . . 0.0 113.443 -176.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -114.84 168.89 12.67 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.887 1.708 . . . . 0.0 113.82 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 21.8 m -141.09 144.59 35.0 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.916 1.286 . . . . 0.0 109.838 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.8 t -137.15 136.87 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.8 0.84 . . . . 0.0 109.185 171.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -104.58 119.8 39.82 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.079 1.751 . . . . 0.0 109.205 173.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -93.09 176.77 6.29 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.301 1.44 . . . . 0.0 109.034 163.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 45.6 p -97.4 -15.73 20.54 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -150.29 126.41 10.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.182 0.993 . . . . 0.0 113.226 -172.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.4 p -46.89 -53.58 11.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.68 1.992 . . . . 0.0 114.261 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -60.05 -28.58 67.89 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.89 -35.45 67.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.498 1.119 . . . . 0.0 112.644 173.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -69.79 -40.52 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.013 0.925 . . . . 0.0 112.272 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.52 -47.53 66.73 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.577 -176.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -66.34 -18.29 65.27 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -70.84 -62.87 1.23 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.696 0.798 . . . . 0.0 110.475 167.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 60.8 mt -60.96 -33.86 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.446 1.099 . . . . 0.0 112.667 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -52.0 -19.9 2.1 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.971 1.709 . . . . 0.0 114.02 170.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -114.26 -6.79 12.99 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.849 1.66 . . . . 0.0 112.815 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -126.84 -22.72 3.8 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -166.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.88 120.71 13.04 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 120.916 1.689 . . . . 0.0 109.637 173.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 98.15 0.28 58.56 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-O 118.219 -1.323 . . . . 0.0 115.2 -168.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.33 108.23 1.26 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.718 1.759 . . . . 0.0 110.218 170.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -56.57 125.14 20.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.273 0.558 . . . . 0.0 109.772 154.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -149.59 110.84 4.41 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.319 1.447 . . . . 0.0 108.076 -159.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 24.1 mmt 55.87 32.95 20.66 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.626 0.77 . . . . 0.0 112.192 -169.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 87.49 0.37 0.47 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.888 2.875 . . . . 0.0 115.985 174.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.49 152.69 50.82 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.806 1.184 . . . . 0.0 112.043 173.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -77.48 129.12 35.3 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.8 -1.187 . . . . 0.0 114.104 -167.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.3 pt -75.58 133.52 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 120.997 -1.064 . . . . 0.0 110.487 164.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -118.24 144.47 45.75 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 166.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.3 p -150.85 140.19 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 120.162 1.347 . . . . 0.0 112.677 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -111.42 137.49 49.14 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.113 1.765 . . . . 0.0 110.255 171.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 -72.52 149.29 44.22 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 167.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -155.2 165.97 35.03 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.18 1.792 . . . . 0.0 111.121 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 C--O 1.254 1.325 0 C-N-CA 124.681 1.193 . . . . 0.0 111.071 179.595 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 CA-C-O 121.097 0.276 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.1 t -162.38 161.06 27.21 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.303 1.441 . . . . 0.0 111.335 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -159.63 153.99 23.85 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.884 1.674 . . . . 0.0 111.728 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -142.73 150.13 39.69 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.866 1.667 . . . . 0.0 111.183 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -161.63 154.41 20.44 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.974 1.709 . . . . 0.0 111.062 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.0 mt -143.48 154.0 43.2 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.808 1.643 . . . . 0.0 111.43 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -161.4 142.55 11.32 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.255 1.822 . . . . 0.0 110.862 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 17.0 t -163.22 153.69 16.19 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.752 1.221 . . . . 0.0 111.857 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 45.4 p -145.85 157.59 43.9 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.589 1.955 . . . . 0.0 110.755 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -160.1 164.52 32.97 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.203 1.401 . . . . 0.0 112.902 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -158.82 144.53 16.54 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.796 1.638 . . . . 0.0 109.965 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -155.0 143.51 20.52 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.26 1.424 . . . . 0.0 110.059 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -157.73 157.74 34.02 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.696 1.199 . . . . 0.0 113.6 -169.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.8 p -163.8 144.63 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 125.672 1.589 . . . . 0.0 110.902 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -155.85 151.5 27.22 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.126 1.37 . . . . 0.0 112.4 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 81.0 ttt180 -164.92 141.32 5.78 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.117 1.767 . . . . 0.0 110.724 -176.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 73.12 137.34 0.05 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.068 2.547 . . . . 0.0 112.233 -175.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -142.17 155.22 45.29 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.668 1.187 . . . . 0.0 112.075 -167.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.0 m 72.13 12.95 5.87 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.273 1.429 . . . . 0.0 113.953 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -77.93 166.62 22.64 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.372 1.069 . . . . 0.0 113.188 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 52.9 m -70.52 164.75 24.12 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 6.8 pt -130.57 151.74 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.815 1.646 . . . . 0.0 110.011 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -132.86 143.51 49.58 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.448 1.899 . . . . 0.0 109.717 -173.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.16 134.59 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 119.495 1.043 . . . . 0.0 111.177 -175.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.42 -71.83 1.03 Allowed Glycine 0 N--CA 1.473 1.161 0 C-N-CA 124.124 0.869 . . . . 0.0 113.657 -173.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -83.91 39.03 0.67 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.032 1.333 . . . . 0.0 114.245 -165.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.75 170.86 15.38 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.339 -1.476 . . . . 0.0 110.677 165.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 45.9 m -75.55 124.39 27.11 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.707 0.803 . . . . 0.0 109.06 167.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -70.18 -13.71 62.31 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -167.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -89.14 0.08 57.02 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 170.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 32.0 t -63.57 138.18 58.4 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 121.254 -0.904 . . . . 0.0 111.022 161.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 41.4 p -98.47 159.89 29.42 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 124.704 1.201 . . . . 0.0 110.728 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.16 -19.52 68.9 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.921 1.747 . . . . 0.0 112.486 167.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -69.16 -44.49 72.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 120.225 1.375 . . . . 0.0 111.2 170.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -59.14 -45.99 89.51 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.396 0.679 . . . . 0.0 110.755 172.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -27.37 68.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.999 0.92 . . . . 0.0 113.341 173.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 52.2 m -76.48 -47.77 21.81 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.52 1.055 . . . . 0.0 110.0 176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -59.02 -31.1 68.52 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.718 1.145 . . . . 0.0 112.168 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -70.87 -67.88 0.47 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.389 1.476 . . . . 0.0 112.005 174.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -71.14 -35.04 71.56 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.5 t -73.33 -10.46 59.78 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -170.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -62.04 -17.25 56.77 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.223 -0.923 . . . . 0.0 113.343 171.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.66 -21.84 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 125.714 1.606 . . . . 0.0 112.667 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 169.94 -90.24 0.09 OUTLIER Glycine 0 N--CA 1.467 0.709 0 C-N-CA 125.055 1.312 . . . . 0.0 110.789 -172.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -159.63 120.31 3.11 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.118 0.967 . . . . 0.0 112.693 174.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.4 t -72.38 127.72 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 162.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.37 -34.03 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 118.691 0.678 . . . . 0.0 110.554 175.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -172.33 145.68 1.72 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.385 1.474 . . . . 0.0 112.045 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -129.23 171.26 12.63 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.821 2.049 . . . . 0.0 110.706 161.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -145.95 -60.18 0.32 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.81 1.782 . . . . 0.0 115.81 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 3.9 mt 65.97 111.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 127.712 2.405 . . . . 0.0 113.219 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 19.1 tt -67.94 111.66 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 120.788 -1.195 . . . . 0.0 111.4 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 14.5 p -151.34 145.45 25.31 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.509 1.923 . . . . 0.0 110.459 -168.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 47.5 t -173.06 -72.92 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.863 1.665 . . . . 0.0 110.636 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -109.56 0.13 19.01 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.812 1.645 . . . . 0.0 114.385 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.26 82.73 1.69 Allowed Glycine 0 N--CA 1.474 1.199 0 C-N-CA 125.447 1.498 . . . . 0.0 109.474 -165.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -70.64 156.48 39.4 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -169.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -64.2 -20.59 66.12 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.459 1.503 . . . . 0.0 114.617 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -117.89 -41.16 2.92 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.791 1.636 . . . . 0.0 112.606 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 66.54 21.55 70.82 Favored Glycine 0 N--CA 1.478 1.45 0 C-N-CA 124.306 0.955 . . . . 0.0 114.106 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -78.25 147.0 34.56 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.809 1.243 . . . . 0.0 113.751 -165.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.28 158.82 19.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.237 1.399 . . . . 0.0 112.81 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.7 m -147.45 142.55 27.11 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.011 1.725 . . . . 0.0 108.745 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 10.8 t -142.95 142.09 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.119 0.967 . . . . 0.0 110.788 -177.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -119.95 139.08 53.0 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.213 1.805 . . . . 0.0 110.01 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -116.78 154.05 31.36 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.676 1.591 . . . . 0.0 112.383 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.3 p -81.07 -17.93 48.37 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.92 0.888 . . . . 0.0 113.102 171.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -102.11 173.03 6.56 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.265 1.426 . . . . 0.0 113.061 -169.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 65.3 p -107.08 -101.1 0.35 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.915 1.686 . . . . 0.0 111.954 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -60.65 -22.16 63.53 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.739 1.216 . . . . 0.0 113.592 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -67.74 -18.04 64.76 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.072 0.949 . . . . 0.0 113.384 173.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.47 -28.99 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.326 0.966 . . . . 0.0 112.033 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.25 -45.96 44.61 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.44 -0.788 . . . . 0.0 110.843 167.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -52.88 -27.35 18.15 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.633 1.973 . . . . 0.0 114.112 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.59 -71.76 0.17 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.023 1.329 . . . . 0.0 110.929 165.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 36.4 mt -54.62 -44.33 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.323 1.449 . . . . 0.0 112.451 -172.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -64.84 0.35 1.21 Allowed 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 176.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -118.31 -1.41 11.31 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.846 1.659 . . . . 0.0 112.566 167.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -122.96 -14.0 7.71 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.132 1.773 . . . . 0.0 114.136 -176.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -48.68 120.96 4.12 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.338 1.455 . . . . 0.0 110.294 166.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 88.89 0.81 80.81 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-O 118.129 -1.373 . . . . 0.0 115.41 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.68 105.19 0.42 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.653 1.727 . . . . 0.0 111.507 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -55.98 110.43 0.74 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 152.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -127.54 110.8 13.09 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.466 1.106 . . . . 0.0 109.317 -170.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 89.9 mtp 55.55 36.14 26.58 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.708 1.203 . . . . 0.0 111.974 -173.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 14.4 t70 98.46 0.14 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 129.216 3.007 . . . . 0.0 115.79 170.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -138.85 137.52 36.65 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.547 1.067 . . . . 0.0 112.592 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -77.0 102.07 6.29 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.211 1.404 . . . . 0.0 113.707 -170.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.3 pt -54.24 143.63 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.535 0.734 . . . . 0.0 112.766 172.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -132.76 135.38 45.69 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.508 1.523 . . . . 0.0 107.4 166.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.6 p -119.8 132.53 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.294 1.038 . . . . 0.0 111.81 -168.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -97.96 136.82 37.69 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.41 2.284 . . . . 0.0 109.576 167.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -98.51 142.12 30.51 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 166.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -140.42 135.78 32.39 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.1 0.864 . . . . 0.0 112.669 -170.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.5 p30 . . . . . 0 C--O 1.253 1.237 0 C-N-CA 126.066 1.747 . . . . 0.0 112.839 -175.698 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.711 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.9 m -146.6 155.18 42.28 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.062 1.345 . . . . 0.0 111.619 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -156.01 153.0 28.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.154 1.382 . . . . 0.0 111.965 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 58.59 46.45 14.68 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.828 1.651 . . . . 0.0 112.452 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -154.95 159.25 40.27 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.037 1.735 . . . . 0.0 112.127 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -164.08 173.77 12.11 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.483 1.913 . . . . 0.0 111.904 -173.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -149.85 153.37 36.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.357 1.463 . . . . 0.0 112.198 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 18.9 m -175.61 -30.35 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 126.894 2.077 . . . . 0.0 113.667 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . 0.268 59.6 p 49.9 -129.33 2.12 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.51 2.324 . . . . 0.0 112.32 177.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -148.23 153.38 38.67 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.272 1.429 . . . . 0.0 113.055 -165.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -140.16 151.08 44.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.49 1.916 . . . . 0.0 109.553 174.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -160.73 164.72 31.4 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.172 0.989 . . . . 0.0 113.1 -171.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -125.95 179.93 4.99 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.584 1.954 . . . . 0.0 110.8 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.8 p -151.27 142.82 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 O-C-N 121.154 -0.966 . . . . 0.0 112.359 -173.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -153.57 150.72 28.96 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.524 1.93 . . . . 0.0 110.571 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -147.86 122.28 9.71 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.583 1.153 . . . . 0.0 110.913 -176.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -159.17 150.96 20.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.372 1.469 . . . . 0.0 111.705 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -145.92 -67.42 0.29 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.803 1.241 . . . . 0.0 113.123 -168.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 83.1 p 32.84 -113.23 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 127.269 2.228 . . . . 0.0 115.63 -170.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -176.44 -33.05 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.492 2.317 . . . . 0.0 112.491 -165.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 73.7 m -140.52 162.91 34.23 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.565 1.146 . . . . 0.0 112.834 -170.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.6 pt -139.39 155.92 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 126.007 1.723 . . . . 0.0 111.321 -170.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -118.16 153.13 34.33 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.749 2.02 . . . . 0.0 111.391 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.1 t -138.89 128.4 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.528 1.531 . . . . 0.0 110.131 -174.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.84 -91.03 1.85 Allowed Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.034 1.302 . . . . 0.0 114.179 -173.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -84.26 35.68 0.55 Allowed 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -160.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -80.3 -5.68 56.7 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -169.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.4 p 91.05 127.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 131.018 3.727 . . . . 0.0 110.609 -167.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -70.64 -13.11 61.95 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -169.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -81.84 -5.49 58.26 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.375 1.47 . . . . 0.0 113.084 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.5 m -64.77 143.02 58.23 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.212 1.005 . . . . 0.0 113.089 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 51.7 p -105.67 157.37 34.75 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 125.108 1.363 . . . . 0.0 110.919 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.08 -31.42 65.38 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.385 2.057 . . . . 0.0 112.606 174.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.31 -39.35 92.37 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.115 0.871 . . . . 0.0 111.621 174.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.17 -29.55 66.47 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.705 -0.622 . . . . 0.0 112.626 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.8 mt -74.06 -27.43 60.91 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 164.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 98.4 m -71.46 -51.14 25.39 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.402 1.001 . . . . 0.0 110.035 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -63.06 -24.61 67.99 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.628 0.649 . . . . 0.0 112.72 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.29 -69.14 0.5 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.54 1.536 . . . . 0.0 111.585 174.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -65.31 -32.41 74.05 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.4 t -73.35 0.08 13.15 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -175.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -71.67 -18.78 62.16 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.318 -0.864 . . . . 0.0 113.179 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 19.4 mm -81.56 -55.0 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.118 0.967 . . . . 0.0 111.628 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -138.74 -96.31 0.36 Allowed Glycine 0 N--CA 1.467 0.75 0 C-N-CA 126.379 1.942 . . . . 0.0 109.878 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -156.03 128.61 7.78 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.898 0.879 . . . . 0.0 112.145 169.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.73 134.93 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 167.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.52 -42.62 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 118.275 0.489 . . . . 0.0 110.426 172.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -157.35 141.24 16.02 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 127.105 2.162 . . . . 0.0 109.529 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -117.69 158.99 23.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.889 1.276 . . . . 0.0 111.055 161.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -152.9 132.07 12.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.071 1.349 . . . . 0.0 111.37 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 3.2 mt -145.11 -45.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 125.051 1.34 . . . . 0.0 112.401 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 59.2 mt -81.22 108.1 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -176.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 25.7 p -87.89 143.39 27.15 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.347 1.459 . . . . 0.0 111.502 -173.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 3.2 t -110.17 9.39 23.94 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.398 1.079 . . . . 0.0 113.378 -168.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.31 0.36 19.64 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.3 1.44 . . . . 0.0 114.608 -175.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 115.74 -9.12 19.2 Favored Glycine 0 N--CA 1.476 1.338 0 C-N-CA 126.301 1.905 . . . . 0.0 114.183 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -146.41 146.66 30.69 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.423 1.889 . . . . 0.0 111.141 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -91.22 119.6 31.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.367 1.067 . . . . 0.0 112.225 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -78.08 -41.85 34.06 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.064 0.946 . . . . 0.0 112.665 -178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 72.11 16.04 76.74 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.096 0.855 . . . . 0.0 115.024 177.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 87.7 mtp -122.15 128.37 51.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.055 1.342 . . . . 0.0 108.269 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -94.82 164.93 25.4 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 115.24 0.856 . . . . 0.0 115.24 -159.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.7 p -146.69 148.35 31.92 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.886 2.074 . . . . 0.0 110.201 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 13.7 t -147.57 136.68 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.674 0.79 . . . . 0.0 110.865 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -109.34 131.61 54.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.551 1.94 . . . . 0.0 109.547 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -103.25 158.34 16.39 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.059 1.343 . . . . 0.0 110.545 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 78.8 p -71.24 0.21 8.43 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.859 0.864 . . . . 0.0 112.899 170.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -138.92 -175.99 4.34 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.203 2.201 . . . . 0.0 112.011 -167.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.6 p -142.8 -66.34 0.38 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.584 1.554 . . . . 0.0 110.16 -174.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -53.15 -33.31 51.89 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 120.677 -1.265 . . . . 0.0 113.288 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.97 -24.85 61.66 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.318 1.447 . . . . 0.0 114.054 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.4 m -70.75 -31.91 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -169.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -56.95 -46.21 82.28 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.691 1.196 . . . . 0.0 111.146 166.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -71.68 -23.69 61.7 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.881 0.872 . . . . 0.0 112.25 -171.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.39 -61.99 1.98 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.992 0.917 . . . . 0.0 110.949 165.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 80.9 mt -59.78 -37.32 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.329 1.051 . . . . 0.0 112.123 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 47.1 ttm-85 -62.46 -4.86 2.1 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.493 1.517 . . . . 0.0 113.838 176.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -121.86 -3.62 9.17 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.498 1.919 . . . . 0.0 112.922 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -124.49 -21.92 4.78 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -173.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.92 120.69 12.43 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 120.22 1.373 . . . . 0.0 109.882 174.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 94.04 0.5 65.88 Favored Glycine 0 N--CA 1.471 1.032 0 CA-C-O 118.107 -1.385 . . . . 0.0 115.522 -170.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.8 108.54 0.87 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.756 1.778 . . . . 0.0 110.725 174.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -55.56 121.28 8.7 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.231 1.013 . . . . 0.0 110.715 161.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -152.53 110.86 3.71 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.511 1.924 . . . . 0.0 107.575 -158.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 16.8 ttt 54.08 35.86 23.28 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.581 0.705 . . . . 0.0 111.397 -164.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 76.05 0.22 3.26 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.394 2.677 . . . . 0.0 115.286 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -120.55 144.02 48.28 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.118 1.367 . . . . 0.0 110.749 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.99 111.49 15.25 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.584 -1.322 . . . . 0.0 112.764 -176.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.4 pt -54.18 148.07 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.472 -0.767 . . . . 0.0 110.928 164.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -137.62 137.52 38.55 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.226 1.01 . . . . 0.0 109.327 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.85 126.6 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 124.163 0.985 . . . . 0.0 109.659 -171.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -94.92 148.08 22.69 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.251 1.02 . . . . 0.0 110.05 164.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -69.85 153.55 43.15 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 163.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -131.04 135.87 47.96 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.45 1.1 . . . . 0.0 111.241 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.302 0 C-N-CA 126.24 1.816 . . . . 0.0 111.855 175.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.765 0 N-CA-C 111.914 -0.475 . . . . 0.0 111.914 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 25.6 p -166.48 146.97 6.12 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.038 1.335 . . . . 0.0 111.885 -176.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -159.59 156.7 28.46 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.448 1.499 . . . . 0.0 111.903 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -161.78 158.39 25.65 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.799 1.64 . . . . 0.0 112.199 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -161.66 150.63 15.88 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.639 1.576 . . . . 0.0 111.381 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -165.65 161.16 18.08 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.618 1.967 . . . . 0.0 111.468 -175.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -161.49 152.24 18.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.225 1.41 . . . . 0.0 112.689 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.5 p -167.05 155.55 9.92 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.254 1.821 . . . . 0.0 110.85 174.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.8 t -158.28 17.03 0.22 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -172.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -133.99 121.14 21.19 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.006 0.922 . . . . 0.0 112.974 -172.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -171.23 140.71 1.51 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.216 2.206 . . . . 0.0 110.238 173.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -168.6 148.54 4.48 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.298 1.439 . . . . 0.0 111.983 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -142.88 5.75 1.55 Allowed 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.2 m -156.49 153.15 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 128.123 2.569 . . . . 0.0 109.067 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -143.84 -50.87 0.31 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.711 0.804 . . . . 0.0 112.19 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 59.6 ttm-85 -165.29 111.22 0.93 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.546 1.938 . . . . 0.0 108.804 173.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -146.15 62.02 1.24 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.58 1.152 . . . . 0.0 110.47 -161.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -167.49 146.3 4.9 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.006 1.322 . . . . 0.0 112.824 -166.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 31.1 t -153.62 -42.03 0.09 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.53 1.132 . . . . 0.0 112.417 161.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 10.2 t30 68.45 -42.02 0.47 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 128.007 2.523 . . . . 0.0 116.454 169.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.8 p -171.09 132.92 0.85 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.606 1.562 . . . . 0.0 109.433 -166.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.59 161.48 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 121.915 -0.491 . . . . 0.0 112.012 -154.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -121.36 124.22 44.03 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.545 1.138 . . . . 0.0 110.688 170.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.27 134.94 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 127.175 2.19 . . . . 0.0 107.772 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.61 -133.47 0.4 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.886 1.232 . . . . 0.0 112.665 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -60.54 -28.19 68.24 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 -168.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . 0.292 2.5 pt? 28.52 -129.96 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.651 1.98 . . . . 0.0 113.192 -164.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.9 m -142.4 130.38 21.86 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.444 1.498 . . . . 0.0 109.133 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -64.5 -18.21 64.58 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -171.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -75.01 -3.38 32.06 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.563 1.545 . . . . 0.0 113.779 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 77.0 p -104.18 168.88 8.82 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.769 1.228 . . . . 0.0 114.124 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 52.1 p -137.06 165.68 32.92 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 126.922 2.089 . . . . 0.0 110.741 -171.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -59.86 -25.04 78.21 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.333 2.022 . . . . 0.0 113.199 169.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.13 -40.83 78.05 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.478 1.035 . . . . 0.0 111.8 172.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -62.72 -42.47 99.67 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.347 0.659 . . . . 0.0 111.097 173.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.6 mt -64.31 -31.3 72.45 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 118.49 -0.766 . . . . 0.0 112.515 170.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.8 m -68.69 -51.26 43.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.633 1.106 . . . . 0.0 110.272 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.95 -30.97 72.0 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.916 0.78 . . . . 0.0 112.26 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -70.85 -61.22 1.85 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.404 1.482 . . . . 0.0 111.718 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -71.34 -36.96 71.7 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.4 t -73.41 -1.52 18.62 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -173.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -73.44 -16.5 61.31 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.431 -0.793 . . . . 0.0 113.01 167.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.5 mm -80.97 -55.24 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 119.176 0.898 . . . . 0.0 111.144 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -134.57 -100.11 0.65 Allowed Glycine 0 N--CA 1.468 0.824 0 C-N-CA 126.0 1.762 . . . . 0.0 110.443 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -156.88 126.73 6.28 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.437 1.095 . . . . 0.0 111.88 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 20.5 t -76.56 134.5 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.01 0.924 . . . . 0.0 108.651 169.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.72 -15.52 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.57 1.148 . . . . 0.0 113.882 168.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.1 mtp85 -161.72 132.28 5.03 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.501 1.521 . . . . 0.0 110.874 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -129.23 145.7 51.29 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.582 1.953 . . . . 0.0 111.494 170.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -161.49 145.31 12.83 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.912 1.285 . . . . 0.0 111.651 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.6 mt -137.96 114.34 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.499 1.119 . . . . 0.0 109.653 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.1 tt -76.13 115.1 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.101 0.56 . . . . 0.0 109.742 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 4.1 p -151.23 165.99 32.28 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.082 2.153 . . . . 0.0 111.202 -160.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 55.3 p -159.23 172.92 17.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.222 1.409 . . . . 0.0 111.592 174.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -74.52 -21.26 59.63 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.876 0.87 . . . . 0.0 112.672 171.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -91.74 -123.79 3.1 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 126.027 1.775 . . . . 0.0 111.255 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -138.91 85.31 2.07 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.85 1.26 . . . . 0.0 111.245 -177.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -134.81 94.23 3.14 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.176 1.391 . . . . 0.0 111.133 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 66.56 -82.94 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.684 2.394 . . . . 0.0 113.206 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 79.19 51.46 5.31 Favored Glycine 0 N--CA 1.472 1.061 0 C-N-CA 124.464 1.031 . . . . 0.0 111.898 -176.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 76.9 mtm -138.9 140.26 38.32 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.62 1.168 . . . . 0.0 112.185 -168.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.52 163.32 13.55 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 124.913 1.244 . . . . 0.0 115.164 -165.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.2 p -153.63 153.1 31.68 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.38 1.872 . . . . 0.0 111.352 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.97 147.15 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.046 1.338 . . . . 0.0 111.17 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -125.52 130.89 52.64 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.364 2.266 . . . . 0.0 110.068 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -108.42 165.09 11.78 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.136 1.374 . . . . 0.0 111.698 -174.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 40.5 p -76.51 0.27 20.5 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.546 1.538 . . . . 0.0 114.559 169.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -133.03 168.77 17.89 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.024 1.73 . . . . 0.0 111.796 -169.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.7 p -107.75 -62.62 1.41 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.728 1.211 . . . . 0.0 112.373 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -79.88 -35.34 38.19 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.896 1.678 . . . . 0.0 112.942 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -60.12 -24.44 64.68 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.7 1.2 . . . . 0.0 112.447 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.69 -29.51 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.462 1.905 . . . . 0.0 112.546 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.34 -38.67 63.19 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.335 -0.853 . . . . 0.0 111.058 172.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -67.63 -21.87 65.36 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.712 1.605 . . . . 0.0 112.969 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.86 -55.84 25.59 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.937 0.895 . . . . 0.0 111.39 164.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 73.5 mt -66.24 -28.54 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 O-C-N 121.292 -0.88 . . . . 0.0 111.851 -171.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -18.82 9.56 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.955 1.302 . . . . 0.0 113.987 171.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -106.62 -14.5 15.02 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.407 1.883 . . . . 0.0 112.109 176.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -122.4 -17.89 6.91 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.806 2.15 . . . . 0.0 116.806 -164.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -66.75 120.68 13.92 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 120.32 1.418 . . . . 0.0 109.991 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 92.52 0.69 69.5 Favored Glycine 0 N--CA 1.472 1.09 0 CA-C-O 117.714 -1.603 . . . . 0.0 115.081 -169.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.83 108.02 0.69 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 120.158 1.979 . . . . 0.0 111.081 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -52.03 122.95 9.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.647 0.779 . . . . 0.0 109.535 155.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -147.57 114.3 6.06 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.496 1.518 . . . . 0.0 107.734 -166.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 54.17 38.44 29.18 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.68 0.792 . . . . 0.0 111.335 -166.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 17.0 t70 84.24 0.61 0.93 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 128.526 2.731 . . . . 0.0 115.417 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.36 141.94 35.6 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.17 0.988 . . . . 0.0 112.663 -173.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -71.48 120.4 17.0 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -169.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.76 156.18 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.669 1.588 . . . . 0.0 112.019 154.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -140.18 156.17 46.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.918 1.687 . . . . 0.0 108.795 167.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 40.3 t -140.47 133.97 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.496 0.718 . . . . 0.0 111.733 -168.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -85.77 136.13 33.45 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.906 1.282 . . . . 0.0 109.854 170.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -102.88 127.85 49.9 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.984 1.314 . . . . 0.0 108.465 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -87.74 132.84 33.99 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -172.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 56.9 t30 . . . . . 0 C--O 1.256 1.429 0 C-N-CA 126.928 2.091 . . . . 0.0 112.802 179.495 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.0 t . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 121.208 0.528 . . . . 0.0 112.047 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 9.9 pt -146.41 150.64 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 126.676 1.99 . . . . 0.0 109.806 -171.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -126.19 149.61 48.9 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.443 1.897 . . . . 0.0 109.709 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.03 118.76 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.907 0.883 . . . . 0.0 110.101 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.44 -3.21 37.96 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 116.967 1.547 . . . . 0.0 116.967 -160.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -142.77 22.61 1.95 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.102 1.451 . . . . 0.0 113.795 -170.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.6 pp -77.53 178.78 6.97 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.757 1.223 . . . . 0.0 111.832 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.3 t -73.56 133.87 43.64 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.77 0.828 . . . . 0.0 111.536 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -66.88 -8.9 32.45 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -87.63 -4.44 58.94 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.473 1.509 . . . . 0.0 113.622 170.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 7.7 t -69.12 139.76 54.73 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 121.064 -1.023 . . . . 0.0 112.509 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 27.4 p -102.6 162.19 20.95 Favored Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 125.589 1.556 . . . . 0.0 109.985 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -58.69 -32.27 96.55 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.139 1.892 . . . . 0.0 112.025 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.76 -38.65 91.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.092 0.957 . . . . 0.0 112.231 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.24 -44.01 97.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.782 0.719 . . . . 0.0 111.443 176.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 36.4 mt -70.45 -29.58 66.19 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.232 -0.89 . . . . 0.0 112.955 173.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 96.4 m -70.0 -51.24 33.95 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.24 0.927 . . . . 0.0 110.678 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -65.9 -24.32 66.82 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.868 0.758 . . . . 0.0 112.676 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -73.55 -66.21 0.72 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.046 1.738 . . . . 0.0 111.594 173.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -69.86 -33.97 72.97 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.8 t -73.45 -3.97 30.75 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -172.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -64.54 -18.49 64.89 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.117 -0.989 . . . . 0.0 112.831 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 30.1 mm -77.98 -23.5 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.856 1.263 . . . . 0.0 112.455 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 169.67 -90.16 0.09 OUTLIER Glycine 0 N--CA 1.468 0.802 0 C-N-CA 124.357 0.979 . . . . 0.0 112.437 -171.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -155.76 110.35 2.89 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.105 0.962 . . . . 0.0 112.845 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 37.4 t -73.66 132.0 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 157.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.37 -29.52 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 171.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -153.35 135.8 15.07 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.192 1.397 . . . . 0.0 110.056 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -115.92 159.58 21.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.595 1.158 . . . . 0.0 110.404 157.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -153.2 129.95 10.86 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.633 1.173 . . . . 0.0 112.081 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 6.0 mt . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 124.664 1.186 . . . . 0.0 111.855 177.812 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 28.3 ptm . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -158.19 -172.0 24.79 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.747 1.165 . . . . 0.0 114.814 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 20.6 m -137.19 150.81 48.16 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.523 1.929 . . . . 0.0 110.254 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.7 t -141.44 142.99 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.881 1.272 . . . . 0.0 110.514 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -126.11 130.67 51.54 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 126.974 2.11 . . . . 0.0 110.782 -176.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -108.87 168.04 9.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.502 1.921 . . . . 0.0 110.952 -177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 49.1 p -81.4 0.06 39.16 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 167.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -127.99 154.56 45.47 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.865 1.666 . . . . 0.0 111.797 -167.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.5 p -114.39 -1.34 13.53 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.729 1.612 . . . . 0.0 113.685 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -130.05 -46.2 1.13 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.983 1.313 . . . . 0.0 112.714 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -65.88 -20.75 66.34 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.082 -1.011 . . . . 0.0 112.925 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.6 p -63.74 -33.29 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.24 1.816 . . . . 0.0 112.547 170.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -77.58 -36.76 51.67 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.66 0.784 . . . . 0.0 112.643 168.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -63.95 -24.14 67.61 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.145 0.978 . . . . 0.0 112.633 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.47 -56.81 15.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.948 1.299 . . . . 0.0 111.569 165.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.35 -35.22 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.735 1.214 . . . . 0.0 111.871 -172.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -57.07 -12.72 2.28 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.252 1.421 . . . . 0.0 114.039 172.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -117.43 -4.87 11.27 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.309 1.844 . . . . 0.0 112.685 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -129.46 -21.05 3.21 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.97 120.95 14.01 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 120.041 1.291 . . . . 0.0 110.381 176.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 97.24 0.73 59.64 Favored Glycine 0 N--CA 1.471 0.967 0 CA-C-O 118.189 -1.339 . . . . 0.0 114.772 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.97 106.52 0.72 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.759 1.779 . . . . 0.0 111.137 173.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -54.19 117.69 3.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.684 0.794 . . . . 0.0 109.461 155.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -137.89 108.68 6.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.5 1.52 . . . . 0.0 107.141 -165.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 18.1 ttt 50.42 47.1 24.51 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.679 0.791 . . . . 0.0 111.413 -162.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 21.5 t70 72.55 0.29 3.57 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 127.189 2.196 . . . . 0.0 114.652 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -123.68 125.05 44.09 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.215 1.406 . . . . 0.0 110.974 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -81.34 102.73 10.63 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.767 1.227 . . . . 0.0 114.264 -165.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -55.1 142.33 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.765 0.826 . . . . 0.0 111.434 167.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -136.4 134.59 37.94 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.084 1.353 . . . . 0.0 108.515 168.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 5.4 t -103.59 143.49 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.461 1.104 . . . . 0.0 110.559 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.47 0 C-N-CA 127.032 2.133 . . . . 0.0 108.639 169.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 64.9 m . . . . . 0 N--CA 1.472 0.63 0 CA-C-O 121.696 0.76 . . . . 0.0 112.648 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 7.6 pt -139.29 154.3 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.803 1.241 . . . . 0.0 111.144 -172.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -134.03 105.31 6.64 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.289 1.435 . . . . 0.0 110.317 -169.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.8 t -89.66 120.22 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.416 1.886 . . . . 0.0 109.08 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.95 -5.94 24.93 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 116.951 1.541 . . . . 0.0 116.951 -168.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -147.7 21.85 1.14 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 119.698 1.749 . . . . 0.0 114.983 -170.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -178.02 2.21 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.672 -1.268 . . . . 0.0 112.806 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 91.4 m -86.95 118.84 26.6 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.597 1.159 . . . . 0.0 108.875 172.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -68.59 -7.99 37.72 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -169.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -74.45 -12.93 60.63 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.005 1.322 . . . . 0.0 112.997 168.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 20.6 t -60.6 138.89 57.99 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.181 -0.95 . . . . 0.0 112.358 173.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 32.7 p -80.87 168.82 22.42 Favored Pre-proline 0 N--CA 1.472 0.666 0 C-N-CA 124.078 0.951 . . . . 0.0 109.216 162.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.67 -20.3 26.81 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.209 1.939 . . . . 0.0 112.887 163.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -69.02 -35.7 76.93 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.498 1.045 . . . . 0.0 111.697 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -59.94 -38.92 83.81 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.122 0.969 . . . . 0.0 111.477 170.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 56.1 mt -70.33 -41.0 73.82 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-O 118.067 -0.968 . . . . 0.0 111.492 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 17.3 m -56.5 -51.04 69.99 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.796 1.18 . . . . 0.0 110.667 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -58.61 -46.18 87.58 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.274 0.488 . . . . 0.0 111.553 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -62.43 -52.84 61.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.487 1.515 . . . . 0.0 112.799 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -71.4 -18.1 62.36 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.973 1.309 . . . . 0.0 114.215 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 64.4 p -64.06 -16.66 62.2 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -65.31 -21.64 66.73 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.737 1.215 . . . . 0.0 113.384 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 37.5 mm -90.47 -16.16 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.675 1.19 . . . . 0.0 112.6 -168.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.56 -90.93 0.11 Allowed Glycine 0 N--CA 1.467 0.767 0 C-N-CA 125.073 1.32 . . . . 0.0 111.974 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -155.44 138.0 15.07 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.078 1.351 . . . . 0.0 111.368 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.1 144.5 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 125.04 1.336 . . . . 0.0 109.566 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.02 -34.54 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.076 0.55 . . . . 0.0 112.146 -160.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -155.91 153.77 30.16 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.352 2.261 . . . . 0.0 109.285 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -151.29 145.71 25.53 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.72 1.608 . . . . 0.0 111.461 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -156.05 156.07 33.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.768 1.627 . . . . 0.0 111.486 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 10.2 mt . . . . . 0 N--CA 1.474 0.75 0 C-N-CA 124.983 1.313 . . . . 0.0 108.034 172.176 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 92.3 mtp . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 120.568 0.223 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.6 146.5 16.08 Favored Glycine 0 N--CA 1.469 0.86 0 C-N-CA 124.522 1.058 . . . . 0.0 111.864 171.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 4.0 p -143.05 147.69 35.48 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.936 1.294 . . . . 0.0 110.921 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.9 t -150.76 142.1 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.517 1.127 . . . . 0.0 109.305 -171.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.94 134.83 54.26 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.922 1.689 . . . . 0.0 110.792 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -113.16 159.87 18.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.272 1.829 . . . . 0.0 111.382 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 38.1 p -74.85 -21.42 59.27 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -137.68 -146.42 0.22 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.965 1.306 . . . . 0.0 111.843 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 62.6 p -136.39 -57.88 0.74 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.647 1.112 . . . . 0.0 113.254 -172.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.58 -29.34 70.51 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.905 -1.122 . . . . 0.0 113.697 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -72.11 -28.69 63.44 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.75 1.62 . . . . 0.0 112.992 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.5 t -69.42 -33.31 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.359 1.463 . . . . 0.0 111.802 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -74.14 -41.94 60.76 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.601 -0.687 . . . . 0.0 112.163 170.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -62.49 -28.48 69.86 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.058 0.943 . . . . 0.0 112.77 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.56 -60.11 4.15 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.761 1.224 . . . . 0.0 111.583 169.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.11 -23.04 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.16 -0.963 . . . . 0.0 112.892 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -14.59 13.3 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.243 1.017 . . . . 0.0 113.549 167.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -101.14 -20.25 15.4 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.046 1.338 . . . . 0.0 112.901 173.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -122.17 -17.56 7.14 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 -159.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -68.15 120.53 14.49 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 120.628 1.558 . . . . 0.0 110.079 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 94.27 0.39 65.45 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 117.791 -1.56 . . . . 0.0 115.015 -169.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.13 107.17 0.51 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 120.0 1.9 . . . . 0.0 110.906 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -53.69 119.85 5.46 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.92 0.888 . . . . 0.0 109.812 160.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -146.88 110.37 4.87 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.411 1.485 . . . . 0.0 108.038 -163.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 51.4 mtt 53.42 35.32 20.21 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.563 0.745 . . . . 0.0 111.757 -169.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 86.01 0.48 0.66 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 128.95 2.9 . . . . 0.0 116.035 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -124.3 140.29 53.1 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.431 1.092 . . . . 0.0 111.974 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 103.14 6.82 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.244 -0.91 . . . . 0.0 112.766 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -52.31 143.31 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 121.36 -0.837 . . . . 0.0 111.015 164.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -129.72 147.42 51.5 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 164.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.2 p -151.09 127.76 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.584 0.707 . . . . 0.0 111.969 -166.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 . . . . . 0 CA--C 1.534 0.327 0 C-N-CA 125.222 1.409 . . . . 0.0 109.971 170.71 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.1 p . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 120.451 0.167 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.6 pt -141.04 154.85 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.21 1.004 . . . . 0.0 112.189 -161.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -122.23 147.43 46.21 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.686 1.995 . . . . 0.0 110.526 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.6 t -134.14 122.65 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.317 1.447 . . . . 0.0 109.766 -172.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.3 -46.12 2.65 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 116.254 1.262 . . . . 0.0 116.254 -163.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -121.57 23.62 10.18 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -163.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.57 -175.97 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.942 1.697 . . . . 0.0 112.882 165.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.6 p -73.7 127.08 31.83 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 120.958 -1.089 . . . . 0.0 110.023 165.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -70.0 -9.46 55.3 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -97.68 0.27 46.8 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.836 2.054 . . . . 0.0 113.283 171.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 7.9 t -58.11 149.16 24.33 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.132 -0.98 . . . . 0.0 113.299 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.1 p -95.12 151.84 39.07 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 123.594 0.758 . . . . 0.0 110.229 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.23 -25.91 30.57 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.376 2.051 . . . . 0.0 111.927 171.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -69.43 -42.79 74.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.209 1.004 . . . . 0.0 112.539 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -65.7 -41.61 92.13 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.718 -0.614 . . . . 0.0 111.547 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 25.5 mt -69.32 -29.26 67.05 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.6 -0.714 . . . . 0.0 112.226 173.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 49.7 m -66.11 -50.94 62.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.515 1.052 . . . . 0.0 109.658 171.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.32 -34.69 74.18 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 118.624 0.647 . . . . 0.0 112.253 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -70.13 -58.18 4.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.663 1.585 . . . . 0.0 112.406 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -71.24 -35.78 71.56 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.6 t -73.43 -6.0 43.51 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -51.98 -25.93 9.46 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.188 1.795 . . . . 0.0 112.544 164.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 28.4 mm -77.1 -22.35 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.198 1.799 . . . . 0.0 113.215 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.69 -90.47 0.11 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.304 0.954 . . . . 0.0 112.892 -172.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -152.47 95.47 2.03 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -171.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 39.9 t -70.09 134.11 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 161.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 5.1 p -104.38 -25.17 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.085 0.954 . . . . 0.0 112.645 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -164.6 119.7 1.43 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.683 1.193 . . . . 0.0 111.567 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -107.48 154.25 21.63 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.216 1.006 . . . . 0.0 111.067 161.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -156.14 131.89 9.7 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.538 1.535 . . . . 0.0 110.89 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 4.8 mm . . . . . 0 N--CA 1.482 1.142 0 C-N-CA 125.117 1.367 . . . . 0.0 109.79 178.532 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.45 156.72 20.33 Favored Glycine 0 N--CA 1.467 0.73 0 C-N-CA 124.593 1.092 . . . . 0.0 112.89 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.0 p -144.42 149.22 35.7 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.903 1.681 . . . . 0.0 111.099 174.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 10.9 t -145.42 139.06 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.983 0.913 . . . . 0.0 110.667 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -127.8 132.1 49.5 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.172 2.189 . . . . 0.0 109.012 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -110.7 164.26 12.93 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.442 1.497 . . . . 0.0 110.055 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 33.1 p -81.05 -25.36 37.17 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 122.01 -0.431 . . . . 0.0 111.893 164.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -81.26 168.44 18.47 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.97 1.708 . . . . 0.0 112.248 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.3 m -122.62 -76.75 0.59 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.575 0.75 . . . . 0.0 110.972 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.94 -25.15 67.42 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.8 -1.187 . . . . 0.0 113.835 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.13 -21.71 61.43 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.09 -25.05 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.565 0.746 . . . . 0.0 111.661 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -73.09 -43.79 61.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.998 0.919 . . . . 0.0 111.231 167.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -60.1 -32.27 70.82 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.888 0.875 . . . . 0.0 112.111 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.07 -65.13 0.67 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.768 1.227 . . . . 0.0 111.748 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 45.2 mt -59.91 -34.76 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.401 -0.812 . . . . 0.0 112.12 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -63.34 -2.76 1.59 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.076 1.35 . . . . 0.0 114.356 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -122.0 -2.99 9.13 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.893 1.677 . . . . 0.0 112.8 171.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -129.09 -21.09 3.33 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -170.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -62.53 120.94 12.09 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.393 1.451 . . . . 0.0 110.079 173.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 97.31 0.52 59.64 Favored Glycine 0 N--CA 1.471 1.011 0 CA-C-O 118.136 -1.369 . . . . 0.0 115.266 -169.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.61 106.66 0.99 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.815 1.808 . . . . 0.0 110.789 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -53.63 115.37 1.93 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 154.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -137.23 110.91 8.09 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.078 1.351 . . . . 0.0 108.758 -166.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 18.9 mmt 60.26 19.1 8.57 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.052 1.341 . . . . 0.0 113.949 -178.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 18.6 t70 106.91 0.14 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 130.929 3.692 . . . . 0.0 115.148 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -129.69 138.21 51.03 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.571 1.078 . . . . 0.0 112.844 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -71.22 104.59 3.15 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.251 1.42 . . . . 0.0 113.191 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 pt -55.15 144.27 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.267 0.627 . . . . 0.0 111.326 168.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -139.76 140.03 36.61 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.848 1.259 . . . . 0.0 109.359 174.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.05 135.06 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.144 1.378 . . . . 0.0 110.35 -171.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 . . . . . 0 N--CA 1.471 0.592 0 C-N-CA 125.333 1.453 . . . . 0.0 108.418 170.275 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.6 m . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 121.414 0.626 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 35.5 pt -141.36 142.19 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 126.531 1.932 . . . . 0.0 109.018 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -109.96 128.67 55.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.365 1.066 . . . . 0.0 110.842 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.09 106.04 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.864 1.666 . . . . 0.0 107.905 -169.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -99.68 -11.58 43.55 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 117.09 1.596 . . . . 0.0 117.09 -158.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -157.25 38.43 0.29 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.335 1.568 . . . . 0.0 113.507 -171.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.35 177.78 6.34 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.011 -1.056 . . . . 0.0 112.441 175.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 t -76.67 142.06 40.71 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.978 1.311 . . . . 0.0 111.806 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -64.04 -12.78 41.7 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 170.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -75.45 -15.24 60.45 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.502 1.121 . . . . 0.0 113.547 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 57.9 m -71.49 137.68 48.36 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.992 -1.068 . . . . 0.0 113.286 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 43.0 p -100.75 159.2 30.24 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 125.377 1.471 . . . . 0.0 109.262 163.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.48 -24.53 78.25 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 121.963 1.775 . . . . 0.0 112.774 170.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.18 -41.33 90.43 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.871 1.214 . . . . 0.0 111.7 173.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -60.56 -47.44 86.17 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.414 0.686 . . . . 0.0 110.858 176.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.514 ' HG ' HD11 ' A' ' 192' ' ' ILE . 1.9 mm? -62.89 -37.52 87.26 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.552 1.141 . . . . 0.0 111.999 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.6 m -63.76 -50.42 69.14 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.203 1.001 . . . . 0.0 110.568 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.62 -41.92 83.18 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.509 0.595 . . . . 0.0 111.694 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -57.17 -55.46 34.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.744 1.618 . . . . 0.0 112.29 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -71.15 -28.34 64.2 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.2 m -73.26 0.24 12.47 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -66.84 -20.91 66.02 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 120.892 -1.13 . . . . 0.0 112.594 166.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 24.1 mm -84.07 -39.91 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.866 1.266 . . . . 0.0 111.762 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -173.62 -98.04 0.11 Allowed Glycine 0 N--CA 1.468 0.796 0 C-N-CA 125.662 1.601 . . . . 0.0 111.633 -174.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -144.41 123.11 12.57 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.539 1.135 . . . . 0.0 112.469 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 29.4 t -74.4 133.54 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 156.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.2 -23.62 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.068 0.547 . . . . 0.0 112.043 175.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -176.18 146.49 0.67 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 127.714 2.405 . . . . 0.0 110.494 176.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -130.45 158.79 38.93 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.548 1.539 . . . . 0.0 112.092 168.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -155.45 142.19 18.9 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.003 1.721 . . . . 0.0 110.772 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.514 HD11 ' HG ' ' A' ' 177' ' ' LEU . 4.1 mt . . . . . 0 N--CA 1.48 1.051 0 C-N-CA 124.802 1.241 . . . . 0.0 110.114 -175.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 120.417 0.151 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -149.51 -178.37 24.43 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.204 0.907 . . . . 0.0 114.383 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.2 m -150.99 144.75 25.1 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.829 1.651 . . . . 0.0 108.457 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.84 143.38 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.851 0.86 . . . . 0.0 110.014 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -110.28 135.13 51.51 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.198 1.799 . . . . 0.0 110.223 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -117.19 159.79 22.08 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.539 1.936 . . . . 0.0 112.118 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.5 p -83.66 -25.46 30.71 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -148.51 142.79 26.16 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 -168.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.8 p -76.36 -14.73 60.07 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.84 2.456 . . . . 0.0 116.013 -161.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -102.05 -33.88 9.53 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.113 0.87 . . . . 0.0 112.776 169.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -62.07 -43.32 99.08 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.703 0.801 . . . . 0.0 110.962 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 13.3 p -62.67 -35.85 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.172 1.389 . . . . 0.0 113.971 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.48 -47.0 35.94 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.739 -0.601 . . . . 0.0 112.609 172.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -58.08 -34.98 70.74 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.799 1.24 . . . . 0.0 112.43 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.67 -58.1 9.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.632 1.173 . . . . 0.0 111.636 171.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 45.1 mt -69.96 -29.88 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.485 -1.385 . . . . 0.0 112.466 -173.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.48 -14.37 12.34 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 168.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -105.92 -40.67 5.62 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.341 1.856 . . . . 0.0 111.963 171.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -95.04 -13.88 24.8 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 -165.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.01 120.62 13.96 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 120.614 1.552 . . . . 0.0 109.936 174.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 93.78 0.78 66.22 Favored Glycine 0 N--CA 1.473 1.104 0 CA-C-O 117.861 -1.522 . . . . 0.0 115.19 -167.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.33 107.0 0.59 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.221 2.01 . . . . 0.0 110.912 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -53.13 120.89 6.47 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.035 0.934 . . . . 0.0 109.85 160.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -141.24 110.74 6.39 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.462 1.505 . . . . 0.0 107.804 -170.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 19.3 mmt 51.22 41.52 27.91 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.587 1.155 . . . . 0.0 111.722 -162.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 76.28 0.53 3.26 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 127.681 2.392 . . . . 0.0 115.169 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -116.14 130.3 56.73 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.597 1.159 . . . . 0.0 111.622 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -71.01 104.15 2.9 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.042 -1.036 . . . . 0.0 112.837 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.1 pt -52.81 146.6 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.246 0.618 . . . . 0.0 111.016 156.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -135.53 147.55 48.84 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.864 1.266 . . . . 0.0 108.576 169.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 1.6 p -153.02 140.56 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.11 0.964 . . . . 0.0 111.254 -166.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 . . . . . 0 CA--C 1.533 0.326 0 C-N-CA 124.817 1.247 . . . . 0.0 110.169 173.57 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.4 t . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 121.783 0.802 . . . . 0.0 112.952 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 6.8 pt -147.62 151.47 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 127.364 2.266 . . . . 0.0 109.989 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -121.85 134.53 54.88 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.298 1.839 . . . . 0.0 110.367 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.47 121.29 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.757 1.223 . . . . 0.0 108.808 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.32 -44.79 1.13 Allowed Glycine 0 N--CA 1.475 1.257 0 N-CA-C 115.333 0.893 . . . . 0.0 115.333 -168.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -100.45 7.41 44.21 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -166.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -62.88 169.01 3.48 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.148 1.379 . . . . 0.0 111.926 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.7 m -64.15 138.87 58.66 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.129 0.972 . . . . 0.0 112.324 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -70.15 0.12 6.79 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.478 1.911 . . . . 0.0 115.244 -169.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -111.9 0.55 16.14 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.244 2.217 . . . . 0.0 112.692 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 9.8 t -61.95 154.87 25.15 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.1 p -130.49 152.28 80.06 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 125.545 1.538 . . . . 0.0 111.062 -168.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.57 -42.87 19.22 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.761 2.307 . . . . 0.0 113.236 -171.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.73 -27.96 67.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.542 1.065 . . . . 0.0 112.816 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.05 -30.2 63.55 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.971 0.909 . . . . 0.0 112.094 174.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.502 HD12 HD11 ' A' ' 192' ' ' ILE . 13.8 mt -74.51 -34.04 62.94 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.058 -0.972 . . . . 0.0 113.283 164.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 81.6 m -62.21 -50.61 71.1 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.145 1.339 . . . . 0.0 110.73 177.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -62.03 -26.74 68.42 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -78.43 -60.12 2.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.522 1.529 . . . . 0.0 111.521 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -71.24 -34.07 70.43 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -175.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.0 t -73.37 -1.21 17.21 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -64.45 -17.65 64.02 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.054 0.942 . . . . 0.0 112.855 169.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.3 mm -82.09 -25.31 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.6 1.56 . . . . 0.0 113.089 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 175.23 -103.45 0.18 Allowed Glycine 0 N--CA 1.47 0.954 0 C-N-CA 124.506 1.051 . . . . 0.0 112.367 -169.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -147.77 109.67 4.48 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.508 0.723 . . . . 0.0 112.489 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 25.6 t -71.25 129.77 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 164.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.81 -33.48 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 118.362 0.528 . . . . 0.0 112.005 173.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -154.71 134.82 13.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.285 1.434 . . . . 0.0 110.715 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -109.71 153.94 23.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.245 1.018 . . . . 0.0 110.595 153.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -153.13 123.03 6.91 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.822 1.249 . . . . 0.0 111.262 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.502 HD11 HD12 ' A' ' 177' ' ' LEU . 6.0 mt . . . . . 0 N--CA 1.482 1.147 0 C-N-CA 123.657 0.783 . . . . 0.0 113.023 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 93.4 mtp . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -173.75 -165.84 31.08 Favored Glycine 0 N--CA 1.474 1.192 0 N-CA-C 116.144 1.218 . . . . 0.0 116.144 -169.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.7 p -132.66 160.9 35.35 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.832 1.653 . . . . 0.0 113.582 -164.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 12.2 t -141.84 142.15 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.942 1.297 . . . . 0.0 110.202 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -125.45 134.98 51.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.862 2.065 . . . . 0.0 111.341 -171.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -118.46 151.66 37.39 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.071 1.748 . . . . 0.0 111.895 -169.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 61.3 p -75.93 -38.21 57.87 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.467 0.307 . . . . 0.0 110.817 163.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -61.18 160.49 10.26 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.377 1.871 . . . . 0.0 113.09 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.7 p -127.08 -66.01 0.92 Allowed 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.707 -0.621 . . . . 0.0 111.895 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -61.95 -30.24 70.78 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.425 1.011 . . . . 0.0 112.154 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -72.21 -17.43 61.92 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 12.4 t -70.26 -22.81 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.872 0.76 . . . . 0.0 112.042 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -74.07 -45.76 47.32 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.752 -1.217 . . . . 0.0 110.967 164.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 10.1 ttt85 -57.01 -29.35 63.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.597 1.559 . . . . 0.0 113.753 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.62 -68.7 0.29 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.681 1.592 . . . . 0.0 110.586 166.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.23 -27.87 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 121.204 -0.935 . . . . 0.0 113.266 -166.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -58.54 -18.79 32.31 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.861 0.864 . . . . 0.0 113.319 170.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -107.46 -6.7 16.91 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.369 1.467 . . . . 0.0 113.295 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -124.68 -22.87 4.48 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -170.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.64 120.5 14.75 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 120.399 1.454 . . . . 0.0 109.833 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 94.62 0.43 64.61 Favored Glycine 0 N--CA 1.469 0.888 0 CA-C-O 118.016 -1.435 . . . . 0.0 115.028 -168.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.8 108.84 1.08 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.909 1.855 . . . . 0.0 110.536 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -48.44 116.72 1.68 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.151 0.98 . . . . 0.0 109.351 156.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -152.0 110.77 3.82 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.851 1.26 . . . . 0.0 108.808 -172.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.13 50.52 13.41 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.472 1.109 . . . . 0.0 112.019 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 16.8 t70 77.48 0.14 2.88 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 127.257 2.223 . . . . 0.0 115.807 171.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 -135.55 154.8 51.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.925 1.29 . . . . 0.0 111.898 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 103.97 16.38 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.311 -0.868 . . . . 0.0 110.611 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.4 pt -54.76 139.54 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 121.215 -0.928 . . . . 0.0 111.287 171.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -132.69 142.66 49.17 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.626 1.17 . . . . 0.0 108.139 167.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 1.1 p -136.93 134.82 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.321 1.048 . . . . 0.0 111.682 -165.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 . . . . . 0 CA--C 1.534 0.364 0 C-N-CA 126.275 1.83 . . . . 0.0 109.919 173.438 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.5 p . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 121.502 0.668 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 28.7 pt -144.1 145.48 21.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 125.589 1.556 . . . . 0.0 110.341 -171.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 94.4 t80 -109.29 150.2 28.32 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.825 1.65 . . . . 0.0 109.56 170.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.95 102.86 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.105 1.362 . . . . 0.0 108.786 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -82.49 -16.28 71.55 Favored Glycine 0 N--CA 1.471 0.974 0 C-N-CA 124.223 0.916 . . . . 0.0 114.315 -171.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -152.2 133.43 14.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.858 1.663 . . . . 0.0 109.926 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 mp -144.01 -77.96 0.22 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.63 1.572 . . . . 0.0 109.95 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 11.3 t -172.25 140.21 1.12 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.975 2.51 . . . . 0.0 108.588 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -63.43 -13.65 42.28 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -88.7 0.09 56.78 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.201 1.4 . . . . 0.0 113.418 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 7.6 t -78.46 152.82 31.89 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.682 -1.261 . . . . 0.0 113.509 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.49 159.7 32.26 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 126.556 1.943 . . . . 0.0 109.066 -176.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.0 -27.07 17.77 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 121.988 1.792 . . . . 0.0 113.29 -167.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.04 -34.77 78.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.196 0.907 . . . . 0.0 111.573 173.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -70.38 -41.27 73.28 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.059 0.944 . . . . 0.0 110.964 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 177' ' ' LEU . 17.1 mt -66.59 -29.69 69.8 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.815 169.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 86.0 m -69.4 -48.36 61.35 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.402 1.001 . . . . 0.0 109.89 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -61.33 -33.77 74.15 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.431 0.693 . . . . 0.0 112.571 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -73.14 -61.48 1.8 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.998 1.719 . . . . 0.0 111.962 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.37 -39.75 71.05 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.3 t -73.28 -7.07 49.96 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -174.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -60.05 -18.62 47.91 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.782 1.233 . . . . 0.0 112.65 167.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 20.6 mm -78.96 -26.0 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.831 1.652 . . . . 0.0 112.607 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 166.22 -95.67 0.12 Allowed Glycine 0 N--CA 1.469 0.87 0 C-N-CA 124.734 1.159 . . . . 0.0 112.457 -171.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -141.67 110.13 6.01 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.361 1.064 . . . . 0.0 112.85 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.66 135.18 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 154.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.29 -18.31 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 172.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -160.47 138.2 9.63 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.419 1.488 . . . . 0.0 111.13 170.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -124.27 152.47 42.98 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.277 1.431 . . . . 0.0 110.554 160.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -152.32 137.0 16.97 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.201 1.001 . . . . 0.0 112.513 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.1 mt . . . . . 0 N--CA 1.483 1.206 0 C-N-CA 126.153 1.781 . . . . 0.0 111.255 179.265 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 4.0 ppp? . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 157.76 -144.79 10.92 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 115.314 0.886 . . . . 0.0 115.314 -174.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.6 m -144.84 150.39 37.04 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.269 1.428 . . . . 0.0 111.13 -160.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.8 t -139.14 147.65 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.733 1.213 . . . . 0.0 110.82 173.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -131.45 133.76 45.51 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.75 2.02 . . . . 0.0 111.001 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -120.61 164.82 15.91 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.985 2.114 . . . . 0.0 111.502 -174.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 29.3 p -74.55 -38.41 62.74 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -150.49 152.8 34.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -171.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 30.8 p -54.05 -40.0 66.73 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.328 1.851 . . . . 0.0 113.326 171.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -76.37 -23.6 54.15 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -79.59 -51.25 9.53 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.886 0.874 . . . . 0.0 112.438 169.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 15.0 p -69.3 -42.46 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -167.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.77 -13.3 62.0 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.158 0.89 . . . . 0.0 113.367 -173.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -73.37 -19.4 61.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.468 1.107 . . . . 0.0 112.657 173.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.65 -61.18 2.0 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.302 1.041 . . . . 0.0 112.612 -173.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 4.2 mp -68.91 -29.21 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 121.447 -0.783 . . . . 0.0 112.271 -160.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -58.5 -21.43 51.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.66 1.184 . . . . 0.0 113.566 170.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -101.4 -10.73 19.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.192 1.397 . . . . 0.0 112.889 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -126.0 -23.69 3.89 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -166.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.97 120.75 13.67 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.379 1.445 . . . . 0.0 109.8 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 93.08 0.83 67.74 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-O 117.982 -1.454 . . . . 0.0 115.079 -169.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.01 109.31 0.93 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.686 1.743 . . . . 0.0 110.501 171.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -57.05 124.17 17.79 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.265 0.555 . . . . 0.0 109.627 155.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -145.88 110.43 5.09 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.315 1.846 . . . . 0.0 107.103 -161.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 88.6 mmm 49.88 41.48 22.73 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.864 0.866 . . . . 0.0 111.728 -163.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 11.6 t70 77.71 -0.41 2.76 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 128.284 2.634 . . . . 0.0 115.085 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -120.38 137.73 54.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.564 1.146 . . . . 0.0 111.626 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -79.62 112.72 17.16 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.697 -1.252 . . . . 0.0 113.435 -170.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -68.18 143.88 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 121.219 -0.926 . . . . 0.0 112.98 169.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -132.31 130.28 40.62 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.282 1.433 . . . . 0.0 109.643 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 12.4 t -119.24 151.09 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.772 2.029 . . . . 0.0 109.541 -170.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 42.0 ptt85 . . . . . 0 N--CA 1.467 0.392 0 C-N-CA 123.546 0.738 . . . . 0.0 110.12 155.621 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 63.5 p . . . . . 0 N--CA 1.472 0.653 0 CA-C-O 121.444 0.64 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 10.4 pt -143.83 142.14 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.522 1.529 . . . . 0.0 109.571 -177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -128.73 123.9 34.22 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.648 1.179 . . . . 0.0 109.401 -168.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.8 t -113.93 129.68 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.814 1.645 . . . . 0.0 109.151 -164.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -74.59 -109.05 0.09 OUTLIER Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.272 1.415 . . . . 0.0 114.652 -169.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -84.26 -26.94 28.24 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.501 ' HG ' ' H ' ' A' ' 169' ' ' THR 0.32 2.3 pt? 32.7 -120.22 0.07 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.579 2.352 . . . . 0.0 115.0 -178.745 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.501 ' H ' ' HG ' ' A' ' 168' ' ' LEU . 57.2 m -142.28 130.32 21.94 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.684 1.594 . . . . 0.0 110.123 -162.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -61.45 -23.37 65.8 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.19 -0.89 57.78 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.885 1.674 . . . . 0.0 113.269 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 92.3 p -72.09 151.97 42.69 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 34.5 p -143.15 162.52 42.6 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 127.654 2.382 . . . . 0.0 108.372 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -63.16 -30.33 74.78 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 121.58 1.52 . . . . 0.0 112.951 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -69.28 -40.16 77.93 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.1 0.864 . . . . 0.0 112.207 173.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -66.18 -40.72 90.68 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.562 1.145 . . . . 0.0 111.838 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.34 -36.06 82.44 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.134 0.973 . . . . 0.0 112.025 170.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 91.7 m -69.48 -50.11 48.44 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.153 0.581 . . . . 0.0 110.314 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -58.75 -28.61 66.05 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.626 0.77 . . . . 0.0 112.399 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -75.56 -66.09 0.82 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.064 1.346 . . . . 0.0 111.7 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.28 -30.84 66.77 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -172.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.35 -5.33 39.02 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.011 -1.056 . . . . 0.0 113.701 -173.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -64.91 -19.45 65.94 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.685 1.194 . . . . 0.0 113.219 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 24.9 mm -82.83 -24.13 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.643 1.177 . . . . 0.0 112.655 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 176.14 -86.04 0.07 OUTLIER Glycine 0 N--CA 1.468 0.771 0 C-N-CA 124.923 1.249 . . . . 0.0 111.707 -175.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -157.51 116.47 3.26 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.494 1.118 . . . . 0.0 112.198 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 19.2 t -71.9 129.99 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 160.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.5 p -100.69 -17.04 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.657 0.783 . . . . 0.0 112.981 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -162.58 138.57 7.35 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.109 1.363 . . . . 0.0 112.112 169.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -127.35 156.02 42.65 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.986 1.314 . . . . 0.0 112.406 165.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -156.52 143.28 18.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.548 1.539 . . . . 0.0 112.27 -174.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.5 mm . . . . . 0 N--CA 1.476 0.871 0 C-N-CA 125.694 1.597 . . . . 0.0 108.012 170.281 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 4.7 ppp? . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -127.27 157.12 20.67 Favored Glycine 0 N--CA 1.471 1.031 0 C-N-CA 124.427 1.013 . . . . 0.0 114.865 -172.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 85.4 m -142.86 144.11 32.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.944 1.698 . . . . 0.0 109.107 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 43.7 t -141.63 152.52 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.848 0.859 . . . . 0.0 109.495 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -130.06 137.46 50.23 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.916 1.687 . . . . 0.0 111.21 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -121.06 160.5 23.49 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 127.306 2.243 . . . . 0.0 110.224 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 43.7 p -88.19 -14.38 38.73 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -175.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -156.25 130.93 8.96 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.2 m -46.79 -50.74 17.8 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 129.372 3.069 . . . . 0.0 115.113 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.75 -26.46 44.6 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.003 -1.061 . . . . 0.0 113.108 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.37 -39.7 64.94 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.303 -0.873 . . . . 0.0 113.332 170.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 14.0 p -69.05 -29.26 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.541 -0.724 . . . . 0.0 112.384 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.91 -39.78 83.52 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.514 0.726 . . . . 0.0 112.56 169.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 53.3 mtt85 -61.97 -33.19 73.84 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.329 0.652 . . . . 0.0 112.494 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.81 -63.71 1.13 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.409 1.004 . . . . 0.0 113.176 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 56.3 mt -65.46 -27.6 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 121.35 -0.844 . . . . 0.0 111.771 -170.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -51.39 -27.73 10.8 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.043 1.337 . . . . 0.0 113.558 168.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -98.88 -13.38 20.07 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.416 1.086 . . . . 0.0 113.443 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -125.18 -19.62 5.09 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -163.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -67.64 120.89 14.76 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 120.408 1.458 . . . . 0.0 110.769 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 91.34 0.82 72.85 Favored Glycine 0 N--CA 1.469 0.885 0 CA-C-O 117.44 -1.755 . . . . 0.0 114.75 -170.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.37 106.22 0.36 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.894 1.847 . . . . 0.0 110.32 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.499 ' CZ ' ' HE2' ' A' ' 229' ' ' LYS . 56.4 m-85 -60.3 116.92 4.61 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 156.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -133.95 110.33 9.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.24 1.416 . . . . 0.0 107.288 -164.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 12.9 ttt 50.07 38.88 17.85 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.13 0.972 . . . . 0.0 111.897 -159.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.7 t70 76.45 6.78 3.47 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 126.858 2.063 . . . . 0.0 114.965 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -121.12 138.67 54.09 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.45 1.1 . . . . 0.0 112.105 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.499 ' HE2' ' CZ ' ' A' ' 224' ' ' PHE . 42.4 mmtt -68.01 115.88 8.02 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.149 1.379 . . . . 0.0 113.584 -175.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.03 145.87 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 120.998 -1.064 . . . . 0.0 110.743 151.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -146.58 142.42 27.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.64 1.976 . . . . 0.0 108.43 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.2 t -137.27 135.38 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -165.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 . . . . . 0 N--CA 1.47 0.526 0 C-N-CA 126.259 1.824 . . . . 0.0 110.965 168.176 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.0 pt -136.43 147.06 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.09 1.356 . . . . 0.0 110.824 176.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -129.48 114.21 15.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.555 1.942 . . . . 0.0 109.356 -167.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.46 106.29 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.308 1.843 . . . . 0.0 108.197 -172.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.54 -10.78 78.97 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.237 0.922 . . . . 0.0 115.268 -169.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -159.44 157.92 31.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.009 1.724 . . . . 0.0 110.408 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 178.26 -144.55 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 128.838 2.855 . . . . 0.0 107.984 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 21.8 p -108.56 141.83 39.89 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 120.865 1.666 . . . . 0.0 111.221 170.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -59.68 -25.18 64.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -88.52 -1.85 58.27 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.045 1.738 . . . . 0.0 113.423 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 22.7 t -69.63 154.64 41.7 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.984 -1.072 . . . . 0.0 112.163 174.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 32.5 p -128.4 155.57 78.35 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 125.33 1.452 . . . . 0.0 109.746 -172.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.02 -23.48 53.79 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.45 1.434 . . . . 0.0 112.394 174.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -69.07 -36.38 77.57 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.516 1.053 . . . . 0.0 111.987 171.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -71.33 -37.98 71.69 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.307 -0.871 . . . . 0.0 111.859 174.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.8 mt -66.14 -30.36 70.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.418 -0.801 . . . . 0.0 112.787 166.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 63.6 m -67.71 -46.82 71.1 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.571 1.078 . . . . 0.0 109.35 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.31 -36.13 79.26 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.796 0.726 . . . . 0.0 112.118 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -66.41 -64.14 0.92 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.55 1.14 . . . . 0.0 111.511 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -71.23 -39.21 71.84 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -173.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.73 -3.88 31.1 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -72.77 -15.95 61.65 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.161 -0.962 . . . . 0.0 112.892 165.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.07 -45.65 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.007 0.822 . . . . 0.0 111.295 175.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.39 -90.75 0.08 OUTLIER Glycine 0 N--CA 1.468 0.779 0 C-N-CA 125.062 1.315 . . . . 0.0 112.405 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -158.4 109.56 2.17 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.74 0.816 . . . . 0.0 112.09 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 36.0 t -74.06 130.44 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 167.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.6 p -102.94 -16.99 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.22 1.008 . . . . 0.0 113.107 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -164.95 134.22 3.55 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.147 1.779 . . . . 0.0 111.066 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -130.15 152.94 49.04 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.716 1.606 . . . . 0.0 112.299 165.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -156.76 156.78 33.89 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.844 2.058 . . . . 0.0 111.216 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.3 mt . . . . . 0 N--CA 1.482 1.147 0 C-N-CA 124.7 1.2 . . . . 0.0 111.316 178.063 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 27.1 ptm . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -108.06 164.73 12.81 Favored Glycine 0 N--CA 1.469 0.865 0 C-N-CA 124.874 1.226 . . . . 0.0 113.789 -177.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.77 142.54 27.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.992 1.717 . . . . 0.0 109.836 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 19.4 t -146.27 146.89 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.609 0.764 . . . . 0.0 109.999 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -129.2 131.95 47.19 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.164 1.786 . . . . 0.0 109.369 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -95.99 171.77 8.42 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.626 1.17 . . . . 0.0 109.915 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 59.0 p -81.48 0.15 39.15 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 168.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -136.22 178.49 7.02 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.264 1.826 . . . . 0.0 112.433 -166.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 20.9 p -124.82 -68.3 0.86 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.179 1.792 . . . . 0.0 110.897 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -54.37 -38.53 66.21 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.016 -1.053 . . . . 0.0 112.956 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.6 -18.38 64.97 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.446 1.098 . . . . 0.0 113.077 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 13.0 t -75.79 -37.23 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.137 1.375 . . . . 0.0 112.062 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -62.17 -43.67 98.31 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.768 -0.582 . . . . 0.0 110.434 168.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -65.74 -17.14 64.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.981 1.312 . . . . 0.0 113.523 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -74.49 -64.27 1.06 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.24 0.927 . . . . 0.0 111.425 166.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 53.5 mt -69.23 -30.8 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.444 -0.785 . . . . 0.0 112.04 -167.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.69 -4.2 2.87 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.545 1.138 . . . . 0.0 113.835 170.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -118.24 -4.91 10.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.388 1.475 . . . . 0.0 112.569 172.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -127.54 -24.03 3.38 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -171.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.54 120.92 12.07 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 121.001 1.728 . . . . 0.0 110.501 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 91.64 0.68 72.14 Favored Glycine 0 N--CA 1.469 0.844 0 CA-C-O 118.06 -1.411 . . . . 0.0 115.336 -171.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.47 107.6 0.81 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.76 1.78 . . . . 0.0 110.363 169.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -52.98 120.4 5.81 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 156.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -142.15 111.06 6.27 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.26 1.424 . . . . 0.0 108.314 -166.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 20.5 ttt 56.72 40.5 29.14 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 121.776 0.798 . . . . 0.0 110.751 -165.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 18.3 t70 74.97 0.18 3.48 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 127.912 2.485 . . . . 0.0 115.285 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -125.64 141.27 52.11 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.05 1.34 . . . . 0.0 111.982 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -87.32 102.62 14.68 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.002 0.921 . . . . 0.0 112.621 -165.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.88 149.73 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 121.226 -0.921 . . . . 0.0 112.484 169.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -141.49 140.49 33.53 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.823 1.649 . . . . 0.0 108.696 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 16.0 t -133.03 133.55 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 118.556 0.616 . . . . 0.0 112.299 -168.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? . . . . . 0 CA--C 1.537 0.454 0 C-N-CA 126.128 1.771 . . . . 0.0 109.456 169.42 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.1 pt -139.06 148.21 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.831 1.652 . . . . 0.0 110.786 -171.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -99.34 148.87 23.73 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.106 1.363 . . . . 0.0 110.601 166.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 14.8 t -131.01 101.41 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.01 -12.86 82.89 Favored Glycine 0 N--CA 1.475 1.247 0 C-N-CA 124.128 0.871 . . . . 0.0 114.963 -161.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -164.26 148.48 9.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.531 1.932 . . . . 0.0 108.785 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.3 mp -144.51 -79.42 0.19 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.541 1.937 . . . . 0.0 109.63 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.5 t 177.03 162.64 0.46 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 128.232 2.613 . . . . 0.0 108.652 -162.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -91.75 0.37 57.49 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.407 1.083 . . . . 0.0 113.511 -174.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -120.24 0.42 10.64 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.424 1.89 . . . . 0.0 114.543 -173.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.8 t -90.15 168.51 11.9 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.932 -1.105 . . . . 0.0 113.152 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 40.0 p -143.41 163.72 35.21 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 127.488 2.315 . . . . 0.0 109.798 -174.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -60.58 -29.08 87.78 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.249 1.966 . . . . 0.0 113.193 169.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -69.08 -39.89 78.76 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.339 0.972 . . . . 0.0 111.837 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -60.98 -40.47 93.55 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.561 0.744 . . . . 0.0 111.585 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.4 mt -70.04 -31.67 69.42 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 172.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 51.8 m -65.9 -47.4 74.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.964 0.802 . . . . 0.0 110.868 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.03 -19.74 60.53 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -79.13 -55.93 4.74 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.307 1.443 . . . . 0.0 111.081 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -70.98 -28.16 64.24 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.162 0.985 . . . . 0.0 113.489 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 45.3 m -72.92 -2.31 20.37 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -64.91 -18.85 65.56 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.244 -0.91 . . . . 0.0 112.58 165.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 23.3 mm -90.08 -21.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.88 1.272 . . . . 0.0 112.222 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 168.64 -87.27 0.09 OUTLIER Glycine 0 N--CA 1.468 0.804 0 C-N-CA 125.379 1.466 . . . . 0.0 111.872 -173.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -162.07 120.18 2.22 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.663 1.185 . . . . 0.0 112.448 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 43.7 t -73.71 131.9 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 157.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.55 -18.34 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 171.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -162.37 141.21 9.11 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.144 1.778 . . . . 0.0 110.803 172.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -132.58 158.05 43.17 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.223 1.409 . . . . 0.0 111.522 164.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -153.31 143.91 22.61 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.471 1.508 . . . . 0.0 111.937 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 N--CA 1.481 1.115 0 C-N-CA 125.697 1.599 . . . . 0.0 110.632 -179.757 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 11.7 ptt? . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 119.45 -0.31 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 164.99 -144.65 9.5 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-N 118.638 0.654 . . . . 0.0 114.388 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.5 p -144.46 159.77 42.2 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.34 1.456 . . . . 0.0 112.954 -165.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 37.8 t -144.97 141.53 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.003 1.321 . . . . 0.0 110.322 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -121.16 134.32 55.22 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 127.018 2.127 . . . . 0.0 110.922 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -118.96 172.79 7.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.676 2.39 . . . . 0.0 111.234 -173.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 80.9 p -92.2 -22.03 20.04 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ASN . . . . . 0.424 ' O ' HG12 ' A' ' 213' ' ' VAL . 18.4 m120 -148.49 137.4 21.64 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -169.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 19.3 m -69.84 -22.89 63.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.98 2.112 . . . . 0.0 115.814 -168.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -90.24 -36.92 14.46 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.639 0.654 . . . . 0.0 111.951 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -72.23 -37.11 69.25 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.102 -0.998 . . . . 0.0 112.573 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 209' ' ' ASN . 14.2 p -63.46 -28.7 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.607 0.763 . . . . 0.0 113.01 170.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.62 -46.57 37.45 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.86 0.864 . . . . 0.0 112.974 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -59.31 -27.84 66.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.317 1.447 . . . . 0.0 112.896 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.64 -60.93 2.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.216 1.006 . . . . 0.0 112.879 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 43.9 mt -65.09 -29.06 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 121.128 -0.982 . . . . 0.0 112.428 -169.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -51.44 -29.1 14.97 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.622 1.569 . . . . 0.0 113.19 168.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -93.87 -15.86 24.62 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.988 1.315 . . . . 0.0 113.698 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -127.6 -18.6 4.33 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -159.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.81 120.9 13.36 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 121.227 1.831 . . . . 0.0 110.506 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 92.98 0.78 68.02 Favored Glycine 0 N--CA 1.472 1.039 0 CA-C-O 117.941 -1.477 . . . . 0.0 115.059 -170.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.97 108.16 0.99 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.839 1.82 . . . . 0.0 110.348 171.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -55.68 129.25 38.44 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.313 0.645 . . . . 0.0 110.333 160.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -152.25 110.84 3.77 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.996 1.719 . . . . 0.0 106.685 -162.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 2.6 mpt? 41.15 59.28 2.35 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.152 0.981 . . . . 0.0 111.435 -160.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 73.21 0.05 3.54 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.922 2.089 . . . . 0.0 116.174 170.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -137.58 147.0 44.71 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.622 1.169 . . . . 0.0 111.775 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -70.83 124.22 23.79 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.903 -1.123 . . . . 0.0 113.698 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.4 pt -65.78 137.13 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.336 -0.853 . . . . 0.0 111.332 153.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -129.76 129.84 44.63 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.068 1.347 . . . . 0.0 109.596 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -156.32 129.09 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.992 0.917 . . . . 0.0 111.614 -169.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? . . . . . 0 N--CA 1.469 0.495 0 C-N-CA 125.919 1.687 . . . . 0.0 109.443 168.354 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 80.2 p . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 121.179 0.514 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 5.1 pt -144.58 154.37 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.219 1.407 . . . . 0.0 111.806 -165.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -119.02 125.85 50.32 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.553 1.941 . . . . 0.0 109.627 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 12.2 t -107.94 129.96 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.743 1.217 . . . . 0.0 109.111 -175.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.37 -97.66 0.12 Allowed Glycine 0 N--CA 1.472 1.094 0 C-N-CA 125.667 1.604 . . . . 0.0 115.036 -161.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -92.68 -56.86 2.85 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 117.625 0.713 . . . . 0.0 111.924 -173.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.45 6.67 1.52 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 118.752 2.871 . . . . 0.0 118.752 155.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.7 m 79.18 124.23 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 127.783 2.433 . . . . 0.0 110.422 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -68.25 -13.35 62.19 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -81.45 -9.14 59.78 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.503 1.521 . . . . 0.0 113.319 172.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.0 m -74.77 141.78 44.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.998 0.919 . . . . 0.0 112.551 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.8 p -122.87 152.78 63.21 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.971 1.308 . . . . 0.0 111.554 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.6 -25.9 14.46 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.607 2.205 . . . . 0.0 113.057 -173.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -69.43 -39.44 77.84 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.437 1.017 . . . . 0.0 111.891 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -73.16 -36.23 66.59 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.451 -0.781 . . . . 0.0 111.349 177.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 49.3 mt -62.24 -31.93 72.55 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.773 0.829 . . . . 0.0 112.289 166.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 54.8 m -67.0 -51.06 59.74 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.48 1.036 . . . . 0.0 109.634 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.92 -36.15 78.55 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.424 0.556 . . . . 0.0 112.359 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -67.38 -57.41 6.64 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.014 1.726 . . . . 0.0 112.29 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -71.57 -34.01 69.57 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.9 t -72.53 -8.79 56.95 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 121.004 -1.06 . . . . 0.0 113.441 -174.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -52.54 -27.99 18.93 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.362 2.265 . . . . 0.0 113.053 164.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 28.4 mm -80.52 -17.26 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.547 1.539 . . . . 0.0 112.451 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 117.25 90.98 1.54 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.909 1.719 . . . . 0.0 112.324 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? 69.69 91.29 0.09 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 126.751 2.02 . . . . 0.0 114.472 162.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 13.9 t -73.14 128.09 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 162.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 66.5 t -91.12 -22.51 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.892 1.677 . . . . 0.0 111.25 -175.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -178.43 140.03 0.2 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.243 2.217 . . . . 0.0 109.576 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -120.03 141.33 49.84 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.487 1.115 . . . . 0.0 110.52 162.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -143.7 92.95 2.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.677 1.191 . . . . 0.0 111.595 -169.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.482 1.148 0 C-N-CA 124.689 1.196 . . . . 0.0 110.815 173.776 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 28.2 ptm . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -166.22 -166.74 25.76 Favored Glycine 0 N--CA 1.471 1.025 0 C-N-CA 124.031 0.824 . . . . 0.0 114.088 174.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.8 p -141.84 161.14 38.69 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.83 1.252 . . . . 0.0 112.599 -167.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 6.4 t -143.54 142.28 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.651 1.18 . . . . 0.0 110.435 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -114.49 145.26 42.12 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.225 2.21 . . . . 0.0 111.218 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -129.83 161.69 30.2 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.936 2.494 . . . . 0.0 109.535 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.2 p -84.21 -28.56 27.22 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.99 -0.444 . . . . 0.0 111.396 171.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -84.66 174.7 9.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.36 1.864 . . . . 0.0 112.902 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 39.3 t -126.03 -65.92 0.96 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.85 0.86 . . . . 0.0 111.49 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -64.5 -25.48 68.01 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.51 -1.369 . . . . 0.0 113.821 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -72.06 -20.92 61.59 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.561 1.144 . . . . 0.0 113.315 171.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 22.0 t -70.05 -28.3 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.049 0.94 . . . . 0.0 111.591 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -74.44 -37.07 63.37 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.283 -0.886 . . . . 0.0 112.208 167.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -64.8 -23.66 67.31 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.239 1.016 . . . . 0.0 112.405 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.97 -63.87 1.12 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.19 0.996 . . . . 0.0 110.565 164.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 83.8 mt -62.09 -35.63 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.215 1.006 . . . . 0.0 112.396 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -64.03 -6.56 6.52 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -114.29 -5.15 12.96 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.525 1.53 . . . . 0.0 112.535 172.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -128.06 -19.43 3.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -169.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -58.64 121.43 10.97 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.072 1.306 . . . . 0.0 109.227 162.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 93.83 0.51 66.35 Favored Glycine 0 N--CA 1.468 0.786 0 CA-C-O 118.379 -1.234 . . . . 0.0 114.849 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.57 108.53 2.46 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.512 1.656 . . . . 0.0 110.463 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -54.8 123.24 12.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.434 0.694 . . . . 0.0 109.963 155.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -148.62 116.51 6.35 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.422 1.489 . . . . 0.0 108.335 -167.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 56.21 31.58 18.67 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.101 0.96 . . . . 0.0 111.968 -163.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 10.7 t70 86.61 0.66 0.57 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 128.37 2.668 . . . . 0.0 115.582 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.4 152.77 48.69 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.638 1.175 . . . . 0.0 111.782 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -82.38 123.68 29.33 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -158.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.75 153.4 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 126.037 1.735 . . . . 0.0 113.318 167.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -145.86 146.65 31.2 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.552 1.941 . . . . 0.0 108.787 164.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 23.4 t -117.41 128.57 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.727 1.211 . . . . 0.0 110.586 -173.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 . . . . . 0 CA--C 1.538 0.493 0 C-N-CA 123.863 0.865 . . . . 0.0 109.364 168.828 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.0 pt -143.61 147.32 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 125.301 1.44 . . . . 0.0 112.275 -165.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -113.78 118.98 35.78 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 128.041 2.536 . . . . 0.0 109.257 173.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 25.5 t -94.57 97.15 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.363 1.465 . . . . 0.0 107.397 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.39 -9.22 67.26 Favored Glycine 0 N--CA 1.475 1.25 0 N-CA-C 116.052 1.181 . . . . 0.0 116.052 -160.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -139.61 18.13 2.53 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -164.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.02 -174.92 2.86 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.28 1.432 . . . . 0.0 112.689 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 38.1 m -97.26 122.96 40.88 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.023 1.329 . . . . 0.0 109.503 171.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -66.94 -10.42 48.92 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -171.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -74.82 -13.11 60.53 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.486 1.514 . . . . 0.0 113.867 174.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 5.8 m -67.24 137.89 56.5 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.022 -1.049 . . . . 0.0 111.447 168.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 78.8 p -76.21 163.27 67.51 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 123.836 0.855 . . . . 0.0 109.908 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -59.91 -35.64 92.98 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 121.758 1.639 . . . . 0.0 111.917 168.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.42 -29.01 69.06 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.787 0.722 . . . . 0.0 112.88 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -65.21 -33.72 76.67 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.078 0.951 . . . . 0.0 111.992 173.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.3 mt -74.59 -34.16 62.81 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 118.003 -0.998 . . . . 0.0 113.451 165.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 84.8 m -61.08 -51.12 70.48 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.94 1.246 . . . . 0.0 110.62 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.24 -30.5 70.95 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.889 0.768 . . . . 0.0 112.973 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -68.27 -56.37 8.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.034 1.334 . . . . 0.0 111.514 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -71.65 -23.38 61.67 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.7 t -61.98 -19.65 63.03 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.651 -1.28 . . . . 0.0 113.457 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -60.97 -17.95 54.55 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.281 1.833 . . . . 0.0 113.306 169.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 25.8 mm -104.45 -51.87 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.144 1.378 . . . . 0.0 111.851 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -172.33 -177.42 41.79 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.165 1.364 . . . . 0.0 112.403 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -74.24 105.6 5.5 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 121.624 -0.927 . . . . 0.0 112.168 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 48.3 t -59.68 130.13 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 160.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.02 -40.16 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.312 0.645 . . . . 0.0 110.422 171.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -155.54 139.4 16.24 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.871 2.068 . . . . 0.0 109.983 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -125.31 152.96 43.99 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.313 1.445 . . . . 0.0 110.665 164.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -150.97 131.67 14.01 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.541 1.136 . . . . 0.0 112.203 -171.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.7 mt . . . . . 0 N--CA 1.48 1.057 0 C-N-CA 125.225 1.41 . . . . 0.0 110.974 171.863 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 3.6 ppp? . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -147.09 172.85 27.45 Favored Glycine 0 N--CA 1.468 0.774 0 C-N-CA 126.025 1.774 . . . . 0.0 112.808 177.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.3 p -142.81 148.77 37.67 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.12 1.368 . . . . 0.0 111.013 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.29 137.28 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.09 0.956 . . . . 0.0 109.983 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -116.09 137.08 52.44 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.706 1.603 . . . . 0.0 109.635 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -110.98 159.12 18.03 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.17 1.788 . . . . 0.0 110.411 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 64.1 p -77.07 0.48 21.28 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 169.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -130.01 157.18 43.05 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.106 1.762 . . . . 0.0 112.886 -165.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 72.1 p -109.14 -7.85 15.24 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.601 1.56 . . . . 0.0 114.916 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.71 -45.42 1.46 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.39 1.476 . . . . 0.0 111.914 -166.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.23 -30.08 68.16 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.596 -0.69 . . . . 0.0 111.505 172.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.5 p -61.13 -32.11 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.276 1.43 . . . . 0.0 113.025 174.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -74.16 -48.11 31.48 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.965 0.906 . . . . 0.0 111.436 171.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -72.34 -11.76 60.84 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.62 -56.75 17.46 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.6 1.16 . . . . 0.0 111.381 163.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 71.2 mt -66.87 -30.33 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.055 0.942 . . . . 0.0 112.109 -168.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -52.41 -28.37 19.58 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.507 1.123 . . . . 0.0 113.471 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -97.1 -15.23 21.07 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.399 1.48 . . . . 0.0 112.579 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -123.29 -15.64 7.14 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -165.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -61.31 120.65 10.83 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.53 1.514 . . . . 0.0 108.88 162.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 97.57 -0.24 59.58 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 118.153 -1.36 . . . . 0.0 114.844 -172.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.17 103.88 2.46 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.727 1.764 . . . . 0.0 110.469 173.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -60.81 119.69 8.67 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 158.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -150.38 110.85 4.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.152 1.381 . . . . 0.0 108.633 -165.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 57.13 55.38 6.04 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.298 1.039 . . . . 0.0 110.865 -170.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 19.5 t70 76.13 0.18 3.23 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.749 2.02 . . . . 0.0 116.088 169.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -146.86 157.36 43.63 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.311 0.959 . . . . 0.0 112.787 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 4.2 tmmm? -86.36 105.42 16.69 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.673 1.189 . . . . 0.0 112.647 -172.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.22 154.1 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.188 0.995 . . . . 0.0 112.052 165.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -156.45 144.77 19.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.466 1.906 . . . . 0.0 107.486 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 13.2 t -127.36 140.31 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.632 0.773 . . . . 0.0 111.926 -162.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 81.6 mtt85 . . . . . 0 CA--C 1.536 0.411 0 C-N-CA 126.95 2.1 . . . . 0.0 108.318 175.399 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 CA--C 1.541 0.617 0 CA-C-O 122.05 0.928 . . . . 0.0 112.806 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 31.7 pt -138.95 138.89 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.898 2.079 . . . . 0.0 107.948 175.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -105.73 131.3 53.25 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.59 1.156 . . . . 0.0 109.52 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.7 t -111.2 122.96 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.677 1.591 . . . . 0.0 108.354 -170.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.12 -141.67 1.78 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.195 1.855 . . . . 0.0 113.312 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -74.97 47.26 0.34 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -162.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.62 ' HB2' HG22 ' A' ' 230' ' ' ILE . 2.5 pt? -53.99 -50.1 67.34 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.819 -1.175 . . . . 0.0 112.606 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.1 t 145.23 142.96 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.388 1 C-N-CA 131.705 4.002 . . . . 0.0 110.18 173.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -68.95 -9.5 52.39 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -80.59 -6.07 57.75 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.748 1.219 . . . . 0.0 113.198 170.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 6.2 t -88.72 167.06 13.63 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.957 0.903 . . . . 0.0 113.163 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.45 151.74 64.71 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 125.741 1.617 . . . . 0.0 111.385 -170.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.41 -21.76 11.42 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.797 2.332 . . . . 0.0 114.331 -167.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.02 -34.79 75.81 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.156 1.344 . . . . 0.0 111.567 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.42 -41.66 84.48 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.777 1.231 . . . . 0.0 110.874 175.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.4 tp -67.38 -33.59 75.51 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.478 1.911 . . . . 0.0 111.455 174.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 68.3 m -64.26 -50.45 67.91 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.428 1.491 . . . . 0.0 110.41 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -67.59 -40.5 84.79 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.918 0.487 . . . . 0.0 111.622 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -56.07 -56.58 19.1 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.484 1.513 . . . . 0.0 112.235 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -71.13 -27.46 63.59 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.6 m -73.3 0.51 11.8 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -68.75 -19.59 64.34 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.169 -0.957 . . . . 0.0 112.597 164.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 14.0 mm -95.05 -55.29 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.104 0.961 . . . . 0.0 111.137 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -135.68 -109.68 1.02 Allowed Glycine 0 N--CA 1.468 0.779 0 C-N-CA 125.906 1.717 . . . . 0.0 110.372 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -152.84 121.99 6.63 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.213 1.005 . . . . 0.0 111.097 173.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 49.1 t -73.4 129.95 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 170.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.61 -24.05 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 170.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -152.78 135.7 15.51 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.463 1.505 . . . . 0.0 110.257 172.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -128.09 148.79 50.58 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.014 1.326 . . . . 0.0 110.598 160.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -145.53 134.98 23.15 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.6 1.16 . . . . 0.0 112.13 -172.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 59.2 mt . . . . . 0 N--CA 1.483 1.201 0 C-N-CA 125.64 1.576 . . . . 0.0 110.165 170.923 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 120.334 0.111 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -145.61 -179.08 21.61 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 124.383 0.992 . . . . 0.0 114.905 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 12.7 m -141.55 148.56 39.53 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.361 1.465 . . . . 0.0 109.087 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 19.6 t -141.25 147.15 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.263 1.025 . . . . 0.0 110.472 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.04 131.1 47.31 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.589 1.556 . . . . 0.0 110.976 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -102.53 161.69 13.52 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.51 1.524 . . . . 0.0 111.196 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 54.1 p -70.52 0.21 7.21 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.559 1.543 . . . . 0.0 113.893 166.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -141.75 162.21 36.03 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.432 1.893 . . . . 0.0 112.108 -165.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 12.5 m -132.67 13.42 4.45 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -132.06 -36.5 1.17 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.068 1.347 . . . . 0.0 112.661 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -66.51 -21.53 66.17 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.748 0.819 . . . . 0.0 112.397 167.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.1 m -63.87 -28.17 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.507 1.523 . . . . 0.0 112.907 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -74.3 -49.64 22.21 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.55 1.14 . . . . 0.0 111.449 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 23.4 ptt-85 -74.37 -11.86 60.36 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.7 -64.5 0.88 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.939 0.895 . . . . 0.0 110.835 160.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 66.3 mt -62.19 -32.83 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.938 0.895 . . . . 0.0 112.449 -171.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 35.0 ttm105 -57.21 -22.69 42.67 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 173.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -98.06 -11.14 23.25 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.41 1.084 . . . . 0.0 112.943 175.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -123.56 -21.29 5.3 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -165.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -66.2 120.44 13.23 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 120.415 1.461 . . . . 0.0 109.559 172.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 90.06 0.59 77.35 Favored Glycine 0 N--CA 1.473 1.127 0 CA-C-O 117.884 -1.509 . . . . 0.0 115.146 -168.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.8 109.46 1.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.986 1.893 . . . . 0.0 109.482 167.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -55.97 119.89 6.57 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 157.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -148.87 118.35 6.94 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.215 1.406 . . . . 0.0 108.259 -172.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.38 44.07 18.87 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-O 122.398 1.094 . . . . 0.0 110.212 -163.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 71.55 0.52 3.51 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 128.066 2.546 . . . . 0.0 116.253 173.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 30.1 mmt85 -135.04 148.69 49.97 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.07 1.348 . . . . 0.0 112.105 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -64.54 117.07 6.83 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.194 -0.941 . . . . 0.0 113.234 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.62 HG22 ' HB2' ' A' ' 168' ' ' LEU . 0.7 OUTLIER -68.26 153.56 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.635 0.774 . . . . 0.0 110.684 156.555 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -137.53 157.37 46.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.533 1.533 . . . . 0.0 107.857 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.12 139.24 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.528 1.058 . . . . 0.0 111.681 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 . . . . . 0 CA--C 1.538 0.481 0 C-N-CA 125.828 1.651 . . . . 0.0 108.84 169.347 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.7 m . . . . . 0 CA--C 1.54 0.58 0 CA-C-O 120.993 0.425 . . . . 0.0 111.917 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.9 pt -130.92 150.2 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.976 1.71 . . . . 0.0 110.976 -170.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -110.0 138.88 45.76 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.503 1.521 . . . . 0.0 111.197 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 44.8 t -126.79 131.04 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.923 1.689 . . . . 0.0 108.786 -169.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.32 -164.2 7.2 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.976 1.751 . . . . 0.0 113.283 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -67.52 -14.96 63.39 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 118.062 2.615 . . . . 0.0 118.062 -157.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.3 mp 51.03 -112.71 0.65 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.537 1.535 . . . . 0.0 109.857 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 71.2 p -122.87 153.39 39.69 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.056 2.143 . . . . 0.0 109.312 154.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -57.12 -28.84 63.05 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -175.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -91.73 -0.98 57.59 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.821 2.048 . . . . 0.0 114.114 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 85.8 p -67.47 160.91 26.56 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.45 152.67 60.97 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 125.799 1.64 . . . . 0.0 111.593 -169.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.79 -18.53 11.7 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.151 2.567 . . . . 0.0 114.647 -165.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.43 -35.48 81.07 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.519 1.054 . . . . 0.0 111.112 172.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -69.64 -36.86 76.48 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.773 1.229 . . . . 0.0 111.399 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.8 mt -67.98 -31.89 71.91 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-O 118.685 -0.674 . . . . 0.0 112.326 169.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 59.7 m -67.16 -50.89 59.51 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.969 0.804 . . . . 0.0 109.516 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -58.13 -38.8 77.23 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.669 0.788 . . . . 0.0 112.293 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -65.56 -63.25 1.14 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.343 1.457 . . . . 0.0 112.236 176.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.16 -33.95 70.5 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -173.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.25 -3.39 26.55 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -172.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -65.47 -18.17 65.12 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 120.967 -1.083 . . . . 0.0 112.739 169.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 29.8 mm -78.53 -27.4 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.616 1.567 . . . . 0.0 112.31 174.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 139.25 169.45 11.58 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.994 1.759 . . . . 0.0 110.755 -158.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -57.72 106.54 0.36 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -164.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 53.9 t -71.05 131.36 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 151.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.29 -26.5 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 171.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 50.7 ttt-85 -162.74 110.47 1.28 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.856 0.463 . . . . 0.0 110.825 -170.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.72 151.74 19.84 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.192 0.997 . . . . 0.0 110.259 161.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -153.23 125.28 7.93 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.911 0.884 . . . . 0.0 111.615 -170.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mt . . . . . 0 N--CA 1.482 1.161 0 C-N-CA 125.565 1.546 . . . . 0.0 111.354 -179.125 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -175.92 -152.46 9.56 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.8 p -143.01 159.83 41.5 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.124 1.77 . . . . 0.0 112.172 -172.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 18.8 t -140.42 140.89 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.294 1.038 . . . . 0.0 110.306 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -128.86 127.68 42.35 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.383 1.473 . . . . 0.0 109.981 -172.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -110.8 170.71 7.92 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.53 1.932 . . . . 0.0 109.746 -174.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 80.9 p -81.47 0.07 39.45 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -139.07 155.08 48.19 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.831 1.253 . . . . 0.0 114.088 -167.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 66.4 p -108.38 4.73 24.73 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.775 1.63 . . . . 0.0 113.68 -177.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -120.37 -46.04 2.41 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.634 1.174 . . . . 0.0 112.783 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -63.53 -22.04 66.67 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.313 -0.867 . . . . 0.0 113.039 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 213' ' ' VAL . 2.3 m -61.34 -29.74 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.896 2.079 . . . . 0.0 113.363 173.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -74.48 -49.46 22.13 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.026 0.83 . . . . 0.0 110.541 166.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -58.4 -28.28 65.05 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.797 1.239 . . . . 0.0 113.399 -174.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.2 -59.57 5.21 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.23 1.412 . . . . 0.0 112.291 168.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 51.6 mt -66.39 -31.25 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.22 1.008 . . . . 0.0 112.282 -170.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -58.91 -5.77 0.67 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 171.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -133.07 5.68 3.86 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.52 1.128 . . . . 0.0 114.038 172.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -123.11 -22.14 5.25 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.01 120.64 13.98 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 121.327 1.876 . . . . 0.0 110.653 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 92.16 0.83 70.38 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-O 118.025 -1.43 . . . . 0.0 115.119 -169.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.42 107.47 0.79 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.953 1.877 . . . . 0.0 109.926 168.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -52.02 123.95 11.68 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.957 161.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -147.97 120.83 8.72 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.022 1.329 . . . . 0.0 108.709 -172.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 50.5 mtt 60.37 28.07 17.68 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.154 0.982 . . . . 0.0 112.159 -169.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.6 t70 92.27 -0.06 0.13 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 129.449 3.1 . . . . 0.0 115.419 173.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 42.9 mmt180 -136.69 150.48 48.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.751 1.221 . . . . 0.0 112.184 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -65.12 111.71 3.05 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.862 -1.149 . . . . 0.0 112.555 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.47 152.0 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 O-C-N 121.169 -0.957 . . . . 0.0 109.761 151.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -132.12 156.66 45.96 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.145 1.378 . . . . 0.0 108.429 170.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.7 p -150.44 127.0 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.517 0.675 . . . . 0.0 112.113 -169.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 125.481 1.512 . . . . 0.0 108.403 175.917 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 6.7 pt -139.22 150.94 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.69 1.596 . . . . 0.0 109.784 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -122.95 143.77 49.69 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.216 1.406 . . . . 0.0 111.986 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.0 t -124.34 116.82 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.226 1.81 . . . . 0.0 108.193 -174.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.06 -25.43 59.77 Favored Glycine 0 N--CA 1.475 1.24 0 C-N-CA 123.542 0.591 . . . . 0.0 114.403 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -162.17 151.22 15.48 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.742 2.017 . . . . 0.0 108.571 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -173.16 11.19 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 126.054 1.742 . . . . 0.0 114.917 -171.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 34.9 m 86.42 111.45 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 128.739 2.816 . . . . 0.0 109.403 -165.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -62.64 -17.43 60.36 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -83.42 -0.35 49.59 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.703 1.601 . . . . 0.0 113.529 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 10.0 t -67.66 167.56 12.9 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.834 -1.166 . . . . 0.0 113.797 175.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 44.8 p -135.7 153.32 77.32 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 125.972 1.709 . . . . 0.0 110.416 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.56 -23.96 26.54 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.566 2.177 . . . . 0.0 113.13 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.28 -37.19 77.75 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.885 0.766 . . . . 0.0 111.712 172.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.47 -35.37 68.21 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.507 -0.746 . . . . 0.0 111.424 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 20.9 mt -62.91 -35.85 81.44 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-O 118.807 -0.616 . . . . 0.0 112.334 166.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 74.7 m -67.93 -45.83 73.22 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.222 0.919 . . . . 0.0 110.337 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.7 -15.79 54.32 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.811 1.245 . . . . 0.0 113.502 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -96.5 -57.94 2.18 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.285 1.834 . . . . 0.0 111.896 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -71.6 -34.2 69.65 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 3.7 t -73.16 -15.92 61.45 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -159.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -64.35 -17.9 64.15 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 35.8 mm -59.8 -24.18 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.114 1.365 . . . . 0.0 112.641 173.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 167.52 -72.05 0.16 Allowed Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.926 1.25 . . . . 0.0 111.467 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -160.28 118.39 2.6 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.965 1.306 . . . . 0.0 111.158 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.29 137.93 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 165.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.5 m -110.27 -16.67 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -159.91 158.46 30.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.739 1.215 . . . . 0.0 111.881 176.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -160.06 149.13 17.5 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.939 1.696 . . . . 0.0 111.696 174.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -149.58 152.54 35.66 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.619 1.967 . . . . 0.0 111.641 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 26.6 mm . . . . . 0 N--CA 1.479 1.019 0 C-N-CA 126.145 1.778 . . . . 0.0 107.844 170.292 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 3.0 mpp? . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 121.256 0.55 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -110.43 158.97 14.11 Favored Glycine 0 N--CA 1.468 0.806 0 C-N-CA 124.656 1.122 . . . . 0.0 113.458 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.2 m -141.97 142.4 32.97 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.887 1.675 . . . . 0.0 108.032 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.7 t -142.4 149.97 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.972 0.909 . . . . 0.0 109.433 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -132.65 129.72 39.23 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.891 0.876 . . . . 0.0 111.523 -176.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -114.9 172.7 6.89 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.243 1.817 . . . . 0.0 111.102 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.8 p -86.85 -11.57 50.44 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -149.35 127.96 12.38 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 116.749 2.129 . . . . 0.0 116.749 -169.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 33.0 p -73.8 2.29 8.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 128.116 2.566 . . . . 0.0 116.064 -174.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -114.07 -36.76 4.64 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.269 1.428 . . . . 0.0 111.693 169.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.68 -27.68 69.09 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.5 -0.75 . . . . 0.0 112.775 173.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.9 m -59.55 -33.43 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 171.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -74.17 -46.61 41.15 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.958 0.799 . . . . 0.0 110.214 172.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -57.88 -29.7 65.25 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.673 0.789 . . . . 0.0 112.829 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.95 -68.57 0.35 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.778 1.231 . . . . 0.0 111.492 167.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 64.7 mt -61.99 -34.83 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.43 -0.793 . . . . 0.0 112.193 -167.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -58.69 -12.78 4.59 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.754 1.222 . . . . 0.0 114.187 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -116.62 -1.99 12.04 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.719 1.608 . . . . 0.0 112.888 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -128.91 -23.21 3.11 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.67 120.57 11.45 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 120.498 1.499 . . . . 0.0 109.832 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 95.68 0.48 62.46 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-O 118.11 -1.383 . . . . 0.0 115.725 -170.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.96 108.46 1.04 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.721 1.76 . . . . 0.0 109.973 169.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -58.12 124.17 18.46 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.788 -0.57 . . . . 0.0 109.921 158.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -150.38 110.97 4.24 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.852 1.261 . . . . 0.0 108.912 -159.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 49.8 mtt 57.91 23.36 9.72 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.585 1.154 . . . . 0.0 113.487 -169.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 19.8 t70 101.16 -11.61 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 130.811 3.644 . . . . 0.0 115.24 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -116.29 147.0 41.97 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 119.978 1.263 . . . . 0.0 111.801 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -68.09 112.06 4.83 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.308 1.443 . . . . 0.0 112.229 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.5 pt -61.21 141.69 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.473 1.033 . . . . 0.0 111.609 166.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -138.37 129.76 27.51 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.644 1.178 . . . . 0.0 109.158 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.2 126.81 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 123.626 0.771 . . . . 0.0 110.713 -164.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 52.7 ttt85 . . . . . 0 CA--C 1.534 0.352 0 C-N-CA 126.539 1.936 . . . . 0.0 108.768 170.937 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 CA--C 1.541 0.608 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -131.15 142.83 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.233 0.613 . . . . 0.0 110.024 158.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -111.93 142.48 44.28 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.71 1.604 . . . . 0.0 111.166 -174.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.3 t -144.61 121.32 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.161 0.984 . . . . 0.0 109.989 174.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -137.75 19.56 3.32 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.88 1.229 . . . . 0.0 115.602 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -128.57 20.02 6.16 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.305 1.442 . . . . 0.0 112.707 -171.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.455 ' HB3' HG22 ' A' ' 230' ' ' ILE . 1.3 pp -96.54 -175.88 3.45 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 126.984 2.114 . . . . 0.0 111.245 -174.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 48.4 m -79.81 121.5 25.47 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.782 0.833 . . . . 0.0 109.407 168.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -66.54 -11.56 53.47 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -170.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -81.38 -10.97 59.42 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.956 1.303 . . . . 0.0 113.588 171.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 91.5 p -77.66 142.6 38.75 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.6 -0.688 . . . . 0.0 111.664 172.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 68.2 p -102.52 163.63 17.25 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 125.067 1.347 . . . . 0.0 111.205 -171.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -64.54 -26.8 61.91 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.499 2.133 . . . . 0.0 112.931 171.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -69.34 -40.03 77.81 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.472 1.033 . . . . 0.0 111.729 171.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -66.93 -36.58 82.56 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.817 0.847 . . . . 0.0 111.64 175.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 45.7 mt -66.21 -32.66 74.22 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.547 -0.74 . . . . 0.0 112.725 166.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 81.8 m -67.1 -48.22 68.83 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.686 1.13 . . . . 0.0 109.965 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.05 -27.84 69.18 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -78.69 -58.96 2.98 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.53 1.532 . . . . 0.0 112.106 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -71.1 -37.83 72.39 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.65 -1.67 19.89 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -176.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -55.87 -26.87 49.09 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.797 1.639 . . . . 0.0 112.165 164.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.4 mm -75.87 -30.7 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.815 1.646 . . . . 0.0 112.88 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 166.86 -103.84 0.21 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.783 1.182 . . . . 0.0 112.181 -165.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -135.01 106.35 6.77 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.991 0.916 . . . . 0.0 113.396 -175.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 56.2 t -80.96 135.68 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 153.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.33 -24.72 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -157.88 88.66 0.98 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.547 0.739 . . . . 0.0 112.235 -170.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -91.18 140.97 29.3 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.812 -1.18 . . . . 0.0 111.709 168.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -153.28 121.44 6.17 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.919 1.287 . . . . 0.0 112.201 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 20.3 mt . . . . . 0 N--CA 1.484 1.252 0 C-N-CA 125.459 1.504 . . . . 0.0 111.08 174.357 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 26.8 ptm . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 120.933 0.397 . . . . 0.0 111.74 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 169.6 -143.45 7.94 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.932 0.777 . . . . 0.0 113.002 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 25.0 p -137.87 160.87 38.12 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.986 0.914 . . . . 0.0 113.272 -162.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.3 t -136.03 102.42 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.126 1.371 . . . . 0.0 108.056 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -88.53 122.85 32.45 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.205 1.002 . . . . 0.0 110.457 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -90.02 176.03 6.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.86 1.664 . . . . 0.0 109.814 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 72.4 p -68.09 0.16 3.91 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 168.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 27.3 m120 85.77 2.91 0.6 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.743 2.817 . . . . 0.0 114.977 165.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.7 t -110.8 -168.53 1.32 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.462 1.505 . . . . 0.0 112.136 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -34.08 -38.37 0.06 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 130.531 3.533 . . . . 0.0 117.28 -164.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -52.15 -33.69 41.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.101 1.76 . . . . 0.0 112.733 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.0 p -68.83 -37.41 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.107 1.363 . . . . 0.0 112.952 -169.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -75.16 -52.07 11.86 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.734 1.214 . . . . 0.0 112.382 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -74.0 -18.47 60.85 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.654 1.182 . . . . 0.0 114.057 -171.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.47 -60.03 4.11 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.065 0.946 . . . . 0.0 111.911 170.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 27.9 mt -65.46 -28.73 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.706 0.803 . . . . 0.0 112.41 -171.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -28.63 37.53 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.324 1.05 . . . . 0.0 112.511 169.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -98.24 -11.31 22.8 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.443 1.097 . . . . 0.0 113.432 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -126.32 -20.12 4.51 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -164.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -62.42 120.79 11.73 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 120.038 1.29 . . . . 0.0 109.627 169.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 95.1 0.52 63.5 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-O 118.163 -1.354 . . . . 0.0 115.334 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.15 107.06 0.81 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.757 1.778 . . . . 0.0 110.673 170.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -57.22 107.32 0.41 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 154.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -129.74 110.66 11.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.323 1.049 . . . . 0.0 108.921 -167.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 48.2 ttm 53.88 43.92 30.22 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.923 0.889 . . . . 0.0 110.816 -168.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.8 t70 86.76 0.21 0.56 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 128.091 2.557 . . . . 0.0 116.146 170.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -136.19 135.89 39.5 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.622 1.101 . . . . 0.0 112.542 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -68.17 102.55 1.37 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.546 1.538 . . . . 0.0 113.541 -176.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.455 HG22 ' HB3' ' A' ' 168' ' ' LEU . 0.9 OUTLIER -56.51 151.25 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.117 0.967 . . . . 0.0 111.456 164.667 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -148.01 135.41 20.61 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.083 1.353 . . . . 0.0 108.921 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -156.94 137.08 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.217 1.407 . . . . 0.0 109.867 -165.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 . . . . . 0 CA--C 1.536 0.438 0 C-N-CA 124.855 1.262 . . . . 0.0 109.579 171.148 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.5 p . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 43.5 pt -137.26 138.04 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.647 1.179 . . . . 0.0 110.06 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -98.99 148.7 23.73 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.907 1.283 . . . . 0.0 109.489 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.6 t -126.4 131.67 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.537 1.535 . . . . 0.0 108.759 -172.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -74.17 -154.57 3.59 Favored Glycine 0 N--CA 1.474 1.192 0 C-N-CA 125.543 1.544 . . . . 0.0 112.93 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -55.48 -42.73 74.77 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -166.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 57.34 -169.44 0.11 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 128.061 2.545 . . . . 0.0 115.81 165.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.2 t -76.39 73.14 3.16 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.258 1.823 . . . . 0.0 110.416 166.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -68.05 -9.29 44.86 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -74.37 -12.42 60.52 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.113 1.365 . . . . 0.0 113.132 167.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 3.8 t -101.3 151.06 22.34 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.274 1.03 . . . . 0.0 113.523 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 17.6 p -81.94 152.67 69.06 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 126.444 1.898 . . . . 0.0 111.457 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.36 -25.79 80.66 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.213 2.609 . . . . 0.0 115.482 -173.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -67.21 -17.03 64.65 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.865 1.211 . . . . 0.0 113.439 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -70.74 -33.99 71.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.29 1.036 . . . . 0.0 111.25 170.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.1 mt -74.33 -32.48 62.83 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.336 -0.84 . . . . 0.0 111.782 167.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 31.1 m -62.75 -51.34 67.52 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.731 1.151 . . . . 0.0 110.264 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.53 -34.12 75.0 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.336 0.516 . . . . 0.0 112.119 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -67.0 -65.04 0.73 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.608 1.563 . . . . 0.0 111.329 176.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -71.24 -29.0 64.58 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -173.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.4 t -73.25 -23.63 60.36 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -173.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -67.34 -10.89 55.46 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 29.5 mm -69.89 -31.31 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.439 1.496 . . . . 0.0 112.59 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.66 42.01 0.03 OUTLIER Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.242 0.925 . . . . 0.0 114.221 -172.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 83.4 tttt 79.34 124.45 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 128.708 2.803 . . . . 0.0 113.606 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.7 149.32 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 126.159 1.784 . . . . 0.0 108.097 164.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 4.3 m -110.27 -18.27 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -157.32 147.29 20.65 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.846 0.858 . . . . 0.0 111.245 -175.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -154.48 144.39 21.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.729 1.611 . . . . 0.0 110.559 170.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -155.11 153.07 30.29 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 122.096 0.95 . . . . 0.0 113.262 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 51.0 mm . . . . . 0 CA--C 1.544 0.745 0 C-N-CA 127.3 2.24 . . . . 0.0 110.543 171.868 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 22.8 ptp . . . . . 0 N--CA 1.475 0.801 0 CA-C-O 120.58 0.228 . . . . 0.0 111.527 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -156.47 175.22 34.16 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.195 1.379 . . . . 0.0 113.197 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 27.5 m -148.17 147.05 29.02 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.148 1.379 . . . . 0.0 109.889 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.1 t -139.0 141.55 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.448 1.099 . . . . 0.0 109.541 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -123.93 131.64 53.6 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.603 1.161 . . . . 0.0 111.509 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -102.2 173.81 6.2 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.306 1.842 . . . . 0.0 110.426 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 81.3 p -68.88 0.65 4.15 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 176.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 93.04 52.48 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 128.169 2.587 . . . . 0.0 113.606 161.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.7 t -161.4 -165.35 1.29 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.947 0.899 . . . . 0.0 112.872 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -57.86 -10.37 1.69 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.097 2.159 . . . . 0.0 115.234 -168.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -52.07 -34.11 42.25 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.177 1.391 . . . . 0.0 111.729 162.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.54 -39.48 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.742 1.617 . . . . 0.0 111.427 176.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.65 -55.03 6.32 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.323 1.049 . . . . 0.0 111.919 171.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -59.11 -29.71 67.58 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.183 1.393 . . . . 0.0 113.706 -172.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.26 -60.59 3.57 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.931 0.892 . . . . 0.0 112.681 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 3.5 mp -68.79 -22.36 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.088 -1.008 . . . . 0.0 112.803 -168.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 16.5 mmt-85 -54.23 -27.91 37.73 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.401 0.68 . . . . 0.0 112.773 168.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -95.5 -17.71 21.24 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.795 1.238 . . . . 0.0 112.817 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -122.46 -18.87 6.57 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -161.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -58.24 120.21 8.27 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 120.585 1.539 . . . . 0.0 110.276 175.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 79.94 0.3 84.93 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.277 -1.291 . . . . 0.0 116.094 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.58 97.67 2.18 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 120.082 1.941 . . . . 0.0 111.377 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -48.92 135.63 15.32 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.028 0.931 . . . . 0.0 112.532 176.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -143.87 116.9 8.88 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.356 1.062 . . . . 0.0 109.852 -162.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 16.8 ttt 59.89 34.36 21.69 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.391 1.077 . . . . 0.0 111.156 -168.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 67.67 0.68 2.33 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.888 2.075 . . . . 0.0 114.095 -174.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -112.26 165.37 12.23 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.297 2.239 . . . . 0.0 111.423 -171.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -66.35 168.91 8.07 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.342 1.057 . . . . 0.0 113.144 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 41.8 pt -158.3 146.76 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 1 C-N-CA 132.204 4.201 . . . . 0.0 107.058 171.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -149.49 141.94 24.3 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.712 1.605 . . . . 0.0 107.219 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.8 p -150.44 137.38 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 120.068 1.303 . . . . 0.0 113.632 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 . . . . . 0 CA--C 1.541 0.626 0 C-N-CA 126.572 1.949 . . . . 0.0 110.931 176.993 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 121.06 0.457 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 8.0 pt -142.36 138.24 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.243 -0.911 . . . . 0.0 110.9 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -128.39 134.41 48.82 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.166 1.786 . . . . 0.0 109.951 -175.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.65 134.24 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.875 1.27 . . . . 0.0 109.979 -156.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.85 -116.23 0.12 Allowed Glycine 0 N--CA 1.478 1.455 0 C-N-CA 127.055 2.264 . . . . 0.0 115.002 -170.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -68.25 -62.59 1.33 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.71 1.255 . . . . 0.0 111.999 -176.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 62.92 5.03 1.66 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.533 2.333 . . . . 0.0 117.166 167.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 58.7 m 74.51 98.25 0.07 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 127.416 2.286 . . . . 0.0 108.643 -162.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -65.03 -16.18 63.16 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -170.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.15 0.38 51.18 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.883 1.673 . . . . 0.0 114.0 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 95.6 p -70.67 167.14 19.29 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 172.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 18.7 p -123.9 151.5 64.86 Favored Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 124.936 1.294 . . . . 0.0 112.392 -170.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.35 -17.44 16.68 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.347 2.698 . . . . 0.0 115.385 -169.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.8 -36.9 81.25 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.966 1.257 . . . . 0.0 111.953 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -72.98 -35.78 66.95 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.284 -0.885 . . . . 0.0 111.536 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.3 mt -64.07 -33.39 75.65 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.119 0.968 . . . . 0.0 111.903 168.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.4 m -65.57 -49.72 67.77 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.009 0.822 . . . . 0.0 109.666 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.35 -41.08 98.3 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.484 0.584 . . . . 0.0 112.008 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.68 -56.33 20.83 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.145 1.378 . . . . 0.0 112.29 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.23 -43.44 67.28 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.4 t -73.62 -12.6 60.8 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -171.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -62.59 -16.48 56.58 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.656 1.116 . . . . 0.0 113.101 170.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 16.3 mm -72.98 -33.0 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.751 1.22 . . . . 0.0 111.976 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.44 -84.49 0.08 OUTLIER Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.221 1.391 . . . . 0.0 112.517 -170.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -157.3 103.48 1.99 Allowed 'General case' 0 CA--C 1.55 0.942 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -170.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 40.4 t -77.35 136.81 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 156.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.0 p -104.86 -20.23 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.282 1.033 . . . . 0.0 112.813 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 30.8 ttm-85 -164.38 139.3 5.68 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.369 1.468 . . . . 0.0 111.706 173.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -129.67 147.12 51.43 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.864 1.266 . . . . 0.0 111.259 164.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -159.11 152.29 22.37 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 174.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 126.564 1.946 . . . . 0.0 111.224 171.888 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -114.84 168.89 12.67 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.887 1.708 . . . . 0.0 113.82 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 21.8 m -141.09 144.59 35.0 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.916 1.286 . . . . 0.0 109.838 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.8 t -137.15 136.87 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.8 0.84 . . . . 0.0 109.185 171.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -104.58 119.8 39.82 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.079 1.751 . . . . 0.0 109.205 173.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.433 ' HB2' HG12 ' A' ' 213' ' ' VAL . 9.2 m-85 -93.09 176.77 6.29 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.301 1.44 . . . . 0.0 109.034 163.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 45.6 p -97.4 -15.73 20.54 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -150.29 126.41 10.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.182 0.993 . . . . 0.0 113.226 -172.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.4 p -46.89 -53.58 11.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.68 1.992 . . . . 0.0 114.261 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -60.05 -28.58 67.89 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.89 -35.45 67.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.498 1.119 . . . . 0.0 112.644 173.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.433 HG12 ' HB2' ' A' ' 207' ' ' PHE . 0.6 OUTLIER -69.79 -40.52 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.013 0.925 . . . . 0.0 112.272 178.394 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.52 -47.53 66.73 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.577 -176.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -66.34 -18.29 65.27 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -70.84 -62.87 1.23 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.696 0.798 . . . . 0.0 110.475 167.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 60.8 mt -60.96 -33.86 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.446 1.099 . . . . 0.0 112.667 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -52.0 -19.9 2.1 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.971 1.709 . . . . 0.0 114.02 170.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -114.26 -6.79 12.99 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.849 1.66 . . . . 0.0 112.815 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -126.84 -22.72 3.8 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -166.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.88 120.71 13.04 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 120.916 1.689 . . . . 0.0 109.637 173.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 98.15 0.28 58.56 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-O 118.219 -1.323 . . . . 0.0 115.2 -168.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.33 108.23 1.26 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.718 1.759 . . . . 0.0 110.218 170.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -56.57 125.14 20.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.273 0.558 . . . . 0.0 109.772 154.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -149.59 110.84 4.41 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.319 1.447 . . . . 0.0 108.076 -159.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 24.1 mmt 55.87 32.95 20.66 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.626 0.77 . . . . 0.0 112.192 -169.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 87.49 0.37 0.47 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.888 2.875 . . . . 0.0 115.985 174.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.49 152.69 50.82 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.806 1.184 . . . . 0.0 112.043 173.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -77.48 129.12 35.3 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.8 -1.187 . . . . 0.0 114.104 -167.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.3 pt -75.58 133.52 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 120.997 -1.064 . . . . 0.0 110.487 164.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -118.24 144.47 45.75 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 166.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.3 p -150.85 140.19 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 120.162 1.347 . . . . 0.0 112.677 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 . . . . . 0 C--O 1.234 0.276 0 C-N-CA 126.113 1.765 . . . . 0.0 110.255 171.716 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 52.9 m . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 6.8 pt -130.57 151.74 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.815 1.646 . . . . 0.0 110.011 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -132.86 143.51 49.58 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.448 1.899 . . . . 0.0 109.717 -173.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.16 134.59 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 119.495 1.043 . . . . 0.0 111.177 -175.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.42 -71.83 1.03 Allowed Glycine 0 N--CA 1.473 1.161 0 C-N-CA 124.124 0.869 . . . . 0.0 113.657 -173.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -83.91 39.03 0.67 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.032 1.333 . . . . 0.0 114.245 -165.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.408 HD23 ' H ' ' A' ' 168' ' ' LEU . 0.5 OUTLIER -75.75 170.86 15.38 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.339 -1.476 . . . . 0.0 110.677 165.949 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 45.9 m -75.55 124.39 27.11 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.707 0.803 . . . . 0.0 109.06 167.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -70.18 -13.71 62.31 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -167.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -89.14 0.08 57.02 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 170.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 32.0 t -63.57 138.18 58.4 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 121.254 -0.904 . . . . 0.0 111.022 161.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 41.4 p -98.47 159.89 29.42 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 124.704 1.201 . . . . 0.0 110.728 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.16 -19.52 68.9 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.921 1.747 . . . . 0.0 112.486 167.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -69.16 -44.49 72.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 120.225 1.375 . . . . 0.0 111.2 170.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -59.14 -45.99 89.51 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.396 0.679 . . . . 0.0 110.755 172.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -27.37 68.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.999 0.92 . . . . 0.0 113.341 173.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 52.2 m -76.48 -47.77 21.81 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.52 1.055 . . . . 0.0 110.0 176.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -59.02 -31.1 68.52 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.718 1.145 . . . . 0.0 112.168 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -70.87 -67.88 0.47 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.389 1.476 . . . . 0.0 112.005 174.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -71.14 -35.04 71.56 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.5 t -73.33 -10.46 59.78 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -170.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -62.04 -17.25 56.77 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.223 -0.923 . . . . 0.0 113.343 171.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.66 -21.84 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 125.714 1.606 . . . . 0.0 112.667 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 169.94 -90.24 0.09 OUTLIER Glycine 0 N--CA 1.467 0.709 0 C-N-CA 125.055 1.312 . . . . 0.0 110.789 -172.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -159.63 120.31 3.11 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.118 0.967 . . . . 0.0 112.693 174.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.4 t -72.38 127.72 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 162.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.37 -34.03 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 118.691 0.678 . . . . 0.0 110.554 175.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -172.33 145.68 1.72 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.385 1.474 . . . . 0.0 112.045 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -129.23 171.26 12.63 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.821 2.049 . . . . 0.0 110.706 161.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -145.95 -60.18 0.32 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.81 1.782 . . . . 0.0 115.81 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 3.9 mt . . . . . 0 N--CA 1.49 1.531 0 C-N-CA 127.712 2.405 . . . . 0.0 113.219 -178.88 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.28 158.82 19.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.237 1.399 . . . . 0.0 112.81 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.7 m -147.45 142.55 27.11 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.011 1.725 . . . . 0.0 108.745 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 10.8 t -142.95 142.09 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.119 0.967 . . . . 0.0 110.788 -177.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -119.95 139.08 53.0 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.213 1.805 . . . . 0.0 110.01 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -116.78 154.05 31.36 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.676 1.591 . . . . 0.0 112.383 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.3 p -81.07 -17.93 48.37 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.92 0.888 . . . . 0.0 113.102 171.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -102.11 173.03 6.56 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.265 1.426 . . . . 0.0 113.061 -169.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 65.3 p -107.08 -101.1 0.35 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.915 1.686 . . . . 0.0 111.954 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -60.65 -22.16 63.53 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.739 1.216 . . . . 0.0 113.592 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -67.74 -18.04 64.76 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.072 0.949 . . . . 0.0 113.384 173.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.47 -28.99 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.326 0.966 . . . . 0.0 112.033 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.25 -45.96 44.61 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.44 -0.788 . . . . 0.0 110.843 167.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -52.88 -27.35 18.15 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.633 1.973 . . . . 0.0 114.112 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.59 -71.76 0.17 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.023 1.329 . . . . 0.0 110.929 165.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 36.4 mt -54.62 -44.33 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.323 1.449 . . . . 0.0 112.451 -172.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -64.84 0.35 1.21 Allowed 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 176.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -118.31 -1.41 11.31 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.846 1.659 . . . . 0.0 112.566 167.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -122.96 -14.0 7.71 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.132 1.773 . . . . 0.0 114.136 -176.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -48.68 120.96 4.12 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.338 1.455 . . . . 0.0 110.294 166.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 88.89 0.81 80.81 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-O 118.129 -1.373 . . . . 0.0 115.41 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.68 105.19 0.42 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.653 1.727 . . . . 0.0 111.507 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -55.98 110.43 0.74 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 152.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -127.54 110.8 13.09 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.466 1.106 . . . . 0.0 109.317 -170.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 89.9 mtp 55.55 36.14 26.58 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.708 1.203 . . . . 0.0 111.974 -173.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 14.4 t70 98.46 0.14 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 129.216 3.007 . . . . 0.0 115.79 170.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -138.85 137.52 36.65 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.547 1.067 . . . . 0.0 112.592 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -77.0 102.07 6.29 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.211 1.404 . . . . 0.0 113.707 -170.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.3 pt -54.24 143.63 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.535 0.734 . . . . 0.0 112.766 172.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -132.76 135.38 45.69 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.508 1.523 . . . . 0.0 107.4 166.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.6 p -119.8 132.53 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.294 1.038 . . . . 0.0 111.81 -168.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 . . . . . 0 CA--C 1.536 0.416 0 C-N-CA 127.41 2.284 . . . . 0.0 109.576 167.565 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.6 pt -139.39 155.92 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 126.007 1.723 . . . . 0.0 111.321 -170.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -118.16 153.13 34.33 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.749 2.02 . . . . 0.0 111.391 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.1 t -138.89 128.4 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.528 1.531 . . . . 0.0 110.131 -174.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.84 -91.03 1.85 Allowed Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.034 1.302 . . . . 0.0 114.179 -173.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -84.26 35.68 0.55 Allowed 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -160.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -80.3 -5.68 56.7 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -169.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.4 p 91.05 127.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 131.018 3.727 . . . . 0.0 110.609 -167.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -70.64 -13.11 61.95 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -169.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -81.84 -5.49 58.26 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.375 1.47 . . . . 0.0 113.084 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.5 m -64.77 143.02 58.23 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.212 1.005 . . . . 0.0 113.089 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 51.7 p -105.67 157.37 34.75 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 125.108 1.363 . . . . 0.0 110.919 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.08 -31.42 65.38 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.385 2.057 . . . . 0.0 112.606 174.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.31 -39.35 92.37 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.115 0.871 . . . . 0.0 111.621 174.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.17 -29.55 66.47 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.705 -0.622 . . . . 0.0 112.626 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.8 mt -74.06 -27.43 60.91 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 164.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 98.4 m -71.46 -51.14 25.39 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.402 1.001 . . . . 0.0 110.035 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -63.06 -24.61 67.99 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.628 0.649 . . . . 0.0 112.72 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.29 -69.14 0.5 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.54 1.536 . . . . 0.0 111.585 174.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -65.31 -32.41 74.05 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.4 t -73.35 0.08 13.15 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -175.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -71.67 -18.78 62.16 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.318 -0.864 . . . . 0.0 113.179 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 19.4 mm -81.56 -55.0 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.118 0.967 . . . . 0.0 111.628 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -138.74 -96.31 0.36 Allowed Glycine 0 N--CA 1.467 0.75 0 C-N-CA 126.379 1.942 . . . . 0.0 109.878 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -156.03 128.61 7.78 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.898 0.879 . . . . 0.0 112.145 169.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.73 134.93 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 167.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.52 -42.62 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 118.275 0.489 . . . . 0.0 110.426 172.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -157.35 141.24 16.02 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 127.105 2.162 . . . . 0.0 109.529 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -117.69 158.99 23.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.889 1.276 . . . . 0.0 111.055 161.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -152.9 132.07 12.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.071 1.349 . . . . 0.0 111.37 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 3.2 mt . . . . . 0 N--CA 1.486 1.345 0 C-N-CA 125.051 1.34 . . . . 0.0 112.401 179.89 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -94.82 164.93 25.4 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 115.24 0.856 . . . . 0.0 115.24 -159.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.7 p -146.69 148.35 31.92 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.886 2.074 . . . . 0.0 110.201 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 13.7 t -147.57 136.68 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.674 0.79 . . . . 0.0 110.865 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -109.34 131.61 54.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.551 1.94 . . . . 0.0 109.547 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -103.25 158.34 16.39 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.059 1.343 . . . . 0.0 110.545 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 78.8 p -71.24 0.21 8.43 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.859 0.864 . . . . 0.0 112.899 170.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -138.92 -175.99 4.34 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.203 2.201 . . . . 0.0 112.011 -167.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.6 p -142.8 -66.34 0.38 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.584 1.554 . . . . 0.0 110.16 -174.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -53.15 -33.31 51.89 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 120.677 -1.265 . . . . 0.0 113.288 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.97 -24.85 61.66 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.318 1.447 . . . . 0.0 114.054 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.4 m -70.75 -31.91 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -169.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -56.95 -46.21 82.28 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.691 1.196 . . . . 0.0 111.146 166.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -71.68 -23.69 61.7 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.881 0.872 . . . . 0.0 112.25 -171.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.39 -61.99 1.98 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.992 0.917 . . . . 0.0 110.949 165.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 80.9 mt -59.78 -37.32 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.329 1.051 . . . . 0.0 112.123 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 47.1 ttm-85 -62.46 -4.86 2.1 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.493 1.517 . . . . 0.0 113.838 176.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -121.86 -3.62 9.17 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.498 1.919 . . . . 0.0 112.922 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -124.49 -21.92 4.78 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -173.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.92 120.69 12.43 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 120.22 1.373 . . . . 0.0 109.882 174.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 94.04 0.5 65.88 Favored Glycine 0 N--CA 1.471 1.032 0 CA-C-O 118.107 -1.385 . . . . 0.0 115.522 -170.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.8 108.54 0.87 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.756 1.778 . . . . 0.0 110.725 174.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -55.56 121.28 8.7 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.231 1.013 . . . . 0.0 110.715 161.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -152.53 110.86 3.71 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.511 1.924 . . . . 0.0 107.575 -158.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 16.8 ttt 54.08 35.86 23.28 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.581 0.705 . . . . 0.0 111.397 -164.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 76.05 0.22 3.26 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.394 2.677 . . . . 0.0 115.286 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -120.55 144.02 48.28 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.118 1.367 . . . . 0.0 110.749 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.99 111.49 15.25 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.584 -1.322 . . . . 0.0 112.764 -176.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.4 pt -54.18 148.07 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.472 -0.767 . . . . 0.0 110.928 164.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -137.62 137.52 38.55 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.226 1.01 . . . . 0.0 109.327 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.85 126.6 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 124.163 0.985 . . . . 0.0 109.659 -171.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 . . . . . 0 CA--C 1.532 0.285 0 C-N-CA 124.251 1.02 . . . . 0.0 110.05 164.521 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.8 p . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.59 161.48 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 121.915 -0.491 . . . . 0.0 112.012 -154.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -121.36 124.22 44.03 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.545 1.138 . . . . 0.0 110.688 170.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.27 134.94 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 127.175 2.19 . . . . 0.0 107.772 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.61 -133.47 0.4 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.886 1.232 . . . . 0.0 112.665 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -60.54 -28.19 68.24 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 -168.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . 0.292 2.5 pt? 28.52 -129.96 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.651 1.98 . . . . 0.0 113.192 -164.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.9 m -142.4 130.38 21.86 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.444 1.498 . . . . 0.0 109.133 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -64.5 -18.21 64.58 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -171.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -75.01 -3.38 32.06 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.563 1.545 . . . . 0.0 113.779 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 77.0 p -104.18 168.88 8.82 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.769 1.228 . . . . 0.0 114.124 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 52.1 p -137.06 165.68 32.92 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 126.922 2.089 . . . . 0.0 110.741 -171.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -59.86 -25.04 78.21 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.333 2.022 . . . . 0.0 113.199 169.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.13 -40.83 78.05 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.478 1.035 . . . . 0.0 111.8 172.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -62.72 -42.47 99.67 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.347 0.659 . . . . 0.0 111.097 173.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.6 mt -64.31 -31.3 72.45 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 118.49 -0.766 . . . . 0.0 112.515 170.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.8 m -68.69 -51.26 43.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.633 1.106 . . . . 0.0 110.272 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.95 -30.97 72.0 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.916 0.78 . . . . 0.0 112.26 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -70.85 -61.22 1.85 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.404 1.482 . . . . 0.0 111.718 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -71.34 -36.96 71.7 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.4 t -73.41 -1.52 18.62 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -173.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -73.44 -16.5 61.31 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.431 -0.793 . . . . 0.0 113.01 167.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.5 mm -80.97 -55.24 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 119.176 0.898 . . . . 0.0 111.144 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -134.57 -100.11 0.65 Allowed Glycine 0 N--CA 1.468 0.824 0 C-N-CA 126.0 1.762 . . . . 0.0 110.443 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -156.88 126.73 6.28 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.437 1.095 . . . . 0.0 111.88 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 20.5 t -76.56 134.5 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.01 0.924 . . . . 0.0 108.651 169.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.72 -15.52 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.57 1.148 . . . . 0.0 113.882 168.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.1 mtp85 -161.72 132.28 5.03 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.501 1.521 . . . . 0.0 110.874 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -129.23 145.7 51.29 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.582 1.953 . . . . 0.0 111.494 170.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -161.49 145.31 12.83 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.912 1.285 . . . . 0.0 111.651 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.6 mt . . . . . 0 N--CA 1.478 0.953 0 C-N-CA 124.499 1.119 . . . . 0.0 109.653 178.95 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 76.9 mtm . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.52 163.32 13.55 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 124.913 1.244 . . . . 0.0 115.164 -165.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.2 p -153.63 153.1 31.68 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.38 1.872 . . . . 0.0 111.352 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.97 147.15 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.046 1.338 . . . . 0.0 111.17 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -125.52 130.89 52.64 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.364 2.266 . . . . 0.0 110.068 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -108.42 165.09 11.78 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.136 1.374 . . . . 0.0 111.698 -174.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 40.5 p -76.51 0.27 20.5 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.546 1.538 . . . . 0.0 114.559 169.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -133.03 168.77 17.89 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.024 1.73 . . . . 0.0 111.796 -169.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.7 p -107.75 -62.62 1.41 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.728 1.211 . . . . 0.0 112.373 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -79.88 -35.34 38.19 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.896 1.678 . . . . 0.0 112.942 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -60.12 -24.44 64.68 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.7 1.2 . . . . 0.0 112.447 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.69 -29.51 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.462 1.905 . . . . 0.0 112.546 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.34 -38.67 63.19 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.335 -0.853 . . . . 0.0 111.058 172.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -67.63 -21.87 65.36 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.712 1.605 . . . . 0.0 112.969 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.86 -55.84 25.59 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.937 0.895 . . . . 0.0 111.39 164.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 73.5 mt -66.24 -28.54 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 O-C-N 121.292 -0.88 . . . . 0.0 111.851 -171.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -18.82 9.56 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.955 1.302 . . . . 0.0 113.987 171.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -106.62 -14.5 15.02 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.407 1.883 . . . . 0.0 112.109 176.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -122.4 -17.89 6.91 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.806 2.15 . . . . 0.0 116.806 -164.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -66.75 120.68 13.92 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 120.32 1.418 . . . . 0.0 109.991 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 92.52 0.69 69.5 Favored Glycine 0 N--CA 1.472 1.09 0 CA-C-O 117.714 -1.603 . . . . 0.0 115.081 -169.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.83 108.02 0.69 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 120.158 1.979 . . . . 0.0 111.081 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -52.03 122.95 9.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.647 0.779 . . . . 0.0 109.535 155.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -147.57 114.3 6.06 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.496 1.518 . . . . 0.0 107.734 -166.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 54.17 38.44 29.18 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.68 0.792 . . . . 0.0 111.335 -166.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 17.0 t70 84.24 0.61 0.93 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 128.526 2.731 . . . . 0.0 115.417 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.36 141.94 35.6 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.17 0.988 . . . . 0.0 112.663 -173.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -71.48 120.4 17.0 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -169.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.76 156.18 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.669 1.588 . . . . 0.0 112.019 154.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -140.18 156.17 46.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.918 1.687 . . . . 0.0 108.795 167.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 40.3 t -140.47 133.97 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.496 0.718 . . . . 0.0 111.733 -168.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 . . . . . 0 CA--C 1.539 0.521 0 C-N-CA 124.906 1.282 . . . . 0.0 109.854 170.918 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 112.019 -0.432 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.1 t 72.72 168.1 0.31 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.801 2.04 . . . . 0.0 113.614 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -163.06 153.33 16.13 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.948 1.699 . . . . 0.0 112.058 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 59.38 35.11 23.02 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.861 1.664 . . . . 0.0 113.43 171.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -78.28 156.89 29.42 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.757 1.223 . . . . 0.0 111.921 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -157.28 164.24 37.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.954 1.702 . . . . 0.0 112.152 -175.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -159.97 149.62 18.07 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.782 1.633 . . . . 0.0 111.405 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 35.2 m -166.37 156.29 11.91 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.504 1.922 . . . . 0.0 111.242 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 41.6 p -140.44 155.3 46.76 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.847 1.659 . . . . 0.0 110.912 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -145.33 160.03 42.14 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.348 1.459 . . . . 0.0 112.141 -170.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -161.69 157.13 23.97 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.405 1.482 . . . . 0.0 111.768 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -113.22 130.29 56.27 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.304 1.442 . . . . 0.0 109.614 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -160.41 150.44 17.98 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.876 1.27 . . . . 0.0 111.855 -168.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 18.3 m -134.94 155.96 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.549 1.54 . . . . 0.0 111.337 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -142.6 164.56 29.77 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.554 1.542 . . . . 0.0 112.029 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.2 mtm105 67.09 30.47 7.37 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.645 1.978 . . . . 0.0 113.153 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -80.46 93.97 6.12 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.37 1.068 . . . . 0.0 111.511 -171.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -168.07 166.3 13.1 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.814 2.046 . . . . 0.0 111.669 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 66.8 m 68.77 177.15 0.26 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.285 1.834 . . . . 0.0 114.152 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -144.22 27.9 1.39 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.437 1.895 . . . . 0.0 111.646 -176.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.0 t -138.5 153.34 48.77 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.988 1.315 . . . . 0.0 112.047 -169.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 9.9 pt -146.41 150.64 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 126.676 1.99 . . . . 0.0 109.806 -171.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -126.19 149.61 48.9 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.443 1.897 . . . . 0.0 109.709 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.03 118.76 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.907 0.883 . . . . 0.0 110.101 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.44 -3.21 37.96 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 116.967 1.547 . . . . 0.0 116.967 -160.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -142.77 22.61 1.95 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.102 1.451 . . . . 0.0 113.795 -170.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.6 pp -77.53 178.78 6.97 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.757 1.223 . . . . 0.0 111.832 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.3 t -73.56 133.87 43.64 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.77 0.828 . . . . 0.0 111.536 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -66.88 -8.9 32.45 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -87.63 -4.44 58.94 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.473 1.509 . . . . 0.0 113.622 170.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 7.7 t -69.12 139.76 54.73 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 121.064 -1.023 . . . . 0.0 112.509 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 27.4 p -102.6 162.19 20.95 Favored Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 125.589 1.556 . . . . 0.0 109.985 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -58.69 -32.27 96.55 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.139 1.892 . . . . 0.0 112.025 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.76 -38.65 91.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.092 0.957 . . . . 0.0 112.231 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.24 -44.01 97.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.782 0.719 . . . . 0.0 111.443 176.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 36.4 mt -70.45 -29.58 66.19 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.232 -0.89 . . . . 0.0 112.955 173.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 96.4 m -70.0 -51.24 33.95 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.24 0.927 . . . . 0.0 110.678 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -65.9 -24.32 66.82 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.868 0.758 . . . . 0.0 112.676 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -73.55 -66.21 0.72 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.046 1.738 . . . . 0.0 111.594 173.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -69.86 -33.97 72.97 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.8 t -73.45 -3.97 30.75 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -172.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -64.54 -18.49 64.89 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.117 -0.989 . . . . 0.0 112.831 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 30.1 mm -77.98 -23.5 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.856 1.263 . . . . 0.0 112.455 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 169.67 -90.16 0.09 OUTLIER Glycine 0 N--CA 1.468 0.802 0 C-N-CA 124.357 0.979 . . . . 0.0 112.437 -171.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -155.76 110.35 2.89 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.105 0.962 . . . . 0.0 112.845 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 37.4 t -73.66 132.0 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 157.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.37 -29.52 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 171.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -153.35 135.8 15.07 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.192 1.397 . . . . 0.0 110.056 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -115.92 159.58 21.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.595 1.158 . . . . 0.0 110.404 157.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -153.2 129.95 10.86 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.633 1.173 . . . . 0.0 112.081 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 6.0 mt -145.98 -48.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 124.664 1.186 . . . . 0.0 111.855 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 40.9 mm -71.18 139.11 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.783 0.833 . . . . 0.0 110.447 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 40.8 p -130.37 155.9 45.61 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.251 1.42 . . . . 0.0 110.757 -176.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.3 t -71.56 -11.95 61.12 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -100.74 -32.25 10.8 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.79 1.236 . . . . 0.0 112.647 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 73.22 24.09 76.19 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 116.138 1.215 . . . . 0.0 116.138 161.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -81.19 60.46 4.33 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.98 1.39 . . . . 0.0 114.309 -170.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 54.26 34.59 20.78 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 126.256 1.822 . . . . 0.0 114.169 164.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -62.89 -40.96 99.14 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -157.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 70.99 22.23 78.4 Favored Glycine 0 N--CA 1.479 1.512 0 C-N-CA 123.753 0.692 . . . . 0.0 114.533 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 28.3 ptm -156.28 150.17 25.07 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.85 1.26 . . . . 0.0 112.849 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -158.19 -172.0 24.79 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.747 1.165 . . . . 0.0 114.814 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 20.6 m -137.19 150.81 48.16 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.523 1.929 . . . . 0.0 110.254 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.7 t -141.44 142.99 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.881 1.272 . . . . 0.0 110.514 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -126.11 130.67 51.54 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 126.974 2.11 . . . . 0.0 110.782 -176.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -108.87 168.04 9.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.502 1.921 . . . . 0.0 110.952 -177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 49.1 p -81.4 0.06 39.16 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 167.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -127.99 154.56 45.47 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.865 1.666 . . . . 0.0 111.797 -167.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.5 p -114.39 -1.34 13.53 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.729 1.612 . . . . 0.0 113.685 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -130.05 -46.2 1.13 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.983 1.313 . . . . 0.0 112.714 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -65.88 -20.75 66.34 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.082 -1.011 . . . . 0.0 112.925 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.6 p -63.74 -33.29 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.24 1.816 . . . . 0.0 112.547 170.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -77.58 -36.76 51.67 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.66 0.784 . . . . 0.0 112.643 168.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -63.95 -24.14 67.61 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.145 0.978 . . . . 0.0 112.633 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.47 -56.81 15.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.948 1.299 . . . . 0.0 111.569 165.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.35 -35.22 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.735 1.214 . . . . 0.0 111.871 -172.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -57.07 -12.72 2.28 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.252 1.421 . . . . 0.0 114.039 172.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -117.43 -4.87 11.27 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.309 1.844 . . . . 0.0 112.685 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -129.46 -21.05 3.21 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.97 120.95 14.01 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 120.041 1.291 . . . . 0.0 110.381 176.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 97.24 0.73 59.64 Favored Glycine 0 N--CA 1.471 0.967 0 CA-C-O 118.189 -1.339 . . . . 0.0 114.772 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.97 106.52 0.72 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.759 1.779 . . . . 0.0 111.137 173.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -54.19 117.69 3.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.684 0.794 . . . . 0.0 109.461 155.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -137.89 108.68 6.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.5 1.52 . . . . 0.0 107.141 -165.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 18.1 ttt 50.42 47.1 24.51 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.679 0.791 . . . . 0.0 111.413 -162.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 21.5 t70 72.55 0.29 3.57 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 127.189 2.196 . . . . 0.0 114.652 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -123.68 125.05 44.09 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.215 1.406 . . . . 0.0 110.974 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -81.34 102.73 10.63 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.767 1.227 . . . . 0.0 114.264 -165.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -55.1 142.33 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.765 0.826 . . . . 0.0 111.434 167.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -136.4 134.59 37.94 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.084 1.353 . . . . 0.0 108.515 168.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 5.4 t -103.59 143.49 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.461 1.104 . . . . 0.0 110.559 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.24 137.83 54.7 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.032 2.133 . . . . 0.0 108.639 169.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -72.69 160.52 32.1 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 121.333 -0.854 . . . . 0.0 110.303 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.47 117.69 9.78 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.324 -0.86 . . . . 0.0 111.341 166.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 . . . . . 0 C--O 1.253 1.268 0 C-N-CA 126.52 1.928 . . . . 0.0 113.208 178.235 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 112.306 -0.317 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.1 p -162.03 163.26 28.91 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.198 1.399 . . . . 0.0 112.14 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -158.68 162.29 37.19 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.449 1.5 . . . . 0.0 112.025 -177.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -156.25 132.48 9.99 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.498 1.519 . . . . 0.0 110.842 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -166.06 165.07 18.08 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.568 1.947 . . . . 0.0 110.831 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 pp -155.84 170.97 20.85 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.493 1.517 . . . . 0.0 112.395 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -166.41 168.85 14.53 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.934 2.094 . . . . 0.0 111.276 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 48.2 m -159.58 129.6 5.56 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.977 1.311 . . . . 0.0 111.104 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.3 p -149.44 146.95 27.71 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.604 1.962 . . . . 0.0 110.221 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -158.52 158.85 34.81 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.364 1.066 . . . . 0.0 113.237 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -165.74 163.23 18.98 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.592 1.957 . . . . 0.0 110.879 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -155.51 136.07 13.35 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.86 1.264 . . . . 0.0 110.815 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -160.01 128.56 4.91 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.822 1.649 . . . . 0.0 110.674 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.9 p -161.08 140.3 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.731 1.213 . . . . 0.0 111.233 -176.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -145.55 156.47 43.72 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.809 1.644 . . . . 0.0 111.112 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -140.52 126.16 19.13 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.873 1.669 . . . . 0.0 109.373 173.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -78.04 -15.79 58.62 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -165.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -122.07 145.84 47.77 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.856 1.262 . . . . 0.0 112.561 -174.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.4 m -63.12 140.32 58.86 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.998 0.919 . . . . 0.0 112.383 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 47.9 p-10 -150.66 -169.65 3.44 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -164.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 64.9 m -142.17 176.08 9.25 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.33 1.052 . . . . 0.0 112.648 -154.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 7.6 pt -139.29 154.3 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.803 1.241 . . . . 0.0 111.144 -172.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -134.03 105.31 6.64 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.289 1.435 . . . . 0.0 110.317 -169.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.8 t -89.66 120.22 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.416 1.886 . . . . 0.0 109.08 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.95 -5.94 24.93 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 116.951 1.541 . . . . 0.0 116.951 -168.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -147.7 21.85 1.14 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 119.698 1.749 . . . . 0.0 114.983 -170.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -178.02 2.21 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.672 -1.268 . . . . 0.0 112.806 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 91.4 m -86.95 118.84 26.6 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.597 1.159 . . . . 0.0 108.875 172.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -68.59 -7.99 37.72 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -169.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -74.45 -12.93 60.63 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.005 1.322 . . . . 0.0 112.997 168.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 20.6 t -60.6 138.89 57.99 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.181 -0.95 . . . . 0.0 112.358 173.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 32.7 p -80.87 168.82 22.42 Favored Pre-proline 0 N--CA 1.472 0.666 0 C-N-CA 124.078 0.951 . . . . 0.0 109.216 162.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.67 -20.3 26.81 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.209 1.939 . . . . 0.0 112.887 163.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -69.02 -35.7 76.93 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.498 1.045 . . . . 0.0 111.697 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -59.94 -38.92 83.81 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.122 0.969 . . . . 0.0 111.477 170.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 56.1 mt -70.33 -41.0 73.82 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-O 118.067 -0.968 . . . . 0.0 111.492 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 17.3 m -56.5 -51.04 69.99 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.796 1.18 . . . . 0.0 110.667 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -58.61 -46.18 87.58 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.274 0.488 . . . . 0.0 111.553 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -62.43 -52.84 61.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.487 1.515 . . . . 0.0 112.799 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -71.4 -18.1 62.36 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.973 1.309 . . . . 0.0 114.215 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 64.4 p -64.06 -16.66 62.2 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -65.31 -21.64 66.73 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.737 1.215 . . . . 0.0 113.384 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 37.5 mm -90.47 -16.16 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.675 1.19 . . . . 0.0 112.6 -168.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.56 -90.93 0.11 Allowed Glycine 0 N--CA 1.467 0.767 0 C-N-CA 125.073 1.32 . . . . 0.0 111.974 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -155.44 138.0 15.07 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.078 1.351 . . . . 0.0 111.368 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.1 144.5 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 125.04 1.336 . . . . 0.0 109.566 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.02 -34.54 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.076 0.55 . . . . 0.0 112.146 -160.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -155.91 153.77 30.16 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.352 2.261 . . . . 0.0 109.285 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -151.29 145.71 25.53 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.72 1.608 . . . . 0.0 111.461 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -156.05 156.07 33.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.768 1.627 . . . . 0.0 111.486 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 10.2 mt -137.82 124.08 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.983 1.313 . . . . 0.0 108.034 172.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.78 107.71 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -172.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 41.5 p -96.73 171.76 8.32 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.866 1.667 . . . . 0.0 111.872 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 37.4 m -167.83 177.01 5.94 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 127.455 2.302 . . . . 0.0 110.64 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -62.53 -29.65 70.72 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.761 0.824 . . . . 0.0 112.915 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -137.58 -148.62 5.43 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 126.242 1.877 . . . . 0.0 112.478 173.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -72.02 0.86 8.35 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.097 1.759 . . . . 0.0 115.454 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -49.3 -30.62 7.66 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.874 2.07 . . . . 0.0 116.301 -167.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -128.68 -96.23 0.4 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.289 1.436 . . . . 0.0 110.351 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 84.34 1.61 89.35 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.046 1.307 . . . . 0.0 115.155 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 92.3 mtp -74.07 140.82 45.61 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.035 1.417 . . . . 0.0 111.492 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.6 146.5 16.08 Favored Glycine 0 N--CA 1.469 0.86 0 C-N-CA 124.522 1.058 . . . . 0.0 111.864 171.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 4.0 p -143.05 147.69 35.48 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.936 1.294 . . . . 0.0 110.921 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.9 t -150.76 142.1 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.517 1.127 . . . . 0.0 109.305 -171.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.94 134.83 54.26 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.922 1.689 . . . . 0.0 110.792 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -113.16 159.87 18.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.272 1.829 . . . . 0.0 111.382 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 38.1 p -74.85 -21.42 59.27 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -137.68 -146.42 0.22 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.965 1.306 . . . . 0.0 111.843 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 62.6 p -136.39 -57.88 0.74 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.647 1.112 . . . . 0.0 113.254 -172.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.58 -29.34 70.51 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.905 -1.122 . . . . 0.0 113.697 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -72.11 -28.69 63.44 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.75 1.62 . . . . 0.0 112.992 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.5 t -69.42 -33.31 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.359 1.463 . . . . 0.0 111.802 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -74.14 -41.94 60.76 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.601 -0.687 . . . . 0.0 112.163 170.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -62.49 -28.48 69.86 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.058 0.943 . . . . 0.0 112.77 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.56 -60.11 4.15 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.761 1.224 . . . . 0.0 111.583 169.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.11 -23.04 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.16 -0.963 . . . . 0.0 112.892 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -14.59 13.3 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.243 1.017 . . . . 0.0 113.549 167.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -101.14 -20.25 15.4 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.046 1.338 . . . . 0.0 112.901 173.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -122.17 -17.56 7.14 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 -159.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -68.15 120.53 14.49 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 120.628 1.558 . . . . 0.0 110.079 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 94.27 0.39 65.45 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 117.791 -1.56 . . . . 0.0 115.015 -169.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.13 107.17 0.51 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 120.0 1.9 . . . . 0.0 110.906 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -53.69 119.85 5.46 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.92 0.888 . . . . 0.0 109.812 160.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -146.88 110.37 4.87 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.411 1.485 . . . . 0.0 108.038 -163.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 51.4 mtt 53.42 35.32 20.21 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.563 0.745 . . . . 0.0 111.757 -169.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 86.01 0.48 0.66 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 128.95 2.9 . . . . 0.0 116.035 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -124.3 140.29 53.1 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.431 1.092 . . . . 0.0 111.974 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 103.14 6.82 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.244 -0.91 . . . . 0.0 112.766 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -52.31 143.31 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 121.36 -0.837 . . . . 0.0 111.015 164.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -129.72 147.42 51.5 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 164.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.2 p -151.09 127.76 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.584 0.707 . . . . 0.0 111.969 -166.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -85.31 136.65 33.39 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.222 1.409 . . . . 0.0 109.971 170.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.62 142.69 27.49 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.795 1.238 . . . . 0.0 108.648 167.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.3 131.24 50.41 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.183 0.901 . . . . 0.0 111.382 167.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.9 p30 . . . . . 0 C--O 1.253 1.24 0 C-N-CA 125.605 1.562 . . . . 0.0 112.661 -177.535 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.1 m -169.63 156.6 6.61 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.865 2.066 . . . . 0.0 111.104 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -156.73 156.67 33.76 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.219 1.407 . . . . 0.0 111.786 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.7 tpp85 -163.69 -33.21 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -159.03 149.14 19.28 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.664 1.586 . . . . 0.0 110.155 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 pp -80.04 0.05 33.44 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -173.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -74.78 141.53 44.36 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.188 1.395 . . . . 0.0 111.921 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 58.1 p -160.88 173.61 15.06 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.2 t -62.69 159.92 15.24 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.952 0.901 . . . . 0.0 110.974 158.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -121.19 11.28 10.83 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.332 1.853 . . . . 0.0 112.639 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -67.99 165.78 17.16 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.138 1.375 . . . . 0.0 113.791 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 80.22 -1.73 1.99 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 127.756 2.422 . . . . 0.0 113.528 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 17.7 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 117.074 2.25 . . . . 0.0 117.074 -172.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.3 p -170.5 141.47 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 128.637 2.775 . . . . 0.0 109.516 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -161.72 -37.37 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.025 1.33 . . . . 0.0 112.575 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -155.36 132.69 10.99 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.325 1.85 . . . . 0.0 109.168 173.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -90.28 101.8 14.52 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.584 0.754 . . . . 0.0 111.416 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -162.5 148.15 12.59 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.383 1.473 . . . . 0.0 112.317 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.3 t -174.79 160.52 2.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.703 2.001 . . . . 0.0 110.666 165.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 177.47 -35.16 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 127.739 2.415 . . . . 0.0 112.213 176.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.1 p -141.45 139.63 33.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.285 1.434 . . . . 0.0 110.873 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.6 pt -141.04 154.85 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.21 1.004 . . . . 0.0 112.189 -161.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -122.23 147.43 46.21 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.686 1.995 . . . . 0.0 110.526 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.6 t -134.14 122.65 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.317 1.447 . . . . 0.0 109.766 -172.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.3 -46.12 2.65 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 116.254 1.262 . . . . 0.0 116.254 -163.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -121.57 23.62 10.18 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -163.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.57 -175.97 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.942 1.697 . . . . 0.0 112.882 165.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.6 p -73.7 127.08 31.83 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 120.958 -1.089 . . . . 0.0 110.023 165.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -70.0 -9.46 55.3 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -97.68 0.27 46.8 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.836 2.054 . . . . 0.0 113.283 171.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 7.9 t -58.11 149.16 24.33 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.132 -0.98 . . . . 0.0 113.299 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.1 p -95.12 151.84 39.07 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 123.594 0.758 . . . . 0.0 110.229 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.23 -25.91 30.57 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.376 2.051 . . . . 0.0 111.927 171.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -69.43 -42.79 74.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.209 1.004 . . . . 0.0 112.539 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -65.7 -41.61 92.13 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.718 -0.614 . . . . 0.0 111.547 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 25.5 mt -69.32 -29.26 67.05 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.6 -0.714 . . . . 0.0 112.226 173.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 49.7 m -66.11 -50.94 62.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.515 1.052 . . . . 0.0 109.658 171.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.32 -34.69 74.18 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 118.624 0.647 . . . . 0.0 112.253 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -70.13 -58.18 4.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.663 1.585 . . . . 0.0 112.406 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -71.24 -35.78 71.56 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.6 t -73.43 -6.0 43.51 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -51.98 -25.93 9.46 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.188 1.795 . . . . 0.0 112.544 164.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 28.4 mm -77.1 -22.35 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.198 1.799 . . . . 0.0 113.215 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.69 -90.47 0.11 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.304 0.954 . . . . 0.0 112.892 -172.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -152.47 95.47 2.03 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -171.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 39.9 t -70.09 134.11 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 161.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 5.1 p -104.38 -25.17 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.085 0.954 . . . . 0.0 112.645 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -164.6 119.7 1.43 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.683 1.193 . . . . 0.0 111.567 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -107.48 154.25 21.63 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.216 1.006 . . . . 0.0 111.067 161.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -156.14 131.89 9.7 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.538 1.535 . . . . 0.0 110.89 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 4.8 mm -118.02 39.28 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 125.117 1.367 . . . . 0.0 109.79 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.7 pp -108.22 162.53 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.698 1.599 . . . . 0.0 111.663 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 17.2 p -134.39 126.67 30.04 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.874 1.27 . . . . 0.0 109.806 -173.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.4 m -73.28 -14.66 61.36 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -161.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 53.6 ttm-85 -91.02 0.01 57.64 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.403 1.481 . . . . 0.0 112.762 176.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.12 -152.55 21.35 Favored Glycine 0 N--CA 1.471 0.994 0 C-N-CA 125.087 1.327 . . . . 0.0 110.501 -166.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -59.29 138.23 57.69 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -160.47 -77.59 0.06 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.651 1.18 . . . . 0.0 112.388 -175.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -153.54 11.4 0.44 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -171.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 62.26 26.43 67.8 Favored Glycine 0 N--CA 1.478 1.483 0 N-CA-C 116.067 1.187 . . . . 0.0 116.067 167.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -66.1 146.55 54.53 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.744 1.272 . . . . 0.0 112.64 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.45 156.72 20.33 Favored Glycine 0 N--CA 1.467 0.73 0 C-N-CA 124.593 1.092 . . . . 0.0 112.89 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.0 p -144.42 149.22 35.7 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.903 1.681 . . . . 0.0 111.099 174.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 10.9 t -145.42 139.06 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.983 0.913 . . . . 0.0 110.667 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -127.8 132.1 49.5 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.172 2.189 . . . . 0.0 109.012 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -110.7 164.26 12.93 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.442 1.497 . . . . 0.0 110.055 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 33.1 p -81.05 -25.36 37.17 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 122.01 -0.431 . . . . 0.0 111.893 164.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -81.26 168.44 18.47 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.97 1.708 . . . . 0.0 112.248 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.3 m -122.62 -76.75 0.59 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.575 0.75 . . . . 0.0 110.972 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.94 -25.15 67.42 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.8 -1.187 . . . . 0.0 113.835 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.13 -21.71 61.43 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.09 -25.05 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.565 0.746 . . . . 0.0 111.661 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -73.09 -43.79 61.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.998 0.919 . . . . 0.0 111.231 167.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -60.1 -32.27 70.82 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.888 0.875 . . . . 0.0 112.111 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.07 -65.13 0.67 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.768 1.227 . . . . 0.0 111.748 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 45.2 mt -59.91 -34.76 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.401 -0.812 . . . . 0.0 112.12 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -63.34 -2.76 1.59 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.076 1.35 . . . . 0.0 114.356 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -122.0 -2.99 9.13 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.893 1.677 . . . . 0.0 112.8 171.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -129.09 -21.09 3.33 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -170.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -62.53 120.94 12.09 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.393 1.451 . . . . 0.0 110.079 173.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 97.31 0.52 59.64 Favored Glycine 0 N--CA 1.471 1.011 0 CA-C-O 118.136 -1.369 . . . . 0.0 115.266 -169.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.61 106.66 0.99 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.815 1.808 . . . . 0.0 110.789 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -53.63 115.37 1.93 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 154.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -137.23 110.91 8.09 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.078 1.351 . . . . 0.0 108.758 -166.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 18.9 mmt 60.26 19.1 8.57 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.052 1.341 . . . . 0.0 113.949 -178.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 18.6 t70 106.91 0.14 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 130.929 3.692 . . . . 0.0 115.148 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -129.69 138.21 51.03 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.571 1.078 . . . . 0.0 112.844 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -71.22 104.59 3.15 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.251 1.42 . . . . 0.0 113.191 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 pt -55.15 144.27 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.267 0.627 . . . . 0.0 111.326 168.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -139.76 140.03 36.61 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.848 1.259 . . . . 0.0 109.359 174.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.05 135.06 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.144 1.378 . . . . 0.0 110.35 -171.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -138.16 136.89 37.11 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.333 1.453 . . . . 0.0 108.418 170.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -79.81 155.14 28.0 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.031 0.932 . . . . 0.0 110.898 -167.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -154.76 151.66 28.95 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -173.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 34.7 m120 . . . . . 0 C--O 1.256 1.407 0 C-N-CA 125.451 1.5 . . . . 0.0 112.44 176.41 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.769 0 N-CA-C 112.288 -0.325 . . . . 0.0 112.288 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 79.4 p -163.0 165.25 25.12 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.352 1.461 . . . . 0.0 111.945 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -156.41 153.7 29.3 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.197 1.399 . . . . 0.0 112.004 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -69.13 -45.75 69.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.466 1.106 . . . . 0.0 112.224 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 78.28 133.98 0.06 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 128.585 2.754 . . . . 0.0 112.049 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.2 mt -137.23 151.66 48.98 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.763 1.625 . . . . 0.0 111.019 -175.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -162.46 155.04 19.39 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.112 1.765 . . . . 0.0 111.108 -176.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.4 p -160.4 142.52 12.82 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.566 1.146 . . . . 0.0 112.815 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.2 m -73.03 142.23 47.67 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.443 1.497 . . . . 0.0 111.053 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -62.34 145.33 54.14 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.596 1.159 . . . . 0.0 113.139 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -87.88 -10.08 51.78 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -174.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 61.85 -123.13 0.77 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.947 1.699 . . . . 0.0 112.343 174.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.4 157.95 36.48 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.945 1.698 . . . . 0.0 113.306 -174.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.2 t -141.88 134.84 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.218 1.407 . . . . 0.0 110.107 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -165.18 178.54 6.9 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.605 2.362 . . . . 0.0 110.295 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -128.13 -174.79 3.31 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.972 1.309 . . . . 0.0 110.617 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -69.12 -23.13 63.95 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -168.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -103.3 -49.76 3.64 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -169.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.0 m 59.75 24.18 13.1 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.99 1.716 . . . . 0.0 113.826 -175.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -63.58 -32.52 74.01 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.542 1.137 . . . . 0.0 112.369 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.6 m -138.55 168.48 19.69 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.341 1.056 . . . . 0.0 112.566 -173.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 35.5 pt -141.36 142.19 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 126.531 1.932 . . . . 0.0 109.018 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -109.96 128.67 55.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.365 1.066 . . . . 0.0 110.842 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.09 106.04 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.864 1.666 . . . . 0.0 107.905 -169.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -99.68 -11.58 43.55 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 117.09 1.596 . . . . 0.0 117.09 -158.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -157.25 38.43 0.29 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.335 1.568 . . . . 0.0 113.507 -171.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.35 177.78 6.34 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.011 -1.056 . . . . 0.0 112.441 175.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 t -76.67 142.06 40.71 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.978 1.311 . . . . 0.0 111.806 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -64.04 -12.78 41.7 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 170.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -75.45 -15.24 60.45 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.502 1.121 . . . . 0.0 113.547 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 57.9 m -71.49 137.68 48.36 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.992 -1.068 . . . . 0.0 113.286 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 43.0 p -100.75 159.2 30.24 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 125.377 1.471 . . . . 0.0 109.262 163.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.48 -24.53 78.25 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 121.963 1.775 . . . . 0.0 112.774 170.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.18 -41.33 90.43 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.871 1.214 . . . . 0.0 111.7 173.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -60.56 -47.44 86.17 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.414 0.686 . . . . 0.0 110.858 176.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.514 ' HG ' HD11 ' A' ' 192' ' ' ILE . 1.9 mm? -62.89 -37.52 87.26 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.552 1.141 . . . . 0.0 111.999 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.6 m -63.76 -50.42 69.14 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.203 1.001 . . . . 0.0 110.568 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.62 -41.92 83.18 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.509 0.595 . . . . 0.0 111.694 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -57.17 -55.46 34.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.744 1.618 . . . . 0.0 112.29 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -71.15 -28.34 64.2 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.2 m -73.26 0.24 12.47 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -66.84 -20.91 66.02 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 120.892 -1.13 . . . . 0.0 112.594 166.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 24.1 mm -84.07 -39.91 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.866 1.266 . . . . 0.0 111.762 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -173.62 -98.04 0.11 Allowed Glycine 0 N--CA 1.468 0.796 0 C-N-CA 125.662 1.601 . . . . 0.0 111.633 -174.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -144.41 123.11 12.57 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.539 1.135 . . . . 0.0 112.469 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 29.4 t -74.4 133.54 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 156.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.2 -23.62 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.068 0.547 . . . . 0.0 112.043 175.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -176.18 146.49 0.67 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 127.714 2.405 . . . . 0.0 110.494 176.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -130.45 158.79 38.93 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.548 1.539 . . . . 0.0 112.092 168.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -155.45 142.19 18.9 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.003 1.721 . . . . 0.0 110.772 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.514 HD11 ' HG ' ' A' ' 177' ' ' LEU . 4.1 mt -146.13 137.46 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.802 1.241 . . . . 0.0 110.114 -175.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.3 mp -104.7 107.71 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.669 1.187 . . . . 0.0 109.104 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 60.7 p -144.22 166.29 25.45 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 127.061 2.144 . . . . 0.0 110.246 -175.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.8 m -170.03 177.52 4.27 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.922 2.089 . . . . 0.0 110.808 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 80.3 ttt-85 -63.14 -39.06 93.58 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.769 0.828 . . . . 0.0 111.883 173.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -88.58 161.06 30.76 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.038 1.304 . . . . 0.0 111.792 168.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -78.72 61.34 2.98 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.839 1.255 . . . . 0.0 112.813 -175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -80.46 -18.74 47.77 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -165.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -163.38 -61.73 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 174.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 73.63 40.25 46.92 Favored Glycine 0 N--CA 1.477 1.431 0 CA-C-N 119.073 0.851 . . . . 0.0 113.838 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 60.2 mtt -140.82 156.62 46.11 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.139 1.375 . . . . 0.0 111.068 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -149.51 -178.37 24.43 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.204 0.907 . . . . 0.0 114.383 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.2 m -150.99 144.75 25.1 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.829 1.651 . . . . 0.0 108.457 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.84 143.38 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.851 0.86 . . . . 0.0 110.014 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -110.28 135.13 51.51 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.198 1.799 . . . . 0.0 110.223 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -117.19 159.79 22.08 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.539 1.936 . . . . 0.0 112.118 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.5 p -83.66 -25.46 30.71 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -148.51 142.79 26.16 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 -168.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.8 p -76.36 -14.73 60.07 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.84 2.456 . . . . 0.0 116.013 -161.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -102.05 -33.88 9.53 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.113 0.87 . . . . 0.0 112.776 169.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -62.07 -43.32 99.08 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.703 0.801 . . . . 0.0 110.962 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 13.3 p -62.67 -35.85 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.172 1.389 . . . . 0.0 113.971 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.48 -47.0 35.94 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.739 -0.601 . . . . 0.0 112.609 172.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -58.08 -34.98 70.74 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.799 1.24 . . . . 0.0 112.43 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.67 -58.1 9.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.632 1.173 . . . . 0.0 111.636 171.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 45.1 mt -69.96 -29.88 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.485 -1.385 . . . . 0.0 112.466 -173.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.48 -14.37 12.34 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 168.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -105.92 -40.67 5.62 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.341 1.856 . . . . 0.0 111.963 171.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -95.04 -13.88 24.8 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 -165.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.01 120.62 13.96 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 120.614 1.552 . . . . 0.0 109.936 174.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 93.78 0.78 66.22 Favored Glycine 0 N--CA 1.473 1.104 0 CA-C-O 117.861 -1.522 . . . . 0.0 115.19 -167.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.33 107.0 0.59 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.221 2.01 . . . . 0.0 110.912 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -53.13 120.89 6.47 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.035 0.934 . . . . 0.0 109.85 160.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -141.24 110.74 6.39 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.462 1.505 . . . . 0.0 107.804 -170.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 19.3 mmt 51.22 41.52 27.91 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.587 1.155 . . . . 0.0 111.722 -162.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 76.28 0.53 3.26 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 127.681 2.392 . . . . 0.0 115.169 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -116.14 130.3 56.73 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.597 1.159 . . . . 0.0 111.622 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -71.01 104.15 2.9 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.042 -1.036 . . . . 0.0 112.837 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.1 pt -52.81 146.6 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.246 0.618 . . . . 0.0 111.016 156.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -135.53 147.55 48.84 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.864 1.266 . . . . 0.0 108.576 169.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 1.6 p -153.02 140.56 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.11 0.964 . . . . 0.0 111.254 -166.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 -117.0 137.98 51.87 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.817 1.247 . . . . 0.0 110.169 173.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -65.88 138.18 57.7 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 62.86 -84.47 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.064 1.745 . . . . 0.0 113.388 -175.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 . . . . . 0 C--O 1.254 1.34 0 C-N-CA 127.043 2.137 . . . . 0.0 112.039 -163.017 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.808 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 47.6 t -164.49 -53.81 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.531 1.132 . . . . 0.0 111.978 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . 58.07 14.28 2.62 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.459 1.904 . . . . 0.0 115.212 171.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 56.29 35.33 25.63 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.959 1.704 . . . . 0.0 112.445 -169.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -68.46 140.45 55.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.135 1.374 . . . . 0.0 111.473 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.8 pp -157.51 179.11 9.55 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.288 1.835 . . . . 0.0 111.423 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -155.52 153.87 30.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.252 1.421 . . . . 0.0 111.847 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 75.3 m -141.29 151.21 43.45 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.573 1.549 . . . . 0.0 111.376 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 54.8 p -132.04 157.81 43.18 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.777 1.231 . . . . 0.0 112.08 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -144.04 139.4 28.96 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.879 1.672 . . . . 0.0 111.092 -172.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -163.62 149.07 11.1 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.597 1.559 . . . . 0.0 109.974 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -130.63 119.71 22.87 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.957 1.303 . . . . 0.0 109.88 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -158.06 117.5 3.23 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.414 1.486 . . . . 0.0 109.583 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.5 m -68.38 153.0 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.157 0.583 . . . . 0.0 112.573 -176.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -142.59 112.52 6.96 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.368 1.467 . . . . 0.0 110.3 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -145.93 121.12 10.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.344 1.057 . . . . 0.0 111.324 -172.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -167.48 157.07 10.38 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.032 2.133 . . . . 0.0 110.309 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -70.29 -17.41 63.1 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 73.0 m -137.83 140.11 40.31 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.175 1.79 . . . . 0.0 109.672 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -139.72 132.14 28.51 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.367 1.067 . . . . 0.0 110.513 -169.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.4 t -155.81 162.14 40.52 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.783 0.802 . . . . 0.0 112.952 -168.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 6.8 pt -147.62 151.47 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 127.364 2.266 . . . . 0.0 109.989 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -121.85 134.53 54.88 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.298 1.839 . . . . 0.0 110.367 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.47 121.29 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.757 1.223 . . . . 0.0 108.808 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.32 -44.79 1.13 Allowed Glycine 0 N--CA 1.475 1.257 0 N-CA-C 115.333 0.893 . . . . 0.0 115.333 -168.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -100.45 7.41 44.21 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -166.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -62.88 169.01 3.48 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.148 1.379 . . . . 0.0 111.926 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.7 m -64.15 138.87 58.66 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.129 0.972 . . . . 0.0 112.324 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -70.15 0.12 6.79 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.478 1.911 . . . . 0.0 115.244 -169.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -111.9 0.55 16.14 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.244 2.217 . . . . 0.0 112.692 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 9.8 t -61.95 154.87 25.15 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.1 p -130.49 152.28 80.06 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 125.545 1.538 . . . . 0.0 111.062 -168.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.57 -42.87 19.22 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.761 2.307 . . . . 0.0 113.236 -171.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.73 -27.96 67.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.542 1.065 . . . . 0.0 112.816 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.05 -30.2 63.55 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.971 0.909 . . . . 0.0 112.094 174.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.502 HD12 HD11 ' A' ' 192' ' ' ILE . 13.8 mt -74.51 -34.04 62.94 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.058 -0.972 . . . . 0.0 113.283 164.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 81.6 m -62.21 -50.61 71.1 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.145 1.339 . . . . 0.0 110.73 177.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -62.03 -26.74 68.42 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -78.43 -60.12 2.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.522 1.529 . . . . 0.0 111.521 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -71.24 -34.07 70.43 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -175.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.0 t -73.37 -1.21 17.21 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -64.45 -17.65 64.02 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.054 0.942 . . . . 0.0 112.855 169.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.3 mm -82.09 -25.31 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.6 1.56 . . . . 0.0 113.089 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 175.23 -103.45 0.18 Allowed Glycine 0 N--CA 1.47 0.954 0 C-N-CA 124.506 1.051 . . . . 0.0 112.367 -169.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -147.77 109.67 4.48 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.508 0.723 . . . . 0.0 112.489 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 25.6 t -71.25 129.77 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 164.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.81 -33.48 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 118.362 0.528 . . . . 0.0 112.005 173.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -154.71 134.82 13.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.285 1.434 . . . . 0.0 110.715 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -109.71 153.94 23.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.245 1.018 . . . . 0.0 110.595 153.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -153.13 123.03 6.91 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.822 1.249 . . . . 0.0 111.262 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.502 HD11 HD12 ' A' ' 177' ' ' LEU . 6.0 mt -143.87 -52.01 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.657 0.783 . . . . 0.0 113.023 -175.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 18.7 tt -76.92 141.44 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 118.722 0.692 . . . . 0.0 111.769 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 67.3 p -128.77 161.58 29.42 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.725 1.61 . . . . 0.0 111.777 -166.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 63.2 m -100.25 6.81 44.73 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -176.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.1 0.18 22.5 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -176.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 125.83 -131.1 7.42 Favored Glycine 0 N--CA 1.468 0.791 0 C-N-CA 125.97 1.748 . . . . 0.0 110.816 -171.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -60.61 136.9 58.2 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.899 0.88 . . . . 0.0 113.027 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -70.9 143.72 50.87 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.86 1.264 . . . . 0.0 112.14 174.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 42.0 mtm105 -123.59 -6.48 8.08 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 72.81 10.56 77.07 Favored Glycine 0 N--CA 1.476 1.323 0 CA-C-O 118.285 -1.286 . . . . 0.0 116.038 170.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 93.4 mtp -107.73 128.97 55.05 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.238 1.519 . . . . 0.0 109.797 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -173.75 -165.84 31.08 Favored Glycine 0 N--CA 1.474 1.192 0 N-CA-C 116.144 1.218 . . . . 0.0 116.144 -169.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.7 p -132.66 160.9 35.35 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.832 1.653 . . . . 0.0 113.582 -164.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 12.2 t -141.84 142.15 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.942 1.297 . . . . 0.0 110.202 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -125.45 134.98 51.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.862 2.065 . . . . 0.0 111.341 -171.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -118.46 151.66 37.39 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.071 1.748 . . . . 0.0 111.895 -169.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 61.3 p -75.93 -38.21 57.87 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.467 0.307 . . . . 0.0 110.817 163.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -61.18 160.49 10.26 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.377 1.871 . . . . 0.0 113.09 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.7 p -127.08 -66.01 0.92 Allowed 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.707 -0.621 . . . . 0.0 111.895 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -61.95 -30.24 70.78 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.425 1.011 . . . . 0.0 112.154 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -72.21 -17.43 61.92 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 12.4 t -70.26 -22.81 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.872 0.76 . . . . 0.0 112.042 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -74.07 -45.76 47.32 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.752 -1.217 . . . . 0.0 110.967 164.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 10.1 ttt85 -57.01 -29.35 63.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.597 1.559 . . . . 0.0 113.753 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.62 -68.7 0.29 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.681 1.592 . . . . 0.0 110.586 166.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.23 -27.87 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 121.204 -0.935 . . . . 0.0 113.266 -166.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -58.54 -18.79 32.31 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.861 0.864 . . . . 0.0 113.319 170.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -107.46 -6.7 16.91 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.369 1.467 . . . . 0.0 113.295 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -124.68 -22.87 4.48 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -170.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.64 120.5 14.75 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 120.399 1.454 . . . . 0.0 109.833 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 94.62 0.43 64.61 Favored Glycine 0 N--CA 1.469 0.888 0 CA-C-O 118.016 -1.435 . . . . 0.0 115.028 -168.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.8 108.84 1.08 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.909 1.855 . . . . 0.0 110.536 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -48.44 116.72 1.68 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.151 0.98 . . . . 0.0 109.351 156.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -152.0 110.77 3.82 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.851 1.26 . . . . 0.0 108.808 -172.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.13 50.52 13.41 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.472 1.109 . . . . 0.0 112.019 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 16.8 t70 77.48 0.14 2.88 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 127.257 2.223 . . . . 0.0 115.807 171.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 -135.55 154.8 51.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.925 1.29 . . . . 0.0 111.898 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 103.97 16.38 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.311 -0.868 . . . . 0.0 110.611 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.4 pt -54.76 139.54 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 121.215 -0.928 . . . . 0.0 111.287 171.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -132.69 142.66 49.17 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.626 1.17 . . . . 0.0 108.139 167.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 1.1 p -136.93 134.82 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.321 1.048 . . . . 0.0 111.682 -165.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -101.12 141.2 34.34 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.275 1.83 . . . . 0.0 109.919 173.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -75.08 132.56 41.36 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.8 125.62 28.55 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.441 1.019 . . . . 0.0 112.294 -173.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 . . . . . 0 C--O 1.254 1.318 0 C-N-CA 126.258 1.823 . . . . 0.0 111.514 -172.126 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 CA-C-O 121.137 0.298 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.3 t -162.06 160.05 26.99 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.353 1.461 . . . . 0.0 111.388 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -160.94 159.25 29.36 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.123 1.769 . . . . 0.0 111.663 -176.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -158.41 131.02 7.08 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.171 1.388 . . . . 0.0 111.03 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -163.49 157.16 19.38 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.254 1.821 . . . . 0.0 110.628 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.9 pp -162.29 173.62 13.94 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.78 1.632 . . . . 0.0 112.292 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -161.79 161.49 29.17 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.495 1.918 . . . . 0.0 111.565 -177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.3 t -161.73 150.47 15.62 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.558 1.143 . . . . 0.0 111.88 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.9 t -165.46 155.19 12.75 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.607 1.963 . . . . 0.0 110.328 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -162.73 160.77 25.85 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.638 1.575 . . . . 0.0 112.57 -174.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -163.08 160.83 24.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.806 1.642 . . . . 0.0 111.258 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -135.85 128.73 31.21 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.39 1.476 . . . . 0.0 109.559 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -143.29 147.7 35.18 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.05 1.34 . . . . 0.0 112.22 -170.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.4 p -164.83 135.47 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 126.171 1.788 . . . . 0.0 110.051 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -89.12 -20.48 24.23 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -167.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 57.66 37.3 27.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.865 1.666 . . . . 0.0 113.969 167.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -62.64 -40.89 98.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.761 0.824 . . . . 0.0 112.56 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -153.37 -55.7 0.12 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.456 1.903 . . . . 0.0 111.832 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.0 m 60.91 8.94 2.05 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.562 1.945 . . . . 0.0 114.961 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -62.69 -7.69 5.32 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -172.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.5 p -151.96 164.4 37.24 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.401 -1.437 . . . . 0.0 111.225 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 28.7 pt -144.1 145.48 21.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 125.589 1.556 . . . . 0.0 110.341 -171.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 94.4 t80 -109.29 150.2 28.32 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.825 1.65 . . . . 0.0 109.56 170.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.95 102.86 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.105 1.362 . . . . 0.0 108.786 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -82.49 -16.28 71.55 Favored Glycine 0 N--CA 1.471 0.974 0 C-N-CA 124.223 0.916 . . . . 0.0 114.315 -171.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -152.2 133.43 14.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.858 1.663 . . . . 0.0 109.926 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 mp -144.01 -77.96 0.22 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.63 1.572 . . . . 0.0 109.95 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 11.3 t -172.25 140.21 1.12 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.975 2.51 . . . . 0.0 108.588 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -63.43 -13.65 42.28 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -88.7 0.09 56.78 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.201 1.4 . . . . 0.0 113.418 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 7.6 t -78.46 152.82 31.89 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.682 -1.261 . . . . 0.0 113.509 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.49 159.7 32.26 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 126.556 1.943 . . . . 0.0 109.066 -176.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.0 -27.07 17.77 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 121.988 1.792 . . . . 0.0 113.29 -167.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.04 -34.77 78.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.196 0.907 . . . . 0.0 111.573 173.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -70.38 -41.27 73.28 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.059 0.944 . . . . 0.0 110.964 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 177' ' ' LEU . 17.1 mt -66.59 -29.69 69.8 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.815 169.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 86.0 m -69.4 -48.36 61.35 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.402 1.001 . . . . 0.0 109.89 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -61.33 -33.77 74.15 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.431 0.693 . . . . 0.0 112.571 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -73.14 -61.48 1.8 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.998 1.719 . . . . 0.0 111.962 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.37 -39.75 71.05 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.3 t -73.28 -7.07 49.96 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -174.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -60.05 -18.62 47.91 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.782 1.233 . . . . 0.0 112.65 167.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 20.6 mm -78.96 -26.0 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.831 1.652 . . . . 0.0 112.607 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 166.22 -95.67 0.12 Allowed Glycine 0 N--CA 1.469 0.87 0 C-N-CA 124.734 1.159 . . . . 0.0 112.457 -171.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -141.67 110.13 6.01 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.361 1.064 . . . . 0.0 112.85 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.66 135.18 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 154.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.29 -18.31 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 172.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -160.47 138.2 9.63 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.419 1.488 . . . . 0.0 111.13 170.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -124.27 152.47 42.98 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.277 1.431 . . . . 0.0 110.554 160.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -152.32 137.0 16.97 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.201 1.001 . . . . 0.0 112.513 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.1 mt -145.57 -53.5 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 126.153 1.781 . . . . 0.0 111.255 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.8 pp -72.79 164.87 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 72.3 p -124.45 160.78 27.47 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.152 1.381 . . . . 0.0 112.141 -162.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 41.7 t -64.36 -33.35 75.65 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.045 0.938 . . . . 0.0 113.396 -174.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -99.21 -6.07 28.81 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.721 1.208 . . . . 0.0 113.266 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 83.24 2.16 90.4 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.282 1.42 . . . . 0.0 114.653 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -77.64 131.0 37.56 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 118.568 1.184 . . . . 0.0 112.393 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 13.6 t60 69.02 158.99 0.17 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 127.352 2.261 . . . . 0.0 114.99 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -164.68 152.41 11.8 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.622 1.969 . . . . 0.0 109.921 -173.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 99.41 21.96 13.8 Favored Glycine 0 N--CA 1.476 1.327 0 N-CA-C 116.214 1.246 . . . . 0.0 116.214 173.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -157.21 157.32 34.13 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.358 1.863 . . . . 0.0 111.569 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 157.76 -144.79 10.92 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 115.314 0.886 . . . . 0.0 115.314 -174.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.6 m -144.84 150.39 37.04 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.269 1.428 . . . . 0.0 111.13 -160.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.8 t -139.14 147.65 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.733 1.213 . . . . 0.0 110.82 173.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -131.45 133.76 45.51 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.75 2.02 . . . . 0.0 111.001 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -120.61 164.82 15.91 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.985 2.114 . . . . 0.0 111.502 -174.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 29.3 p -74.55 -38.41 62.74 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -150.49 152.8 34.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -171.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 30.8 p -54.05 -40.0 66.73 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.328 1.851 . . . . 0.0 113.326 171.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -76.37 -23.6 54.15 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -79.59 -51.25 9.53 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.886 0.874 . . . . 0.0 112.438 169.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 15.0 p -69.3 -42.46 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -167.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.77 -13.3 62.0 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.158 0.89 . . . . 0.0 113.367 -173.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -73.37 -19.4 61.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.468 1.107 . . . . 0.0 112.657 173.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.65 -61.18 2.0 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.302 1.041 . . . . 0.0 112.612 -173.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 4.2 mp -68.91 -29.21 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 121.447 -0.783 . . . . 0.0 112.271 -160.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -58.5 -21.43 51.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.66 1.184 . . . . 0.0 113.566 170.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -101.4 -10.73 19.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.192 1.397 . . . . 0.0 112.889 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -126.0 -23.69 3.89 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -166.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.97 120.75 13.67 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.379 1.445 . . . . 0.0 109.8 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 93.08 0.83 67.74 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-O 117.982 -1.454 . . . . 0.0 115.079 -169.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.01 109.31 0.93 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.686 1.743 . . . . 0.0 110.501 171.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -57.05 124.17 17.79 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.265 0.555 . . . . 0.0 109.627 155.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -145.88 110.43 5.09 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.315 1.846 . . . . 0.0 107.103 -161.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 88.6 mmm 49.88 41.48 22.73 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.864 0.866 . . . . 0.0 111.728 -163.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 11.6 t70 77.71 -0.41 2.76 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 128.284 2.634 . . . . 0.0 115.085 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -120.38 137.73 54.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.564 1.146 . . . . 0.0 111.626 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -79.62 112.72 17.16 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.697 -1.252 . . . . 0.0 113.435 -170.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -68.18 143.88 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 121.219 -0.926 . . . . 0.0 112.98 169.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -132.31 130.28 40.62 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.282 1.433 . . . . 0.0 109.643 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 12.4 t -119.24 151.09 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.772 2.029 . . . . 0.0 109.541 -170.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 42.0 ptt85 -133.4 148.63 51.81 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.546 0.738 . . . . 0.0 110.12 155.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -77.08 164.64 25.52 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.7 -0.625 . . . . 0.0 110.31 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -107.13 132.39 53.06 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.27 1.428 . . . . 0.0 111.079 168.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 . . . . . 0 C--O 1.254 1.331 0 C-N-CA 126.97 2.108 . . . . 0.0 111.771 -173.434 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 112.076 -0.409 . . . . 0.0 112.076 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 12.4 t -162.61 158.83 23.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.291 1.436 . . . . 0.0 111.312 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -160.35 155.72 25.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.878 1.671 . . . . 0.0 111.844 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 35.4 ptt-85 -162.48 157.11 21.89 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.975 1.71 . . . . 0.0 112.038 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -162.41 153.32 17.44 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.629 1.571 . . . . 0.0 111.595 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 60.7 tp -159.97 130.02 5.43 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.03 1.732 . . . . 0.0 109.657 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -162.55 139.75 8.02 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.388 1.475 . . . . 0.0 111.398 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 31.9 m -169.1 138.39 2.11 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.967 2.107 . . . . 0.0 110.823 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.5 t -166.12 148.19 6.98 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.235 1.814 . . . . 0.0 110.232 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -147.86 129.71 15.24 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.019 1.328 . . . . 0.0 111.625 -171.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -148.7 134.6 19.01 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.584 1.554 . . . . 0.0 110.254 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -165.18 147.87 8.07 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.286 1.434 . . . . 0.0 111.874 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -164.63 152.19 11.71 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.254 1.821 . . . . 0.0 112.018 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.8 m -148.94 139.77 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 125.58 1.552 . . . . 0.0 111.018 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -167.9 147.38 4.83 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.824 1.65 . . . . 0.0 111.738 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -146.77 16.86 1.26 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.547 1.539 . . . . 0.0 113.745 174.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -72.0 163.6 27.58 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -152.45 114.36 4.39 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.309 1.444 . . . . 0.0 110.184 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.8 p -167.45 151.55 6.63 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -171.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -146.72 -3.47 0.61 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 63.5 p -134.13 154.7 51.04 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.497 -1.377 . . . . 0.0 112.053 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 10.4 pt -143.83 142.14 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.522 1.529 . . . . 0.0 109.571 -177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -128.73 123.9 34.22 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.648 1.179 . . . . 0.0 109.401 -168.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.8 t -113.93 129.68 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.814 1.645 . . . . 0.0 109.151 -164.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -74.59 -109.05 0.09 OUTLIER Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.272 1.415 . . . . 0.0 114.652 -169.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -84.26 -26.94 28.24 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.501 ' HG ' ' H ' ' A' ' 169' ' ' THR 0.32 2.3 pt? 32.7 -120.22 0.07 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.579 2.352 . . . . 0.0 115.0 -178.745 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.501 ' H ' ' HG ' ' A' ' 168' ' ' LEU . 57.2 m -142.28 130.32 21.94 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.684 1.594 . . . . 0.0 110.123 -162.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -61.45 -23.37 65.8 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.19 -0.89 57.78 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.885 1.674 . . . . 0.0 113.269 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 92.3 p -72.09 151.97 42.69 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 34.5 p -143.15 162.52 42.6 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 127.654 2.382 . . . . 0.0 108.372 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -63.16 -30.33 74.78 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 121.58 1.52 . . . . 0.0 112.951 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -69.28 -40.16 77.93 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.1 0.864 . . . . 0.0 112.207 173.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -66.18 -40.72 90.68 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.562 1.145 . . . . 0.0 111.838 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.34 -36.06 82.44 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.134 0.973 . . . . 0.0 112.025 170.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 91.7 m -69.48 -50.11 48.44 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.153 0.581 . . . . 0.0 110.314 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -58.75 -28.61 66.05 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.626 0.77 . . . . 0.0 112.399 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -75.56 -66.09 0.82 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.064 1.346 . . . . 0.0 111.7 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.28 -30.84 66.77 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -172.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.35 -5.33 39.02 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.011 -1.056 . . . . 0.0 113.701 -173.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -64.91 -19.45 65.94 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.685 1.194 . . . . 0.0 113.219 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 24.9 mm -82.83 -24.13 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.643 1.177 . . . . 0.0 112.655 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 176.14 -86.04 0.07 OUTLIER Glycine 0 N--CA 1.468 0.771 0 C-N-CA 124.923 1.249 . . . . 0.0 111.707 -175.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -157.51 116.47 3.26 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.494 1.118 . . . . 0.0 112.198 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 19.2 t -71.9 129.99 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 160.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.5 p -100.69 -17.04 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.657 0.783 . . . . 0.0 112.981 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -162.58 138.57 7.35 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.109 1.363 . . . . 0.0 112.112 169.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -127.35 156.02 42.65 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.986 1.314 . . . . 0.0 112.406 165.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -156.52 143.28 18.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.548 1.539 . . . . 0.0 112.27 -174.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.5 mm -128.64 120.32 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.694 1.597 . . . . 0.0 108.012 170.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 20.7 tt -108.73 107.81 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.581 1.153 . . . . 0.0 110.998 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 6.3 t -152.64 172.46 16.6 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.878 1.671 . . . . 0.0 111.612 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 58.7 m -149.5 156.42 41.96 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.428 1.891 . . . . 0.0 111.389 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -62.27 -33.31 74.38 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.062 0.945 . . . . 0.0 113.275 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -87.3 -90.63 1.02 Allowed Glycine 0 N--CA 1.471 1.0 0 C-N-CA 125.31 1.433 . . . . 0.0 110.556 170.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -159.6 148.28 17.72 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.619 1.568 . . . . 0.0 112.161 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -166.37 -62.26 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.786 1.234 . . . . 0.0 113.172 -177.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -144.52 -69.32 0.3 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.817 1.647 . . . . 0.0 110.595 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 81.1 42.18 9.7 Favored Glycine 0 N--CA 1.47 0.962 0 C-N-CA 124.508 1.052 . . . . 0.0 113.105 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -150.87 171.53 17.09 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.175 0.99 . . . . 0.0 113.326 -171.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -127.27 157.12 20.67 Favored Glycine 0 N--CA 1.471 1.031 0 C-N-CA 124.427 1.013 . . . . 0.0 114.865 -172.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 85.4 m -142.86 144.11 32.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.944 1.698 . . . . 0.0 109.107 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 43.7 t -141.63 152.52 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.848 0.859 . . . . 0.0 109.495 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -130.06 137.46 50.23 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.916 1.687 . . . . 0.0 111.21 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -121.06 160.5 23.49 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 127.306 2.243 . . . . 0.0 110.224 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 43.7 p -88.19 -14.38 38.73 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -175.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -156.25 130.93 8.96 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.2 m -46.79 -50.74 17.8 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 129.372 3.069 . . . . 0.0 115.113 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.75 -26.46 44.6 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.003 -1.061 . . . . 0.0 113.108 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.37 -39.7 64.94 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.303 -0.873 . . . . 0.0 113.332 170.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 14.0 p -69.05 -29.26 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.541 -0.724 . . . . 0.0 112.384 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.91 -39.78 83.52 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.514 0.726 . . . . 0.0 112.56 169.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 53.3 mtt85 -61.97 -33.19 73.84 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.329 0.652 . . . . 0.0 112.494 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.81 -63.71 1.13 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.409 1.004 . . . . 0.0 113.176 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 56.3 mt -65.46 -27.6 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 121.35 -0.844 . . . . 0.0 111.771 -170.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -51.39 -27.73 10.8 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.043 1.337 . . . . 0.0 113.558 168.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -98.88 -13.38 20.07 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.416 1.086 . . . . 0.0 113.443 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -125.18 -19.62 5.09 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -163.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -67.64 120.89 14.76 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 120.408 1.458 . . . . 0.0 110.769 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 91.34 0.82 72.85 Favored Glycine 0 N--CA 1.469 0.885 0 CA-C-O 117.44 -1.755 . . . . 0.0 114.75 -170.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.37 106.22 0.36 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.894 1.847 . . . . 0.0 110.32 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.499 ' CZ ' ' HE2' ' A' ' 229' ' ' LYS . 56.4 m-85 -60.3 116.92 4.61 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 156.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -133.95 110.33 9.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.24 1.416 . . . . 0.0 107.288 -164.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 12.9 ttt 50.07 38.88 17.85 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.13 0.972 . . . . 0.0 111.897 -159.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.7 t70 76.45 6.78 3.47 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 126.858 2.063 . . . . 0.0 114.965 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -121.12 138.67 54.09 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.45 1.1 . . . . 0.0 112.105 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.499 ' HE2' ' CZ ' ' A' ' 224' ' ' PHE . 42.4 mmtt -68.01 115.88 8.02 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.149 1.379 . . . . 0.0 113.584 -175.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.03 145.87 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 120.998 -1.064 . . . . 0.0 110.743 151.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -146.58 142.42 27.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.64 1.976 . . . . 0.0 108.43 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.2 t -137.27 135.38 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -165.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -101.43 141.47 34.25 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.259 1.824 . . . . 0.0 110.965 168.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -92.98 122.07 34.97 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.819 0.848 . . . . 0.0 110.005 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.37 -26.66 0.14 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 128.883 2.873 . . . . 0.0 117.49 164.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.079 0 C-N-CA 128.039 2.536 . . . . 0.0 110.918 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.835 0 CA-C-O 121.179 0.322 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.0 t -162.57 150.32 13.94 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.212 1.405 . . . . 0.0 111.552 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -85.06 -5.24 59.35 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.583 1.153 . . . . 0.0 113.758 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 62.71 -151.4 0.35 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.088 1.755 . . . . 0.0 111.52 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -162.48 161.25 26.98 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.971 1.708 . . . . 0.0 111.297 -174.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 93.7 mt -141.26 159.24 42.64 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.269 1.828 . . . . 0.0 111.09 -177.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -160.08 161.53 33.89 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.949 1.7 . . . . 0.0 112.183 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.3 m -165.37 152.98 10.92 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.408 1.883 . . . . 0.0 111.484 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.6 p -144.0 148.3 35.08 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.109 1.764 . . . . 0.0 111.13 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -158.7 169.33 24.62 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.349 1.459 . . . . 0.0 112.735 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -142.11 156.83 45.39 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.754 1.622 . . . . 0.0 111.1 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -141.48 150.66 42.52 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.728 1.611 . . . . 0.0 110.758 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -154.09 142.01 20.17 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.998 1.319 . . . . 0.0 111.748 -173.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.6 m -143.3 152.39 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.531 1.533 . . . . 0.0 111.633 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -161.91 148.91 14.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.045 1.738 . . . . 0.0 111.22 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -156.9 136.96 12.66 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.922 1.289 . . . . 0.0 112.137 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -161.03 142.72 12.02 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.84 2.056 . . . . 0.0 109.801 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -137.44 -21.24 1.17 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.415 1.486 . . . . 0.0 113.468 -172.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 54.4 p -149.06 178.55 8.61 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.197 0.999 . . . . 0.0 113.01 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -92.11 8.91 35.74 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.189 0.996 . . . . 0.0 112.066 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.4 m -90.19 143.28 26.91 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.858 1.263 . . . . 0.0 113.835 -165.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.0 pt -136.43 147.06 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.09 1.356 . . . . 0.0 110.824 176.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -129.48 114.21 15.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.555 1.942 . . . . 0.0 109.356 -167.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.46 106.29 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.308 1.843 . . . . 0.0 108.197 -172.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.54 -10.78 78.97 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.237 0.922 . . . . 0.0 115.268 -169.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -159.44 157.92 31.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.009 1.724 . . . . 0.0 110.408 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 178.26 -144.55 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 128.838 2.855 . . . . 0.0 107.984 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 21.8 p -108.56 141.83 39.89 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 120.865 1.666 . . . . 0.0 111.221 170.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -59.68 -25.18 64.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -88.52 -1.85 58.27 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.045 1.738 . . . . 0.0 113.423 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 22.7 t -69.63 154.64 41.7 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.984 -1.072 . . . . 0.0 112.163 174.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 32.5 p -128.4 155.57 78.35 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 125.33 1.452 . . . . 0.0 109.746 -172.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.02 -23.48 53.79 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.45 1.434 . . . . 0.0 112.394 174.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -69.07 -36.38 77.57 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.516 1.053 . . . . 0.0 111.987 171.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -71.33 -37.98 71.69 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.307 -0.871 . . . . 0.0 111.859 174.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.8 mt -66.14 -30.36 70.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.418 -0.801 . . . . 0.0 112.787 166.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 63.6 m -67.71 -46.82 71.1 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.571 1.078 . . . . 0.0 109.35 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.31 -36.13 79.26 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.796 0.726 . . . . 0.0 112.118 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -66.41 -64.14 0.92 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.55 1.14 . . . . 0.0 111.511 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -71.23 -39.21 71.84 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -173.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.73 -3.88 31.1 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -72.77 -15.95 61.65 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.161 -0.962 . . . . 0.0 112.892 165.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.07 -45.65 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.007 0.822 . . . . 0.0 111.295 175.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.39 -90.75 0.08 OUTLIER Glycine 0 N--CA 1.468 0.779 0 C-N-CA 125.062 1.315 . . . . 0.0 112.405 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -158.4 109.56 2.17 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.74 0.816 . . . . 0.0 112.09 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 36.0 t -74.06 130.44 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 167.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.6 p -102.94 -16.99 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.22 1.008 . . . . 0.0 113.107 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -164.95 134.22 3.55 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.147 1.779 . . . . 0.0 111.066 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -130.15 152.94 49.04 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.716 1.606 . . . . 0.0 112.299 165.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -156.76 156.78 33.89 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.844 2.058 . . . . 0.0 111.216 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.3 mt -141.75 133.57 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.7 1.2 . . . . 0.0 111.316 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 63.5 mt -93.81 107.52 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.205 1.402 . . . . 0.0 107.753 168.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 8.9 t -151.93 141.17 21.4 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.544 1.538 . . . . 0.0 110.036 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 68.9 m -157.58 163.34 38.43 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.706 2.003 . . . . 0.0 109.82 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 27.4 mmt85 -70.99 -15.93 62.6 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -91.05 -137.86 7.47 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.901 1.715 . . . . 0.0 113.863 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 35.1 p80 -82.22 0.1 42.74 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 -170.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -63.61 150.41 44.21 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.535 1.134 . . . . 0.0 113.351 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -33.64 74.3 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -168.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 75.78 78.86 0.65 Allowed Glycine 0 N--CA 1.473 1.141 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -168.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 27.1 ptm -148.13 134.69 19.77 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.157 0.983 . . . . 0.0 112.372 -168.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -108.06 164.73 12.81 Favored Glycine 0 N--CA 1.469 0.865 0 C-N-CA 124.874 1.226 . . . . 0.0 113.789 -177.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.77 142.54 27.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.992 1.717 . . . . 0.0 109.836 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 19.4 t -146.27 146.89 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.609 0.764 . . . . 0.0 109.999 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -129.2 131.95 47.19 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.164 1.786 . . . . 0.0 109.369 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -95.99 171.77 8.42 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.626 1.17 . . . . 0.0 109.915 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 59.0 p -81.48 0.15 39.15 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 168.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -136.22 178.49 7.02 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.264 1.826 . . . . 0.0 112.433 -166.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 20.9 p -124.82 -68.3 0.86 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.179 1.792 . . . . 0.0 110.897 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -54.37 -38.53 66.21 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.016 -1.053 . . . . 0.0 112.956 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.6 -18.38 64.97 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.446 1.098 . . . . 0.0 113.077 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 13.0 t -75.79 -37.23 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.137 1.375 . . . . 0.0 112.062 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -62.17 -43.67 98.31 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.768 -0.582 . . . . 0.0 110.434 168.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -65.74 -17.14 64.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.981 1.312 . . . . 0.0 113.523 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -74.49 -64.27 1.06 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.24 0.927 . . . . 0.0 111.425 166.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 53.5 mt -69.23 -30.8 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.444 -0.785 . . . . 0.0 112.04 -167.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.69 -4.2 2.87 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.545 1.138 . . . . 0.0 113.835 170.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -118.24 -4.91 10.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.388 1.475 . . . . 0.0 112.569 172.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -127.54 -24.03 3.38 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -171.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.54 120.92 12.07 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 121.001 1.728 . . . . 0.0 110.501 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 91.64 0.68 72.14 Favored Glycine 0 N--CA 1.469 0.844 0 CA-C-O 118.06 -1.411 . . . . 0.0 115.336 -171.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.47 107.6 0.81 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.76 1.78 . . . . 0.0 110.363 169.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -52.98 120.4 5.81 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 156.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -142.15 111.06 6.27 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.26 1.424 . . . . 0.0 108.314 -166.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 20.5 ttt 56.72 40.5 29.14 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 121.776 0.798 . . . . 0.0 110.751 -165.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 18.3 t70 74.97 0.18 3.48 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 127.912 2.485 . . . . 0.0 115.285 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -125.64 141.27 52.11 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.05 1.34 . . . . 0.0 111.982 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -87.32 102.62 14.68 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.002 0.921 . . . . 0.0 112.621 -165.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.88 149.73 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 121.226 -0.921 . . . . 0.0 112.484 169.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -141.49 140.49 33.53 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.823 1.649 . . . . 0.0 108.696 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 16.0 t -133.03 133.55 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 118.556 0.616 . . . . 0.0 112.299 -168.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -107.31 145.03 33.31 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.128 1.771 . . . . 0.0 109.456 169.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -104.59 148.17 26.81 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.123 0.969 . . . . 0.0 110.475 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 71.21 -34.3 0.3 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 128.048 2.539 . . . . 0.0 115.457 172.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 29.6 m120 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 126.929 2.091 . . . . 0.0 112.978 -174.546 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.3 p -164.8 144.96 7.37 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.934 1.294 . . . . 0.0 111.688 -176.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -161.49 163.29 30.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.319 1.448 . . . . 0.0 111.964 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 32.1 mmm180 -70.45 150.56 46.08 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.275 1.03 . . . . 0.0 112.056 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -160.0 145.26 15.18 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.143 1.777 . . . . 0.0 109.543 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 31.0 mt 69.38 5.86 5.37 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 126.972 2.109 . . . . 0.0 113.416 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -75.48 145.1 41.67 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.647 1.979 . . . . 0.0 113.306 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.7 t -163.57 136.87 5.53 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.05 1.34 . . . . 0.0 111.121 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.6 m -167.3 144.91 4.67 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.309 2.244 . . . . 0.0 109.154 -176.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -152.2 139.26 19.16 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.253 1.421 . . . . 0.0 111.611 176.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -164.56 152.14 11.8 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.419 1.488 . . . . 0.0 110.586 -174.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 67.34 -161.6 0.23 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.566 1.946 . . . . 0.0 111.893 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 69.9 tttt 68.7 15.57 9.02 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.577 1.551 . . . . 0.0 114.707 167.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 99.1 t -140.26 134.21 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 125.858 1.663 . . . . 0.0 110.055 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -158.46 123.66 4.34 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.872 1.669 . . . . 0.0 110.32 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -156.85 52.91 0.51 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.221 1.408 . . . . 0.0 110.837 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -134.33 126.4 29.6 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.723 1.209 . . . . 0.0 111.031 -173.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -130.33 22.22 5.19 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.926 1.69 . . . . 0.0 112.14 -171.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 80.6 p -95.7 -172.94 2.73 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.866 2.466 . . . . 0.0 111.923 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -147.87 25.6 1.03 Allowed 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.11 -0.994 . . . . 0.0 113.257 172.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.9 t -149.76 149.92 31.27 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.676 -1.265 . . . . 0.0 111.595 -174.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.1 pt -139.06 148.21 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.831 1.652 . . . . 0.0 110.786 -171.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -99.34 148.87 23.73 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.106 1.363 . . . . 0.0 110.601 166.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 14.8 t -131.01 101.41 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.01 -12.86 82.89 Favored Glycine 0 N--CA 1.475 1.247 0 C-N-CA 124.128 0.871 . . . . 0.0 114.963 -161.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -164.26 148.48 9.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.531 1.932 . . . . 0.0 108.785 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.3 mp -144.51 -79.42 0.19 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.541 1.937 . . . . 0.0 109.63 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.5 t 177.03 162.64 0.46 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 128.232 2.613 . . . . 0.0 108.652 -162.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -91.75 0.37 57.49 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.407 1.083 . . . . 0.0 113.511 -174.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -120.24 0.42 10.64 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.424 1.89 . . . . 0.0 114.543 -173.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.8 t -90.15 168.51 11.9 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.932 -1.105 . . . . 0.0 113.152 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 40.0 p -143.41 163.72 35.21 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 127.488 2.315 . . . . 0.0 109.798 -174.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -60.58 -29.08 87.78 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.249 1.966 . . . . 0.0 113.193 169.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -69.08 -39.89 78.76 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.339 0.972 . . . . 0.0 111.837 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -60.98 -40.47 93.55 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.561 0.744 . . . . 0.0 111.585 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.4 mt -70.04 -31.67 69.42 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 172.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 51.8 m -65.9 -47.4 74.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.964 0.802 . . . . 0.0 110.868 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.03 -19.74 60.53 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -79.13 -55.93 4.74 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.307 1.443 . . . . 0.0 111.081 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -70.98 -28.16 64.24 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.162 0.985 . . . . 0.0 113.489 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 45.3 m -72.92 -2.31 20.37 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -64.91 -18.85 65.56 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.244 -0.91 . . . . 0.0 112.58 165.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 23.3 mm -90.08 -21.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.88 1.272 . . . . 0.0 112.222 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 168.64 -87.27 0.09 OUTLIER Glycine 0 N--CA 1.468 0.804 0 C-N-CA 125.379 1.466 . . . . 0.0 111.872 -173.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -162.07 120.18 2.22 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.663 1.185 . . . . 0.0 112.448 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 43.7 t -73.71 131.9 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 157.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.55 -18.34 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 171.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -162.37 141.21 9.11 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.144 1.778 . . . . 0.0 110.803 172.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -132.58 158.05 43.17 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.223 1.409 . . . . 0.0 111.522 164.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -153.31 143.91 22.61 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.471 1.508 . . . . 0.0 111.937 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 29.2 mm -141.13 137.43 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.697 1.599 . . . . 0.0 110.632 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 75.6 mt -89.77 113.74 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.625 1.57 . . . . 0.0 107.855 166.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 41.5 p -98.46 -178.85 4.15 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.35 1.86 . . . . 0.0 112.324 -170.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 26.6 t -156.62 167.25 31.01 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.091 1.356 . . . . 0.0 111.484 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -68.11 -18.23 64.59 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.11 1.364 . . . . 0.0 114.004 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 161.19 -1.3 0.07 OUTLIER Glycine 0 N--CA 1.475 1.292 0 N-CA-C 116.573 1.389 . . . . 0.0 116.573 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -151.74 143.76 23.85 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.791 1.296 . . . . 0.0 112.437 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 65.48 175.11 0.22 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 126.569 1.947 . . . . 0.0 113.452 -177.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 14.0 mmp_? 59.16 -145.41 0.53 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.328 1.451 . . . . 0.0 109.755 -171.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 79.25 62.11 2.24 Favored Glycine 0 N--CA 1.47 0.924 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -175.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 11.7 ptt? -155.83 155.65 33.35 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.862 1.665 . . . . 0.0 111.036 -170.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 164.99 -144.65 9.5 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-N 118.638 0.654 . . . . 0.0 114.388 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.5 p -144.46 159.77 42.2 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.34 1.456 . . . . 0.0 112.954 -165.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 37.8 t -144.97 141.53 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.003 1.321 . . . . 0.0 110.322 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -121.16 134.32 55.22 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 127.018 2.127 . . . . 0.0 110.922 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -118.96 172.79 7.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.676 2.39 . . . . 0.0 111.234 -173.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 80.9 p -92.2 -22.03 20.04 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASN . . . . . 0.424 ' O ' HG12 ' A' ' 213' ' ' VAL . 18.4 m120 -148.49 137.4 21.64 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -169.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 19.3 m -69.84 -22.89 63.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.98 2.112 . . . . 0.0 115.814 -168.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -90.24 -36.92 14.46 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.639 0.654 . . . . 0.0 111.951 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -72.23 -37.11 69.25 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.102 -0.998 . . . . 0.0 112.573 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 209' ' ' ASN . 14.2 p -63.46 -28.7 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.607 0.763 . . . . 0.0 113.01 170.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.62 -46.57 37.45 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.86 0.864 . . . . 0.0 112.974 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -59.31 -27.84 66.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.317 1.447 . . . . 0.0 112.896 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.64 -60.93 2.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.216 1.006 . . . . 0.0 112.879 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 43.9 mt -65.09 -29.06 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 121.128 -0.982 . . . . 0.0 112.428 -169.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -51.44 -29.1 14.97 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.622 1.569 . . . . 0.0 113.19 168.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -93.87 -15.86 24.62 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.988 1.315 . . . . 0.0 113.698 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -127.6 -18.6 4.33 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -159.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.81 120.9 13.36 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 121.227 1.831 . . . . 0.0 110.506 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 92.98 0.78 68.02 Favored Glycine 0 N--CA 1.472 1.039 0 CA-C-O 117.941 -1.477 . . . . 0.0 115.059 -170.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.97 108.16 0.99 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.839 1.82 . . . . 0.0 110.348 171.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -55.68 129.25 38.44 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.313 0.645 . . . . 0.0 110.333 160.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -152.25 110.84 3.77 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.996 1.719 . . . . 0.0 106.685 -162.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 2.6 mpt? 41.15 59.28 2.35 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.152 0.981 . . . . 0.0 111.435 -160.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 73.21 0.05 3.54 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.922 2.089 . . . . 0.0 116.174 170.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -137.58 147.0 44.71 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.622 1.169 . . . . 0.0 111.775 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -70.83 124.22 23.79 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.903 -1.123 . . . . 0.0 113.698 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.4 pt -65.78 137.13 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.336 -0.853 . . . . 0.0 111.332 153.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -129.76 129.84 44.63 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.068 1.347 . . . . 0.0 109.596 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -156.32 129.09 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.992 0.917 . . . . 0.0 111.614 -169.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -106.95 148.59 28.45 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.919 1.687 . . . . 0.0 109.443 168.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.21 162.0 27.72 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.884 0.874 . . . . 0.0 111.806 178.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -131.63 153.58 49.79 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.433 1.493 . . . . 0.0 112.209 -171.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 37.5 t30 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.032 1.733 . . . . 0.0 111.978 -179.994 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 112.186 -0.366 . . . . 0.0 112.186 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.1 m -169.24 152.22 4.9 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.959 2.104 . . . . 0.0 110.781 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -160.66 162.8 32.77 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.513 1.525 . . . . 0.0 111.833 -176.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -66.71 145.68 55.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.557 1.143 . . . . 0.0 111.924 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -147.31 138.36 23.72 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.559 1.544 . . . . 0.0 110.528 173.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 pp -168.39 175.61 6.26 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.343 1.857 . . . . 0.0 111.906 -169.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -146.66 152.52 39.0 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.455 1.902 . . . . 0.0 110.839 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 10.4 t -160.33 160.94 33.05 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.636 1.174 . . . . 0.0 112.033 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.8 m -165.22 138.72 4.65 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 127.349 2.26 . . . . 0.0 108.734 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -160.11 145.32 15.05 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.429 1.091 . . . . 0.0 113.197 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.71 153.06 7.1 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.997 2.119 . . . . 0.0 109.243 173.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -161.72 129.76 4.18 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.282 1.033 . . . . 0.0 111.916 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -139.14 154.48 48.11 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.061 1.745 . . . . 0.0 111.258 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.38 146.82 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 125.547 1.539 . . . . 0.0 111.2 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -162.26 149.93 14.2 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.26 1.424 . . . . 0.0 111.55 -174.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.2 mmt-85 -140.07 118.32 12.03 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.531 1.532 . . . . 0.0 109.909 172.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -166.11 144.3 5.64 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.231 1.813 . . . . 0.0 110.743 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -129.53 123.5 31.59 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.18 0.992 . . . . 0.0 110.135 165.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 67.7 m -149.26 93.78 2.13 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.929 1.292 . . . . 0.0 110.417 -174.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -96.78 11.71 34.63 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 80.2 p -151.11 155.67 39.42 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.652 -1.28 . . . . 0.0 111.861 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 5.1 pt -144.58 154.37 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.219 1.407 . . . . 0.0 111.806 -165.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -119.02 125.85 50.32 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.553 1.941 . . . . 0.0 109.627 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 12.2 t -107.94 129.96 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.743 1.217 . . . . 0.0 109.111 -175.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.37 -97.66 0.12 Allowed Glycine 0 N--CA 1.472 1.094 0 C-N-CA 125.667 1.604 . . . . 0.0 115.036 -161.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -92.68 -56.86 2.85 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 117.625 0.713 . . . . 0.0 111.924 -173.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.45 6.67 1.52 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 118.752 2.871 . . . . 0.0 118.752 155.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.7 m 79.18 124.23 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 127.783 2.433 . . . . 0.0 110.422 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -68.25 -13.35 62.19 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -81.45 -9.14 59.78 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.503 1.521 . . . . 0.0 113.319 172.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.0 m -74.77 141.78 44.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.998 0.919 . . . . 0.0 112.551 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.8 p -122.87 152.78 63.21 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.971 1.308 . . . . 0.0 111.554 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.6 -25.9 14.46 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.607 2.205 . . . . 0.0 113.057 -173.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -69.43 -39.44 77.84 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.437 1.017 . . . . 0.0 111.891 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -73.16 -36.23 66.59 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.451 -0.781 . . . . 0.0 111.349 177.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 49.3 mt -62.24 -31.93 72.55 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.773 0.829 . . . . 0.0 112.289 166.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 54.8 m -67.0 -51.06 59.74 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.48 1.036 . . . . 0.0 109.634 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.92 -36.15 78.55 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.424 0.556 . . . . 0.0 112.359 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -67.38 -57.41 6.64 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.014 1.726 . . . . 0.0 112.29 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -71.57 -34.01 69.57 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.9 t -72.53 -8.79 56.95 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 121.004 -1.06 . . . . 0.0 113.441 -174.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -52.54 -27.99 18.93 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.362 2.265 . . . . 0.0 113.053 164.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 28.4 mm -80.52 -17.26 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.547 1.539 . . . . 0.0 112.451 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 117.25 90.98 1.54 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.909 1.719 . . . . 0.0 112.324 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? 69.69 91.29 0.09 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 126.751 2.02 . . . . 0.0 114.472 162.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 13.9 t -73.14 128.09 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 162.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 66.5 t -91.12 -22.51 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.892 1.677 . . . . 0.0 111.25 -175.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -178.43 140.03 0.2 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.243 2.217 . . . . 0.0 109.576 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -120.03 141.33 49.84 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.487 1.115 . . . . 0.0 110.52 162.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -143.7 92.95 2.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.677 1.191 . . . . 0.0 111.595 -169.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.6 -49.53 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.689 1.196 . . . . 0.0 110.815 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 18.8 tt -70.26 132.32 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.341 0.656 . . . . 0.0 111.923 -172.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 7.1 t -151.9 150.27 29.87 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.174 1.79 . . . . 0.0 110.559 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 3.9 t -95.99 -0.07 51.08 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.371 1.068 . . . . 0.0 112.769 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -82.72 0.13 44.92 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.191 1.397 . . . . 0.0 114.487 -171.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.98 162.43 28.72 Favored Glycine 0 N--CA 1.472 1.098 0 C-N-CA 125.606 1.574 . . . . 0.0 112.841 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -140.89 131.55 25.62 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.747 1.219 . . . . 0.0 112.868 -169.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -133.67 12.02 4.06 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.22 1.408 . . . . 0.0 113.487 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -167.19 -40.11 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.394 1.878 . . . . 0.0 112.909 -176.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 90.26 16.94 54.74 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.604 1.097 . . . . 0.0 114.317 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 28.2 ptm -66.95 162.52 21.74 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.954 1.302 . . . . 0.0 113.76 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -166.22 -166.74 25.76 Favored Glycine 0 N--CA 1.471 1.025 0 C-N-CA 124.031 0.824 . . . . 0.0 114.088 174.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.8 p -141.84 161.14 38.69 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.83 1.252 . . . . 0.0 112.599 -167.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 6.4 t -143.54 142.28 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.651 1.18 . . . . 0.0 110.435 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -114.49 145.26 42.12 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.225 2.21 . . . . 0.0 111.218 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -129.83 161.69 30.2 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.936 2.494 . . . . 0.0 109.535 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.2 p -84.21 -28.56 27.22 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.99 -0.444 . . . . 0.0 111.396 171.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -84.66 174.7 9.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.36 1.864 . . . . 0.0 112.902 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 39.3 t -126.03 -65.92 0.96 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.85 0.86 . . . . 0.0 111.49 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -64.5 -25.48 68.01 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.51 -1.369 . . . . 0.0 113.821 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -72.06 -20.92 61.59 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.561 1.144 . . . . 0.0 113.315 171.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 22.0 t -70.05 -28.3 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.049 0.94 . . . . 0.0 111.591 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -74.44 -37.07 63.37 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.283 -0.886 . . . . 0.0 112.208 167.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -64.8 -23.66 67.31 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.239 1.016 . . . . 0.0 112.405 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.97 -63.87 1.12 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.19 0.996 . . . . 0.0 110.565 164.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 83.8 mt -62.09 -35.63 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.215 1.006 . . . . 0.0 112.396 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -64.03 -6.56 6.52 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -114.29 -5.15 12.96 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.525 1.53 . . . . 0.0 112.535 172.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -128.06 -19.43 3.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -169.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -58.64 121.43 10.97 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.072 1.306 . . . . 0.0 109.227 162.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 93.83 0.51 66.35 Favored Glycine 0 N--CA 1.468 0.786 0 CA-C-O 118.379 -1.234 . . . . 0.0 114.849 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.57 108.53 2.46 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.512 1.656 . . . . 0.0 110.463 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -54.8 123.24 12.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.434 0.694 . . . . 0.0 109.963 155.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -148.62 116.51 6.35 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.422 1.489 . . . . 0.0 108.335 -167.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 56.21 31.58 18.67 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.101 0.96 . . . . 0.0 111.968 -163.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 10.7 t70 86.61 0.66 0.57 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 128.37 2.668 . . . . 0.0 115.582 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.4 152.77 48.69 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.638 1.175 . . . . 0.0 111.782 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -82.38 123.68 29.33 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -158.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.75 153.4 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 126.037 1.735 . . . . 0.0 113.318 167.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -145.86 146.65 31.2 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.552 1.941 . . . . 0.0 108.787 164.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 23.4 t -117.41 128.57 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.727 1.211 . . . . 0.0 110.586 -173.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -75.56 129.59 37.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.863 0.865 . . . . 0.0 109.364 168.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -100.28 136.94 39.39 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.005 1.322 . . . . 0.0 108.605 173.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 69.19 150.31 0.08 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 127.088 2.155 . . . . 0.0 113.96 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 12.0 t30 . . . . . 0 C--O 1.255 1.345 0 C-N-CA 125.7 1.6 . . . . 0.0 112.076 -179.859 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.824 0 N-CA-C 112.335 -0.306 . . . . 0.0 112.335 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.1 m -170.06 155.36 5.48 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.908 2.083 . . . . 0.0 110.98 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.34 143.08 50.37 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.835 0.854 . . . . 0.0 112.15 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -153.38 22.0 0.55 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.901 1.28 . . . . 0.0 114.171 -174.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -141.05 154.47 45.98 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.06 1.744 . . . . 0.0 110.631 -175.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -159.06 168.92 25.45 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.074 1.75 . . . . 0.0 112.177 -176.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -143.7 145.84 32.73 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.785 1.634 . . . . 0.0 111.307 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.7 p -164.23 167.44 20.0 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.648 1.579 . . . . 0.0 111.642 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.7 p -139.91 152.47 46.43 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.415 1.486 . . . . 0.0 111.449 -173.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -71.21 -10.77 60.31 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -172.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -78.39 -7.27 57.15 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -78.95 60.14 2.82 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 123.045 1.403 . . . . 0.0 111.271 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -81.98 -9.39 59.58 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.35 1.86 . . . . 0.0 114.542 -173.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.6 t 72.82 -69.68 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 128.38 2.672 . . . . 0.0 112.282 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 68.02 144.44 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 127.33 2.252 . . . . 0.0 113.339 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? 62.1 55.56 2.45 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.276 1.83 . . . . 0.0 111.348 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -81.82 57.12 3.3 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.903 1.681 . . . . 0.0 112.498 -168.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -129.78 18.94 5.63 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.667 1.587 . . . . 0.0 113.058 -166.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 29.8 t -154.24 163.7 39.72 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.498 1.519 . . . . 0.0 111.267 -171.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -153.16 22.29 0.56 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.891 1.276 . . . . 0.0 113.843 -169.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.2 t -144.88 156.86 44.23 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.508 -1.37 . . . . 0.0 113.165 -174.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.0 pt -143.61 147.32 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 125.301 1.44 . . . . 0.0 112.275 -165.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -113.78 118.98 35.78 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 128.041 2.536 . . . . 0.0 109.257 173.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 25.5 t -94.57 97.15 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.363 1.465 . . . . 0.0 107.397 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.39 -9.22 67.26 Favored Glycine 0 N--CA 1.475 1.25 0 N-CA-C 116.052 1.181 . . . . 0.0 116.052 -160.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -139.61 18.13 2.53 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -164.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.02 -174.92 2.86 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.28 1.432 . . . . 0.0 112.689 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 38.1 m -97.26 122.96 40.88 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.023 1.329 . . . . 0.0 109.503 171.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -66.94 -10.42 48.92 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -171.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -74.82 -13.11 60.53 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.486 1.514 . . . . 0.0 113.867 174.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 5.8 m -67.24 137.89 56.5 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.022 -1.049 . . . . 0.0 111.447 168.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 78.8 p -76.21 163.27 67.51 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 123.836 0.855 . . . . 0.0 109.908 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -59.91 -35.64 92.98 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 121.758 1.639 . . . . 0.0 111.917 168.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.42 -29.01 69.06 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.787 0.722 . . . . 0.0 112.88 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -65.21 -33.72 76.67 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.078 0.951 . . . . 0.0 111.992 173.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.3 mt -74.59 -34.16 62.81 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 118.003 -0.998 . . . . 0.0 113.451 165.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 84.8 m -61.08 -51.12 70.48 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.94 1.246 . . . . 0.0 110.62 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.24 -30.5 70.95 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.889 0.768 . . . . 0.0 112.973 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -68.27 -56.37 8.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.034 1.334 . . . . 0.0 111.514 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -71.65 -23.38 61.67 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.7 t -61.98 -19.65 63.03 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.651 -1.28 . . . . 0.0 113.457 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -60.97 -17.95 54.55 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.281 1.833 . . . . 0.0 113.306 169.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 25.8 mm -104.45 -51.87 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.144 1.378 . . . . 0.0 111.851 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -172.33 -177.42 41.79 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.165 1.364 . . . . 0.0 112.403 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -74.24 105.6 5.5 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 121.624 -0.927 . . . . 0.0 112.168 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 48.3 t -59.68 130.13 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 160.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.02 -40.16 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.312 0.645 . . . . 0.0 110.422 171.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -155.54 139.4 16.24 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.871 2.068 . . . . 0.0 109.983 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -125.31 152.96 43.99 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.313 1.445 . . . . 0.0 110.665 164.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -150.97 131.67 14.01 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.541 1.136 . . . . 0.0 112.203 -171.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.7 mt -142.48 -63.28 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.225 1.41 . . . . 0.0 110.974 171.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 15.7 tt -80.47 137.34 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.554 0.742 . . . . 0.0 111.081 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 43.5 p -137.08 144.34 43.07 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.354 1.062 . . . . 0.0 110.879 -168.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 14.4 m -61.07 -12.86 13.41 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -170.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 26.3 mmt85 -74.47 -17.69 60.74 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.048 0.939 . . . . 0.0 113.029 173.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 77.06 8.08 86.82 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.429 1.49 . . . . 0.0 115.562 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -83.58 137.01 34.03 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 118.9 1.35 . . . . 0.0 113.419 -174.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -72.7 101.69 3.14 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.897 0.879 . . . . 0.0 111.415 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -85.76 -30.21 23.24 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -173.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 73.5 14.61 79.44 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 123.888 0.756 . . . . 0.0 114.759 -175.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -153.97 167.82 28.47 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.04 1.336 . . . . 0.0 112.809 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -147.09 172.85 27.45 Favored Glycine 0 N--CA 1.468 0.774 0 C-N-CA 126.025 1.774 . . . . 0.0 112.808 177.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.3 p -142.81 148.77 37.67 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.12 1.368 . . . . 0.0 111.013 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.29 137.28 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.09 0.956 . . . . 0.0 109.983 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -116.09 137.08 52.44 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.706 1.603 . . . . 0.0 109.635 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -110.98 159.12 18.03 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.17 1.788 . . . . 0.0 110.411 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 64.1 p -77.07 0.48 21.28 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 169.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -130.01 157.18 43.05 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.106 1.762 . . . . 0.0 112.886 -165.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 72.1 p -109.14 -7.85 15.24 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.601 1.56 . . . . 0.0 114.916 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.71 -45.42 1.46 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.39 1.476 . . . . 0.0 111.914 -166.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.23 -30.08 68.16 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.596 -0.69 . . . . 0.0 111.505 172.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.5 p -61.13 -32.11 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.276 1.43 . . . . 0.0 113.025 174.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -74.16 -48.11 31.48 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.965 0.906 . . . . 0.0 111.436 171.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -72.34 -11.76 60.84 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.62 -56.75 17.46 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.6 1.16 . . . . 0.0 111.381 163.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 71.2 mt -66.87 -30.33 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.055 0.942 . . . . 0.0 112.109 -168.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -52.41 -28.37 19.58 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.507 1.123 . . . . 0.0 113.471 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -97.1 -15.23 21.07 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.399 1.48 . . . . 0.0 112.579 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -123.29 -15.64 7.14 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -165.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -61.31 120.65 10.83 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.53 1.514 . . . . 0.0 108.88 162.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 97.57 -0.24 59.58 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 118.153 -1.36 . . . . 0.0 114.844 -172.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.17 103.88 2.46 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.727 1.764 . . . . 0.0 110.469 173.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -60.81 119.69 8.67 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 158.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -150.38 110.85 4.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.152 1.381 . . . . 0.0 108.633 -165.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 57.13 55.38 6.04 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.298 1.039 . . . . 0.0 110.865 -170.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 19.5 t70 76.13 0.18 3.23 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.749 2.02 . . . . 0.0 116.088 169.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -146.86 157.36 43.63 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.311 0.959 . . . . 0.0 112.787 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 4.2 tmmm? -86.36 105.42 16.69 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.673 1.189 . . . . 0.0 112.647 -172.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.22 154.1 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.188 0.995 . . . . 0.0 112.052 165.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -156.45 144.77 19.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.466 1.906 . . . . 0.0 107.486 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 13.2 t -127.36 140.31 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.632 0.773 . . . . 0.0 111.926 -162.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 81.6 mtt85 -119.25 136.73 54.08 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.95 2.1 . . . . 0.0 108.318 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -94.76 151.78 18.98 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.227 -0.92 . . . . 0.0 110.49 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -73.29 140.47 46.82 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.672 -0.642 . . . . 0.0 111.561 167.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.253 0 C-N-CA 125.869 1.668 . . . . 0.0 111.097 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.5 t -163.45 -47.33 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.08 0.952 . . . . 0.0 113.379 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.93 -10.97 59.99 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -173.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 57.3 55.91 5.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.131 1.773 . . . . 0.0 112.265 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -73.07 134.1 44.43 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.58 0.752 . . . . 0.0 109.725 170.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.4 mt -140.69 158.66 43.65 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.295 1.438 . . . . 0.0 111.925 -171.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -72.51 166.22 23.08 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.221 1.408 . . . . 0.0 112.832 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.9 m -160.92 152.92 19.9 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.275 1.83 . . . . 0.0 111.679 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 37.8 p -126.66 147.05 49.97 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.569 1.548 . . . . 0.0 111.537 -172.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -144.05 162.71 35.53 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.196 1.398 . . . . 0.0 112.279 -170.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -160.21 163.03 33.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.992 1.317 . . . . 0.0 112.436 -175.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.86 126.49 17.92 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.768 1.627 . . . . 0.0 109.541 173.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -87.12 152.07 22.66 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.251 1.02 . . . . 0.0 112.37 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.5 m -146.1 152.23 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 126.068 1.747 . . . . 0.0 111.152 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -145.86 139.98 26.71 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.228 1.411 . . . . 0.0 111.474 -175.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -95.47 135.53 37.0 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.969 1.308 . . . . 0.0 110.949 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -92.8 -8.03 44.78 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 48.3 t80 76.37 117.44 0.06 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 128.461 2.704 . . . . 0.0 113.109 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 30.6 m 50.49 39.28 20.54 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.186 1.395 . . . . 0.0 113.189 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -60.19 131.54 51.14 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -154.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.7 t -78.04 158.38 29.23 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.529 1.532 . . . . 0.0 112.806 170.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 31.7 pt -138.95 138.89 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.898 2.079 . . . . 0.0 107.948 175.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -105.73 131.3 53.25 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.59 1.156 . . . . 0.0 109.52 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.7 t -111.2 122.96 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.677 1.591 . . . . 0.0 108.354 -170.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.12 -141.67 1.78 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.195 1.855 . . . . 0.0 113.312 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -74.97 47.26 0.34 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -162.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.62 ' HB2' HG22 ' A' ' 230' ' ' ILE . 2.5 pt? -53.99 -50.1 67.34 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.819 -1.175 . . . . 0.0 112.606 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.1 t 145.23 142.96 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.388 1 C-N-CA 131.705 4.002 . . . . 0.0 110.18 173.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -68.95 -9.5 52.39 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -80.59 -6.07 57.75 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.748 1.219 . . . . 0.0 113.198 170.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 6.2 t -88.72 167.06 13.63 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.957 0.903 . . . . 0.0 113.163 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.45 151.74 64.71 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 125.741 1.617 . . . . 0.0 111.385 -170.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.41 -21.76 11.42 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.797 2.332 . . . . 0.0 114.331 -167.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.02 -34.79 75.81 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.156 1.344 . . . . 0.0 111.567 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.42 -41.66 84.48 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.777 1.231 . . . . 0.0 110.874 175.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.4 tp -67.38 -33.59 75.51 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.478 1.911 . . . . 0.0 111.455 174.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 68.3 m -64.26 -50.45 67.91 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.428 1.491 . . . . 0.0 110.41 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -67.59 -40.5 84.79 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.918 0.487 . . . . 0.0 111.622 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -56.07 -56.58 19.1 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.484 1.513 . . . . 0.0 112.235 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -71.13 -27.46 63.59 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.6 m -73.3 0.51 11.8 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -68.75 -19.59 64.34 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.169 -0.957 . . . . 0.0 112.597 164.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 14.0 mm -95.05 -55.29 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.104 0.961 . . . . 0.0 111.137 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -135.68 -109.68 1.02 Allowed Glycine 0 N--CA 1.468 0.779 0 C-N-CA 125.906 1.717 . . . . 0.0 110.372 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -152.84 121.99 6.63 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.213 1.005 . . . . 0.0 111.097 173.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 49.1 t -73.4 129.95 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 170.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.61 -24.05 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 170.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -152.78 135.7 15.51 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.463 1.505 . . . . 0.0 110.257 172.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -128.09 148.79 50.58 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.014 1.326 . . . . 0.0 110.598 160.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -145.53 134.98 23.15 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.6 1.16 . . . . 0.0 112.13 -172.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 59.2 mt -142.7 -60.48 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 125.64 1.576 . . . . 0.0 110.165 170.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 9.8 tp -65.68 137.21 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.729 0.811 . . . . 0.0 111.911 -175.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 3.7 t -151.44 136.74 17.6 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.061 1.744 . . . . 0.0 110.083 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 62.8 p -97.38 -2.99 41.14 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.916 1.286 . . . . 0.0 112.937 174.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -109.07 -33.35 6.92 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.669 1.588 . . . . 0.0 112.964 -176.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -97.08 168.36 24.49 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.129 1.347 . . . . 0.0 112.318 173.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -76.33 162.59 27.77 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-O 121.392 0.615 . . . . 0.0 112.254 169.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -79.58 83.56 5.55 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.316 -0.865 . . . . 0.0 111.572 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -71.0 -24.0 62.3 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.473 1.509 . . . . 0.0 113.458 -173.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 77.91 35.13 36.13 Favored Glycine 0 N--CA 1.475 1.243 0 C-N-CA 124.035 0.826 . . . . 0.0 112.483 -174.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 61.0 mtt -145.04 159.57 42.74 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.027 2.131 . . . . 0.0 110.772 -173.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -145.61 -179.08 21.61 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 124.383 0.992 . . . . 0.0 114.905 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 12.7 m -141.55 148.56 39.53 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.361 1.465 . . . . 0.0 109.087 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 19.6 t -141.25 147.15 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.263 1.025 . . . . 0.0 110.472 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.04 131.1 47.31 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.589 1.556 . . . . 0.0 110.976 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -102.53 161.69 13.52 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.51 1.524 . . . . 0.0 111.196 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 54.1 p -70.52 0.21 7.21 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.559 1.543 . . . . 0.0 113.893 166.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -141.75 162.21 36.03 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.432 1.893 . . . . 0.0 112.108 -165.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 12.5 m -132.67 13.42 4.45 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -132.06 -36.5 1.17 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.068 1.347 . . . . 0.0 112.661 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -66.51 -21.53 66.17 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.748 0.819 . . . . 0.0 112.397 167.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.1 m -63.87 -28.17 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.507 1.523 . . . . 0.0 112.907 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -74.3 -49.64 22.21 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.55 1.14 . . . . 0.0 111.449 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 23.4 ptt-85 -74.37 -11.86 60.36 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.7 -64.5 0.88 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.939 0.895 . . . . 0.0 110.835 160.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 66.3 mt -62.19 -32.83 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.938 0.895 . . . . 0.0 112.449 -171.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 35.0 ttm105 -57.21 -22.69 42.67 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 173.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -98.06 -11.14 23.25 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.41 1.084 . . . . 0.0 112.943 175.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -123.56 -21.29 5.3 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -165.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -66.2 120.44 13.23 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 120.415 1.461 . . . . 0.0 109.559 172.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 90.06 0.59 77.35 Favored Glycine 0 N--CA 1.473 1.127 0 CA-C-O 117.884 -1.509 . . . . 0.0 115.146 -168.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.8 109.46 1.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.986 1.893 . . . . 0.0 109.482 167.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -55.97 119.89 6.57 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 157.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -148.87 118.35 6.94 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.215 1.406 . . . . 0.0 108.259 -172.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.38 44.07 18.87 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-O 122.398 1.094 . . . . 0.0 110.212 -163.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 71.55 0.52 3.51 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 128.066 2.546 . . . . 0.0 116.253 173.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 30.1 mmt85 -135.04 148.69 49.97 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.07 1.348 . . . . 0.0 112.105 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -64.54 117.07 6.83 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.194 -0.941 . . . . 0.0 113.234 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.62 HG22 ' HB2' ' A' ' 168' ' ' LEU . 0.7 OUTLIER -68.26 153.56 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.635 0.774 . . . . 0.0 110.684 156.555 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -137.53 157.37 46.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.533 1.533 . . . . 0.0 107.857 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.12 139.24 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.528 1.058 . . . . 0.0 111.681 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -115.62 136.57 52.94 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.828 1.651 . . . . 0.0 108.84 169.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -72.51 139.9 47.87 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.512 -0.742 . . . . 0.0 109.278 172.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -126.42 -141.15 0.28 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.158 0.983 . . . . 0.0 111.333 -169.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 125.471 1.508 . . . . 0.0 111.654 -178.697 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 112.101 -0.4 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.0 t -161.86 159.1 26.44 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.18 1.392 . . . . 0.0 111.356 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -161.49 157.23 24.65 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.163 1.785 . . . . 0.0 111.579 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -74.09 132.02 41.89 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.042 0.937 . . . . 0.0 111.538 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -165.66 154.81 12.0 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.395 1.878 . . . . 0.0 110.894 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.7 pp -161.52 175.03 12.56 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.849 1.66 . . . . 0.0 112.247 -176.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -158.81 157.76 32.2 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.986 1.714 . . . . 0.0 111.731 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.3 t -164.58 176.23 9.11 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.286 1.435 . . . . 0.0 111.515 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.6 t -160.57 160.19 31.51 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.354 1.861 . . . . 0.0 110.849 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -65.51 127.64 32.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.842 0.857 . . . . 0.0 112.798 -177.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -159.08 129.6 5.92 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.451 1.9 . . . . 0.0 108.232 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -162.72 135.09 5.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.571 0.748 . . . . 0.0 111.505 -163.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -85.76 176.44 8.13 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.43 1.092 . . . . 0.0 113.431 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 31.2 m -128.55 170.64 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 125.497 1.519 . . . . 0.0 111.056 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -152.55 133.93 14.42 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.868 1.267 . . . . 0.0 110.564 -173.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -121.82 117.94 27.76 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.137 1.375 . . . . 0.0 109.966 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -163.98 139.46 6.19 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.225 1.81 . . . . 0.0 109.337 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -106.54 8.86 31.55 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.315 1.446 . . . . 0.0 114.311 -176.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.5 m -78.86 178.77 7.69 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.485 1.114 . . . . 0.0 113.387 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -64.46 34.62 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 128.271 2.628 . . . . 0.0 114.447 171.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.7 m -148.72 144.99 27.45 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.968 1.707 . . . . 0.0 111.917 -165.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.9 pt -130.92 150.2 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.976 1.71 . . . . 0.0 110.976 -170.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -110.0 138.88 45.76 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.503 1.521 . . . . 0.0 111.197 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 44.8 t -126.79 131.04 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.923 1.689 . . . . 0.0 108.786 -169.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.32 -164.2 7.2 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.976 1.751 . . . . 0.0 113.283 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -67.52 -14.96 63.39 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 118.062 2.615 . . . . 0.0 118.062 -157.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.3 mp 51.03 -112.71 0.65 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.537 1.535 . . . . 0.0 109.857 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 71.2 p -122.87 153.39 39.69 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.056 2.143 . . . . 0.0 109.312 154.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -57.12 -28.84 63.05 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -175.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -91.73 -0.98 57.59 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.821 2.048 . . . . 0.0 114.114 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 85.8 p -67.47 160.91 26.56 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.45 152.67 60.97 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 125.799 1.64 . . . . 0.0 111.593 -169.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.79 -18.53 11.7 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.151 2.567 . . . . 0.0 114.647 -165.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.43 -35.48 81.07 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.519 1.054 . . . . 0.0 111.112 172.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -69.64 -36.86 76.48 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.773 1.229 . . . . 0.0 111.399 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.8 mt -67.98 -31.89 71.91 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-O 118.685 -0.674 . . . . 0.0 112.326 169.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 59.7 m -67.16 -50.89 59.51 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.969 0.804 . . . . 0.0 109.516 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -58.13 -38.8 77.23 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.669 0.788 . . . . 0.0 112.293 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -65.56 -63.25 1.14 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.343 1.457 . . . . 0.0 112.236 176.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.16 -33.95 70.5 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -173.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.25 -3.39 26.55 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -172.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -65.47 -18.17 65.12 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 120.967 -1.083 . . . . 0.0 112.739 169.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 29.8 mm -78.53 -27.4 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.616 1.567 . . . . 0.0 112.31 174.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 139.25 169.45 11.58 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.994 1.759 . . . . 0.0 110.755 -158.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -57.72 106.54 0.36 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -164.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 53.9 t -71.05 131.36 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 151.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.29 -26.5 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 171.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 50.7 ttt-85 -162.74 110.47 1.28 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.856 0.463 . . . . 0.0 110.825 -170.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.72 151.74 19.84 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.192 0.997 . . . . 0.0 110.259 161.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -153.23 125.28 7.93 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.911 0.884 . . . . 0.0 111.615 -170.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mt -138.29 -53.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 125.565 1.546 . . . . 0.0 111.354 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 40.0 pt -65.9 124.72 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-O 121.409 0.623 . . . . 0.0 112.534 -168.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 14.6 t -151.7 153.33 34.16 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.494 1.918 . . . . 0.0 110.116 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 5.0 t 70.12 -173.61 0.18 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.077 1.751 . . . . 0.0 112.396 -168.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -81.34 -32.77 32.86 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.315 1.046 . . . . 0.0 112.884 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -104.59 127.56 9.13 Favored Glycine 0 N--CA 1.471 1.025 0 C-N-CA 125.488 1.518 . . . . 0.0 111.363 175.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -105.09 85.4 2.27 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.27 1.028 . . . . 0.0 111.995 -172.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -145.7 22.91 1.43 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.021 1.328 . . . . 0.0 112.869 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -97.56 -13.82 21.4 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -165.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 74.6 -76.74 1.13 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.881 1.229 . . . . 0.0 113.661 174.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.33 153.73 14.92 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.138 1.375 . . . . 0.0 114.545 -169.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -175.92 -152.46 9.56 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.8 p -143.01 159.83 41.5 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.124 1.77 . . . . 0.0 112.172 -172.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 18.8 t -140.42 140.89 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.294 1.038 . . . . 0.0 110.306 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -128.86 127.68 42.35 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.383 1.473 . . . . 0.0 109.981 -172.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -110.8 170.71 7.92 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.53 1.932 . . . . 0.0 109.746 -174.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 80.9 p -81.47 0.07 39.45 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -139.07 155.08 48.19 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.831 1.253 . . . . 0.0 114.088 -167.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 66.4 p -108.38 4.73 24.73 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.775 1.63 . . . . 0.0 113.68 -177.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -120.37 -46.04 2.41 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.634 1.174 . . . . 0.0 112.783 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -63.53 -22.04 66.67 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.313 -0.867 . . . . 0.0 113.039 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 213' ' ' VAL . 2.3 m -61.34 -29.74 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.896 2.079 . . . . 0.0 113.363 173.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -74.48 -49.46 22.13 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.026 0.83 . . . . 0.0 110.541 166.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -58.4 -28.28 65.05 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.797 1.239 . . . . 0.0 113.399 -174.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.2 -59.57 5.21 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.23 1.412 . . . . 0.0 112.291 168.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 51.6 mt -66.39 -31.25 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.22 1.008 . . . . 0.0 112.282 -170.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -58.91 -5.77 0.67 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 171.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -133.07 5.68 3.86 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.52 1.128 . . . . 0.0 114.038 172.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -123.11 -22.14 5.25 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.01 120.64 13.98 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 121.327 1.876 . . . . 0.0 110.653 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 92.16 0.83 70.38 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-O 118.025 -1.43 . . . . 0.0 115.119 -169.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.42 107.47 0.79 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.953 1.877 . . . . 0.0 109.926 168.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -52.02 123.95 11.68 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.957 161.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -147.97 120.83 8.72 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.022 1.329 . . . . 0.0 108.709 -172.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 50.5 mtt 60.37 28.07 17.68 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.154 0.982 . . . . 0.0 112.159 -169.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.6 t70 92.27 -0.06 0.13 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 129.449 3.1 . . . . 0.0 115.419 173.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 42.9 mmt180 -136.69 150.48 48.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.751 1.221 . . . . 0.0 112.184 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -65.12 111.71 3.05 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.862 -1.149 . . . . 0.0 112.555 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.47 152.0 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 O-C-N 121.169 -0.957 . . . . 0.0 109.761 151.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -132.12 156.66 45.96 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.145 1.378 . . . . 0.0 108.429 170.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.7 p -150.44 127.0 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.517 0.675 . . . . 0.0 112.113 -169.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -85.0 131.7 34.44 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.481 1.512 . . . . 0.0 108.403 175.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.402 ' NE2' ' H ' ' A' ' 235' ' ' ASP . 0.1 OUTLIER -86.51 154.78 20.84 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.315 1.046 . . . . 0.0 109.774 178.737 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.402 ' H ' ' NE2' ' A' ' 234' ' ' GLN . 3.3 p30 -68.78 150.57 47.7 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.919 -1.113 . . . . 0.0 113.38 178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 . . . . . 0 C--O 1.255 1.364 0 C-N-CA 128.125 2.57 . . . . 0.0 113.04 -178.565 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.718 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 25.3 m -130.94 14.25 5.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.067 0.947 . . . . 0.0 113.452 -169.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.18 137.67 48.93 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.378 1.071 . . . . 0.0 112.626 -177.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.1 mtt-85 -77.73 153.45 32.96 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.525 1.13 . . . . 0.0 112.033 177.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.06 -11.15 1.27 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.812 1.645 . . . . 0.0 113.788 177.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -84.9 -3.78 58.84 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.725 1.61 . . . . 0.0 114.312 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -80.75 40.7 0.53 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.609 2.364 . . . . 0.0 113.626 -171.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 49.0 m -162.51 140.37 8.44 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.634 1.974 . . . . 0.0 111.456 177.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.7 t -165.66 165.95 18.35 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.61 1.964 . . . . 0.0 110.639 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -161.12 162.43 31.49 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.727 1.611 . . . . 0.0 113.015 -174.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -160.64 127.44 4.19 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.524 1.53 . . . . 0.0 110.078 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -164.53 146.12 8.31 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.846 1.658 . . . . 0.0 110.45 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -150.57 -55.85 0.16 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.344 1.058 . . . . 0.0 112.59 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.9 m -145.66 141.5 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 125.958 1.703 . . . . 0.0 110.429 174.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -122.0 -3.45 9.1 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -173.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 73.2 ttp85 -165.82 140.53 4.71 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.428 1.491 . . . . 0.0 111.583 -172.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -159.97 -42.91 0.05 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.394 1.078 . . . . 0.0 112.737 166.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 67.48 160.06 0.16 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 127.527 2.331 . . . . 0.0 114.516 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 80.8 p -167.97 172.44 8.91 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.903 1.281 . . . . 0.0 112.867 -174.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -168.12 -46.09 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.834 2.054 . . . . 0.0 110.186 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 1.9 m -73.1 155.48 39.67 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 143.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 6.7 pt -139.22 150.94 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.69 1.596 . . . . 0.0 109.784 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -122.95 143.77 49.69 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.216 1.406 . . . . 0.0 111.986 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.0 t -124.34 116.82 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.226 1.81 . . . . 0.0 108.193 -174.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.06 -25.43 59.77 Favored Glycine 0 N--CA 1.475 1.24 0 C-N-CA 123.542 0.591 . . . . 0.0 114.403 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -162.17 151.22 15.48 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.742 2.017 . . . . 0.0 108.571 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -173.16 11.19 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 126.054 1.742 . . . . 0.0 114.917 -171.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 34.9 m 86.42 111.45 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 128.739 2.816 . . . . 0.0 109.403 -165.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -62.64 -17.43 60.36 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -83.42 -0.35 49.59 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.703 1.601 . . . . 0.0 113.529 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 10.0 t -67.66 167.56 12.9 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.834 -1.166 . . . . 0.0 113.797 175.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 44.8 p -135.7 153.32 77.32 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 125.972 1.709 . . . . 0.0 110.416 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.56 -23.96 26.54 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.566 2.177 . . . . 0.0 113.13 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.28 -37.19 77.75 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.885 0.766 . . . . 0.0 111.712 172.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.47 -35.37 68.21 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.507 -0.746 . . . . 0.0 111.424 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 20.9 mt -62.91 -35.85 81.44 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-O 118.807 -0.616 . . . . 0.0 112.334 166.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 74.7 m -67.93 -45.83 73.22 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.222 0.919 . . . . 0.0 110.337 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.7 -15.79 54.32 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.811 1.245 . . . . 0.0 113.502 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -96.5 -57.94 2.18 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.285 1.834 . . . . 0.0 111.896 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -71.6 -34.2 69.65 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 3.7 t -73.16 -15.92 61.45 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -159.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -64.35 -17.9 64.15 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 35.8 mm -59.8 -24.18 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.114 1.365 . . . . 0.0 112.641 173.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 167.52 -72.05 0.16 Allowed Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.926 1.25 . . . . 0.0 111.467 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -160.28 118.39 2.6 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.965 1.306 . . . . 0.0 111.158 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.29 137.93 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 165.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.5 m -110.27 -16.67 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -159.91 158.46 30.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.739 1.215 . . . . 0.0 111.881 176.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -160.06 149.13 17.5 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.939 1.696 . . . . 0.0 111.696 174.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -149.58 152.54 35.66 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.619 1.967 . . . . 0.0 111.641 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 26.6 mm -133.29 128.0 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 126.145 1.778 . . . . 0.0 107.844 170.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 17.4 tt -80.59 140.29 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 O-C-N 121.494 -0.753 . . . . 0.0 111.775 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 49.4 p -146.14 174.9 10.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.342 1.857 . . . . 0.0 111.049 -174.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 45.7 p -149.55 -173.27 4.36 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.836 1.254 . . . . 0.0 112.086 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.91 -10.55 58.93 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.253 1.021 . . . . 0.0 113.172 175.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -134.33 -151.38 6.39 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.025 1.774 . . . . 0.0 112.464 176.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -73.3 149.68 42.5 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.153 0.581 . . . . 0.0 112.273 170.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -154.74 163.7 39.87 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.18 1.392 . . . . 0.0 112.145 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -63.38 -24.93 68.06 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.975 1.31 . . . . 0.0 113.721 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 74.55 37.26 46.86 Favored Glycine 0 N--CA 1.471 1.008 0 CA-C-O 119.175 -0.792 . . . . 0.0 114.79 164.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -59.34 148.18 33.29 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.507 1.154 . . . . 0.0 112.415 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -110.43 158.97 14.11 Favored Glycine 0 N--CA 1.468 0.806 0 C-N-CA 124.656 1.122 . . . . 0.0 113.458 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.2 m -141.97 142.4 32.97 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.887 1.675 . . . . 0.0 108.032 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.7 t -142.4 149.97 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.972 0.909 . . . . 0.0 109.433 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -132.65 129.72 39.23 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.891 0.876 . . . . 0.0 111.523 -176.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -114.9 172.7 6.89 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.243 1.817 . . . . 0.0 111.102 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.8 p -86.85 -11.57 50.44 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -149.35 127.96 12.38 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 116.749 2.129 . . . . 0.0 116.749 -169.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 33.0 p -73.8 2.29 8.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 128.116 2.566 . . . . 0.0 116.064 -174.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -114.07 -36.76 4.64 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.269 1.428 . . . . 0.0 111.693 169.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.68 -27.68 69.09 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.5 -0.75 . . . . 0.0 112.775 173.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.9 m -59.55 -33.43 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 171.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -74.17 -46.61 41.15 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.958 0.799 . . . . 0.0 110.214 172.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -57.88 -29.7 65.25 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.673 0.789 . . . . 0.0 112.829 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.95 -68.57 0.35 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.778 1.231 . . . . 0.0 111.492 167.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 64.7 mt -61.99 -34.83 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.43 -0.793 . . . . 0.0 112.193 -167.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -58.69 -12.78 4.59 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.754 1.222 . . . . 0.0 114.187 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -116.62 -1.99 12.04 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.719 1.608 . . . . 0.0 112.888 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -128.91 -23.21 3.11 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.67 120.57 11.45 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 120.498 1.499 . . . . 0.0 109.832 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 95.68 0.48 62.46 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-O 118.11 -1.383 . . . . 0.0 115.725 -170.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.96 108.46 1.04 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.721 1.76 . . . . 0.0 109.973 169.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -58.12 124.17 18.46 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.788 -0.57 . . . . 0.0 109.921 158.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -150.38 110.97 4.24 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.852 1.261 . . . . 0.0 108.912 -159.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 49.8 mtt 57.91 23.36 9.72 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.585 1.154 . . . . 0.0 113.487 -169.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 19.8 t70 101.16 -11.61 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 130.811 3.644 . . . . 0.0 115.24 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -116.29 147.0 41.97 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 119.978 1.263 . . . . 0.0 111.801 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -68.09 112.06 4.83 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.308 1.443 . . . . 0.0 112.229 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.5 pt -61.21 141.69 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.473 1.033 . . . . 0.0 111.609 166.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -138.37 129.76 27.51 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.644 1.178 . . . . 0.0 109.158 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.2 126.81 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 123.626 0.771 . . . . 0.0 110.713 -164.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 52.7 ttt85 -97.04 140.57 31.37 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.539 1.936 . . . . 0.0 108.768 170.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 13.0 mp0 -70.68 101.27 2.03 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 169.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -163.78 147.17 9.98 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.862 1.265 . . . . 0.0 111.54 -166.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.795 1.638 . . . . 0.0 111.787 -167.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.3 t -163.57 173.37 13.11 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.64 1.576 . . . . 0.0 111.162 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . 63.97 15.84 9.47 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.882 2.073 . . . . 0.0 115.209 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -63.9 132.01 49.47 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.735 1.214 . . . . 0.0 111.618 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -73.77 162.87 28.67 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.47 1.108 . . . . 0.0 113.266 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.8 pp -155.66 178.4 10.29 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.037 1.735 . . . . 0.0 111.863 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -142.84 152.65 42.4 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.394 1.477 . . . . 0.0 112.248 -173.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.4 m -147.07 167.45 24.06 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.412 1.885 . . . . 0.0 111.136 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.2 t -148.94 150.68 33.31 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.278 1.431 . . . . 0.0 111.193 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -150.2 163.99 36.83 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.595 1.558 . . . . 0.0 112.614 -167.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -92.24 157.79 16.49 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.443 1.097 . . . . 0.0 111.201 170.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -146.42 40.87 1.13 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.02 1.328 . . . . 0.0 110.667 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -132.92 153.09 51.72 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.502 1.921 . . . . 0.0 111.33 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.2 p -160.96 143.04 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.879 1.272 . . . . 0.0 111.547 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -159.69 145.77 15.99 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.541 1.536 . . . . 0.0 111.497 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -153.44 143.13 21.89 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.963 1.305 . . . . 0.0 112.033 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -166.55 136.91 3.26 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.383 1.473 . . . . 0.0 111.315 -171.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -53.4 123.16 11.23 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.62 0.768 . . . . 0.0 111.67 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 69.0 m -133.32 126.3 31.1 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.783 0.833 . . . . 0.0 110.855 -165.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -76.12 -11.6 59.96 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.852 1.426 . . . . 0.0 114.852 -169.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.6 t -170.96 161.35 6.95 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.02 1.328 . . . . 0.0 111.486 -169.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -131.15 142.83 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.233 0.613 . . . . 0.0 110.024 158.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -111.93 142.48 44.28 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.71 1.604 . . . . 0.0 111.166 -174.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.3 t -144.61 121.32 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.161 0.984 . . . . 0.0 109.989 174.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -137.75 19.56 3.32 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.88 1.229 . . . . 0.0 115.602 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -128.57 20.02 6.16 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.305 1.442 . . . . 0.0 112.707 -171.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.455 ' HB3' HG22 ' A' ' 230' ' ' ILE . 1.3 pp -96.54 -175.88 3.45 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 126.984 2.114 . . . . 0.0 111.245 -174.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 48.4 m -79.81 121.5 25.47 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.782 0.833 . . . . 0.0 109.407 168.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -66.54 -11.56 53.47 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -170.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -81.38 -10.97 59.42 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.956 1.303 . . . . 0.0 113.588 171.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 91.5 p -77.66 142.6 38.75 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.6 -0.688 . . . . 0.0 111.664 172.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 68.2 p -102.52 163.63 17.25 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 125.067 1.347 . . . . 0.0 111.205 -171.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -64.54 -26.8 61.91 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.499 2.133 . . . . 0.0 112.931 171.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -69.34 -40.03 77.81 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.472 1.033 . . . . 0.0 111.729 171.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -66.93 -36.58 82.56 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.817 0.847 . . . . 0.0 111.64 175.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 45.7 mt -66.21 -32.66 74.22 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.547 -0.74 . . . . 0.0 112.725 166.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 81.8 m -67.1 -48.22 68.83 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.686 1.13 . . . . 0.0 109.965 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.05 -27.84 69.18 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -78.69 -58.96 2.98 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.53 1.532 . . . . 0.0 112.106 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -71.1 -37.83 72.39 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.65 -1.67 19.89 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -176.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -55.87 -26.87 49.09 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.797 1.639 . . . . 0.0 112.165 164.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.4 mm -75.87 -30.7 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.815 1.646 . . . . 0.0 112.88 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 166.86 -103.84 0.21 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.783 1.182 . . . . 0.0 112.181 -165.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -135.01 106.35 6.77 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.991 0.916 . . . . 0.0 113.396 -175.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 56.2 t -80.96 135.68 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 153.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.33 -24.72 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -157.88 88.66 0.98 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.547 0.739 . . . . 0.0 112.235 -170.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -91.18 140.97 29.3 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.812 -1.18 . . . . 0.0 111.709 168.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -153.28 121.44 6.17 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.919 1.287 . . . . 0.0 112.201 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 20.3 mt -141.78 -56.75 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 125.459 1.504 . . . . 0.0 111.08 174.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.4 mm -88.04 111.1 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 40.0 p -140.01 151.5 45.51 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.775 1.23 . . . . 0.0 111.052 -166.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 18.9 t -75.91 -28.54 58.09 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -172.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.34 -0.12 44.42 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.949 1.3 . . . . 0.0 113.286 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -78.33 162.1 49.24 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.69 1.138 . . . . 0.0 114.522 -174.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -130.28 0.95 4.62 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 126.827 2.051 . . . . 0.0 112.577 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -138.66 27.42 2.48 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.508 1.923 . . . . 0.0 113.119 -155.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -51.06 142.27 12.55 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.619 1.167 . . . . 0.0 113.076 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 100.06 -4.71 57.48 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.197 1.38 . . . . 0.0 114.161 -169.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 26.8 ptm -149.42 153.0 36.66 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.21 1.404 . . . . 0.0 111.74 173.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 169.6 -143.45 7.94 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.932 0.777 . . . . 0.0 113.002 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 25.0 p -137.87 160.87 38.12 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.986 0.914 . . . . 0.0 113.272 -162.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.3 t -136.03 102.42 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.126 1.371 . . . . 0.0 108.056 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -88.53 122.85 32.45 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.205 1.002 . . . . 0.0 110.457 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -90.02 176.03 6.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.86 1.664 . . . . 0.0 109.814 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 72.4 p -68.09 0.16 3.91 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 168.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 27.3 m120 85.77 2.91 0.6 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.743 2.817 . . . . 0.0 114.977 165.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.7 t -110.8 -168.53 1.32 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.462 1.505 . . . . 0.0 112.136 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -34.08 -38.37 0.06 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 130.531 3.533 . . . . 0.0 117.28 -164.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -52.15 -33.69 41.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.101 1.76 . . . . 0.0 112.733 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.0 p -68.83 -37.41 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.107 1.363 . . . . 0.0 112.952 -169.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -75.16 -52.07 11.86 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.734 1.214 . . . . 0.0 112.382 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -74.0 -18.47 60.85 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.654 1.182 . . . . 0.0 114.057 -171.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.47 -60.03 4.11 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.065 0.946 . . . . 0.0 111.911 170.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 27.9 mt -65.46 -28.73 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.706 0.803 . . . . 0.0 112.41 -171.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -28.63 37.53 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.324 1.05 . . . . 0.0 112.511 169.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -98.24 -11.31 22.8 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.443 1.097 . . . . 0.0 113.432 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -126.32 -20.12 4.51 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -164.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -62.42 120.79 11.73 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 120.038 1.29 . . . . 0.0 109.627 169.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 95.1 0.52 63.5 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-O 118.163 -1.354 . . . . 0.0 115.334 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.15 107.06 0.81 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.757 1.778 . . . . 0.0 110.673 170.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -57.22 107.32 0.41 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 154.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -129.74 110.66 11.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.323 1.049 . . . . 0.0 108.921 -167.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 48.2 ttm 53.88 43.92 30.22 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.923 0.889 . . . . 0.0 110.816 -168.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.8 t70 86.76 0.21 0.56 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 128.091 2.557 . . . . 0.0 116.146 170.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -136.19 135.89 39.5 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.622 1.101 . . . . 0.0 112.542 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -68.17 102.55 1.37 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.546 1.538 . . . . 0.0 113.541 -176.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.455 HG22 ' HB3' ' A' ' 168' ' ' LEU . 0.9 OUTLIER -56.51 151.25 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.117 0.967 . . . . 0.0 111.456 164.667 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -148.01 135.41 20.61 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.083 1.353 . . . . 0.0 108.921 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -156.94 137.08 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.217 1.407 . . . . 0.0 109.867 -165.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -119.55 140.6 50.27 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.855 1.262 . . . . 0.0 109.579 171.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -65.8 165.07 13.48 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.07 0.948 . . . . 0.0 111.819 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -72.25 5.26 2.95 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.315 1.446 . . . . 0.0 114.192 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 . . . . . 0 C--O 1.254 1.319 0 C-N-CA 126.622 1.969 . . . . 0.0 112.317 -179.247 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.693 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.6 m 69.92 172.78 0.3 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.682 1.993 . . . . 0.0 113.76 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -154.06 153.71 32.39 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.964 1.305 . . . . 0.0 112.46 -175.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.95 136.02 4.06 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.671 1.988 . . . . 0.0 111.242 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -90.28 -28.02 19.07 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -172.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 76.9 mt 66.42 -34.18 0.21 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 128.859 2.864 . . . . 0.0 115.452 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -69.49 129.14 38.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.375 1.47 . . . . 0.0 112.727 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 13.8 t -170.15 154.96 5.21 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.245 1.818 . . . . 0.0 110.811 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.4 t -164.85 158.12 17.01 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.997 1.719 . . . . 0.0 111.7 -174.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -159.47 143.24 14.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.404 1.882 . . . . 0.0 111.885 175.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -146.63 144.7 29.69 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.194 1.797 . . . . 0.0 110.173 178.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -159.73 139.25 11.3 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.965 1.306 . . . . 0.0 109.851 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -76.54 42.92 0.3 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.996 1.318 . . . . 0.0 113.135 -172.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.2 136.78 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.566 1.147 . . . . 0.0 110.575 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -163.89 -50.92 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.631 1.573 . . . . 0.0 111.096 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 68.54 156.82 0.13 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 127.499 2.32 . . . . 0.0 114.162 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -77.1 -27.94 54.29 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.264 -0.898 . . . . 0.0 112.987 174.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -169.04 149.27 4.25 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.843 2.057 . . . . 0.0 111.219 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.1 m -167.92 123.45 1.02 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.123 0.969 . . . . 0.0 112.366 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -147.31 -40.8 0.18 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.629 1.971 . . . . 0.0 111.817 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.5 p -166.97 168.06 14.2 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.73 -1.231 . . . . 0.0 114.08 -166.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 43.5 pt -137.26 138.04 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.647 1.179 . . . . 0.0 110.06 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -98.99 148.7 23.73 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.907 1.283 . . . . 0.0 109.489 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.6 t -126.4 131.67 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.537 1.535 . . . . 0.0 108.759 -172.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -74.17 -154.57 3.59 Favored Glycine 0 N--CA 1.474 1.192 0 C-N-CA 125.543 1.544 . . . . 0.0 112.93 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -55.48 -42.73 74.77 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -166.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 57.34 -169.44 0.11 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 128.061 2.545 . . . . 0.0 115.81 165.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.2 t -76.39 73.14 3.16 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.258 1.823 . . . . 0.0 110.416 166.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -68.05 -9.29 44.86 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -74.37 -12.42 60.52 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.113 1.365 . . . . 0.0 113.132 167.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 3.8 t -101.3 151.06 22.34 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.274 1.03 . . . . 0.0 113.523 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 17.6 p -81.94 152.67 69.06 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 126.444 1.898 . . . . 0.0 111.457 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.36 -25.79 80.66 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.213 2.609 . . . . 0.0 115.482 -173.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -67.21 -17.03 64.65 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.865 1.211 . . . . 0.0 113.439 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -70.74 -33.99 71.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.29 1.036 . . . . 0.0 111.25 170.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.1 mt -74.33 -32.48 62.83 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.336 -0.84 . . . . 0.0 111.782 167.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 31.1 m -62.75 -51.34 67.52 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.731 1.151 . . . . 0.0 110.264 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.53 -34.12 75.0 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.336 0.516 . . . . 0.0 112.119 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -67.0 -65.04 0.73 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.608 1.563 . . . . 0.0 111.329 176.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -71.24 -29.0 64.58 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -173.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.4 t -73.25 -23.63 60.36 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -173.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -67.34 -10.89 55.46 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 29.5 mm -69.89 -31.31 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.439 1.496 . . . . 0.0 112.59 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.66 42.01 0.03 OUTLIER Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.242 0.925 . . . . 0.0 114.221 -172.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 83.4 tttt 79.34 124.45 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 128.708 2.803 . . . . 0.0 113.606 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.7 149.32 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 126.159 1.784 . . . . 0.0 108.097 164.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 4.3 m -110.27 -18.27 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -157.32 147.29 20.65 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.846 0.858 . . . . 0.0 111.245 -175.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -154.48 144.39 21.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.729 1.611 . . . . 0.0 110.559 170.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -155.11 153.07 30.29 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 122.096 0.95 . . . . 0.0 113.262 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 51.0 mm -110.32 -23.65 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 127.3 2.24 . . . . 0.0 110.543 171.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 46.3 mm -68.76 120.66 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 O-C-N 120.792 -1.193 . . . . 0.0 108.206 170.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 2.5 p -151.2 160.79 43.64 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.356 1.462 . . . . 0.0 111.35 -159.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.4 m -63.78 158.59 21.39 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.474 1.109 . . . . 0.0 113.019 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -57.48 -43.36 84.02 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -175.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 56.28 -140.88 41.88 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.081 1.324 . . . . 0.0 114.016 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -139.96 132.41 28.54 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.014 1.726 . . . . 0.0 110.665 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 1.4 t60 70.44 138.09 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 127.588 2.355 . . . . 0.0 113.082 -173.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -74.71 135.19 41.84 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.163 0.985 . . . . 0.0 112.4 -171.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 88.16 131.23 3.64 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.698 1.618 . . . . 0.0 112.773 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 22.8 ptp -174.3 168.66 3.94 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 127.219 2.207 . . . . 0.0 111.527 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -156.47 175.22 34.16 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.195 1.379 . . . . 0.0 113.197 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 27.5 m -148.17 147.05 29.02 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.148 1.379 . . . . 0.0 109.889 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.1 t -139.0 141.55 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.448 1.099 . . . . 0.0 109.541 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -123.93 131.64 53.6 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.603 1.161 . . . . 0.0 111.509 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -102.2 173.81 6.2 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.306 1.842 . . . . 0.0 110.426 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 81.3 p -68.88 0.65 4.15 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 176.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 93.04 52.48 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 128.169 2.587 . . . . 0.0 113.606 161.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.7 t -161.4 -165.35 1.29 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.947 0.899 . . . . 0.0 112.872 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -57.86 -10.37 1.69 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.097 2.159 . . . . 0.0 115.234 -168.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -52.07 -34.11 42.25 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.177 1.391 . . . . 0.0 111.729 162.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.54 -39.48 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.742 1.617 . . . . 0.0 111.427 176.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.65 -55.03 6.32 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.323 1.049 . . . . 0.0 111.919 171.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -59.11 -29.71 67.58 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.183 1.393 . . . . 0.0 113.706 -172.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.26 -60.59 3.57 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.931 0.892 . . . . 0.0 112.681 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 3.5 mp -68.79 -22.36 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.088 -1.008 . . . . 0.0 112.803 -168.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 16.5 mmt-85 -54.23 -27.91 37.73 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.401 0.68 . . . . 0.0 112.773 168.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -95.5 -17.71 21.24 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.795 1.238 . . . . 0.0 112.817 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -122.46 -18.87 6.57 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -161.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -58.24 120.21 8.27 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 120.585 1.539 . . . . 0.0 110.276 175.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 79.94 0.3 84.93 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.277 -1.291 . . . . 0.0 116.094 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.58 97.67 2.18 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 120.082 1.941 . . . . 0.0 111.377 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -48.92 135.63 15.32 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.028 0.931 . . . . 0.0 112.532 176.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -143.87 116.9 8.88 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.356 1.062 . . . . 0.0 109.852 -162.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 16.8 ttt 59.89 34.36 21.69 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.391 1.077 . . . . 0.0 111.156 -168.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 67.67 0.68 2.33 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.888 2.075 . . . . 0.0 114.095 -174.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -112.26 165.37 12.23 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.297 2.239 . . . . 0.0 111.423 -171.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -66.35 168.91 8.07 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.342 1.057 . . . . 0.0 113.144 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 41.8 pt -158.3 146.76 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 1 C-N-CA 132.204 4.201 . . . . 0.0 107.058 171.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -149.49 141.94 24.3 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.712 1.605 . . . . 0.0 107.219 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.8 p -150.44 137.38 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 120.068 1.303 . . . . 0.0 113.632 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -99.06 139.08 35.23 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.572 1.949 . . . . 0.0 110.931 176.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -106.26 1.79 26.26 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.43 1.492 . . . . 0.0 113.671 -167.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -118.09 69.24 0.78 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.654 1.182 . . . . 0.0 114.188 -156.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 24.5 t30 . . . . . 0 C--O 1.252 1.192 0 C-N-CA 126.493 1.917 . . . . 0.0 112.453 167.58 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.8 m 70.14 15.97 7.51 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.952 1.701 . . . . 0.0 114.698 171.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.92 137.21 51.37 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.332 1.053 . . . . 0.0 111.933 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -80.94 101.33 9.41 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.137 0.975 . . . . 0.0 110.845 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -164.67 127.86 2.39 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.98 1.312 . . . . 0.0 110.492 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 87.0 mt -145.29 117.3 8.29 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.623 1.569 . . . . 0.0 109.271 174.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -166.23 158.64 14.33 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.781 1.632 . . . . 0.0 111.449 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.6 t -161.86 162.18 29.21 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.041 1.337 . . . . 0.0 110.82 175.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.8 t -163.95 157.1 18.17 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.434 1.894 . . . . 0.0 111.133 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -162.46 122.81 2.44 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.575 1.55 . . . . 0.0 111.816 -171.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -86.25 103.66 15.06 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.739 1.216 . . . . 0.0 108.609 172.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.56 142.99 38.69 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -164.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -68.69 131.09 44.6 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.536 1.534 . . . . 0.0 112.234 -174.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 33.4 m -84.97 -10.96 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -89.72 7.37 37.13 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.884 1.274 . . . . 0.0 113.968 -173.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -60.62 140.05 57.57 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.046 0.938 . . . . 0.0 111.027 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -162.55 -41.48 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.457 1.103 . . . . 0.0 113.552 -170.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -81.14 -33.38 33.21 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.776 -0.578 . . . . 0.0 111.808 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.4 m 60.9 25.18 15.16 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 156.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -87.1 -5.3 59.07 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -173.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.8 m -125.09 164.37 20.37 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.739 1.616 . . . . 0.0 111.719 -171.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 8.0 pt -142.36 138.24 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.243 -0.911 . . . . 0.0 110.9 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -128.39 134.41 48.82 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.166 1.786 . . . . 0.0 109.951 -175.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.65 134.24 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.875 1.27 . . . . 0.0 109.979 -156.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.85 -116.23 0.12 Allowed Glycine 0 N--CA 1.478 1.455 0 C-N-CA 127.055 2.264 . . . . 0.0 115.002 -170.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -68.25 -62.59 1.33 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.71 1.255 . . . . 0.0 111.999 -176.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 62.92 5.03 1.66 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.533 2.333 . . . . 0.0 117.166 167.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 58.7 m 74.51 98.25 0.07 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 127.416 2.286 . . . . 0.0 108.643 -162.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -65.03 -16.18 63.16 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -170.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.15 0.38 51.18 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.883 1.673 . . . . 0.0 114.0 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 95.6 p -70.67 167.14 19.29 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 172.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 18.7 p -123.9 151.5 64.86 Favored Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 124.936 1.294 . . . . 0.0 112.392 -170.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.35 -17.44 16.68 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.347 2.698 . . . . 0.0 115.385 -169.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.8 -36.9 81.25 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.966 1.257 . . . . 0.0 111.953 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -72.98 -35.78 66.95 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.284 -0.885 . . . . 0.0 111.536 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.3 mt -64.07 -33.39 75.65 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.119 0.968 . . . . 0.0 111.903 168.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.4 m -65.57 -49.72 67.77 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.009 0.822 . . . . 0.0 109.666 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.35 -41.08 98.3 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.484 0.584 . . . . 0.0 112.008 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.68 -56.33 20.83 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.145 1.378 . . . . 0.0 112.29 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.23 -43.44 67.28 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.4 t -73.62 -12.6 60.8 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -171.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -62.59 -16.48 56.58 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.656 1.116 . . . . 0.0 113.101 170.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 16.3 mm -72.98 -33.0 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.751 1.22 . . . . 0.0 111.976 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.44 -84.49 0.08 OUTLIER Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.221 1.391 . . . . 0.0 112.517 -170.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -157.3 103.48 1.99 Allowed 'General case' 0 CA--C 1.55 0.942 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -170.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 40.4 t -77.35 136.81 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 156.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.0 p -104.86 -20.23 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.282 1.033 . . . . 0.0 112.813 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 30.8 ttm-85 -164.38 139.3 5.68 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.369 1.468 . . . . 0.0 111.706 173.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -129.67 147.12 51.43 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.864 1.266 . . . . 0.0 111.259 164.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -159.11 152.29 22.37 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 174.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.6 mm -113.78 -19.92 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 126.564 1.946 . . . . 0.0 111.224 171.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.03 136.12 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.857 1.263 . . . . 0.0 108.935 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 76.6 p -128.96 126.7 40.16 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.951 1.3 . . . . 0.0 110.245 -177.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 59.6 p -107.2 -16.99 14.27 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -171.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -87.07 -5.7 58.95 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.528 1.131 . . . . 0.0 113.508 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 163.82 173.37 32.42 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.336 1.922 . . . . 0.0 112.508 -178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -77.73 138.96 39.32 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.615 0.766 . . . . 0.0 112.989 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -131.06 128.46 40.29 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.507 1.523 . . . . 0.0 110.001 171.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -82.73 59.14 4.61 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.232 1.413 . . . . 0.0 112.172 -171.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 96.87 -13.66 64.85 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.251 1.881 . . . . 0.0 115.213 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -64.15 135.87 56.73 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.047 1.423 . . . . 0.0 113.443 -176.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -114.84 168.89 12.67 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.887 1.708 . . . . 0.0 113.82 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 21.8 m -141.09 144.59 35.0 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.916 1.286 . . . . 0.0 109.838 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.8 t -137.15 136.87 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.8 0.84 . . . . 0.0 109.185 171.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -104.58 119.8 39.82 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.079 1.751 . . . . 0.0 109.205 173.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.433 ' HB2' HG12 ' A' ' 213' ' ' VAL . 9.2 m-85 -93.09 176.77 6.29 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.301 1.44 . . . . 0.0 109.034 163.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 45.6 p -97.4 -15.73 20.54 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -150.29 126.41 10.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.182 0.993 . . . . 0.0 113.226 -172.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.4 p -46.89 -53.58 11.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.68 1.992 . . . . 0.0 114.261 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -60.05 -28.58 67.89 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.89 -35.45 67.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.498 1.119 . . . . 0.0 112.644 173.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.433 HG12 ' HB2' ' A' ' 207' ' ' PHE . 0.6 OUTLIER -69.79 -40.52 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.013 0.925 . . . . 0.0 112.272 178.394 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.52 -47.53 66.73 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.577 -176.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -66.34 -18.29 65.27 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -70.84 -62.87 1.23 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.696 0.798 . . . . 0.0 110.475 167.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 60.8 mt -60.96 -33.86 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.446 1.099 . . . . 0.0 112.667 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -52.0 -19.9 2.1 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.971 1.709 . . . . 0.0 114.02 170.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -114.26 -6.79 12.99 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.849 1.66 . . . . 0.0 112.815 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -126.84 -22.72 3.8 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -166.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.88 120.71 13.04 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 120.916 1.689 . . . . 0.0 109.637 173.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 98.15 0.28 58.56 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-O 118.219 -1.323 . . . . 0.0 115.2 -168.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.33 108.23 1.26 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.718 1.759 . . . . 0.0 110.218 170.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -56.57 125.14 20.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.273 0.558 . . . . 0.0 109.772 154.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -149.59 110.84 4.41 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.319 1.447 . . . . 0.0 108.076 -159.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 24.1 mmt 55.87 32.95 20.66 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.626 0.77 . . . . 0.0 112.192 -169.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 87.49 0.37 0.47 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.888 2.875 . . . . 0.0 115.985 174.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.49 152.69 50.82 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.806 1.184 . . . . 0.0 112.043 173.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -77.48 129.12 35.3 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.8 -1.187 . . . . 0.0 114.104 -167.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.3 pt -75.58 133.52 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 120.997 -1.064 . . . . 0.0 110.487 164.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -118.24 144.47 45.75 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 166.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.3 p -150.85 140.19 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 120.162 1.347 . . . . 0.0 112.677 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -111.42 137.49 49.14 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.113 1.765 . . . . 0.0 110.255 171.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 -72.52 149.29 44.22 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 167.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -155.2 165.97 35.03 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.18 1.792 . . . . 0.0 111.121 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 C--O 1.254 1.325 0 C-N-CA 124.681 1.193 . . . . 0.0 111.071 179.595 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 CA-C-O 121.097 0.276 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.1 t -162.38 161.06 27.21 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.303 1.441 . . . . 0.0 111.335 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -159.63 153.99 23.85 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.884 1.674 . . . . 0.0 111.728 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -142.73 150.13 39.69 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.866 1.667 . . . . 0.0 111.183 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -161.63 154.41 20.44 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.974 1.709 . . . . 0.0 111.062 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.0 mt -143.48 154.0 43.2 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.808 1.643 . . . . 0.0 111.43 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -161.4 142.55 11.32 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.255 1.822 . . . . 0.0 110.862 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 17.0 t -163.22 153.69 16.19 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.752 1.221 . . . . 0.0 111.857 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 45.4 p -145.85 157.59 43.9 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.589 1.955 . . . . 0.0 110.755 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -160.1 164.52 32.97 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.203 1.401 . . . . 0.0 112.902 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -158.82 144.53 16.54 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.796 1.638 . . . . 0.0 109.965 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -155.0 143.51 20.52 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.26 1.424 . . . . 0.0 110.059 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -157.73 157.74 34.02 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.696 1.199 . . . . 0.0 113.6 -169.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.8 p -163.8 144.63 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 125.672 1.589 . . . . 0.0 110.902 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -155.85 151.5 27.22 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.126 1.37 . . . . 0.0 112.4 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 81.0 ttt180 -164.92 141.32 5.78 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.117 1.767 . . . . 0.0 110.724 -176.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 73.12 137.34 0.05 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.068 2.547 . . . . 0.0 112.233 -175.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -142.17 155.22 45.29 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.668 1.187 . . . . 0.0 112.075 -167.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.0 m 72.13 12.95 5.87 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.273 1.429 . . . . 0.0 113.953 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -77.93 166.62 22.64 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.372 1.069 . . . . 0.0 113.188 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 52.9 m -70.52 164.75 24.12 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 6.8 pt -130.57 151.74 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.815 1.646 . . . . 0.0 110.011 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -132.86 143.51 49.58 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.448 1.899 . . . . 0.0 109.717 -173.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.16 134.59 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 119.495 1.043 . . . . 0.0 111.177 -175.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.42 -71.83 1.03 Allowed Glycine 0 N--CA 1.473 1.161 0 C-N-CA 124.124 0.869 . . . . 0.0 113.657 -173.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -83.91 39.03 0.67 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.032 1.333 . . . . 0.0 114.245 -165.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.408 HD23 ' H ' ' A' ' 168' ' ' LEU . 0.5 OUTLIER -75.75 170.86 15.38 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.339 -1.476 . . . . 0.0 110.677 165.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 45.9 m -75.55 124.39 27.11 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.707 0.803 . . . . 0.0 109.06 167.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -70.18 -13.71 62.31 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -167.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -89.14 0.08 57.02 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 170.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 32.0 t -63.57 138.18 58.4 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 121.254 -0.904 . . . . 0.0 111.022 161.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 41.4 p -98.47 159.89 29.42 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 124.704 1.201 . . . . 0.0 110.728 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.16 -19.52 68.9 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.921 1.747 . . . . 0.0 112.486 167.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -69.16 -44.49 72.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 120.225 1.375 . . . . 0.0 111.2 170.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -59.14 -45.99 89.51 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.396 0.679 . . . . 0.0 110.755 172.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -27.37 68.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.999 0.92 . . . . 0.0 113.341 173.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 52.2 m -76.48 -47.77 21.81 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.52 1.055 . . . . 0.0 110.0 176.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -59.02 -31.1 68.52 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.718 1.145 . . . . 0.0 112.168 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -70.87 -67.88 0.47 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.389 1.476 . . . . 0.0 112.005 174.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -71.14 -35.04 71.56 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.5 t -73.33 -10.46 59.78 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -170.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -62.04 -17.25 56.77 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.223 -0.923 . . . . 0.0 113.343 171.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.66 -21.84 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 125.714 1.606 . . . . 0.0 112.667 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 169.94 -90.24 0.09 OUTLIER Glycine 0 N--CA 1.467 0.709 0 C-N-CA 125.055 1.312 . . . . 0.0 110.789 -172.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -159.63 120.31 3.11 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.118 0.967 . . . . 0.0 112.693 174.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.4 t -72.38 127.72 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 162.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.37 -34.03 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 118.691 0.678 . . . . 0.0 110.554 175.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -172.33 145.68 1.72 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.385 1.474 . . . . 0.0 112.045 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -129.23 171.26 12.63 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.821 2.049 . . . . 0.0 110.706 161.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -145.95 -60.18 0.32 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.81 1.782 . . . . 0.0 115.81 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 3.9 mt 65.97 111.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 127.712 2.405 . . . . 0.0 113.219 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 19.1 tt -67.94 111.66 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 120.788 -1.195 . . . . 0.0 111.4 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 14.5 p -151.34 145.45 25.31 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.509 1.923 . . . . 0.0 110.459 -168.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 47.5 t -173.06 -72.92 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.863 1.665 . . . . 0.0 110.636 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -109.56 0.13 19.01 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.812 1.645 . . . . 0.0 114.385 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.26 82.73 1.69 Allowed Glycine 0 N--CA 1.474 1.199 0 C-N-CA 125.447 1.498 . . . . 0.0 109.474 -165.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -70.64 156.48 39.4 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -169.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -64.2 -20.59 66.12 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.459 1.503 . . . . 0.0 114.617 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -117.89 -41.16 2.92 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.791 1.636 . . . . 0.0 112.606 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 66.54 21.55 70.82 Favored Glycine 0 N--CA 1.478 1.45 0 C-N-CA 124.306 0.955 . . . . 0.0 114.106 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -78.25 147.0 34.56 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.809 1.243 . . . . 0.0 113.751 -165.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.28 158.82 19.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.237 1.399 . . . . 0.0 112.81 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.7 m -147.45 142.55 27.11 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.011 1.725 . . . . 0.0 108.745 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 10.8 t -142.95 142.09 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.119 0.967 . . . . 0.0 110.788 -177.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -119.95 139.08 53.0 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.213 1.805 . . . . 0.0 110.01 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -116.78 154.05 31.36 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.676 1.591 . . . . 0.0 112.383 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.3 p -81.07 -17.93 48.37 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.92 0.888 . . . . 0.0 113.102 171.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -102.11 173.03 6.56 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.265 1.426 . . . . 0.0 113.061 -169.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 65.3 p -107.08 -101.1 0.35 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.915 1.686 . . . . 0.0 111.954 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -60.65 -22.16 63.53 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.739 1.216 . . . . 0.0 113.592 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -67.74 -18.04 64.76 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.072 0.949 . . . . 0.0 113.384 173.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.47 -28.99 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.326 0.966 . . . . 0.0 112.033 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.25 -45.96 44.61 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.44 -0.788 . . . . 0.0 110.843 167.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -52.88 -27.35 18.15 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.633 1.973 . . . . 0.0 114.112 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.59 -71.76 0.17 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.023 1.329 . . . . 0.0 110.929 165.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 36.4 mt -54.62 -44.33 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.323 1.449 . . . . 0.0 112.451 -172.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -64.84 0.35 1.21 Allowed 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 176.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -118.31 -1.41 11.31 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.846 1.659 . . . . 0.0 112.566 167.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -122.96 -14.0 7.71 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.132 1.773 . . . . 0.0 114.136 -176.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -48.68 120.96 4.12 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.338 1.455 . . . . 0.0 110.294 166.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 88.89 0.81 80.81 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-O 118.129 -1.373 . . . . 0.0 115.41 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.68 105.19 0.42 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.653 1.727 . . . . 0.0 111.507 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -55.98 110.43 0.74 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 152.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -127.54 110.8 13.09 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.466 1.106 . . . . 0.0 109.317 -170.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 89.9 mtp 55.55 36.14 26.58 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.708 1.203 . . . . 0.0 111.974 -173.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 14.4 t70 98.46 0.14 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 129.216 3.007 . . . . 0.0 115.79 170.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -138.85 137.52 36.65 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.547 1.067 . . . . 0.0 112.592 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -77.0 102.07 6.29 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.211 1.404 . . . . 0.0 113.707 -170.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.3 pt -54.24 143.63 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.535 0.734 . . . . 0.0 112.766 172.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -132.76 135.38 45.69 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.508 1.523 . . . . 0.0 107.4 166.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.6 p -119.8 132.53 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.294 1.038 . . . . 0.0 111.81 -168.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -97.96 136.82 37.69 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.41 2.284 . . . . 0.0 109.576 167.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -98.51 142.12 30.51 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 166.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -140.42 135.78 32.39 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.1 0.864 . . . . 0.0 112.669 -170.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.5 p30 . . . . . 0 C--O 1.253 1.237 0 C-N-CA 126.066 1.747 . . . . 0.0 112.839 -175.698 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.711 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.9 m -146.6 155.18 42.28 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.062 1.345 . . . . 0.0 111.619 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -156.01 153.0 28.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.154 1.382 . . . . 0.0 111.965 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 58.59 46.45 14.68 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.828 1.651 . . . . 0.0 112.452 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -154.95 159.25 40.27 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.037 1.735 . . . . 0.0 112.127 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -164.08 173.77 12.11 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.483 1.913 . . . . 0.0 111.904 -173.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -149.85 153.37 36.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.357 1.463 . . . . 0.0 112.198 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 18.9 m -175.61 -30.35 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 126.894 2.077 . . . . 0.0 113.667 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . 0.268 59.6 p 49.9 -129.33 2.12 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.51 2.324 . . . . 0.0 112.32 177.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -148.23 153.38 38.67 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.272 1.429 . . . . 0.0 113.055 -165.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -140.16 151.08 44.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.49 1.916 . . . . 0.0 109.553 174.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -160.73 164.72 31.4 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.172 0.989 . . . . 0.0 113.1 -171.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -125.95 179.93 4.99 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.584 1.954 . . . . 0.0 110.8 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.8 p -151.27 142.82 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 O-C-N 121.154 -0.966 . . . . 0.0 112.359 -173.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -153.57 150.72 28.96 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.524 1.93 . . . . 0.0 110.571 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -147.86 122.28 9.71 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.583 1.153 . . . . 0.0 110.913 -176.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -159.17 150.96 20.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.372 1.469 . . . . 0.0 111.705 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -145.92 -67.42 0.29 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.803 1.241 . . . . 0.0 113.123 -168.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 83.1 p 32.84 -113.23 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 127.269 2.228 . . . . 0.0 115.63 -170.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -176.44 -33.05 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.492 2.317 . . . . 0.0 112.491 -165.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 73.7 m -140.52 162.91 34.23 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.565 1.146 . . . . 0.0 112.834 -170.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.6 pt -139.39 155.92 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 126.007 1.723 . . . . 0.0 111.321 -170.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -118.16 153.13 34.33 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.749 2.02 . . . . 0.0 111.391 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.1 t -138.89 128.4 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.528 1.531 . . . . 0.0 110.131 -174.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.84 -91.03 1.85 Allowed Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.034 1.302 . . . . 0.0 114.179 -173.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -84.26 35.68 0.55 Allowed 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -160.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -80.3 -5.68 56.7 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -169.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.4 p 91.05 127.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 131.018 3.727 . . . . 0.0 110.609 -167.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -70.64 -13.11 61.95 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -169.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -81.84 -5.49 58.26 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.375 1.47 . . . . 0.0 113.084 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.5 m -64.77 143.02 58.23 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.212 1.005 . . . . 0.0 113.089 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 51.7 p -105.67 157.37 34.75 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 125.108 1.363 . . . . 0.0 110.919 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.08 -31.42 65.38 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.385 2.057 . . . . 0.0 112.606 174.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.31 -39.35 92.37 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.115 0.871 . . . . 0.0 111.621 174.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.17 -29.55 66.47 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.705 -0.622 . . . . 0.0 112.626 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.8 mt -74.06 -27.43 60.91 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 164.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 98.4 m -71.46 -51.14 25.39 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.402 1.001 . . . . 0.0 110.035 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -63.06 -24.61 67.99 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.628 0.649 . . . . 0.0 112.72 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.29 -69.14 0.5 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.54 1.536 . . . . 0.0 111.585 174.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -65.31 -32.41 74.05 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.4 t -73.35 0.08 13.15 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -175.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -71.67 -18.78 62.16 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.318 -0.864 . . . . 0.0 113.179 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 19.4 mm -81.56 -55.0 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.118 0.967 . . . . 0.0 111.628 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -138.74 -96.31 0.36 Allowed Glycine 0 N--CA 1.467 0.75 0 C-N-CA 126.379 1.942 . . . . 0.0 109.878 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -156.03 128.61 7.78 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.898 0.879 . . . . 0.0 112.145 169.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.73 134.93 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 167.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.52 -42.62 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 118.275 0.489 . . . . 0.0 110.426 172.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -157.35 141.24 16.02 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 127.105 2.162 . . . . 0.0 109.529 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -117.69 158.99 23.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.889 1.276 . . . . 0.0 111.055 161.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -152.9 132.07 12.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.071 1.349 . . . . 0.0 111.37 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 3.2 mt -145.11 -45.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 125.051 1.34 . . . . 0.0 112.401 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 59.2 mt -81.22 108.1 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -176.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 25.7 p -87.89 143.39 27.15 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.347 1.459 . . . . 0.0 111.502 -173.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 3.2 t -110.17 9.39 23.94 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.398 1.079 . . . . 0.0 113.378 -168.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.31 0.36 19.64 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.3 1.44 . . . . 0.0 114.608 -175.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 115.74 -9.12 19.2 Favored Glycine 0 N--CA 1.476 1.338 0 C-N-CA 126.301 1.905 . . . . 0.0 114.183 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -146.41 146.66 30.69 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.423 1.889 . . . . 0.0 111.141 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -91.22 119.6 31.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.367 1.067 . . . . 0.0 112.225 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -78.08 -41.85 34.06 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.064 0.946 . . . . 0.0 112.665 -178.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 72.11 16.04 76.74 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.096 0.855 . . . . 0.0 115.024 177.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 87.7 mtp -122.15 128.37 51.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.055 1.342 . . . . 0.0 108.269 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -94.82 164.93 25.4 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 115.24 0.856 . . . . 0.0 115.24 -159.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.7 p -146.69 148.35 31.92 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.886 2.074 . . . . 0.0 110.201 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 13.7 t -147.57 136.68 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.674 0.79 . . . . 0.0 110.865 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -109.34 131.61 54.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.551 1.94 . . . . 0.0 109.547 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -103.25 158.34 16.39 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.059 1.343 . . . . 0.0 110.545 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 78.8 p -71.24 0.21 8.43 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.859 0.864 . . . . 0.0 112.899 170.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -138.92 -175.99 4.34 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.203 2.201 . . . . 0.0 112.011 -167.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.6 p -142.8 -66.34 0.38 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.584 1.554 . . . . 0.0 110.16 -174.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -53.15 -33.31 51.89 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 120.677 -1.265 . . . . 0.0 113.288 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.97 -24.85 61.66 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.318 1.447 . . . . 0.0 114.054 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.4 m -70.75 -31.91 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -169.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -56.95 -46.21 82.28 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.691 1.196 . . . . 0.0 111.146 166.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -71.68 -23.69 61.7 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.881 0.872 . . . . 0.0 112.25 -171.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.39 -61.99 1.98 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.992 0.917 . . . . 0.0 110.949 165.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 80.9 mt -59.78 -37.32 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.329 1.051 . . . . 0.0 112.123 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 47.1 ttm-85 -62.46 -4.86 2.1 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.493 1.517 . . . . 0.0 113.838 176.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -121.86 -3.62 9.17 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.498 1.919 . . . . 0.0 112.922 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -124.49 -21.92 4.78 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -173.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.92 120.69 12.43 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 120.22 1.373 . . . . 0.0 109.882 174.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 94.04 0.5 65.88 Favored Glycine 0 N--CA 1.471 1.032 0 CA-C-O 118.107 -1.385 . . . . 0.0 115.522 -170.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.8 108.54 0.87 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.756 1.778 . . . . 0.0 110.725 174.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -55.56 121.28 8.7 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.231 1.013 . . . . 0.0 110.715 161.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -152.53 110.86 3.71 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.511 1.924 . . . . 0.0 107.575 -158.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 16.8 ttt 54.08 35.86 23.28 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.581 0.705 . . . . 0.0 111.397 -164.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 76.05 0.22 3.26 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.394 2.677 . . . . 0.0 115.286 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -120.55 144.02 48.28 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.118 1.367 . . . . 0.0 110.749 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.99 111.49 15.25 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.584 -1.322 . . . . 0.0 112.764 -176.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.4 pt -54.18 148.07 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.472 -0.767 . . . . 0.0 110.928 164.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -137.62 137.52 38.55 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.226 1.01 . . . . 0.0 109.327 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.85 126.6 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 124.163 0.985 . . . . 0.0 109.659 -171.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -94.92 148.08 22.69 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.251 1.02 . . . . 0.0 110.05 164.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -69.85 153.55 43.15 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 163.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -131.04 135.87 47.96 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.45 1.1 . . . . 0.0 111.241 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.302 0 C-N-CA 126.24 1.816 . . . . 0.0 111.855 175.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.765 0 N-CA-C 111.914 -0.475 . . . . 0.0 111.914 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 25.6 p -166.48 146.97 6.12 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.038 1.335 . . . . 0.0 111.885 -176.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -159.59 156.7 28.46 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.448 1.499 . . . . 0.0 111.903 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -161.78 158.39 25.65 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.799 1.64 . . . . 0.0 112.199 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -161.66 150.63 15.88 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.639 1.576 . . . . 0.0 111.381 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -165.65 161.16 18.08 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.618 1.967 . . . . 0.0 111.468 -175.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -161.49 152.24 18.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.225 1.41 . . . . 0.0 112.689 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.5 p -167.05 155.55 9.92 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.254 1.821 . . . . 0.0 110.85 174.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.8 t -158.28 17.03 0.22 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -172.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -133.99 121.14 21.19 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.006 0.922 . . . . 0.0 112.974 -172.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -171.23 140.71 1.51 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.216 2.206 . . . . 0.0 110.238 173.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -168.6 148.54 4.48 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.298 1.439 . . . . 0.0 111.983 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -142.88 5.75 1.55 Allowed 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.2 m -156.49 153.15 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 128.123 2.569 . . . . 0.0 109.067 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -143.84 -50.87 0.31 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.711 0.804 . . . . 0.0 112.19 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 59.6 ttm-85 -165.29 111.22 0.93 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.546 1.938 . . . . 0.0 108.804 173.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -146.15 62.02 1.24 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.58 1.152 . . . . 0.0 110.47 -161.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -167.49 146.3 4.9 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.006 1.322 . . . . 0.0 112.824 -166.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 31.1 t -153.62 -42.03 0.09 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.53 1.132 . . . . 0.0 112.417 161.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 10.2 t30 68.45 -42.02 0.47 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 128.007 2.523 . . . . 0.0 116.454 169.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.8 p -171.09 132.92 0.85 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.606 1.562 . . . . 0.0 109.433 -166.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.59 161.48 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 121.915 -0.491 . . . . 0.0 112.012 -154.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -121.36 124.22 44.03 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.545 1.138 . . . . 0.0 110.688 170.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.27 134.94 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 127.175 2.19 . . . . 0.0 107.772 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.61 -133.47 0.4 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.886 1.232 . . . . 0.0 112.665 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -60.54 -28.19 68.24 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 -168.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . 0.292 2.5 pt? 28.52 -129.96 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.651 1.98 . . . . 0.0 113.192 -164.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.9 m -142.4 130.38 21.86 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.444 1.498 . . . . 0.0 109.133 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -64.5 -18.21 64.58 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -171.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -75.01 -3.38 32.06 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.563 1.545 . . . . 0.0 113.779 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 77.0 p -104.18 168.88 8.82 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.769 1.228 . . . . 0.0 114.124 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 52.1 p -137.06 165.68 32.92 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 126.922 2.089 . . . . 0.0 110.741 -171.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -59.86 -25.04 78.21 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.333 2.022 . . . . 0.0 113.199 169.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.13 -40.83 78.05 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.478 1.035 . . . . 0.0 111.8 172.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -62.72 -42.47 99.67 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.347 0.659 . . . . 0.0 111.097 173.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.6 mt -64.31 -31.3 72.45 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 118.49 -0.766 . . . . 0.0 112.515 170.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.8 m -68.69 -51.26 43.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.633 1.106 . . . . 0.0 110.272 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.95 -30.97 72.0 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.916 0.78 . . . . 0.0 112.26 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -70.85 -61.22 1.85 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.404 1.482 . . . . 0.0 111.718 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -71.34 -36.96 71.7 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.4 t -73.41 -1.52 18.62 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -173.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -73.44 -16.5 61.31 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.431 -0.793 . . . . 0.0 113.01 167.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.5 mm -80.97 -55.24 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 119.176 0.898 . . . . 0.0 111.144 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -134.57 -100.11 0.65 Allowed Glycine 0 N--CA 1.468 0.824 0 C-N-CA 126.0 1.762 . . . . 0.0 110.443 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -156.88 126.73 6.28 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.437 1.095 . . . . 0.0 111.88 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 20.5 t -76.56 134.5 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.01 0.924 . . . . 0.0 108.651 169.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.72 -15.52 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.57 1.148 . . . . 0.0 113.882 168.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.1 mtp85 -161.72 132.28 5.03 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.501 1.521 . . . . 0.0 110.874 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -129.23 145.7 51.29 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.582 1.953 . . . . 0.0 111.494 170.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -161.49 145.31 12.83 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.912 1.285 . . . . 0.0 111.651 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.6 mt -137.96 114.34 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.499 1.119 . . . . 0.0 109.653 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.1 tt -76.13 115.1 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.101 0.56 . . . . 0.0 109.742 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 4.1 p -151.23 165.99 32.28 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.082 2.153 . . . . 0.0 111.202 -160.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 55.3 p -159.23 172.92 17.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.222 1.409 . . . . 0.0 111.592 174.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -74.52 -21.26 59.63 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.876 0.87 . . . . 0.0 112.672 171.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -91.74 -123.79 3.1 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 126.027 1.775 . . . . 0.0 111.255 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -138.91 85.31 2.07 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.85 1.26 . . . . 0.0 111.245 -177.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -134.81 94.23 3.14 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.176 1.391 . . . . 0.0 111.133 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 66.56 -82.94 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.684 2.394 . . . . 0.0 113.206 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 79.19 51.46 5.31 Favored Glycine 0 N--CA 1.472 1.061 0 C-N-CA 124.464 1.031 . . . . 0.0 111.898 -176.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 76.9 mtm -138.9 140.26 38.32 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.62 1.168 . . . . 0.0 112.185 -168.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.52 163.32 13.55 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 124.913 1.244 . . . . 0.0 115.164 -165.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.2 p -153.63 153.1 31.68 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.38 1.872 . . . . 0.0 111.352 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.97 147.15 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.046 1.338 . . . . 0.0 111.17 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -125.52 130.89 52.64 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.364 2.266 . . . . 0.0 110.068 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -108.42 165.09 11.78 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.136 1.374 . . . . 0.0 111.698 -174.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 40.5 p -76.51 0.27 20.5 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.546 1.538 . . . . 0.0 114.559 169.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -133.03 168.77 17.89 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.024 1.73 . . . . 0.0 111.796 -169.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.7 p -107.75 -62.62 1.41 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.728 1.211 . . . . 0.0 112.373 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -79.88 -35.34 38.19 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.896 1.678 . . . . 0.0 112.942 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -60.12 -24.44 64.68 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.7 1.2 . . . . 0.0 112.447 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.69 -29.51 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.462 1.905 . . . . 0.0 112.546 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.34 -38.67 63.19 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.335 -0.853 . . . . 0.0 111.058 172.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -67.63 -21.87 65.36 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.712 1.605 . . . . 0.0 112.969 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.86 -55.84 25.59 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.937 0.895 . . . . 0.0 111.39 164.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 73.5 mt -66.24 -28.54 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 O-C-N 121.292 -0.88 . . . . 0.0 111.851 -171.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -18.82 9.56 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.955 1.302 . . . . 0.0 113.987 171.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -106.62 -14.5 15.02 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.407 1.883 . . . . 0.0 112.109 176.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -122.4 -17.89 6.91 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.806 2.15 . . . . 0.0 116.806 -164.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -66.75 120.68 13.92 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 120.32 1.418 . . . . 0.0 109.991 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 92.52 0.69 69.5 Favored Glycine 0 N--CA 1.472 1.09 0 CA-C-O 117.714 -1.603 . . . . 0.0 115.081 -169.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.83 108.02 0.69 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 120.158 1.979 . . . . 0.0 111.081 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -52.03 122.95 9.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.647 0.779 . . . . 0.0 109.535 155.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -147.57 114.3 6.06 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.496 1.518 . . . . 0.0 107.734 -166.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 54.17 38.44 29.18 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.68 0.792 . . . . 0.0 111.335 -166.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 17.0 t70 84.24 0.61 0.93 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 128.526 2.731 . . . . 0.0 115.417 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.36 141.94 35.6 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.17 0.988 . . . . 0.0 112.663 -173.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -71.48 120.4 17.0 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -169.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.76 156.18 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.669 1.588 . . . . 0.0 112.019 154.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -140.18 156.17 46.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.918 1.687 . . . . 0.0 108.795 167.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 40.3 t -140.47 133.97 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.496 0.718 . . . . 0.0 111.733 -168.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -85.77 136.13 33.45 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.906 1.282 . . . . 0.0 109.854 170.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -102.88 127.85 49.9 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.984 1.314 . . . . 0.0 108.465 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -87.74 132.84 33.99 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -172.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 56.9 t30 . . . . . 0 C--O 1.256 1.429 0 C-N-CA 126.928 2.091 . . . . 0.0 112.802 179.495 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.0 t . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 121.208 0.528 . . . . 0.0 112.047 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 9.9 pt -146.41 150.64 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 126.676 1.99 . . . . 0.0 109.806 -171.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -126.19 149.61 48.9 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.443 1.897 . . . . 0.0 109.709 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.03 118.76 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.907 0.883 . . . . 0.0 110.101 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.44 -3.21 37.96 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 116.967 1.547 . . . . 0.0 116.967 -160.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -142.77 22.61 1.95 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.102 1.451 . . . . 0.0 113.795 -170.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.6 pp -77.53 178.78 6.97 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.757 1.223 . . . . 0.0 111.832 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.3 t -73.56 133.87 43.64 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.77 0.828 . . . . 0.0 111.536 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -66.88 -8.9 32.45 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -87.63 -4.44 58.94 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.473 1.509 . . . . 0.0 113.622 170.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 7.7 t -69.12 139.76 54.73 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 121.064 -1.023 . . . . 0.0 112.509 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 27.4 p -102.6 162.19 20.95 Favored Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 125.589 1.556 . . . . 0.0 109.985 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -58.69 -32.27 96.55 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.139 1.892 . . . . 0.0 112.025 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.76 -38.65 91.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.092 0.957 . . . . 0.0 112.231 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.24 -44.01 97.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.782 0.719 . . . . 0.0 111.443 176.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 36.4 mt -70.45 -29.58 66.19 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.232 -0.89 . . . . 0.0 112.955 173.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 96.4 m -70.0 -51.24 33.95 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.24 0.927 . . . . 0.0 110.678 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -65.9 -24.32 66.82 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.868 0.758 . . . . 0.0 112.676 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -73.55 -66.21 0.72 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.046 1.738 . . . . 0.0 111.594 173.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -69.86 -33.97 72.97 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -174.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.8 t -73.45 -3.97 30.75 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -172.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -64.54 -18.49 64.89 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.117 -0.989 . . . . 0.0 112.831 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 30.1 mm -77.98 -23.5 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.856 1.263 . . . . 0.0 112.455 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 169.67 -90.16 0.09 OUTLIER Glycine 0 N--CA 1.468 0.802 0 C-N-CA 124.357 0.979 . . . . 0.0 112.437 -171.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -155.76 110.35 2.89 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.105 0.962 . . . . 0.0 112.845 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 37.4 t -73.66 132.0 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 157.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.37 -29.52 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 171.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -153.35 135.8 15.07 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.192 1.397 . . . . 0.0 110.056 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -115.92 159.58 21.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.595 1.158 . . . . 0.0 110.404 157.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -153.2 129.95 10.86 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.633 1.173 . . . . 0.0 112.081 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 6.0 mt . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 124.664 1.186 . . . . 0.0 111.855 177.812 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 28.3 ptm . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -158.19 -172.0 24.79 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.747 1.165 . . . . 0.0 114.814 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 20.6 m -137.19 150.81 48.16 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.523 1.929 . . . . 0.0 110.254 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.7 t -141.44 142.99 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.881 1.272 . . . . 0.0 110.514 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -126.11 130.67 51.54 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 126.974 2.11 . . . . 0.0 110.782 -176.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -108.87 168.04 9.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.502 1.921 . . . . 0.0 110.952 -177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 49.1 p -81.4 0.06 39.16 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 167.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -127.99 154.56 45.47 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.865 1.666 . . . . 0.0 111.797 -167.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.5 p -114.39 -1.34 13.53 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.729 1.612 . . . . 0.0 113.685 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -130.05 -46.2 1.13 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.983 1.313 . . . . 0.0 112.714 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -65.88 -20.75 66.34 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.082 -1.011 . . . . 0.0 112.925 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.6 p -63.74 -33.29 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.24 1.816 . . . . 0.0 112.547 170.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -77.58 -36.76 51.67 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.66 0.784 . . . . 0.0 112.643 168.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -63.95 -24.14 67.61 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.145 0.978 . . . . 0.0 112.633 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.47 -56.81 15.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.948 1.299 . . . . 0.0 111.569 165.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.35 -35.22 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.735 1.214 . . . . 0.0 111.871 -172.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -57.07 -12.72 2.28 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.252 1.421 . . . . 0.0 114.039 172.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -117.43 -4.87 11.27 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.309 1.844 . . . . 0.0 112.685 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -129.46 -21.05 3.21 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.97 120.95 14.01 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 120.041 1.291 . . . . 0.0 110.381 176.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 97.24 0.73 59.64 Favored Glycine 0 N--CA 1.471 0.967 0 CA-C-O 118.189 -1.339 . . . . 0.0 114.772 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.97 106.52 0.72 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.759 1.779 . . . . 0.0 111.137 173.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -54.19 117.69 3.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.684 0.794 . . . . 0.0 109.461 155.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -137.89 108.68 6.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.5 1.52 . . . . 0.0 107.141 -165.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 18.1 ttt 50.42 47.1 24.51 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.679 0.791 . . . . 0.0 111.413 -162.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 21.5 t70 72.55 0.29 3.57 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 127.189 2.196 . . . . 0.0 114.652 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -123.68 125.05 44.09 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.215 1.406 . . . . 0.0 110.974 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -81.34 102.73 10.63 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.767 1.227 . . . . 0.0 114.264 -165.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -55.1 142.33 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.765 0.826 . . . . 0.0 111.434 167.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -136.4 134.59 37.94 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.084 1.353 . . . . 0.0 108.515 168.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 5.4 t -103.59 143.49 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.461 1.104 . . . . 0.0 110.559 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.47 0 C-N-CA 127.032 2.133 . . . . 0.0 108.639 169.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 64.9 m . . . . . 0 N--CA 1.472 0.63 0 CA-C-O 121.696 0.76 . . . . 0.0 112.648 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 7.6 pt -139.29 154.3 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.803 1.241 . . . . 0.0 111.144 -172.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -134.03 105.31 6.64 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.289 1.435 . . . . 0.0 110.317 -169.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.8 t -89.66 120.22 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.416 1.886 . . . . 0.0 109.08 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.95 -5.94 24.93 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 116.951 1.541 . . . . 0.0 116.951 -168.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -147.7 21.85 1.14 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 119.698 1.749 . . . . 0.0 114.983 -170.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -178.02 2.21 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.672 -1.268 . . . . 0.0 112.806 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 91.4 m -86.95 118.84 26.6 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.597 1.159 . . . . 0.0 108.875 172.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -68.59 -7.99 37.72 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -169.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -74.45 -12.93 60.63 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.005 1.322 . . . . 0.0 112.997 168.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 20.6 t -60.6 138.89 57.99 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.181 -0.95 . . . . 0.0 112.358 173.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 32.7 p -80.87 168.82 22.42 Favored Pre-proline 0 N--CA 1.472 0.666 0 C-N-CA 124.078 0.951 . . . . 0.0 109.216 162.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.67 -20.3 26.81 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.209 1.939 . . . . 0.0 112.887 163.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -69.02 -35.7 76.93 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.498 1.045 . . . . 0.0 111.697 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -59.94 -38.92 83.81 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.122 0.969 . . . . 0.0 111.477 170.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 56.1 mt -70.33 -41.0 73.82 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-O 118.067 -0.968 . . . . 0.0 111.492 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 17.3 m -56.5 -51.04 69.99 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.796 1.18 . . . . 0.0 110.667 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -58.61 -46.18 87.58 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.274 0.488 . . . . 0.0 111.553 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -62.43 -52.84 61.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.487 1.515 . . . . 0.0 112.799 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -71.4 -18.1 62.36 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.973 1.309 . . . . 0.0 114.215 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 64.4 p -64.06 -16.66 62.2 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -65.31 -21.64 66.73 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.737 1.215 . . . . 0.0 113.384 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 37.5 mm -90.47 -16.16 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.675 1.19 . . . . 0.0 112.6 -168.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.56 -90.93 0.11 Allowed Glycine 0 N--CA 1.467 0.767 0 C-N-CA 125.073 1.32 . . . . 0.0 111.974 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -155.44 138.0 15.07 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.078 1.351 . . . . 0.0 111.368 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.1 144.5 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 125.04 1.336 . . . . 0.0 109.566 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.02 -34.54 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.076 0.55 . . . . 0.0 112.146 -160.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -155.91 153.77 30.16 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.352 2.261 . . . . 0.0 109.285 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -151.29 145.71 25.53 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.72 1.608 . . . . 0.0 111.461 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -156.05 156.07 33.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.768 1.627 . . . . 0.0 111.486 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 10.2 mt . . . . . 0 N--CA 1.474 0.75 0 C-N-CA 124.983 1.313 . . . . 0.0 108.034 172.176 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 92.3 mtp . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 120.568 0.223 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.6 146.5 16.08 Favored Glycine 0 N--CA 1.469 0.86 0 C-N-CA 124.522 1.058 . . . . 0.0 111.864 171.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 4.0 p -143.05 147.69 35.48 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.936 1.294 . . . . 0.0 110.921 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.9 t -150.76 142.1 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.517 1.127 . . . . 0.0 109.305 -171.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.94 134.83 54.26 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.922 1.689 . . . . 0.0 110.792 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -113.16 159.87 18.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.272 1.829 . . . . 0.0 111.382 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 38.1 p -74.85 -21.42 59.27 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -137.68 -146.42 0.22 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.965 1.306 . . . . 0.0 111.843 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 62.6 p -136.39 -57.88 0.74 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.647 1.112 . . . . 0.0 113.254 -172.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.58 -29.34 70.51 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.905 -1.122 . . . . 0.0 113.697 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -72.11 -28.69 63.44 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.75 1.62 . . . . 0.0 112.992 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.5 t -69.42 -33.31 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.359 1.463 . . . . 0.0 111.802 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -74.14 -41.94 60.76 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.601 -0.687 . . . . 0.0 112.163 170.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -62.49 -28.48 69.86 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.058 0.943 . . . . 0.0 112.77 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.56 -60.11 4.15 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.761 1.224 . . . . 0.0 111.583 169.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.11 -23.04 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.16 -0.963 . . . . 0.0 112.892 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -14.59 13.3 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.243 1.017 . . . . 0.0 113.549 167.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -101.14 -20.25 15.4 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.046 1.338 . . . . 0.0 112.901 173.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -122.17 -17.56 7.14 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 -159.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -68.15 120.53 14.49 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 120.628 1.558 . . . . 0.0 110.079 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 94.27 0.39 65.45 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 117.791 -1.56 . . . . 0.0 115.015 -169.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.13 107.17 0.51 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 120.0 1.9 . . . . 0.0 110.906 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -53.69 119.85 5.46 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.92 0.888 . . . . 0.0 109.812 160.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -146.88 110.37 4.87 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.411 1.485 . . . . 0.0 108.038 -163.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 51.4 mtt 53.42 35.32 20.21 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.563 0.745 . . . . 0.0 111.757 -169.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 86.01 0.48 0.66 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 128.95 2.9 . . . . 0.0 116.035 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -124.3 140.29 53.1 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.431 1.092 . . . . 0.0 111.974 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 103.14 6.82 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.244 -0.91 . . . . 0.0 112.766 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -52.31 143.31 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 121.36 -0.837 . . . . 0.0 111.015 164.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -129.72 147.42 51.5 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 164.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.2 p -151.09 127.76 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.584 0.707 . . . . 0.0 111.969 -166.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 . . . . . 0 CA--C 1.534 0.327 0 C-N-CA 125.222 1.409 . . . . 0.0 109.971 170.71 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.1 p . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 120.451 0.167 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.6 pt -141.04 154.85 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.21 1.004 . . . . 0.0 112.189 -161.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -122.23 147.43 46.21 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.686 1.995 . . . . 0.0 110.526 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.6 t -134.14 122.65 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.317 1.447 . . . . 0.0 109.766 -172.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.3 -46.12 2.65 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 116.254 1.262 . . . . 0.0 116.254 -163.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -121.57 23.62 10.18 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -163.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.57 -175.97 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.942 1.697 . . . . 0.0 112.882 165.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.6 p -73.7 127.08 31.83 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 120.958 -1.089 . . . . 0.0 110.023 165.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -70.0 -9.46 55.3 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -97.68 0.27 46.8 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.836 2.054 . . . . 0.0 113.283 171.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 7.9 t -58.11 149.16 24.33 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.132 -0.98 . . . . 0.0 113.299 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.1 p -95.12 151.84 39.07 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 123.594 0.758 . . . . 0.0 110.229 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.23 -25.91 30.57 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.376 2.051 . . . . 0.0 111.927 171.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -69.43 -42.79 74.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.209 1.004 . . . . 0.0 112.539 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -65.7 -41.61 92.13 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.718 -0.614 . . . . 0.0 111.547 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 25.5 mt -69.32 -29.26 67.05 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.6 -0.714 . . . . 0.0 112.226 173.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 49.7 m -66.11 -50.94 62.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.515 1.052 . . . . 0.0 109.658 171.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.32 -34.69 74.18 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 118.624 0.647 . . . . 0.0 112.253 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -70.13 -58.18 4.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.663 1.585 . . . . 0.0 112.406 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -71.24 -35.78 71.56 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.6 t -73.43 -6.0 43.51 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -51.98 -25.93 9.46 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.188 1.795 . . . . 0.0 112.544 164.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 28.4 mm -77.1 -22.35 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.198 1.799 . . . . 0.0 113.215 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.69 -90.47 0.11 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.304 0.954 . . . . 0.0 112.892 -172.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -152.47 95.47 2.03 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -171.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 39.9 t -70.09 134.11 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 161.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 5.1 p -104.38 -25.17 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.085 0.954 . . . . 0.0 112.645 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -164.6 119.7 1.43 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.683 1.193 . . . . 0.0 111.567 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -107.48 154.25 21.63 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.216 1.006 . . . . 0.0 111.067 161.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -156.14 131.89 9.7 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.538 1.535 . . . . 0.0 110.89 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 4.8 mm . . . . . 0 N--CA 1.482 1.142 0 C-N-CA 125.117 1.367 . . . . 0.0 109.79 178.532 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.45 156.72 20.33 Favored Glycine 0 N--CA 1.467 0.73 0 C-N-CA 124.593 1.092 . . . . 0.0 112.89 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.0 p -144.42 149.22 35.7 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.903 1.681 . . . . 0.0 111.099 174.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 10.9 t -145.42 139.06 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.983 0.913 . . . . 0.0 110.667 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -127.8 132.1 49.5 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.172 2.189 . . . . 0.0 109.012 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -110.7 164.26 12.93 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.442 1.497 . . . . 0.0 110.055 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 33.1 p -81.05 -25.36 37.17 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 122.01 -0.431 . . . . 0.0 111.893 164.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -81.26 168.44 18.47 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.97 1.708 . . . . 0.0 112.248 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.3 m -122.62 -76.75 0.59 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.575 0.75 . . . . 0.0 110.972 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.94 -25.15 67.42 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.8 -1.187 . . . . 0.0 113.835 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.13 -21.71 61.43 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.09 -25.05 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.565 0.746 . . . . 0.0 111.661 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -73.09 -43.79 61.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.998 0.919 . . . . 0.0 111.231 167.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -60.1 -32.27 70.82 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.888 0.875 . . . . 0.0 112.111 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.07 -65.13 0.67 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.768 1.227 . . . . 0.0 111.748 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 45.2 mt -59.91 -34.76 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.401 -0.812 . . . . 0.0 112.12 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -63.34 -2.76 1.59 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.076 1.35 . . . . 0.0 114.356 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -122.0 -2.99 9.13 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.893 1.677 . . . . 0.0 112.8 171.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -129.09 -21.09 3.33 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -170.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -62.53 120.94 12.09 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.393 1.451 . . . . 0.0 110.079 173.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 97.31 0.52 59.64 Favored Glycine 0 N--CA 1.471 1.011 0 CA-C-O 118.136 -1.369 . . . . 0.0 115.266 -169.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.61 106.66 0.99 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.815 1.808 . . . . 0.0 110.789 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -53.63 115.37 1.93 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 154.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -137.23 110.91 8.09 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.078 1.351 . . . . 0.0 108.758 -166.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 18.9 mmt 60.26 19.1 8.57 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.052 1.341 . . . . 0.0 113.949 -178.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 18.6 t70 106.91 0.14 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 130.929 3.692 . . . . 0.0 115.148 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -129.69 138.21 51.03 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.571 1.078 . . . . 0.0 112.844 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -71.22 104.59 3.15 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.251 1.42 . . . . 0.0 113.191 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 pt -55.15 144.27 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.267 0.627 . . . . 0.0 111.326 168.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -139.76 140.03 36.61 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.848 1.259 . . . . 0.0 109.359 174.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.05 135.06 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.144 1.378 . . . . 0.0 110.35 -171.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 . . . . . 0 N--CA 1.471 0.592 0 C-N-CA 125.333 1.453 . . . . 0.0 108.418 170.275 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.6 m . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 121.414 0.626 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 35.5 pt -141.36 142.19 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 126.531 1.932 . . . . 0.0 109.018 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -109.96 128.67 55.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.365 1.066 . . . . 0.0 110.842 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.09 106.04 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.864 1.666 . . . . 0.0 107.905 -169.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -99.68 -11.58 43.55 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 117.09 1.596 . . . . 0.0 117.09 -158.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -157.25 38.43 0.29 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.335 1.568 . . . . 0.0 113.507 -171.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.35 177.78 6.34 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.011 -1.056 . . . . 0.0 112.441 175.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 t -76.67 142.06 40.71 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.978 1.311 . . . . 0.0 111.806 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -64.04 -12.78 41.7 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 170.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -75.45 -15.24 60.45 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.502 1.121 . . . . 0.0 113.547 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 57.9 m -71.49 137.68 48.36 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.992 -1.068 . . . . 0.0 113.286 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 43.0 p -100.75 159.2 30.24 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 125.377 1.471 . . . . 0.0 109.262 163.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.48 -24.53 78.25 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 121.963 1.775 . . . . 0.0 112.774 170.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.18 -41.33 90.43 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.871 1.214 . . . . 0.0 111.7 173.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -60.56 -47.44 86.17 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.414 0.686 . . . . 0.0 110.858 176.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.514 ' HG ' HD11 ' A' ' 192' ' ' ILE . 1.9 mm? -62.89 -37.52 87.26 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.552 1.141 . . . . 0.0 111.999 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.6 m -63.76 -50.42 69.14 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.203 1.001 . . . . 0.0 110.568 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.62 -41.92 83.18 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.509 0.595 . . . . 0.0 111.694 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -57.17 -55.46 34.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.744 1.618 . . . . 0.0 112.29 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -71.15 -28.34 64.2 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.2 m -73.26 0.24 12.47 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -66.84 -20.91 66.02 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 120.892 -1.13 . . . . 0.0 112.594 166.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 24.1 mm -84.07 -39.91 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.866 1.266 . . . . 0.0 111.762 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -173.62 -98.04 0.11 Allowed Glycine 0 N--CA 1.468 0.796 0 C-N-CA 125.662 1.601 . . . . 0.0 111.633 -174.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -144.41 123.11 12.57 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.539 1.135 . . . . 0.0 112.469 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 29.4 t -74.4 133.54 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 156.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.2 -23.62 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.068 0.547 . . . . 0.0 112.043 175.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -176.18 146.49 0.67 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 127.714 2.405 . . . . 0.0 110.494 176.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -130.45 158.79 38.93 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.548 1.539 . . . . 0.0 112.092 168.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -155.45 142.19 18.9 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.003 1.721 . . . . 0.0 110.772 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.514 HD11 ' HG ' ' A' ' 177' ' ' LEU . 4.1 mt . . . . . 0 N--CA 1.48 1.051 0 C-N-CA 124.802 1.241 . . . . 0.0 110.114 -175.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 120.417 0.151 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -149.51 -178.37 24.43 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.204 0.907 . . . . 0.0 114.383 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.2 m -150.99 144.75 25.1 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.829 1.651 . . . . 0.0 108.457 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.84 143.38 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.851 0.86 . . . . 0.0 110.014 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -110.28 135.13 51.51 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.198 1.799 . . . . 0.0 110.223 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -117.19 159.79 22.08 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.539 1.936 . . . . 0.0 112.118 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.5 p -83.66 -25.46 30.71 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -148.51 142.79 26.16 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 -168.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.8 p -76.36 -14.73 60.07 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.84 2.456 . . . . 0.0 116.013 -161.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -102.05 -33.88 9.53 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.113 0.87 . . . . 0.0 112.776 169.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -62.07 -43.32 99.08 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.703 0.801 . . . . 0.0 110.962 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 13.3 p -62.67 -35.85 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.172 1.389 . . . . 0.0 113.971 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.48 -47.0 35.94 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.739 -0.601 . . . . 0.0 112.609 172.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -58.08 -34.98 70.74 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.799 1.24 . . . . 0.0 112.43 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.67 -58.1 9.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.632 1.173 . . . . 0.0 111.636 171.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 45.1 mt -69.96 -29.88 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.485 -1.385 . . . . 0.0 112.466 -173.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.48 -14.37 12.34 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 168.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -105.92 -40.67 5.62 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.341 1.856 . . . . 0.0 111.963 171.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -95.04 -13.88 24.8 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 -165.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.01 120.62 13.96 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 120.614 1.552 . . . . 0.0 109.936 174.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 93.78 0.78 66.22 Favored Glycine 0 N--CA 1.473 1.104 0 CA-C-O 117.861 -1.522 . . . . 0.0 115.19 -167.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.33 107.0 0.59 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.221 2.01 . . . . 0.0 110.912 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -53.13 120.89 6.47 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.035 0.934 . . . . 0.0 109.85 160.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -141.24 110.74 6.39 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.462 1.505 . . . . 0.0 107.804 -170.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 19.3 mmt 51.22 41.52 27.91 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.587 1.155 . . . . 0.0 111.722 -162.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 76.28 0.53 3.26 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 127.681 2.392 . . . . 0.0 115.169 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -116.14 130.3 56.73 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.597 1.159 . . . . 0.0 111.622 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -71.01 104.15 2.9 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.042 -1.036 . . . . 0.0 112.837 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.1 pt -52.81 146.6 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.246 0.618 . . . . 0.0 111.016 156.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -135.53 147.55 48.84 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.864 1.266 . . . . 0.0 108.576 169.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 1.6 p -153.02 140.56 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.11 0.964 . . . . 0.0 111.254 -166.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 . . . . . 0 CA--C 1.533 0.326 0 C-N-CA 124.817 1.247 . . . . 0.0 110.169 173.57 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.4 t . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 121.783 0.802 . . . . 0.0 112.952 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 6.8 pt -147.62 151.47 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 127.364 2.266 . . . . 0.0 109.989 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -121.85 134.53 54.88 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.298 1.839 . . . . 0.0 110.367 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.47 121.29 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.757 1.223 . . . . 0.0 108.808 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.32 -44.79 1.13 Allowed Glycine 0 N--CA 1.475 1.257 0 N-CA-C 115.333 0.893 . . . . 0.0 115.333 -168.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -100.45 7.41 44.21 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -166.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -62.88 169.01 3.48 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.148 1.379 . . . . 0.0 111.926 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.7 m -64.15 138.87 58.66 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.129 0.972 . . . . 0.0 112.324 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -70.15 0.12 6.79 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.478 1.911 . . . . 0.0 115.244 -169.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -111.9 0.55 16.14 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.244 2.217 . . . . 0.0 112.692 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 9.8 t -61.95 154.87 25.15 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.1 p -130.49 152.28 80.06 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 125.545 1.538 . . . . 0.0 111.062 -168.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.57 -42.87 19.22 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.761 2.307 . . . . 0.0 113.236 -171.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.73 -27.96 67.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.542 1.065 . . . . 0.0 112.816 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.05 -30.2 63.55 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.971 0.909 . . . . 0.0 112.094 174.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.502 HD12 HD11 ' A' ' 192' ' ' ILE . 13.8 mt -74.51 -34.04 62.94 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.058 -0.972 . . . . 0.0 113.283 164.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 81.6 m -62.21 -50.61 71.1 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.145 1.339 . . . . 0.0 110.73 177.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -62.03 -26.74 68.42 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -78.43 -60.12 2.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.522 1.529 . . . . 0.0 111.521 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -71.24 -34.07 70.43 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -175.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.0 t -73.37 -1.21 17.21 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -64.45 -17.65 64.02 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.054 0.942 . . . . 0.0 112.855 169.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.3 mm -82.09 -25.31 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.6 1.56 . . . . 0.0 113.089 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 175.23 -103.45 0.18 Allowed Glycine 0 N--CA 1.47 0.954 0 C-N-CA 124.506 1.051 . . . . 0.0 112.367 -169.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -147.77 109.67 4.48 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.508 0.723 . . . . 0.0 112.489 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 25.6 t -71.25 129.77 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 164.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.81 -33.48 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 118.362 0.528 . . . . 0.0 112.005 173.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -154.71 134.82 13.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.285 1.434 . . . . 0.0 110.715 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -109.71 153.94 23.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.245 1.018 . . . . 0.0 110.595 153.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -153.13 123.03 6.91 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.822 1.249 . . . . 0.0 111.262 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.502 HD11 HD12 ' A' ' 177' ' ' LEU . 6.0 mt . . . . . 0 N--CA 1.482 1.147 0 C-N-CA 123.657 0.783 . . . . 0.0 113.023 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 93.4 mtp . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -173.75 -165.84 31.08 Favored Glycine 0 N--CA 1.474 1.192 0 N-CA-C 116.144 1.218 . . . . 0.0 116.144 -169.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.7 p -132.66 160.9 35.35 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.832 1.653 . . . . 0.0 113.582 -164.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 12.2 t -141.84 142.15 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.942 1.297 . . . . 0.0 110.202 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -125.45 134.98 51.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.862 2.065 . . . . 0.0 111.341 -171.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -118.46 151.66 37.39 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.071 1.748 . . . . 0.0 111.895 -169.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 61.3 p -75.93 -38.21 57.87 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.467 0.307 . . . . 0.0 110.817 163.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -61.18 160.49 10.26 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.377 1.871 . . . . 0.0 113.09 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.7 p -127.08 -66.01 0.92 Allowed 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.707 -0.621 . . . . 0.0 111.895 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -61.95 -30.24 70.78 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.425 1.011 . . . . 0.0 112.154 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -72.21 -17.43 61.92 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 12.4 t -70.26 -22.81 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.872 0.76 . . . . 0.0 112.042 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -74.07 -45.76 47.32 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.752 -1.217 . . . . 0.0 110.967 164.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 10.1 ttt85 -57.01 -29.35 63.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.597 1.559 . . . . 0.0 113.753 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.62 -68.7 0.29 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.681 1.592 . . . . 0.0 110.586 166.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.23 -27.87 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 121.204 -0.935 . . . . 0.0 113.266 -166.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -58.54 -18.79 32.31 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.861 0.864 . . . . 0.0 113.319 170.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -107.46 -6.7 16.91 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.369 1.467 . . . . 0.0 113.295 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -124.68 -22.87 4.48 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -170.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.64 120.5 14.75 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 120.399 1.454 . . . . 0.0 109.833 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 94.62 0.43 64.61 Favored Glycine 0 N--CA 1.469 0.888 0 CA-C-O 118.016 -1.435 . . . . 0.0 115.028 -168.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.8 108.84 1.08 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.909 1.855 . . . . 0.0 110.536 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -48.44 116.72 1.68 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.151 0.98 . . . . 0.0 109.351 156.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -152.0 110.77 3.82 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.851 1.26 . . . . 0.0 108.808 -172.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.13 50.52 13.41 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.472 1.109 . . . . 0.0 112.019 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 16.8 t70 77.48 0.14 2.88 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 127.257 2.223 . . . . 0.0 115.807 171.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 -135.55 154.8 51.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.925 1.29 . . . . 0.0 111.898 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 103.97 16.38 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.311 -0.868 . . . . 0.0 110.611 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.4 pt -54.76 139.54 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 121.215 -0.928 . . . . 0.0 111.287 171.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -132.69 142.66 49.17 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.626 1.17 . . . . 0.0 108.139 167.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 1.1 p -136.93 134.82 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.321 1.048 . . . . 0.0 111.682 -165.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 . . . . . 0 CA--C 1.534 0.364 0 C-N-CA 126.275 1.83 . . . . 0.0 109.919 173.438 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.5 p . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 121.502 0.668 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 28.7 pt -144.1 145.48 21.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 125.589 1.556 . . . . 0.0 110.341 -171.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 94.4 t80 -109.29 150.2 28.32 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.825 1.65 . . . . 0.0 109.56 170.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.95 102.86 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.105 1.362 . . . . 0.0 108.786 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -82.49 -16.28 71.55 Favored Glycine 0 N--CA 1.471 0.974 0 C-N-CA 124.223 0.916 . . . . 0.0 114.315 -171.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -152.2 133.43 14.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.858 1.663 . . . . 0.0 109.926 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 mp -144.01 -77.96 0.22 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.63 1.572 . . . . 0.0 109.95 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 11.3 t -172.25 140.21 1.12 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.975 2.51 . . . . 0.0 108.588 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -63.43 -13.65 42.28 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -88.7 0.09 56.78 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.201 1.4 . . . . 0.0 113.418 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 7.6 t -78.46 152.82 31.89 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.682 -1.261 . . . . 0.0 113.509 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.49 159.7 32.26 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 126.556 1.943 . . . . 0.0 109.066 -176.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.0 -27.07 17.77 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 121.988 1.792 . . . . 0.0 113.29 -167.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.04 -34.77 78.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.196 0.907 . . . . 0.0 111.573 173.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -70.38 -41.27 73.28 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.059 0.944 . . . . 0.0 110.964 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 177' ' ' LEU . 17.1 mt -66.59 -29.69 69.8 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.815 169.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 86.0 m -69.4 -48.36 61.35 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.402 1.001 . . . . 0.0 109.89 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -61.33 -33.77 74.15 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.431 0.693 . . . . 0.0 112.571 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -73.14 -61.48 1.8 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.998 1.719 . . . . 0.0 111.962 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.37 -39.75 71.05 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.3 t -73.28 -7.07 49.96 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -174.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -60.05 -18.62 47.91 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.782 1.233 . . . . 0.0 112.65 167.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 20.6 mm -78.96 -26.0 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.831 1.652 . . . . 0.0 112.607 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 166.22 -95.67 0.12 Allowed Glycine 0 N--CA 1.469 0.87 0 C-N-CA 124.734 1.159 . . . . 0.0 112.457 -171.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -141.67 110.13 6.01 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.361 1.064 . . . . 0.0 112.85 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.66 135.18 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 154.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.29 -18.31 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 172.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -160.47 138.2 9.63 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.419 1.488 . . . . 0.0 111.13 170.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -124.27 152.47 42.98 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.277 1.431 . . . . 0.0 110.554 160.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -152.32 137.0 16.97 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.201 1.001 . . . . 0.0 112.513 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.1 mt . . . . . 0 N--CA 1.483 1.206 0 C-N-CA 126.153 1.781 . . . . 0.0 111.255 179.265 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 4.0 ppp? . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 157.76 -144.79 10.92 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 115.314 0.886 . . . . 0.0 115.314 -174.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.6 m -144.84 150.39 37.04 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.269 1.428 . . . . 0.0 111.13 -160.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.8 t -139.14 147.65 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.733 1.213 . . . . 0.0 110.82 173.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -131.45 133.76 45.51 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.75 2.02 . . . . 0.0 111.001 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -120.61 164.82 15.91 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.985 2.114 . . . . 0.0 111.502 -174.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 29.3 p -74.55 -38.41 62.74 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -150.49 152.8 34.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -171.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 30.8 p -54.05 -40.0 66.73 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.328 1.851 . . . . 0.0 113.326 171.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -76.37 -23.6 54.15 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -79.59 -51.25 9.53 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.886 0.874 . . . . 0.0 112.438 169.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 15.0 p -69.3 -42.46 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -167.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.77 -13.3 62.0 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.158 0.89 . . . . 0.0 113.367 -173.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -73.37 -19.4 61.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.468 1.107 . . . . 0.0 112.657 173.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.65 -61.18 2.0 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.302 1.041 . . . . 0.0 112.612 -173.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 4.2 mp -68.91 -29.21 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 121.447 -0.783 . . . . 0.0 112.271 -160.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -58.5 -21.43 51.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.66 1.184 . . . . 0.0 113.566 170.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -101.4 -10.73 19.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.192 1.397 . . . . 0.0 112.889 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -126.0 -23.69 3.89 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -166.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.97 120.75 13.67 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.379 1.445 . . . . 0.0 109.8 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 93.08 0.83 67.74 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-O 117.982 -1.454 . . . . 0.0 115.079 -169.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.01 109.31 0.93 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.686 1.743 . . . . 0.0 110.501 171.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -57.05 124.17 17.79 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.265 0.555 . . . . 0.0 109.627 155.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -145.88 110.43 5.09 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.315 1.846 . . . . 0.0 107.103 -161.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 88.6 mmm 49.88 41.48 22.73 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.864 0.866 . . . . 0.0 111.728 -163.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 11.6 t70 77.71 -0.41 2.76 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 128.284 2.634 . . . . 0.0 115.085 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -120.38 137.73 54.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.564 1.146 . . . . 0.0 111.626 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -79.62 112.72 17.16 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.697 -1.252 . . . . 0.0 113.435 -170.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -68.18 143.88 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 121.219 -0.926 . . . . 0.0 112.98 169.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -132.31 130.28 40.62 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.282 1.433 . . . . 0.0 109.643 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 12.4 t -119.24 151.09 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.772 2.029 . . . . 0.0 109.541 -170.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 42.0 ptt85 . . . . . 0 N--CA 1.467 0.392 0 C-N-CA 123.546 0.738 . . . . 0.0 110.12 155.621 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 63.5 p . . . . . 0 N--CA 1.472 0.653 0 CA-C-O 121.444 0.64 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 10.4 pt -143.83 142.14 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.522 1.529 . . . . 0.0 109.571 -177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -128.73 123.9 34.22 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.648 1.179 . . . . 0.0 109.401 -168.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.8 t -113.93 129.68 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.814 1.645 . . . . 0.0 109.151 -164.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -74.59 -109.05 0.09 OUTLIER Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.272 1.415 . . . . 0.0 114.652 -169.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -84.26 -26.94 28.24 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.501 ' HG ' ' H ' ' A' ' 169' ' ' THR 0.32 2.3 pt? 32.7 -120.22 0.07 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.579 2.352 . . . . 0.0 115.0 -178.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.501 ' H ' ' HG ' ' A' ' 168' ' ' LEU . 57.2 m -142.28 130.32 21.94 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.684 1.594 . . . . 0.0 110.123 -162.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -61.45 -23.37 65.8 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.19 -0.89 57.78 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.885 1.674 . . . . 0.0 113.269 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 92.3 p -72.09 151.97 42.69 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 34.5 p -143.15 162.52 42.6 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 127.654 2.382 . . . . 0.0 108.372 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -63.16 -30.33 74.78 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 121.58 1.52 . . . . 0.0 112.951 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -69.28 -40.16 77.93 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.1 0.864 . . . . 0.0 112.207 173.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -66.18 -40.72 90.68 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.562 1.145 . . . . 0.0 111.838 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.34 -36.06 82.44 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.134 0.973 . . . . 0.0 112.025 170.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 91.7 m -69.48 -50.11 48.44 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.153 0.581 . . . . 0.0 110.314 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -58.75 -28.61 66.05 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.626 0.77 . . . . 0.0 112.399 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -75.56 -66.09 0.82 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.064 1.346 . . . . 0.0 111.7 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.28 -30.84 66.77 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -172.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.35 -5.33 39.02 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.011 -1.056 . . . . 0.0 113.701 -173.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -64.91 -19.45 65.94 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.685 1.194 . . . . 0.0 113.219 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 24.9 mm -82.83 -24.13 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.643 1.177 . . . . 0.0 112.655 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 176.14 -86.04 0.07 OUTLIER Glycine 0 N--CA 1.468 0.771 0 C-N-CA 124.923 1.249 . . . . 0.0 111.707 -175.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -157.51 116.47 3.26 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.494 1.118 . . . . 0.0 112.198 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 19.2 t -71.9 129.99 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 160.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.5 p -100.69 -17.04 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.657 0.783 . . . . 0.0 112.981 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -162.58 138.57 7.35 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.109 1.363 . . . . 0.0 112.112 169.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -127.35 156.02 42.65 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.986 1.314 . . . . 0.0 112.406 165.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -156.52 143.28 18.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.548 1.539 . . . . 0.0 112.27 -174.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.5 mm . . . . . 0 N--CA 1.476 0.871 0 C-N-CA 125.694 1.597 . . . . 0.0 108.012 170.281 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 4.7 ppp? . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -127.27 157.12 20.67 Favored Glycine 0 N--CA 1.471 1.031 0 C-N-CA 124.427 1.013 . . . . 0.0 114.865 -172.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 85.4 m -142.86 144.11 32.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.944 1.698 . . . . 0.0 109.107 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 43.7 t -141.63 152.52 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.848 0.859 . . . . 0.0 109.495 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -130.06 137.46 50.23 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.916 1.687 . . . . 0.0 111.21 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -121.06 160.5 23.49 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 127.306 2.243 . . . . 0.0 110.224 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 43.7 p -88.19 -14.38 38.73 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -175.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -156.25 130.93 8.96 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.2 m -46.79 -50.74 17.8 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 129.372 3.069 . . . . 0.0 115.113 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.75 -26.46 44.6 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.003 -1.061 . . . . 0.0 113.108 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.37 -39.7 64.94 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.303 -0.873 . . . . 0.0 113.332 170.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 14.0 p -69.05 -29.26 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.541 -0.724 . . . . 0.0 112.384 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.91 -39.78 83.52 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.514 0.726 . . . . 0.0 112.56 169.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 53.3 mtt85 -61.97 -33.19 73.84 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.329 0.652 . . . . 0.0 112.494 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.81 -63.71 1.13 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.409 1.004 . . . . 0.0 113.176 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 56.3 mt -65.46 -27.6 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 121.35 -0.844 . . . . 0.0 111.771 -170.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -51.39 -27.73 10.8 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.043 1.337 . . . . 0.0 113.558 168.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -98.88 -13.38 20.07 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.416 1.086 . . . . 0.0 113.443 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -125.18 -19.62 5.09 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -163.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -67.64 120.89 14.76 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 120.408 1.458 . . . . 0.0 110.769 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 91.34 0.82 72.85 Favored Glycine 0 N--CA 1.469 0.885 0 CA-C-O 117.44 -1.755 . . . . 0.0 114.75 -170.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.37 106.22 0.36 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.894 1.847 . . . . 0.0 110.32 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.499 ' CZ ' ' HE2' ' A' ' 229' ' ' LYS . 56.4 m-85 -60.3 116.92 4.61 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 156.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -133.95 110.33 9.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.24 1.416 . . . . 0.0 107.288 -164.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 12.9 ttt 50.07 38.88 17.85 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.13 0.972 . . . . 0.0 111.897 -159.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.7 t70 76.45 6.78 3.47 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 126.858 2.063 . . . . 0.0 114.965 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -121.12 138.67 54.09 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.45 1.1 . . . . 0.0 112.105 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.499 ' HE2' ' CZ ' ' A' ' 224' ' ' PHE . 42.4 mmtt -68.01 115.88 8.02 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.149 1.379 . . . . 0.0 113.584 -175.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.03 145.87 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 120.998 -1.064 . . . . 0.0 110.743 151.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -146.58 142.42 27.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.64 1.976 . . . . 0.0 108.43 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.2 t -137.27 135.38 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -165.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 . . . . . 0 N--CA 1.47 0.526 0 C-N-CA 126.259 1.824 . . . . 0.0 110.965 168.176 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.0 pt -136.43 147.06 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.09 1.356 . . . . 0.0 110.824 176.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -129.48 114.21 15.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.555 1.942 . . . . 0.0 109.356 -167.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.46 106.29 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.308 1.843 . . . . 0.0 108.197 -172.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.54 -10.78 78.97 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.237 0.922 . . . . 0.0 115.268 -169.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -159.44 157.92 31.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.009 1.724 . . . . 0.0 110.408 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 178.26 -144.55 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 128.838 2.855 . . . . 0.0 107.984 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 21.8 p -108.56 141.83 39.89 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 120.865 1.666 . . . . 0.0 111.221 170.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -59.68 -25.18 64.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -88.52 -1.85 58.27 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.045 1.738 . . . . 0.0 113.423 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 22.7 t -69.63 154.64 41.7 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.984 -1.072 . . . . 0.0 112.163 174.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 32.5 p -128.4 155.57 78.35 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 125.33 1.452 . . . . 0.0 109.746 -172.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.02 -23.48 53.79 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.45 1.434 . . . . 0.0 112.394 174.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -69.07 -36.38 77.57 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.516 1.053 . . . . 0.0 111.987 171.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -71.33 -37.98 71.69 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.307 -0.871 . . . . 0.0 111.859 174.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.8 mt -66.14 -30.36 70.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.418 -0.801 . . . . 0.0 112.787 166.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 63.6 m -67.71 -46.82 71.1 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.571 1.078 . . . . 0.0 109.35 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.31 -36.13 79.26 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.796 0.726 . . . . 0.0 112.118 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -66.41 -64.14 0.92 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.55 1.14 . . . . 0.0 111.511 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -71.23 -39.21 71.84 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -173.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.73 -3.88 31.1 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -72.77 -15.95 61.65 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.161 -0.962 . . . . 0.0 112.892 165.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.07 -45.65 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.007 0.822 . . . . 0.0 111.295 175.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.39 -90.75 0.08 OUTLIER Glycine 0 N--CA 1.468 0.779 0 C-N-CA 125.062 1.315 . . . . 0.0 112.405 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -158.4 109.56 2.17 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.74 0.816 . . . . 0.0 112.09 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 36.0 t -74.06 130.44 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 167.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.6 p -102.94 -16.99 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.22 1.008 . . . . 0.0 113.107 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -164.95 134.22 3.55 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.147 1.779 . . . . 0.0 111.066 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -130.15 152.94 49.04 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.716 1.606 . . . . 0.0 112.299 165.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -156.76 156.78 33.89 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.844 2.058 . . . . 0.0 111.216 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.3 mt . . . . . 0 N--CA 1.482 1.147 0 C-N-CA 124.7 1.2 . . . . 0.0 111.316 178.063 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 27.1 ptm . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -108.06 164.73 12.81 Favored Glycine 0 N--CA 1.469 0.865 0 C-N-CA 124.874 1.226 . . . . 0.0 113.789 -177.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.77 142.54 27.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.992 1.717 . . . . 0.0 109.836 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 19.4 t -146.27 146.89 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.609 0.764 . . . . 0.0 109.999 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -129.2 131.95 47.19 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.164 1.786 . . . . 0.0 109.369 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -95.99 171.77 8.42 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.626 1.17 . . . . 0.0 109.915 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 59.0 p -81.48 0.15 39.15 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 168.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -136.22 178.49 7.02 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.264 1.826 . . . . 0.0 112.433 -166.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 20.9 p -124.82 -68.3 0.86 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.179 1.792 . . . . 0.0 110.897 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -54.37 -38.53 66.21 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.016 -1.053 . . . . 0.0 112.956 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.6 -18.38 64.97 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.446 1.098 . . . . 0.0 113.077 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 13.0 t -75.79 -37.23 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.137 1.375 . . . . 0.0 112.062 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -62.17 -43.67 98.31 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.768 -0.582 . . . . 0.0 110.434 168.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -65.74 -17.14 64.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.981 1.312 . . . . 0.0 113.523 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -74.49 -64.27 1.06 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.24 0.927 . . . . 0.0 111.425 166.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 53.5 mt -69.23 -30.8 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.444 -0.785 . . . . 0.0 112.04 -167.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.69 -4.2 2.87 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.545 1.138 . . . . 0.0 113.835 170.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -118.24 -4.91 10.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.388 1.475 . . . . 0.0 112.569 172.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -127.54 -24.03 3.38 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -171.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.54 120.92 12.07 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 121.001 1.728 . . . . 0.0 110.501 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 91.64 0.68 72.14 Favored Glycine 0 N--CA 1.469 0.844 0 CA-C-O 118.06 -1.411 . . . . 0.0 115.336 -171.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.47 107.6 0.81 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.76 1.78 . . . . 0.0 110.363 169.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -52.98 120.4 5.81 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 156.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -142.15 111.06 6.27 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.26 1.424 . . . . 0.0 108.314 -166.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 20.5 ttt 56.72 40.5 29.14 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 121.776 0.798 . . . . 0.0 110.751 -165.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 18.3 t70 74.97 0.18 3.48 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 127.912 2.485 . . . . 0.0 115.285 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -125.64 141.27 52.11 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.05 1.34 . . . . 0.0 111.982 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -87.32 102.62 14.68 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.002 0.921 . . . . 0.0 112.621 -165.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.88 149.73 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 121.226 -0.921 . . . . 0.0 112.484 169.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -141.49 140.49 33.53 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.823 1.649 . . . . 0.0 108.696 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 16.0 t -133.03 133.55 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 118.556 0.616 . . . . 0.0 112.299 -168.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? . . . . . 0 CA--C 1.537 0.454 0 C-N-CA 126.128 1.771 . . . . 0.0 109.456 169.42 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.1 pt -139.06 148.21 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.831 1.652 . . . . 0.0 110.786 -171.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -99.34 148.87 23.73 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.106 1.363 . . . . 0.0 110.601 166.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 14.8 t -131.01 101.41 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.01 -12.86 82.89 Favored Glycine 0 N--CA 1.475 1.247 0 C-N-CA 124.128 0.871 . . . . 0.0 114.963 -161.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -164.26 148.48 9.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.531 1.932 . . . . 0.0 108.785 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.3 mp -144.51 -79.42 0.19 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.541 1.937 . . . . 0.0 109.63 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.5 t 177.03 162.64 0.46 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 128.232 2.613 . . . . 0.0 108.652 -162.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -91.75 0.37 57.49 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.407 1.083 . . . . 0.0 113.511 -174.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -120.24 0.42 10.64 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.424 1.89 . . . . 0.0 114.543 -173.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.8 t -90.15 168.51 11.9 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.932 -1.105 . . . . 0.0 113.152 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 40.0 p -143.41 163.72 35.21 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 127.488 2.315 . . . . 0.0 109.798 -174.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -60.58 -29.08 87.78 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.249 1.966 . . . . 0.0 113.193 169.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -69.08 -39.89 78.76 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.339 0.972 . . . . 0.0 111.837 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -60.98 -40.47 93.55 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.561 0.744 . . . . 0.0 111.585 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.4 mt -70.04 -31.67 69.42 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 172.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 51.8 m -65.9 -47.4 74.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.964 0.802 . . . . 0.0 110.868 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.03 -19.74 60.53 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -79.13 -55.93 4.74 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.307 1.443 . . . . 0.0 111.081 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -70.98 -28.16 64.24 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.162 0.985 . . . . 0.0 113.489 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 45.3 m -72.92 -2.31 20.37 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -64.91 -18.85 65.56 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.244 -0.91 . . . . 0.0 112.58 165.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 23.3 mm -90.08 -21.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.88 1.272 . . . . 0.0 112.222 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 168.64 -87.27 0.09 OUTLIER Glycine 0 N--CA 1.468 0.804 0 C-N-CA 125.379 1.466 . . . . 0.0 111.872 -173.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -162.07 120.18 2.22 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.663 1.185 . . . . 0.0 112.448 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 43.7 t -73.71 131.9 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 157.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.55 -18.34 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 171.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -162.37 141.21 9.11 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.144 1.778 . . . . 0.0 110.803 172.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -132.58 158.05 43.17 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.223 1.409 . . . . 0.0 111.522 164.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -153.31 143.91 22.61 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.471 1.508 . . . . 0.0 111.937 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 N--CA 1.481 1.115 0 C-N-CA 125.697 1.599 . . . . 0.0 110.632 -179.757 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 11.7 ptt? . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 119.45 -0.31 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 164.99 -144.65 9.5 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-N 118.638 0.654 . . . . 0.0 114.388 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.5 p -144.46 159.77 42.2 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.34 1.456 . . . . 0.0 112.954 -165.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 37.8 t -144.97 141.53 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.003 1.321 . . . . 0.0 110.322 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -121.16 134.32 55.22 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 127.018 2.127 . . . . 0.0 110.922 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -118.96 172.79 7.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.676 2.39 . . . . 0.0 111.234 -173.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 80.9 p -92.2 -22.03 20.04 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . 0.424 ' O ' HG12 ' A' ' 213' ' ' VAL . 18.4 m120 -148.49 137.4 21.64 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -169.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 19.3 m -69.84 -22.89 63.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.98 2.112 . . . . 0.0 115.814 -168.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -90.24 -36.92 14.46 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.639 0.654 . . . . 0.0 111.951 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -72.23 -37.11 69.25 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.102 -0.998 . . . . 0.0 112.573 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 209' ' ' ASN . 14.2 p -63.46 -28.7 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.607 0.763 . . . . 0.0 113.01 170.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.62 -46.57 37.45 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.86 0.864 . . . . 0.0 112.974 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -59.31 -27.84 66.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.317 1.447 . . . . 0.0 112.896 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.64 -60.93 2.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.216 1.006 . . . . 0.0 112.879 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 43.9 mt -65.09 -29.06 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 121.128 -0.982 . . . . 0.0 112.428 -169.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -51.44 -29.1 14.97 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.622 1.569 . . . . 0.0 113.19 168.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -93.87 -15.86 24.62 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.988 1.315 . . . . 0.0 113.698 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -127.6 -18.6 4.33 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -159.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.81 120.9 13.36 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 121.227 1.831 . . . . 0.0 110.506 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 92.98 0.78 68.02 Favored Glycine 0 N--CA 1.472 1.039 0 CA-C-O 117.941 -1.477 . . . . 0.0 115.059 -170.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.97 108.16 0.99 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.839 1.82 . . . . 0.0 110.348 171.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -55.68 129.25 38.44 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.313 0.645 . . . . 0.0 110.333 160.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -152.25 110.84 3.77 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.996 1.719 . . . . 0.0 106.685 -162.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 2.6 mpt? 41.15 59.28 2.35 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.152 0.981 . . . . 0.0 111.435 -160.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 73.21 0.05 3.54 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.922 2.089 . . . . 0.0 116.174 170.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -137.58 147.0 44.71 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.622 1.169 . . . . 0.0 111.775 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -70.83 124.22 23.79 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.903 -1.123 . . . . 0.0 113.698 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.4 pt -65.78 137.13 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.336 -0.853 . . . . 0.0 111.332 153.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -129.76 129.84 44.63 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.068 1.347 . . . . 0.0 109.596 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -156.32 129.09 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.992 0.917 . . . . 0.0 111.614 -169.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? . . . . . 0 N--CA 1.469 0.495 0 C-N-CA 125.919 1.687 . . . . 0.0 109.443 168.354 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 80.2 p . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 121.179 0.514 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 5.1 pt -144.58 154.37 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.219 1.407 . . . . 0.0 111.806 -165.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -119.02 125.85 50.32 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.553 1.941 . . . . 0.0 109.627 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 12.2 t -107.94 129.96 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.743 1.217 . . . . 0.0 109.111 -175.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.37 -97.66 0.12 Allowed Glycine 0 N--CA 1.472 1.094 0 C-N-CA 125.667 1.604 . . . . 0.0 115.036 -161.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -92.68 -56.86 2.85 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 117.625 0.713 . . . . 0.0 111.924 -173.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.45 6.67 1.52 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 118.752 2.871 . . . . 0.0 118.752 155.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.7 m 79.18 124.23 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 127.783 2.433 . . . . 0.0 110.422 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -68.25 -13.35 62.19 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -81.45 -9.14 59.78 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.503 1.521 . . . . 0.0 113.319 172.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.0 m -74.77 141.78 44.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.998 0.919 . . . . 0.0 112.551 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.8 p -122.87 152.78 63.21 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.971 1.308 . . . . 0.0 111.554 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.6 -25.9 14.46 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.607 2.205 . . . . 0.0 113.057 -173.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -69.43 -39.44 77.84 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.437 1.017 . . . . 0.0 111.891 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -73.16 -36.23 66.59 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.451 -0.781 . . . . 0.0 111.349 177.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 49.3 mt -62.24 -31.93 72.55 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.773 0.829 . . . . 0.0 112.289 166.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 54.8 m -67.0 -51.06 59.74 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.48 1.036 . . . . 0.0 109.634 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.92 -36.15 78.55 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.424 0.556 . . . . 0.0 112.359 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -67.38 -57.41 6.64 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.014 1.726 . . . . 0.0 112.29 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -71.57 -34.01 69.57 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.9 t -72.53 -8.79 56.95 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 121.004 -1.06 . . . . 0.0 113.441 -174.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -52.54 -27.99 18.93 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.362 2.265 . . . . 0.0 113.053 164.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 28.4 mm -80.52 -17.26 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.547 1.539 . . . . 0.0 112.451 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 117.25 90.98 1.54 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.909 1.719 . . . . 0.0 112.324 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? 69.69 91.29 0.09 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 126.751 2.02 . . . . 0.0 114.472 162.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 13.9 t -73.14 128.09 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 162.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 66.5 t -91.12 -22.51 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.892 1.677 . . . . 0.0 111.25 -175.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -178.43 140.03 0.2 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.243 2.217 . . . . 0.0 109.576 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -120.03 141.33 49.84 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.487 1.115 . . . . 0.0 110.52 162.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -143.7 92.95 2.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.677 1.191 . . . . 0.0 111.595 -169.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.482 1.148 0 C-N-CA 124.689 1.196 . . . . 0.0 110.815 173.776 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 28.2 ptm . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -166.22 -166.74 25.76 Favored Glycine 0 N--CA 1.471 1.025 0 C-N-CA 124.031 0.824 . . . . 0.0 114.088 174.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.8 p -141.84 161.14 38.69 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.83 1.252 . . . . 0.0 112.599 -167.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 6.4 t -143.54 142.28 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.651 1.18 . . . . 0.0 110.435 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -114.49 145.26 42.12 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.225 2.21 . . . . 0.0 111.218 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -129.83 161.69 30.2 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.936 2.494 . . . . 0.0 109.535 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.2 p -84.21 -28.56 27.22 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.99 -0.444 . . . . 0.0 111.396 171.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -84.66 174.7 9.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.36 1.864 . . . . 0.0 112.902 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 39.3 t -126.03 -65.92 0.96 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.85 0.86 . . . . 0.0 111.49 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -64.5 -25.48 68.01 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.51 -1.369 . . . . 0.0 113.821 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -72.06 -20.92 61.59 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.561 1.144 . . . . 0.0 113.315 171.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 22.0 t -70.05 -28.3 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.049 0.94 . . . . 0.0 111.591 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -74.44 -37.07 63.37 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.283 -0.886 . . . . 0.0 112.208 167.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -64.8 -23.66 67.31 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.239 1.016 . . . . 0.0 112.405 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.97 -63.87 1.12 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.19 0.996 . . . . 0.0 110.565 164.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 83.8 mt -62.09 -35.63 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.215 1.006 . . . . 0.0 112.396 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -64.03 -6.56 6.52 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -114.29 -5.15 12.96 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.525 1.53 . . . . 0.0 112.535 172.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -128.06 -19.43 3.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -169.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -58.64 121.43 10.97 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.072 1.306 . . . . 0.0 109.227 162.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 93.83 0.51 66.35 Favored Glycine 0 N--CA 1.468 0.786 0 CA-C-O 118.379 -1.234 . . . . 0.0 114.849 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.57 108.53 2.46 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.512 1.656 . . . . 0.0 110.463 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -54.8 123.24 12.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.434 0.694 . . . . 0.0 109.963 155.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -148.62 116.51 6.35 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.422 1.489 . . . . 0.0 108.335 -167.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 56.21 31.58 18.67 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.101 0.96 . . . . 0.0 111.968 -163.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 10.7 t70 86.61 0.66 0.57 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 128.37 2.668 . . . . 0.0 115.582 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.4 152.77 48.69 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.638 1.175 . . . . 0.0 111.782 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -82.38 123.68 29.33 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -158.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.75 153.4 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 126.037 1.735 . . . . 0.0 113.318 167.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -145.86 146.65 31.2 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.552 1.941 . . . . 0.0 108.787 164.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 23.4 t -117.41 128.57 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.727 1.211 . . . . 0.0 110.586 -173.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 . . . . . 0 CA--C 1.538 0.493 0 C-N-CA 123.863 0.865 . . . . 0.0 109.364 168.828 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.0 pt -143.61 147.32 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 125.301 1.44 . . . . 0.0 112.275 -165.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -113.78 118.98 35.78 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 128.041 2.536 . . . . 0.0 109.257 173.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 25.5 t -94.57 97.15 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.363 1.465 . . . . 0.0 107.397 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.39 -9.22 67.26 Favored Glycine 0 N--CA 1.475 1.25 0 N-CA-C 116.052 1.181 . . . . 0.0 116.052 -160.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -139.61 18.13 2.53 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -164.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.02 -174.92 2.86 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.28 1.432 . . . . 0.0 112.689 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 38.1 m -97.26 122.96 40.88 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.023 1.329 . . . . 0.0 109.503 171.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -66.94 -10.42 48.92 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -171.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -74.82 -13.11 60.53 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.486 1.514 . . . . 0.0 113.867 174.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 5.8 m -67.24 137.89 56.5 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.022 -1.049 . . . . 0.0 111.447 168.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 78.8 p -76.21 163.27 67.51 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 123.836 0.855 . . . . 0.0 109.908 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -59.91 -35.64 92.98 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 121.758 1.639 . . . . 0.0 111.917 168.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.42 -29.01 69.06 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.787 0.722 . . . . 0.0 112.88 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -65.21 -33.72 76.67 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.078 0.951 . . . . 0.0 111.992 173.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.3 mt -74.59 -34.16 62.81 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 118.003 -0.998 . . . . 0.0 113.451 165.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 84.8 m -61.08 -51.12 70.48 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.94 1.246 . . . . 0.0 110.62 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.24 -30.5 70.95 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.889 0.768 . . . . 0.0 112.973 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -68.27 -56.37 8.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.034 1.334 . . . . 0.0 111.514 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -71.65 -23.38 61.67 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.7 t -61.98 -19.65 63.03 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.651 -1.28 . . . . 0.0 113.457 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -60.97 -17.95 54.55 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.281 1.833 . . . . 0.0 113.306 169.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 25.8 mm -104.45 -51.87 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.144 1.378 . . . . 0.0 111.851 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -172.33 -177.42 41.79 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.165 1.364 . . . . 0.0 112.403 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -74.24 105.6 5.5 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 121.624 -0.927 . . . . 0.0 112.168 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 48.3 t -59.68 130.13 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 160.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.02 -40.16 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.312 0.645 . . . . 0.0 110.422 171.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -155.54 139.4 16.24 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.871 2.068 . . . . 0.0 109.983 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -125.31 152.96 43.99 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.313 1.445 . . . . 0.0 110.665 164.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -150.97 131.67 14.01 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.541 1.136 . . . . 0.0 112.203 -171.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.7 mt . . . . . 0 N--CA 1.48 1.057 0 C-N-CA 125.225 1.41 . . . . 0.0 110.974 171.863 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 3.6 ppp? . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -147.09 172.85 27.45 Favored Glycine 0 N--CA 1.468 0.774 0 C-N-CA 126.025 1.774 . . . . 0.0 112.808 177.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.3 p -142.81 148.77 37.67 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.12 1.368 . . . . 0.0 111.013 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.29 137.28 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.09 0.956 . . . . 0.0 109.983 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -116.09 137.08 52.44 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.706 1.603 . . . . 0.0 109.635 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -110.98 159.12 18.03 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.17 1.788 . . . . 0.0 110.411 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 64.1 p -77.07 0.48 21.28 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 169.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -130.01 157.18 43.05 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.106 1.762 . . . . 0.0 112.886 -165.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 72.1 p -109.14 -7.85 15.24 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.601 1.56 . . . . 0.0 114.916 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.71 -45.42 1.46 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.39 1.476 . . . . 0.0 111.914 -166.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.23 -30.08 68.16 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.596 -0.69 . . . . 0.0 111.505 172.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.5 p -61.13 -32.11 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.276 1.43 . . . . 0.0 113.025 174.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -74.16 -48.11 31.48 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.965 0.906 . . . . 0.0 111.436 171.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -72.34 -11.76 60.84 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.62 -56.75 17.46 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.6 1.16 . . . . 0.0 111.381 163.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 71.2 mt -66.87 -30.33 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.055 0.942 . . . . 0.0 112.109 -168.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -52.41 -28.37 19.58 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.507 1.123 . . . . 0.0 113.471 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -97.1 -15.23 21.07 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.399 1.48 . . . . 0.0 112.579 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -123.29 -15.64 7.14 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -165.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -61.31 120.65 10.83 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.53 1.514 . . . . 0.0 108.88 162.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 97.57 -0.24 59.58 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 118.153 -1.36 . . . . 0.0 114.844 -172.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.17 103.88 2.46 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.727 1.764 . . . . 0.0 110.469 173.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -60.81 119.69 8.67 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 158.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -150.38 110.85 4.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.152 1.381 . . . . 0.0 108.633 -165.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 57.13 55.38 6.04 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.298 1.039 . . . . 0.0 110.865 -170.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 19.5 t70 76.13 0.18 3.23 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.749 2.02 . . . . 0.0 116.088 169.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -146.86 157.36 43.63 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.311 0.959 . . . . 0.0 112.787 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 4.2 tmmm? -86.36 105.42 16.69 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.673 1.189 . . . . 0.0 112.647 -172.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.22 154.1 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.188 0.995 . . . . 0.0 112.052 165.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -156.45 144.77 19.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.466 1.906 . . . . 0.0 107.486 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 13.2 t -127.36 140.31 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.632 0.773 . . . . 0.0 111.926 -162.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 81.6 mtt85 . . . . . 0 CA--C 1.536 0.411 0 C-N-CA 126.95 2.1 . . . . 0.0 108.318 175.399 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 CA--C 1.541 0.617 0 CA-C-O 122.05 0.928 . . . . 0.0 112.806 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 31.7 pt -138.95 138.89 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.898 2.079 . . . . 0.0 107.948 175.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -105.73 131.3 53.25 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.59 1.156 . . . . 0.0 109.52 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.7 t -111.2 122.96 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.677 1.591 . . . . 0.0 108.354 -170.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.12 -141.67 1.78 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.195 1.855 . . . . 0.0 113.312 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -74.97 47.26 0.34 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -162.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.62 ' HB2' HG22 ' A' ' 230' ' ' ILE . 2.5 pt? -53.99 -50.1 67.34 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.819 -1.175 . . . . 0.0 112.606 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.1 t 145.23 142.96 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.388 1 C-N-CA 131.705 4.002 . . . . 0.0 110.18 173.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -68.95 -9.5 52.39 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -80.59 -6.07 57.75 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.748 1.219 . . . . 0.0 113.198 170.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 6.2 t -88.72 167.06 13.63 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.957 0.903 . . . . 0.0 113.163 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.45 151.74 64.71 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 125.741 1.617 . . . . 0.0 111.385 -170.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.41 -21.76 11.42 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.797 2.332 . . . . 0.0 114.331 -167.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.02 -34.79 75.81 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.156 1.344 . . . . 0.0 111.567 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.42 -41.66 84.48 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.777 1.231 . . . . 0.0 110.874 175.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.4 tp -67.38 -33.59 75.51 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.478 1.911 . . . . 0.0 111.455 174.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 68.3 m -64.26 -50.45 67.91 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.428 1.491 . . . . 0.0 110.41 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -67.59 -40.5 84.79 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.918 0.487 . . . . 0.0 111.622 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -56.07 -56.58 19.1 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.484 1.513 . . . . 0.0 112.235 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -71.13 -27.46 63.59 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.6 m -73.3 0.51 11.8 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -68.75 -19.59 64.34 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.169 -0.957 . . . . 0.0 112.597 164.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 14.0 mm -95.05 -55.29 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.104 0.961 . . . . 0.0 111.137 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -135.68 -109.68 1.02 Allowed Glycine 0 N--CA 1.468 0.779 0 C-N-CA 125.906 1.717 . . . . 0.0 110.372 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -152.84 121.99 6.63 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.213 1.005 . . . . 0.0 111.097 173.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 49.1 t -73.4 129.95 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 170.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.61 -24.05 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 170.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -152.78 135.7 15.51 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.463 1.505 . . . . 0.0 110.257 172.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -128.09 148.79 50.58 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.014 1.326 . . . . 0.0 110.598 160.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -145.53 134.98 23.15 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.6 1.16 . . . . 0.0 112.13 -172.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 59.2 mt . . . . . 0 N--CA 1.483 1.201 0 C-N-CA 125.64 1.576 . . . . 0.0 110.165 170.923 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 120.334 0.111 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -145.61 -179.08 21.61 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 124.383 0.992 . . . . 0.0 114.905 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 12.7 m -141.55 148.56 39.53 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.361 1.465 . . . . 0.0 109.087 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 19.6 t -141.25 147.15 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.263 1.025 . . . . 0.0 110.472 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.04 131.1 47.31 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.589 1.556 . . . . 0.0 110.976 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -102.53 161.69 13.52 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.51 1.524 . . . . 0.0 111.196 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 54.1 p -70.52 0.21 7.21 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.559 1.543 . . . . 0.0 113.893 166.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -141.75 162.21 36.03 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.432 1.893 . . . . 0.0 112.108 -165.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 12.5 m -132.67 13.42 4.45 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -132.06 -36.5 1.17 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.068 1.347 . . . . 0.0 112.661 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -66.51 -21.53 66.17 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.748 0.819 . . . . 0.0 112.397 167.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.1 m -63.87 -28.17 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.507 1.523 . . . . 0.0 112.907 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -74.3 -49.64 22.21 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.55 1.14 . . . . 0.0 111.449 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 23.4 ptt-85 -74.37 -11.86 60.36 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.7 -64.5 0.88 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.939 0.895 . . . . 0.0 110.835 160.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 66.3 mt -62.19 -32.83 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.938 0.895 . . . . 0.0 112.449 -171.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 35.0 ttm105 -57.21 -22.69 42.67 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 173.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -98.06 -11.14 23.25 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.41 1.084 . . . . 0.0 112.943 175.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -123.56 -21.29 5.3 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -165.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -66.2 120.44 13.23 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 120.415 1.461 . . . . 0.0 109.559 172.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 90.06 0.59 77.35 Favored Glycine 0 N--CA 1.473 1.127 0 CA-C-O 117.884 -1.509 . . . . 0.0 115.146 -168.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.8 109.46 1.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.986 1.893 . . . . 0.0 109.482 167.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -55.97 119.89 6.57 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 157.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -148.87 118.35 6.94 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.215 1.406 . . . . 0.0 108.259 -172.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.38 44.07 18.87 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-O 122.398 1.094 . . . . 0.0 110.212 -163.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 71.55 0.52 3.51 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 128.066 2.546 . . . . 0.0 116.253 173.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 30.1 mmt85 -135.04 148.69 49.97 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.07 1.348 . . . . 0.0 112.105 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -64.54 117.07 6.83 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.194 -0.941 . . . . 0.0 113.234 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.62 HG22 ' HB2' ' A' ' 168' ' ' LEU . 0.7 OUTLIER -68.26 153.56 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.635 0.774 . . . . 0.0 110.684 156.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -137.53 157.37 46.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.533 1.533 . . . . 0.0 107.857 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.12 139.24 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.528 1.058 . . . . 0.0 111.681 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 . . . . . 0 CA--C 1.538 0.481 0 C-N-CA 125.828 1.651 . . . . 0.0 108.84 169.347 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.7 m . . . . . 0 CA--C 1.54 0.58 0 CA-C-O 120.993 0.425 . . . . 0.0 111.917 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.9 pt -130.92 150.2 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.976 1.71 . . . . 0.0 110.976 -170.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -110.0 138.88 45.76 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.503 1.521 . . . . 0.0 111.197 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 44.8 t -126.79 131.04 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.923 1.689 . . . . 0.0 108.786 -169.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.32 -164.2 7.2 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.976 1.751 . . . . 0.0 113.283 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -67.52 -14.96 63.39 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 118.062 2.615 . . . . 0.0 118.062 -157.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.3 mp 51.03 -112.71 0.65 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.537 1.535 . . . . 0.0 109.857 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 71.2 p -122.87 153.39 39.69 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.056 2.143 . . . . 0.0 109.312 154.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -57.12 -28.84 63.05 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -175.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -91.73 -0.98 57.59 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.821 2.048 . . . . 0.0 114.114 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 85.8 p -67.47 160.91 26.56 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.45 152.67 60.97 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 125.799 1.64 . . . . 0.0 111.593 -169.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.79 -18.53 11.7 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.151 2.567 . . . . 0.0 114.647 -165.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.43 -35.48 81.07 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.519 1.054 . . . . 0.0 111.112 172.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -69.64 -36.86 76.48 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.773 1.229 . . . . 0.0 111.399 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.8 mt -67.98 -31.89 71.91 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-O 118.685 -0.674 . . . . 0.0 112.326 169.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 59.7 m -67.16 -50.89 59.51 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.969 0.804 . . . . 0.0 109.516 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -58.13 -38.8 77.23 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.669 0.788 . . . . 0.0 112.293 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -65.56 -63.25 1.14 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.343 1.457 . . . . 0.0 112.236 176.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.16 -33.95 70.5 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -173.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.25 -3.39 26.55 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -172.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -65.47 -18.17 65.12 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 120.967 -1.083 . . . . 0.0 112.739 169.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 29.8 mm -78.53 -27.4 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.616 1.567 . . . . 0.0 112.31 174.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 139.25 169.45 11.58 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.994 1.759 . . . . 0.0 110.755 -158.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -57.72 106.54 0.36 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -164.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 53.9 t -71.05 131.36 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 151.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.29 -26.5 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 171.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 50.7 ttt-85 -162.74 110.47 1.28 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.856 0.463 . . . . 0.0 110.825 -170.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.72 151.74 19.84 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.192 0.997 . . . . 0.0 110.259 161.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -153.23 125.28 7.93 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.911 0.884 . . . . 0.0 111.615 -170.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mt . . . . . 0 N--CA 1.482 1.161 0 C-N-CA 125.565 1.546 . . . . 0.0 111.354 -179.125 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -175.92 -152.46 9.56 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.8 p -143.01 159.83 41.5 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.124 1.77 . . . . 0.0 112.172 -172.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 18.8 t -140.42 140.89 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.294 1.038 . . . . 0.0 110.306 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -128.86 127.68 42.35 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.383 1.473 . . . . 0.0 109.981 -172.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -110.8 170.71 7.92 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.53 1.932 . . . . 0.0 109.746 -174.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 80.9 p -81.47 0.07 39.45 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -139.07 155.08 48.19 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.831 1.253 . . . . 0.0 114.088 -167.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 66.4 p -108.38 4.73 24.73 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.775 1.63 . . . . 0.0 113.68 -177.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -120.37 -46.04 2.41 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.634 1.174 . . . . 0.0 112.783 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -63.53 -22.04 66.67 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.313 -0.867 . . . . 0.0 113.039 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 213' ' ' VAL . 2.3 m -61.34 -29.74 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.896 2.079 . . . . 0.0 113.363 173.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -74.48 -49.46 22.13 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.026 0.83 . . . . 0.0 110.541 166.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -58.4 -28.28 65.05 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.797 1.239 . . . . 0.0 113.399 -174.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.2 -59.57 5.21 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.23 1.412 . . . . 0.0 112.291 168.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 51.6 mt -66.39 -31.25 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.22 1.008 . . . . 0.0 112.282 -170.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -58.91 -5.77 0.67 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 171.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -133.07 5.68 3.86 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.52 1.128 . . . . 0.0 114.038 172.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -123.11 -22.14 5.25 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.01 120.64 13.98 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 121.327 1.876 . . . . 0.0 110.653 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 92.16 0.83 70.38 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-O 118.025 -1.43 . . . . 0.0 115.119 -169.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.42 107.47 0.79 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.953 1.877 . . . . 0.0 109.926 168.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -52.02 123.95 11.68 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.957 161.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -147.97 120.83 8.72 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.022 1.329 . . . . 0.0 108.709 -172.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 50.5 mtt 60.37 28.07 17.68 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.154 0.982 . . . . 0.0 112.159 -169.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.6 t70 92.27 -0.06 0.13 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 129.449 3.1 . . . . 0.0 115.419 173.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 42.9 mmt180 -136.69 150.48 48.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.751 1.221 . . . . 0.0 112.184 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -65.12 111.71 3.05 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.862 -1.149 . . . . 0.0 112.555 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.47 152.0 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 O-C-N 121.169 -0.957 . . . . 0.0 109.761 151.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -132.12 156.66 45.96 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.145 1.378 . . . . 0.0 108.429 170.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.7 p -150.44 127.0 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.517 0.675 . . . . 0.0 112.113 -169.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 125.481 1.512 . . . . 0.0 108.403 175.917 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 6.7 pt -139.22 150.94 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.69 1.596 . . . . 0.0 109.784 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -122.95 143.77 49.69 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.216 1.406 . . . . 0.0 111.986 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.0 t -124.34 116.82 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.226 1.81 . . . . 0.0 108.193 -174.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.06 -25.43 59.77 Favored Glycine 0 N--CA 1.475 1.24 0 C-N-CA 123.542 0.591 . . . . 0.0 114.403 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -162.17 151.22 15.48 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.742 2.017 . . . . 0.0 108.571 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -173.16 11.19 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 126.054 1.742 . . . . 0.0 114.917 -171.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 34.9 m 86.42 111.45 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 128.739 2.816 . . . . 0.0 109.403 -165.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -62.64 -17.43 60.36 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -83.42 -0.35 49.59 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.703 1.601 . . . . 0.0 113.529 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 10.0 t -67.66 167.56 12.9 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.834 -1.166 . . . . 0.0 113.797 175.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 44.8 p -135.7 153.32 77.32 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 125.972 1.709 . . . . 0.0 110.416 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.56 -23.96 26.54 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.566 2.177 . . . . 0.0 113.13 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.28 -37.19 77.75 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.885 0.766 . . . . 0.0 111.712 172.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.47 -35.37 68.21 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.507 -0.746 . . . . 0.0 111.424 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 20.9 mt -62.91 -35.85 81.44 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-O 118.807 -0.616 . . . . 0.0 112.334 166.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 74.7 m -67.93 -45.83 73.22 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.222 0.919 . . . . 0.0 110.337 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.7 -15.79 54.32 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.811 1.245 . . . . 0.0 113.502 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -96.5 -57.94 2.18 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.285 1.834 . . . . 0.0 111.896 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -71.6 -34.2 69.65 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 3.7 t -73.16 -15.92 61.45 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -159.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -64.35 -17.9 64.15 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 35.8 mm -59.8 -24.18 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.114 1.365 . . . . 0.0 112.641 173.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 167.52 -72.05 0.16 Allowed Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.926 1.25 . . . . 0.0 111.467 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -160.28 118.39 2.6 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.965 1.306 . . . . 0.0 111.158 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.29 137.93 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 165.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.5 m -110.27 -16.67 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -159.91 158.46 30.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.739 1.215 . . . . 0.0 111.881 176.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -160.06 149.13 17.5 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.939 1.696 . . . . 0.0 111.696 174.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -149.58 152.54 35.66 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.619 1.967 . . . . 0.0 111.641 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 26.6 mm . . . . . 0 N--CA 1.479 1.019 0 C-N-CA 126.145 1.778 . . . . 0.0 107.844 170.292 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 3.0 mpp? . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 121.256 0.55 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -110.43 158.97 14.11 Favored Glycine 0 N--CA 1.468 0.806 0 C-N-CA 124.656 1.122 . . . . 0.0 113.458 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.2 m -141.97 142.4 32.97 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.887 1.675 . . . . 0.0 108.032 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.7 t -142.4 149.97 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.972 0.909 . . . . 0.0 109.433 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -132.65 129.72 39.23 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.891 0.876 . . . . 0.0 111.523 -176.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -114.9 172.7 6.89 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.243 1.817 . . . . 0.0 111.102 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.8 p -86.85 -11.57 50.44 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -149.35 127.96 12.38 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 116.749 2.129 . . . . 0.0 116.749 -169.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 33.0 p -73.8 2.29 8.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 128.116 2.566 . . . . 0.0 116.064 -174.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -114.07 -36.76 4.64 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.269 1.428 . . . . 0.0 111.693 169.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.68 -27.68 69.09 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.5 -0.75 . . . . 0.0 112.775 173.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.9 m -59.55 -33.43 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 171.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -74.17 -46.61 41.15 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.958 0.799 . . . . 0.0 110.214 172.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -57.88 -29.7 65.25 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.673 0.789 . . . . 0.0 112.829 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.95 -68.57 0.35 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.778 1.231 . . . . 0.0 111.492 167.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 64.7 mt -61.99 -34.83 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.43 -0.793 . . . . 0.0 112.193 -167.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -58.69 -12.78 4.59 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.754 1.222 . . . . 0.0 114.187 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -116.62 -1.99 12.04 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.719 1.608 . . . . 0.0 112.888 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -128.91 -23.21 3.11 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.67 120.57 11.45 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 120.498 1.499 . . . . 0.0 109.832 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 95.68 0.48 62.46 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-O 118.11 -1.383 . . . . 0.0 115.725 -170.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.96 108.46 1.04 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.721 1.76 . . . . 0.0 109.973 169.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -58.12 124.17 18.46 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.788 -0.57 . . . . 0.0 109.921 158.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -150.38 110.97 4.24 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.852 1.261 . . . . 0.0 108.912 -159.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 49.8 mtt 57.91 23.36 9.72 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.585 1.154 . . . . 0.0 113.487 -169.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 19.8 t70 101.16 -11.61 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 130.811 3.644 . . . . 0.0 115.24 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -116.29 147.0 41.97 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 119.978 1.263 . . . . 0.0 111.801 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -68.09 112.06 4.83 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.308 1.443 . . . . 0.0 112.229 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.5 pt -61.21 141.69 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.473 1.033 . . . . 0.0 111.609 166.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -138.37 129.76 27.51 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.644 1.178 . . . . 0.0 109.158 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.2 126.81 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 123.626 0.771 . . . . 0.0 110.713 -164.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 52.7 ttt85 . . . . . 0 CA--C 1.534 0.352 0 C-N-CA 126.539 1.936 . . . . 0.0 108.768 170.937 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 CA--C 1.541 0.608 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -131.15 142.83 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.233 0.613 . . . . 0.0 110.024 158.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -111.93 142.48 44.28 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.71 1.604 . . . . 0.0 111.166 -174.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.3 t -144.61 121.32 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.161 0.984 . . . . 0.0 109.989 174.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -137.75 19.56 3.32 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.88 1.229 . . . . 0.0 115.602 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -128.57 20.02 6.16 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.305 1.442 . . . . 0.0 112.707 -171.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.455 ' HB3' HG22 ' A' ' 230' ' ' ILE . 1.3 pp -96.54 -175.88 3.45 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 126.984 2.114 . . . . 0.0 111.245 -174.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 48.4 m -79.81 121.5 25.47 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.782 0.833 . . . . 0.0 109.407 168.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -66.54 -11.56 53.47 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -170.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -81.38 -10.97 59.42 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.956 1.303 . . . . 0.0 113.588 171.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 91.5 p -77.66 142.6 38.75 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.6 -0.688 . . . . 0.0 111.664 172.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 68.2 p -102.52 163.63 17.25 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 125.067 1.347 . . . . 0.0 111.205 -171.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -64.54 -26.8 61.91 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.499 2.133 . . . . 0.0 112.931 171.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -69.34 -40.03 77.81 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.472 1.033 . . . . 0.0 111.729 171.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -66.93 -36.58 82.56 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.817 0.847 . . . . 0.0 111.64 175.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 45.7 mt -66.21 -32.66 74.22 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.547 -0.74 . . . . 0.0 112.725 166.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 81.8 m -67.1 -48.22 68.83 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.686 1.13 . . . . 0.0 109.965 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.05 -27.84 69.18 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -78.69 -58.96 2.98 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.53 1.532 . . . . 0.0 112.106 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -71.1 -37.83 72.39 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.65 -1.67 19.89 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -176.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -55.87 -26.87 49.09 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.797 1.639 . . . . 0.0 112.165 164.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.4 mm -75.87 -30.7 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.815 1.646 . . . . 0.0 112.88 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 166.86 -103.84 0.21 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.783 1.182 . . . . 0.0 112.181 -165.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -135.01 106.35 6.77 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.991 0.916 . . . . 0.0 113.396 -175.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 56.2 t -80.96 135.68 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 153.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.33 -24.72 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -157.88 88.66 0.98 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.547 0.739 . . . . 0.0 112.235 -170.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -91.18 140.97 29.3 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.812 -1.18 . . . . 0.0 111.709 168.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -153.28 121.44 6.17 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.919 1.287 . . . . 0.0 112.201 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 20.3 mt . . . . . 0 N--CA 1.484 1.252 0 C-N-CA 125.459 1.504 . . . . 0.0 111.08 174.357 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 26.8 ptm . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 120.933 0.397 . . . . 0.0 111.74 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 169.6 -143.45 7.94 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.932 0.777 . . . . 0.0 113.002 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 25.0 p -137.87 160.87 38.12 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.986 0.914 . . . . 0.0 113.272 -162.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.3 t -136.03 102.42 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.126 1.371 . . . . 0.0 108.056 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -88.53 122.85 32.45 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.205 1.002 . . . . 0.0 110.457 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -90.02 176.03 6.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.86 1.664 . . . . 0.0 109.814 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 72.4 p -68.09 0.16 3.91 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 168.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 27.3 m120 85.77 2.91 0.6 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.743 2.817 . . . . 0.0 114.977 165.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.7 t -110.8 -168.53 1.32 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.462 1.505 . . . . 0.0 112.136 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -34.08 -38.37 0.06 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 130.531 3.533 . . . . 0.0 117.28 -164.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -52.15 -33.69 41.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.101 1.76 . . . . 0.0 112.733 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.0 p -68.83 -37.41 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.107 1.363 . . . . 0.0 112.952 -169.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -75.16 -52.07 11.86 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.734 1.214 . . . . 0.0 112.382 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -74.0 -18.47 60.85 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.654 1.182 . . . . 0.0 114.057 -171.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.47 -60.03 4.11 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.065 0.946 . . . . 0.0 111.911 170.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 27.9 mt -65.46 -28.73 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.706 0.803 . . . . 0.0 112.41 -171.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -28.63 37.53 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.324 1.05 . . . . 0.0 112.511 169.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -98.24 -11.31 22.8 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.443 1.097 . . . . 0.0 113.432 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -126.32 -20.12 4.51 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -164.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -62.42 120.79 11.73 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 120.038 1.29 . . . . 0.0 109.627 169.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 95.1 0.52 63.5 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-O 118.163 -1.354 . . . . 0.0 115.334 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.15 107.06 0.81 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.757 1.778 . . . . 0.0 110.673 170.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -57.22 107.32 0.41 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 154.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -129.74 110.66 11.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.323 1.049 . . . . 0.0 108.921 -167.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 48.2 ttm 53.88 43.92 30.22 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.923 0.889 . . . . 0.0 110.816 -168.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.8 t70 86.76 0.21 0.56 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 128.091 2.557 . . . . 0.0 116.146 170.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -136.19 135.89 39.5 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.622 1.101 . . . . 0.0 112.542 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -68.17 102.55 1.37 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.546 1.538 . . . . 0.0 113.541 -176.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.455 HG22 ' HB3' ' A' ' 168' ' ' LEU . 0.9 OUTLIER -56.51 151.25 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.117 0.967 . . . . 0.0 111.456 164.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -148.01 135.41 20.61 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.083 1.353 . . . . 0.0 108.921 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -156.94 137.08 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.217 1.407 . . . . 0.0 109.867 -165.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 . . . . . 0 CA--C 1.536 0.438 0 C-N-CA 124.855 1.262 . . . . 0.0 109.579 171.148 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.5 p . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 43.5 pt -137.26 138.04 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.647 1.179 . . . . 0.0 110.06 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -98.99 148.7 23.73 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.907 1.283 . . . . 0.0 109.489 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.6 t -126.4 131.67 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.537 1.535 . . . . 0.0 108.759 -172.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -74.17 -154.57 3.59 Favored Glycine 0 N--CA 1.474 1.192 0 C-N-CA 125.543 1.544 . . . . 0.0 112.93 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -55.48 -42.73 74.77 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -166.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 57.34 -169.44 0.11 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 128.061 2.545 . . . . 0.0 115.81 165.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.2 t -76.39 73.14 3.16 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.258 1.823 . . . . 0.0 110.416 166.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -68.05 -9.29 44.86 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -74.37 -12.42 60.52 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.113 1.365 . . . . 0.0 113.132 167.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 3.8 t -101.3 151.06 22.34 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.274 1.03 . . . . 0.0 113.523 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 17.6 p -81.94 152.67 69.06 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 126.444 1.898 . . . . 0.0 111.457 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.36 -25.79 80.66 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.213 2.609 . . . . 0.0 115.482 -173.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -67.21 -17.03 64.65 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.865 1.211 . . . . 0.0 113.439 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -70.74 -33.99 71.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.29 1.036 . . . . 0.0 111.25 170.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.1 mt -74.33 -32.48 62.83 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.336 -0.84 . . . . 0.0 111.782 167.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 31.1 m -62.75 -51.34 67.52 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.731 1.151 . . . . 0.0 110.264 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.53 -34.12 75.0 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.336 0.516 . . . . 0.0 112.119 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -67.0 -65.04 0.73 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.608 1.563 . . . . 0.0 111.329 176.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -71.24 -29.0 64.58 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -173.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.4 t -73.25 -23.63 60.36 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -173.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -67.34 -10.89 55.46 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 29.5 mm -69.89 -31.31 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.439 1.496 . . . . 0.0 112.59 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.66 42.01 0.03 OUTLIER Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.242 0.925 . . . . 0.0 114.221 -172.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 83.4 tttt 79.34 124.45 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 128.708 2.803 . . . . 0.0 113.606 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.7 149.32 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 126.159 1.784 . . . . 0.0 108.097 164.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 4.3 m -110.27 -18.27 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -157.32 147.29 20.65 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.846 0.858 . . . . 0.0 111.245 -175.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -154.48 144.39 21.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.729 1.611 . . . . 0.0 110.559 170.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -155.11 153.07 30.29 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 122.096 0.95 . . . . 0.0 113.262 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 51.0 mm . . . . . 0 CA--C 1.544 0.745 0 C-N-CA 127.3 2.24 . . . . 0.0 110.543 171.868 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 22.8 ptp . . . . . 0 N--CA 1.475 0.801 0 CA-C-O 120.58 0.228 . . . . 0.0 111.527 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -156.47 175.22 34.16 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.195 1.379 . . . . 0.0 113.197 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 27.5 m -148.17 147.05 29.02 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.148 1.379 . . . . 0.0 109.889 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.1 t -139.0 141.55 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.448 1.099 . . . . 0.0 109.541 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -123.93 131.64 53.6 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.603 1.161 . . . . 0.0 111.509 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -102.2 173.81 6.2 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.306 1.842 . . . . 0.0 110.426 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 81.3 p -68.88 0.65 4.15 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 176.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 93.04 52.48 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 128.169 2.587 . . . . 0.0 113.606 161.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.7 t -161.4 -165.35 1.29 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.947 0.899 . . . . 0.0 112.872 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -57.86 -10.37 1.69 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.097 2.159 . . . . 0.0 115.234 -168.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -52.07 -34.11 42.25 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.177 1.391 . . . . 0.0 111.729 162.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.54 -39.48 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.742 1.617 . . . . 0.0 111.427 176.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.65 -55.03 6.32 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.323 1.049 . . . . 0.0 111.919 171.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -59.11 -29.71 67.58 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.183 1.393 . . . . 0.0 113.706 -172.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.26 -60.59 3.57 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.931 0.892 . . . . 0.0 112.681 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 3.5 mp -68.79 -22.36 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.088 -1.008 . . . . 0.0 112.803 -168.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 16.5 mmt-85 -54.23 -27.91 37.73 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.401 0.68 . . . . 0.0 112.773 168.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -95.5 -17.71 21.24 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.795 1.238 . . . . 0.0 112.817 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -122.46 -18.87 6.57 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -161.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -58.24 120.21 8.27 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 120.585 1.539 . . . . 0.0 110.276 175.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 79.94 0.3 84.93 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.277 -1.291 . . . . 0.0 116.094 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.58 97.67 2.18 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 120.082 1.941 . . . . 0.0 111.377 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -48.92 135.63 15.32 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.028 0.931 . . . . 0.0 112.532 176.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -143.87 116.9 8.88 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.356 1.062 . . . . 0.0 109.852 -162.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 16.8 ttt 59.89 34.36 21.69 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.391 1.077 . . . . 0.0 111.156 -168.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 67.67 0.68 2.33 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.888 2.075 . . . . 0.0 114.095 -174.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -112.26 165.37 12.23 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.297 2.239 . . . . 0.0 111.423 -171.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -66.35 168.91 8.07 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.342 1.057 . . . . 0.0 113.144 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 41.8 pt -158.3 146.76 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 1 C-N-CA 132.204 4.201 . . . . 0.0 107.058 171.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -149.49 141.94 24.3 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.712 1.605 . . . . 0.0 107.219 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.8 p -150.44 137.38 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 120.068 1.303 . . . . 0.0 113.632 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 . . . . . 0 CA--C 1.541 0.626 0 C-N-CA 126.572 1.949 . . . . 0.0 110.931 176.993 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 121.06 0.457 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 8.0 pt -142.36 138.24 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.243 -0.911 . . . . 0.0 110.9 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -128.39 134.41 48.82 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.166 1.786 . . . . 0.0 109.951 -175.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.65 134.24 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.875 1.27 . . . . 0.0 109.979 -156.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.85 -116.23 0.12 Allowed Glycine 0 N--CA 1.478 1.455 0 C-N-CA 127.055 2.264 . . . . 0.0 115.002 -170.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -68.25 -62.59 1.33 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.71 1.255 . . . . 0.0 111.999 -176.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 62.92 5.03 1.66 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.533 2.333 . . . . 0.0 117.166 167.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 58.7 m 74.51 98.25 0.07 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 127.416 2.286 . . . . 0.0 108.643 -162.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -65.03 -16.18 63.16 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -170.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.15 0.38 51.18 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.883 1.673 . . . . 0.0 114.0 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 95.6 p -70.67 167.14 19.29 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 172.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 18.7 p -123.9 151.5 64.86 Favored Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 124.936 1.294 . . . . 0.0 112.392 -170.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.35 -17.44 16.68 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.347 2.698 . . . . 0.0 115.385 -169.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.8 -36.9 81.25 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.966 1.257 . . . . 0.0 111.953 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -72.98 -35.78 66.95 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.284 -0.885 . . . . 0.0 111.536 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.3 mt -64.07 -33.39 75.65 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.119 0.968 . . . . 0.0 111.903 168.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.4 m -65.57 -49.72 67.77 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.009 0.822 . . . . 0.0 109.666 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.35 -41.08 98.3 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.484 0.584 . . . . 0.0 112.008 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.68 -56.33 20.83 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.145 1.378 . . . . 0.0 112.29 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.23 -43.44 67.28 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.4 t -73.62 -12.6 60.8 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -171.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -62.59 -16.48 56.58 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.656 1.116 . . . . 0.0 113.101 170.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 16.3 mm -72.98 -33.0 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.751 1.22 . . . . 0.0 111.976 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.44 -84.49 0.08 OUTLIER Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.221 1.391 . . . . 0.0 112.517 -170.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -157.3 103.48 1.99 Allowed 'General case' 0 CA--C 1.55 0.942 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -170.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 40.4 t -77.35 136.81 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 156.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.0 p -104.86 -20.23 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.282 1.033 . . . . 0.0 112.813 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 30.8 ttm-85 -164.38 139.3 5.68 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.369 1.468 . . . . 0.0 111.706 173.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -129.67 147.12 51.43 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.864 1.266 . . . . 0.0 111.259 164.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -159.11 152.29 22.37 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 174.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 126.564 1.946 . . . . 0.0 111.224 171.888 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -114.84 168.89 12.67 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.887 1.708 . . . . 0.0 113.82 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 21.8 m -141.09 144.59 35.0 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.916 1.286 . . . . 0.0 109.838 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.8 t -137.15 136.87 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.8 0.84 . . . . 0.0 109.185 171.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -104.58 119.8 39.82 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.079 1.751 . . . . 0.0 109.205 173.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.433 ' HB2' HG12 ' A' ' 213' ' ' VAL . 9.2 m-85 -93.09 176.77 6.29 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.301 1.44 . . . . 0.0 109.034 163.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 45.6 p -97.4 -15.73 20.54 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -150.29 126.41 10.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.182 0.993 . . . . 0.0 113.226 -172.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.4 p -46.89 -53.58 11.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.68 1.992 . . . . 0.0 114.261 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -60.05 -28.58 67.89 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.89 -35.45 67.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.498 1.119 . . . . 0.0 112.644 173.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.433 HG12 ' HB2' ' A' ' 207' ' ' PHE . 0.6 OUTLIER -69.79 -40.52 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.013 0.925 . . . . 0.0 112.272 178.394 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.52 -47.53 66.73 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.577 -176.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -66.34 -18.29 65.27 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -70.84 -62.87 1.23 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.696 0.798 . . . . 0.0 110.475 167.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 60.8 mt -60.96 -33.86 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.446 1.099 . . . . 0.0 112.667 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -52.0 -19.9 2.1 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.971 1.709 . . . . 0.0 114.02 170.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -114.26 -6.79 12.99 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.849 1.66 . . . . 0.0 112.815 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -126.84 -22.72 3.8 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -166.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.88 120.71 13.04 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 120.916 1.689 . . . . 0.0 109.637 173.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 98.15 0.28 58.56 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-O 118.219 -1.323 . . . . 0.0 115.2 -168.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.33 108.23 1.26 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.718 1.759 . . . . 0.0 110.218 170.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -56.57 125.14 20.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.273 0.558 . . . . 0.0 109.772 154.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -149.59 110.84 4.41 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.319 1.447 . . . . 0.0 108.076 -159.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 24.1 mmt 55.87 32.95 20.66 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.626 0.77 . . . . 0.0 112.192 -169.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 87.49 0.37 0.47 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.888 2.875 . . . . 0.0 115.985 174.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.49 152.69 50.82 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.806 1.184 . . . . 0.0 112.043 173.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -77.48 129.12 35.3 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.8 -1.187 . . . . 0.0 114.104 -167.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.3 pt -75.58 133.52 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 120.997 -1.064 . . . . 0.0 110.487 164.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -118.24 144.47 45.75 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 166.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.3 p -150.85 140.19 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 120.162 1.347 . . . . 0.0 112.677 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 . . . . . 0 C--O 1.234 0.276 0 C-N-CA 126.113 1.765 . . . . 0.0 110.255 171.716 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 52.9 m . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 6.8 pt -130.57 151.74 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.815 1.646 . . . . 0.0 110.011 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -132.86 143.51 49.58 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.448 1.899 . . . . 0.0 109.717 -173.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.16 134.59 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 119.495 1.043 . . . . 0.0 111.177 -175.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.42 -71.83 1.03 Allowed Glycine 0 N--CA 1.473 1.161 0 C-N-CA 124.124 0.869 . . . . 0.0 113.657 -173.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -83.91 39.03 0.67 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.032 1.333 . . . . 0.0 114.245 -165.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.408 HD23 ' H ' ' A' ' 168' ' ' LEU . 0.5 OUTLIER -75.75 170.86 15.38 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.339 -1.476 . . . . 0.0 110.677 165.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 45.9 m -75.55 124.39 27.11 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.707 0.803 . . . . 0.0 109.06 167.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -70.18 -13.71 62.31 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -167.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -89.14 0.08 57.02 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 170.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 32.0 t -63.57 138.18 58.4 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 121.254 -0.904 . . . . 0.0 111.022 161.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 41.4 p -98.47 159.89 29.42 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 124.704 1.201 . . . . 0.0 110.728 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.16 -19.52 68.9 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.921 1.747 . . . . 0.0 112.486 167.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -69.16 -44.49 72.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 120.225 1.375 . . . . 0.0 111.2 170.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -59.14 -45.99 89.51 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.396 0.679 . . . . 0.0 110.755 172.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -27.37 68.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.999 0.92 . . . . 0.0 113.341 173.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 52.2 m -76.48 -47.77 21.81 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.52 1.055 . . . . 0.0 110.0 176.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -59.02 -31.1 68.52 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.718 1.145 . . . . 0.0 112.168 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -70.87 -67.88 0.47 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.389 1.476 . . . . 0.0 112.005 174.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -71.14 -35.04 71.56 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.5 t -73.33 -10.46 59.78 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -170.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -62.04 -17.25 56.77 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.223 -0.923 . . . . 0.0 113.343 171.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.66 -21.84 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 125.714 1.606 . . . . 0.0 112.667 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 169.94 -90.24 0.09 OUTLIER Glycine 0 N--CA 1.467 0.709 0 C-N-CA 125.055 1.312 . . . . 0.0 110.789 -172.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -159.63 120.31 3.11 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.118 0.967 . . . . 0.0 112.693 174.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.4 t -72.38 127.72 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 162.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.37 -34.03 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 118.691 0.678 . . . . 0.0 110.554 175.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -172.33 145.68 1.72 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.385 1.474 . . . . 0.0 112.045 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -129.23 171.26 12.63 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.821 2.049 . . . . 0.0 110.706 161.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -145.95 -60.18 0.32 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.81 1.782 . . . . 0.0 115.81 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 3.9 mt . . . . . 0 N--CA 1.49 1.531 0 C-N-CA 127.712 2.405 . . . . 0.0 113.219 -178.88 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.28 158.82 19.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.237 1.399 . . . . 0.0 112.81 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.7 m -147.45 142.55 27.11 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.011 1.725 . . . . 0.0 108.745 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 10.8 t -142.95 142.09 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.119 0.967 . . . . 0.0 110.788 -177.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -119.95 139.08 53.0 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.213 1.805 . . . . 0.0 110.01 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -116.78 154.05 31.36 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.676 1.591 . . . . 0.0 112.383 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.3 p -81.07 -17.93 48.37 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.92 0.888 . . . . 0.0 113.102 171.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -102.11 173.03 6.56 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.265 1.426 . . . . 0.0 113.061 -169.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 65.3 p -107.08 -101.1 0.35 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.915 1.686 . . . . 0.0 111.954 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -60.65 -22.16 63.53 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.739 1.216 . . . . 0.0 113.592 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -67.74 -18.04 64.76 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.072 0.949 . . . . 0.0 113.384 173.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.47 -28.99 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.326 0.966 . . . . 0.0 112.033 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.25 -45.96 44.61 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.44 -0.788 . . . . 0.0 110.843 167.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -52.88 -27.35 18.15 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.633 1.973 . . . . 0.0 114.112 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.59 -71.76 0.17 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.023 1.329 . . . . 0.0 110.929 165.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 36.4 mt -54.62 -44.33 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.323 1.449 . . . . 0.0 112.451 -172.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -64.84 0.35 1.21 Allowed 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 176.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -118.31 -1.41 11.31 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.846 1.659 . . . . 0.0 112.566 167.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -122.96 -14.0 7.71 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.132 1.773 . . . . 0.0 114.136 -176.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -48.68 120.96 4.12 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.338 1.455 . . . . 0.0 110.294 166.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 88.89 0.81 80.81 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-O 118.129 -1.373 . . . . 0.0 115.41 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.68 105.19 0.42 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.653 1.727 . . . . 0.0 111.507 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -55.98 110.43 0.74 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 152.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -127.54 110.8 13.09 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.466 1.106 . . . . 0.0 109.317 -170.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 89.9 mtp 55.55 36.14 26.58 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.708 1.203 . . . . 0.0 111.974 -173.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 14.4 t70 98.46 0.14 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 129.216 3.007 . . . . 0.0 115.79 170.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -138.85 137.52 36.65 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.547 1.067 . . . . 0.0 112.592 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -77.0 102.07 6.29 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.211 1.404 . . . . 0.0 113.707 -170.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.3 pt -54.24 143.63 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.535 0.734 . . . . 0.0 112.766 172.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -132.76 135.38 45.69 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.508 1.523 . . . . 0.0 107.4 166.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.6 p -119.8 132.53 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.294 1.038 . . . . 0.0 111.81 -168.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 . . . . . 0 CA--C 1.536 0.416 0 C-N-CA 127.41 2.284 . . . . 0.0 109.576 167.565 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.6 pt -139.39 155.92 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 126.007 1.723 . . . . 0.0 111.321 -170.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -118.16 153.13 34.33 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.749 2.02 . . . . 0.0 111.391 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.1 t -138.89 128.4 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.528 1.531 . . . . 0.0 110.131 -174.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.84 -91.03 1.85 Allowed Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.034 1.302 . . . . 0.0 114.179 -173.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -84.26 35.68 0.55 Allowed 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -160.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -80.3 -5.68 56.7 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -169.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.4 p 91.05 127.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 131.018 3.727 . . . . 0.0 110.609 -167.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -70.64 -13.11 61.95 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -169.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -81.84 -5.49 58.26 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.375 1.47 . . . . 0.0 113.084 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.5 m -64.77 143.02 58.23 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.212 1.005 . . . . 0.0 113.089 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 51.7 p -105.67 157.37 34.75 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 125.108 1.363 . . . . 0.0 110.919 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.08 -31.42 65.38 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.385 2.057 . . . . 0.0 112.606 174.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.31 -39.35 92.37 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.115 0.871 . . . . 0.0 111.621 174.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.17 -29.55 66.47 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.705 -0.622 . . . . 0.0 112.626 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.8 mt -74.06 -27.43 60.91 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 164.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 98.4 m -71.46 -51.14 25.39 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.402 1.001 . . . . 0.0 110.035 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -63.06 -24.61 67.99 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.628 0.649 . . . . 0.0 112.72 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.29 -69.14 0.5 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.54 1.536 . . . . 0.0 111.585 174.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -65.31 -32.41 74.05 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.4 t -73.35 0.08 13.15 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -175.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -71.67 -18.78 62.16 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.318 -0.864 . . . . 0.0 113.179 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 19.4 mm -81.56 -55.0 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.118 0.967 . . . . 0.0 111.628 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -138.74 -96.31 0.36 Allowed Glycine 0 N--CA 1.467 0.75 0 C-N-CA 126.379 1.942 . . . . 0.0 109.878 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -156.03 128.61 7.78 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.898 0.879 . . . . 0.0 112.145 169.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.73 134.93 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 167.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.52 -42.62 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 118.275 0.489 . . . . 0.0 110.426 172.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -157.35 141.24 16.02 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 127.105 2.162 . . . . 0.0 109.529 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -117.69 158.99 23.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.889 1.276 . . . . 0.0 111.055 161.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -152.9 132.07 12.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.071 1.349 . . . . 0.0 111.37 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 3.2 mt . . . . . 0 N--CA 1.486 1.345 0 C-N-CA 125.051 1.34 . . . . 0.0 112.401 179.89 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -94.82 164.93 25.4 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 115.24 0.856 . . . . 0.0 115.24 -159.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.7 p -146.69 148.35 31.92 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.886 2.074 . . . . 0.0 110.201 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 13.7 t -147.57 136.68 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.674 0.79 . . . . 0.0 110.865 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -109.34 131.61 54.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.551 1.94 . . . . 0.0 109.547 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -103.25 158.34 16.39 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.059 1.343 . . . . 0.0 110.545 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 78.8 p -71.24 0.21 8.43 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.859 0.864 . . . . 0.0 112.899 170.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -138.92 -175.99 4.34 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.203 2.201 . . . . 0.0 112.011 -167.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.6 p -142.8 -66.34 0.38 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.584 1.554 . . . . 0.0 110.16 -174.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -53.15 -33.31 51.89 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 120.677 -1.265 . . . . 0.0 113.288 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.97 -24.85 61.66 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.318 1.447 . . . . 0.0 114.054 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.4 m -70.75 -31.91 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -169.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -56.95 -46.21 82.28 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.691 1.196 . . . . 0.0 111.146 166.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -71.68 -23.69 61.7 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.881 0.872 . . . . 0.0 112.25 -171.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.39 -61.99 1.98 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.992 0.917 . . . . 0.0 110.949 165.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 80.9 mt -59.78 -37.32 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.329 1.051 . . . . 0.0 112.123 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 47.1 ttm-85 -62.46 -4.86 2.1 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.493 1.517 . . . . 0.0 113.838 176.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -121.86 -3.62 9.17 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.498 1.919 . . . . 0.0 112.922 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -124.49 -21.92 4.78 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -173.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.92 120.69 12.43 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 120.22 1.373 . . . . 0.0 109.882 174.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 94.04 0.5 65.88 Favored Glycine 0 N--CA 1.471 1.032 0 CA-C-O 118.107 -1.385 . . . . 0.0 115.522 -170.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.8 108.54 0.87 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.756 1.778 . . . . 0.0 110.725 174.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -55.56 121.28 8.7 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.231 1.013 . . . . 0.0 110.715 161.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -152.53 110.86 3.71 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.511 1.924 . . . . 0.0 107.575 -158.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 16.8 ttt 54.08 35.86 23.28 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.581 0.705 . . . . 0.0 111.397 -164.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 76.05 0.22 3.26 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.394 2.677 . . . . 0.0 115.286 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -120.55 144.02 48.28 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.118 1.367 . . . . 0.0 110.749 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.99 111.49 15.25 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.584 -1.322 . . . . 0.0 112.764 -176.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.4 pt -54.18 148.07 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.472 -0.767 . . . . 0.0 110.928 164.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -137.62 137.52 38.55 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.226 1.01 . . . . 0.0 109.327 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.85 126.6 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 124.163 0.985 . . . . 0.0 109.659 -171.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 . . . . . 0 CA--C 1.532 0.285 0 C-N-CA 124.251 1.02 . . . . 0.0 110.05 164.521 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.8 p . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.59 161.48 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 121.915 -0.491 . . . . 0.0 112.012 -154.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -121.36 124.22 44.03 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.545 1.138 . . . . 0.0 110.688 170.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.27 134.94 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 127.175 2.19 . . . . 0.0 107.772 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.61 -133.47 0.4 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.886 1.232 . . . . 0.0 112.665 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -60.54 -28.19 68.24 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 -168.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . 0.292 2.5 pt? 28.52 -129.96 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.651 1.98 . . . . 0.0 113.192 -164.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.9 m -142.4 130.38 21.86 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.444 1.498 . . . . 0.0 109.133 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -64.5 -18.21 64.58 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -171.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -75.01 -3.38 32.06 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.563 1.545 . . . . 0.0 113.779 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 77.0 p -104.18 168.88 8.82 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.769 1.228 . . . . 0.0 114.124 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 52.1 p -137.06 165.68 32.92 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 126.922 2.089 . . . . 0.0 110.741 -171.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -59.86 -25.04 78.21 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.333 2.022 . . . . 0.0 113.199 169.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.13 -40.83 78.05 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.478 1.035 . . . . 0.0 111.8 172.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -62.72 -42.47 99.67 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.347 0.659 . . . . 0.0 111.097 173.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.6 mt -64.31 -31.3 72.45 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 118.49 -0.766 . . . . 0.0 112.515 170.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.8 m -68.69 -51.26 43.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.633 1.106 . . . . 0.0 110.272 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.95 -30.97 72.0 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.916 0.78 . . . . 0.0 112.26 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -70.85 -61.22 1.85 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.404 1.482 . . . . 0.0 111.718 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -71.34 -36.96 71.7 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.4 t -73.41 -1.52 18.62 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -173.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -73.44 -16.5 61.31 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.431 -0.793 . . . . 0.0 113.01 167.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.5 mm -80.97 -55.24 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 119.176 0.898 . . . . 0.0 111.144 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -134.57 -100.11 0.65 Allowed Glycine 0 N--CA 1.468 0.824 0 C-N-CA 126.0 1.762 . . . . 0.0 110.443 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -156.88 126.73 6.28 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.437 1.095 . . . . 0.0 111.88 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 20.5 t -76.56 134.5 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.01 0.924 . . . . 0.0 108.651 169.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.72 -15.52 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.57 1.148 . . . . 0.0 113.882 168.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.1 mtp85 -161.72 132.28 5.03 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.501 1.521 . . . . 0.0 110.874 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -129.23 145.7 51.29 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.582 1.953 . . . . 0.0 111.494 170.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -161.49 145.31 12.83 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.912 1.285 . . . . 0.0 111.651 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.6 mt . . . . . 0 N--CA 1.478 0.953 0 C-N-CA 124.499 1.119 . . . . 0.0 109.653 178.95 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 76.9 mtm . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.52 163.32 13.55 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 124.913 1.244 . . . . 0.0 115.164 -165.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.2 p -153.63 153.1 31.68 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.38 1.872 . . . . 0.0 111.352 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.97 147.15 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.046 1.338 . . . . 0.0 111.17 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -125.52 130.89 52.64 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.364 2.266 . . . . 0.0 110.068 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -108.42 165.09 11.78 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.136 1.374 . . . . 0.0 111.698 -174.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 40.5 p -76.51 0.27 20.5 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.546 1.538 . . . . 0.0 114.559 169.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -133.03 168.77 17.89 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.024 1.73 . . . . 0.0 111.796 -169.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.7 p -107.75 -62.62 1.41 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.728 1.211 . . . . 0.0 112.373 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -79.88 -35.34 38.19 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.896 1.678 . . . . 0.0 112.942 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -60.12 -24.44 64.68 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.7 1.2 . . . . 0.0 112.447 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.69 -29.51 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.462 1.905 . . . . 0.0 112.546 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.34 -38.67 63.19 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.335 -0.853 . . . . 0.0 111.058 172.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -67.63 -21.87 65.36 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.712 1.605 . . . . 0.0 112.969 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.86 -55.84 25.59 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.937 0.895 . . . . 0.0 111.39 164.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 73.5 mt -66.24 -28.54 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 O-C-N 121.292 -0.88 . . . . 0.0 111.851 -171.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -18.82 9.56 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.955 1.302 . . . . 0.0 113.987 171.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -106.62 -14.5 15.02 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.407 1.883 . . . . 0.0 112.109 176.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -122.4 -17.89 6.91 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.806 2.15 . . . . 0.0 116.806 -164.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -66.75 120.68 13.92 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 120.32 1.418 . . . . 0.0 109.991 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 92.52 0.69 69.5 Favored Glycine 0 N--CA 1.472 1.09 0 CA-C-O 117.714 -1.603 . . . . 0.0 115.081 -169.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.83 108.02 0.69 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 120.158 1.979 . . . . 0.0 111.081 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -52.03 122.95 9.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.647 0.779 . . . . 0.0 109.535 155.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -147.57 114.3 6.06 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.496 1.518 . . . . 0.0 107.734 -166.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 54.17 38.44 29.18 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.68 0.792 . . . . 0.0 111.335 -166.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 17.0 t70 84.24 0.61 0.93 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 128.526 2.731 . . . . 0.0 115.417 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.36 141.94 35.6 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.17 0.988 . . . . 0.0 112.663 -173.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -71.48 120.4 17.0 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -169.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.76 156.18 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.669 1.588 . . . . 0.0 112.019 154.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -140.18 156.17 46.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.918 1.687 . . . . 0.0 108.795 167.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 40.3 t -140.47 133.97 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.496 0.718 . . . . 0.0 111.733 -168.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 . . . . . 0 CA--C 1.539 0.521 0 C-N-CA 124.906 1.282 . . . . 0.0 109.854 170.918 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 112.019 -0.432 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.1 t 72.72 168.1 0.31 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.801 2.04 . . . . 0.0 113.614 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -163.06 153.33 16.13 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.948 1.699 . . . . 0.0 112.058 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 59.38 35.11 23.02 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.861 1.664 . . . . 0.0 113.43 171.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -78.28 156.89 29.42 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.757 1.223 . . . . 0.0 111.921 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -157.28 164.24 37.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.954 1.702 . . . . 0.0 112.152 -175.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -159.97 149.62 18.07 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.782 1.633 . . . . 0.0 111.405 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 35.2 m -166.37 156.29 11.91 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.504 1.922 . . . . 0.0 111.242 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 41.6 p -140.44 155.3 46.76 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.847 1.659 . . . . 0.0 110.912 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -145.33 160.03 42.14 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.348 1.459 . . . . 0.0 112.141 -170.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -161.69 157.13 23.97 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.405 1.482 . . . . 0.0 111.768 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -113.22 130.29 56.27 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.304 1.442 . . . . 0.0 109.614 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -160.41 150.44 17.98 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.876 1.27 . . . . 0.0 111.855 -168.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 18.3 m -134.94 155.96 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.549 1.54 . . . . 0.0 111.337 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -142.6 164.56 29.77 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.554 1.542 . . . . 0.0 112.029 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.2 mtm105 67.09 30.47 7.37 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.645 1.978 . . . . 0.0 113.153 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -80.46 93.97 6.12 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.37 1.068 . . . . 0.0 111.511 -171.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -168.07 166.3 13.1 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.814 2.046 . . . . 0.0 111.669 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 66.8 m 68.77 177.15 0.26 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.285 1.834 . . . . 0.0 114.152 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -144.22 27.9 1.39 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.437 1.895 . . . . 0.0 111.646 -176.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.0 t -138.5 153.34 48.77 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.988 1.315 . . . . 0.0 112.047 -169.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 9.9 pt -146.41 150.64 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 126.676 1.99 . . . . 0.0 109.806 -171.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -126.19 149.61 48.9 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.443 1.897 . . . . 0.0 109.709 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.03 118.76 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.907 0.883 . . . . 0.0 110.101 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.44 -3.21 37.96 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 116.967 1.547 . . . . 0.0 116.967 -160.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -142.77 22.61 1.95 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.102 1.451 . . . . 0.0 113.795 -170.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.6 pp -77.53 178.78 6.97 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.757 1.223 . . . . 0.0 111.832 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.3 t -73.56 133.87 43.64 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.77 0.828 . . . . 0.0 111.536 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -66.88 -8.9 32.45 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -87.63 -4.44 58.94 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.473 1.509 . . . . 0.0 113.622 170.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 7.7 t -69.12 139.76 54.73 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 121.064 -1.023 . . . . 0.0 112.509 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 27.4 p -102.6 162.19 20.95 Favored Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 125.589 1.556 . . . . 0.0 109.985 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -58.69 -32.27 96.55 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.139 1.892 . . . . 0.0 112.025 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.76 -38.65 91.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.092 0.957 . . . . 0.0 112.231 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -61.24 -44.01 97.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.782 0.719 . . . . 0.0 111.443 176.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 36.4 mt -70.45 -29.58 66.19 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.232 -0.89 . . . . 0.0 112.955 173.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 96.4 m -70.0 -51.24 33.95 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.24 0.927 . . . . 0.0 110.678 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -65.9 -24.32 66.82 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.868 0.758 . . . . 0.0 112.676 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -73.55 -66.21 0.72 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.046 1.738 . . . . 0.0 111.594 173.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -69.86 -33.97 72.97 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -174.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.8 t -73.45 -3.97 30.75 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -172.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -64.54 -18.49 64.89 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.117 -0.989 . . . . 0.0 112.831 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 30.1 mm -77.98 -23.5 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.856 1.263 . . . . 0.0 112.455 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 169.67 -90.16 0.09 OUTLIER Glycine 0 N--CA 1.468 0.802 0 C-N-CA 124.357 0.979 . . . . 0.0 112.437 -171.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -155.76 110.35 2.89 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.105 0.962 . . . . 0.0 112.845 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 37.4 t -73.66 132.0 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 157.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.37 -29.52 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 171.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 -153.35 135.8 15.07 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.192 1.397 . . . . 0.0 110.056 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -115.92 159.58 21.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.595 1.158 . . . . 0.0 110.404 157.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -153.2 129.95 10.86 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.633 1.173 . . . . 0.0 112.081 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 6.0 mt -145.98 -48.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 124.664 1.186 . . . . 0.0 111.855 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 40.9 mm -71.18 139.11 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.783 0.833 . . . . 0.0 110.447 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 40.8 p -130.37 155.9 45.61 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.251 1.42 . . . . 0.0 110.757 -176.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.3 t -71.56 -11.95 61.12 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -100.74 -32.25 10.8 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.79 1.236 . . . . 0.0 112.647 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 73.22 24.09 76.19 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 116.138 1.215 . . . . 0.0 116.138 161.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -81.19 60.46 4.33 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.98 1.39 . . . . 0.0 114.309 -170.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 54.26 34.59 20.78 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 126.256 1.822 . . . . 0.0 114.169 164.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -62.89 -40.96 99.14 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -157.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 70.99 22.23 78.4 Favored Glycine 0 N--CA 1.479 1.512 0 C-N-CA 123.753 0.692 . . . . 0.0 114.533 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 28.3 ptm -156.28 150.17 25.07 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.85 1.26 . . . . 0.0 112.849 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -158.19 -172.0 24.79 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.747 1.165 . . . . 0.0 114.814 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 20.6 m -137.19 150.81 48.16 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.523 1.929 . . . . 0.0 110.254 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.7 t -141.44 142.99 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.881 1.272 . . . . 0.0 110.514 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -126.11 130.67 51.54 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 126.974 2.11 . . . . 0.0 110.782 -176.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -108.87 168.04 9.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.502 1.921 . . . . 0.0 110.952 -177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 49.1 p -81.4 0.06 39.16 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 167.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -127.99 154.56 45.47 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.865 1.666 . . . . 0.0 111.797 -167.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.5 p -114.39 -1.34 13.53 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.729 1.612 . . . . 0.0 113.685 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -130.05 -46.2 1.13 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.983 1.313 . . . . 0.0 112.714 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -65.88 -20.75 66.34 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.082 -1.011 . . . . 0.0 112.925 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.6 p -63.74 -33.29 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.24 1.816 . . . . 0.0 112.547 170.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -77.58 -36.76 51.67 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.66 0.784 . . . . 0.0 112.643 168.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -63.95 -24.14 67.61 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.145 0.978 . . . . 0.0 112.633 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.47 -56.81 15.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.948 1.299 . . . . 0.0 111.569 165.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.35 -35.22 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.735 1.214 . . . . 0.0 111.871 -172.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -57.07 -12.72 2.28 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.252 1.421 . . . . 0.0 114.039 172.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -117.43 -4.87 11.27 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.309 1.844 . . . . 0.0 112.685 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -129.46 -21.05 3.21 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.97 120.95 14.01 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 120.041 1.291 . . . . 0.0 110.381 176.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 97.24 0.73 59.64 Favored Glycine 0 N--CA 1.471 0.967 0 CA-C-O 118.189 -1.339 . . . . 0.0 114.772 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.97 106.52 0.72 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.759 1.779 . . . . 0.0 111.137 173.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -54.19 117.69 3.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.684 0.794 . . . . 0.0 109.461 155.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -137.89 108.68 6.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.5 1.52 . . . . 0.0 107.141 -165.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 18.1 ttt 50.42 47.1 24.51 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.679 0.791 . . . . 0.0 111.413 -162.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 21.5 t70 72.55 0.29 3.57 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 127.189 2.196 . . . . 0.0 114.652 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -123.68 125.05 44.09 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.215 1.406 . . . . 0.0 110.974 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -81.34 102.73 10.63 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.767 1.227 . . . . 0.0 114.264 -165.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -55.1 142.33 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.765 0.826 . . . . 0.0 111.434 167.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -136.4 134.59 37.94 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.084 1.353 . . . . 0.0 108.515 168.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 5.4 t -103.59 143.49 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.461 1.104 . . . . 0.0 110.559 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.24 137.83 54.7 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.032 2.133 . . . . 0.0 108.639 169.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -72.69 160.52 32.1 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 121.333 -0.854 . . . . 0.0 110.303 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.47 117.69 9.78 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.324 -0.86 . . . . 0.0 111.341 166.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 . . . . . 0 C--O 1.253 1.268 0 C-N-CA 126.52 1.928 . . . . 0.0 113.208 178.235 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 112.306 -0.317 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.1 p -162.03 163.26 28.91 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.198 1.399 . . . . 0.0 112.14 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -158.68 162.29 37.19 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.449 1.5 . . . . 0.0 112.025 -177.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -156.25 132.48 9.99 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.498 1.519 . . . . 0.0 110.842 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -166.06 165.07 18.08 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.568 1.947 . . . . 0.0 110.831 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 pp -155.84 170.97 20.85 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.493 1.517 . . . . 0.0 112.395 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -166.41 168.85 14.53 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.934 2.094 . . . . 0.0 111.276 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 48.2 m -159.58 129.6 5.56 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.977 1.311 . . . . 0.0 111.104 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.3 p -149.44 146.95 27.71 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.604 1.962 . . . . 0.0 110.221 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -158.52 158.85 34.81 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.364 1.066 . . . . 0.0 113.237 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -165.74 163.23 18.98 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.592 1.957 . . . . 0.0 110.879 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -155.51 136.07 13.35 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.86 1.264 . . . . 0.0 110.815 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -160.01 128.56 4.91 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.822 1.649 . . . . 0.0 110.674 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.9 p -161.08 140.3 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.731 1.213 . . . . 0.0 111.233 -176.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -145.55 156.47 43.72 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.809 1.644 . . . . 0.0 111.112 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -140.52 126.16 19.13 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.873 1.669 . . . . 0.0 109.373 173.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -78.04 -15.79 58.62 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -165.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -122.07 145.84 47.77 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.856 1.262 . . . . 0.0 112.561 -174.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.4 m -63.12 140.32 58.86 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.998 0.919 . . . . 0.0 112.383 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 47.9 p-10 -150.66 -169.65 3.44 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -164.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 64.9 m -142.17 176.08 9.25 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.33 1.052 . . . . 0.0 112.648 -154.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 7.6 pt -139.29 154.3 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.803 1.241 . . . . 0.0 111.144 -172.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -134.03 105.31 6.64 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.289 1.435 . . . . 0.0 110.317 -169.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.8 t -89.66 120.22 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.416 1.886 . . . . 0.0 109.08 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.95 -5.94 24.93 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 116.951 1.541 . . . . 0.0 116.951 -168.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -147.7 21.85 1.14 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 119.698 1.749 . . . . 0.0 114.983 -170.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -178.02 2.21 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.672 -1.268 . . . . 0.0 112.806 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 91.4 m -86.95 118.84 26.6 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.597 1.159 . . . . 0.0 108.875 172.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -68.59 -7.99 37.72 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -169.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -74.45 -12.93 60.63 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.005 1.322 . . . . 0.0 112.997 168.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 20.6 t -60.6 138.89 57.99 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.181 -0.95 . . . . 0.0 112.358 173.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 32.7 p -80.87 168.82 22.42 Favored Pre-proline 0 N--CA 1.472 0.666 0 C-N-CA 124.078 0.951 . . . . 0.0 109.216 162.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.67 -20.3 26.81 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.209 1.939 . . . . 0.0 112.887 163.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -69.02 -35.7 76.93 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.498 1.045 . . . . 0.0 111.697 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -59.94 -38.92 83.81 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.122 0.969 . . . . 0.0 111.477 170.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 56.1 mt -70.33 -41.0 73.82 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-O 118.067 -0.968 . . . . 0.0 111.492 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 17.3 m -56.5 -51.04 69.99 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.796 1.18 . . . . 0.0 110.667 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -58.61 -46.18 87.58 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.274 0.488 . . . . 0.0 111.553 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -62.43 -52.84 61.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.487 1.515 . . . . 0.0 112.799 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -71.4 -18.1 62.36 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.973 1.309 . . . . 0.0 114.215 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 64.4 p -64.06 -16.66 62.2 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -65.31 -21.64 66.73 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.737 1.215 . . . . 0.0 113.384 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 37.5 mm -90.47 -16.16 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.675 1.19 . . . . 0.0 112.6 -168.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.56 -90.93 0.11 Allowed Glycine 0 N--CA 1.467 0.767 0 C-N-CA 125.073 1.32 . . . . 0.0 111.974 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -155.44 138.0 15.07 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.078 1.351 . . . . 0.0 111.368 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.1 144.5 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 125.04 1.336 . . . . 0.0 109.566 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.02 -34.54 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.076 0.55 . . . . 0.0 112.146 -160.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -155.91 153.77 30.16 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.352 2.261 . . . . 0.0 109.285 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -151.29 145.71 25.53 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.72 1.608 . . . . 0.0 111.461 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -156.05 156.07 33.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.768 1.627 . . . . 0.0 111.486 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 10.2 mt -137.82 124.08 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.983 1.313 . . . . 0.0 108.034 172.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.78 107.71 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -172.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 41.5 p -96.73 171.76 8.32 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.866 1.667 . . . . 0.0 111.872 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 37.4 m -167.83 177.01 5.94 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 127.455 2.302 . . . . 0.0 110.64 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -62.53 -29.65 70.72 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.761 0.824 . . . . 0.0 112.915 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -137.58 -148.62 5.43 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 126.242 1.877 . . . . 0.0 112.478 173.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -72.02 0.86 8.35 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.097 1.759 . . . . 0.0 115.454 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -49.3 -30.62 7.66 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.874 2.07 . . . . 0.0 116.301 -167.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -128.68 -96.23 0.4 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.289 1.436 . . . . 0.0 110.351 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 84.34 1.61 89.35 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.046 1.307 . . . . 0.0 115.155 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 92.3 mtp -74.07 140.82 45.61 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.035 1.417 . . . . 0.0 111.492 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.6 146.5 16.08 Favored Glycine 0 N--CA 1.469 0.86 0 C-N-CA 124.522 1.058 . . . . 0.0 111.864 171.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 4.0 p -143.05 147.69 35.48 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.936 1.294 . . . . 0.0 110.921 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.9 t -150.76 142.1 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.517 1.127 . . . . 0.0 109.305 -171.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.94 134.83 54.26 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.922 1.689 . . . . 0.0 110.792 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -113.16 159.87 18.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.272 1.829 . . . . 0.0 111.382 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 38.1 p -74.85 -21.42 59.27 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -137.68 -146.42 0.22 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.965 1.306 . . . . 0.0 111.843 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 62.6 p -136.39 -57.88 0.74 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.647 1.112 . . . . 0.0 113.254 -172.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.58 -29.34 70.51 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.905 -1.122 . . . . 0.0 113.697 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -72.11 -28.69 63.44 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.75 1.62 . . . . 0.0 112.992 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.5 t -69.42 -33.31 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.359 1.463 . . . . 0.0 111.802 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -74.14 -41.94 60.76 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.601 -0.687 . . . . 0.0 112.163 170.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -62.49 -28.48 69.86 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.058 0.943 . . . . 0.0 112.77 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.56 -60.11 4.15 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.761 1.224 . . . . 0.0 111.583 169.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.11 -23.04 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.16 -0.963 . . . . 0.0 112.892 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -14.59 13.3 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.243 1.017 . . . . 0.0 113.549 167.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -101.14 -20.25 15.4 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.046 1.338 . . . . 0.0 112.901 173.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -122.17 -17.56 7.14 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 -159.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -68.15 120.53 14.49 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 120.628 1.558 . . . . 0.0 110.079 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 94.27 0.39 65.45 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 117.791 -1.56 . . . . 0.0 115.015 -169.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.13 107.17 0.51 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 120.0 1.9 . . . . 0.0 110.906 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -53.69 119.85 5.46 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.92 0.888 . . . . 0.0 109.812 160.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -146.88 110.37 4.87 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.411 1.485 . . . . 0.0 108.038 -163.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 51.4 mtt 53.42 35.32 20.21 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.563 0.745 . . . . 0.0 111.757 -169.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 86.01 0.48 0.66 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 128.95 2.9 . . . . 0.0 116.035 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -124.3 140.29 53.1 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.431 1.092 . . . . 0.0 111.974 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 103.14 6.82 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.244 -0.91 . . . . 0.0 112.766 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -52.31 143.31 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 121.36 -0.837 . . . . 0.0 111.015 164.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -129.72 147.42 51.5 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 164.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.2 p -151.09 127.76 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.584 0.707 . . . . 0.0 111.969 -166.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -85.31 136.65 33.39 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.222 1.409 . . . . 0.0 109.971 170.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.62 142.69 27.49 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.795 1.238 . . . . 0.0 108.648 167.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.3 131.24 50.41 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.183 0.901 . . . . 0.0 111.382 167.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.9 p30 . . . . . 0 C--O 1.253 1.24 0 C-N-CA 125.605 1.562 . . . . 0.0 112.661 -177.535 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.1 m -169.63 156.6 6.61 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.865 2.066 . . . . 0.0 111.104 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -156.73 156.67 33.76 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.219 1.407 . . . . 0.0 111.786 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.7 tpp85 -163.69 -33.21 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -159.03 149.14 19.28 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.664 1.586 . . . . 0.0 110.155 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 pp -80.04 0.05 33.44 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -173.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -74.78 141.53 44.36 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.188 1.395 . . . . 0.0 111.921 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 58.1 p -160.88 173.61 15.06 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.2 t -62.69 159.92 15.24 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.952 0.901 . . . . 0.0 110.974 158.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -121.19 11.28 10.83 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.332 1.853 . . . . 0.0 112.639 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -67.99 165.78 17.16 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.138 1.375 . . . . 0.0 113.791 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 80.22 -1.73 1.99 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 127.756 2.422 . . . . 0.0 113.528 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 17.7 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 117.074 2.25 . . . . 0.0 117.074 -172.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.3 p -170.5 141.47 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 128.637 2.775 . . . . 0.0 109.516 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -161.72 -37.37 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.025 1.33 . . . . 0.0 112.575 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -155.36 132.69 10.99 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.325 1.85 . . . . 0.0 109.168 173.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -90.28 101.8 14.52 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.584 0.754 . . . . 0.0 111.416 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -162.5 148.15 12.59 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.383 1.473 . . . . 0.0 112.317 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.3 t -174.79 160.52 2.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.703 2.001 . . . . 0.0 110.666 165.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 177.47 -35.16 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 127.739 2.415 . . . . 0.0 112.213 176.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.1 p -141.45 139.63 33.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.285 1.434 . . . . 0.0 110.873 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.6 pt -141.04 154.85 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.21 1.004 . . . . 0.0 112.189 -161.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -122.23 147.43 46.21 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.686 1.995 . . . . 0.0 110.526 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.6 t -134.14 122.65 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.317 1.447 . . . . 0.0 109.766 -172.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.3 -46.12 2.65 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 116.254 1.262 . . . . 0.0 116.254 -163.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -121.57 23.62 10.18 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -163.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.57 -175.97 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.942 1.697 . . . . 0.0 112.882 165.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.6 p -73.7 127.08 31.83 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 120.958 -1.089 . . . . 0.0 110.023 165.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -70.0 -9.46 55.3 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -97.68 0.27 46.8 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.836 2.054 . . . . 0.0 113.283 171.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 7.9 t -58.11 149.16 24.33 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.132 -0.98 . . . . 0.0 113.299 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.1 p -95.12 151.84 39.07 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 123.594 0.758 . . . . 0.0 110.229 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.23 -25.91 30.57 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.376 2.051 . . . . 0.0 111.927 171.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -69.43 -42.79 74.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.209 1.004 . . . . 0.0 112.539 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -65.7 -41.61 92.13 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.718 -0.614 . . . . 0.0 111.547 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 25.5 mt -69.32 -29.26 67.05 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.6 -0.714 . . . . 0.0 112.226 173.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 49.7 m -66.11 -50.94 62.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.515 1.052 . . . . 0.0 109.658 171.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.32 -34.69 74.18 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 118.624 0.647 . . . . 0.0 112.253 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -70.13 -58.18 4.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.663 1.585 . . . . 0.0 112.406 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -71.24 -35.78 71.56 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.6 t -73.43 -6.0 43.51 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -51.98 -25.93 9.46 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.188 1.795 . . . . 0.0 112.544 164.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 28.4 mm -77.1 -22.35 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.198 1.799 . . . . 0.0 113.215 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.69 -90.47 0.11 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.304 0.954 . . . . 0.0 112.892 -172.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -152.47 95.47 2.03 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -171.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 39.9 t -70.09 134.11 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 161.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 5.1 p -104.38 -25.17 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.085 0.954 . . . . 0.0 112.645 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -164.6 119.7 1.43 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.683 1.193 . . . . 0.0 111.567 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -107.48 154.25 21.63 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.216 1.006 . . . . 0.0 111.067 161.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -156.14 131.89 9.7 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.538 1.535 . . . . 0.0 110.89 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 4.8 mm -118.02 39.28 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 125.117 1.367 . . . . 0.0 109.79 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.7 pp -108.22 162.53 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.698 1.599 . . . . 0.0 111.663 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 17.2 p -134.39 126.67 30.04 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.874 1.27 . . . . 0.0 109.806 -173.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.4 m -73.28 -14.66 61.36 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -161.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 53.6 ttm-85 -91.02 0.01 57.64 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.403 1.481 . . . . 0.0 112.762 176.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 92.12 -152.55 21.35 Favored Glycine 0 N--CA 1.471 0.994 0 C-N-CA 125.087 1.327 . . . . 0.0 110.501 -166.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -59.29 138.23 57.69 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -160.47 -77.59 0.06 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.651 1.18 . . . . 0.0 112.388 -175.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -153.54 11.4 0.44 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -171.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 62.26 26.43 67.8 Favored Glycine 0 N--CA 1.478 1.483 0 N-CA-C 116.067 1.187 . . . . 0.0 116.067 167.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -66.1 146.55 54.53 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.744 1.272 . . . . 0.0 112.64 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.45 156.72 20.33 Favored Glycine 0 N--CA 1.467 0.73 0 C-N-CA 124.593 1.092 . . . . 0.0 112.89 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.0 p -144.42 149.22 35.7 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.903 1.681 . . . . 0.0 111.099 174.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 10.9 t -145.42 139.06 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.983 0.913 . . . . 0.0 110.667 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -127.8 132.1 49.5 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.172 2.189 . . . . 0.0 109.012 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -110.7 164.26 12.93 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.442 1.497 . . . . 0.0 110.055 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 33.1 p -81.05 -25.36 37.17 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 122.01 -0.431 . . . . 0.0 111.893 164.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -81.26 168.44 18.47 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.97 1.708 . . . . 0.0 112.248 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.3 m -122.62 -76.75 0.59 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.575 0.75 . . . . 0.0 110.972 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.94 -25.15 67.42 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.8 -1.187 . . . . 0.0 113.835 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.13 -21.71 61.43 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.09 -25.05 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.565 0.746 . . . . 0.0 111.661 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -73.09 -43.79 61.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.998 0.919 . . . . 0.0 111.231 167.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -60.1 -32.27 70.82 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.888 0.875 . . . . 0.0 112.111 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.07 -65.13 0.67 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.768 1.227 . . . . 0.0 111.748 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 45.2 mt -59.91 -34.76 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.401 -0.812 . . . . 0.0 112.12 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -63.34 -2.76 1.59 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.076 1.35 . . . . 0.0 114.356 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -122.0 -2.99 9.13 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.893 1.677 . . . . 0.0 112.8 171.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -129.09 -21.09 3.33 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -170.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -62.53 120.94 12.09 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.393 1.451 . . . . 0.0 110.079 173.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 97.31 0.52 59.64 Favored Glycine 0 N--CA 1.471 1.011 0 CA-C-O 118.136 -1.369 . . . . 0.0 115.266 -169.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.61 106.66 0.99 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.815 1.808 . . . . 0.0 110.789 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -53.63 115.37 1.93 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 154.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -137.23 110.91 8.09 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.078 1.351 . . . . 0.0 108.758 -166.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 18.9 mmt 60.26 19.1 8.57 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.052 1.341 . . . . 0.0 113.949 -178.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 18.6 t70 106.91 0.14 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 130.929 3.692 . . . . 0.0 115.148 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -129.69 138.21 51.03 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.571 1.078 . . . . 0.0 112.844 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -71.22 104.59 3.15 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.251 1.42 . . . . 0.0 113.191 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 pt -55.15 144.27 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.267 0.627 . . . . 0.0 111.326 168.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -139.76 140.03 36.61 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.848 1.259 . . . . 0.0 109.359 174.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.05 135.06 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.144 1.378 . . . . 0.0 110.35 -171.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -138.16 136.89 37.11 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.333 1.453 . . . . 0.0 108.418 170.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -79.81 155.14 28.0 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.031 0.932 . . . . 0.0 110.898 -167.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -154.76 151.66 28.95 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -173.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 34.7 m120 . . . . . 0 C--O 1.256 1.407 0 C-N-CA 125.451 1.5 . . . . 0.0 112.44 176.41 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.769 0 N-CA-C 112.288 -0.325 . . . . 0.0 112.288 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 79.4 p -163.0 165.25 25.12 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.352 1.461 . . . . 0.0 111.945 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -156.41 153.7 29.3 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.197 1.399 . . . . 0.0 112.004 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -69.13 -45.75 69.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.466 1.106 . . . . 0.0 112.224 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 78.28 133.98 0.06 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 128.585 2.754 . . . . 0.0 112.049 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.2 mt -137.23 151.66 48.98 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.763 1.625 . . . . 0.0 111.019 -175.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -162.46 155.04 19.39 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.112 1.765 . . . . 0.0 111.108 -176.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.4 p -160.4 142.52 12.82 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.566 1.146 . . . . 0.0 112.815 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.2 m -73.03 142.23 47.67 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.443 1.497 . . . . 0.0 111.053 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -62.34 145.33 54.14 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.596 1.159 . . . . 0.0 113.139 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -87.88 -10.08 51.78 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -174.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 61.85 -123.13 0.77 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.947 1.699 . . . . 0.0 112.343 174.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.4 157.95 36.48 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.945 1.698 . . . . 0.0 113.306 -174.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.2 t -141.88 134.84 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.218 1.407 . . . . 0.0 110.107 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -165.18 178.54 6.9 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.605 2.362 . . . . 0.0 110.295 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -128.13 -174.79 3.31 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.972 1.309 . . . . 0.0 110.617 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -69.12 -23.13 63.95 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -168.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -103.3 -49.76 3.64 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -169.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.0 m 59.75 24.18 13.1 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.99 1.716 . . . . 0.0 113.826 -175.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -63.58 -32.52 74.01 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.542 1.137 . . . . 0.0 112.369 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.6 m -138.55 168.48 19.69 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.341 1.056 . . . . 0.0 112.566 -173.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 35.5 pt -141.36 142.19 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 126.531 1.932 . . . . 0.0 109.018 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -109.96 128.67 55.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.365 1.066 . . . . 0.0 110.842 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.09 106.04 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.864 1.666 . . . . 0.0 107.905 -169.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -99.68 -11.58 43.55 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 117.09 1.596 . . . . 0.0 117.09 -158.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -157.25 38.43 0.29 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.335 1.568 . . . . 0.0 113.507 -171.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.35 177.78 6.34 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.011 -1.056 . . . . 0.0 112.441 175.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 t -76.67 142.06 40.71 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.978 1.311 . . . . 0.0 111.806 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -64.04 -12.78 41.7 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 170.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -75.45 -15.24 60.45 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.502 1.121 . . . . 0.0 113.547 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 57.9 m -71.49 137.68 48.36 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.992 -1.068 . . . . 0.0 113.286 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 43.0 p -100.75 159.2 30.24 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 125.377 1.471 . . . . 0.0 109.262 163.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.48 -24.53 78.25 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 121.963 1.775 . . . . 0.0 112.774 170.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.18 -41.33 90.43 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.871 1.214 . . . . 0.0 111.7 173.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -60.56 -47.44 86.17 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.414 0.686 . . . . 0.0 110.858 176.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.514 ' HG ' HD11 ' A' ' 192' ' ' ILE . 1.9 mm? -62.89 -37.52 87.26 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.552 1.141 . . . . 0.0 111.999 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.6 m -63.76 -50.42 69.14 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.203 1.001 . . . . 0.0 110.568 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.62 -41.92 83.18 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.509 0.595 . . . . 0.0 111.694 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -57.17 -55.46 34.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.744 1.618 . . . . 0.0 112.29 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -71.15 -28.34 64.2 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.2 m -73.26 0.24 12.47 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -66.84 -20.91 66.02 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 120.892 -1.13 . . . . 0.0 112.594 166.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 24.1 mm -84.07 -39.91 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.866 1.266 . . . . 0.0 111.762 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -173.62 -98.04 0.11 Allowed Glycine 0 N--CA 1.468 0.796 0 C-N-CA 125.662 1.601 . . . . 0.0 111.633 -174.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -144.41 123.11 12.57 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.539 1.135 . . . . 0.0 112.469 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 29.4 t -74.4 133.54 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 156.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.2 -23.62 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.068 0.547 . . . . 0.0 112.043 175.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -176.18 146.49 0.67 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 127.714 2.405 . . . . 0.0 110.494 176.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -130.45 158.79 38.93 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.548 1.539 . . . . 0.0 112.092 168.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -155.45 142.19 18.9 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.003 1.721 . . . . 0.0 110.772 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.514 HD11 ' HG ' ' A' ' 177' ' ' LEU . 4.1 mt -146.13 137.46 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.802 1.241 . . . . 0.0 110.114 -175.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.3 mp -104.7 107.71 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.669 1.187 . . . . 0.0 109.104 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 60.7 p -144.22 166.29 25.45 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 127.061 2.144 . . . . 0.0 110.246 -175.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.8 m -170.03 177.52 4.27 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.922 2.089 . . . . 0.0 110.808 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 80.3 ttt-85 -63.14 -39.06 93.58 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.769 0.828 . . . . 0.0 111.883 173.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -88.58 161.06 30.76 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.038 1.304 . . . . 0.0 111.792 168.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -78.72 61.34 2.98 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.839 1.255 . . . . 0.0 112.813 -175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -80.46 -18.74 47.77 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -165.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -163.38 -61.73 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 174.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 73.63 40.25 46.92 Favored Glycine 0 N--CA 1.477 1.431 0 CA-C-N 119.073 0.851 . . . . 0.0 113.838 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 60.2 mtt -140.82 156.62 46.11 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.139 1.375 . . . . 0.0 111.068 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -149.51 -178.37 24.43 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.204 0.907 . . . . 0.0 114.383 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.2 m -150.99 144.75 25.1 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.829 1.651 . . . . 0.0 108.457 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.84 143.38 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.851 0.86 . . . . 0.0 110.014 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -110.28 135.13 51.51 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.198 1.799 . . . . 0.0 110.223 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -117.19 159.79 22.08 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.539 1.936 . . . . 0.0 112.118 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.5 p -83.66 -25.46 30.71 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -148.51 142.79 26.16 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 -168.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.8 p -76.36 -14.73 60.07 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.84 2.456 . . . . 0.0 116.013 -161.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -102.05 -33.88 9.53 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.113 0.87 . . . . 0.0 112.776 169.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -62.07 -43.32 99.08 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.703 0.801 . . . . 0.0 110.962 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 13.3 p -62.67 -35.85 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.172 1.389 . . . . 0.0 113.971 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.48 -47.0 35.94 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.739 -0.601 . . . . 0.0 112.609 172.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -58.08 -34.98 70.74 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.799 1.24 . . . . 0.0 112.43 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.67 -58.1 9.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.632 1.173 . . . . 0.0 111.636 171.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 45.1 mt -69.96 -29.88 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 120.485 -1.385 . . . . 0.0 112.466 -173.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.48 -14.37 12.34 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 168.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -105.92 -40.67 5.62 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.341 1.856 . . . . 0.0 111.963 171.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -95.04 -13.88 24.8 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 -165.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.01 120.62 13.96 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 120.614 1.552 . . . . 0.0 109.936 174.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 93.78 0.78 66.22 Favored Glycine 0 N--CA 1.473 1.104 0 CA-C-O 117.861 -1.522 . . . . 0.0 115.19 -167.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.33 107.0 0.59 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.221 2.01 . . . . 0.0 110.912 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -53.13 120.89 6.47 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.035 0.934 . . . . 0.0 109.85 160.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -141.24 110.74 6.39 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.462 1.505 . . . . 0.0 107.804 -170.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 19.3 mmt 51.22 41.52 27.91 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.587 1.155 . . . . 0.0 111.722 -162.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 76.28 0.53 3.26 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 127.681 2.392 . . . . 0.0 115.169 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -116.14 130.3 56.73 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.597 1.159 . . . . 0.0 111.622 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -71.01 104.15 2.9 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.042 -1.036 . . . . 0.0 112.837 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.1 pt -52.81 146.6 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.246 0.618 . . . . 0.0 111.016 156.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -135.53 147.55 48.84 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.864 1.266 . . . . 0.0 108.576 169.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 1.6 p -153.02 140.56 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.11 0.964 . . . . 0.0 111.254 -166.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 -117.0 137.98 51.87 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.817 1.247 . . . . 0.0 110.169 173.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -65.88 138.18 57.7 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 62.86 -84.47 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.064 1.745 . . . . 0.0 113.388 -175.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 . . . . . 0 C--O 1.254 1.34 0 C-N-CA 127.043 2.137 . . . . 0.0 112.039 -163.017 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.808 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 47.6 t -164.49 -53.81 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.531 1.132 . . . . 0.0 111.978 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . 58.07 14.28 2.62 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.459 1.904 . . . . 0.0 115.212 171.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 56.29 35.33 25.63 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.959 1.704 . . . . 0.0 112.445 -169.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -68.46 140.45 55.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.135 1.374 . . . . 0.0 111.473 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.8 pp -157.51 179.11 9.55 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.288 1.835 . . . . 0.0 111.423 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -155.52 153.87 30.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.252 1.421 . . . . 0.0 111.847 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 75.3 m -141.29 151.21 43.45 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.573 1.549 . . . . 0.0 111.376 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 54.8 p -132.04 157.81 43.18 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.777 1.231 . . . . 0.0 112.08 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -144.04 139.4 28.96 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.879 1.672 . . . . 0.0 111.092 -172.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -163.62 149.07 11.1 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.597 1.559 . . . . 0.0 109.974 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -130.63 119.71 22.87 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.957 1.303 . . . . 0.0 109.88 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -158.06 117.5 3.23 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.414 1.486 . . . . 0.0 109.583 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.5 m -68.38 153.0 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.157 0.583 . . . . 0.0 112.573 -176.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -142.59 112.52 6.96 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.368 1.467 . . . . 0.0 110.3 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -145.93 121.12 10.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.344 1.057 . . . . 0.0 111.324 -172.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -167.48 157.07 10.38 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.032 2.133 . . . . 0.0 110.309 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -70.29 -17.41 63.1 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 73.0 m -137.83 140.11 40.31 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.175 1.79 . . . . 0.0 109.672 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -139.72 132.14 28.51 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.367 1.067 . . . . 0.0 110.513 -169.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.4 t -155.81 162.14 40.52 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.783 0.802 . . . . 0.0 112.952 -168.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 6.8 pt -147.62 151.47 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 127.364 2.266 . . . . 0.0 109.989 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -121.85 134.53 54.88 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.298 1.839 . . . . 0.0 110.367 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.47 121.29 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.757 1.223 . . . . 0.0 108.808 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.32 -44.79 1.13 Allowed Glycine 0 N--CA 1.475 1.257 0 N-CA-C 115.333 0.893 . . . . 0.0 115.333 -168.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -100.45 7.41 44.21 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -166.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -62.88 169.01 3.48 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.148 1.379 . . . . 0.0 111.926 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.7 m -64.15 138.87 58.66 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.129 0.972 . . . . 0.0 112.324 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -70.15 0.12 6.79 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.478 1.911 . . . . 0.0 115.244 -169.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -111.9 0.55 16.14 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.244 2.217 . . . . 0.0 112.692 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 9.8 t -61.95 154.87 25.15 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.1 p -130.49 152.28 80.06 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 125.545 1.538 . . . . 0.0 111.062 -168.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.57 -42.87 19.22 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.761 2.307 . . . . 0.0 113.236 -171.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.73 -27.96 67.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.542 1.065 . . . . 0.0 112.816 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.05 -30.2 63.55 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.971 0.909 . . . . 0.0 112.094 174.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.502 HD12 HD11 ' A' ' 192' ' ' ILE . 13.8 mt -74.51 -34.04 62.94 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.058 -0.972 . . . . 0.0 113.283 164.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 81.6 m -62.21 -50.61 71.1 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.145 1.339 . . . . 0.0 110.73 177.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -62.03 -26.74 68.42 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -78.43 -60.12 2.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.522 1.529 . . . . 0.0 111.521 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -71.24 -34.07 70.43 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -175.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.0 t -73.37 -1.21 17.21 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -64.45 -17.65 64.02 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.054 0.942 . . . . 0.0 112.855 169.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 32.3 mm -82.09 -25.31 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.6 1.56 . . . . 0.0 113.089 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 175.23 -103.45 0.18 Allowed Glycine 0 N--CA 1.47 0.954 0 C-N-CA 124.506 1.051 . . . . 0.0 112.367 -169.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -147.77 109.67 4.48 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.508 0.723 . . . . 0.0 112.489 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 25.6 t -71.25 129.77 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 164.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.81 -33.48 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 118.362 0.528 . . . . 0.0 112.005 173.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -154.71 134.82 13.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.285 1.434 . . . . 0.0 110.715 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -109.71 153.94 23.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.245 1.018 . . . . 0.0 110.595 153.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -153.13 123.03 6.91 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.822 1.249 . . . . 0.0 111.262 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.502 HD11 HD12 ' A' ' 177' ' ' LEU . 6.0 mt -143.87 -52.01 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.657 0.783 . . . . 0.0 113.023 -175.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 18.7 tt -76.92 141.44 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 118.722 0.692 . . . . 0.0 111.769 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 67.3 p -128.77 161.58 29.42 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.725 1.61 . . . . 0.0 111.777 -166.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 63.2 m -100.25 6.81 44.73 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -176.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.1 0.18 22.5 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -176.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 125.83 -131.1 7.42 Favored Glycine 0 N--CA 1.468 0.791 0 C-N-CA 125.97 1.748 . . . . 0.0 110.816 -171.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -60.61 136.9 58.2 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.899 0.88 . . . . 0.0 113.027 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -70.9 143.72 50.87 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.86 1.264 . . . . 0.0 112.14 174.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 42.0 mtm105 -123.59 -6.48 8.08 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 72.81 10.56 77.07 Favored Glycine 0 N--CA 1.476 1.323 0 CA-C-O 118.285 -1.286 . . . . 0.0 116.038 170.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 93.4 mtp -107.73 128.97 55.05 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.238 1.519 . . . . 0.0 109.797 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -173.75 -165.84 31.08 Favored Glycine 0 N--CA 1.474 1.192 0 N-CA-C 116.144 1.218 . . . . 0.0 116.144 -169.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.7 p -132.66 160.9 35.35 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.832 1.653 . . . . 0.0 113.582 -164.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 12.2 t -141.84 142.15 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.942 1.297 . . . . 0.0 110.202 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -125.45 134.98 51.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.862 2.065 . . . . 0.0 111.341 -171.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -118.46 151.66 37.39 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.071 1.748 . . . . 0.0 111.895 -169.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 61.3 p -75.93 -38.21 57.87 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.467 0.307 . . . . 0.0 110.817 163.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -61.18 160.49 10.26 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.377 1.871 . . . . 0.0 113.09 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.7 p -127.08 -66.01 0.92 Allowed 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.707 -0.621 . . . . 0.0 111.895 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -61.95 -30.24 70.78 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.425 1.011 . . . . 0.0 112.154 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -72.21 -17.43 61.92 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 12.4 t -70.26 -22.81 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.872 0.76 . . . . 0.0 112.042 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -74.07 -45.76 47.32 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.752 -1.217 . . . . 0.0 110.967 164.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 10.1 ttt85 -57.01 -29.35 63.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.597 1.559 . . . . 0.0 113.753 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.62 -68.7 0.29 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.681 1.592 . . . . 0.0 110.586 166.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.23 -27.87 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 121.204 -0.935 . . . . 0.0 113.266 -166.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -58.54 -18.79 32.31 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.861 0.864 . . . . 0.0 113.319 170.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -107.46 -6.7 16.91 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.369 1.467 . . . . 0.0 113.295 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -124.68 -22.87 4.48 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -170.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.64 120.5 14.75 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 120.399 1.454 . . . . 0.0 109.833 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 94.62 0.43 64.61 Favored Glycine 0 N--CA 1.469 0.888 0 CA-C-O 118.016 -1.435 . . . . 0.0 115.028 -168.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.8 108.84 1.08 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.909 1.855 . . . . 0.0 110.536 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -48.44 116.72 1.68 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.151 0.98 . . . . 0.0 109.351 156.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -152.0 110.77 3.82 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.851 1.26 . . . . 0.0 108.808 -172.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.13 50.52 13.41 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.472 1.109 . . . . 0.0 112.019 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 16.8 t70 77.48 0.14 2.88 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 127.257 2.223 . . . . 0.0 115.807 171.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 -135.55 154.8 51.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.925 1.29 . . . . 0.0 111.898 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 103.97 16.38 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.311 -0.868 . . . . 0.0 110.611 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.4 pt -54.76 139.54 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 121.215 -0.928 . . . . 0.0 111.287 171.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -132.69 142.66 49.17 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.626 1.17 . . . . 0.0 108.139 167.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 1.1 p -136.93 134.82 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.321 1.048 . . . . 0.0 111.682 -165.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -101.12 141.2 34.34 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.275 1.83 . . . . 0.0 109.919 173.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -75.08 132.56 41.36 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.8 125.62 28.55 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.441 1.019 . . . . 0.0 112.294 -173.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 . . . . . 0 C--O 1.254 1.318 0 C-N-CA 126.258 1.823 . . . . 0.0 111.514 -172.126 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 CA-C-O 121.137 0.298 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.3 t -162.06 160.05 26.99 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.353 1.461 . . . . 0.0 111.388 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -160.94 159.25 29.36 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.123 1.769 . . . . 0.0 111.663 -176.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -158.41 131.02 7.08 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.171 1.388 . . . . 0.0 111.03 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -163.49 157.16 19.38 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.254 1.821 . . . . 0.0 110.628 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.9 pp -162.29 173.62 13.94 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.78 1.632 . . . . 0.0 112.292 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -161.79 161.49 29.17 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.495 1.918 . . . . 0.0 111.565 -177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.3 t -161.73 150.47 15.62 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.558 1.143 . . . . 0.0 111.88 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.9 t -165.46 155.19 12.75 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.607 1.963 . . . . 0.0 110.328 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -162.73 160.77 25.85 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.638 1.575 . . . . 0.0 112.57 -174.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -163.08 160.83 24.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.806 1.642 . . . . 0.0 111.258 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -135.85 128.73 31.21 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.39 1.476 . . . . 0.0 109.559 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -143.29 147.7 35.18 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.05 1.34 . . . . 0.0 112.22 -170.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.4 p -164.83 135.47 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 126.171 1.788 . . . . 0.0 110.051 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -89.12 -20.48 24.23 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -167.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 57.66 37.3 27.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.865 1.666 . . . . 0.0 113.969 167.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -62.64 -40.89 98.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.761 0.824 . . . . 0.0 112.56 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -153.37 -55.7 0.12 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.456 1.903 . . . . 0.0 111.832 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.0 m 60.91 8.94 2.05 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.562 1.945 . . . . 0.0 114.961 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -62.69 -7.69 5.32 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -172.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.5 p -151.96 164.4 37.24 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.401 -1.437 . . . . 0.0 111.225 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 28.7 pt -144.1 145.48 21.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 125.589 1.556 . . . . 0.0 110.341 -171.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 94.4 t80 -109.29 150.2 28.32 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.825 1.65 . . . . 0.0 109.56 170.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.95 102.86 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.105 1.362 . . . . 0.0 108.786 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -82.49 -16.28 71.55 Favored Glycine 0 N--CA 1.471 0.974 0 C-N-CA 124.223 0.916 . . . . 0.0 114.315 -171.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -152.2 133.43 14.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.858 1.663 . . . . 0.0 109.926 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 mp -144.01 -77.96 0.22 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.63 1.572 . . . . 0.0 109.95 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 11.3 t -172.25 140.21 1.12 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.975 2.51 . . . . 0.0 108.588 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -63.43 -13.65 42.28 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -88.7 0.09 56.78 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.201 1.4 . . . . 0.0 113.418 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 7.6 t -78.46 152.82 31.89 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.682 -1.261 . . . . 0.0 113.509 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.49 159.7 32.26 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 126.556 1.943 . . . . 0.0 109.066 -176.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.0 -27.07 17.77 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 121.988 1.792 . . . . 0.0 113.29 -167.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.04 -34.77 78.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.196 0.907 . . . . 0.0 111.573 173.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -70.38 -41.27 73.28 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.059 0.944 . . . . 0.0 110.964 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 177' ' ' LEU . 17.1 mt -66.59 -29.69 69.8 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.815 169.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 86.0 m -69.4 -48.36 61.35 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.402 1.001 . . . . 0.0 109.89 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -61.33 -33.77 74.15 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.431 0.693 . . . . 0.0 112.571 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -73.14 -61.48 1.8 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.998 1.719 . . . . 0.0 111.962 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.37 -39.75 71.05 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.3 t -73.28 -7.07 49.96 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -174.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -60.05 -18.62 47.91 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.782 1.233 . . . . 0.0 112.65 167.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 20.6 mm -78.96 -26.0 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.831 1.652 . . . . 0.0 112.607 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 166.22 -95.67 0.12 Allowed Glycine 0 N--CA 1.469 0.87 0 C-N-CA 124.734 1.159 . . . . 0.0 112.457 -171.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -141.67 110.13 6.01 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.361 1.064 . . . . 0.0 112.85 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.66 135.18 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 154.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.29 -18.31 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 172.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -160.47 138.2 9.63 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.419 1.488 . . . . 0.0 111.13 170.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -124.27 152.47 42.98 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.277 1.431 . . . . 0.0 110.554 160.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -152.32 137.0 16.97 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.201 1.001 . . . . 0.0 112.513 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.1 mt -145.57 -53.5 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 126.153 1.781 . . . . 0.0 111.255 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.8 pp -72.79 164.87 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 72.3 p -124.45 160.78 27.47 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.152 1.381 . . . . 0.0 112.141 -162.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 41.7 t -64.36 -33.35 75.65 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.045 0.938 . . . . 0.0 113.396 -174.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -99.21 -6.07 28.81 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.721 1.208 . . . . 0.0 113.266 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 83.24 2.16 90.4 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.282 1.42 . . . . 0.0 114.653 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -77.64 131.0 37.56 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 118.568 1.184 . . . . 0.0 112.393 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 13.6 t60 69.02 158.99 0.17 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 127.352 2.261 . . . . 0.0 114.99 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -164.68 152.41 11.8 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.622 1.969 . . . . 0.0 109.921 -173.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 99.41 21.96 13.8 Favored Glycine 0 N--CA 1.476 1.327 0 N-CA-C 116.214 1.246 . . . . 0.0 116.214 173.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -157.21 157.32 34.13 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.358 1.863 . . . . 0.0 111.569 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 157.76 -144.79 10.92 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 115.314 0.886 . . . . 0.0 115.314 -174.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.6 m -144.84 150.39 37.04 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.269 1.428 . . . . 0.0 111.13 -160.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.8 t -139.14 147.65 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.733 1.213 . . . . 0.0 110.82 173.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -131.45 133.76 45.51 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.75 2.02 . . . . 0.0 111.001 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -120.61 164.82 15.91 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.985 2.114 . . . . 0.0 111.502 -174.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 29.3 p -74.55 -38.41 62.74 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -150.49 152.8 34.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -171.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 30.8 p -54.05 -40.0 66.73 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.328 1.851 . . . . 0.0 113.326 171.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -76.37 -23.6 54.15 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -79.59 -51.25 9.53 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.886 0.874 . . . . 0.0 112.438 169.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 15.0 p -69.3 -42.46 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -167.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.77 -13.3 62.0 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.158 0.89 . . . . 0.0 113.367 -173.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -73.37 -19.4 61.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.468 1.107 . . . . 0.0 112.657 173.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.65 -61.18 2.0 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.302 1.041 . . . . 0.0 112.612 -173.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 4.2 mp -68.91 -29.21 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 121.447 -0.783 . . . . 0.0 112.271 -160.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -58.5 -21.43 51.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.66 1.184 . . . . 0.0 113.566 170.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -101.4 -10.73 19.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.192 1.397 . . . . 0.0 112.889 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -126.0 -23.69 3.89 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -166.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.97 120.75 13.67 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.379 1.445 . . . . 0.0 109.8 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 93.08 0.83 67.74 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-O 117.982 -1.454 . . . . 0.0 115.079 -169.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.01 109.31 0.93 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.686 1.743 . . . . 0.0 110.501 171.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -57.05 124.17 17.79 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.265 0.555 . . . . 0.0 109.627 155.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -145.88 110.43 5.09 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.315 1.846 . . . . 0.0 107.103 -161.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 88.6 mmm 49.88 41.48 22.73 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.864 0.866 . . . . 0.0 111.728 -163.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 11.6 t70 77.71 -0.41 2.76 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 128.284 2.634 . . . . 0.0 115.085 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -120.38 137.73 54.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.564 1.146 . . . . 0.0 111.626 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -79.62 112.72 17.16 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.697 -1.252 . . . . 0.0 113.435 -170.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -68.18 143.88 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 121.219 -0.926 . . . . 0.0 112.98 169.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -132.31 130.28 40.62 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.282 1.433 . . . . 0.0 109.643 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 12.4 t -119.24 151.09 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.772 2.029 . . . . 0.0 109.541 -170.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 42.0 ptt85 -133.4 148.63 51.81 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.546 0.738 . . . . 0.0 110.12 155.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -77.08 164.64 25.52 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.7 -0.625 . . . . 0.0 110.31 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -107.13 132.39 53.06 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.27 1.428 . . . . 0.0 111.079 168.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 . . . . . 0 C--O 1.254 1.331 0 C-N-CA 126.97 2.108 . . . . 0.0 111.771 -173.434 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 112.076 -0.409 . . . . 0.0 112.076 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 12.4 t -162.61 158.83 23.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.291 1.436 . . . . 0.0 111.312 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -160.35 155.72 25.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.878 1.671 . . . . 0.0 111.844 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 35.4 ptt-85 -162.48 157.11 21.89 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.975 1.71 . . . . 0.0 112.038 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -162.41 153.32 17.44 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.629 1.571 . . . . 0.0 111.595 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 60.7 tp -159.97 130.02 5.43 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.03 1.732 . . . . 0.0 109.657 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -162.55 139.75 8.02 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.388 1.475 . . . . 0.0 111.398 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 31.9 m -169.1 138.39 2.11 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.967 2.107 . . . . 0.0 110.823 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.5 t -166.12 148.19 6.98 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.235 1.814 . . . . 0.0 110.232 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -147.86 129.71 15.24 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.019 1.328 . . . . 0.0 111.625 -171.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -148.7 134.6 19.01 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.584 1.554 . . . . 0.0 110.254 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -165.18 147.87 8.07 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.286 1.434 . . . . 0.0 111.874 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -164.63 152.19 11.71 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.254 1.821 . . . . 0.0 112.018 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.8 m -148.94 139.77 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 125.58 1.552 . . . . 0.0 111.018 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -167.9 147.38 4.83 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.824 1.65 . . . . 0.0 111.738 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -146.77 16.86 1.26 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.547 1.539 . . . . 0.0 113.745 174.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -72.0 163.6 27.58 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -152.45 114.36 4.39 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.309 1.444 . . . . 0.0 110.184 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.8 p -167.45 151.55 6.63 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -171.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -146.72 -3.47 0.61 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 63.5 p -134.13 154.7 51.04 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.497 -1.377 . . . . 0.0 112.053 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 10.4 pt -143.83 142.14 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.522 1.529 . . . . 0.0 109.571 -177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -128.73 123.9 34.22 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.648 1.179 . . . . 0.0 109.401 -168.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.8 t -113.93 129.68 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.814 1.645 . . . . 0.0 109.151 -164.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -74.59 -109.05 0.09 OUTLIER Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.272 1.415 . . . . 0.0 114.652 -169.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -84.26 -26.94 28.24 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.501 ' HG ' ' H ' ' A' ' 169' ' ' THR 0.32 2.3 pt? 32.7 -120.22 0.07 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.579 2.352 . . . . 0.0 115.0 -178.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.501 ' H ' ' HG ' ' A' ' 168' ' ' LEU . 57.2 m -142.28 130.32 21.94 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.684 1.594 . . . . 0.0 110.123 -162.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -61.45 -23.37 65.8 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.19 -0.89 57.78 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.885 1.674 . . . . 0.0 113.269 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 92.3 p -72.09 151.97 42.69 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 34.5 p -143.15 162.52 42.6 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 127.654 2.382 . . . . 0.0 108.372 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -63.16 -30.33 74.78 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 121.58 1.52 . . . . 0.0 112.951 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -69.28 -40.16 77.93 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.1 0.864 . . . . 0.0 112.207 173.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -66.18 -40.72 90.68 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.562 1.145 . . . . 0.0 111.838 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.34 -36.06 82.44 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.134 0.973 . . . . 0.0 112.025 170.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 91.7 m -69.48 -50.11 48.44 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.153 0.581 . . . . 0.0 110.314 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -58.75 -28.61 66.05 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.626 0.77 . . . . 0.0 112.399 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -75.56 -66.09 0.82 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.064 1.346 . . . . 0.0 111.7 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.28 -30.84 66.77 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -172.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.35 -5.33 39.02 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.011 -1.056 . . . . 0.0 113.701 -173.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -64.91 -19.45 65.94 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.685 1.194 . . . . 0.0 113.219 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 24.9 mm -82.83 -24.13 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.643 1.177 . . . . 0.0 112.655 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 176.14 -86.04 0.07 OUTLIER Glycine 0 N--CA 1.468 0.771 0 C-N-CA 124.923 1.249 . . . . 0.0 111.707 -175.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -157.51 116.47 3.26 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.494 1.118 . . . . 0.0 112.198 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 19.2 t -71.9 129.99 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 160.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.5 p -100.69 -17.04 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.657 0.783 . . . . 0.0 112.981 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -162.58 138.57 7.35 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.109 1.363 . . . . 0.0 112.112 169.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -127.35 156.02 42.65 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.986 1.314 . . . . 0.0 112.406 165.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -156.52 143.28 18.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.548 1.539 . . . . 0.0 112.27 -174.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.5 mm -128.64 120.32 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.694 1.597 . . . . 0.0 108.012 170.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 20.7 tt -108.73 107.81 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.581 1.153 . . . . 0.0 110.998 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 6.3 t -152.64 172.46 16.6 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.878 1.671 . . . . 0.0 111.612 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 58.7 m -149.5 156.42 41.96 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.428 1.891 . . . . 0.0 111.389 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -62.27 -33.31 74.38 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.062 0.945 . . . . 0.0 113.275 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -87.3 -90.63 1.02 Allowed Glycine 0 N--CA 1.471 1.0 0 C-N-CA 125.31 1.433 . . . . 0.0 110.556 170.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -159.6 148.28 17.72 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.619 1.568 . . . . 0.0 112.161 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -166.37 -62.26 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.786 1.234 . . . . 0.0 113.172 -177.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -144.52 -69.32 0.3 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.817 1.647 . . . . 0.0 110.595 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 81.1 42.18 9.7 Favored Glycine 0 N--CA 1.47 0.962 0 C-N-CA 124.508 1.052 . . . . 0.0 113.105 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -150.87 171.53 17.09 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.175 0.99 . . . . 0.0 113.326 -171.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -127.27 157.12 20.67 Favored Glycine 0 N--CA 1.471 1.031 0 C-N-CA 124.427 1.013 . . . . 0.0 114.865 -172.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 85.4 m -142.86 144.11 32.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.944 1.698 . . . . 0.0 109.107 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 43.7 t -141.63 152.52 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.848 0.859 . . . . 0.0 109.495 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -130.06 137.46 50.23 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.916 1.687 . . . . 0.0 111.21 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -121.06 160.5 23.49 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 127.306 2.243 . . . . 0.0 110.224 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 43.7 p -88.19 -14.38 38.73 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -175.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -156.25 130.93 8.96 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.2 m -46.79 -50.74 17.8 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 129.372 3.069 . . . . 0.0 115.113 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.75 -26.46 44.6 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.003 -1.061 . . . . 0.0 113.108 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.37 -39.7 64.94 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.303 -0.873 . . . . 0.0 113.332 170.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 14.0 p -69.05 -29.26 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.541 -0.724 . . . . 0.0 112.384 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.91 -39.78 83.52 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.514 0.726 . . . . 0.0 112.56 169.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 53.3 mtt85 -61.97 -33.19 73.84 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.329 0.652 . . . . 0.0 112.494 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.81 -63.71 1.13 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.409 1.004 . . . . 0.0 113.176 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 56.3 mt -65.46 -27.6 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 121.35 -0.844 . . . . 0.0 111.771 -170.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -51.39 -27.73 10.8 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.043 1.337 . . . . 0.0 113.558 168.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -98.88 -13.38 20.07 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.416 1.086 . . . . 0.0 113.443 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -125.18 -19.62 5.09 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -163.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -67.64 120.89 14.76 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 120.408 1.458 . . . . 0.0 110.769 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 91.34 0.82 72.85 Favored Glycine 0 N--CA 1.469 0.885 0 CA-C-O 117.44 -1.755 . . . . 0.0 114.75 -170.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.37 106.22 0.36 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.894 1.847 . . . . 0.0 110.32 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.499 ' CZ ' ' HE2' ' A' ' 229' ' ' LYS . 56.4 m-85 -60.3 116.92 4.61 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 156.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -133.95 110.33 9.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.24 1.416 . . . . 0.0 107.288 -164.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 12.9 ttt 50.07 38.88 17.85 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.13 0.972 . . . . 0.0 111.897 -159.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.7 t70 76.45 6.78 3.47 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 126.858 2.063 . . . . 0.0 114.965 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -121.12 138.67 54.09 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.45 1.1 . . . . 0.0 112.105 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.499 ' HE2' ' CZ ' ' A' ' 224' ' ' PHE . 42.4 mmtt -68.01 115.88 8.02 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.149 1.379 . . . . 0.0 113.584 -175.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.03 145.87 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 O-C-N 120.998 -1.064 . . . . 0.0 110.743 151.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -146.58 142.42 27.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.64 1.976 . . . . 0.0 108.43 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.2 t -137.27 135.38 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -165.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -101.43 141.47 34.25 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.259 1.824 . . . . 0.0 110.965 168.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -92.98 122.07 34.97 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.819 0.848 . . . . 0.0 110.005 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.37 -26.66 0.14 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 128.883 2.873 . . . . 0.0 117.49 164.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.079 0 C-N-CA 128.039 2.536 . . . . 0.0 110.918 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.835 0 CA-C-O 121.179 0.322 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.0 t -162.57 150.32 13.94 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.212 1.405 . . . . 0.0 111.552 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -85.06 -5.24 59.35 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.583 1.153 . . . . 0.0 113.758 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 62.71 -151.4 0.35 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.088 1.755 . . . . 0.0 111.52 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -162.48 161.25 26.98 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.971 1.708 . . . . 0.0 111.297 -174.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 93.7 mt -141.26 159.24 42.64 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.269 1.828 . . . . 0.0 111.09 -177.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -160.08 161.53 33.89 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.949 1.7 . . . . 0.0 112.183 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.3 m -165.37 152.98 10.92 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.408 1.883 . . . . 0.0 111.484 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.6 p -144.0 148.3 35.08 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.109 1.764 . . . . 0.0 111.13 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -158.7 169.33 24.62 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.349 1.459 . . . . 0.0 112.735 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -142.11 156.83 45.39 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.754 1.622 . . . . 0.0 111.1 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -141.48 150.66 42.52 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.728 1.611 . . . . 0.0 110.758 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -154.09 142.01 20.17 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.998 1.319 . . . . 0.0 111.748 -173.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.6 m -143.3 152.39 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.531 1.533 . . . . 0.0 111.633 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -161.91 148.91 14.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.045 1.738 . . . . 0.0 111.22 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -156.9 136.96 12.66 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.922 1.289 . . . . 0.0 112.137 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -161.03 142.72 12.02 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.84 2.056 . . . . 0.0 109.801 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -137.44 -21.24 1.17 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.415 1.486 . . . . 0.0 113.468 -172.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 54.4 p -149.06 178.55 8.61 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.197 0.999 . . . . 0.0 113.01 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -92.11 8.91 35.74 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.189 0.996 . . . . 0.0 112.066 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.4 m -90.19 143.28 26.91 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.858 1.263 . . . . 0.0 113.835 -165.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.0 pt -136.43 147.06 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.09 1.356 . . . . 0.0 110.824 176.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -129.48 114.21 15.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.555 1.942 . . . . 0.0 109.356 -167.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.46 106.29 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.308 1.843 . . . . 0.0 108.197 -172.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.54 -10.78 78.97 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.237 0.922 . . . . 0.0 115.268 -169.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -159.44 157.92 31.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.009 1.724 . . . . 0.0 110.408 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 178.26 -144.55 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 128.838 2.855 . . . . 0.0 107.984 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 21.8 p -108.56 141.83 39.89 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 120.865 1.666 . . . . 0.0 111.221 170.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -59.68 -25.18 64.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -88.52 -1.85 58.27 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.045 1.738 . . . . 0.0 113.423 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 22.7 t -69.63 154.64 41.7 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.984 -1.072 . . . . 0.0 112.163 174.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 32.5 p -128.4 155.57 78.35 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 125.33 1.452 . . . . 0.0 109.746 -172.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.02 -23.48 53.79 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.45 1.434 . . . . 0.0 112.394 174.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -69.07 -36.38 77.57 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.516 1.053 . . . . 0.0 111.987 171.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -71.33 -37.98 71.69 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.307 -0.871 . . . . 0.0 111.859 174.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.8 mt -66.14 -30.36 70.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.418 -0.801 . . . . 0.0 112.787 166.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 63.6 m -67.71 -46.82 71.1 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.571 1.078 . . . . 0.0 109.35 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.31 -36.13 79.26 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.796 0.726 . . . . 0.0 112.118 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -66.41 -64.14 0.92 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.55 1.14 . . . . 0.0 111.511 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -71.23 -39.21 71.84 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -173.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.73 -3.88 31.1 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -72.77 -15.95 61.65 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.161 -0.962 . . . . 0.0 112.892 165.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.07 -45.65 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.007 0.822 . . . . 0.0 111.295 175.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.39 -90.75 0.08 OUTLIER Glycine 0 N--CA 1.468 0.779 0 C-N-CA 125.062 1.315 . . . . 0.0 112.405 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -158.4 109.56 2.17 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.74 0.816 . . . . 0.0 112.09 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 36.0 t -74.06 130.44 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 167.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.6 p -102.94 -16.99 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.22 1.008 . . . . 0.0 113.107 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -164.95 134.22 3.55 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.147 1.779 . . . . 0.0 111.066 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -130.15 152.94 49.04 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.716 1.606 . . . . 0.0 112.299 165.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -156.76 156.78 33.89 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.844 2.058 . . . . 0.0 111.216 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.3 mt -141.75 133.57 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.7 1.2 . . . . 0.0 111.316 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 63.5 mt -93.81 107.52 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.205 1.402 . . . . 0.0 107.753 168.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 8.9 t -151.93 141.17 21.4 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.544 1.538 . . . . 0.0 110.036 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 68.9 m -157.58 163.34 38.43 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.706 2.003 . . . . 0.0 109.82 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 27.4 mmt85 -70.99 -15.93 62.6 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -91.05 -137.86 7.47 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.901 1.715 . . . . 0.0 113.863 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 35.1 p80 -82.22 0.1 42.74 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 -170.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -63.61 150.41 44.21 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.535 1.134 . . . . 0.0 113.351 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -33.64 74.3 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -168.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 75.78 78.86 0.65 Allowed Glycine 0 N--CA 1.473 1.141 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -168.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 27.1 ptm -148.13 134.69 19.77 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.157 0.983 . . . . 0.0 112.372 -168.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -108.06 164.73 12.81 Favored Glycine 0 N--CA 1.469 0.865 0 C-N-CA 124.874 1.226 . . . . 0.0 113.789 -177.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.77 142.54 27.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.992 1.717 . . . . 0.0 109.836 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 19.4 t -146.27 146.89 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.609 0.764 . . . . 0.0 109.999 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -129.2 131.95 47.19 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.164 1.786 . . . . 0.0 109.369 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -95.99 171.77 8.42 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.626 1.17 . . . . 0.0 109.915 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 59.0 p -81.48 0.15 39.15 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 168.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -136.22 178.49 7.02 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.264 1.826 . . . . 0.0 112.433 -166.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 20.9 p -124.82 -68.3 0.86 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.179 1.792 . . . . 0.0 110.897 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -54.37 -38.53 66.21 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.016 -1.053 . . . . 0.0 112.956 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.6 -18.38 64.97 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.446 1.098 . . . . 0.0 113.077 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 13.0 t -75.79 -37.23 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.137 1.375 . . . . 0.0 112.062 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -62.17 -43.67 98.31 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.768 -0.582 . . . . 0.0 110.434 168.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -65.74 -17.14 64.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.981 1.312 . . . . 0.0 113.523 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -74.49 -64.27 1.06 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.24 0.927 . . . . 0.0 111.425 166.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 53.5 mt -69.23 -30.8 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.444 -0.785 . . . . 0.0 112.04 -167.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.69 -4.2 2.87 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.545 1.138 . . . . 0.0 113.835 170.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -118.24 -4.91 10.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.388 1.475 . . . . 0.0 112.569 172.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -127.54 -24.03 3.38 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -171.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.54 120.92 12.07 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 121.001 1.728 . . . . 0.0 110.501 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 91.64 0.68 72.14 Favored Glycine 0 N--CA 1.469 0.844 0 CA-C-O 118.06 -1.411 . . . . 0.0 115.336 -171.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.47 107.6 0.81 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.76 1.78 . . . . 0.0 110.363 169.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -52.98 120.4 5.81 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 156.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -142.15 111.06 6.27 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.26 1.424 . . . . 0.0 108.314 -166.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 20.5 ttt 56.72 40.5 29.14 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 121.776 0.798 . . . . 0.0 110.751 -165.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 18.3 t70 74.97 0.18 3.48 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 127.912 2.485 . . . . 0.0 115.285 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -125.64 141.27 52.11 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.05 1.34 . . . . 0.0 111.982 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -87.32 102.62 14.68 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.002 0.921 . . . . 0.0 112.621 -165.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.88 149.73 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 121.226 -0.921 . . . . 0.0 112.484 169.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -141.49 140.49 33.53 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.823 1.649 . . . . 0.0 108.696 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 16.0 t -133.03 133.55 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 118.556 0.616 . . . . 0.0 112.299 -168.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -107.31 145.03 33.31 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.128 1.771 . . . . 0.0 109.456 169.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -104.59 148.17 26.81 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.123 0.969 . . . . 0.0 110.475 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 71.21 -34.3 0.3 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 128.048 2.539 . . . . 0.0 115.457 172.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 29.6 m120 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 126.929 2.091 . . . . 0.0 112.978 -174.546 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.3 p -164.8 144.96 7.37 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.934 1.294 . . . . 0.0 111.688 -176.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -161.49 163.29 30.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.319 1.448 . . . . 0.0 111.964 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 32.1 mmm180 -70.45 150.56 46.08 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.275 1.03 . . . . 0.0 112.056 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -160.0 145.26 15.18 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.143 1.777 . . . . 0.0 109.543 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 31.0 mt 69.38 5.86 5.37 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 126.972 2.109 . . . . 0.0 113.416 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -75.48 145.1 41.67 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.647 1.979 . . . . 0.0 113.306 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.7 t -163.57 136.87 5.53 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.05 1.34 . . . . 0.0 111.121 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.6 m -167.3 144.91 4.67 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.309 2.244 . . . . 0.0 109.154 -176.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -152.2 139.26 19.16 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.253 1.421 . . . . 0.0 111.611 176.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -164.56 152.14 11.8 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.419 1.488 . . . . 0.0 110.586 -174.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 67.34 -161.6 0.23 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.566 1.946 . . . . 0.0 111.893 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 69.9 tttt 68.7 15.57 9.02 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.577 1.551 . . . . 0.0 114.707 167.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 99.1 t -140.26 134.21 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 125.858 1.663 . . . . 0.0 110.055 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -158.46 123.66 4.34 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.872 1.669 . . . . 0.0 110.32 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -156.85 52.91 0.51 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.221 1.408 . . . . 0.0 110.837 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -134.33 126.4 29.6 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.723 1.209 . . . . 0.0 111.031 -173.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -130.33 22.22 5.19 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.926 1.69 . . . . 0.0 112.14 -171.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 80.6 p -95.7 -172.94 2.73 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.866 2.466 . . . . 0.0 111.923 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -147.87 25.6 1.03 Allowed 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.11 -0.994 . . . . 0.0 113.257 172.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.9 t -149.76 149.92 31.27 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.676 -1.265 . . . . 0.0 111.595 -174.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.1 pt -139.06 148.21 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.831 1.652 . . . . 0.0 110.786 -171.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -99.34 148.87 23.73 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.106 1.363 . . . . 0.0 110.601 166.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 14.8 t -131.01 101.41 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.01 -12.86 82.89 Favored Glycine 0 N--CA 1.475 1.247 0 C-N-CA 124.128 0.871 . . . . 0.0 114.963 -161.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -164.26 148.48 9.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.531 1.932 . . . . 0.0 108.785 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.3 mp -144.51 -79.42 0.19 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.541 1.937 . . . . 0.0 109.63 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.5 t 177.03 162.64 0.46 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 128.232 2.613 . . . . 0.0 108.652 -162.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -91.75 0.37 57.49 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.407 1.083 . . . . 0.0 113.511 -174.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -120.24 0.42 10.64 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.424 1.89 . . . . 0.0 114.543 -173.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.8 t -90.15 168.51 11.9 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.932 -1.105 . . . . 0.0 113.152 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 40.0 p -143.41 163.72 35.21 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 127.488 2.315 . . . . 0.0 109.798 -174.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -60.58 -29.08 87.78 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.249 1.966 . . . . 0.0 113.193 169.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -69.08 -39.89 78.76 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.339 0.972 . . . . 0.0 111.837 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -60.98 -40.47 93.55 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.561 0.744 . . . . 0.0 111.585 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.4 mt -70.04 -31.67 69.42 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 172.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 51.8 m -65.9 -47.4 74.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.964 0.802 . . . . 0.0 110.868 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.03 -19.74 60.53 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -79.13 -55.93 4.74 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.307 1.443 . . . . 0.0 111.081 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -70.98 -28.16 64.24 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.162 0.985 . . . . 0.0 113.489 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 45.3 m -72.92 -2.31 20.37 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -64.91 -18.85 65.56 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.244 -0.91 . . . . 0.0 112.58 165.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 23.3 mm -90.08 -21.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.88 1.272 . . . . 0.0 112.222 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 168.64 -87.27 0.09 OUTLIER Glycine 0 N--CA 1.468 0.804 0 C-N-CA 125.379 1.466 . . . . 0.0 111.872 -173.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -162.07 120.18 2.22 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.663 1.185 . . . . 0.0 112.448 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 43.7 t -73.71 131.9 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 157.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.55 -18.34 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 171.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -162.37 141.21 9.11 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.144 1.778 . . . . 0.0 110.803 172.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -132.58 158.05 43.17 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.223 1.409 . . . . 0.0 111.522 164.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -153.31 143.91 22.61 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.471 1.508 . . . . 0.0 111.937 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 29.2 mm -141.13 137.43 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.697 1.599 . . . . 0.0 110.632 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 75.6 mt -89.77 113.74 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.625 1.57 . . . . 0.0 107.855 166.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 41.5 p -98.46 -178.85 4.15 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.35 1.86 . . . . 0.0 112.324 -170.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 26.6 t -156.62 167.25 31.01 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.091 1.356 . . . . 0.0 111.484 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -68.11 -18.23 64.59 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.11 1.364 . . . . 0.0 114.004 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 161.19 -1.3 0.07 OUTLIER Glycine 0 N--CA 1.475 1.292 0 N-CA-C 116.573 1.389 . . . . 0.0 116.573 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -151.74 143.76 23.85 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.791 1.296 . . . . 0.0 112.437 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 65.48 175.11 0.22 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 126.569 1.947 . . . . 0.0 113.452 -177.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 14.0 mmp_? 59.16 -145.41 0.53 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.328 1.451 . . . . 0.0 109.755 -171.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 79.25 62.11 2.24 Favored Glycine 0 N--CA 1.47 0.924 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -175.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 11.7 ptt? -155.83 155.65 33.35 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.862 1.665 . . . . 0.0 111.036 -170.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 164.99 -144.65 9.5 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-N 118.638 0.654 . . . . 0.0 114.388 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.5 p -144.46 159.77 42.2 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.34 1.456 . . . . 0.0 112.954 -165.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 37.8 t -144.97 141.53 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.003 1.321 . . . . 0.0 110.322 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -121.16 134.32 55.22 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 127.018 2.127 . . . . 0.0 110.922 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -118.96 172.79 7.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.676 2.39 . . . . 0.0 111.234 -173.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 80.9 p -92.2 -22.03 20.04 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.424 ' O ' HG12 ' A' ' 213' ' ' VAL . 18.4 m120 -148.49 137.4 21.64 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -169.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 19.3 m -69.84 -22.89 63.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.98 2.112 . . . . 0.0 115.814 -168.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -90.24 -36.92 14.46 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.639 0.654 . . . . 0.0 111.951 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -72.23 -37.11 69.25 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.102 -0.998 . . . . 0.0 112.573 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 209' ' ' ASN . 14.2 p -63.46 -28.7 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.607 0.763 . . . . 0.0 113.01 170.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.62 -46.57 37.45 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.86 0.864 . . . . 0.0 112.974 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -59.31 -27.84 66.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.317 1.447 . . . . 0.0 112.896 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.64 -60.93 2.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.216 1.006 . . . . 0.0 112.879 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 43.9 mt -65.09 -29.06 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 121.128 -0.982 . . . . 0.0 112.428 -169.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -51.44 -29.1 14.97 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.622 1.569 . . . . 0.0 113.19 168.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -93.87 -15.86 24.62 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.988 1.315 . . . . 0.0 113.698 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -127.6 -18.6 4.33 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -159.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.81 120.9 13.36 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 121.227 1.831 . . . . 0.0 110.506 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 92.98 0.78 68.02 Favored Glycine 0 N--CA 1.472 1.039 0 CA-C-O 117.941 -1.477 . . . . 0.0 115.059 -170.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.97 108.16 0.99 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.839 1.82 . . . . 0.0 110.348 171.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -55.68 129.25 38.44 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.313 0.645 . . . . 0.0 110.333 160.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -152.25 110.84 3.77 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.996 1.719 . . . . 0.0 106.685 -162.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 2.6 mpt? 41.15 59.28 2.35 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.152 0.981 . . . . 0.0 111.435 -160.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 73.21 0.05 3.54 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.922 2.089 . . . . 0.0 116.174 170.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -137.58 147.0 44.71 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.622 1.169 . . . . 0.0 111.775 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -70.83 124.22 23.79 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.903 -1.123 . . . . 0.0 113.698 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.4 pt -65.78 137.13 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.336 -0.853 . . . . 0.0 111.332 153.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -129.76 129.84 44.63 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.068 1.347 . . . . 0.0 109.596 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -156.32 129.09 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.992 0.917 . . . . 0.0 111.614 -169.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -106.95 148.59 28.45 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.919 1.687 . . . . 0.0 109.443 168.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.21 162.0 27.72 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.884 0.874 . . . . 0.0 111.806 178.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -131.63 153.58 49.79 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.433 1.493 . . . . 0.0 112.209 -171.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 37.5 t30 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.032 1.733 . . . . 0.0 111.978 -179.994 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 112.186 -0.366 . . . . 0.0 112.186 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.1 m -169.24 152.22 4.9 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.959 2.104 . . . . 0.0 110.781 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -160.66 162.8 32.77 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.513 1.525 . . . . 0.0 111.833 -176.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -66.71 145.68 55.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.557 1.143 . . . . 0.0 111.924 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -147.31 138.36 23.72 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.559 1.544 . . . . 0.0 110.528 173.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 pp -168.39 175.61 6.26 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.343 1.857 . . . . 0.0 111.906 -169.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -146.66 152.52 39.0 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.455 1.902 . . . . 0.0 110.839 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 10.4 t -160.33 160.94 33.05 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.636 1.174 . . . . 0.0 112.033 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.8 m -165.22 138.72 4.65 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 127.349 2.26 . . . . 0.0 108.734 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -160.11 145.32 15.05 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.429 1.091 . . . . 0.0 113.197 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.71 153.06 7.1 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.997 2.119 . . . . 0.0 109.243 173.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -161.72 129.76 4.18 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.282 1.033 . . . . 0.0 111.916 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -139.14 154.48 48.11 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.061 1.745 . . . . 0.0 111.258 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.38 146.82 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 125.547 1.539 . . . . 0.0 111.2 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -162.26 149.93 14.2 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.26 1.424 . . . . 0.0 111.55 -174.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.2 mmt-85 -140.07 118.32 12.03 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.531 1.532 . . . . 0.0 109.909 172.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -166.11 144.3 5.64 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.231 1.813 . . . . 0.0 110.743 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -129.53 123.5 31.59 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.18 0.992 . . . . 0.0 110.135 165.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 67.7 m -149.26 93.78 2.13 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.929 1.292 . . . . 0.0 110.417 -174.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -96.78 11.71 34.63 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 80.2 p -151.11 155.67 39.42 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.652 -1.28 . . . . 0.0 111.861 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 5.1 pt -144.58 154.37 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.219 1.407 . . . . 0.0 111.806 -165.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -119.02 125.85 50.32 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.553 1.941 . . . . 0.0 109.627 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 12.2 t -107.94 129.96 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.743 1.217 . . . . 0.0 109.111 -175.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.37 -97.66 0.12 Allowed Glycine 0 N--CA 1.472 1.094 0 C-N-CA 125.667 1.604 . . . . 0.0 115.036 -161.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -92.68 -56.86 2.85 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 117.625 0.713 . . . . 0.0 111.924 -173.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.45 6.67 1.52 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 118.752 2.871 . . . . 0.0 118.752 155.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.7 m 79.18 124.23 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 127.783 2.433 . . . . 0.0 110.422 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -68.25 -13.35 62.19 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -81.45 -9.14 59.78 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.503 1.521 . . . . 0.0 113.319 172.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.0 m -74.77 141.78 44.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.998 0.919 . . . . 0.0 112.551 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.8 p -122.87 152.78 63.21 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.971 1.308 . . . . 0.0 111.554 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.6 -25.9 14.46 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.607 2.205 . . . . 0.0 113.057 -173.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -69.43 -39.44 77.84 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.437 1.017 . . . . 0.0 111.891 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -73.16 -36.23 66.59 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.451 -0.781 . . . . 0.0 111.349 177.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 49.3 mt -62.24 -31.93 72.55 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.773 0.829 . . . . 0.0 112.289 166.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 54.8 m -67.0 -51.06 59.74 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.48 1.036 . . . . 0.0 109.634 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.92 -36.15 78.55 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.424 0.556 . . . . 0.0 112.359 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -67.38 -57.41 6.64 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.014 1.726 . . . . 0.0 112.29 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -71.57 -34.01 69.57 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.9 t -72.53 -8.79 56.95 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 121.004 -1.06 . . . . 0.0 113.441 -174.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -52.54 -27.99 18.93 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.362 2.265 . . . . 0.0 113.053 164.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 28.4 mm -80.52 -17.26 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.547 1.539 . . . . 0.0 112.451 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 117.25 90.98 1.54 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.909 1.719 . . . . 0.0 112.324 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? 69.69 91.29 0.09 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 126.751 2.02 . . . . 0.0 114.472 162.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 13.9 t -73.14 128.09 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 162.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 66.5 t -91.12 -22.51 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.892 1.677 . . . . 0.0 111.25 -175.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -178.43 140.03 0.2 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.243 2.217 . . . . 0.0 109.576 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -120.03 141.33 49.84 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.487 1.115 . . . . 0.0 110.52 162.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -143.7 92.95 2.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.677 1.191 . . . . 0.0 111.595 -169.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.6 -49.53 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.689 1.196 . . . . 0.0 110.815 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 18.8 tt -70.26 132.32 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.341 0.656 . . . . 0.0 111.923 -172.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 7.1 t -151.9 150.27 29.87 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.174 1.79 . . . . 0.0 110.559 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 3.9 t -95.99 -0.07 51.08 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.371 1.068 . . . . 0.0 112.769 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -82.72 0.13 44.92 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.191 1.397 . . . . 0.0 114.487 -171.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.98 162.43 28.72 Favored Glycine 0 N--CA 1.472 1.098 0 C-N-CA 125.606 1.574 . . . . 0.0 112.841 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -140.89 131.55 25.62 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.747 1.219 . . . . 0.0 112.868 -169.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -133.67 12.02 4.06 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.22 1.408 . . . . 0.0 113.487 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -167.19 -40.11 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.394 1.878 . . . . 0.0 112.909 -176.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 90.26 16.94 54.74 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.604 1.097 . . . . 0.0 114.317 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 28.2 ptm -66.95 162.52 21.74 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.954 1.302 . . . . 0.0 113.76 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -166.22 -166.74 25.76 Favored Glycine 0 N--CA 1.471 1.025 0 C-N-CA 124.031 0.824 . . . . 0.0 114.088 174.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.8 p -141.84 161.14 38.69 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.83 1.252 . . . . 0.0 112.599 -167.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 6.4 t -143.54 142.28 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.651 1.18 . . . . 0.0 110.435 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -114.49 145.26 42.12 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.225 2.21 . . . . 0.0 111.218 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -129.83 161.69 30.2 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.936 2.494 . . . . 0.0 109.535 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.2 p -84.21 -28.56 27.22 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.99 -0.444 . . . . 0.0 111.396 171.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -84.66 174.7 9.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.36 1.864 . . . . 0.0 112.902 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 39.3 t -126.03 -65.92 0.96 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.85 0.86 . . . . 0.0 111.49 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -64.5 -25.48 68.01 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.51 -1.369 . . . . 0.0 113.821 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -72.06 -20.92 61.59 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.561 1.144 . . . . 0.0 113.315 171.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 22.0 t -70.05 -28.3 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.049 0.94 . . . . 0.0 111.591 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -74.44 -37.07 63.37 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.283 -0.886 . . . . 0.0 112.208 167.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -64.8 -23.66 67.31 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.239 1.016 . . . . 0.0 112.405 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.97 -63.87 1.12 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.19 0.996 . . . . 0.0 110.565 164.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 83.8 mt -62.09 -35.63 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.215 1.006 . . . . 0.0 112.396 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -64.03 -6.56 6.52 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -114.29 -5.15 12.96 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.525 1.53 . . . . 0.0 112.535 172.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -128.06 -19.43 3.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -169.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -58.64 121.43 10.97 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.072 1.306 . . . . 0.0 109.227 162.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 93.83 0.51 66.35 Favored Glycine 0 N--CA 1.468 0.786 0 CA-C-O 118.379 -1.234 . . . . 0.0 114.849 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.57 108.53 2.46 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.512 1.656 . . . . 0.0 110.463 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -54.8 123.24 12.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.434 0.694 . . . . 0.0 109.963 155.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -148.62 116.51 6.35 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.422 1.489 . . . . 0.0 108.335 -167.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 56.21 31.58 18.67 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.101 0.96 . . . . 0.0 111.968 -163.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 10.7 t70 86.61 0.66 0.57 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 128.37 2.668 . . . . 0.0 115.582 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.4 152.77 48.69 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.638 1.175 . . . . 0.0 111.782 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -82.38 123.68 29.33 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -158.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.75 153.4 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 126.037 1.735 . . . . 0.0 113.318 167.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -145.86 146.65 31.2 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.552 1.941 . . . . 0.0 108.787 164.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 23.4 t -117.41 128.57 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.727 1.211 . . . . 0.0 110.586 -173.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -75.56 129.59 37.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.863 0.865 . . . . 0.0 109.364 168.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -100.28 136.94 39.39 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.005 1.322 . . . . 0.0 108.605 173.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 69.19 150.31 0.08 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 127.088 2.155 . . . . 0.0 113.96 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 12.0 t30 . . . . . 0 C--O 1.255 1.345 0 C-N-CA 125.7 1.6 . . . . 0.0 112.076 -179.859 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.824 0 N-CA-C 112.335 -0.306 . . . . 0.0 112.335 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.1 m -170.06 155.36 5.48 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.908 2.083 . . . . 0.0 110.98 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.34 143.08 50.37 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.835 0.854 . . . . 0.0 112.15 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -153.38 22.0 0.55 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.901 1.28 . . . . 0.0 114.171 -174.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -141.05 154.47 45.98 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.06 1.744 . . . . 0.0 110.631 -175.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -159.06 168.92 25.45 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.074 1.75 . . . . 0.0 112.177 -176.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -143.7 145.84 32.73 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.785 1.634 . . . . 0.0 111.307 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.7 p -164.23 167.44 20.0 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.648 1.579 . . . . 0.0 111.642 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.7 p -139.91 152.47 46.43 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.415 1.486 . . . . 0.0 111.449 -173.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -71.21 -10.77 60.31 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -172.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -78.39 -7.27 57.15 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -78.95 60.14 2.82 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 123.045 1.403 . . . . 0.0 111.271 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -81.98 -9.39 59.58 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.35 1.86 . . . . 0.0 114.542 -173.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.6 t 72.82 -69.68 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 128.38 2.672 . . . . 0.0 112.282 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 68.02 144.44 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 127.33 2.252 . . . . 0.0 113.339 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? 62.1 55.56 2.45 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.276 1.83 . . . . 0.0 111.348 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -81.82 57.12 3.3 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.903 1.681 . . . . 0.0 112.498 -168.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -129.78 18.94 5.63 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.667 1.587 . . . . 0.0 113.058 -166.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 29.8 t -154.24 163.7 39.72 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.498 1.519 . . . . 0.0 111.267 -171.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -153.16 22.29 0.56 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.891 1.276 . . . . 0.0 113.843 -169.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.2 t -144.88 156.86 44.23 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.508 -1.37 . . . . 0.0 113.165 -174.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.0 pt -143.61 147.32 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 125.301 1.44 . . . . 0.0 112.275 -165.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -113.78 118.98 35.78 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 128.041 2.536 . . . . 0.0 109.257 173.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 25.5 t -94.57 97.15 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.363 1.465 . . . . 0.0 107.397 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.39 -9.22 67.26 Favored Glycine 0 N--CA 1.475 1.25 0 N-CA-C 116.052 1.181 . . . . 0.0 116.052 -160.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -139.61 18.13 2.53 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -164.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.02 -174.92 2.86 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.28 1.432 . . . . 0.0 112.689 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 38.1 m -97.26 122.96 40.88 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.023 1.329 . . . . 0.0 109.503 171.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -66.94 -10.42 48.92 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -171.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -74.82 -13.11 60.53 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.486 1.514 . . . . 0.0 113.867 174.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 5.8 m -67.24 137.89 56.5 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.022 -1.049 . . . . 0.0 111.447 168.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 78.8 p -76.21 163.27 67.51 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 123.836 0.855 . . . . 0.0 109.908 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -59.91 -35.64 92.98 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 121.758 1.639 . . . . 0.0 111.917 168.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.42 -29.01 69.06 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.787 0.722 . . . . 0.0 112.88 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -65.21 -33.72 76.67 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.078 0.951 . . . . 0.0 111.992 173.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.3 mt -74.59 -34.16 62.81 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 118.003 -0.998 . . . . 0.0 113.451 165.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 84.8 m -61.08 -51.12 70.48 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.94 1.246 . . . . 0.0 110.62 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.24 -30.5 70.95 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.889 0.768 . . . . 0.0 112.973 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -68.27 -56.37 8.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.034 1.334 . . . . 0.0 111.514 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -71.65 -23.38 61.67 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.7 t -61.98 -19.65 63.03 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.651 -1.28 . . . . 0.0 113.457 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -60.97 -17.95 54.55 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.281 1.833 . . . . 0.0 113.306 169.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 25.8 mm -104.45 -51.87 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.144 1.378 . . . . 0.0 111.851 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -172.33 -177.42 41.79 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.165 1.364 . . . . 0.0 112.403 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -74.24 105.6 5.5 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 121.624 -0.927 . . . . 0.0 112.168 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 48.3 t -59.68 130.13 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 160.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.02 -40.16 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.312 0.645 . . . . 0.0 110.422 171.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -155.54 139.4 16.24 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.871 2.068 . . . . 0.0 109.983 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -125.31 152.96 43.99 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.313 1.445 . . . . 0.0 110.665 164.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -150.97 131.67 14.01 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.541 1.136 . . . . 0.0 112.203 -171.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.7 mt -142.48 -63.28 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.225 1.41 . . . . 0.0 110.974 171.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 15.7 tt -80.47 137.34 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.554 0.742 . . . . 0.0 111.081 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 43.5 p -137.08 144.34 43.07 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.354 1.062 . . . . 0.0 110.879 -168.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 14.4 m -61.07 -12.86 13.41 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -170.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 26.3 mmt85 -74.47 -17.69 60.74 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.048 0.939 . . . . 0.0 113.029 173.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 77.06 8.08 86.82 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.429 1.49 . . . . 0.0 115.562 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -83.58 137.01 34.03 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 118.9 1.35 . . . . 0.0 113.419 -174.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -72.7 101.69 3.14 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.897 0.879 . . . . 0.0 111.415 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -85.76 -30.21 23.24 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -173.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 73.5 14.61 79.44 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 123.888 0.756 . . . . 0.0 114.759 -175.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -153.97 167.82 28.47 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.04 1.336 . . . . 0.0 112.809 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -147.09 172.85 27.45 Favored Glycine 0 N--CA 1.468 0.774 0 C-N-CA 126.025 1.774 . . . . 0.0 112.808 177.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.3 p -142.81 148.77 37.67 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.12 1.368 . . . . 0.0 111.013 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.29 137.28 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.09 0.956 . . . . 0.0 109.983 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -116.09 137.08 52.44 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.706 1.603 . . . . 0.0 109.635 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -110.98 159.12 18.03 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.17 1.788 . . . . 0.0 110.411 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 64.1 p -77.07 0.48 21.28 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 169.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -130.01 157.18 43.05 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.106 1.762 . . . . 0.0 112.886 -165.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 72.1 p -109.14 -7.85 15.24 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.601 1.56 . . . . 0.0 114.916 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.71 -45.42 1.46 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.39 1.476 . . . . 0.0 111.914 -166.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.23 -30.08 68.16 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.596 -0.69 . . . . 0.0 111.505 172.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.5 p -61.13 -32.11 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.276 1.43 . . . . 0.0 113.025 174.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -74.16 -48.11 31.48 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.965 0.906 . . . . 0.0 111.436 171.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -72.34 -11.76 60.84 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.62 -56.75 17.46 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.6 1.16 . . . . 0.0 111.381 163.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 71.2 mt -66.87 -30.33 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.055 0.942 . . . . 0.0 112.109 -168.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -52.41 -28.37 19.58 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.507 1.123 . . . . 0.0 113.471 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -97.1 -15.23 21.07 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.399 1.48 . . . . 0.0 112.579 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -123.29 -15.64 7.14 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -165.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -61.31 120.65 10.83 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.53 1.514 . . . . 0.0 108.88 162.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 97.57 -0.24 59.58 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 118.153 -1.36 . . . . 0.0 114.844 -172.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.17 103.88 2.46 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.727 1.764 . . . . 0.0 110.469 173.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -60.81 119.69 8.67 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 158.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -150.38 110.85 4.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.152 1.381 . . . . 0.0 108.633 -165.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 57.13 55.38 6.04 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.298 1.039 . . . . 0.0 110.865 -170.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 19.5 t70 76.13 0.18 3.23 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.749 2.02 . . . . 0.0 116.088 169.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -146.86 157.36 43.63 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.311 0.959 . . . . 0.0 112.787 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 4.2 tmmm? -86.36 105.42 16.69 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.673 1.189 . . . . 0.0 112.647 -172.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.22 154.1 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.188 0.995 . . . . 0.0 112.052 165.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -156.45 144.77 19.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.466 1.906 . . . . 0.0 107.486 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 13.2 t -127.36 140.31 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.632 0.773 . . . . 0.0 111.926 -162.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 81.6 mtt85 -119.25 136.73 54.08 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.95 2.1 . . . . 0.0 108.318 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -94.76 151.78 18.98 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.227 -0.92 . . . . 0.0 110.49 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -73.29 140.47 46.82 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.672 -0.642 . . . . 0.0 111.561 167.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.253 0 C-N-CA 125.869 1.668 . . . . 0.0 111.097 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.5 t -163.45 -47.33 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.08 0.952 . . . . 0.0 113.379 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.93 -10.97 59.99 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -173.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 57.3 55.91 5.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.131 1.773 . . . . 0.0 112.265 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -73.07 134.1 44.43 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.58 0.752 . . . . 0.0 109.725 170.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.4 mt -140.69 158.66 43.65 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.295 1.438 . . . . 0.0 111.925 -171.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -72.51 166.22 23.08 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.221 1.408 . . . . 0.0 112.832 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.9 m -160.92 152.92 19.9 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.275 1.83 . . . . 0.0 111.679 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 37.8 p -126.66 147.05 49.97 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.569 1.548 . . . . 0.0 111.537 -172.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -144.05 162.71 35.53 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.196 1.398 . . . . 0.0 112.279 -170.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -160.21 163.03 33.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.992 1.317 . . . . 0.0 112.436 -175.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.86 126.49 17.92 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.768 1.627 . . . . 0.0 109.541 173.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -87.12 152.07 22.66 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.251 1.02 . . . . 0.0 112.37 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.5 m -146.1 152.23 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 126.068 1.747 . . . . 0.0 111.152 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -145.86 139.98 26.71 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.228 1.411 . . . . 0.0 111.474 -175.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -95.47 135.53 37.0 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.969 1.308 . . . . 0.0 110.949 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -92.8 -8.03 44.78 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 48.3 t80 76.37 117.44 0.06 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 128.461 2.704 . . . . 0.0 113.109 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 30.6 m 50.49 39.28 20.54 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.186 1.395 . . . . 0.0 113.189 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -60.19 131.54 51.14 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -154.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.7 t -78.04 158.38 29.23 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.529 1.532 . . . . 0.0 112.806 170.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 31.7 pt -138.95 138.89 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.898 2.079 . . . . 0.0 107.948 175.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -105.73 131.3 53.25 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.59 1.156 . . . . 0.0 109.52 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.7 t -111.2 122.96 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.677 1.591 . . . . 0.0 108.354 -170.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.12 -141.67 1.78 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.195 1.855 . . . . 0.0 113.312 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -74.97 47.26 0.34 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -162.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.62 ' HB2' HG22 ' A' ' 230' ' ' ILE . 2.5 pt? -53.99 -50.1 67.34 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.819 -1.175 . . . . 0.0 112.606 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.1 t 145.23 142.96 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.388 1 C-N-CA 131.705 4.002 . . . . 0.0 110.18 173.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -68.95 -9.5 52.39 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -80.59 -6.07 57.75 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.748 1.219 . . . . 0.0 113.198 170.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 6.2 t -88.72 167.06 13.63 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.957 0.903 . . . . 0.0 113.163 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.45 151.74 64.71 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 125.741 1.617 . . . . 0.0 111.385 -170.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.41 -21.76 11.42 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.797 2.332 . . . . 0.0 114.331 -167.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.02 -34.79 75.81 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.156 1.344 . . . . 0.0 111.567 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.42 -41.66 84.48 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.777 1.231 . . . . 0.0 110.874 175.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.4 tp -67.38 -33.59 75.51 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.478 1.911 . . . . 0.0 111.455 174.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 68.3 m -64.26 -50.45 67.91 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.428 1.491 . . . . 0.0 110.41 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -67.59 -40.5 84.79 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.918 0.487 . . . . 0.0 111.622 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -56.07 -56.58 19.1 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.484 1.513 . . . . 0.0 112.235 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -71.13 -27.46 63.59 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.6 m -73.3 0.51 11.8 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -68.75 -19.59 64.34 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.169 -0.957 . . . . 0.0 112.597 164.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 14.0 mm -95.05 -55.29 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.104 0.961 . . . . 0.0 111.137 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -135.68 -109.68 1.02 Allowed Glycine 0 N--CA 1.468 0.779 0 C-N-CA 125.906 1.717 . . . . 0.0 110.372 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -152.84 121.99 6.63 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.213 1.005 . . . . 0.0 111.097 173.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 49.1 t -73.4 129.95 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 170.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.61 -24.05 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 170.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -152.78 135.7 15.51 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.463 1.505 . . . . 0.0 110.257 172.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -128.09 148.79 50.58 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.014 1.326 . . . . 0.0 110.598 160.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -145.53 134.98 23.15 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.6 1.16 . . . . 0.0 112.13 -172.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 59.2 mt -142.7 -60.48 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 125.64 1.576 . . . . 0.0 110.165 170.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 9.8 tp -65.68 137.21 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.729 0.811 . . . . 0.0 111.911 -175.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 3.7 t -151.44 136.74 17.6 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.061 1.744 . . . . 0.0 110.083 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 62.8 p -97.38 -2.99 41.14 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.916 1.286 . . . . 0.0 112.937 174.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -109.07 -33.35 6.92 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.669 1.588 . . . . 0.0 112.964 -176.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -97.08 168.36 24.49 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.129 1.347 . . . . 0.0 112.318 173.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -76.33 162.59 27.77 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-O 121.392 0.615 . . . . 0.0 112.254 169.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -79.58 83.56 5.55 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.316 -0.865 . . . . 0.0 111.572 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -71.0 -24.0 62.3 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.473 1.509 . . . . 0.0 113.458 -173.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 77.91 35.13 36.13 Favored Glycine 0 N--CA 1.475 1.243 0 C-N-CA 124.035 0.826 . . . . 0.0 112.483 -174.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 61.0 mtt -145.04 159.57 42.74 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.027 2.131 . . . . 0.0 110.772 -173.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -145.61 -179.08 21.61 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 124.383 0.992 . . . . 0.0 114.905 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 12.7 m -141.55 148.56 39.53 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.361 1.465 . . . . 0.0 109.087 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 19.6 t -141.25 147.15 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.263 1.025 . . . . 0.0 110.472 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.04 131.1 47.31 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.589 1.556 . . . . 0.0 110.976 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -102.53 161.69 13.52 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.51 1.524 . . . . 0.0 111.196 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 54.1 p -70.52 0.21 7.21 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.559 1.543 . . . . 0.0 113.893 166.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -141.75 162.21 36.03 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.432 1.893 . . . . 0.0 112.108 -165.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 12.5 m -132.67 13.42 4.45 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -132.06 -36.5 1.17 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.068 1.347 . . . . 0.0 112.661 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -66.51 -21.53 66.17 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.748 0.819 . . . . 0.0 112.397 167.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.1 m -63.87 -28.17 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.507 1.523 . . . . 0.0 112.907 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -74.3 -49.64 22.21 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.55 1.14 . . . . 0.0 111.449 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 23.4 ptt-85 -74.37 -11.86 60.36 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.7 -64.5 0.88 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.939 0.895 . . . . 0.0 110.835 160.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 66.3 mt -62.19 -32.83 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.938 0.895 . . . . 0.0 112.449 -171.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 35.0 ttm105 -57.21 -22.69 42.67 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 173.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -98.06 -11.14 23.25 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.41 1.084 . . . . 0.0 112.943 175.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -123.56 -21.29 5.3 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -165.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -66.2 120.44 13.23 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 120.415 1.461 . . . . 0.0 109.559 172.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 90.06 0.59 77.35 Favored Glycine 0 N--CA 1.473 1.127 0 CA-C-O 117.884 -1.509 . . . . 0.0 115.146 -168.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.8 109.46 1.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.986 1.893 . . . . 0.0 109.482 167.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -55.97 119.89 6.57 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 157.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -148.87 118.35 6.94 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.215 1.406 . . . . 0.0 108.259 -172.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.38 44.07 18.87 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-O 122.398 1.094 . . . . 0.0 110.212 -163.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 71.55 0.52 3.51 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 128.066 2.546 . . . . 0.0 116.253 173.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 30.1 mmt85 -135.04 148.69 49.97 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.07 1.348 . . . . 0.0 112.105 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -64.54 117.07 6.83 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.194 -0.941 . . . . 0.0 113.234 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.62 HG22 ' HB2' ' A' ' 168' ' ' LEU . 0.7 OUTLIER -68.26 153.56 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.635 0.774 . . . . 0.0 110.684 156.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -137.53 157.37 46.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.533 1.533 . . . . 0.0 107.857 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.12 139.24 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.528 1.058 . . . . 0.0 111.681 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -115.62 136.57 52.94 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.828 1.651 . . . . 0.0 108.84 169.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -72.51 139.9 47.87 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.512 -0.742 . . . . 0.0 109.278 172.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -126.42 -141.15 0.28 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.158 0.983 . . . . 0.0 111.333 -169.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 125.471 1.508 . . . . 0.0 111.654 -178.697 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 112.101 -0.4 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.0 t -161.86 159.1 26.44 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.18 1.392 . . . . 0.0 111.356 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -161.49 157.23 24.65 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.163 1.785 . . . . 0.0 111.579 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -74.09 132.02 41.89 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.042 0.937 . . . . 0.0 111.538 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -165.66 154.81 12.0 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.395 1.878 . . . . 0.0 110.894 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.7 pp -161.52 175.03 12.56 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.849 1.66 . . . . 0.0 112.247 -176.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -158.81 157.76 32.2 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.986 1.714 . . . . 0.0 111.731 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.3 t -164.58 176.23 9.11 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.286 1.435 . . . . 0.0 111.515 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.6 t -160.57 160.19 31.51 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.354 1.861 . . . . 0.0 110.849 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -65.51 127.64 32.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.842 0.857 . . . . 0.0 112.798 -177.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -159.08 129.6 5.92 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.451 1.9 . . . . 0.0 108.232 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -162.72 135.09 5.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.571 0.748 . . . . 0.0 111.505 -163.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -85.76 176.44 8.13 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.43 1.092 . . . . 0.0 113.431 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 31.2 m -128.55 170.64 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 125.497 1.519 . . . . 0.0 111.056 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -152.55 133.93 14.42 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.868 1.267 . . . . 0.0 110.564 -173.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -121.82 117.94 27.76 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.137 1.375 . . . . 0.0 109.966 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -163.98 139.46 6.19 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.225 1.81 . . . . 0.0 109.337 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -106.54 8.86 31.55 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.315 1.446 . . . . 0.0 114.311 -176.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.5 m -78.86 178.77 7.69 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.485 1.114 . . . . 0.0 113.387 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -64.46 34.62 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 128.271 2.628 . . . . 0.0 114.447 171.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.7 m -148.72 144.99 27.45 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.968 1.707 . . . . 0.0 111.917 -165.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.9 pt -130.92 150.2 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.976 1.71 . . . . 0.0 110.976 -170.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -110.0 138.88 45.76 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.503 1.521 . . . . 0.0 111.197 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 44.8 t -126.79 131.04 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.923 1.689 . . . . 0.0 108.786 -169.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.32 -164.2 7.2 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.976 1.751 . . . . 0.0 113.283 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -67.52 -14.96 63.39 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 118.062 2.615 . . . . 0.0 118.062 -157.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.3 mp 51.03 -112.71 0.65 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.537 1.535 . . . . 0.0 109.857 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 71.2 p -122.87 153.39 39.69 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.056 2.143 . . . . 0.0 109.312 154.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -57.12 -28.84 63.05 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -175.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -91.73 -0.98 57.59 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.821 2.048 . . . . 0.0 114.114 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 85.8 p -67.47 160.91 26.56 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.45 152.67 60.97 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 125.799 1.64 . . . . 0.0 111.593 -169.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.79 -18.53 11.7 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.151 2.567 . . . . 0.0 114.647 -165.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.43 -35.48 81.07 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.519 1.054 . . . . 0.0 111.112 172.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -69.64 -36.86 76.48 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.773 1.229 . . . . 0.0 111.399 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.8 mt -67.98 -31.89 71.91 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-O 118.685 -0.674 . . . . 0.0 112.326 169.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 59.7 m -67.16 -50.89 59.51 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.969 0.804 . . . . 0.0 109.516 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -58.13 -38.8 77.23 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.669 0.788 . . . . 0.0 112.293 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -65.56 -63.25 1.14 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.343 1.457 . . . . 0.0 112.236 176.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.16 -33.95 70.5 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -173.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.25 -3.39 26.55 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -172.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -65.47 -18.17 65.12 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 120.967 -1.083 . . . . 0.0 112.739 169.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 29.8 mm -78.53 -27.4 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.616 1.567 . . . . 0.0 112.31 174.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 139.25 169.45 11.58 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.994 1.759 . . . . 0.0 110.755 -158.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -57.72 106.54 0.36 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -164.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 53.9 t -71.05 131.36 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 151.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.29 -26.5 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 171.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 50.7 ttt-85 -162.74 110.47 1.28 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.856 0.463 . . . . 0.0 110.825 -170.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.72 151.74 19.84 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.192 0.997 . . . . 0.0 110.259 161.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -153.23 125.28 7.93 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.911 0.884 . . . . 0.0 111.615 -170.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mt -138.29 -53.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 125.565 1.546 . . . . 0.0 111.354 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 40.0 pt -65.9 124.72 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-O 121.409 0.623 . . . . 0.0 112.534 -168.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 14.6 t -151.7 153.33 34.16 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.494 1.918 . . . . 0.0 110.116 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 5.0 t 70.12 -173.61 0.18 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.077 1.751 . . . . 0.0 112.396 -168.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -81.34 -32.77 32.86 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.315 1.046 . . . . 0.0 112.884 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -104.59 127.56 9.13 Favored Glycine 0 N--CA 1.471 1.025 0 C-N-CA 125.488 1.518 . . . . 0.0 111.363 175.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -105.09 85.4 2.27 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.27 1.028 . . . . 0.0 111.995 -172.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -145.7 22.91 1.43 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.021 1.328 . . . . 0.0 112.869 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -97.56 -13.82 21.4 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -165.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 74.6 -76.74 1.13 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.881 1.229 . . . . 0.0 113.661 174.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.33 153.73 14.92 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.138 1.375 . . . . 0.0 114.545 -169.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -175.92 -152.46 9.56 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.8 p -143.01 159.83 41.5 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.124 1.77 . . . . 0.0 112.172 -172.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 18.8 t -140.42 140.89 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.294 1.038 . . . . 0.0 110.306 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -128.86 127.68 42.35 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.383 1.473 . . . . 0.0 109.981 -172.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -110.8 170.71 7.92 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.53 1.932 . . . . 0.0 109.746 -174.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 80.9 p -81.47 0.07 39.45 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -139.07 155.08 48.19 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.831 1.253 . . . . 0.0 114.088 -167.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 66.4 p -108.38 4.73 24.73 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.775 1.63 . . . . 0.0 113.68 -177.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -120.37 -46.04 2.41 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.634 1.174 . . . . 0.0 112.783 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -63.53 -22.04 66.67 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.313 -0.867 . . . . 0.0 113.039 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 213' ' ' VAL . 2.3 m -61.34 -29.74 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.896 2.079 . . . . 0.0 113.363 173.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -74.48 -49.46 22.13 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.026 0.83 . . . . 0.0 110.541 166.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -58.4 -28.28 65.05 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.797 1.239 . . . . 0.0 113.399 -174.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.2 -59.57 5.21 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.23 1.412 . . . . 0.0 112.291 168.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 51.6 mt -66.39 -31.25 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.22 1.008 . . . . 0.0 112.282 -170.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -58.91 -5.77 0.67 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 171.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -133.07 5.68 3.86 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.52 1.128 . . . . 0.0 114.038 172.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -123.11 -22.14 5.25 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.01 120.64 13.98 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 121.327 1.876 . . . . 0.0 110.653 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 92.16 0.83 70.38 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-O 118.025 -1.43 . . . . 0.0 115.119 -169.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.42 107.47 0.79 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.953 1.877 . . . . 0.0 109.926 168.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -52.02 123.95 11.68 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.957 161.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -147.97 120.83 8.72 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.022 1.329 . . . . 0.0 108.709 -172.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 50.5 mtt 60.37 28.07 17.68 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.154 0.982 . . . . 0.0 112.159 -169.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.6 t70 92.27 -0.06 0.13 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 129.449 3.1 . . . . 0.0 115.419 173.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 42.9 mmt180 -136.69 150.48 48.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.751 1.221 . . . . 0.0 112.184 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -65.12 111.71 3.05 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.862 -1.149 . . . . 0.0 112.555 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.47 152.0 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 O-C-N 121.169 -0.957 . . . . 0.0 109.761 151.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -132.12 156.66 45.96 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.145 1.378 . . . . 0.0 108.429 170.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.7 p -150.44 127.0 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.517 0.675 . . . . 0.0 112.113 -169.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -85.0 131.7 34.44 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.481 1.512 . . . . 0.0 108.403 175.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.402 ' NE2' ' H ' ' A' ' 235' ' ' ASP . 0.1 OUTLIER -86.51 154.78 20.84 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.315 1.046 . . . . 0.0 109.774 178.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.402 ' H ' ' NE2' ' A' ' 234' ' ' GLN . 3.3 p30 -68.78 150.57 47.7 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.919 -1.113 . . . . 0.0 113.38 178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 . . . . . 0 C--O 1.255 1.364 0 C-N-CA 128.125 2.57 . . . . 0.0 113.04 -178.565 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.718 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 25.3 m -130.94 14.25 5.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.067 0.947 . . . . 0.0 113.452 -169.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.18 137.67 48.93 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.378 1.071 . . . . 0.0 112.626 -177.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.1 mtt-85 -77.73 153.45 32.96 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.525 1.13 . . . . 0.0 112.033 177.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.06 -11.15 1.27 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.812 1.645 . . . . 0.0 113.788 177.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -84.9 -3.78 58.84 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.725 1.61 . . . . 0.0 114.312 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -80.75 40.7 0.53 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.609 2.364 . . . . 0.0 113.626 -171.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 49.0 m -162.51 140.37 8.44 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.634 1.974 . . . . 0.0 111.456 177.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.7 t -165.66 165.95 18.35 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.61 1.964 . . . . 0.0 110.639 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -161.12 162.43 31.49 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.727 1.611 . . . . 0.0 113.015 -174.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -160.64 127.44 4.19 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.524 1.53 . . . . 0.0 110.078 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -164.53 146.12 8.31 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.846 1.658 . . . . 0.0 110.45 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -150.57 -55.85 0.16 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.344 1.058 . . . . 0.0 112.59 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.9 m -145.66 141.5 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 125.958 1.703 . . . . 0.0 110.429 174.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -122.0 -3.45 9.1 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -173.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 73.2 ttp85 -165.82 140.53 4.71 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.428 1.491 . . . . 0.0 111.583 -172.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -159.97 -42.91 0.05 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.394 1.078 . . . . 0.0 112.737 166.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 67.48 160.06 0.16 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 127.527 2.331 . . . . 0.0 114.516 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 80.8 p -167.97 172.44 8.91 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.903 1.281 . . . . 0.0 112.867 -174.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -168.12 -46.09 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.834 2.054 . . . . 0.0 110.186 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 1.9 m -73.1 155.48 39.67 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 143.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 6.7 pt -139.22 150.94 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.69 1.596 . . . . 0.0 109.784 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -122.95 143.77 49.69 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.216 1.406 . . . . 0.0 111.986 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.0 t -124.34 116.82 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.226 1.81 . . . . 0.0 108.193 -174.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.06 -25.43 59.77 Favored Glycine 0 N--CA 1.475 1.24 0 C-N-CA 123.542 0.591 . . . . 0.0 114.403 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -162.17 151.22 15.48 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.742 2.017 . . . . 0.0 108.571 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -173.16 11.19 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 126.054 1.742 . . . . 0.0 114.917 -171.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 34.9 m 86.42 111.45 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 128.739 2.816 . . . . 0.0 109.403 -165.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -62.64 -17.43 60.36 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -83.42 -0.35 49.59 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.703 1.601 . . . . 0.0 113.529 173.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 10.0 t -67.66 167.56 12.9 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.834 -1.166 . . . . 0.0 113.797 175.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 44.8 p -135.7 153.32 77.32 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 125.972 1.709 . . . . 0.0 110.416 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.56 -23.96 26.54 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.566 2.177 . . . . 0.0 113.13 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.28 -37.19 77.75 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.885 0.766 . . . . 0.0 111.712 172.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.47 -35.37 68.21 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.507 -0.746 . . . . 0.0 111.424 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 20.9 mt -62.91 -35.85 81.44 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-O 118.807 -0.616 . . . . 0.0 112.334 166.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 74.7 m -67.93 -45.83 73.22 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.222 0.919 . . . . 0.0 110.337 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.7 -15.79 54.32 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.811 1.245 . . . . 0.0 113.502 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -96.5 -57.94 2.18 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.285 1.834 . . . . 0.0 111.896 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -71.6 -34.2 69.65 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 3.7 t -73.16 -15.92 61.45 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -159.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -64.35 -17.9 64.15 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 35.8 mm -59.8 -24.18 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.114 1.365 . . . . 0.0 112.641 173.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 167.52 -72.05 0.16 Allowed Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.926 1.25 . . . . 0.0 111.467 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -160.28 118.39 2.6 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.965 1.306 . . . . 0.0 111.158 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.29 137.93 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 165.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.5 m -110.27 -16.67 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -159.91 158.46 30.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.739 1.215 . . . . 0.0 111.881 176.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -160.06 149.13 17.5 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.939 1.696 . . . . 0.0 111.696 174.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -149.58 152.54 35.66 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.619 1.967 . . . . 0.0 111.641 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 26.6 mm -133.29 128.0 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 126.145 1.778 . . . . 0.0 107.844 170.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 17.4 tt -80.59 140.29 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 O-C-N 121.494 -0.753 . . . . 0.0 111.775 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 49.4 p -146.14 174.9 10.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.342 1.857 . . . . 0.0 111.049 -174.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 45.7 p -149.55 -173.27 4.36 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.836 1.254 . . . . 0.0 112.086 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.91 -10.55 58.93 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.253 1.021 . . . . 0.0 113.172 175.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -134.33 -151.38 6.39 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.025 1.774 . . . . 0.0 112.464 176.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -73.3 149.68 42.5 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.153 0.581 . . . . 0.0 112.273 170.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -154.74 163.7 39.87 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.18 1.392 . . . . 0.0 112.145 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -63.38 -24.93 68.06 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.975 1.31 . . . . 0.0 113.721 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 74.55 37.26 46.86 Favored Glycine 0 N--CA 1.471 1.008 0 CA-C-O 119.175 -0.792 . . . . 0.0 114.79 164.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -59.34 148.18 33.29 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.507 1.154 . . . . 0.0 112.415 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -110.43 158.97 14.11 Favored Glycine 0 N--CA 1.468 0.806 0 C-N-CA 124.656 1.122 . . . . 0.0 113.458 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.2 m -141.97 142.4 32.97 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.887 1.675 . . . . 0.0 108.032 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.7 t -142.4 149.97 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.972 0.909 . . . . 0.0 109.433 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -132.65 129.72 39.23 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.891 0.876 . . . . 0.0 111.523 -176.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -114.9 172.7 6.89 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.243 1.817 . . . . 0.0 111.102 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.8 p -86.85 -11.57 50.44 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -149.35 127.96 12.38 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 116.749 2.129 . . . . 0.0 116.749 -169.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 33.0 p -73.8 2.29 8.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 128.116 2.566 . . . . 0.0 116.064 -174.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -114.07 -36.76 4.64 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.269 1.428 . . . . 0.0 111.693 169.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.68 -27.68 69.09 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.5 -0.75 . . . . 0.0 112.775 173.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.9 m -59.55 -33.43 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 171.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -74.17 -46.61 41.15 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.958 0.799 . . . . 0.0 110.214 172.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -57.88 -29.7 65.25 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.673 0.789 . . . . 0.0 112.829 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.95 -68.57 0.35 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.778 1.231 . . . . 0.0 111.492 167.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 64.7 mt -61.99 -34.83 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.43 -0.793 . . . . 0.0 112.193 -167.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -58.69 -12.78 4.59 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.754 1.222 . . . . 0.0 114.187 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -116.62 -1.99 12.04 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.719 1.608 . . . . 0.0 112.888 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -128.91 -23.21 3.11 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.67 120.57 11.45 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 120.498 1.499 . . . . 0.0 109.832 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 95.68 0.48 62.46 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-O 118.11 -1.383 . . . . 0.0 115.725 -170.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.96 108.46 1.04 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.721 1.76 . . . . 0.0 109.973 169.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -58.12 124.17 18.46 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.788 -0.57 . . . . 0.0 109.921 158.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -150.38 110.97 4.24 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.852 1.261 . . . . 0.0 108.912 -159.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 49.8 mtt 57.91 23.36 9.72 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.585 1.154 . . . . 0.0 113.487 -169.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 19.8 t70 101.16 -11.61 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 130.811 3.644 . . . . 0.0 115.24 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -116.29 147.0 41.97 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 119.978 1.263 . . . . 0.0 111.801 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -68.09 112.06 4.83 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.308 1.443 . . . . 0.0 112.229 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.5 pt -61.21 141.69 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.473 1.033 . . . . 0.0 111.609 166.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -138.37 129.76 27.51 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.644 1.178 . . . . 0.0 109.158 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.2 126.81 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 123.626 0.771 . . . . 0.0 110.713 -164.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 52.7 ttt85 -97.04 140.57 31.37 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.539 1.936 . . . . 0.0 108.768 170.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 13.0 mp0 -70.68 101.27 2.03 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 169.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -163.78 147.17 9.98 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.862 1.265 . . . . 0.0 111.54 -166.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.795 1.638 . . . . 0.0 111.787 -167.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.3 t -163.57 173.37 13.11 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.64 1.576 . . . . 0.0 111.162 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . 63.97 15.84 9.47 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.882 2.073 . . . . 0.0 115.209 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -63.9 132.01 49.47 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.735 1.214 . . . . 0.0 111.618 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -73.77 162.87 28.67 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.47 1.108 . . . . 0.0 113.266 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.8 pp -155.66 178.4 10.29 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.037 1.735 . . . . 0.0 111.863 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -142.84 152.65 42.4 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.394 1.477 . . . . 0.0 112.248 -173.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.4 m -147.07 167.45 24.06 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.412 1.885 . . . . 0.0 111.136 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.2 t -148.94 150.68 33.31 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.278 1.431 . . . . 0.0 111.193 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -150.2 163.99 36.83 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.595 1.558 . . . . 0.0 112.614 -167.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -92.24 157.79 16.49 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.443 1.097 . . . . 0.0 111.201 170.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -146.42 40.87 1.13 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.02 1.328 . . . . 0.0 110.667 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -132.92 153.09 51.72 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.502 1.921 . . . . 0.0 111.33 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.2 p -160.96 143.04 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.879 1.272 . . . . 0.0 111.547 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -159.69 145.77 15.99 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.541 1.536 . . . . 0.0 111.497 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -153.44 143.13 21.89 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.963 1.305 . . . . 0.0 112.033 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -166.55 136.91 3.26 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.383 1.473 . . . . 0.0 111.315 -171.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -53.4 123.16 11.23 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.62 0.768 . . . . 0.0 111.67 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 69.0 m -133.32 126.3 31.1 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.783 0.833 . . . . 0.0 110.855 -165.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -76.12 -11.6 59.96 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.852 1.426 . . . . 0.0 114.852 -169.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.6 t -170.96 161.35 6.95 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.02 1.328 . . . . 0.0 111.486 -169.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -131.15 142.83 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.233 0.613 . . . . 0.0 110.024 158.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -111.93 142.48 44.28 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.71 1.604 . . . . 0.0 111.166 -174.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.3 t -144.61 121.32 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.161 0.984 . . . . 0.0 109.989 174.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -137.75 19.56 3.32 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.88 1.229 . . . . 0.0 115.602 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -128.57 20.02 6.16 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.305 1.442 . . . . 0.0 112.707 -171.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.455 ' HB3' HG22 ' A' ' 230' ' ' ILE . 1.3 pp -96.54 -175.88 3.45 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 126.984 2.114 . . . . 0.0 111.245 -174.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 48.4 m -79.81 121.5 25.47 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.782 0.833 . . . . 0.0 109.407 168.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -66.54 -11.56 53.47 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -170.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -81.38 -10.97 59.42 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.956 1.303 . . . . 0.0 113.588 171.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 91.5 p -77.66 142.6 38.75 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.6 -0.688 . . . . 0.0 111.664 172.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 68.2 p -102.52 163.63 17.25 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 125.067 1.347 . . . . 0.0 111.205 -171.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -64.54 -26.8 61.91 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.499 2.133 . . . . 0.0 112.931 171.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -69.34 -40.03 77.81 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.472 1.033 . . . . 0.0 111.729 171.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -66.93 -36.58 82.56 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.817 0.847 . . . . 0.0 111.64 175.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 45.7 mt -66.21 -32.66 74.22 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.547 -0.74 . . . . 0.0 112.725 166.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 81.8 m -67.1 -48.22 68.83 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.686 1.13 . . . . 0.0 109.965 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.05 -27.84 69.18 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -78.69 -58.96 2.98 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.53 1.532 . . . . 0.0 112.106 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -71.1 -37.83 72.39 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.65 -1.67 19.89 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -176.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -55.87 -26.87 49.09 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.797 1.639 . . . . 0.0 112.165 164.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.4 mm -75.87 -30.7 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.815 1.646 . . . . 0.0 112.88 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 166.86 -103.84 0.21 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.783 1.182 . . . . 0.0 112.181 -165.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -135.01 106.35 6.77 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.991 0.916 . . . . 0.0 113.396 -175.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 56.2 t -80.96 135.68 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 153.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.33 -24.72 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -157.88 88.66 0.98 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.547 0.739 . . . . 0.0 112.235 -170.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -91.18 140.97 29.3 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.812 -1.18 . . . . 0.0 111.709 168.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -153.28 121.44 6.17 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.919 1.287 . . . . 0.0 112.201 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 20.3 mt -141.78 -56.75 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 125.459 1.504 . . . . 0.0 111.08 174.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.4 mm -88.04 111.1 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 40.0 p -140.01 151.5 45.51 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.775 1.23 . . . . 0.0 111.052 -166.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 18.9 t -75.91 -28.54 58.09 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -172.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.34 -0.12 44.42 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.949 1.3 . . . . 0.0 113.286 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -78.33 162.1 49.24 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.69 1.138 . . . . 0.0 114.522 -174.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -130.28 0.95 4.62 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 126.827 2.051 . . . . 0.0 112.577 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -138.66 27.42 2.48 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.508 1.923 . . . . 0.0 113.119 -155.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -51.06 142.27 12.55 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.619 1.167 . . . . 0.0 113.076 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 100.06 -4.71 57.48 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.197 1.38 . . . . 0.0 114.161 -169.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 26.8 ptm -149.42 153.0 36.66 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.21 1.404 . . . . 0.0 111.74 173.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 169.6 -143.45 7.94 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.932 0.777 . . . . 0.0 113.002 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 25.0 p -137.87 160.87 38.12 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.986 0.914 . . . . 0.0 113.272 -162.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.3 t -136.03 102.42 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.126 1.371 . . . . 0.0 108.056 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -88.53 122.85 32.45 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.205 1.002 . . . . 0.0 110.457 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -90.02 176.03 6.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.86 1.664 . . . . 0.0 109.814 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 72.4 p -68.09 0.16 3.91 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 168.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 27.3 m120 85.77 2.91 0.6 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.743 2.817 . . . . 0.0 114.977 165.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.7 t -110.8 -168.53 1.32 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.462 1.505 . . . . 0.0 112.136 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -34.08 -38.37 0.06 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 130.531 3.533 . . . . 0.0 117.28 -164.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -52.15 -33.69 41.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.101 1.76 . . . . 0.0 112.733 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.0 p -68.83 -37.41 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.107 1.363 . . . . 0.0 112.952 -169.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -75.16 -52.07 11.86 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.734 1.214 . . . . 0.0 112.382 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -74.0 -18.47 60.85 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.654 1.182 . . . . 0.0 114.057 -171.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.47 -60.03 4.11 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.065 0.946 . . . . 0.0 111.911 170.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 27.9 mt -65.46 -28.73 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.706 0.803 . . . . 0.0 112.41 -171.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -28.63 37.53 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.324 1.05 . . . . 0.0 112.511 169.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -98.24 -11.31 22.8 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.443 1.097 . . . . 0.0 113.432 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -126.32 -20.12 4.51 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -164.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -62.42 120.79 11.73 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 120.038 1.29 . . . . 0.0 109.627 169.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 95.1 0.52 63.5 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-O 118.163 -1.354 . . . . 0.0 115.334 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.15 107.06 0.81 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.757 1.778 . . . . 0.0 110.673 170.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -57.22 107.32 0.41 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 154.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -129.74 110.66 11.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.323 1.049 . . . . 0.0 108.921 -167.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 48.2 ttm 53.88 43.92 30.22 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.923 0.889 . . . . 0.0 110.816 -168.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.8 t70 86.76 0.21 0.56 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 128.091 2.557 . . . . 0.0 116.146 170.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -136.19 135.89 39.5 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.622 1.101 . . . . 0.0 112.542 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -68.17 102.55 1.37 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.546 1.538 . . . . 0.0 113.541 -176.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.455 HG22 ' HB3' ' A' ' 168' ' ' LEU . 0.9 OUTLIER -56.51 151.25 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.117 0.967 . . . . 0.0 111.456 164.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -148.01 135.41 20.61 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.083 1.353 . . . . 0.0 108.921 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -156.94 137.08 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.217 1.407 . . . . 0.0 109.867 -165.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -119.55 140.6 50.27 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.855 1.262 . . . . 0.0 109.579 171.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -65.8 165.07 13.48 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.07 0.948 . . . . 0.0 111.819 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -72.25 5.26 2.95 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.315 1.446 . . . . 0.0 114.192 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 . . . . . 0 C--O 1.254 1.319 0 C-N-CA 126.622 1.969 . . . . 0.0 112.317 -179.247 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.693 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.6 m 69.92 172.78 0.3 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.682 1.993 . . . . 0.0 113.76 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -154.06 153.71 32.39 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.964 1.305 . . . . 0.0 112.46 -175.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.95 136.02 4.06 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.671 1.988 . . . . 0.0 111.242 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -90.28 -28.02 19.07 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -172.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 76.9 mt 66.42 -34.18 0.21 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 128.859 2.864 . . . . 0.0 115.452 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -69.49 129.14 38.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.375 1.47 . . . . 0.0 112.727 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 13.8 t -170.15 154.96 5.21 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.245 1.818 . . . . 0.0 110.811 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.4 t -164.85 158.12 17.01 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.997 1.719 . . . . 0.0 111.7 -174.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -159.47 143.24 14.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.404 1.882 . . . . 0.0 111.885 175.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -146.63 144.7 29.69 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.194 1.797 . . . . 0.0 110.173 178.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -159.73 139.25 11.3 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.965 1.306 . . . . 0.0 109.851 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -76.54 42.92 0.3 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.996 1.318 . . . . 0.0 113.135 -172.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.2 136.78 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.566 1.147 . . . . 0.0 110.575 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -163.89 -50.92 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.631 1.573 . . . . 0.0 111.096 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 68.54 156.82 0.13 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 127.499 2.32 . . . . 0.0 114.162 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -77.1 -27.94 54.29 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.264 -0.898 . . . . 0.0 112.987 174.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -169.04 149.27 4.25 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.843 2.057 . . . . 0.0 111.219 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.1 m -167.92 123.45 1.02 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.123 0.969 . . . . 0.0 112.366 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -147.31 -40.8 0.18 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.629 1.971 . . . . 0.0 111.817 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.5 p -166.97 168.06 14.2 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.73 -1.231 . . . . 0.0 114.08 -166.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 43.5 pt -137.26 138.04 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.647 1.179 . . . . 0.0 110.06 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -98.99 148.7 23.73 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.907 1.283 . . . . 0.0 109.489 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.6 t -126.4 131.67 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.537 1.535 . . . . 0.0 108.759 -172.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -74.17 -154.57 3.59 Favored Glycine 0 N--CA 1.474 1.192 0 C-N-CA 125.543 1.544 . . . . 0.0 112.93 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.432 HD21 ' CD2' ' A' ' 199' ' ' HIS . 19.0 m120 -55.48 -42.73 74.77 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -166.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 57.34 -169.44 0.11 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 128.061 2.545 . . . . 0.0 115.81 165.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.2 t -76.39 73.14 3.16 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.258 1.823 . . . . 0.0 110.416 166.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -68.05 -9.29 44.86 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -74.37 -12.42 60.52 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.113 1.365 . . . . 0.0 113.132 167.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 3.8 t -101.3 151.06 22.34 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.274 1.03 . . . . 0.0 113.523 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 17.6 p -81.94 152.67 69.06 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 126.444 1.898 . . . . 0.0 111.457 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.36 -25.79 80.66 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.213 2.609 . . . . 0.0 115.482 -173.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -67.21 -17.03 64.65 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.865 1.211 . . . . 0.0 113.439 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -70.74 -33.99 71.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.29 1.036 . . . . 0.0 111.25 170.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.1 mt -74.33 -32.48 62.83 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.336 -0.84 . . . . 0.0 111.782 167.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 31.1 m -62.75 -51.34 67.52 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.731 1.151 . . . . 0.0 110.264 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.53 -34.12 75.0 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.336 0.516 . . . . 0.0 112.119 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -67.0 -65.04 0.73 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.608 1.563 . . . . 0.0 111.329 176.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -71.24 -29.0 64.58 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -173.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.4 t -73.25 -23.63 60.36 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -173.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -67.34 -10.89 55.46 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 29.5 mm -69.89 -31.31 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.439 1.496 . . . . 0.0 112.59 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.66 42.01 0.03 OUTLIER Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.242 0.925 . . . . 0.0 114.221 -172.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 83.4 tttt 79.34 124.45 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 128.708 2.803 . . . . 0.0 113.606 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.7 149.32 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 126.159 1.784 . . . . 0.0 108.097 164.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 4.3 m -110.27 -18.27 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -157.32 147.29 20.65 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.846 0.858 . . . . 0.0 111.245 -175.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -154.48 144.39 21.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.729 1.611 . . . . 0.0 110.559 170.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -155.11 153.07 30.29 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 122.096 0.95 . . . . 0.0 113.262 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 51.0 mm -110.32 -23.65 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 127.3 2.24 . . . . 0.0 110.543 171.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 46.3 mm -68.76 120.66 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 O-C-N 120.792 -1.193 . . . . 0.0 108.206 170.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 2.5 p -151.2 160.79 43.64 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.356 1.462 . . . . 0.0 111.35 -159.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.4 m -63.78 158.59 21.39 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.474 1.109 . . . . 0.0 113.019 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -57.48 -43.36 84.02 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -175.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 56.28 -140.88 41.88 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.081 1.324 . . . . 0.0 114.016 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -139.96 132.41 28.54 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.014 1.726 . . . . 0.0 110.665 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.432 ' CD2' HD21 ' A' ' 167' ' ' ASN . 1.4 t60 70.44 138.09 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 127.588 2.355 . . . . 0.0 113.082 -173.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -74.71 135.19 41.84 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.163 0.985 . . . . 0.0 112.4 -171.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 88.16 131.23 3.64 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.698 1.618 . . . . 0.0 112.773 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 22.8 ptp -174.3 168.66 3.94 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 127.219 2.207 . . . . 0.0 111.527 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -156.47 175.22 34.16 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.195 1.379 . . . . 0.0 113.197 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 27.5 m -148.17 147.05 29.02 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.148 1.379 . . . . 0.0 109.889 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.1 t -139.0 141.55 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.448 1.099 . . . . 0.0 109.541 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -123.93 131.64 53.6 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.603 1.161 . . . . 0.0 111.509 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -102.2 173.81 6.2 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.306 1.842 . . . . 0.0 110.426 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 81.3 p -68.88 0.65 4.15 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 176.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 93.04 52.48 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 128.169 2.587 . . . . 0.0 113.606 161.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.7 t -161.4 -165.35 1.29 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.947 0.899 . . . . 0.0 112.872 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -57.86 -10.37 1.69 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.097 2.159 . . . . 0.0 115.234 -168.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -52.07 -34.11 42.25 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.177 1.391 . . . . 0.0 111.729 162.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.54 -39.48 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.742 1.617 . . . . 0.0 111.427 176.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.65 -55.03 6.32 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.323 1.049 . . . . 0.0 111.919 171.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -59.11 -29.71 67.58 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.183 1.393 . . . . 0.0 113.706 -172.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.26 -60.59 3.57 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.931 0.892 . . . . 0.0 112.681 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 3.5 mp -68.79 -22.36 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.088 -1.008 . . . . 0.0 112.803 -168.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 16.5 mmt-85 -54.23 -27.91 37.73 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.401 0.68 . . . . 0.0 112.773 168.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -95.5 -17.71 21.24 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.795 1.238 . . . . 0.0 112.817 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -122.46 -18.87 6.57 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -161.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -58.24 120.21 8.27 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 120.585 1.539 . . . . 0.0 110.276 175.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 79.94 0.3 84.93 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.277 -1.291 . . . . 0.0 116.094 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.58 97.67 2.18 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 120.082 1.941 . . . . 0.0 111.377 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -48.92 135.63 15.32 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.028 0.931 . . . . 0.0 112.532 176.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -143.87 116.9 8.88 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.356 1.062 . . . . 0.0 109.852 -162.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 16.8 ttt 59.89 34.36 21.69 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.391 1.077 . . . . 0.0 111.156 -168.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 67.67 0.68 2.33 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.888 2.075 . . . . 0.0 114.095 -174.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -112.26 165.37 12.23 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.297 2.239 . . . . 0.0 111.423 -171.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -66.35 168.91 8.07 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.342 1.057 . . . . 0.0 113.144 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 41.8 pt -158.3 146.76 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 1 C-N-CA 132.204 4.201 . . . . 0.0 107.058 171.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -149.49 141.94 24.3 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.712 1.605 . . . . 0.0 107.219 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.8 p -150.44 137.38 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 120.068 1.303 . . . . 0.0 113.632 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -99.06 139.08 35.23 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.572 1.949 . . . . 0.0 110.931 176.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -106.26 1.79 26.26 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.43 1.492 . . . . 0.0 113.671 -167.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -118.09 69.24 0.78 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.654 1.182 . . . . 0.0 114.188 -156.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 24.5 t30 . . . . . 0 C--O 1.252 1.192 0 C-N-CA 126.493 1.917 . . . . 0.0 112.453 167.58 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.8 m 70.14 15.97 7.51 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.952 1.701 . . . . 0.0 114.698 171.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.92 137.21 51.37 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.332 1.053 . . . . 0.0 111.933 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -80.94 101.33 9.41 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.137 0.975 . . . . 0.0 110.845 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -164.67 127.86 2.39 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.98 1.312 . . . . 0.0 110.492 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 87.0 mt -145.29 117.3 8.29 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.623 1.569 . . . . 0.0 109.271 174.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -166.23 158.64 14.33 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.781 1.632 . . . . 0.0 111.449 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.6 t -161.86 162.18 29.21 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.041 1.337 . . . . 0.0 110.82 175.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.8 t -163.95 157.1 18.17 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.434 1.894 . . . . 0.0 111.133 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -162.46 122.81 2.44 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.575 1.55 . . . . 0.0 111.816 -171.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -86.25 103.66 15.06 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.739 1.216 . . . . 0.0 108.609 172.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.56 142.99 38.69 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -164.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -68.69 131.09 44.6 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.536 1.534 . . . . 0.0 112.234 -174.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 33.4 m -84.97 -10.96 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -89.72 7.37 37.13 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.884 1.274 . . . . 0.0 113.968 -173.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -60.62 140.05 57.57 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.046 0.938 . . . . 0.0 111.027 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -162.55 -41.48 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.457 1.103 . . . . 0.0 113.552 -170.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -81.14 -33.38 33.21 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.776 -0.578 . . . . 0.0 111.808 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.4 m 60.9 25.18 15.16 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 156.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -87.1 -5.3 59.07 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -173.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.8 m -125.09 164.37 20.37 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.739 1.616 . . . . 0.0 111.719 -171.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 8.0 pt -142.36 138.24 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.243 -0.911 . . . . 0.0 110.9 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -128.39 134.41 48.82 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.166 1.786 . . . . 0.0 109.951 -175.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.65 134.24 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.875 1.27 . . . . 0.0 109.979 -156.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.85 -116.23 0.12 Allowed Glycine 0 N--CA 1.478 1.455 0 C-N-CA 127.055 2.264 . . . . 0.0 115.002 -170.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -68.25 -62.59 1.33 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.71 1.255 . . . . 0.0 111.999 -176.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 62.92 5.03 1.66 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.533 2.333 . . . . 0.0 117.166 167.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 58.7 m 74.51 98.25 0.07 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 127.416 2.286 . . . . 0.0 108.643 -162.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -65.03 -16.18 63.16 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -170.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.15 0.38 51.18 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.883 1.673 . . . . 0.0 114.0 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 95.6 p -70.67 167.14 19.29 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 172.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 18.7 p -123.9 151.5 64.86 Favored Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 124.936 1.294 . . . . 0.0 112.392 -170.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.35 -17.44 16.68 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.347 2.698 . . . . 0.0 115.385 -169.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.8 -36.9 81.25 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.966 1.257 . . . . 0.0 111.953 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -72.98 -35.78 66.95 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.284 -0.885 . . . . 0.0 111.536 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.3 mt -64.07 -33.39 75.65 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.119 0.968 . . . . 0.0 111.903 168.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.4 m -65.57 -49.72 67.77 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.009 0.822 . . . . 0.0 109.666 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.35 -41.08 98.3 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.484 0.584 . . . . 0.0 112.008 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -61.68 -56.33 20.83 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.145 1.378 . . . . 0.0 112.29 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.23 -43.44 67.28 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.4 t -73.62 -12.6 60.8 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -171.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -62.59 -16.48 56.58 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.656 1.116 . . . . 0.0 113.101 170.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 16.3 mm -72.98 -33.0 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.751 1.22 . . . . 0.0 111.976 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.44 -84.49 0.08 OUTLIER Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.221 1.391 . . . . 0.0 112.517 -170.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -157.3 103.48 1.99 Allowed 'General case' 0 CA--C 1.55 0.942 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -170.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 40.4 t -77.35 136.81 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 156.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.0 p -104.86 -20.23 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.282 1.033 . . . . 0.0 112.813 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 30.8 ttm-85 -164.38 139.3 5.68 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.369 1.468 . . . . 0.0 111.706 173.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -129.67 147.12 51.43 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.864 1.266 . . . . 0.0 111.259 164.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -159.11 152.29 22.37 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 174.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.6 mm -113.78 -19.92 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 126.564 1.946 . . . . 0.0 111.224 171.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.03 136.12 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.857 1.263 . . . . 0.0 108.935 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 76.6 p -128.96 126.7 40.16 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.951 1.3 . . . . 0.0 110.245 -177.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 59.6 p -107.2 -16.99 14.27 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -171.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -87.07 -5.7 58.95 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.528 1.131 . . . . 0.0 113.508 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 163.82 173.37 32.42 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.336 1.922 . . . . 0.0 112.508 -178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -77.73 138.96 39.32 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.615 0.766 . . . . 0.0 112.989 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -131.06 128.46 40.29 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.507 1.523 . . . . 0.0 110.001 171.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -82.73 59.14 4.61 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.232 1.413 . . . . 0.0 112.172 -171.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 96.87 -13.66 64.85 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.251 1.881 . . . . 0.0 115.213 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -64.15 135.87 56.73 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.047 1.423 . . . . 0.0 113.443 -176.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -114.84 168.89 12.67 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.887 1.708 . . . . 0.0 113.82 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 21.8 m -141.09 144.59 35.0 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.916 1.286 . . . . 0.0 109.838 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.8 t -137.15 136.87 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.8 0.84 . . . . 0.0 109.185 171.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -104.58 119.8 39.82 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.079 1.751 . . . . 0.0 109.205 173.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.433 ' HB2' HG12 ' A' ' 213' ' ' VAL . 9.2 m-85 -93.09 176.77 6.29 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.301 1.44 . . . . 0.0 109.034 163.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 45.6 p -97.4 -15.73 20.54 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -150.29 126.41 10.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.182 0.993 . . . . 0.0 113.226 -172.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.4 p -46.89 -53.58 11.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.68 1.992 . . . . 0.0 114.261 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -60.05 -28.58 67.89 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.89 -35.45 67.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.498 1.119 . . . . 0.0 112.644 173.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.433 HG12 ' HB2' ' A' ' 207' ' ' PHE . 0.6 OUTLIER -69.79 -40.52 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.013 0.925 . . . . 0.0 112.272 178.394 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.52 -47.53 66.73 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.577 -176.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -66.34 -18.29 65.27 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -70.84 -62.87 1.23 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.696 0.798 . . . . 0.0 110.475 167.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 60.8 mt -60.96 -33.86 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.446 1.099 . . . . 0.0 112.667 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -52.0 -19.9 2.1 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.971 1.709 . . . . 0.0 114.02 170.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -114.26 -6.79 12.99 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.849 1.66 . . . . 0.0 112.815 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -126.84 -22.72 3.8 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -166.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.88 120.71 13.04 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 120.916 1.689 . . . . 0.0 109.637 173.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 98.15 0.28 58.56 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-O 118.219 -1.323 . . . . 0.0 115.2 -168.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.33 108.23 1.26 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.718 1.759 . . . . 0.0 110.218 170.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -56.57 125.14 20.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.273 0.558 . . . . 0.0 109.772 154.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -149.59 110.84 4.41 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.319 1.447 . . . . 0.0 108.076 -159.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 24.1 mmt 55.87 32.95 20.66 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.626 0.77 . . . . 0.0 112.192 -169.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 87.49 0.37 0.47 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.888 2.875 . . . . 0.0 115.985 174.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.49 152.69 50.82 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.806 1.184 . . . . 0.0 112.043 173.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -77.48 129.12 35.3 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.8 -1.187 . . . . 0.0 114.104 -167.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.3 pt -75.58 133.52 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 120.997 -1.064 . . . . 0.0 110.487 164.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -118.24 144.47 45.75 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 166.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.3 p -150.85 140.19 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 120.162 1.347 . . . . 0.0 112.677 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -111.42 137.49 49.14 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.113 1.765 . . . . 0.0 110.255 171.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 -72.52 149.29 44.22 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 167.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -155.2 165.97 35.03 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.18 1.792 . . . . 0.0 111.121 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 C--O 1.254 1.325 0 C-N-CA 124.681 1.193 . . . . 0.0 111.071 179.595 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 CA-C-O 121.097 0.276 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.1 t -162.38 161.06 27.21 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.303 1.441 . . . . 0.0 111.335 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -159.63 153.99 23.85 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.884 1.674 . . . . 0.0 111.728 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -142.73 150.13 39.69 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.866 1.667 . . . . 0.0 111.183 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -161.63 154.41 20.44 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.974 1.709 . . . . 0.0 111.062 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.0 mt -143.48 154.0 43.2 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.808 1.643 . . . . 0.0 111.43 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -161.4 142.55 11.32 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.255 1.822 . . . . 0.0 110.862 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 17.0 t -163.22 153.69 16.19 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.752 1.221 . . . . 0.0 111.857 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 45.4 p -145.85 157.59 43.9 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.589 1.955 . . . . 0.0 110.755 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -160.1 164.52 32.97 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.203 1.401 . . . . 0.0 112.902 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -158.82 144.53 16.54 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.796 1.638 . . . . 0.0 109.965 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -155.0 143.51 20.52 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.26 1.424 . . . . 0.0 110.059 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -157.73 157.74 34.02 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.696 1.199 . . . . 0.0 113.6 -169.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.8 p -163.8 144.63 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 125.672 1.589 . . . . 0.0 110.902 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -155.85 151.5 27.22 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.126 1.37 . . . . 0.0 112.4 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 81.0 ttt180 -164.92 141.32 5.78 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.117 1.767 . . . . 0.0 110.724 -176.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 73.12 137.34 0.05 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.068 2.547 . . . . 0.0 112.233 -175.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -142.17 155.22 45.29 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.668 1.187 . . . . 0.0 112.075 -167.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.0 m 72.13 12.95 5.87 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.273 1.429 . . . . 0.0 113.953 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -77.93 166.62 22.64 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.372 1.069 . . . . 0.0 113.188 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 52.9 m -70.52 164.75 24.12 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 6.8 pt -130.57 151.74 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.815 1.646 . . . . 0.0 110.011 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -132.86 143.51 49.58 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.448 1.899 . . . . 0.0 109.717 -173.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.16 134.59 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 119.495 1.043 . . . . 0.0 111.177 -175.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.42 -71.83 1.03 Allowed Glycine 0 N--CA 1.473 1.161 0 C-N-CA 124.124 0.869 . . . . 0.0 113.657 -173.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -83.91 39.03 0.67 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.032 1.333 . . . . 0.0 114.245 -165.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.408 HD23 ' H ' ' A' ' 168' ' ' LEU . 0.5 OUTLIER -75.75 170.86 15.38 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.339 -1.476 . . . . 0.0 110.677 165.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 45.9 m -75.55 124.39 27.11 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.707 0.803 . . . . 0.0 109.06 167.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -70.18 -13.71 62.31 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -167.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -89.14 0.08 57.02 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 170.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 32.0 t -63.57 138.18 58.4 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 121.254 -0.904 . . . . 0.0 111.022 161.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 41.4 p -98.47 159.89 29.42 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 124.704 1.201 . . . . 0.0 110.728 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.16 -19.52 68.9 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.921 1.747 . . . . 0.0 112.486 167.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -69.16 -44.49 72.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 120.225 1.375 . . . . 0.0 111.2 170.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -59.14 -45.99 89.51 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.396 0.679 . . . . 0.0 110.755 172.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -27.37 68.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.999 0.92 . . . . 0.0 113.341 173.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 52.2 m -76.48 -47.77 21.81 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.52 1.055 . . . . 0.0 110.0 176.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -59.02 -31.1 68.52 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.718 1.145 . . . . 0.0 112.168 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -70.87 -67.88 0.47 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.389 1.476 . . . . 0.0 112.005 174.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -71.14 -35.04 71.56 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.5 t -73.33 -10.46 59.78 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -170.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -62.04 -17.25 56.77 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.223 -0.923 . . . . 0.0 113.343 171.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.66 -21.84 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 125.714 1.606 . . . . 0.0 112.667 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 169.94 -90.24 0.09 OUTLIER Glycine 0 N--CA 1.467 0.709 0 C-N-CA 125.055 1.312 . . . . 0.0 110.789 -172.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -159.63 120.31 3.11 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.118 0.967 . . . . 0.0 112.693 174.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.4 t -72.38 127.72 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 162.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.37 -34.03 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 118.691 0.678 . . . . 0.0 110.554 175.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -172.33 145.68 1.72 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.385 1.474 . . . . 0.0 112.045 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -129.23 171.26 12.63 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.821 2.049 . . . . 0.0 110.706 161.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -145.95 -60.18 0.32 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.81 1.782 . . . . 0.0 115.81 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 3.9 mt 65.97 111.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 127.712 2.405 . . . . 0.0 113.219 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 19.1 tt -67.94 111.66 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 120.788 -1.195 . . . . 0.0 111.4 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 14.5 p -151.34 145.45 25.31 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.509 1.923 . . . . 0.0 110.459 -168.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 47.5 t -173.06 -72.92 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.863 1.665 . . . . 0.0 110.636 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -109.56 0.13 19.01 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.812 1.645 . . . . 0.0 114.385 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.26 82.73 1.69 Allowed Glycine 0 N--CA 1.474 1.199 0 C-N-CA 125.447 1.498 . . . . 0.0 109.474 -165.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -70.64 156.48 39.4 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -169.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -64.2 -20.59 66.12 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.459 1.503 . . . . 0.0 114.617 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -117.89 -41.16 2.92 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.791 1.636 . . . . 0.0 112.606 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 66.54 21.55 70.82 Favored Glycine 0 N--CA 1.478 1.45 0 C-N-CA 124.306 0.955 . . . . 0.0 114.106 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -78.25 147.0 34.56 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.809 1.243 . . . . 0.0 113.751 -165.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.28 158.82 19.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.237 1.399 . . . . 0.0 112.81 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.7 m -147.45 142.55 27.11 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.011 1.725 . . . . 0.0 108.745 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 10.8 t -142.95 142.09 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.119 0.967 . . . . 0.0 110.788 -177.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -119.95 139.08 53.0 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.213 1.805 . . . . 0.0 110.01 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -116.78 154.05 31.36 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.676 1.591 . . . . 0.0 112.383 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.3 p -81.07 -17.93 48.37 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.92 0.888 . . . . 0.0 113.102 171.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -102.11 173.03 6.56 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.265 1.426 . . . . 0.0 113.061 -169.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 65.3 p -107.08 -101.1 0.35 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.915 1.686 . . . . 0.0 111.954 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -60.65 -22.16 63.53 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.739 1.216 . . . . 0.0 113.592 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -67.74 -18.04 64.76 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.072 0.949 . . . . 0.0 113.384 173.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.47 -28.99 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.326 0.966 . . . . 0.0 112.033 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.25 -45.96 44.61 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.44 -0.788 . . . . 0.0 110.843 167.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -52.88 -27.35 18.15 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.633 1.973 . . . . 0.0 114.112 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.59 -71.76 0.17 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.023 1.329 . . . . 0.0 110.929 165.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 36.4 mt -54.62 -44.33 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.323 1.449 . . . . 0.0 112.451 -172.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -64.84 0.35 1.21 Allowed 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 176.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -118.31 -1.41 11.31 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.846 1.659 . . . . 0.0 112.566 167.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -122.96 -14.0 7.71 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.132 1.773 . . . . 0.0 114.136 -176.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -48.68 120.96 4.12 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.338 1.455 . . . . 0.0 110.294 166.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 88.89 0.81 80.81 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-O 118.129 -1.373 . . . . 0.0 115.41 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.68 105.19 0.42 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.653 1.727 . . . . 0.0 111.507 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -55.98 110.43 0.74 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 152.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -127.54 110.8 13.09 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.466 1.106 . . . . 0.0 109.317 -170.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 89.9 mtp 55.55 36.14 26.58 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.708 1.203 . . . . 0.0 111.974 -173.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 14.4 t70 98.46 0.14 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 129.216 3.007 . . . . 0.0 115.79 170.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -138.85 137.52 36.65 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.547 1.067 . . . . 0.0 112.592 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -77.0 102.07 6.29 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.211 1.404 . . . . 0.0 113.707 -170.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.3 pt -54.24 143.63 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.535 0.734 . . . . 0.0 112.766 172.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -132.76 135.38 45.69 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.508 1.523 . . . . 0.0 107.4 166.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.6 p -119.8 132.53 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.294 1.038 . . . . 0.0 111.81 -168.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -97.96 136.82 37.69 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.41 2.284 . . . . 0.0 109.576 167.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -98.51 142.12 30.51 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 166.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -140.42 135.78 32.39 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.1 0.864 . . . . 0.0 112.669 -170.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.5 p30 . . . . . 0 C--O 1.253 1.237 0 C-N-CA 126.066 1.747 . . . . 0.0 112.839 -175.698 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.711 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.9 m -146.6 155.18 42.28 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.062 1.345 . . . . 0.0 111.619 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -156.01 153.0 28.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.154 1.382 . . . . 0.0 111.965 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 58.59 46.45 14.68 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.828 1.651 . . . . 0.0 112.452 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -154.95 159.25 40.27 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.037 1.735 . . . . 0.0 112.127 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -164.08 173.77 12.11 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.483 1.913 . . . . 0.0 111.904 -173.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -149.85 153.37 36.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.357 1.463 . . . . 0.0 112.198 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 18.9 m -175.61 -30.35 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 126.894 2.077 . . . . 0.0 113.667 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . 0.268 59.6 p 49.9 -129.33 2.12 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.51 2.324 . . . . 0.0 112.32 177.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -148.23 153.38 38.67 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.272 1.429 . . . . 0.0 113.055 -165.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -140.16 151.08 44.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.49 1.916 . . . . 0.0 109.553 174.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -160.73 164.72 31.4 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.172 0.989 . . . . 0.0 113.1 -171.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -125.95 179.93 4.99 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.584 1.954 . . . . 0.0 110.8 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.8 p -151.27 142.82 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 O-C-N 121.154 -0.966 . . . . 0.0 112.359 -173.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -153.57 150.72 28.96 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.524 1.93 . . . . 0.0 110.571 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -147.86 122.28 9.71 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.583 1.153 . . . . 0.0 110.913 -176.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -159.17 150.96 20.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.372 1.469 . . . . 0.0 111.705 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -145.92 -67.42 0.29 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.803 1.241 . . . . 0.0 113.123 -168.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 83.1 p 32.84 -113.23 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 127.269 2.228 . . . . 0.0 115.63 -170.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -176.44 -33.05 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.492 2.317 . . . . 0.0 112.491 -165.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 73.7 m -140.52 162.91 34.23 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.565 1.146 . . . . 0.0 112.834 -170.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.6 pt -139.39 155.92 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 126.007 1.723 . . . . 0.0 111.321 -170.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -118.16 153.13 34.33 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.749 2.02 . . . . 0.0 111.391 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.1 t -138.89 128.4 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.528 1.531 . . . . 0.0 110.131 -174.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.84 -91.03 1.85 Allowed Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.034 1.302 . . . . 0.0 114.179 -173.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -84.26 35.68 0.55 Allowed 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -160.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -80.3 -5.68 56.7 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -169.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.4 p 91.05 127.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 131.018 3.727 . . . . 0.0 110.609 -167.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -70.64 -13.11 61.95 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -169.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -81.84 -5.49 58.26 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.375 1.47 . . . . 0.0 113.084 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.5 m -64.77 143.02 58.23 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.212 1.005 . . . . 0.0 113.089 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 51.7 p -105.67 157.37 34.75 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 125.108 1.363 . . . . 0.0 110.919 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.08 -31.42 65.38 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.385 2.057 . . . . 0.0 112.606 174.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.31 -39.35 92.37 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.115 0.871 . . . . 0.0 111.621 174.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.17 -29.55 66.47 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.705 -0.622 . . . . 0.0 112.626 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.8 mt -74.06 -27.43 60.91 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 164.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 98.4 m -71.46 -51.14 25.39 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.402 1.001 . . . . 0.0 110.035 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -63.06 -24.61 67.99 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.628 0.649 . . . . 0.0 112.72 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.29 -69.14 0.5 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.54 1.536 . . . . 0.0 111.585 174.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -65.31 -32.41 74.05 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.4 t -73.35 0.08 13.15 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -175.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -71.67 -18.78 62.16 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.318 -0.864 . . . . 0.0 113.179 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 19.4 mm -81.56 -55.0 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.118 0.967 . . . . 0.0 111.628 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -138.74 -96.31 0.36 Allowed Glycine 0 N--CA 1.467 0.75 0 C-N-CA 126.379 1.942 . . . . 0.0 109.878 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -156.03 128.61 7.78 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.898 0.879 . . . . 0.0 112.145 169.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.73 134.93 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 167.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.52 -42.62 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 118.275 0.489 . . . . 0.0 110.426 172.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -157.35 141.24 16.02 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 127.105 2.162 . . . . 0.0 109.529 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -117.69 158.99 23.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.889 1.276 . . . . 0.0 111.055 161.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -152.9 132.07 12.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.071 1.349 . . . . 0.0 111.37 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 3.2 mt -145.11 -45.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 125.051 1.34 . . . . 0.0 112.401 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 59.2 mt -81.22 108.1 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -176.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 25.7 p -87.89 143.39 27.15 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.347 1.459 . . . . 0.0 111.502 -173.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 3.2 t -110.17 9.39 23.94 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.398 1.079 . . . . 0.0 113.378 -168.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.31 0.36 19.64 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.3 1.44 . . . . 0.0 114.608 -175.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 115.74 -9.12 19.2 Favored Glycine 0 N--CA 1.476 1.338 0 C-N-CA 126.301 1.905 . . . . 0.0 114.183 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -146.41 146.66 30.69 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.423 1.889 . . . . 0.0 111.141 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -91.22 119.6 31.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.367 1.067 . . . . 0.0 112.225 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -78.08 -41.85 34.06 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.064 0.946 . . . . 0.0 112.665 -178.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 72.11 16.04 76.74 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.096 0.855 . . . . 0.0 115.024 177.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 87.7 mtp -122.15 128.37 51.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.055 1.342 . . . . 0.0 108.269 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -94.82 164.93 25.4 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 115.24 0.856 . . . . 0.0 115.24 -159.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.7 p -146.69 148.35 31.92 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.886 2.074 . . . . 0.0 110.201 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 13.7 t -147.57 136.68 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.674 0.79 . . . . 0.0 110.865 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -109.34 131.61 54.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.551 1.94 . . . . 0.0 109.547 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -103.25 158.34 16.39 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.059 1.343 . . . . 0.0 110.545 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 78.8 p -71.24 0.21 8.43 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.859 0.864 . . . . 0.0 112.899 170.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -138.92 -175.99 4.34 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.203 2.201 . . . . 0.0 112.011 -167.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.6 p -142.8 -66.34 0.38 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.584 1.554 . . . . 0.0 110.16 -174.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -53.15 -33.31 51.89 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 120.677 -1.265 . . . . 0.0 113.288 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.97 -24.85 61.66 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.318 1.447 . . . . 0.0 114.054 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.4 m -70.75 -31.91 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -169.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -56.95 -46.21 82.28 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.691 1.196 . . . . 0.0 111.146 166.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -71.68 -23.69 61.7 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.881 0.872 . . . . 0.0 112.25 -171.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.39 -61.99 1.98 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.992 0.917 . . . . 0.0 110.949 165.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 80.9 mt -59.78 -37.32 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.329 1.051 . . . . 0.0 112.123 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 47.1 ttm-85 -62.46 -4.86 2.1 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.493 1.517 . . . . 0.0 113.838 176.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -121.86 -3.62 9.17 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.498 1.919 . . . . 0.0 112.922 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -124.49 -21.92 4.78 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -173.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.92 120.69 12.43 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 120.22 1.373 . . . . 0.0 109.882 174.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 94.04 0.5 65.88 Favored Glycine 0 N--CA 1.471 1.032 0 CA-C-O 118.107 -1.385 . . . . 0.0 115.522 -170.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.8 108.54 0.87 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.756 1.778 . . . . 0.0 110.725 174.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -55.56 121.28 8.7 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.231 1.013 . . . . 0.0 110.715 161.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -152.53 110.86 3.71 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.511 1.924 . . . . 0.0 107.575 -158.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 16.8 ttt 54.08 35.86 23.28 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.581 0.705 . . . . 0.0 111.397 -164.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 76.05 0.22 3.26 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.394 2.677 . . . . 0.0 115.286 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -120.55 144.02 48.28 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.118 1.367 . . . . 0.0 110.749 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.99 111.49 15.25 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.584 -1.322 . . . . 0.0 112.764 -176.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.4 pt -54.18 148.07 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.472 -0.767 . . . . 0.0 110.928 164.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -137.62 137.52 38.55 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.226 1.01 . . . . 0.0 109.327 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.85 126.6 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 124.163 0.985 . . . . 0.0 109.659 -171.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -94.92 148.08 22.69 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.251 1.02 . . . . 0.0 110.05 164.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -69.85 153.55 43.15 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 163.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -131.04 135.87 47.96 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.45 1.1 . . . . 0.0 111.241 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.302 0 C-N-CA 126.24 1.816 . . . . 0.0 111.855 175.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.765 0 N-CA-C 111.914 -0.475 . . . . 0.0 111.914 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 25.6 p -166.48 146.97 6.12 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.038 1.335 . . . . 0.0 111.885 -176.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -159.59 156.7 28.46 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.448 1.499 . . . . 0.0 111.903 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -161.78 158.39 25.65 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.799 1.64 . . . . 0.0 112.199 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -161.66 150.63 15.88 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.639 1.576 . . . . 0.0 111.381 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -165.65 161.16 18.08 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.618 1.967 . . . . 0.0 111.468 -175.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -161.49 152.24 18.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.225 1.41 . . . . 0.0 112.689 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.5 p -167.05 155.55 9.92 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.254 1.821 . . . . 0.0 110.85 174.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.8 t -158.28 17.03 0.22 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -172.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -133.99 121.14 21.19 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.006 0.922 . . . . 0.0 112.974 -172.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -171.23 140.71 1.51 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.216 2.206 . . . . 0.0 110.238 173.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -168.6 148.54 4.48 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.298 1.439 . . . . 0.0 111.983 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -142.88 5.75 1.55 Allowed 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.2 m -156.49 153.15 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 128.123 2.569 . . . . 0.0 109.067 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -143.84 -50.87 0.31 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.711 0.804 . . . . 0.0 112.19 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 59.6 ttm-85 -165.29 111.22 0.93 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.546 1.938 . . . . 0.0 108.804 173.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -146.15 62.02 1.24 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.58 1.152 . . . . 0.0 110.47 -161.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -167.49 146.3 4.9 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.006 1.322 . . . . 0.0 112.824 -166.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 31.1 t -153.62 -42.03 0.09 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.53 1.132 . . . . 0.0 112.417 161.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 10.2 t30 68.45 -42.02 0.47 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 128.007 2.523 . . . . 0.0 116.454 169.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.8 p -171.09 132.92 0.85 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.606 1.562 . . . . 0.0 109.433 -166.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.59 161.48 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 121.915 -0.491 . . . . 0.0 112.012 -154.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -121.36 124.22 44.03 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.545 1.138 . . . . 0.0 110.688 170.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.27 134.94 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 127.175 2.19 . . . . 0.0 107.772 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.61 -133.47 0.4 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.886 1.232 . . . . 0.0 112.665 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -60.54 -28.19 68.24 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 -168.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . 0.292 2.5 pt? 28.52 -129.96 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.651 1.98 . . . . 0.0 113.192 -164.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.9 m -142.4 130.38 21.86 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.444 1.498 . . . . 0.0 109.133 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -64.5 -18.21 64.58 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -171.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -75.01 -3.38 32.06 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.563 1.545 . . . . 0.0 113.779 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 77.0 p -104.18 168.88 8.82 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.769 1.228 . . . . 0.0 114.124 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 52.1 p -137.06 165.68 32.92 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 126.922 2.089 . . . . 0.0 110.741 -171.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -59.86 -25.04 78.21 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.333 2.022 . . . . 0.0 113.199 169.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.13 -40.83 78.05 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.478 1.035 . . . . 0.0 111.8 172.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -62.72 -42.47 99.67 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.347 0.659 . . . . 0.0 111.097 173.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.6 mt -64.31 -31.3 72.45 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 118.49 -0.766 . . . . 0.0 112.515 170.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.8 m -68.69 -51.26 43.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.633 1.106 . . . . 0.0 110.272 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.95 -30.97 72.0 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.916 0.78 . . . . 0.0 112.26 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -70.85 -61.22 1.85 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.404 1.482 . . . . 0.0 111.718 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -71.34 -36.96 71.7 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.4 t -73.41 -1.52 18.62 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -173.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -73.44 -16.5 61.31 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.431 -0.793 . . . . 0.0 113.01 167.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.5 mm -80.97 -55.24 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 119.176 0.898 . . . . 0.0 111.144 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -134.57 -100.11 0.65 Allowed Glycine 0 N--CA 1.468 0.824 0 C-N-CA 126.0 1.762 . . . . 0.0 110.443 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -156.88 126.73 6.28 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.437 1.095 . . . . 0.0 111.88 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 20.5 t -76.56 134.5 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.01 0.924 . . . . 0.0 108.651 169.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.72 -15.52 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.57 1.148 . . . . 0.0 113.882 168.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.1 mtp85 -161.72 132.28 5.03 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.501 1.521 . . . . 0.0 110.874 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -129.23 145.7 51.29 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.582 1.953 . . . . 0.0 111.494 170.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -161.49 145.31 12.83 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.912 1.285 . . . . 0.0 111.651 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.6 mt -137.96 114.34 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.499 1.119 . . . . 0.0 109.653 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.1 tt -76.13 115.1 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.101 0.56 . . . . 0.0 109.742 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 4.1 p -151.23 165.99 32.28 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.082 2.153 . . . . 0.0 111.202 -160.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 55.3 p -159.23 172.92 17.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.222 1.409 . . . . 0.0 111.592 174.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -74.52 -21.26 59.63 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.876 0.87 . . . . 0.0 112.672 171.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -91.74 -123.79 3.1 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 126.027 1.775 . . . . 0.0 111.255 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -138.91 85.31 2.07 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.85 1.26 . . . . 0.0 111.245 -177.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -134.81 94.23 3.14 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.176 1.391 . . . . 0.0 111.133 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 66.56 -82.94 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.684 2.394 . . . . 0.0 113.206 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 79.19 51.46 5.31 Favored Glycine 0 N--CA 1.472 1.061 0 C-N-CA 124.464 1.031 . . . . 0.0 111.898 -176.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 76.9 mtm -138.9 140.26 38.32 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.62 1.168 . . . . 0.0 112.185 -168.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.52 163.32 13.55 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 124.913 1.244 . . . . 0.0 115.164 -165.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.2 p -153.63 153.1 31.68 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.38 1.872 . . . . 0.0 111.352 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.97 147.15 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.046 1.338 . . . . 0.0 111.17 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -125.52 130.89 52.64 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.364 2.266 . . . . 0.0 110.068 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -108.42 165.09 11.78 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.136 1.374 . . . . 0.0 111.698 -174.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 40.5 p -76.51 0.27 20.5 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.546 1.538 . . . . 0.0 114.559 169.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -133.03 168.77 17.89 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.024 1.73 . . . . 0.0 111.796 -169.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.7 p -107.75 -62.62 1.41 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.728 1.211 . . . . 0.0 112.373 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -79.88 -35.34 38.19 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.896 1.678 . . . . 0.0 112.942 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -60.12 -24.44 64.68 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.7 1.2 . . . . 0.0 112.447 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.69 -29.51 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.462 1.905 . . . . 0.0 112.546 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.34 -38.67 63.19 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.335 -0.853 . . . . 0.0 111.058 172.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -67.63 -21.87 65.36 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.712 1.605 . . . . 0.0 112.969 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.86 -55.84 25.59 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.937 0.895 . . . . 0.0 111.39 164.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 73.5 mt -66.24 -28.54 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 O-C-N 121.292 -0.88 . . . . 0.0 111.851 -171.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -18.82 9.56 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.955 1.302 . . . . 0.0 113.987 171.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -106.62 -14.5 15.02 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.407 1.883 . . . . 0.0 112.109 176.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -122.4 -17.89 6.91 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.806 2.15 . . . . 0.0 116.806 -164.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -66.75 120.68 13.92 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 120.32 1.418 . . . . 0.0 109.991 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 92.52 0.69 69.5 Favored Glycine 0 N--CA 1.472 1.09 0 CA-C-O 117.714 -1.603 . . . . 0.0 115.081 -169.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.83 108.02 0.69 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 120.158 1.979 . . . . 0.0 111.081 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -52.03 122.95 9.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.647 0.779 . . . . 0.0 109.535 155.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -147.57 114.3 6.06 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.496 1.518 . . . . 0.0 107.734 -166.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 54.17 38.44 29.18 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.68 0.792 . . . . 0.0 111.335 -166.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 17.0 t70 84.24 0.61 0.93 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 128.526 2.731 . . . . 0.0 115.417 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.36 141.94 35.6 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.17 0.988 . . . . 0.0 112.663 -173.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -71.48 120.4 17.0 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -169.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.76 156.18 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.669 1.588 . . . . 0.0 112.019 154.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -140.18 156.17 46.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.918 1.687 . . . . 0.0 108.795 167.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 40.3 t -140.47 133.97 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.496 0.718 . . . . 0.0 111.733 -168.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -85.77 136.13 33.45 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.906 1.282 . . . . 0.0 109.854 170.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -102.88 127.85 49.9 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.984 1.314 . . . . 0.0 108.465 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -87.74 132.84 33.99 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -172.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 56.9 t30 . . . . . 0 C--O 1.256 1.429 0 C-N-CA 126.928 2.091 . . . . 0.0 112.802 179.495 . . . . . . . . 0 0 . 1 stop_ save_